Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular response to copper ion (GO:0071280),-0.6906945063508305,-1.9800465763662478,0.0,0.4590581962635533,0.321,9/16,10.34%,HSF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4265795205698466,-1.9107287505626003,0.0,0.530515368323446,0.585,59/110,21.66%,DCP1A;EIF3E;RPS24;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;UPF3B;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;SMG6;ETF1;RPL7A;EIF4A3;RPL31;NCBP2;PPP2CA;RBM8A;HELZ2;RPL36A
prerank,response to copper ion (GO:0046688),-0.6144139162366838,-1.8810660317878896,0.004048582995951417,0.5016437836527823,0.71,9/20,10.34%,HSF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,skeletal muscle contraction (GO:0003009),0.7749427479740603,1.8368807312463002,0.001326259946949602,1.0,0.599,4/19,4.00%,TNNI3;TNNC1;TNNI1;MYH14
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7992810004553262,1.8355699563351602,0.0,0.5962640117050706,0.61,4/15,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,body fluid secretion (GO:0007589),0.7873300521073612,1.8240491601714224,0.001375515818431912,0.4892171612183366,0.683,6/15,10.20%,APLN;GUCA1B;SLC22A4;GPAT4;ZBTB7B;PRLR
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7315701540037296,1.8230695952590839,0.0,0.3740112520054794,0.688,4/23,3.17%,IL10RA;OCIAD2;CENPJ;IL10RB
prerank,sodium-independent organic anion transport (GO:0043252),-0.7191942196553627,-1.8164112810907906,0.005865102639296188,0.771683324025584,0.911,4/10,5.80%,SLCO3A1;SLC16A2;SLCO1C1;SLCO2A1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.620131163746945,-1.8039808141498728,0.00684931506849315,0.7011464337270686,0.937,6/15,17.60%,GRM7;GRM1;GRM3;DAGLB;HOMER3;GRIK3
prerank,regulation of phospholipase activity (GO:0010517),0.8395652008232454,1.7975758234906116,0.0,0.4807317401431686,0.83,4/10,3.62%,PLA2G5;PDPK1;FGFR2;FGFR1
prerank,negative regulation of vascular permeability (GO:0043116),-0.6824929547446223,-1.794064613067582,0.003194888178913738,0.6458212596019094,0.949,9/12,25.93%,FERMT2;ANGPT1;SLIT2;CLDN5;RAMP2;PTPRJ;VEGFA;PDE2A;CEACAM1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.536920634171919,-1.789903057790279,0.0,0.5789268290480054,0.952,13/26,15.95%,ITSN2;GAK;PICALM;INPP5F;AP2A2;CLTA;GPR107;SGIP1;CLTB;ITSN1;FNBP1L;AP2M1;PIP5K1C
prerank,retina homeostasis (GO:0001895),-0.5408368162718238,-1.7858331166476364,0.004761904761904762,0.5280793283668588,0.963,8/23,17.73%,POTEF;ACTB;CCDC66;POC1B;WHRN;BBS4;ACTG1;HSPB1
prerank,cytoplasmic translation (GO:0002181),-0.40001995709743154,-1.7762689327331005,0.0,0.5153577863713475,0.976,44/91,17.70%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;EIF4A2;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;FTSJ1;RPL39;RPL12;RPL27;RPS17;TMA7;RPS26;RPS27;RPL10A;RPS10;ETF1;RPL7A
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5381510092019804,-1.7680305607247842,0.004629629629629629,0.5021490363845189,0.979,17/24,32.79%,SEC31A;TAPBP;ERAP1;SAR1B;CALR;SEC24C;TAP2;SEC24A;ACE;ABCB9;SEC13;IDE;MFSD6;TAP1;HFE;TAPBPL;FCER1G
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.8343607084842544,1.7614318303802503,0.0,0.7354575535727295,0.954,4/11,4.87%,MST1R;SIRT2;RAC1;NRP1
prerank,gonad development (GO:0008406),0.6560830465993324,1.75384118107336,0.0011862396204033216,0.7130551094704316,0.964,8/41,8.36%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;NR2F2;WNT4;SOX9
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.548109416163619,-1.7401039846714206,0.0045662100456621,0.594689026977785,0.988,12/22,18.68%,CYRIB;SLIT2;PRKCD;TMSB4X;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1;TMSB10
prerank,positive regulation of cyclase activity (GO:0031281),-0.6240479255469676,-1.7337593896431283,0.0031746031746031746,0.5790557200509995,0.989,4/14,6.90%,MAPK8;CACNA1D;NOS3;CACNA1C
prerank,granulocyte differentiation (GO:0030851),-0.5652526880302748,-1.717403727246936,0.013986013986013986,0.6127993846348376,0.996,11/18,29.51%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;JAGN1;CDK2;CDK4;TAL1;CDKN1A
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.8181867448941798,1.712468798952835,0.0029069767441860465,1.0,0.997,6/10,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;SDHAF3
prerank,negative regulation of dephosphorylation (GO:0035305),-0.5551325927714312,-1.7104248275373217,0.00851063829787234,0.6046019168444171,0.998,8/18,19.70%,MFHAS1;ENSA;URI1;INPP5K;PPP1R8;PTPA;SH3RF2;ZCCHC9
prerank,regulation of spindle organization (GO:0090224),0.7169789215273807,1.7066111730536317,0.013908205841446454,1.0,0.998,5/18,11.26%,PSRC1;FSD1;RAE1;MAP9;GPSM2
prerank,male gonad development (GO:0008584),0.6553030351289144,1.704782884038123,0.0024906600249066002,1.0,0.998,7/34,8.36%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,regulation of glucose metabolic process (GO:0010906),0.6455232855839619,1.7033690679175044,0.002369668246445498,0.9652908205615003,0.998,11/34,10.40%,GPLD1;SIRT7;SELENOS;PDK1;MLYCD;USP7;RORA;OGT;ZNF692;SDHAF3;IRS2
prerank,positive regulation of heart contraction (GO:0045823),0.7087096950282432,1.7000896399178658,0.009345794392523364,0.9228711325117753,0.999,5/19,7.53%,APLN;ADM;EDN3;ATP2A2;ATP1A2
prerank,visual system development (GO:0150063),-0.4787921880249967,-1.698486088434343,0.0,0.6295449037438227,0.999,19/37,31.42%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;CHRDL1;C1QA
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7501269675856057,1.6950916984295792,0.01098901098901099,0.911981927211911,1.0,4/13,7.49%,IGF1;IL33;ABCA2;SOAT1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.678430079967961,1.6937012501725672,0.007863695937090432,0.8616665362676724,1.0,6/24,10.20%,IL10RA;OCIAD2;CENPJ;IL10RB;PIBF1;PRLR
prerank,bicarbonate transport (GO:0015701),0.6720411383867502,1.6887252473202075,0.0025974025974025974,0.8574844358806254,1.0,3/25,0.31%,CYB5R2;SLC4A4;SLC4A5
prerank,development of primary male sexual characteristics (GO:0046546),0.6482855455514429,1.6827214456212887,0.002484472049689441,0.8699800343196828,1.0,7/34,8.36%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,myotube cell development (GO:0014904),0.8108244406942795,1.6825685734874107,0.005873715124816446,0.8204749454989313,1.0,2/10,1.18%,MYORG;IGF1
prerank,leukotriene biosynthetic process (GO:0019370),0.7452625758372572,1.6798124212091101,0.014204545454545454,0.8056798523422282,1.0,2/14,0.56%,PLA2G5;ALOX5AP
prerank,neuron projection fasciculation (GO:0106030),0.805407664934229,1.6733216229292776,0.008771929824561403,0.8342852259532532,1.0,2/10,1.72%,AMIGO1;EPHB2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7056616204949404,1.673211185937004,0.010403120936280884,0.7934031886456552,1.0,8/18,12.36%,HDAC3;TMEM119;XBP1;HDAC5;FRS2;HDAC4;SOX6;HDAC1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.6163417022092743,-1.6600050175796734,0.018726591760299626,0.8064645611835243,0.999,3/13,3.43%,AXL;LAMP1;ZBTB1
prerank,response to insulin (GO:0032868),0.5764919207377016,1.659732964637206,0.0010526315789473684,0.892880763794183,1.0,33/80,16.50%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;OGT;CAPN10;PIK3R1;ZBTB7B;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;ZBED3;PRKCI;RAB31;RAB8A;RAB8B;SLC27A1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.6016277288419588,-1.6593453720791411,0.028985507246376812,0.7634198943689253,0.999,7/15,20.22%,STAT3;APPL1;HIF1A;TLR4;IL17RA;GBP5;IL17D
prerank,lipid catabolic process (GO:0016042),0.7077879635646012,1.6572926134093233,0.005361930294906166,0.8788196327168256,1.0,2/18,1.59%,LPL;SIRT2
prerank,cellular response to zinc ion (GO:0071294),-0.5886596600660341,-1.6570106269488318,0.025179856115107913,0.7343006367905475,0.999,9/15,15.35%,MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;GLRA2
prerank,response to organophosphorus (GO:0046683),-0.561263096085763,-1.655807389354983,0.021660649819494584,0.7032320258302522,0.999,11/16,37.99%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;TRIM16;TYMS;RFC3;VGF;P2RX4
prerank,regulation of hormone secretion (GO:0046883),0.7406334229809795,1.6549290391456477,0.011920529801324504,0.8640656035974529,1.0,5/15,9.55%,EDN3;ANXA1;VAMP3;SNX6;SOX11
prerank,response to prostaglandin E (GO:0034695),0.7842741746091964,1.6482815407125846,0.009202453987730062,0.9002705398404146,1.0,3/10,6.64%,SFRP1;PTGER4;GNG2
prerank,renal absorption (GO:0070293),0.7787755395872579,1.6472374265524545,0.013493253373313344,0.876008762812415,1.0,1/10,0.03%,MAGED2
prerank,histone methylation (GO:0016571),0.6580638337302291,1.646577788453363,0.0129366106080207,0.8494709849717684,1.0,15/26,19.80%,SIRT7;PRMT6;FBL;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;NSD1;PRMT2;CARM1
prerank,natural killer cell activation (GO:0030101),-0.5026857337216032,-1.6434668681579727,0.018957345971563982,0.7349261877917452,1.0,8/23,22.73%,AXL;TOX;KAT7;ELF4;PTPRC;BAG6;PBX1;PIK3CD
prerank,establishment of endothelial barrier (GO:0061028),-0.47306853967399426,-1.6408920531362552,0.020512820512820513,0.7145717205989273,1.0,14/29,23.91%,RDX;RAPGEF6;RAPGEF3;PECAM1;TJP1;EZR;F11R;RAB1A;MYADM;RAP2C;MSN;PDE2A;RAB1B;ROBO4
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5989323822330218,-1.6406864406108226,0.013745704467353952,0.683469149840076,1.0,8/13,16.00%,NR3C1;MED1;AR;ABHD2;BMP7;ESR1;PGR;BMP4
prerank,respiratory tube development (GO:0030323),0.6575312989552645,1.6391890159682718,0.008760951188986232,0.8918032500068602,1.0,6/28,6.59%,FGF9;STRA6;FGFR2;HECA;PCSK5;ZIC3
prerank,embryonic hemopoiesis (GO:0035162),-0.6161826706674045,-1.6382271985376864,0.0220125786163522,0.6659450679389344,1.0,8/12,18.53%,KITLG;KIT;TGFBR2;KDR;THOC5;FLT3LG;SH2B3;ATF4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7143678005047001,1.6370125738481787,0.009446693657219974,0.8803391249523139,1.0,5/16,5.73%,SFRP2;CDKN2D;CXCL12;SNAI1;FBH1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6590132958935665,1.6357485450491889,0.007802340702210663,0.8622380723025763,1.0,9/23,23.39%,TNNI3;TNNC1;FGFR2;TPM1;TGFB1;TGFBR3;SMAD7;ID2;FKBP1A
prerank,"wound healing, spreading of cells (GO:0044319)",0.6541854542115001,1.6355427498129769,0.01507537688442211,0.8353570686153797,1.0,6/24,5.68%,CARMIL2;MMP12;LCP1;DDR1;MRTFA;CD151
prerank,negative regulation of GTPase activity (GO:0034260),-0.509354108048742,-1.6351821834985316,0.01762114537444934,0.653174491322719,1.0,7/22,8.37%,LRCH1;DAB2IP;RDX;SH3BP4;CPEB2;LRRK2;F11R
prerank,negative regulation of myotube differentiation (GO:0010832),0.7630241604528161,1.6341192365271442,0.015492957746478873,0.8226542037651344,1.0,6/12,12.36%,HDAC3;TMEM119;XBP1;HDAC5;HDAC4;HDAC1
prerank,response to purine-containing compound (GO:0014074),-0.5552763492027304,-1.6334076529807826,0.01937984496124031,0.6347129173998715,1.0,12/17,37.99%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;P2RY1;RYR2;TRPM2;P2RY6;VGF;P2RX4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6891954121244258,1.6330641583986,0.018741633199464525,0.8074102527137269,1.0,4/16,11.52%,MYORG;IGF1;IGFBP3;BMP5
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6683011410635104,-1.6321760679315205,0.015527950310559006,0.6159225127843085,1.0,5/10,16.60%,BICD1;UBXN2B;MARK4;NSFL1C;CEP250
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5230539847412792,-1.6307823580617113,0.02608695652173913,0.5996066744172704,1.0,14/19,27.23%,HIPK2;PML;USP28;SIRT1;HIPK1;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;BCL3;RPS27L
prerank,positive regulation of transport (GO:0051050),0.5594386067466233,1.6279651107951576,0.0010615711252653928,0.8319866356288794,1.0,27/85,19.12%,PLA2G5;CALY;FCGR2B;BAX;GPLD1;TUB;CHCHD10;KCTD7;ANXA1;MLC1;ZNF205;CAPN10;CD151;SIRPA;ABCA7;CLIP3;CD47;LRP1;IL15RA;NUMA1;CAMK1D;ANXA2;FMR1;APOE;KMT2A;FLOT1;SMPD1
prerank,regulation of membrane repolarization (GO:0060306),-0.5952265921120194,-1.6275853326210763,0.02,0.5918803748489059,1.0,5/13,13.21%,CAV1;CACNA2D1;KCNJ2;AKAP9;NEDD4L
prerank,negative regulation of ATP metabolic process (GO:1903579),0.693055587026215,1.6247239658851063,0.01978891820580475,0.8371770186559361,1.0,8/17,15.32%,PPIF;PARP1;FIS1;FLCN;PID1;HDAC4;GIT1;NUPR1
prerank,lung development (GO:0030324),0.6292424306239944,1.6218422108393489,0.01566265060240964,0.8398328951165671,1.0,8/33,9.55%,FGF9;STRA6;FGFR2;FGF10;ERRFI1;ZIC3;RCN3;SOX11
prerank,negative regulation of hydrolase activity (GO:0051346),-0.4212478058754173,-1.6167018835268958,0.0,0.6203408416651921,1.0,11/49,9.78%,LRCH1;DAB2IP;RDX;SH3BP4;SLC39A14;CPEB2;URI1;CST3;LRRK2;F11R;ECM1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3741956127092369,-1.613841053242961,0.0,0.6118249686522028,1.0,43/91,17.70%,RPS24;SSR1;ARL6IP1;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;TRAM1;RPS10;RPL7A
prerank,triglyceride biosynthetic process (GO:0019432),0.6788584565401823,1.6112321298261698,0.022972972972972974,0.9207225803805628,1.0,7/18,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6971547250608517,1.6088843044531138,0.020134228187919462,0.9193098136353729,1.0,2/17,4.97%,PLA2G5;CRLS1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7601107960033038,1.6080869274627696,0.016296296296296295,0.9037488754026037,1.0,3/11,0.80%,SFRP2;WNT2B;WNT5A
prerank,protein kinase B signaling (GO:0043491),0.6506406607950019,1.6071401427667313,0.010282776349614395,0.8899148114572584,1.0,5/23,4.02%,IGF1;SIRT2;TSC2;THEM4;ZFP36L1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5891849713538014,1.60586665190394,0.005773672055427252,0.8791956911508387,1.0,6/44,2.88%,CARMIL2;SPIRE2;CDC42EP5;CDC42EP4;BIN1;WHAMM
prerank,regulation of gluconeogenesis (GO:0006111),0.6332599845577996,1.6030958936685942,0.02012578616352201,0.8838529216719961,1.0,9/27,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;DDB1;SIK1;NNMT;SDHAF3
prerank,B cell activation involved in immune response (GO:0002312),0.7186037698978595,1.6029658936584004,0.01447178002894356,0.8639510727109869,1.0,4/13,8.82%,FCGR2B;EXOSC3;RNF8;RNF168
prerank,actin filament network formation (GO:0051639),0.7413720188546089,1.6000615817155341,0.029914529914529916,0.8704539238352291,1.0,3/11,0.97%,CARMIL2;SPIRE2;LCP1
prerank,phospholipid metabolic process (GO:0006644),0.554663899884252,1.5995057585212626,0.002197802197802198,0.855544063369031,1.0,20/71,19.12%,PLA2G5;LPL;PIP4K2B;SMPD2;PCYT2;ABCA2;AGPAT1;AGPAT5;PLPPR2;AGPAT3;GPAM;FADS1;ENPP2;PLPP3;PIP4K2A;PLPPR5;GPX4;GDE1;PIP5K1A;SMPD1
prerank,actin-myosin filament sliding (GO:0033275),0.594266497781038,1.5989892226900306,0.011778563015312132,0.8225395420983241,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,muscle filament sliding (GO:0030049),0.594266497781038,1.5989892226900306,0.011778563015312132,0.8225395420983241,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,epiboly involved in wound healing (GO:0090505),0.6940360990484827,1.5988123611842504,0.02351313969571231,0.8066219053639394,1.0,5/16,5.68%,CARMIL2;LCP1;DDR1;MRTFA;CD151
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6288506259821227,1.59792106152098,0.011363636363636364,0.7978743528275706,1.0,4/27,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6879788789994593,1.5958828269440226,0.02312925170068027,0.797915980678214,1.0,1/17,0.14%,PLA2G5
prerank,negative regulation by host of viral process (GO:0044793),-0.6552721291296948,-1.5952808432924068,0.017391304347826087,0.6791574623053147,1.0,6/10,26.41%,EIF2AK4;VAPA;CCNK;PSMC3;ZC3H12A;PRKN
prerank,icosanoid biosynthetic process (GO:0046456),0.7609986606950166,1.5950851527442995,0.027777777777777776,0.7885958712442235,1.0,2/10,0.56%,PLA2G5;ALOX5AP
prerank,rRNA 3'-end processing (GO:0031125),0.766489185717163,1.5944987244439728,0.014705882352941176,0.7780670379083295,1.0,4/10,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,axonal fasciculation (GO:0007413),0.7393688268716321,1.5940468027354653,0.028368794326241134,0.7667946152800619,1.0,2/12,1.72%,AMIGO1;EPHB2
prerank,mitochondrial fusion (GO:0008053),0.6566275943262037,1.5934551557490202,0.02316076294277929,0.7569636008187556,1.0,8/18,13.20%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1
prerank,lipid phosphorylation (GO:0046834),-0.6342979744677288,-1.5885565649219262,0.030726256983240222,0.6910233343519172,1.0,7/10,19.02%,DGKH;DGKB;DGKE;DGKZ;DGKD;DGKG;DGKQ
prerank,cardiac conduction system development (GO:0003161),-0.4960104296595952,-1.586667003805564,0.0228310502283105,0.6784822397605976,1.0,9/24,17.80%,SMAD4;GJA1;MAML1;SMAD1;BMPR1A;CACNA1G;TBX18;BMP4;NOTCH2
prerank,negative regulation of bone remodeling (GO:0046851),0.7548823346097358,1.5866240758533936,0.013333333333333334,0.7983185682471039,1.0,3/11,4.85%,TMEM119;SFRP1;TNFAIP3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7289331764434638,1.5863618782366522,0.020864381520119227,0.7860644861878131,1.0,1/11,0.14%,PLA2G5
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5291736186403874,-1.5851836002895539,0.01606425702811245,0.6656917031693662,1.0,5/18,3.85%,SMAD4;IL6R;FER;STAT3;STAT1
prerank,phagosome-lysosome fusion (GO:0090385),0.7666596469176408,1.5851102583222447,0.02391629297458894,0.7826052572115403,1.0,3/10,4.78%,PLA2G5;CLN3;RAB34
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6865959373691629,1.5844279197695816,0.01556420233463035,0.7744063233863797,1.0,4/17,4.87%,FGF9;VTN;IGF1;NRP1
prerank,regulation of cell division (GO:0051302),0.5529533004472396,1.5813497243586976,0.002162162162162162,0.7852446926132374,1.0,28/72,21.79%,SFRP2;CCP110;FSD1;SIRT2;RAB11FIP4;MYO19;FGFR2;CALM3;FLCN;PLK5;ENTR1;ORC6;RACK1;GIT1;CSPP1;PRPF40A;KLHL13;TXNIP;PIK3C3;CALM1;PIK3R4;NCOA3;MLLT3;PRDM15;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,neurotransmitter uptake (GO:0001504),0.7158016116911046,1.576721677942249,0.024285714285714285,0.8098875296333046,1.0,5/12,13.89%,SLC29A1;ATP1A2;GLUL;SNAP25;SLC1A3
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6897044989031176,1.5759328557937675,0.03207810320781032,0.8032593315868117,1.0,5/15,14.28%,CARMIL2;DDR1;DDR2;LRP1;TGFB1
prerank,vacuolar acidification (GO:0007035),0.6534479765991618,1.574655530615327,0.019762845849802372,0.8003153826923532,1.0,7/21,12.68%,CLN3;ATP6AP2;CLN6;ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.638837362827312,1.5737888673427356,0.023106546854942234,0.7946712642889602,1.0,8/23,10.71%,SLC4A4;IGF1;NFKB1;ARNT;PRXL2C;EGF;ZBTB20;APP
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.46330966317144995,-1.5735159061991995,0.02,0.7031880672144942,1.0,15/29,19.82%,SMAD4;CYRIB;TJP1;SLIT2;PRKCD;KANK3;MYADM;KANK4;SHANK3;PIK3CA;TWF2;PFN1;KANK1;TWF1;FKBP4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4998744029414141,-1.5733596675727508,0.04201680672268908,0.6842264821273651,1.0,9/21,22.71%,FOXP1;PRKCH;PTPRC;IKBKG;SLC39A10;NECTIN2;RAB29;CD81;BCL10
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5496330881175642,1.573060397175942,0.0032537960954446853,0.7880252033653221,1.0,19/72,14.97%,FGF20;FGF9;FGFRL1;FGFR2;FGFR1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6359667127523142,1.5711028502282471,0.028833551769331587,0.7914388952573409,1.0,5/24,5.09%,SFRP2;CDKN2D;TAF9B;CXCL12;SNAI1
prerank,lung epithelium development (GO:0060428),0.7615732150268794,1.5702160822957496,0.019877675840978593,0.7864479048915861,1.0,4/10,7.81%,STRA6;FGF10;ERRFI1;RCN3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.309179109626469,-1.5679253768612655,0.0,0.6911915893639338,1.0,76/168,23.01%,CNOT1;DCP1A;EIF3E;CSDE1;RPS24;PATL1;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;DCPS;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;TENT2;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;LSM1;RC3H1;RPL28;RPL22;RPL34;RPS13;RPLP0;PARN;UPF3B;RPL36;RPL10;ERI1;CNOT8;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;CNOT7;SMG6;ETF1;RPL7A;EXOSC9;EIF4A3;RPL31;NCBP2;PPP2CA;TUT1;RBM8A;HELZ2;RPL36A;TUT4;CNOT2;RPL29;CNOT11
prerank,fatty acid metabolic process (GO:0006631),0.5194147101525471,1.5673663467270718,0.002053388090349076,0.7960571079294795,1.0,26/115,15.47%,SLC27A6;FASN;ALOX5AP;NDUFAB1;LPL;MLYCD;SLC27A4;THEM4;PON2;XBP1;LPIN1;PON3;ACOT11;SGPL1;LPIN3;MSMO1;GPAM;ELOVL4;CROT;CPT2;ACADSB;LPIN2;MECR;PTGS2;ACSL6;ABCD2
prerank,regulation of dopamine secretion (GO:0014059),0.6231256082784903,1.5657100174281506,0.02176696542893726,0.7968745636911306,1.0,3/25,0.87%,FGF20;SYT3;SYT10
prerank,mucosal immune response (GO:0002385),-0.5407127164000478,-1.5647687416681129,0.0456140350877193,0.6880744438781536,1.0,3/15,14.64%,RNASE3;DEFA6;RPL39
prerank,female gonad development (GO:0008585),0.6505006119294395,1.5636263919469444,0.03462050599201065,0.8013827480798034,1.0,2/19,2.96%,FSHR;NR2F2
prerank,vesicle transport along actin filament (GO:0030050),0.653810872286374,1.5635677798353333,0.023346303501945526,0.7900806780357044,1.0,3/19,5.26%,MYO1A;MYO19;MYO1B
prerank,megakaryocyte differentiation (GO:0030219),-0.5867874547451501,-1.5632848471614726,0.01812688821752266,0.6769276159706389,1.0,3/11,4.62%,MED1;KIT;UBA5
prerank,digestive tract morphogenesis (GO:0048546),0.6928796019667953,1.563170311266335,0.025280898876404494,0.7820947332512486,1.0,6/14,11.29%,STRA6;FGFR2;NIPBL;BBS7;SOX11;PDGFRA
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6524602367484195,1.5618766659640226,0.02906208718626156,0.7809115548196406,1.0,9/19,11.98%,CAMK2B;CUL7;CDKL5;OBSL1;DBN1;LRP8;DHX36;DBNL;IL1RAPL1
prerank,regulation of mitotic spindle organization (GO:0060236),0.5873431826459371,1.5605974417595414,0.022754491017964073,0.7792716989320099,1.0,14/35,21.47%,PSRC1;FSD1;RAE1;CEP97;DRG1;CHMP3;MAP9;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4633593081647217,-1.559010477105954,0.03902439024390244,0.6801694229897896,1.0,9/27,10.78%,MAPK8;KAT7;IKBKB;CUL1;TAOK2;SKP1;MAP3K8;UBB;IKBKG
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6077130151545642,-1.5588925270669958,0.024844720496894408,0.6642400982980569,1.0,6/11,23.57%,RAPGEF6;TJP1;F11R;RAB1A;RAP2C;RAB1B
prerank,regulation of catecholamine secretion (GO:0050433),0.6096841609538235,1.5588841880658084,0.02746566791510612,0.781619943094145,1.0,3/29,0.87%,FGF20;SYT3;SYT10
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6019403701043422,1.5579236227224729,0.01893939393939394,0.7778581971364844,1.0,8/29,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,positive regulation of cellular respiration (GO:1901857),0.7334359371456225,1.5569874877424388,0.022727272727272728,0.7747189441628334,1.0,6/11,15.32%,IFNAR1;IL10RB;PRELID1;VCP;PARK7;NUPR1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6531666120475257,1.5560873307406689,0.033921302578018994,0.7707476296839288,1.0,4/18,4.44%,BAX;CHCHD10;FZD9;ZNF205
prerank,maintenance of protein localization in organelle (GO:0072595),-0.49972548247294063,-1.5550058808594118,0.01282051282051282,0.665490026658799,1.0,16/19,25.31%,MORC3;TAPT1;HK1;PML;SKP1;ARL2BP;TAF8;BBS4;TAF3;PINK1;HSPA5;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,regulation of myotube differentiation (GO:0010830),0.6300098664365357,1.5521723394527067,0.03366583541147132,0.7899198003786088,1.0,8/24,12.36%,HDAC3;TMEM119;DMPK;XBP1;HDAC5;SIK1;HDAC4;HDAC1
prerank,innate immune response in mucosa (GO:0002227),-0.6475692010035249,-1.5520277630500958,0.025078369905956112,0.6632323358807733,1.0,3/10,14.64%,RNASE3;DEFA6;RPL39
prerank,tRNA aminoacylation (GO:0043039),0.5813047441511969,1.5505041904320107,0.02264600715137068,0.7920312115398624,1.0,17/37,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;GATB;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;SARS1;NARS1;HARS1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.46816354788711895,-1.5494158889398193,0.02242152466367713,0.6591333567384114,1.0,6/23,21.27%,LAMP1;CADM1;LGALS9;NECTIN2;PIK3R6;PVR
prerank,regulation of oxidative phosphorylation (GO:0002082),0.670798666964113,1.5474632382711715,0.03162055335968379,0.805119390417919,1.0,7/16,15.32%,PPIF;SLC25A33;COX7A2;VCP;AK4;UQCC2;NUPR1
prerank,pancreas development (GO:0031016),0.707334469318142,1.5452452993127561,0.031117397454031116,0.8119691267769481,1.0,4/12,8.63%,NKX6-1;TCF7L2;ZIC3;SELENOT
prerank,response to hexose (GO:0009746),0.620056226633127,1.5447537676067107,0.025380710659898477,0.8059699522080459,1.0,7/25,13.32%,LPL;GPLD1;SELENOS;TCF7L2;SELENOT;IRS2;ZBED3
prerank,regulation of stem cell population maintenance (GO:2000036),-0.5108256070269328,-1.5446574069511192,0.03501945525291829,0.6657546828516134,1.0,8/18,25.65%,CNOT1;WDR43;REST;TAF5L;CNOT2;ELAVL1;TAF6L;HMGA2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.45879283890034467,-1.5445362945615584,0.0410958904109589,0.6516583408505434,1.0,8/26,13.21%,CACNA1D;CAB39;ATP1B3;AKAP9;ACTN2;VAMP2;ATP1B1;NEDD4L
prerank,acylglycerol metabolic process (GO:0006639),-0.4214092716470295,-1.5441479109625778,0.013605442176870748,0.6395209576810903,1.0,13/37,12.91%,DGKH;CAV1;DGKB;GK5;MGLL;DGKE;DGKZ;ABHD6;ABHD2;DGKD;DGKG;LMF1;PGS1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.567841999935095,1.5414219278543793,0.02112676056338028,0.8207256873036852,1.0,18/42,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.6908461193191681,1.5404979680752504,0.044137931034482755,0.8179269599304843,1.0,7/14,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7037806694033717,1.5403055122904166,0.04178674351585014,0.8094951836132057,1.0,1/12,0.02%,DPYSL4
prerank,epidermis development (GO:0008544),0.5431612254503396,1.5386376443664866,0.016778523489932886,0.8125155437392828,1.0,8/56,5.53%,ATP2C1;EDAR;FGFR2;SCEL;PTHLH;EDA2R;ATP2A2;PLOD1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.34723404900344007,-1.5373400859236113,0.0,0.6545052909286324,1.0,35/103,16.22%,RAPGEF5;RAPGEF6;KRAS;ARHGEF18;RALBP1;RB1;RAB18;ARHGAP18;RREB1;PLCE1;ABR;USP28;PRKD1;TIAM2;NRAS;TNK2;RRAGC;RHEB;NUCB1;RGL1;USP8;RASGRP3;RALB;ARL3;TP53;RIT1;PLD2;SHC3;ARHGAP1;ARHGAP31;JUN;RGL2;ARFIP2;PLK2;DNMT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.6309685295466939,1.5352721246952974,0.03638814016172507,0.8276245578896363,1.0,3/20,7.66%,FSHR;TCIM;ADGRV1
prerank,lipoxygenase pathway (GO:0019372),0.6783381144190149,1.5350643756986146,0.042134831460674156,0.8197209359338964,1.0,5/14,17.75%,ALOX5AP;PON2;PON3;PTGS2;GPX4
prerank,regulation of lysosomal lumen pH (GO:0035751),0.7197139206559082,1.5350471369285446,0.02627939142461964,0.8106395710708958,1.0,3/12,2.20%,CLN3;ATP6AP2;CLN6
prerank,regulation of histone deacetylation (GO:0031063),0.6948422601747697,1.5348632562379567,0.039603960396039604,0.8028403776724479,1.0,7/13,16.05%,PRMT6;NIPBL;AKAP8L;ZBTB7B;CAMK2D;SAP30BP;CTBP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.720247683069952,1.5334262107670893,0.04833836858006042,0.8043200092212077,1.0,3/11,3.32%,EXOSC3;EXOSC2;FBL
prerank,organelle fusion (GO:0048284),0.6105872404810754,1.531567507574203,0.035386631716906945,0.808586031355152,1.0,9/22,16.00%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1;VPS18
prerank,positive regulation of integrin activation (GO:0033625),-0.6043378586594595,-1.5286182603807659,0.0440251572327044,0.6756171768940445,1.0,5/11,18.46%,FERMT2;PLEK;RASIP1;SRC;P2RY12
prerank,nucleoside salvage (GO:0043174),0.7366068354319488,1.5272903398258066,0.04437869822485207,0.8327986715922144,1.0,6/10,13.10%,DCK;TK1;TK2;UPP2;UCKL1;HPRT1
prerank,positive regulation of double-strand break repair (GO:2000781),0.5702148595717742,1.5269842884512883,0.01871345029239766,0.8263073565108954,1.0,10/39,9.77%,SPIRE2;KDM4D;FOXM1;PARP1;ACTR2;MGMT;SLF2;FUS;WRAP53;MRNIP
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.49745474572304726,-1.526852187831952,0.03731343283582089,0.6700517370367638,1.0,7/18,9.67%,SMAD4;CD46;HIF1A;TGFB2;LGALS9;CD34;FN1
prerank,phagolysosome assembly (GO:0001845),0.7059164280175497,1.526677134130131,0.03602305475504323,0.8195791850089994,1.0,3/12,4.78%,PLA2G5;CLN3;RAB34
prerank,GPI anchor metabolic process (GO:0006505),0.6069264312353551,1.525192835944271,0.03178484107579462,0.8221548527482258,1.0,8/26,10.68%,PIGG;GPLD1;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.5164319753031836,1.5251337253625268,0.005219206680584551,0.8139680961648482,1.0,33/102,15.66%,CPEB1;GPLD1;SELENOS;PDPK1;NFKB1;ADCY7;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;SLC30A10;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;PRKCI;ADCY1;RAB31;RAB8A;RAB8B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5201534511000789,-1.5249555250526576,0.040955631399317405,0.6642587384890206,1.0,7/15,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,response to cadmium ion (GO:0046686),-0.44762506245166556,-1.524448770986055,0.03125,0.6534208714322883,1.0,12/26,13.89%,MAPK8;EGFR;HSF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;JUN
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5816730548062262,1.5224649492461952,0.033623910336239106,0.8250877576694527,1.0,6/30,15.47%,SLC27A6;ELOVL1;SLC27A4;ELOVL4;ACSL6;ABCD2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.36923600282247904,-1.5219684804676066,0.0,0.6517760239402336,1.0,29/63,23.88%,ANO4;GABRB1;SLC12A7;SLC26A2;GABRG2;CLCN3;SLC25A3;SLC37A3;ANO6;ANO1;SLC20A1;SLC25A14;GABRA5;SLC12A4;SLC5A6;SLC5A5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;SLC25A30;GLRA3;SLC25A11;SLC12A8
prerank,DNA modification (GO:0006304),0.6159339811645161,1.519434949066882,0.03761348897535668,0.8396570590754491,1.0,5/22,4.96%,EXOSC3;PARP1;NTHL1;MPG;PARP2
prerank,substantia nigra development (GO:0021762),0.5725194141358005,1.5190483594771294,0.017793594306049824,0.8337865734327028,1.0,8/37,8.88%,FGF9;NDRG2;SIRT2;INA;CALM3;ATP5PF;SEC16A;YWHAH
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6144445431200214,-1.5172447571126269,0.0425531914893617,0.6603973999182792,1.0,6/10,28.14%,HK1;GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5930953384320828,1.516231290961313,0.0322180916976456,0.8459507904653779,1.0,10/30,10.18%,SFRP2;SFRP1;SH3BP5;NTF3;THY1;DMTN;PIBF1;SH3BP5L;MVP;SRCIN1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4372971186485948,-1.5138423090740711,0.035897435897435895,0.6625634978489999,1.0,8/27,9.22%,EGFR;PUM1;EIF4ENIF1;STAT3;RIPK1;AGO2;TP53;LIMD1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6508011067841643,1.5135567248964035,0.05049088359046283,0.8572052506632245,1.0,5/15,8.95%,AATK;DDR1;ABL1;SRMS;TEC
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5351242540174692,1.5133071265563085,0.014317180616740088,0.8506442650003485,1.0,18/62,14.52%,IGF1;RAC1;FGF10;RASGEF1A;ARRB1;GPR4;RAPGEF1;PRAG1;IRS2;PIK3CB;ADGRG1;ROBO1;ALS2;AKAP13;LPAR1;AUTS2;STK19;LPAR6
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5757635722532604,1.5131776938461716,0.0345252774352651,0.8433076356660935,1.0,8/31,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,response to UV-A (GO:0070141),-0.5325638159889345,-1.5131716703213571,0.045283018867924525,0.6539607264409826,1.0,7/14,28.73%,EGFR;MME;MMP2;AKT1;MMP1;CERS1;CCND1
prerank,regulation of lamellipodium organization (GO:1902743),0.6704953614863408,1.5129930713774518,0.0547945205479452,0.8366675389707754,1.0,3/14,6.44%,CARMIL2;RAC1;DMTN
prerank,protein localization to mitochondrion (GO:0070585),-0.5921900687891213,-1.5095661549079682,0.06875,0.6573793907019744,1.0,9/11,21.99%,HK1;LRRK2;PINK1;RALA;HK2;COX18;MAIP1;AKT1;DNAJA1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5963416852655876,-1.5086706163538028,0.03715170278637771,0.6494986532528495,1.0,4/10,9.08%,KAT7;SIRT1;KAT2B;EP300
prerank,P-body assembly (GO:0033962),-0.5661238975693115,-1.5073213464275554,0.048859934853420196,0.6438302212946422,1.0,4/12,10.42%,EIF4ENIF1;PATL1;LIMD1;RC3H1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.42616211952138205,-1.5072814630287108,0.01020408163265306,0.6333703887126856,1.0,11/30,9.79%,GJA1;JAM2;PECAM1;TJP1;ACTB;CLDN5;ESAM;DMD;F11R;OCLN;LSR
prerank,cellular response to cadmium ion (GO:0071276),-0.4531244855265601,-1.5072429184249598,0.029556650246305417,0.6231292589862677,1.0,12/24,13.89%,MAPK8;EGFR;HSF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;JUN
prerank,diterpenoid metabolic process (GO:0016101),0.5337545133347573,1.5059746863105008,0.013452914798206279,0.881989585974627,1.0,15/55,17.19%,LPL;RDH10;STRA6;GPC6;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;GPC4;LRP1;HSPG2;ALDH3A2;APOE
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.49762535944423547,-1.5055085618214583,0.03169014084507042,0.6205004141750167,1.0,10/18,22.86%,PREPL;RIMS2;SYN1;LRRK2;DTNBP1;NLGN1;SLC4A8;RAB5A;RAB3GAP1;SNAPIN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6271976541716973,1.5052810769323006,0.04025974025974026,0.8791462749649692,1.0,5/21,7.92%,SFRP1;STK36;DCDC2;RAB34;TUBD1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6185441366938641,1.5048118585536392,0.041666666666666664,0.8743979358612224,1.0,8/21,15.68%,PTGER4;IGF1;ZFP36L1;FGF10;SOX9;EGF;MAP2K2;CTSH
prerank,snRNA 3'-end processing (GO:0034472),0.6328974027926808,1.5036483875865991,0.036986301369863014,0.8752675576552509,1.0,6/19,6.42%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;EXOSC8
prerank,leukotriene metabolic process (GO:0006691),0.630678176188096,1.5033910441689524,0.0461133069828722,0.8690789823066946,1.0,2/19,0.56%,PLA2G5;ALOX5AP
prerank,diacylglycerol metabolic process (GO:0046339),-0.45705532066006044,-1.503287678168177,0.053811659192825115,0.6185393306348387,1.0,11/23,21.92%,DGKH;PLCE1;DGKB;DGKE;DGKZ;DGKD;DGKG;PGS1;DGKQ;DGAT1;LIPE
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5532601189944966,-1.5028187067554841,0.046357615894039736,0.6109046868908253,1.0,7/13,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3498792995829163,-1.5007055127495774,0.0,0.6091682276397196,1.0,46/87,22.59%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;RPS10;RPL7A;SEC61A1;RPL31;RPL36A;SEC61B;SRP14;RPL29
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5164346632694928,1.5006278816259828,0.008429926238145416,0.8815877788228157,1.0,23/87,16.76%,FGF20;FGF9;SFRP1;FGFRL1;FGFR2;FGFR1;ZFP36L1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL;NDNF;ITGB1BP1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6046432565733684,1.4989104778529088,0.026785714285714284,0.8869734792678411,1.0,6/25,6.19%,GMPS;ADSL;PRPSAP2;DCK;PAICS;GART
prerank,ovarian follicle development (GO:0001541),-0.5383668439331339,-1.4982640841544976,0.07333333333333333,0.6090756063847009,1.0,12/13,44.46%,KIT;CEBPB;VEGFA;EIF2B5;INHBA;EIF2B2;EIF2B4;INHBB;INHA;FOXL2;ANG;LHCGR
prerank,regulation of immunoglobulin production (GO:0002637),0.6127952394289037,1.4968516516990744,0.04331210191082802,0.8943960175576059,1.0,4/23,6.58%,FCGR2B;EPHB2;XBP1;VAMP3
prerank,histone H3 deacetylation (GO:0070932),0.6511664054621532,1.49670562354267,0.05213903743315508,0.8874687600869489,1.0,6/15,12.36%,HDAC3;SIRT2;SIRT7;PER1;HDAC4;HDAC1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5015250434573026,-1.4925657542894228,0.061371841155234655,0.6210730327792667,1.0,8/17,25.22%,CAV1;ADIPOR1;PRKAB2;PPARD;PRKAA2;ADIPOR2;PPARG;PPARA
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4159347341626403,-1.4925452002197541,0.056338028169014086,0.612003293145757,1.0,20/32,28.54%,HIPK2;FHIT;PML;USP28;SIRT1;HIPK1;JMY;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;RRP8;BCL3;MYBBP1A;RPS27L;BOK;PDK2
prerank,positive regulation of receptor internalization (GO:0002092),0.6128247953250076,1.4899710941402724,0.042440318302387266,0.9316614447288141,1.0,9/22,16.79%,APLN;NTF3;PICK1;CD63;ARRB1;EGF;MAGI2;AHI1;FMR1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6324903330481945,1.4884408424037072,0.04532967032967033,0.9354963890362412,1.0,1/16,0.02%,DPYSL4
prerank,somite development (GO:0061053),0.7000504242739515,1.4875987560074009,0.06156156156156156,0.9337705095824651,1.0,3/11,9.55%,SFRP2;PTCH1;SOX11
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6221656729670636,1.4872154724602962,0.0520694259012016,0.9290029789544076,1.0,4/18,8.86%,ZFP36L1;PRELID1;ABL1;XRCC6
prerank,positive regulation of stem cell differentiation (GO:2000738),0.647182525858911,1.4866887057132998,0.050824175824175824,0.9251791781073515,1.0,6/16,14.84%,SP7;SOX9;DHX36;NUDT21;SOX6;SOX5
prerank,neural tube development (GO:0021915),0.6617685017068453,1.4861097200604314,0.05750350631136045,0.9218063410662568,1.0,8/15,19.15%,ARL13B;ALDH1A2;DVL1;PTCH1;SOX11;TGFB1;PKD2;SOX4
prerank,autophagosome maturation (GO:0097352),0.579658693085255,1.4844660974664294,0.03850782190132371,0.9270077752859197,1.0,15/32,16.15%,UBQLN1;CLN3;VPS16;ATP2A2;SNX14;LIX1L;ATG14;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;VMP1;STX17;VAMP8
prerank,endothelial cell proliferation (GO:0001935),-0.5079510958242183,-1.4835377224468917,0.07636363636363637,0.6370264100323947,1.0,8/17,23.62%,BMPER;ERN1;TEK;CD34;PRKX;BMP4;DLG1;SEMA5A
prerank,regulation of actomyosin structure organization (GO:0110020),0.6643320119787995,1.4835054352845192,0.05547850208044383,0.9267018442988088,1.0,5/13,14.18%,PTGER4;RAC1;ALMS1;AKAP13;ROCK2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.573395516973996,1.481030110777524,0.048994974874371856,0.9376684549194964,1.0,3/29,2.97%,TNNI3;TNNC1;FGFR2
prerank,cellular senescence (GO:0090398),-0.4364257255459078,-1.4808122431597865,0.03664921465968586,0.638180600944423,1.0,16/27,38.23%,SMC5;PRKCD;PML;SIRT1;CALR;TBX3;TBX2;HMGA2;NSMCE2;ECRG4;KAT6A;CDKN1A;SMC6;ULK3;HRAS;SRF
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.586709342892831,1.4802301110282017,0.05555555555555555,0.9360310972327146,1.0,6/26,6.55%,SIRT2;TNFAIP3;PPM1B;CARD16;DHX58;TRAFD1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6949375714404695,1.479574961629032,0.04824561403508772,0.9335989787594131,1.0,4/12,6.19%,GMPS;ADSL;PAICS;GART
prerank,positive regulation of cell killing (GO:0031343),0.6690169052059214,1.4793616138886596,0.04239766081871345,0.9279630378815741,1.0,3/13,2.78%,WNT5A;DVL2;RAC1
prerank,glycolipid biosynthetic process (GO:0009247),0.5538088627515033,1.4784819974886554,0.03143189755529686,0.9268613007554555,1.0,10/38,10.43%,PIGG;A4GALT;PGAP4;ST8SIA3;DPM2;ST3GAL2;PIGM;PIGU;ST3GAL5;PIGA
prerank,sensory perception of taste (GO:0050909),0.7043636411056592,1.4767568764854888,0.05803571428571429,0.9328001287804549,1.0,1/10,1.86%,ASIC1
prerank,regulation of pseudopodium assembly (GO:0031272),0.7054588573503271,1.4753060237998779,0.06534954407294832,0.9293661227488726,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.7054588573503271,1.4753060237998779,0.06534954407294832,0.9293661227488726,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,regulation of wound healing (GO:0061041),0.5469958723467069,1.4741629740677362,0.03267211201866978,0.9310967189475112,1.0,7/42,6.44%,VTN;EPHB2;AJAP1;CASK;ANXA1;TNFAIP3;DMTN
prerank,arachidonate transport (GO:1903963),0.7009874541270832,1.473825458554724,0.061746987951807226,0.9194220758684596,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.7009874541270832,1.473825458554724,0.061746987951807226,0.9194220758684596,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,cardiac muscle contraction (GO:0060048),0.5622378225730136,1.4737371830477817,0.031363088057901084,0.9131054140259743,1.0,8/34,14.61%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1;CAMK2D;GRK2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3452994198211446,-1.4733646194029342,0.02,0.6574791785177838,1.0,23/87,10.84%,PARD3;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;FMOD;TWSG1;FNTA;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6139507130513764,1.4719368479846286,0.06060606060606061,0.9191508452866548,1.0,4/19,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6701208945047512,1.4719330342732422,0.05285714285714286,0.9124075929765628,1.0,3/13,3.62%,APLN;PDPK1;FGFR1
prerank,presynapse organization (GO:0099172),0.695726456102913,1.4718270144874308,0.05757575757575758,0.9064834230880418,1.0,4/10,14.38%,WNT5A;DVL1;NLGN3;NLGN2
prerank,negative regulation of protein processing (GO:0010955),-0.5444728441117637,-1.4717751993969403,0.06711409395973154,0.6543173248825994,1.0,4/12,7.45%,TMEM59;SERPINE2;THBS1;LRRK2
prerank,actin nucleation (GO:0045010),0.5962235314036445,1.471337362741676,0.054304635761589407,0.9031899344298637,1.0,4/21,3.87%,SPIRE2;WHAMM;ACTR2;ARPC1A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5629357778381474,-1.4708414692779925,0.0771513353115727,0.6486466210127456,1.0,3/11,3.57%,SMAD4;LMNA;GLRX3
prerank,protein deacylation (GO:0035601),0.6040386929367194,1.4704350455815678,0.06177606177606178,0.9027395419592761,1.0,8/23,12.36%,HDAC3;SIRT2;SIRT7;ABHD10;LYPLAL1;HDAC5;HDAC4;HDAC1
prerank,acidic amino acid transport (GO:0015800),-0.4956422905810334,-1.46877697696083,0.06015037593984962,0.647650118428176,1.0,5/17,5.58%,SLC6A6;GJA1;ARL6IP5;SLC25A13;LRRC8D
prerank,regulation of osteoblast proliferation (GO:0033688),0.6267739643342621,1.4681117133025972,0.07055630936227951,0.9131078502246095,1.0,4/17,4.87%,TMEM119;SFRP1;FGFR2;NELL1
prerank,genitalia development (GO:0048806),0.6740808879050642,1.4651813968189986,0.05555555555555555,0.9281045858946742,1.0,2/12,2.18%,WNT5A;STRA6
prerank,positive regulation of secretion (GO:0051047),0.6855563707591676,1.4646601165729654,0.06784660766961652,0.9254525198151253,1.0,2/11,3.80%,GPLD1;XBP1
prerank,actin filament-based transport (GO:0099515),0.6107877772535014,1.4642636446417547,0.05806451612903226,0.9218931946278414,1.0,3/21,5.26%,MYO1A;MYO19;MYO1B
prerank,regulation of double-strand break repair (GO:2000779),0.5414846756542976,1.464177395235406,0.03278688524590164,0.916096831514904,1.0,14/39,19.07%,SPIRE2;FOXM1;SIRT7;ACTR2;MGMT;SLF2;WRAP53;MRNIP;TWIST1;SPIRE1;UBR5;TERF2IP;FMN2;PPP4C
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6984118789177876,1.4637898976333472,0.05891238670694864,0.9127267028289623,1.0,2/10,4.88%,EPB41L4B;FGF10
prerank,ncRNA catabolic process (GO:0034661),0.5751339227407852,1.4621000083431996,0.052434456928838954,0.9189305884939104,1.0,11/28,16.22%,EXOSC3;EXOSC7;EXOSC2;ZCCHC8;EXOSC8;LIN28B;MTREX;SND1;XRN1;DIS3L2;NUDT16L1
prerank,regulation of nuclear division (GO:0051783),0.6089771714640063,1.4619124552737026,0.0625,0.9140247010299584,1.0,6/20,12.64%,CUL7;OBSL1;CDK13;FBXO5;PRMT5;RCC1
prerank,regulation of B cell activation (GO:0050864),0.5883319736129861,1.4613182142652081,0.04878048780487805,0.9121028401073186,1.0,3/25,4.85%,FCGR2B;ZFP36L1;TNFAIP3
prerank,protein K11-linked ubiquitination (GO:0070979),0.5782203648527455,1.4603843123997216,0.04591836734693878,0.9126414369900225,1.0,13/27,18.59%,CDC23;UBE2S;UBE2E2;CDC16;FZR1;ANAPC2;UBE2A;ANAPC11;ANAPC4;CDC26;UBE2L3;ANAPC10;ANAPC5
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6894534519627222,1.4584794882986654,0.05812220566318927,0.9077433730975193,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6894534519627222,1.4584794882986654,0.05812220566318927,0.9077433730975193,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.6894534519627222,1.4584794882986654,0.05812220566318927,0.9077433730975193,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,pseudouridine synthesis (GO:0001522),0.6638993462031234,1.4580491268329003,0.06465517241379311,0.9045282802230201,1.0,4/13,9.92%,NHP2;TRUB2;PUS10;PUS7
prerank,cellular response to insulin stimulus (GO:0032869),0.4915759294531144,1.4569555403044334,0.008238928939237899,0.9063658366534594,1.0,42/124,16.91%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;SLC27A4;ATP6V0A2;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;GAB1;ATP6V0E2;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;BAIAP2;RAB10;IRS2;DENND4C;ATP6V1G1;PIK3R2;TCIRG1;MYO5A;ENPP1;LPIN2;ATP6V0A4;RAB13;PRKCI;ATP6V1D;RAB31;FOXC2;RAB8A;RAB8B;ATP6V1B2;SLC27A1;PHIP
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7049536771524245,1.4554479762982493,0.061224489795918366,0.9112884479747296,1.0,4/10,13.34%,CBARP;BIN1;ATP1A2;VDAC1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.33572229304289297,-1.454910429377355,0.0,0.6903773326449111,1.0,18/65,16.00%,LEF1;FOXP1;KIT;SBNO2;PML;SIRT1;PIR;LGALS9;TGFBR2;EP300;RARA;MT1G;OSTM1;CBFA2T3;THOC5;GLO1;TNFRSF11A;BMP4
prerank,regulation of protein sumoylation (GO:0033233),0.6177486046569916,1.4546852602193234,0.07475317348377997,0.9109110052010501,1.0,7/17,15.02%,GNL3;RWDD3;SAE1;HDAC4;ZMIZ1;PARK7;PIAS3
prerank,dicarboxylic acid transport (GO:0006835),-0.4228999178676308,-1.4544137170673102,0.055,0.6833305765942732,1.0,7/28,14.42%,GJA1;ARL6IP5;SLC26A7;SLC25A13;SLC25A32;SLC22A6;GIPC1
prerank,regulation of neuroinflammatory response (GO:0150077),0.6113323290094491,1.454113132539922,0.0693717277486911,0.9087308561195021,1.0,5/19,15.32%,IGF1;IL33;CD200R1;PTGS2;NUPR1
prerank,regulation of blood circulation (GO:1903522),0.5452167813273553,1.451892706509602,0.048426150121065374,0.9182215084084235,1.0,7/34,11.50%,KCNG2;DMPK;CELF2;DES;BDKRB2;TPM1;CAMK2D
prerank,urogenital system development (GO:0001655),0.6806999655241398,1.4507921092866125,0.0755287009063444,0.9197593294811666,1.0,3/11,8.36%,EPHB2;ANXA1;SOX9
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5613454638798668,1.4505719343388224,0.05845771144278607,0.9155387557735631,1.0,9/30,14.52%,RAC1;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6876352186619062,1.450481848638392,0.06787330316742081,0.9103673750139918,1.0,1/10,0.06%,CARMIL2
prerank,cellular response to calcium ion (GO:0071277),0.504570227193129,1.45032073329557,0.02810810810810811,0.9058926887539306,1.0,28/67,23.24%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;PKD2;PRKAA1;KCNH1;SMPD1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6549681924983705,1.4497567914592553,0.07256894049346879,0.904011619360022,1.0,8/12,21.94%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6787568362060509,1.4496918137019998,0.07412790697674419,0.8988619759597206,1.0,5/12,10.28%,DCK;TK1;TK2;UPP2;UCKL1
prerank,ncRNA metabolic process (GO:0034660),0.5362868504398911,1.4476442606611648,0.04609929078014184,0.9076793631665988,1.0,5/37,4.08%,KHSRP;TARBP2;DGCR8;DDX17;ZCCHC8
prerank,histone H4 deacetylation (GO:0070933),0.6822795037038836,1.4469699426356977,0.09024745269286755,0.906664274951249,1.0,5/10,12.36%,HDAC3;SIRT2;HDAC4;RCOR1;HDAC1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3987104090311245,-1.4466723040552727,0.03636363636363636,0.704040153917924,1.0,22/32,39.58%,SORBS1;ASAH1;CREBL2;ADIPOR1;PRKAB2;CREB1;PRKAA2;ADIPOR2;AKT1;PPARA;AVIL;CEACAM1;SIRT4;MID1IP1;GPER1;ASXL3;EIF6;MLXIPL;FITM2;STAR;C3;PDK4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.6375581108458851,1.445580173082446,0.06906077348066299,0.9107102029333575,1.0,4/16,6.19%,GMPS;ADSL;PAICS;GART
prerank,regulation of multicellular organism growth (GO:0040014),0.6331057568112048,1.4448614924682708,0.08579465541490858,0.9104336979015408,1.0,4/15,10.71%,IGF1;PTCH1;PPIB;APP
prerank,triglyceride catabolic process (GO:0019433),0.6101561603380474,1.4446306151192476,0.05789473684210526,0.9065238755640788,1.0,1/19,0.96%,LPL
prerank,digestive tract development (GO:0048565),0.5567074749292069,1.4444570674343633,0.0539568345323741,0.902364859174966,1.0,8/33,6.59%,STRA6;FGFR2;PCSK5;NIPBL;CHD8;CLMP;BBS7;ZIC3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5400470076667659,1.4428948518657634,0.06181818181818182,0.9076770453852103,1.0,8/36,11.37%,IL10RA;OCIAD2;CENPJ;IL10RB;PIGU;HGS;EGF;LEPROT
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5477371949362695,-1.4414287039969225,0.08278145695364239,0.7163761946408438,1.0,4/11,9.22%,PUM1;STAT3;XPO5;LIMD1
prerank,renal filtration (GO:0097205),0.6833920598024885,1.4407559021167047,0.09090909090909091,0.9174618197177369,1.0,3/10,6.14%,XPNPEP3;SULF1;TMEM63C
prerank,peptidyl-amino acid modification (GO:0018193),0.6888684754901586,1.4404631935380259,0.0871559633027523,0.91392083483477,1.0,4/10,13.29%,TTLL4;METAP1;METAP1D;METAP2
prerank,negative regulation of B cell activation (GO:0050869),0.5786755517578176,1.436943120724308,0.06777493606138107,0.9332680371139361,1.0,3/21,4.85%,FCGR2B;SFRP1;TNFAIP3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6309720172031512,1.4340308108140056,0.07475317348377997,0.9478631734304479,1.0,3/14,7.22%,APLN;SULF1;GPC1
prerank,ketone body metabolic process (GO:1902224),0.6814766413169723,1.4324054545805305,0.07518796992481203,0.9533790186685672,1.0,4/10,7.50%,HMGCLL1;OXCT1;BDH1;ACAT1
prerank,response to interferon-beta (GO:0035456),-0.44431598463488003,-1.4322247691385517,0.09012875536480687,0.7449828185661123,1.0,13/22,23.52%,UBE2K;IFNAR2;STAT1;PLSCR1;IKBKE;AIM2;XAF1;IRGM;NDUFA13;BST2;IFITM2;IFITM1;UBE2G2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5966695467978244,1.4320539619378934,0.0655307994757536,0.9505711368869629,1.0,9/21,14.68%,MED24;MED12;MED14;MED13;MED4;DHX36;TWIST1;SETX;BCLAF1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6470611560647203,1.4309095554113573,0.07244318181818182,0.9537082258225917,1.0,4/14,6.19%,GMPS;ADSL;PAICS;GART
prerank,regulation of exocytosis (GO:0017157),0.5209137031390975,1.4305243168111765,0.0456140350877193,0.9510400535766721,1.0,16/46,17.01%,UNC13D;CPLANE2;ANXA1;RAB12;CPLX1;CHMP3;RAB10;RAB3B;RAB2B;IL1RAPL1;SYT1;RAB13;RAB8A;RAB8B;NSF;RAB21
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5810830137985353,1.4297497930917769,0.05964467005076142,0.9514702286935147,1.0,5/22,6.42%,EXOSC3;NOP9;EXOSC7;EXOSC2;EXOSC8
prerank,positive regulation of glycolytic process (GO:0045821),0.5904454938245491,1.4282154354777745,0.06928104575163399,0.9514075531005719,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5904454938245491,1.4282154354777745,0.06928104575163399,0.9514075531005719,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,negative regulation of histone modification (GO:0031057),0.636978077257402,1.4274879871357065,0.06611570247933884,0.9512583806796633,1.0,5/14,16.05%,AASS;PRMT6;TWIST1;JARID2;CTBP1
prerank,positive regulation of neuron differentiation (GO:0045666),0.5314555730134565,1.4271249330491116,0.04257767548906789,0.9486818466491517,1.0,11/40,17.06%,FGF20;FGFR1;TCF4;ZEB1;BRINP3;MMD;GPRC5B;SOX11;IMPACT;TCF3;BRINP1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5367134524904638,1.4237734344380333,0.0630952380952381,0.9669921294274948,1.0,10/38,10.71%,IL34;SH3BP5;DLG3;THY1;LRP8;GPRC5B;SH3BP5L;MVP;SRCIN1;APP
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5255893328115283,1.423730758665463,0.056140350877192984,0.9620985637763706,1.0,10/39,17.25%,MYO1A;CLN3;MYO19;TANC2;MYO1B;MYO5A;BICDL1;HTT;TRAK1;KIF5B
prerank,protein heterotetramerization (GO:0051290),0.6392258095074923,1.4231428981521517,0.10419681620839363,0.9610634232133144,1.0,6/13,18.02%,FARSB;GRIN1;CPSF7;NUDT21;CPSF6;PKD2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6801267820785416,1.4221834178605923,0.10434782608695652,0.9623535594200959,1.0,1/10,0.17%,RNF157
prerank,regulation of keratinocyte migration (GO:0051547),0.6585870846007857,1.4221408065360381,0.06259097525473072,0.9575106767290217,1.0,2/12,4.88%,EPB41L4B;FGF10
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5234895738715389,1.4216804748994072,0.05214368482039398,0.9558324346766257,1.0,7/41,10.90%,SFRP2;TNNI3;TNNC1;FGFR2;SOX11;TPM1;RBPJ
prerank,positive regulation of protein sumoylation (GO:0033235),0.6814920486841017,1.421135436641855,0.08333333333333333,0.9546047178666721,1.0,7/10,22.92%,GNL3;RWDD3;SAE1;HDAC4;PIAS3;PIAS1;UBA2
prerank,DNA catabolic process (GO:0006308),0.6491865186778045,1.4193161517641286,0.07917888563049853,0.9624835762150271,1.0,3/11,6.72%,DNASE1L2;FBH1;DFFB
prerank,retinoid metabolic process (GO:0001523),0.48720304278006205,1.4179385644808467,0.03489640130861505,0.9669810437498778,1.0,16/71,17.19%,LPL;RDH10;STRA6;GPC6;ALDH1A2;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;CYP26B1;GPC4;LRP1;HSPG2;APOE
prerank,mammary gland development (GO:0030879),0.5813590454198376,1.417773952885,0.06806282722513089,0.9630310341597291,1.0,6/21,14.05%,APLN;GPAT4;ZBTB7B;WNT4;PRLR;NRG1
prerank,response to zinc ion (GO:0010043),-0.42269814420143714,-1.417026372406834,0.05907172995780591,0.7988722366521607,1.0,13/25,21.71%,SLC30A4;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;D2HGDH;GLRA2;CRIP1;MT2A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5816274475589256,1.416925011300246,0.07782101167315175,0.9639061510637248,1.0,5/22,4.88%,EPB41L4B;FGFR2;CASK;ZFP36L1;FGF10
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5634428447465066,1.4163919171875146,0.07207207207207207,0.9625329445993615,1.0,8/26,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;SARS1;PTGS2;TGFB1
prerank,embryonic digestive tract development (GO:0048566),0.6036973208456747,1.4162461324476934,0.07462686567164178,0.9586261259864773,1.0,6/18,11.29%,STRA6;FGFR2;PCSK5;NIPBL;SOX11;PDGFRA
prerank,cytoplasmic translational initiation (GO:0002183),-0.47573693831570923,-1.4162367940507865,0.07509881422924901,0.7924715333121811,1.0,9/17,26.18%,EIF2S2;EIF4B;MCTS1;RBM4;EIF4A2;EIF2D;EIF5;EIF3I;EIF3D
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6306944185869977,1.4155282678572716,0.091164095371669,0.958610708890117,1.0,6/14,13.47%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19
prerank,response to amyloid-beta (GO:1904645),0.5258887669642665,1.4154539177543612,0.056128293241695305,0.9541697762735908,1.0,10/44,10.71%,MMP12;FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP
prerank,protein targeting to ER (GO:0045047),-0.3192934844852345,-1.4146815070611807,0.0196078431372549,0.7892241320598722,1.0,46/99,20.16%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;SRPRB;RPS5;SPCS3;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;SGTA;RPS26;RPS27;RPL10A;RPS10;RPL7A;SGTB;SEC61A1;RPL31
prerank,negative regulation of cilium assembly (GO:1902018),0.643561501925891,1.4141656100460394,0.08832335329341318,0.9582310170201687,1.0,7/12,18.26%,CCP110;TBC1D7;CEP97;TCHP;EVI5L;MAP4;CDK10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5677158109936784,1.4136577640174608,0.08712613784135241,0.9570429022685237,1.0,4/23,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,histone H2A ubiquitination (GO:0033522),0.612696213905453,1.4133825247929728,0.08533333333333333,0.954195829170292,1.0,7/17,12.70%,RNF8;PCGF1;DDB1;RNF168;CUL4B;KDM2B;UBE2A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4541819624553823,-1.4131993619989198,0.061224489795918366,0.7859897594868267,1.0,8/20,17.09%,PDCD4;THBS1;ANO6;PLCG1;SFRP4;ITGA4;PIAS4;RGCC
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.47063597400965845,-1.4113329847570626,0.08695652173913043,0.784172862215706,1.0,9/17,22.95%,MAML3;MAML1;STAT1;NOTCH3;KAT2B;EP300;HEYL;PBX1;NOTCH4
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5135246759083059,-1.4111669955539445,0.09740259740259741,0.7756223847135558,1.0,4/14,12.55%,ATP1B3;AKAP9;ACTN2;ATP1B1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5574592824448259,1.4108457441883187,0.08631319358816276,0.9671441239459508,1.0,7/27,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,positive regulation of lipid localization (GO:1905954),0.6468043303132305,1.4105067215349867,0.11078717201166181,0.9646660113173592,1.0,2/11,2.19%,LPL;NFKB1
prerank,regulation of cellular protein localization (GO:1903827),0.5136152657128802,1.4104336942369085,0.05148741418764302,0.9603836048667032,1.0,11/45,9.82%,TRIM67;KCNAB2;LCP1;PARP1;HSP90AA1;ABCA2;GPC6;DVL1;GPC1;EGF;VCP
prerank,regulation of interleukin-13 production (GO:0032656),-0.5132476964914936,-1.4100249555224451,0.08783783783783784,0.7710097935983106,1.0,3/13,9.42%,LEF1;LGALS9;RARA
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5503418829437032,1.409561548397823,0.05867970660146699,0.9570195657762837,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5503418829437032,1.409561548397823,0.05867970660146699,0.9570195657762837,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,negative regulation of cellular protein localization (GO:1903828),-0.38425275340443765,-1.408435956614204,0.06179775280898876,0.7685192721279477,1.0,13/34,13.78%,LATS1;MFHAS1;PICALM;GPM6B;UBXN2B;GOPC;NSFL1C;TTBK2;ILRUN;ACTN2;MAP1A;NEDD4L;SIN3A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6283800176918691,1.40728881706927,0.09447674418604651,0.967787342035222,1.0,8/13,21.94%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,regulation of microtubule polymerization (GO:0031113),0.5162399516429459,1.4070020174987015,0.05854241338112306,0.9653515855792858,1.0,19/40,23.05%,PSRC1;RAC1;MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;DRG1;CLIP3;MAPT;EML2;TBCD;NUMA1;TUBB4A;RPS3;CAMSAP1;PAK1;MAP2;CDK5RAP2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4800033638451526,1.4053508536514254,0.04415011037527594,0.9718352445081381,1.0,11/66,12.83%,WNT5A;LPL;IGF1;GSDMD;TNFAIP3;CARD16;TMEM106A;SIRPA;MALT1;APP;GIT1
prerank,mesenchyme development (GO:0060485),0.6302901639043871,1.4053031046332836,0.09483960948396095,0.967491859105124,1.0,2/15,2.97%,SFRP2;FGFR2
prerank,alanine transport (GO:0032328),-0.565488365056674,-1.4047150206984036,0.10422535211267606,0.7750298031578656,1.0,5/10,27.21%,SLC6A6;SLC36A4;SLC1A4;SLC6A17;SLC36A1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5167325100113265,-1.4043605448463836,0.08996539792387544,0.7676719174054359,1.0,5/12,16.22%,TASOR;PPHLN1;APOBEC1;SETDB2;DNMT1
prerank,cellular response to pH (GO:0071467),0.6052267830299272,1.4043508599960919,0.08082191780821918,0.9691059275215549,1.0,3/17,4.43%,GPLD1;ASIC1;GPR68
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6526527159059375,1.403595690185736,0.08296943231441048,0.9694116350416152,1.0,1/12,1.00%,B3GALNT1
prerank,positive regulation of phospholipase activity (GO:0010518),0.5717151968648797,1.4031979801594128,0.08104575163398693,0.9672874393883079,1.0,5/22,3.62%,PLA2G5;PDPK1;NTF3;FGFR2;FGFR1
prerank,negative regulation of cation channel activity (GO:2001258),0.5653023801473464,1.4020948804837698,0.0722291407222914,0.9703027147492548,1.0,4/26,3.09%,UBQLN1;CBARP;EPHB2;CALM3
prerank,carbohydrate derivative transport (GO:1901264),0.5863666363613635,1.4018525642112103,0.0957004160887656,0.9674245265407532,1.0,4/18,8.90%,SLC29A1;CLN3;SLC25A19;VLDLR
prerank,immunoglobulin mediated immune response (GO:0016064),0.6598321374733696,1.4018432204533073,0.08647798742138364,0.9630091686338972,1.0,1/10,0.85%,FCGR2B
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5817328151002925,1.4017200889469592,0.08900523560209424,0.9594331154420486,1.0,1/21,0.14%,PLA2G5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6073756837441523,1.4011729600689782,0.09659863945578231,0.9588136575440916,1.0,4/16,9.11%,KHSRP;PLEKHN1;ZFP36L1;DHX36
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6092336604004569,1.400986070505689,0.07785234899328859,0.9557141380826143,1.0,7/16,17.19%,LRPAP1;ABCA7;IFNGR1;HDAC1;CYP51A1;LRP1;APOE
prerank,regulation of T cell migration (GO:2000404),0.5807666322927842,1.4009769797685865,0.09673024523160763,0.9514100364705307,1.0,5/18,10.71%,CXCL12;CD200R1;RIPOR2;DOCK8;APP
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.43212432064957557,-1.4001620197064293,0.07456140350877193,0.7755509133887583,1.0,8/24,10.78%,UBE2N;IRAK2;IRAK1;NOD1;RNF34;CYLD;UBB;IKBKG
prerank,negative regulation of cholesterol transport (GO:0032375),0.6809712025161568,1.4001338037814575,0.09244992295839753,0.9525365101506967,1.0,2/10,4.31%,NFKB1;ABCA2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5445369920781533,1.3997234178737565,0.08673469387755102,0.9509184481705749,1.0,6/27,13.55%,SELENOS;TNFAIP3;CD200R1;SIRPA;ARRB1;PTPN22
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6023417272026677,1.3990122734102104,0.08798882681564246,0.9511457468299843,1.0,5/17,9.08%,NTF3;NRP1;CDK5;ABL1;BAIAP2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4745722093778225,1.398499701879047,0.030623020063357972,0.9504268963844831,1.0,13/85,8.36%,SFRP2;FGF9;EPB41L4B;SFRP1;IGF1;BMP6;FGFR2;ZFP36L1;FGF10;LAMC1;TCF7L2;MAGED1;SOX9
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5023931093439084,1.3984591313316248,0.05499438832772166,0.9465073817041054,1.0,8/54,8.20%,AMIGO1;KCNAB2;BIN1;CD63;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,regulation of cell cycle process (GO:0010564),0.47118640044782556,1.3982675675785308,0.032091097308488616,0.9436536269643415,1.0,34/104,22.08%,CCP110;FSD1;SFRP1;CUL7;CSNK2A2;RAB11FIP4;MYO19;CALM3;OBSL1;CDK13;FLCN;FBXO5;PLK5;SOX9;ENTR1;PRMT5;MAP9;USP19;RCC1;GIT1;SND1;PRPF40A;KLHL13;NUMA1;PIK3C3;KIF20B;CALM1;PIK3R4;YTHDF2;UVRAG;KLHL9;RAB11FIP3;CALM2;CUL9
prerank,regulation of axon guidance (GO:1902667),0.668311066724223,1.3980764995159525,0.08850931677018634,0.9406999338330035,1.0,5/10,16.03%,ZSWIM6;NRP1;MYCBP2;YTHDF1;ZSWIM8
prerank,miRNA metabolic process (GO:0010586),0.5773169949112398,1.397767413591398,0.08119079837618404,0.9384935828515834,1.0,7/20,15.03%,KHSRP;TARBP2;DGCR8;DDX17;LIN28B;SND1;DIS3L2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6111812159317229,1.396614879550675,0.09491059147180192,0.9417663011328443,1.0,3/15,15.38%,HGD;FAH;QDPR
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5410070199015642,1.396384530180201,0.07352941176470588,0.9390083317053115,1.0,8/31,11.07%,BAX;CHCHD10;TFDP1;ZNF205;NMT1;YWHAH;YWHAG;BCL2
prerank,tyrosine metabolic process (GO:0006570),0.6610159493130644,1.3952850330950426,0.10134128166915052,0.9419029317039694,1.0,1/11,0.55%,HGD
prerank,neuron projection extension (GO:1990138),0.5324773724334778,1.394787228924495,0.07720588235294118,0.9409448543244009,1.0,14/32,15.90%,HSP90AA1;NRP1;CDK5;TMEM108;CYFIP1;FLRT1;IQGAP1;NLGN3;USP9X;ALCAM;AUTS2;IMPACT;SEMA3A;SLC9A6
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5239035185850076,1.3947641491308007,0.0713436385255648,0.9370745480049202,1.0,9/35,15.44%,FASN;ALOX5AP;HMGCLL1;FAR2;BDH1;ACAT1;PAM;FAR1;SLC25A1
prerank,isotype switching (GO:0045190),0.6583404897969317,1.3943522424407133,0.1004566210045662,0.9356097244562273,1.0,4/10,15.53%,EXOSC3;RNF8;RNF168;HSPD1
prerank,regulation of exit from mitosis (GO:0007096),0.5253907762782275,1.3941368546436819,0.0715962441314554,0.9330782885751494,1.0,16/38,19.74%,CDC23;SIRT2;UBE2S;MAD2L1;CDC16;ANAPC2;CDC14B;PPP1R9B;ANAPC11;ANAPC4;CDC26;UBE2E1;UBE2D1;ANAPC10;ANAPC5;ZW10
prerank,regulation of protein neddylation (GO:2000434),-0.5689473298258406,-1.3939512242204153,0.12573099415204678,0.7919182200263936,1.0,4/10,6.65%,DCUN1D4;RPL11;HIF1A;RPL5
prerank,protein secretion (GO:0009306),0.4922831321497245,1.3936873336803666,0.054857142857142854,0.9320618281547944,1.0,20/56,18.19%,PTPRN;ANXA1;PCSK5;TVP23B;MIA3;RAB12;RCN3;RAB10;WLS;RAB3B;PORCN;PARK7;TANGO2;CAMK2G;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3
prerank,regulation of B cell differentiation (GO:0045577),0.5868946708005434,1.3930532931845125,0.11066666666666666,0.9321858857587251,1.0,3/17,4.02%,SFRP1;XBP1;ZFP36L1
prerank,positive regulation of T cell migration (GO:2000406),0.5643628498157514,1.3929503088601354,0.10675675675675676,0.9289520309858915,1.0,4/20,10.71%,WNT5A;CXCL12;DOCK8;APP
prerank,protein heterooligomerization (GO:0051291),0.5967029716851511,1.392747786854814,0.10445682451253482,0.9262491193776744,1.0,8/17,18.44%,FARSB;GRIN1;KCNC2;CPSF7;NUDT21;CPSF6;PKD2;MAT2A
prerank,negative regulation of immune effector process (GO:0002698),-0.5232615390344408,-1.3922503202108403,0.10784313725490197,0.7899359712365349,1.0,6/13,13.96%,FER;APPL1;RPS19;RC3H1;GRN;ENPP3
prerank,sensory perception of chemical stimulus (GO:0007606),0.6166411491092825,1.3913818646306688,0.09497206703910614,0.9309322825331848,1.0,4/15,10.58%,SYT10;SLC24A4;GNAS;UBR3
prerank,glycosphingolipid metabolic process (GO:0006687),0.5152732356152779,1.390672027816663,0.07258064516129033,0.9316236696589312,1.0,12/42,14.35%,B3GALNT1;A4GALT;CLN6;ST8SIA3;SMPD2;GBA2;GLB1;ABCA2;ST3GAL5;PSAP;SMPD4;ST6GALNAC6
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5497780055884565,-1.3906660413089733,0.10670731707317073,0.7882524703491817,1.0,7/10,34.88%,MTHFR;MTHFS;MTHFD1;MTHFD1L;MTHFD2;DHFR;TYMS
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5472370423422002,-1.3904381285070886,0.09302325581395349,0.7807306497272355,1.0,4/10,3.95%,PRKG1;RDX;SERPINE2;PRKCD
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5293630339338071,-1.390306714676673,0.11333333333333333,0.7728999194191077,1.0,6/13,24.20%,GJA1;GJC1;CACNA1C;CACNB2;KCNJ3;KCNQ1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.43041804820726287,-1.3902842594080471,0.09734513274336283,0.7648827124801113,1.0,7/23,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.48586117407333884,1.389503223297459,0.05726872246696035,0.9351292753698075,1.0,11/59,12.08%,NDUFAB1;LPL;CYP27A1;MLYCD;XBP1;ALDH1A2;CYP7B1;HSD17B4;ELOVL4;AMACR;PARK7
prerank,regulation of dendrite extension (GO:1903859),0.5868963846433727,1.3892773972833314,0.10307898259705489,0.9327959727128233,1.0,3/18,3.59%,RNF157;SYT3;UNC13A
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5989812773180136,1.389208949615654,0.08615819209039548,0.9294144301000038,1.0,9/17,17.69%,CPEB1;CDK9;RNF40;CPSF7;ZC3H14;NUDT21;ZC3H3;CCNT1;CPSF6
prerank,regulation of cellular localization (GO:0060341),0.5071133456073561,1.3886484174679343,0.08,0.9290576971630075,1.0,19/46,23.25%,TRIM67;UNC13D;PARP1;HSP90AA1;DVL1;BRSK2;BRSK1;CAMK2D;NUMA1;ADCY5;EPHA5;WWC1;LYN;PARD6G;GSN;PPM1F;GOSR1;MAP2;STXBP4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4670990100929974,1.3883129840432098,0.023735810113519093,0.9275018958424309,1.0,48/129,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;FGF10;PPM1B;USP47;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,regulation of secretion (GO:0051046),0.6267408657372516,1.3880853698173632,0.1,0.9252253677968391,1.0,6/13,16.96%,GPLD1;OPRK1;FGF10;EGF;NRG1;OAS2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5559297410491411,1.3880090161027603,0.08596713021491782,0.9219881118012544,1.0,10/26,21.10%,SMPDL3B;GPR108;IRF1;LGR4;LRRC14;TLR3;GPS2;FLOT1;BIRC3;APPL2
prerank,organic anion transport (GO:0015711),0.47401748232012364,1.3876496165245102,0.0427807486631016,0.9204637186780072,1.0,7/76,2.23%,CYB5R2;SLC4A4;SLC4A5;SLC35B2;SLC35B1;SLC25A19;LRRC8A
prerank,secretion (GO:0046903),0.6208588757828841,1.3876232564542235,0.09971509971509972,0.916926768686271,1.0,4/14,13.35%,GUCA1B;SLC22A4;FBLN5;PRKCI
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.631479721317812,1.3871833335115409,0.09668109668109669,0.9160393023425749,1.0,1/13,1.00%,B3GALNT1
prerank,acylglycerol biosynthetic process (GO:0046463),0.572328592939767,1.387030003153389,0.08769633507853403,0.913367771728872,1.0,7/23,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.617000269994281,1.3870162564504482,0.10267229254571027,0.9098427604375997,1.0,5/15,17.19%,GPLD1;NRDC;PACSIN3;SNX33;APOE
prerank,Golgi ribbon formation (GO:0090161),0.64247462347398,1.3861427757890654,0.1019202363367799,0.9114876394749112,1.0,5/13,15.63%,STX6;TRIP11;STX16;PRMT5;VTI1A
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4257724111086896,-1.384996246592601,0.08906882591093117,0.7776687830254462,1.0,8/24,16.70%,PECAM1;EZR;F11R;SEMA4D;NT5E;ROCK1;ITGA4;MSN
prerank,regulation of cell junction assembly (GO:1901888),-0.3989905785254112,-1.3849344460268787,0.08465608465608465,0.7699874866861911,1.0,9/27,11.89%,MEF2C;PRKCH;PDLIM5;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6408749257346286,1.384787352081363,0.10186513629842181,0.9123752683723736,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6408749257346286,1.384787352081363,0.10186513629842181,0.9123752683723736,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5334667477525633,1.3844577356723986,0.0885286783042394,0.9108823957540092,1.0,6/30,9.79%,SFRP2;CDKN2D;CXCL12;SNAI1;FBXO5;TWIST1
prerank,negative regulation of blood pressure (GO:0045776),0.617239163888294,1.3839568180351287,0.10814606741573034,0.9103422337283821,1.0,1/13,0.18%,APLN
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5903634436982906,1.3832576084753265,0.09054593874833555,0.9109289797222542,1.0,2/17,0.87%,UNC13D;SYT10
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4484368314957004,-1.3816342602111384,0.0912863070539419,0.7746005570600156,1.0,8/19,11.89%,PRKCH;IKBKB;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6683212175830837,1.3807276592673468,0.11027190332326284,0.9197153586481656,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,DNA dealkylation (GO:0035510),0.6683212175830837,1.3807276592673468,0.11027190332326284,0.9197153586481656,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,response to glucose (GO:0009749),0.49727286075705057,1.379835982240756,0.06533776301218161,0.9217544002754441,1.0,12/46,13.42%,LPL;GPLD1;SELENOS;NKX6-1;XBP1;TCF7L2;SELENOT;IRS2;ZBTB20;RACK1;ZBED3;TRA2B
prerank,positive regulation of cell adhesion (GO:0045785),0.47406111835628184,1.3797429165217474,0.048179871520342615,0.9188787778826316,1.0,13/74,12.46%,SFRP2;EPB41L4B;DUSP26;RAC1;CXCL12;PRKCA;FLCN;RHOD;TPM1;ADGRG1;FBLN2;CD47;ECM2
prerank,peptide catabolic process (GO:0043171),-0.4207396715264743,-1.379736021305895,0.0990990990990991,0.7753211436940877,1.0,12/23,23.93%,NPEPPS;LNPEP;LTA4H;ERAP1;TPP1;GGT5;XPNPEP1;ACE;ENPEP;IDE;CHAC2;TRHDE
prerank,T cell homeostasis (GO:0043029),-0.547930839756097,-1.3784324383986515,0.12074303405572756,0.7727365294193561,1.0,5/10,24.62%,PPP2R3C;FAS;AKT1;NCKAP1L;ZC3H8
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5117064521030895,1.3782036529117723,0.07827102803738317,0.9249776531283379,1.0,12/40,14.63%,BAX;SLC25A33;PRELID1;ABL1;PPA2;SLC25A36;PID1;VCP;BCL2;PARK7;MAPT;RNF122
prerank,membrane lipid catabolic process (GO:0046466),0.6723749161558449,1.3773832772841972,0.10962962962962963,0.9262902399515337,1.0,4/10,10.25%,SMPDL3B;SMPD2;SGPL1;ENPP2
prerank,axon development (GO:0061564),0.47644794295899384,1.3769269423782602,0.04736275565123789,0.92556484881752,1.0,28/78,21.89%,AMIGO1;EPHB2;ATL1;FGFR2;NEFH;CDK5;PAK3;BRSK2;CAMSAP2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;MAPK8IP3;DOCK7;MAPT;RAB8A;DCC;ZDHHC17;SLITRK1;SLITRK5;SPTBN4;LLGL1;RYK;ARHGAP35
prerank,sympathetic nervous system development (GO:0048485),0.5951508785883235,1.375438500940604,0.11141678129298486,0.9311484517520184,1.0,6/15,19.15%,FZD3;NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,rRNA catabolic process (GO:0016075),0.6037649223490573,1.3751321769135854,0.09849521203830369,0.9296029648458062,1.0,4/16,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5501928267463226,1.3749289482657414,0.09541511771995044,0.9273992584494068,1.0,10/25,17.62%,STUB1;ZYG11B;NGLY1;AUP1;POMT2;KLHL15;VCP;UGGT2;DERL1;OMA1
prerank,heart contraction (GO:0060047),0.5031539149261026,1.3744489871889394,0.08027522935779817,0.9267784150795074,1.0,6/41,10.81%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1
prerank,sodium ion export across plasma membrane (GO:0036376),0.6297759808561636,1.372494726375283,0.12129760225669958,0.9352665792576501,1.0,3/13,7.53%,SLC4A4;ATP1A3;ATP1A2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5994952321152593,1.372226358239577,0.10505319148936171,0.9334047172995157,1.0,9/17,22.65%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,positive regulation of dendrite extension (GO:1903861),0.5886356196172378,1.3719340659414854,0.11580381471389646,0.9317645065232494,1.0,3/17,3.59%,RNF157;SYT3;UNC13A
prerank,regulation of protein polymerization (GO:0032271),0.5185928237852704,1.371297653041538,0.0914560770156438,0.9321980681840243,1.0,11/35,9.64%,ABITRAM;HSP90AA1;MAPRE3;GBA2;ABL1;PAK3;DBN1;TPPP3;CAMSAP2;PRUNE1;DBNL
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6295724938983004,1.3702262121469386,0.10057471264367816,0.9352346283727307,1.0,6/12,21.25%,HGS;NDRG4;IFT20;CBL;F3;CBLB
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4782667528404396,1.369802429889096,0.061555075593952485,0.9343150992293723,1.0,23/65,19.03%,CPEB1;UBQLN1;SFRP1;SIRT2;STUB1;PICK1;RORA;ZFP36L1;CARD16;FAM162A;TBL2;MDM4;NDRG1;TWIST1;SUV39H1;AK4;EGLN2;PTGS2;NDNF;HP1BP3;MDM2;PGK1;FMN2
prerank,cellular response to interleukin-6 (GO:0071354),-0.4140348437573804,-1.3687940793785556,0.09523809523809523,0.8038719565674177,1.0,7/26,4.13%,SMAD4;ST3GAL6;IL6R;FER;STAT3;STAT1;SBNO2
prerank,regulation of mitotic nuclear division (GO:0007088),0.49204257288401104,1.3687346100809699,0.06562847608453838,0.9374740803263961,1.0,10/55,9.18%,IGF1;CUL7;LCMT1;EDN3;OBSL1;CDK13;FBXO5;AURKAIP1;EGF;PRMT5
prerank,negative regulation of protein phosphorylation (GO:0001933),0.45344982114444726,1.36871940989964,0.021148036253776436,0.9341934406965368,1.0,49/150,19.00%,SFRP2;SFRP1;SIRT2;TARBP2;EPHB2;GSKIP;TSC2;PDPK1;NTF3;GPD1L;CALM3;PRKRIP1;WARS1;FBLN1;PMEPA1;ERRFI1;THY1;ATG14;DMTN;DVL1;CNKSR3;SIRPA;PID1;CDK5RAP3;TWIST1;MVP;YWHAG;IGFBP3;ENPP1;PARK7;RACK1;PLPP3;ZBED3;TGFB1;FKBP8;PPM1E;IMPACT;SMAD6;ITGB1BP1;SPRY2;GNAQ;DNAJC10;CAMK2N1;RASSF2;TAB1;TERF2IP;TRIM27;CALM1;PRKAG2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5309582432462375,1.3686264776805337,0.08859223300970874,0.9313714679953674,1.0,11/32,16.50%,CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5187096954162005,-1.3679831678488783,0.11683848797250859,0.7995571922235569,1.0,3/12,5.12%,WAPL;RB1;HDAC8
prerank,respiratory system development (GO:0060541),0.5328572638991915,1.36743840393233,0.08241082410824108,0.9349861691402499,1.0,4/32,6.59%,FGF9;STRA6;FGFR2;ZIC3
prerank,purine nucleotide catabolic process (GO:0006195),-0.5090018092786883,-1.3657988262817338,0.11326860841423948,0.8010511390577747,1.0,8/13,34.73%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,chloride transmembrane transport (GO:1902476),-0.34699311799589394,-1.365555685974391,0.02608695652173913,0.7945356988564263,1.0,20/48,23.88%,ANO4;GABRB1;SLC12A7;GABRG2;CLCN3;ANO6;ANO1;GABRA5;SLC12A4;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;GLRA3;SLC12A8
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.488085319477977,-1.3650723995673786,0.11224489795918367,0.7888785997778466,1.0,6/14,17.09%,PDCD4;THBS1;ANO6;PLCG1;ITGA4;RGCC
prerank,regulation of ion transport (GO:0043269),0.47129839277704905,1.3646809306745749,0.05166846071044134,0.948690052831547,1.0,13/76,12.73%,FGF20;SYT3;SYT10;NKAIN4;VAMP3;SNX6;SIK1;KCNJ10;YWHAH;PER1;GDNF;ANK3;SYT1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5522930404193686,1.364491518142479,0.09801324503311258,0.9464855316291054,1.0,7/24,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;PTGS2;TGFB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6372049305614866,1.36400407672562,0.1144578313253012,0.9460402645403062,1.0,4/11,5.91%,IGF1;TSC2;EIF2AK3;PIK3R1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5078146328388049,-1.3637059786420866,0.11044776119402985,0.7866663610586746,1.0,9/12,35.55%,CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;MUL1;CGAS
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5336574058662229,1.3628850846777594,0.10687022900763359,0.9494524265109234,1.0,8/27,13.59%,FCGR2B;FBXO7;BRSK2;NTNG2;BRSK1;IL1RAPL1;CAMK2G;DISC1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.46024698557831956,-1.3619608477955736,0.10175438596491228,0.7856379232830715,1.0,4/16,21.27%,LAMP1;CADM1;NECTIN2;PVR
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4782302787387269,1.3616247740294944,0.06688963210702341,0.9536479608749983,1.0,14/62,12.60%,SFRP2;CDKN2D;PPIF;SELENOS;SYVN1;XBP1;DDX3X;CXCL12;SNAI1;BCL2;RTKN2;PARK7;SOD2;CREB3
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5040810397097207,-1.361404355334053,0.10069444444444445,0.780824061110393,1.0,8/13,18.49%,GOT2;IDH1;IDH2;PHYH;D2HGDH;GPT2;L2HGDH;GOT1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5736620291866483,1.361100260226411,0.11038107752956636,0.9535451993771669,1.0,5/21,13.55%,FCGR2B;TNFAIP3;PIBF1;SOX11;PTPN22
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6159016771686306,1.3605591185310635,0.1188118811881188,0.953664898440518,1.0,5/13,11.52%,NFKB1;SCAP;DKK3;ERLIN2;BMP5
prerank,nuclear membrane disassembly (GO:0051081),0.6044866468801282,1.3597966090866556,0.1258741258741259,0.955092615264356,1.0,4/14,6.66%,LPIN1;PRKCA;NEK9;AKAP8L
prerank,canonical Wnt signaling pathway (GO:0060070),0.4766570844687952,1.35970205906677,0.06580366774541532,0.952367117928009,1.0,15/68,15.29%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;FZD9;FZD3;TCF7L2;DVL1;WNT4;DIXDC1;PORCN;PLPP3;CSNK1A1;TCF7L1
prerank,cellular response to amyloid-beta (GO:1904646),0.5187048961111272,1.3592885209375927,0.08028335301062574,0.951547691812424,1.0,11/35,16.06%,FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP;LRP1;ICAM1
prerank,regulation of leukocyte migration (GO:0002685),0.5798642044740367,1.358724731611903,0.0997229916897507,0.9516759743752888,1.0,3/16,6.68%,RAC1;ANXA1;MIA3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.49239205663060354,1.3587153913884171,0.09630459126539753,0.948467105646973,1.0,12/48,16.59%,GMPS;ADSL;SLC35B2;ADCY7;DCAKD;PANK4;COASY;ACAT1;AK5;ADCY1;NPR2;ADCY5
prerank,negative regulation of neuron differentiation (GO:0045665),-0.4323634606629742,-1.3584255684438478,0.11555555555555555,0.784552504806343,1.0,9/22,24.88%,EIF2AK4;MED1;CALR;REST;BMP7;HES1;DTX1;SOX2;NEPRO
prerank,regulation of glucose import (GO:0046324),0.5224972687392067,1.3566050632033986,0.13080684596577016,0.9582355004654083,1.0,9/30,13.35%,RTN2;IGF1;SELENOS;CAPN10;PIK3R1;PID1;IRS2;ENPP1;PRKCI
prerank,cellular lipid catabolic process (GO:0044242),0.53900442671558,1.3561118717707843,0.09871794871794871,0.9579301083237182,1.0,6/27,12.41%,SMPDL3B;SIRT2;LPIN1;LPIN3;ENPP2;LPIN2
prerank,steroid metabolic process (GO:0008202),0.463446722875363,1.3555199797937116,0.055853920515574654,0.9583005312832206,1.0,13/72,13.04%,CYP27A1;GBA2;CYP7B1;LSS;HSD17B4;GC;RDH5;MSMO1;PRLR;AMACR;STARD3;CYP26B1;CYP51A1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45114804260882624,-1.354990483152724,0.11328125,0.7904083999281201,1.0,6/18,13.96%,DOCK2;SBNO2;LBP;PLCG2;DYSF;ENPP3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5584649564618664,1.3544248341387917,0.11023622047244094,0.9618041761169279,1.0,6/20,18.02%,APLN;SULF1;GPC1;NPTN;SPRY2;PRKD2
prerank,photoperiodism (GO:0009648),0.5322161664725369,1.3536543604060896,0.12315270935960591,0.9634315441487595,1.0,7/28,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,regulation of neuron apoptotic process (GO:0043523),0.45513022975212525,1.3527111051226925,0.04407135362014691,0.9659909364975844,1.0,23/96,17.19%,FGF20;CLN3;EPHA7;BAX;NTF3;FZD9;CDK5;SNX6;SLC30A10;DDIT3;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;LANCL1;PRKCI;EGLN2;NUPR1;NDNF;FAIM2;APOE
prerank,glycoprotein catabolic process (GO:0006516),0.5803333932990672,1.3527065168645505,0.13164893617021275,0.9627798448112475,1.0,4/17,8.34%,MMP12;EDEM1;NGLY1;MANBA
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4486890283965379,-1.3523701939256232,0.09420289855072464,0.7934433476060518,1.0,4/17,21.27%,LAMP1;CADM1;NECTIN2;PVR
prerank,presynapse assembly (GO:0099054),0.584307976018473,1.351635207698339,0.12292817679558012,0.9662446886998453,1.0,5/16,14.38%,WNT5A;DVL1;IL1RAPL1;NLGN3;NLGN2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5503577492199582,1.3514304551531562,0.12857142857142856,0.9643194219055541,1.0,7/21,15.91%,SIRT2;SLC30A10;PARK7;COA8;ABCB7;ABCD2;SIRT5
prerank,positive regulation of protein processing (GO:0010954),0.5632940581751124,1.3509627196511416,0.12217795484727756,0.9640019741866899,1.0,2/19,4.19%,CLEC3B;CCBE1
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5002028778524505,-1.348884135496375,0.15857605177993528,0.7997013765056245,1.0,11/12,45.59%,MCM6;CDC7;MCM4;MUS81;MCMDC2;GINS4;CDC45;MCM3;MCM2;MCM7;MCM5
prerank,positive regulation of heart rate (GO:0010460),0.5774131849977479,1.3488262081671498,0.12150837988826815,0.9740365090005331,1.0,4/17,10.81%,ADM;EDN3;ATP2A2;TPM1
prerank,sensory perception of smell (GO:0007608),0.6427784331069715,1.3473252610923598,0.13049853372434017,0.9799405276199297,1.0,3/11,10.58%,SYT10;SLC24A4;UBR3
prerank,neurotransmitter transport (GO:0006836),0.4694819632831682,1.3472366236058426,0.0611587982832618,0.9772957993567262,1.0,16/73,14.29%,SLC29A1;PPFIA4;GLS2;CASK;UNC13A;DVL1;ATP1A2;GLUL;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1;SLC6A4;SLC1A3;SLC6A15
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5616387779150029,1.3472302273426773,0.1152317880794702,0.9741532163286132,1.0,6/20,18.98%,RNF157;APLP1;GRK3;GRK2;MRAP2;GPRASP1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6327398401847658,1.34712415287515,0.14413075780089152,0.9716817047131117,1.0,5/11,19.47%,ATL1;BNIP1;MOSPD3;VAPB;VCPIP1
prerank,activation of adenylate cyclase activity (GO:0007190),0.5158348781837606,1.3467789047333312,0.11204819277108434,0.9706757993207414,1.0,2/35,2.40%,FSHR;ADCY7
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6309476022724869,1.345781127637807,0.1338235294117647,0.9736561241613357,1.0,4/11,11.50%,BIN1;NOS1AP;CACNB1;CAMK2D
prerank,ear morphogenesis (GO:0042471),0.5536542137066848,1.3442812399422404,0.11984536082474227,0.9797439829599371,1.0,4/20,9.79%,EPHB2;FGFR2;NIPBL;TWIST1
prerank,protein polymerization (GO:0051258),0.4676980020882174,1.3440916879017701,0.08496732026143791,0.9776388797981648,1.0,21/56,21.47%,SPIRE2;CENPJ;RAC1;UBE2S;TPPP3;TTC17;CHMP3;WASF1;MAPT;SPIRE1;TPPP;GPX4;GAS7;ARHGAP6;PSTPIP2;PREX1;FGF13;GSN;DIAPH1;CHMP4A;CHMP4B
prerank,regulation of viral life cycle (GO:1903900),-0.42561896076000666,-1.343628626867782,0.11711711711711711,0.812497677684195,1.0,9/21,21.33%,TSG101;AXL;TRIM25;KPNA6;TRIM5;TRIM14;VPS4A;NECTIN2;HS3ST5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5707812056056175,1.3432784982038173,0.11756935270805813,0.9797115289372623,1.0,7/17,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,triglyceride metabolic process (GO:0006641),0.4859773870155774,1.3428105283227498,0.08587570621468926,0.9794655440443581,1.0,8/48,12.41%,LPL;MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,T cell migration (GO:0072678),-0.5032960762266355,-1.3424900992419921,0.15488215488215487,0.8096031691855621,1.0,5/13,22.73%,CXCL16;S1PR1;MSN;SLC12A2;PIK3CD
prerank,cellular response to sterol (GO:0036315),0.6100181813280707,1.342224083764089,0.13848396501457727,0.979804212806231,1.0,5/13,8.42%,GPLD1;RORA;MLC1;INSIG1;PTCH1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.6112553401488698,1.3413330681540656,0.14202049780380674,0.982207692834202,1.0,4/12,13.10%,ADSL;PRPSAP2;GART;HPRT1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.6069266477288817,1.340765094426574,0.13793103448275862,0.9826129998551407,1.0,3/12,5.13%,LPIN1;PRKCA;NEK9
prerank,mRNA splice site selection (GO:0006376),0.522843009601682,1.3402773844321634,0.10442260442260443,0.9825092188957261,1.0,14/30,17.68%,SRSF12;SRSF5;CELF2;CELF1;SRSF9;SF3A1;SRSF1;PSIP1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3
prerank,positive regulation of ossification (GO:0045778),0.5068040923747084,1.3401377827361518,0.11750881316098707,0.9802570253671881,1.0,11/39,9.70%,WNT5A;TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;SOX11;KL
prerank,positive regulation of cell growth (GO:0030307),0.45080029385444,1.3396436576128457,0.05345911949685535,0.9801213804729586,1.0,21/96,13.93%,SFRP2;RNF157;SYT3;SFRP1;IGF1;CDKN2AIP;EXOSC2;CDKL5;TAF9B;UNC13A;SLC25A33;DDX3X;USP47;DBN1;SDCBP;DBNL;BCL2;EIF4G2;SYT1;RPS6KA3;MAPT
prerank,cardiolipin metabolic process (GO:0032048),0.6102289086709151,1.3394770850657258,0.1375886524822695,0.9780222899710038,1.0,6/13,16.50%,PLA2G5;PTPMT1;CRLS1;HADHB;LCLAT1;SLC27A1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.38718895609371307,-1.3384024510345758,0.11940298507462686,0.8185560928454353,1.0,10/25,18.44%,KAT7;WDR43;ELL;HTATSF1;EAF2;SCAF8;THOC5;CCNK;CCAR2;ERCC6
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5774219790938316,1.338270001223989,0.13802435723951287,0.9822317161241583,1.0,6/17,14.84%,BAX;FIS1;FZD9;BCL2;SOD2;DNM1L
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4469656981786571,1.338027298693536,0.03483606557377049,0.9806316937805533,1.0,52/152,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;TNFAIP3;FGF10;PPM1B;USP47;SULF1;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CDC73;DISC1;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4039682694408755,-1.3379181697349993,0.0967741935483871,0.8134106295307734,1.0,9/26,10.78%,UBE2N;IRAK2;IRAK1;NOD1;IFIH1;CYLD;UBB;ALPK1;IKBKG
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4858381605839202,1.3378516779170437,0.09192825112107623,0.9787020810202548,1.0,14/50,16.45%,SFRP1;STK36;FGFR2;DCDC2;GLIS2;RORA;RAB34;TUBD1;PTCH1;VCP;RACK1;SUFU;TULP3;MEGF8
prerank,icosanoid secretion (GO:0032309),0.6086965962336995,1.337653421315091,0.14138438880706922,0.9768841012787097,1.0,3/12,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,positive regulation of cell differentiation (GO:0045597),0.43932090526243356,1.3375849352500844,0.005035246727089627,0.9742880143160378,1.0,59/237,16.48%,SFRP2;PLA2G5;MAPK9;LPL;TMEM119;SFRP1;IGF1;SP7;FBN2;NFKB1;LRRC8A;BMP6;EDN3;FGFR1;XBP1;GLIPR2;ZFP36L1;NELL1;SNAI1;OLFM1;DDR2;TCF4;ABL1;FBXO5;SUCO;EZH2;ZEB1;RANBP3L;GPC1;RIPOR2;TGFB1I1;WDFY2;BRINP3;WNT4;SOX9;MMD;GPRC5B;SDCBP;DHX36;SOX11;TWIST1;GDNF;IGFBP3;BNIP2;NUDT21;SOX6;AXIN2;RPS6KA3;TGFB1;AAMDC;IMPACT;SOX5;LMO3;TCF3;CTNNBIP1;RPS6KA1;CDS1;MEDAG;AGTR1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4659077394979002,1.3374209346602013,0.06731813246471227,0.9723625811883373,1.0,30/75,21.78%,ATL1;ABITRAM;FGFR2;DCDC2;MINK1;NEFH;CDK5;PAK3;DVL1;BRSK2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;DOCK7;FARP1;RAB8A;BTBD3;TBCD;DCC;ZDHHC17;SLITRK1;SLITRK5;MAP6;SPTBN4;LLGL1;RYK
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5330459069476352,-1.337347076263345,0.14705882352941177,0.8083707280422098,1.0,6/10,27.10%,CSGALNACT1;XYLT1;DSEL;B3GAT2;XYLT2;B3GAT1
prerank,myelin assembly (GO:0032288),0.6335415367491766,1.337243186212542,0.15279878971255673,0.9704698834599804,1.0,6/10,21.60%,ABCA2;GPC1;EPB41L3;TENM4;TPPP;CD9
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5096633393284351,1.3368773533690883,0.11799761620977355,0.9697230347357941,1.0,6/34,14.67%,WNT5A;EPHB2;XBP1;VAMP3;PTPN22;LACC1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5326270364721905,1.3368321059329145,0.1246684350132626,0.9669838647010331,1.0,5/24,8.37%,CARMIL2;RAC1;ACTR2;PIK3R1;CYFIP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5200111913077319,1.3367416663535108,0.10957178841309824,0.9646440297243022,1.0,7/28,9.17%,STMN4;MAPRE3;GBA2;ABL1;CAMSAP2;GAS2L1;PRUNE1
prerank,regulation of cell adhesion (GO:0030155),0.441939287990517,1.3366152203183235,0.03881511746680286,0.9624573571680207,1.0,24/129,11.14%,EPB41L4B;DUSP26;DACT2;EPHA7;EPHB2;PLXNA2;FBLN1;CXCL12;MINK1;PRKCA;FLCN;NUAK1;ABL1;ADAM22;EPHA8;MIA3;RHOD;CXCR4;RIPOR2;DSCAM;PLXNA1;GPR4;TPM1;ADGRG1
prerank,axon extension (GO:0048675),0.5392419858474687,1.336507730382165,0.11938382541720154,0.960207181846339,1.0,12/23,15.90%,HSP90AA1;NRP1;CDK5;CYFIP1;NLGN3;USP9X;ALCAM;AUTS2;SLIT1;SLIT3;SEMA3A;SLC9A6
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5148518428336325,1.3364140568974479,0.10643564356435643,0.9578440924334155,1.0,10/31,20.88%,TNNI3;TNNC1;FGFR2;TPM1;RBPJ;NRG1;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.559513536351268,1.3358242493824655,0.14056224899598393,0.9584001690161101,1.0,6/19,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.49812557721466816,1.3352322156932637,0.1050767414403778,0.9589090860200811,1.0,7/41,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;ANK3;GABBR1
prerank,neuron projection morphogenesis (GO:0048812),0.4384025849962283,1.3348498468215182,0.03153611393692777,0.9583076729290546,1.0,51/137,21.78%,EPHB2;ATL1;ABITRAM;NTF3;FGFR2;DCDC2;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;DVL1;DBN1;BRSK2;FLRT1;BAIAP2;RAB10;DBNL;NTNG2;BRSK1;AFG3L2;APP;ANK3;ALS2;IQGAP1;DOCK7;FARP1;ALCAM;EPB41L3;IMPACT;CNTNAP2;RAB8A;TRIO;SLC9A6;BTBD3;DCC;ZDHHC17;SLITRK1;GAS7;KIF20B;SHANK1;NRK;SLITRK5;NBL1;MAP6;SPTBN4;MAP4K4;LLGL1;RYK
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.6134999509794877,1.3347107187338203,0.1545595054095827,0.956245556438699,1.0,3/10,13.59%,SMARCD3;FZD3;DISC1
prerank,regulation of chemotaxis (GO:0050920),0.5157238943212823,1.3346906521780892,0.11138310893512852,0.9534975353762171,1.0,10/30,16.26%,USP14;ZSWIM6;CXCR4;MYCBP2;EFNB2;PDGFRA;YTHDF1;TGFB1;ZSWIM8;ADGRA2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6389202057757716,1.3346857729358574,0.1452599388379205,0.950722404391664,1.0,3/10,6.42%,EMC1;EMC8;MMGT1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3846807398629784,-1.3320914022576555,0.0782122905027933,0.8215027294122605,1.0,6/30,9.55%,CD46;STAT3;TLR4;LGALS9;CD34;PLCG2
prerank,lipoprotein localization (GO:0044872),0.6214066817871293,1.3317483497666598,0.15417867435158503,0.9649997123271651,1.0,5/11,17.86%,MIA3;ZDHHC3;LRP1;VMP1;ZDHHC17
prerank,positive regulation of nuclear division (GO:0051785),0.5435165772879531,1.3299109468840575,0.13670886075949368,0.972908175212669,1.0,4/25,9.15%,IGF1;SIRT2;EDN3;EGF
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5451566510057957,1.3286595788166171,0.13043478260869565,0.9773550364227263,1.0,7/22,19.25%,GPLD1;NRDC;PACSIN3;SNX33;PTPN3;APOE;TIMP2
prerank,peptide hormone secretion (GO:0030072),0.5264989504677982,1.3285141255652113,0.140485312899106,0.9754390201778,1.0,5/26,12.18%,PTPRN;EDN3;ANXA1;PARK7;CAMK2G
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5407588904914481,1.328464345565999,0.1348464619492657,0.9729705992734471,1.0,7/21,12.60%,SELENOS;EIF2AK3;SYVN1;XBP1;DDIT3;PARK7;CREB3
prerank,regulation of sodium ion transport (GO:0002028),0.5065432284618054,1.3276712242013744,0.10861865407319952,0.9748329848632992,1.0,10/34,11.41%,GPD1L;NKAIN4;CNKSR3;SIK1;YWHAH;PER1;WNK2;ANK3;SLMAP;FGF12
prerank,negative regulation of ATPase activity (GO:0032780),0.5718791106098903,1.3274490694903462,0.11203319502074689,0.9732549708222058,1.0,2/16,1.61%,TNNI3;PPIF
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.49534937923949945,1.3264998532806693,0.09644087256027555,0.9761046407692832,1.0,20/45,22.11%,MAD2L1;HECA;ZFP36L1;FZD3;SCRIB;WEE1;TRIM35;BRINP3;AURKAIP1;CHFR;PTPN3;TGFB1;BCL6;ZWINT;BRINP1;NABP2;ZW10;TOM1L2;ANGEL2;SMAD3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5270129281347485,1.3264625478973489,0.12371134020618557,0.9734826178304742,1.0,6/24,6.14%,SFRP1;RAC1;NRP1;PIK3R1;ABL1;THY1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5669544850797354,1.32557665601084,0.14037433155080214,0.9757598344187118,1.0,5/16,15.47%,CHID1;ADCY7;SIRPA;CUEDC2;ABCD2
prerank,sensory organ development (GO:0007423),-0.3321918428856412,-1.324585338390716,0.05426356589147287,0.8437720620001476,1.0,21/51,30.11%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMCHD1;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;PAX8;MAFB;CHRDL1
prerank,regulation of lipase activity (GO:0060191),0.5920212457209736,1.3244278785363783,0.15329512893982808,0.9794339236886049,1.0,2/13,4.57%,LPL;PCSK5
prerank,negative regulation of hormone secretion (GO:0046888),-0.5372668675647067,-1.3243348671829496,0.1411042944785276,0.8377740499368517,1.0,3/10,18.74%,GJA1;RAB11FIP5;RAB11FIP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.622414722284842,1.323292581308543,0.14285714285714285,0.9834636499181088,1.0,4/11,14.61%,ADM;ARRB1;GRK3;GRK2
prerank,nuclear transport (GO:0051169),0.5652658324372425,1.3228599228097424,0.1565934065934066,0.9832231336094487,1.0,5/16,12.27%,NXT2;NXT1;ANP32A;PSIP1;NPM1
prerank,positive regulation of cell projection organization (GO:0031346),0.4458405320187858,1.3228151119438876,0.05572755417956656,0.9806763300752962,1.0,41/115,20.96%,CARMIL2;AMIGO1;WNT5A;CAMK2B;DVL2;CUL7;CDKL5;PLXNA2;OBSL1;TENM3;DVL1;PLXNA1;PLK5;RAPGEF1;ROBO2;ROBO1;MAGI2;IL1RAPL1;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SLITRK1;CUX1;SCARB2;CARMIL1;LYN;ATP1B2;PTK2B;MAP6;NTRK2;SCN1B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5349269975266518,1.3224471683767343,0.12960609911054638,0.9799472055292795,1.0,5/23,11.50%,CBARP;NOS1AP;ATP1A2;CACNB1;CAMK2D
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4304462118935066,-1.3222233053433046,0.13983050847457626,0.8393022910536952,1.0,9/17,16.00%,NR3C1;MED1;AR;ATP1A1;URI1;ABHD2;BMP7;SRC;BMP4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5069738269778715,1.3215956681037029,0.13653136531365315,0.9821291119600859,1.0,9/30,15.21%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5664472997659903,1.3213292194947734,0.14572192513368984,0.9808719558246237,1.0,1/17,0.11%,SFRP2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5066071649333461,1.3213047350353668,0.12440191387559808,0.9782615423695317,1.0,8/32,10.71%,SLC4A4;IGF1;ARNT;PID1;PRXL2C;VCP;ZBTB20;APP
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5592037803764792,1.3210131247712147,0.1287779237844941,0.9771726311208122,1.0,8/20,15.76%,GMPS;ADSL;PAICS;GART;AK4;HPRT1;AK3;GMPR2
prerank,base conversion or substitution editing (GO:0016553),-0.5329850419354923,-1.320458468740599,0.1566265060240964,0.8393356965507528,1.0,3/11,13.01%,ADARB2;APOBEC1;METTL3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2926433899943078,-1.3185564103131608,0.05405405405405406,0.8397265476158507,1.0,28/94,14.52%,UBE2N;IKBKB;PSMB7;IRAK2;CUL1;IL1R1;RPS6KA5;RBX1;SKP1;IRAK1;NOD1;PSMB2;PSMD7;NFKBIA;PELI1;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;MAP3K8;UBB;TOLLIP;IKBKG;PSMD9;PSMD2;IRAK4;PSMB3
prerank,regulation of protein autophosphorylation (GO:0031952),0.4982979990334706,1.3185553405641335,0.11611374407582939,0.9888370086765645,1.0,15/36,18.96%,EPHA7;CALM3;DDX3X;ERRFI1;RAP2A;PPP2R5E;MVP;ENPP1;IMPACT;PPP2R5D;MRE11;RAD50;PPP2R5A;RASSF2;CALM1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3634292279340736,-1.3183441977393338,0.09090909090909091,0.8339008672012475,1.0,20/37,21.70%,HIPK2;WAC;FHIT;CSNK2A1;PML;RPL11;HSP90AB1;UCHL5;RPL5;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;PDCL3;UBXN1;NOP53
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5192478730200538,-1.3177459518845756,0.14860681114551083,0.8296370153384683,1.0,3/10,28.86%,BMP4;FZD7;PAX8
prerank,response to ethanol (GO:0045471),0.586652440493096,1.3177268948309488,0.16552667578659372,0.9908252129554118,1.0,4/14,14.46%,ADCY7;GRIN1;GRIN2A;GLRA1
prerank,coenzyme A metabolic process (GO:0015936),0.5910104402539014,1.3172156123238998,0.1473533619456366,0.990955426409726,1.0,5/14,10.94%,DCAKD;PANK4;COASY;ACAT1;CROT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.45919236160310145,1.3169987942312225,0.09320175438596491,0.9893755751107316,1.0,25/65,23.39%,ADAMTSL2;FBN2;PDPK1;STUB1;PMEPA1;SNX6;HTRA3;TGFB1I1;LTBP1;LEMD3;PEG10;FBN1;TGFB1;SMAD6;VASN;MTMR4;SPRY2;SMURF1;TGFBR1;PPM1A;SMAD7;SMAD2;SMAD3;DAND5;FKBP1A
prerank,regulation of fibroblast migration (GO:0010762),0.5440084869294558,1.3169309895341408,0.14136125654450263,0.9869952653777357,1.0,11/20,21.29%,CLN3;RAC1;DDR2;ARHGEF7;DMTN;RFFL;TGFB1;ITGB1BP1;ITGB1;APPL2;FGF2
prerank,neutral amino acid transport (GO:0015804),-0.37902737490526944,-1.3162217410934076,0.08585858585858586,0.828858865508844,1.0,17/28,39.44%,SLC6A6;SLC3A2;SLC6A9;SLC36A4;CTNS;SLC43A2;SLC38A5;SLC1A4;SLC6A17;SLC36A1;SLC43A1;SLC6A7;LLGL2;SLC38A2;SLC7A8;SLC38A1;SLC7A10
prerank,ganglion development (GO:0061548),0.6044886986453557,1.3159672272811354,0.136431784107946,0.9901609520057899,1.0,4/11,15.56%,FZD3;NRP1;UNC5C;SEMA3A
prerank,RNA transport (GO:0050658),0.4539464834623313,1.315806306065595,0.09032258064516129,0.9884245868911359,1.0,33/71,24.90%,SLBP;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;THOC7;SIDT1;HNRNPA2B1;THOC1;NUP214;FMR1;SRRM1;NUP153;FLOT1;RTRAF;YBX1;TPR;SARNP;U2AF2;SIDT2;NUP155;SRSF6;ATXN2;RBFOX1;CHTOP;PNPT1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4601412965727422,1.315540191820865,0.09229098805646037,0.9873691605170831,1.0,23/71,19.05%,ADAMTS7;STUB1;ZYG11B;TNFAIP3;OTUD7A;NGLY1;DDB1;HM13;CAPN2;CUL4B;VCP;CHFR;MALT1;VPS4B;USP9X;RNF41;CTSZ;CTSH;NEDD8;MDM2;OMA1;CTSK;CTSO
prerank,fatty acid transport (GO:0015908),0.5690878852160444,1.3147490362663687,0.14439946018893388,0.9892567469268002,1.0,2/17,3.04%,SLC27A6;SLC27A4
prerank,striated muscle contraction (GO:0006941),0.46714555688885323,1.3138758152545433,0.10589519650655022,0.9918630688748202,1.0,7/53,10.81%,TNNI3;TNNC1;TNNI1;MYH14;ATP1A2;SCN2B;TPM1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.43884781328146316,1.3138605291513834,0.06345957011258956,0.9892334668318993,1.0,18/113,9.55%,FGF9;MMP12;WNT5A;PTPRN;SFRP1;IGF1;BMP6;FGFR2;XBP1;NRP1;FGF10;PRKCA;LAMC1;TCF7L2;ARNT;SOX9;EGF;SOX11
prerank,mitochondrion morphogenesis (GO:0070584),0.6089429662106298,1.3134082265123364,0.15976331360946747,0.9891663513578342,1.0,5/11,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,negative regulation of cartilage development (GO:0061037),0.583175050915665,1.313012961916226,0.17024320457796852,0.9888594442655987,1.0,3/13,8.36%,ADAMTS7;PTHLH;SOX9
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5352626861655932,1.3128827665075777,0.16169154228855723,0.9869618547826855,1.0,7/22,10.46%,MED24;MED12;MED14;MED13;MED4;DHX36;PSMC5
prerank,positive regulation of leukocyte migration (GO:0002687),0.5078286469348894,1.3125338118503185,0.12797992471769135,0.9862372699669213,1.0,4/27,8.46%,EDN3;THY1;MIA3;JAM3
prerank,autophagy of peroxisome (GO:0030242),0.6094677104216498,1.3124313953462816,0.16100443131462333,0.9842547418701747,1.0,7/12,19.00%,TRAPPC8;USP30;SQSTM1;PEX5;MAP1LC3B;PIK3C3;PIK3R4
prerank,amino acid import (GO:0043090),-0.423461587790985,-1.3120936525613098,0.14537444933920704,0.8377947417362992,1.0,6/21,5.29%,SLC6A6;SLC16A2;SH3BP4;SLC47A1;SLC7A1;SFXN2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5571314683170224,1.3117583850114733,0.17569352708058125,0.9854498074917427,1.0,5/18,11.50%,PPIF;CBARP;BIN1;ATP1A2;CAMK2D
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.34390733204332113,-1.311445587398068,0.10256410256410256,0.8339607589536342,1.0,26/39,28.94%,RIOK3;RPS24;RIOK2;NOL11;RPS19;RPS16;RPS6;NOM1;RPS28;RPS5;RPS17;NOB1;RPS27;NOP14;WDR3;METTL17;RRP36;SNU13;RPS14;ERAL1;LTV1;RRP7A;EMG1;RPS27L;SURF6;MRPS7
prerank,histone H2A acetylation (GO:0043968),-0.4459527962563948,-1.311233126290844,0.14814814814814814,0.8283701820239127,1.0,6/16,17.77%,EPC1;TRRAP;NAA40;MSL3;ACTL6A;ING3
prerank,activation of protein kinase B activity (GO:0032148),0.5109922579072687,1.310039898234474,0.1310096153846154,0.9928984239911531,1.0,4/29,2.60%,WNT5A;IGF1;PDPK1;NTF3
prerank,protein localization to phagophore assembly site (GO:0034497),0.6212465236294461,1.309059828127653,0.1584852734922861,0.9959834405794812,1.0,6/11,18.15%,TRAPPC8;WIPI1;MFN2;ATG13;STX17;ATG9A
prerank,negative regulation of blood coagulation (GO:0030195),0.4938760392963822,1.3082531994761768,0.1376470588235294,0.9978736036238328,1.0,10/38,17.19%,VTN;C1QTNF1;SERPING1;PLAT;PDGFRA;TFPI;F3;F8;SERPINE1;APOE
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5659510503539056,1.3075551230885487,0.15546218487394958,0.9992112901352372,1.0,6/17,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,positive regulation of signaling (GO:0023056),0.5005422104321883,1.3069046323212254,0.12066905615292713,1.0,1.0,13/37,18.43%,CDKN2AIP;EDN3;SCRIB;VAMP3;NMU;SOX11;WLS;CLSTN2;SYT1;NSF;ANXA2;ILK;CLSTN3
prerank,positive regulation of cell communication (GO:0010647),0.5106649176085886,1.3065860813799126,0.14407814407814407,0.9994474321070691,1.0,10/28,18.43%,CDKN2AIP;EDN3;NMU;SOX11;WLS;CLSTN2;ANK3;SYT1;ILK;CLSTN3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3872361426878097,-1.306573210654126,0.12315270935960591,0.8400887310168768,1.0,10/28,17.15%,UBE2N;IRAK2;IRAK1;NOD1;OTULIN;CYLD;UBB;IKBKG;IRGM;AAMP
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5215778854012662,1.3064928294195588,0.14936708860759493,0.9973462516472971,1.0,12/25,21.94%,HEXIM1;EAPP;RNF8;CDK13;BRD4;RNF168;CDC73;NELFA;RECQL5;HNRNPU;EAF1;TCERG1
prerank,regulation of amyloid-beta formation (GO:1902003),0.4990463590547695,1.306451181346156,0.13599062133645956,0.9949901816523223,1.0,16/34,23.03%,RTN2;IGF1;BIN1;ABCA2;ABCA7;IFNGR1;TMED10;ROCK2;APOE;SORL1;NTRK2;ABCG1;GGA3;RTN1;EPHA4;SP1
prerank,protein methylation (GO:0006479),0.48898312348562123,1.3063874355439935,0.13216374269005848,0.9927203243249443,1.0,19/40,19.80%,LCMT1;PRMT6;ETFBKMT;EZH2;EHMT2;PRMT5;NTMT1;NSD3;PRMT1;EHMT1;GSPT1;FAM98A;ATPSCKMT;PRMT8;PCMT1;NSD1;RAB6A;PRMT2;CARM1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5024033192054331,1.3063011212252702,0.13374233128834356,0.9906250157915172,1.0,17/32,24.80%,MMP12;AJAP1;CASK;DMTN;SEMA3E;JAG1;SERPINE1;ITGB1BP1;DLC1;ARHGAP6;NF2;MAP4K4;CLASP2;HOXA7;PTEN;CORO1C;PHLDB2
prerank,rRNA modification (GO:0000154),0.5309373964442313,1.3057188014143735,0.14032869785082175,0.9913028067694806,1.0,8/21,19.52%,NHP2;FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,response to sterol (GO:0036314),0.6052545370125935,1.3056508397461315,0.1597542242703533,0.9890777829206419,1.0,6/11,21.52%,RORA;ABCA2;INSIG1;TGFB1;TGFBR1;SMAD2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5584457687618858,1.3054197899489193,0.15978695073235685,0.9877348082443784,1.0,2/17,3.12%,PSRC1;MAPRE3
prerank,DNA conformation change (GO:0071103),0.5577973715125012,1.3040910020419458,0.1539528432732316,0.9927514779288363,1.0,8/17,22.00%,HMGB3;ABL1;TOP1;HAT1;TOP3B;TOP3A;TOP2B;HMGB1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5602357053713158,1.3039643075162308,0.14385474860335196,0.990888811772149,1.0,6/16,9.68%,DDX17;RBM17;CDK13;SRSF9;SRSF1;HNRNPM
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4436147667873729,1.3038803091347269,0.0859538784067086,0.9888328445451171,1.0,15/86,10.71%,SFRP2;VTN;SFRP1;IGF1;EPHA7;BMP6;NTF3;NRP1;FGF10;ABL1;DMTN;LRP8;TEC;ENPP2;APP
prerank,Notch signaling pathway (GO:0007219),-0.316371918597533,-1.30386448668294,0.047619047619047616,0.8436162210601639,1.0,25/59,24.82%,MAML3;MIB1;MAML1;POFUT1;STAT1;NOTCH3;KAT2B;EP300;NCSTN;ADAM10;TRAF7;HES1;APH1A;HEYL;DTX1;NOTCH2;DTX3L;PBX1;JAG2;SORBS2;APH1B;NOTCH4;PSEN2;BMP2;MDK
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46318658072895874,1.3038491460044088,0.10774410774410774,0.9865076277904704,1.0,11/52,11.48%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;CNOT10;DCP1B;EXOSC8;RC3H2;CNOT9
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3592881085433151,-1.3033353962429974,0.12886597938144329,0.8393979083827501,1.0,13/30,31.18%,NIBAN2;DACH1;GNL3L;STN1;TP53;NAT10;SRC;CTC1;CERS1;TEN1;CDKN1A;TINF2;MEN1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4384321190921719,1.3028369125069255,0.0734229576008273,0.9898146522873387,1.0,8/116,3.71%,FSHR;FCGR2B;PTGER4;SELENOS;ADCY7;ADM;VIPR2;PTHLH
prerank,regulation of smooth muscle cell migration (GO:0014910),0.548287781934208,1.3007078536291887,0.16153846153846155,0.9994142858290835,1.0,10/20,21.65%,VTN;IGF1;NRP1;IGFBP3;NDRG4;LRP1;SERPINE1;SORL1;S100A11;IGFBP5
prerank,regulation of cell killing (GO:0031341),0.5624148594252791,1.299793007644462,0.1587516960651289,1.0,1.0,3/16,2.78%,WNT5A;DVL2;RAC1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4778812536624723,1.2995931358250699,0.12031782065834279,1.0,1.0,11/47,20.46%,VTN;BIN1;SERPING1;SPOCK1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;SORL1;TIMP2;SERPINF1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.34645149675527975,-1.299058734911406,0.11834319526627218,0.8492770544504122,1.0,18/36,21.74%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;GABARAPL2;GIPC1;CCAR2;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,positive regulation of proteolysis (GO:0045862),0.4697275714582618,1.2989410717556906,0.11399548532731377,1.0,1.0,14/55,17.26%,GPLD1;CLN6;STUB1;NRDC;CCBE1;OGT;RCN3;PACSIN3;AURKAIP1;SNX33;CTSH;APOE;TANK;TNIP1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5624713762001161,1.2987670475348985,0.17366946778711484,1.0,1.0,3/14,8.36%,ADAMTS7;PTHLH;SOX9
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4926938344427428,1.2983238054868962,0.1452991452991453,1.0,1.0,7/32,10.25%,CARMIL2;RAC1;ACTR2;PIK3R1;ARHGEF7;CYFIP1;ENPP2
prerank,regulation of cellular pH (GO:0030641),0.5049789885128448,1.2980629447856553,0.13459119496855346,0.9993786261866309,1.0,3/29,0.91%,SLC4A4;SLC4A5;CLN3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.41478838072030233,-1.2977808746367496,0.12735849056603774,0.8476536861614257,1.0,9/25,11.38%,HIPK2;CSNK2A1;PML;RPL11;HSP90AB1;RPL5;PSMF1;TRIM39;GABARAPL2
prerank,B cell mediated immunity (GO:0019724),0.6273021679026902,1.2973887289051749,0.18012422360248448,1.0,1.0,1/10,0.85%,FCGR2B
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6144174340901914,1.2973475089876276,0.19971056439942114,0.9984374117852248,1.0,4/10,18.96%,CBARP;CALM3;FMR1;CALM1
prerank,intraciliary retrograde transport (GO:0035721),-0.5009905632930107,-1.2963794073218176,0.16363636363636364,0.8466671813821048,1.0,8/12,24.23%,IFT43;DYNC2I1;IFT122;IFT140;WDR19;DYNC2LI1;DYNLT2B;DYNC2I2
prerank,protein mannosylation (GO:0035268),0.5209633893801696,1.2962854610135268,0.14659685863874344,1.0,1.0,8/22,18.89%,TMTC4;DPM2;TMTC1;POMT2;DPY19L1;DPY19L3;DPM1;DPY19L4
prerank,dendrite morphogenesis (GO:0048813),0.4947542660004728,1.2956452064689281,0.13942307692307693,1.0,1.0,7/35,6.49%,EPHB2;ABITRAM;DCDC2;CTNND2;MINK1;PAK3;DVL1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4498088132472181,1.2953807940840623,0.08695652173913043,1.0,1.0,31/84,22.70%,ILF3;RTN2;IGF1;PAIP2;BIN1;EIF2AK3;DDX3X;CNOT10;IGF2BP2;EPRS1;DHX36;ABCA7;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;SORL1;SAMD4B;RPS3;YBX1;NTRK2;IGFBP5;SAMD4A;GGA3;RTN1;RPL13A
prerank,cell-cell junction maintenance (GO:0045217),-0.5101627357196661,-1.2949202958275103,0.17325227963525835,0.8460428015974206,1.0,3/11,10.41%,FERMT2;TJP1;MYADM
prerank,peptidyl-asparagine modification (GO:0018196),0.49390976182603874,1.2948389799802376,0.1597051597051597,1.0,1.0,9/31,15.21%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,heart process (GO:0003015),0.561595047610081,1.2947050153308675,0.17372881355932204,1.0,1.0,1/14,0.42%,TNNI3
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.45115566679904173,-1.2933217490487918,0.15467625899280577,0.8462512524229546,1.0,7/16,20.27%,NAA15;KAT2B;NAA40;EP300;NAA25;NAA60;NAA80
prerank,mRNA metabolic process (GO:0016071),0.43732321518102274,1.2928352418865594,0.09763948497854077,1.0,1.0,33/90,19.58%,LSM6;TBRG4;SLBP;U2AF1;SRSF2;GEMIN2;PRPF8;DHX15;CNOT10;SRSF5;SF3B2;CELF1;AKAP8L;SRSF9;SF3A1;SRSF1;AURKAIP1;KIN;NUDT12;NUDT21;CPSF3;HNRNPA0;AGO3;HNRNPA2B1;DIS3L2;DDX5;NUDT16L1;SON;CPSF6;PCBP2;NONO;YTHDF2;CSTF3
prerank,neuromuscular process controlling balance (GO:0050885),0.5976663036845851,1.2918968464632405,0.18947368421052632,1.0,1.0,2/12,5.21%,CLN3;PCDH15
prerank,sterol transport (GO:0015918),-0.4233764983748815,-1.291661833489301,0.14173228346456693,0.8462931329277747,1.0,6/19,18.44%,OSBPL2;CAV1;OSBPL5;OSBP;ARV1;LDLRAP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.4209915115060487,-1.2916241884807502,0.15849056603773584,0.8404337850226021,1.0,8/18,13.00%,ADGRG6;TEK;RBP4;TGFB2;ENG;BMPR1A;S1PR1;BMP7
prerank,positive regulation of protein deacetylation (GO:0090312),0.57461195441582,1.2914317580552743,0.16923076923076924,1.0,1.0,6/14,16.05%,NIPBL;AKAP8L;ZBTB7B;NNMT;SAP30BP;CTBP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.47141178296177544,1.2911806080500845,0.1318435754189944,1.0,1.0,12/47,16.69%,KHSRP;NFKB1;ABCA2;SNAI1;ERLIN2;SIRPA;SIK1;WNT4;ROCK2;SLC27A1;ACADL;ACADVL
prerank,regulation of NMDA receptor activity (GO:2000310),0.4894655321302824,1.2907526073107825,0.14389359129383314,1.0,1.0,10/32,14.10%,CAMK2B;EPHB2;NEFL;GRIN1;DLG3;GRIN2A;APP;GRIA1;DAPK1;GRIA2
prerank,placenta development (GO:0001890),0.5949805879245764,1.2906220097932504,0.17862371888726208,1.0,1.0,1/12,1.38%,CUL7
prerank,ruffle organization (GO:0031529),0.5573851589311913,1.2903657942353899,0.1530758226037196,1.0,1.0,8/16,20.42%,AIF1L;RAC1;CYFIP1;TPM1;PIP5K1A;PLEKHA1;CARMIL1;LIMA1
prerank,nucleotide biosynthetic process (GO:0009165),0.5320246374171863,1.2897953891610943,0.16404199475065617,1.0,1.0,5/18,13.10%,ADSL;PRPSAP2;GART;RRM2B;HPRT1
prerank,import into cell (GO:0098657),0.4767031124591464,1.2897233033425277,0.13801169590643275,1.0,1.0,11/41,16.50%,IL10RA;SLC29A1;LRRC8A;SLC5A3;SLC22A4;ATP1A2;GLUL;SNAP25;SLC1A3;SLC6A13;SLC27A1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.578060394431954,1.2896621085654894,0.1630901287553648,1.0,1.0,2/13,4.87%,SFRP2;NRP1
prerank,positive regulation of neutrophil migration (GO:1902624),0.5528284189475381,1.2894404508599542,0.17154811715481172,1.0,1.0,6/18,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,apoptotic mitochondrial changes (GO:0008637),0.5013644939964279,1.2886261881886485,0.15947242206235013,1.0,1.0,10/32,15.53%,BAX;THEM4;FIS1;AIFM2;FZD9;BCL2;SOD2;ATG3;DNM1L;HSPD1
prerank,nucleocytoplasmic transport (GO:0006913),0.47398224125121824,1.2882212295514655,0.16279069767441862,1.0,1.0,11/40,12.27%,SMN1;NXT2;NXT1;GEMIN2;ANP32A;HTATIP2;ATXN1;MALT1;BACH2;NEMF;NPM1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.4288595857349953,-1.2874600456546568,0.16091954022988506,0.850367990519323,1.0,8/18,13.64%,RNF103;RNF185;AMFR;MAN1B1;EDEM2;OS9;UBB;RNF139
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5392431964872421,1.2872794894248691,0.16734143049932523,1.0,1.0,6/18,16.48%,EDN3;ABL1;POR;GDNF;PARK7;AGTR1
prerank,positive regulation of chemokine production (GO:0032722),0.4692090716307476,1.2870086728808436,0.13931523022432113,1.0,1.0,8/44,13.29%,WNT5A;LPL;IL33;DDX3X;TIRAP;TWIST1;APP;TLR3
prerank,phospholipid biosynthetic process (GO:0008654),0.4857652318367941,1.2864859233932713,0.15240328253223914,1.0,1.0,10/36,9.95%,CLN3;PCYT2;AGPAT5;CRLS1;DHDDS;CPNE7;AGPAT3;DPAGT1;GPAM;FADS1
prerank,lipid biosynthetic process (GO:0008610),0.4460188684818923,1.2864473715563853,0.0978494623655914,1.0,1.0,16/77,14.55%,NDUFAB1;LPL;MLYCD;PCYT2;XBP1;AGPAT5;GPAT4;LSS;AGPAT3;GPAM;ELOVL4;FADS1;PRLR;CYP51A1;PAM;ACSL6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5383829454497874,1.2864098668058888,0.16861219195849547,1.0,1.0,9/19,18.22%,SCRIB;MTCL1;DLG3;PATJ;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP
prerank,embryonic axis specification (GO:0000578),-0.45410202179683484,-1.2861545329784336,0.14590747330960854,0.8488932101613612,1.0,4/15,9.15%,TASOR;COBL;CXXC4;TBX3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4281142081968515,-1.2854251857774246,0.144,0.845682533118652,1.0,6/19,7.34%,PRKCE;LBP;IRAK1;TLR4;LGALS9;RAB11FIP2
prerank,myelin maintenance (GO:0043217),0.6243508376219662,1.285330679707358,0.17937219730941703,1.0,1.0,4/10,15.47%,MYRF;CXCR4;EPB41L3;ABCD2
prerank,lamellipodium assembly (GO:0030032),0.5030861877695957,1.2852485862519416,0.15734720416124837,1.0,1.0,13/26,20.98%,RAC1;WHAMM;SRGAP2;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5940465181324882,1.2849046838335192,0.19011976047904192,1.0,1.0,3/12,4.44%,GRIN1;SLC5A3;ZNF205
prerank,regulation of fat cell differentiation (GO:0045598),0.442990525164209,1.2847580898932147,0.1041890440386681,1.0,1.0,19/74,18.39%,SFRP2;WNT5A;LPL;SFRP1;SIRT2;XBP1;RORA;ZFP36L1;WDFY2;ENPP1;RUNX1T1;TGFB1;AAMDC;LMO3;TRIO;CDS1;MEDAG;FTO;GPS2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.452819871197721,1.2839420476226697,0.1251360174102285,1.0,1.0,16/59,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;TWIST1;AGO3;SETX;CBFB;BCLAF1;MED23
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4336847969024759,1.283756114268379,0.08677685950413223,1.0,1.0,16/110,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;PTHLH;GNG2;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;LPAR1;ADCY1
prerank,regulation of synapse organization (GO:0050807),0.51819561274312,1.282647318705214,0.14432989690721648,1.0,1.0,5/26,6.07%,WNT5A;CLN3;CAMK2B;CDKL5;ABL1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5037332926865333,1.2822863831293883,0.16604244694132334,1.0,1.0,8/26,15.47%,GRIN1;SLC25A33;SLC5A3;SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5406212593679073,1.2820698800517054,0.1639784946236559,1.0,1.0,4/17,8.36%,AJAP1;MAFG;CD24;SOX9
prerank,protein polyglutamylation (GO:0018095),0.6110021744038967,1.2818583189764121,0.2,1.0,1.0,4/11,16.03%,TTLL4;TPGS1;CFAP20;TTLL11
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6048962119815027,1.2809796753697578,0.18404907975460122,1.0,1.0,2/11,4.50%,SELENOS;CXCL12
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5449554678979713,1.2808041255898346,0.17753120665742025,1.0,1.0,4/17,7.16%,EMC1;EMC8;MMGT1;GET1
prerank,regulation of exosomal secretion (GO:1903541),0.533696403220729,1.2807294381030538,0.17092866756393002,1.0,1.0,6/19,12.16%,ATP9A;SNF8;HGS;SDCBP;CHMP3;VPS4B
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6138615608305891,1.2805113184252206,0.19584569732937684,1.0,1.0,2/10,1.24%,SFRP1;SP7
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.43716937380685217,1.2798046052416796,0.12903225806451613,1.0,1.0,12/69,13.29%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,positive regulation of endocytosis (GO:0045807),0.47221650664123466,1.2793875797498886,0.134009009009009,1.0,1.0,17/45,22.07%,CALY;VTN;CLN3;CD151;HNRNPK;CLIP3;LRP1;CBL;RAB31;SERPINE1;RAB21;APOE;FLOT1;SMPD1;DAB2;APPL2;B2M
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4884027040308493,-1.2787548984620014,0.18835616438356165,0.8648392964395224,1.0,4/12,6.44%,LRP6;MBNL1;FBXW4;TGFB2
prerank,negative regulation of response to external stimulus (GO:0032102),0.43159372383057154,1.2786823442486066,0.0865979381443299,1.0,1.0,14/105,7.34%,SMPDL3B;PTGER4;SIRT2;AJAP1;SELENOS;CASK;RORA;TNFAIP3;PPM1B;CARD16;DHX58;CERS2;TRAFD1;SIRPA
prerank,glucan catabolic process (GO:0009251),-0.4516219664437407,-1.2786650726029376,0.18681318681318682,0.8591884926423968,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3723708842989411,-1.278100267581807,0.10465116279069768,0.8552317081074418,1.0,3/29,6.14%,CYRIB;LAMP1;CADM1
prerank,cellular response to alcohol (GO:0097306),0.4669503825831725,1.277841043108738,0.15294117647058825,1.0,1.0,11/42,16.59%,SFRP1;PTGER4;GPLD1;ADCY7;MLC1;GNG2;PTCH1;JUP;GLRA1;ADCY1;ADCY5
prerank,metal ion homeostasis (GO:0055065),-0.340913357796017,-1.2775462509751274,0.13013698630136986,0.8516233653825269,1.0,18/40,30.31%,SLC12A7;CNNM2;CAV1;LETM1;TMTC2;LETM2;FAM20A;SLC12A4;COX11;SELENON;SLC12A9;SLC12A2;SLC12A8;CNNM4;SLC12A6;WFS1;SLC8A1;JPH2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4278004038883807,-1.2775055067528835,0.1511627906976744,0.8460081467250629,1.0,9/18,19.69%,SLC25A13;MSRA;MTHFR;GOT2;FOLH1;MTHFD1;NAALAD2;GOT1;ASPG
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4649237971839552,1.2774324879309324,0.16819221967963388,1.0,1.0,8/46,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,positive regulation of ruffle assembly (GO:1900029),0.5798874994664279,1.2771720870385932,0.1613394216133942,1.0,1.0,1/13,0.06%,CARMIL2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.449540740408018,1.2770565332353416,0.13340683572216097,1.0,1.0,9/57,5.90%,BAX;PPIF;CHCHD10;FIS1;ZNF205;FBXO7;FAM162A;DCN;MIEF2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5355371629794914,1.276568116665445,0.16888297872340424,1.0,1.0,5/21,7.42%,UBE2S;MAD2L1;FZR1;FBXO5;CDC14B
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4719468930428167,1.276334709633374,0.14336075205640422,1.0,1.0,15/38,24.20%,KHSRP;HSP90AA1;RAC1;NOS1AP;SIRPA;CD47;ROCK2;PTGS2;PKD2;ASS1;KLF4;ATP2B4;SMAD3;INSR;JAK2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4377365446887092,1.276171873758582,0.1298283261802575,1.0,1.0,13/72,11.29%,FSHR;IGF1;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;IRS2;PIK3CB;MAZ;PDGFRA
prerank,regulation of cytoplasmic transport (GO:1903649),0.588524310959163,1.2755282599119608,0.20535714285714285,1.0,1.0,5/11,14.89%,ATP9A;USP7;CHMP3;MAP2K2;DNAJC13
prerank,regulation of protein localization to membrane (GO:1905475),0.5029041554323934,1.2746744406373267,0.1620603015075377,1.0,1.0,13/28,19.45%,CLN3;SLC5A3;CDK5;GPC6;GPC1;VTI1B;GPC4;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14;GPC5
prerank,regulation of cation channel activity (GO:2001257),0.4283110460580395,1.273570791995522,0.11696522655426765,1.0,1.0,32/89,22.19%,CAMK2B;NEFL;CACNG3;CACNB4;GRIN1;MINK1;DLG3;GRIN2A;CACNB1;APP;ANK3;SLMAP;FGF12;CAMK2D;GRIA1;FGF14;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;AHNAK;JPH1;DLG2;SHISA9;CALM1;SHANK1;PTK2B;ITGB1;FGF13;CALM2;GRIA4
prerank,protein homotrimerization (GO:0070207),0.5581411672127795,1.2726975161848115,0.1916083916083916,1.0,1.0,5/14,17.80%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,protein trimerization (GO:0070206),0.5581411672127795,1.2726975161848115,0.1916083916083916,1.0,1.0,5/14,17.80%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,regulation of secretion by cell (GO:1903530),0.4605284780723731,1.2722380527743171,0.13534675615212527,1.0,1.0,18/54,17.84%,CPLANE2;ANXA1;VAMP3;RAB12;CPLX1;RAB10;RAB3B;MCTP2;SYT1;RAB13;RHBDF1;RAB8A;RAB8B;VAMP8;NSF;FMR1;RAB21;MCTP1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.505957733001829,1.2719634579843315,0.1585518102372035,1.0,1.0,10/24,23.37%,ADAMTS7;PTHLH;SOX9;SOX6;TRPS1;SOX5;TGFBR1;MBOAT2;ADAMTS12;EFEMP1
prerank,calcium-mediated signaling (GO:0019722),0.43173401662580013,1.2712255870622229,0.1049317943336831,1.0,1.0,15/93,11.17%,TNNI3;PDPK1;EIF2AK3;DMPK;CCR9;ACKR2;FIS1;RCAN2;ATP2A2;DMTN;CXCR4;RCAN3;PPP1R9B;STIMATE;MCTP2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5848672713462262,1.2710675042095727,0.19555555555555557,1.0,1.0,3/12,5.91%,BAX;XBP1;PIK3R1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5685025876175531,1.2709292519965094,0.19491525423728814,1.0,1.0,1/13,0.11%,SFRP2
prerank,organic acid transport (GO:0015849),-0.28730924030532234,-1.270643146313403,0.07142857142857142,0.865893218275078,1.0,21/94,14.75%,ABCG2;ABCC4;SLC6A6;ATP8B1;SLC25A17;SLC26A7;SLC3A2;SLC7A1;SLCO1C1;LRRC8D;SLC16A1;GOT2;SLC25A32;SLC7A6;SLC7A7;PPARD;SLC22A6;SLC25A14;SLC43A2;SLC16A10;SLC5A6
prerank,synaptic vesicle cycle (GO:0099504),0.49232209937344423,1.2702901898482086,0.18469015795868773,1.0,1.0,6/30,10.56%,SYT10;CDK5;DNAJC5;CPLX1;SNAP25;BRSK1
prerank,error-prone translesion synthesis (GO:0042276),-0.405266144155716,-1.269967906686161,0.15289256198347106,0.8629067047406299,1.0,15/21,38.97%,REV3L;RPA1;UBB;REV1;PRIMPOL;RFC2;PCNA;POLE2;POLK;POLI;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,regulation of interleukin-6 production (GO:0032675),0.4232067207306866,1.2699518101202447,0.09832635983263599,1.0,1.0,16/96,13.55%,WNT5A;LPL;SELENOS;IL33;XBP1;TNFAIP3;TIRAP;TMEM106A;CD200R1;SIRPA;ARRB1;TWIST1;APP;CD47;TLR3;PTPN22
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.44765263056036275,1.2699237536010606,0.13077790304396844,1.0,1.0,19/57,19.05%,CAMK2B;NPTXR;NEFL;CACNG3;GRIN1;MINK1;DLG3;GRIN2A;APP;GRIA1;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;DLGAP1;DLG2;SHISA9;SHANK1
prerank,GPI anchor biosynthetic process (GO:0006506),0.4978914140639926,1.2692453521411975,0.18282208588957055,1.0,1.0,10/30,18.41%,PIGG;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1;PIGK;PIGX;DPM1
prerank,natural killer cell mediated immunity (GO:0002228),0.5563188167778211,1.269187788580434,0.1986111111111111,1.0,1.0,6/15,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;LYST
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4179801363350766,1.2691431623467213,0.06097560975609756,1.0,1.0,27/150,15.02%,FGF20;MYORG;FGF9;MST1R;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;TCF7L2;PIK3R1;GAB1;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;PARK7;NRG2;NRG1;TGFB1;F3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5386811024070863,1.268887883600063,0.1771117166212534,1.0,1.0,5/18,8.54%,FCGR2B;BAX;XBP1;PIK3R1;DDIT3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6033401528145598,1.2688029224546937,0.19849624060150375,1.0,1.0,2/10,6.69%,VTN;ARNT
prerank,regulation of cellular respiration (GO:0043457),0.5447919687610792,1.2679523472343708,0.19380888290713325,1.0,1.0,4/17,9.82%,IFNAR1;IL10RB;PRELID1;VCP
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5658656966841645,1.2678848238975489,0.18549511854951187,1.0,1.0,3/13,11.81%,LCMT1;MAD2L1;DYNC1LI1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4981049471891122,1.2675067870324286,0.17875,1.0,1.0,7/25,11.37%,CCP110;TBC1D7;CEP97;TCHP;RAP1GAP;ARHGAP24;EVI5L
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.514568140125184,1.267373203537182,0.18286445012787725,1.0,1.0,1/23,0.14%,PLA2G5
prerank,positive regulation of sodium ion transport (GO:0010765),0.5841265725434958,1.266494829233416,0.1914008321775312,1.0,1.0,6/12,22.71%,GPD1L;CNKSR3;ANK3;AHCYL1;SCN1B;WNK3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.49724992685471014,1.2652777204990882,0.1934673366834171,1.0,1.0,10/29,18.47%,CLN3;CAMK2B;EPHB2;DBN1;APP;NETO1;APOE;MCTP1;ZDHHC2;SHISA9
prerank,negative regulation of interferon-beta production (GO:0032688),0.6160937401022123,1.265157827837584,0.21019108280254778,1.0,1.0,6/10,23.35%,PPM1B;SIRPA;YY1;RELB;PTPRS;REL
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5229338146175069,1.2651049506399648,0.16819973718791065,1.0,1.0,5/20,11.50%,TNNI3;CALM3;ATP2A2;ATP1A2;CAMK2D
prerank,regulation of macrophage activation (GO:0043030),0.48767715306464754,1.2649913753103172,0.17452229299363056,1.0,1.0,4/30,4.92%,WNT5A;FCGR2B;IL33;IL31RA
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4405946422317195,1.2645072185020045,0.12554585152838427,1.0,1.0,13/69,13.35%,FGF20;CLN3;NTF3;FZD9;SNX6;SLC30A10;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5119325222182813,-1.2642419806525405,0.18633540372670807,0.87940504675635,1.0,3/10,6.97%,CTTNBP2NL;INPP5K;THBS1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5403894628534888,1.2641627646389486,0.1891156462585034,1.0,1.0,2/18,5.54%,CARMIL2;DDR2
prerank,positive chemotaxis (GO:0050918),0.539571975009863,1.2641435032705086,0.19154557463672392,1.0,1.0,4/17,5.37%,TSC2;NRP1;FGF10;SCRIB
prerank,regulation of centriole replication (GO:0046599),0.5307181534540052,1.2641353714334622,0.20561941251596424,1.0,1.0,6/18,17.13%,CENPJ;MDM1;ALMS1;NPM1;SPICE1;CEP76
prerank,metanephros development (GO:0001656),0.5114984822859487,1.2639695769208286,0.16305732484076432,1.0,1.0,9/26,18.92%,NIPBL;FGF10;PTCH1;GDNF;ROBO2;CTSH;OSR1;PKD2;FOXD1
prerank,positive regulation of phosphorylation (GO:0042327),0.4144998559475777,1.263746681242552,0.03911735205616851,1.0,1.0,49/240,14.28%,FGF20;FGF9;SLC4A4;HDAC3;TMEM119;MST1R;IGF1;IL34;DVL2;EPHA7;EPHB2;HSP90AA1;RAC1;FGFR2;FGFR1;ERP29;DDR1;NRP1;FGF10;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;EPHA8;ARNT;RAP2A;DSCAM;WDFY2;ARRB1;SOX9;PRXL2C;SDCBP;EGF;EPHA10;CLIP3;MUSK;ZBTB20;APP;PDGFRA;LEPR;AXIN2;RACK1;ROR2;NPTN;CSNK1D;ROCK2;TGFB1
prerank,regulation of ERAD pathway (GO:1904292),-0.4973739605818283,-1.2625151350815293,0.2229299363057325,0.8800514874744685,1.0,7/11,21.74%,RNF185;USP13;HERPUD1;RNFT1;BAG6;UBXN1;AQP11
prerank,receptor clustering (GO:0043113),0.5008564127901953,1.2623482369628505,0.17683686176836863,1.0,1.0,10/27,18.22%,PICK1;SCRIB;DLG3;THY1;DVL1;MUSK;MAGI2;ITGB1BP1;DLG2;SYNJ2BP
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4606749218687021,1.262336103452984,0.16169724770642202,1.0,1.0,18/42,25.24%,RAC1;MINK1;THY1;DMTN;SPOCK1;PIK3CB;FBLN2;ECM2;EMP2;TBCD;NDNF;GCNT2;PPM1F;TSC1;CORO1C;JAK2;CX3CL1;ATXN3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.43331881585231186,1.261773060465652,0.10620399579390116,1.0,1.0,27/88,19.43%,ILF3;CLN3;PAIP2;NFKB1;EIF2AK3;DDX3X;NELL1;CNOT10;CDK5;IGF2BP2;EPRS1;DHX36;CDK5RAP3;PLAT;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;CAMK2N1;ATRAID;SAMD4B;RPS3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.5464041797932364,1.2613235604776312,0.21031207598371776,1.0,1.0,3/16,3.85%,PDK1;MLYCD;RORA
prerank,axonogenesis (GO:0007409),0.4107166065348419,1.2606885068090492,0.04613841524573721,1.0,1.0,67/237,17.96%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;ATL1;HSP90AA1;FGFR2;CXCL12;NRP1;NEFH;PRKCA;CDK5;PIK3R1;GAB1;PAK3;EFNB3;EPHA8;BRSK2;CXCR4;GPC1;DSCAM;RAP1GAP;CYFIP1;FRS2;EFNB2;VLDLR;BAIAP2;EPHA10;RAB10;SEMA3D;NTNG2;GDNF;IRS2;GFRA2;BRSK1;AFG3L2;PIK3CB;APP;ROBO2;ANK3;ROBO1;KIF5C;DAG1;NLGN3;DOCK7;B4GALT5;USP9X;FEZ2;NPTN;UNC5D;AUTS2;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;RAB8A;SLC9A6;EPHA5;KIF5B;USP33;DAB1;DCC;ZDHHC17;SLITRK1
prerank,chordate embryonic development (GO:0043009),0.4467564698613342,1.259802855506992,0.16666666666666666,1.0,1.0,10/55,8.42%,WNT5A;ZNF568;FGFR2;FGFR1;PCSK5;FLCN;SULF1;ALDH1A2;DVL1;PTCH1
prerank,regulation of calcium ion import (GO:0090279),0.5187632224988762,1.2594267338801468,0.19359145527369825,1.0,1.0,7/21,22.71%,CXCL12;EGF;SLC30A1;PLPP4;PKD2;TRIM27;WNK3
prerank,protein-DNA complex disassembly (GO:0032986),0.5427321610882391,1.2593186147754738,0.20299727520435967,1.0,1.0,4/16,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4413687331959825,1.2591551441032656,0.14101184068891282,1.0,1.0,14/70,16.50%,PLA2G5;GPLD1;CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;ENPP2;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,regulation of establishment of protein localization (GO:0070201),0.5532335059348348,1.2589490882043675,0.19618528610354224,1.0,1.0,4/14,14.58%,CENPJ;GAPVD1;SCFD1;CEP120
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.606175586334311,1.2587955478098376,0.20119225037257824,1.0,1.0,4/10,15.82%,HGS;NDRG4;LRP1;PTPN12
prerank,ethanol metabolic process (GO:0006067),0.5792213309192731,1.2583577359640512,0.19456366237482117,1.0,1.0,1/12,0.66%,ADH5
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5562858740212091,1.2581190732629919,0.19119669876203577,1.0,1.0,3/15,6.02%,IGF1;PPIF;PRELID1
prerank,regulation of T cell differentiation (GO:0045580),0.47864586404998677,1.2576830174260842,0.1619283065512979,1.0,1.0,8/33,17.45%,XBP1;PRELID1;ABL1;CLPTM1;ZMIZ1;CBFB;FANCA;TCF7
prerank,nucleosome disassembly (GO:0006337),0.5651175353235244,1.2575117828707452,0.19971671388101983,1.0,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,chromatin disassembly (GO:0031498),0.5651175353235244,1.2575117828707452,0.19971671388101983,1.0,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,regulation of neuron projection arborization (GO:0150011),0.5631589950091861,1.2573891169113212,0.20054570259208732,1.0,1.0,4/15,10.01%,WNT5A;DVL2;DVL1;NTNG2
prerank,long-chain fatty acid transport (GO:0015909),0.4779294029978403,1.2566104553822763,0.16417910447761194,1.0,1.0,8/30,19.00%,SLC27A6;SLC27A4;CPT2;ABCD2;SLC27A1;APOE;SLC25A20;PRKAG2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.37012391940039263,-1.2565856377172548,0.14953271028037382,0.8967174533006146,1.0,10/27,16.58%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28;SHANK3;PFN1;MET
prerank,negative regulation of immune response (GO:0050777),0.415281827273259,1.256504607478156,0.08409321175278622,1.0,1.0,13/154,6.64%,FSHR;FCGR2B;PTGER4;SIRT2;ADCY7;ADM;VIPR2;PTHLH;TNFAIP3;PPM1B;DHX58;TRAFD1;GNG2
prerank,negative regulation of signal transduction (GO:0009968),0.40484243510906204,1.2542419120154658,0.04321608040201005,1.0,1.0,49/249,14.49%,SFRP2;RNF157;APLN;DLK1;SMPDL3B;GPR108;SFRP1;TCIM;TSC2;PIP4K2B;CSNK2A2;SLC27A4;GLIS2;DKK3;BRAP;TNFAIP3;CARD16;SULF1;DCN;SRMS;EZH2;TMBIM1;HGS;GPC1;PID1;ARRB1;PTCH1;LRPAP1;EGF;LGR4;VCP;PIK3CB;IGFBP3;BCL2;MAZ;LEPROT;BMP5;ENPP1;NDRG4;CD47;LRRC14;RACK1;CYP26B1;PIP4K2A;SUFU;TNS2;LRP1;PIP4K2C;TULP3
prerank,plasma membrane invagination (GO:0099024),0.4924037309986175,1.2538623253248309,0.17258261933904528,1.0,1.0,2/29,0.85%,SPIRE2;FCGR2B
prerank,regulation of lipid catabolic process (GO:0050994),-0.4031116767217534,-1.2538484377874266,0.15808823529411764,0.9013418143556285,1.0,5/19,21.92%,LONP2;PDE3B;ALK;BSCL2;ADRA2A
prerank,cellular response to peptide (GO:1901653),0.4491590897775663,1.253591919787189,0.15604395604395604,1.0,1.0,14/56,13.61%,FCGR2B;IGF1;GRIN1;XBP1;ATP1A3;ZFP36L1;CDK5;SNX6;GRIN2A;TRIM41;CACNB1;APP;PTPN22;LRP1
prerank,neuromuscular process (GO:0050905),0.5519913892910026,1.253485434332452,0.2106703146374829,1.0,1.0,7/16,19.92%,CLN3;STRA6;MYCBP2;KCNA1;SHANK1;AGTPBP1;PAFAH1B1
prerank,negative regulation of protein polymerization (GO:0032272),-0.37139702202913266,-1.2533439988764492,0.15865384615384615,0.8976082539965256,1.0,11/27,17.39%,CYRIB;MAPRE1;SLIT2;PRKCD;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1
prerank,positive regulation of potassium ion transport (GO:0043268),0.4762516038165085,1.2530315323874273,0.15035799522673032,1.0,1.0,5/38,8.20%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5339970771638104,1.2529802931971696,0.19298245614035087,1.0,1.0,3/18,3.62%,APLN;PDPK1;FGFR1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.508066413045664,1.2528295629780941,0.1921119592875318,1.0,1.0,10/23,16.45%,GLIS2;PTCH1;VCP;RFX4;ENPP1;GPR161;RACK1;SUFU;TULP3;MEGF8
prerank,phosphatidic acid metabolic process (GO:0046473),0.45511542964478285,1.2522467303874443,0.1859931113662457,1.0,1.0,8/48,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4117614995891453,-1.2520509992013245,0.17131474103585656,0.8969068822498114,1.0,7/17,32.79%,LGALS9;RARA;CEBPB;CD86;SYK;HAVCR2;FCER1G
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4544329791087688,1.2516411692595226,0.18463302752293578,1.0,1.0,13/47,17.11%,SFRP2;LPL;SFRP1;XBP1;ZFP36L1;ZBTB7B;WDFY2;PTGS2;AAMDC;LMO3;CDS1;MEDAG;SOX13
prerank,chromosome organization (GO:0051276),0.4222386166859245,1.2510133063067905,0.11954261954261955,1.0,1.0,23/99,15.29%,COPS7A;HDAC3;CENPT;PARP1;FAM50A;GATAD1;RAE1;TCF7L2;ABL1;DDB1;PHF1;SETD7;EZH2;HDAC5;COPS7B;CUL4B;SUV39H1;HDAC1;AXIN2;EHMT1;NUCKS1;SATB1;TCF7L1
prerank,regulation of mRNA stability (GO:0043488),0.41257867823989863,1.2509505284301101,0.10010111223458039,1.0,1.0,54/145,22.24%,KHSRP;EXOSC1;EXOSC3;PSMD4;TBRG4;EXOSC7;EXOSC2;PAIP1;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;CELF1;FUS;PSMD11;HNRNPD;DHX36;PABPC1;GDNF;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;NPM1;AXIN2;YTHDF1;CSDC2;ROCK2;XRN1;NUP214;PSMD1;TNPO1;FMR1;THRAP3;PSMD6;FASTKD1;FTO;TENT5A;SAMD4B;YTHDF2;PSMD5;CIRBP;HNRNPU;MAPKAPK2;YBX1;PSMA4;PSMA1;PSMC6;SAMD4A;METTL14
prerank,negative regulation of binding (GO:0051100),-0.2885854393490173,-1.2509462404185445,0.078125,0.8956144862897558,1.0,25/81,16.01%,WAPL;MAPK8;LEF1;CAV1;ACTB;PRKCD;SP100;GNL3L;STYX;CSNK1E;NFKBIA;LRRK2;RALB;ARHGAP28;IFIT2;ILRUN;CAMK1;TMBIM6;ROCK1;DACT1;BTAF1;JUN;HABP4;EFHB;PEX19
prerank,synaptic membrane adhesion (GO:0099560),0.5494834550236539,1.2507310355477768,0.22145804676753783,1.0,1.0,6/14,20.04%,LRRC4;GPC6;PTPRF;GPC4;SLITRK1;PTPRS
prerank,regulation of amyloid fibril formation (GO:1905906),0.5497707820413131,1.2498812976605504,0.2016348773841962,1.0,1.0,6/15,17.23%,PFDN4;VBP1;PFDN1;APP;APOE;PFDN2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2905311529193428,-1.249854843962979,0.07575757575757576,0.8937834026935164,1.0,20/72,12.74%,ELF1;AXL;IFNAR2;IKBKB;IRAK2;STAT1;RIPK1;IRAK1;HSP90AB1;HIPK1;OTULIN;CYLD;TRIM44;TAX1BP1;PTPRC;IKBKG;LIFR;MADD;TNFRSF1A;CDC37
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5154208412004695,1.2498081828139886,0.20052770448548812,1.0,1.0,6/20,11.50%,BAX;FIS1;RAP1GDS1;ATP2A2;BCL2;CAMK2D
prerank,reticulophagy (GO:0061709),-0.47698985759839185,-1.2496572615586707,0.21003134796238246,0.8889179597280957,1.0,7/12,22.06%,ATG2B;UBA5;DDRGK1;ULK2;UFC1;UFL1;UFM1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5664261992429269,1.2495958489200751,0.22237762237762237,1.0,1.0,4/12,7.40%,CCT8;GNL3;CCT6A;WRAP53
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4995560532443494,1.24942569603927,0.16791044776119404,1.0,1.0,4/26,7.53%,UBQLN1;CBARP;CALM3;ATP1A2
prerank,amino acid transmembrane transport (GO:0003333),-0.3189469800638621,-1.2492726055814876,0.14912280701754385,0.88476971223249,1.0,12/45,10.86%,SLC6A6;SLC16A2;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SFXN2;LRRC8D;SLC7A6;SLC38A11;SLC7A7;SLC36A4
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5151518388799551,1.2482369682816623,0.204574332909784,1.0,1.0,4/19,7.40%,CENPJ;CCT8;CCT6A;WRAP53
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3863710509369003,-1.248142134630664,0.15948275862068967,0.8832821979788058,1.0,7/24,8.93%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28
prerank,regulation of adaptive immune response (GO:0002819),0.5313124371415779,1.2480170600831906,0.2073170731707317,1.0,1.0,3/18,5.88%,FCGR2B;ADCY7;IRF1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4334615613134644,1.2469103580066019,0.16083150984682712,1.0,1.0,12/67,11.29%,AATK;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;PIBF1;TEC;PRLR;PDGFRA
prerank,ubiquinone metabolic process (GO:0006743),0.5491145163766716,1.246811526364728,0.2078804347826087,1.0,1.0,3/15,3.34%,COQ6;COQ8B;AIFM2
prerank,positive regulation of lipid storage (GO:0010884),0.5103057817984387,1.2464356170317643,0.1961038961038961,1.0,1.0,4/21,9.13%,LPL;NFKB1;OSBPL11;PLIN3
prerank,neutrophil activation (GO:0042119),-0.47403073749093194,-1.2463613997178842,0.18471337579617833,0.8845799082962291,1.0,2/12,3.95%,KMT2E;PRKCD
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.40722403142908553,1.2462997157512397,0.06012024048096192,1.0,1.0,75/248,20.37%,SFRP2;TMEM198;WNT5A;BICC1;ATP6AP2;SFRP1;DVL2;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DKK3;DDX3X;FZD9;CTNND2;CHD8;FGF10;PPM1B;TCF7L2;USP47;KLHL12;PSMB10;DVL1;STK11;PSMD11;XIAP;SOX9;DDIT3;GPRC5B;RBMS3;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;LZTS2;JUP;ZNRF3;HDAC1;AXIN2;KREMEN1;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;CSNK1A1;PSMD1;INVS;USP34;NKD1;ADGRA2;TNKS;PTK7;UBR5;PSMD6;SOX13;APOE;TLE5;GNAQ;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;MLLT3;PRDM15;LRRK1;DAB2;CDK14
prerank,positive regulation of phagocytosis (GO:0050766),0.45638684166874477,1.2459073148985365,0.16414435389988358,1.0,1.0,9/47,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;IL15RA;RAB31;CAMK1D
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.42784020417013247,-1.2458615556116326,0.19117647058823528,0.8811523506500567,1.0,3/17,1.94%,FERMT2;GJA1;KAT7
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4728074695931433,1.2449561629981503,0.1790341578327444,1.0,1.0,10/40,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;FBXO5;ADGRV1;WNT4;ATP2B1;KL
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3807450798445942,-1.2447922365894297,0.14666666666666667,0.8794698399366953,1.0,6/23,7.62%,LATS1;SMAD4;BCL9;TRIM33;ITGA3;ENG
prerank,synaptic vesicle exocytosis (GO:0016079),0.46908545205992186,1.2447495570215623,0.17200474495848161,1.0,1.0,9/40,14.94%,SYT10;UNC13A;CDK5;STX2;DNAJC5;CPLX1;SNAP25;SYT1;STX11
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5909266263940783,1.2446769832489473,0.20562130177514792,1.0,1.0,2/10,10.25%,PLA2G5;ENPP2
prerank,regulation of myoblast differentiation (GO:0045661),0.4788245326067464,1.2444124693365726,0.18102372034956304,1.0,1.0,9/32,16.49%,LRRC8A;ZFP36L1;RANBP3L;RIPOR2;SOX9;SRA1;IGFBP3;TGFB1;TRIP4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4229770834384107,1.2439143387443576,0.15021459227467812,1.0,1.0,12/73,13.29%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,protein-containing complex disassembly (GO:0032984),0.4462935680771175,1.2435557438557328,0.1787709497206704,1.0,1.0,15/54,16.15%,UBQLN1;CLN3;DVL2;VPS16;SNX14;LIX1L;DVL1;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;CSNK1A1;STX17;VAMP8
prerank,regulation of lamellipodium assembly (GO:0010591),0.4672248467114776,1.243241765227205,0.20048019207683074,1.0,1.0,6/34,8.37%,CARMIL2;RAC1;ACTR2;PIK3R1;DMTN;CYFIP1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.41036524677630276,-1.2430672597846506,0.16923076923076924,0.8805570855600886,1.0,6/18,13.78%,LATS1;MDFIC;MFHAS1;ILRUN;RAB23;SIN3A
prerank,regulation of regulated secretory pathway (GO:1903305),0.470400860904332,1.24280647772856,0.18765432098765433,1.0,1.0,3/34,0.87%,UNC13D;SYT3;SYT10
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4987832234864831,1.2424773422161712,0.2186287192755498,1.0,1.0,8/23,18.75%,RAC1;MOSPD2;TIRAP;RIPOR2;JAM3;DNM1L;CAMK1D;MPP1
prerank,brain development (GO:0007420),0.4171390766772477,1.2424693921695757,0.10542476970317298,1.0,1.0,27/136,16.11%,AATK;AMIGO1;AFF2;POU6F1;EPHA7;SYNJ2;NKX2-2;GRIN1;NIPBL;CHD8;ATXN1;CXCR4;GRIN2A;PTCH1;ZFHX2;CDK5RAP3;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;SLC6A4;ZIC2;CNTNAP2;CIC;HSPG2
prerank,neuromuscular junction development (GO:0007528),0.5068378288641705,1.2422237791989008,0.20149253731343283,1.0,1.0,7/24,11.13%,CACNB4;UNC13A;PDZRN3;DVL1;MUSK;CACNB1;ANK3
prerank,positive regulation of neuron death (GO:1901216),0.44873244070197027,1.2418387788777774,0.1791569086651054,1.0,1.0,7/46,8.85%,WNT5A;FCGR2B;EPHA7;BAX;CDK5;DDIT3;EFNB2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41267635182126516,1.2416468234386595,0.12280701754385964,1.0,1.0,18/112,13.55%,WNT5A;LPL;IGF1;DDT;EPHB2;SELENOS;IL33;TNFAIP3;TIRAP;TMEM106A;SIRPA;TWIST1;LY96;APP;IFNGR1;CD47;TLR3;PTPN22
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.574691136562719,1.2416237714401792,0.22693997071742314,1.0,1.0,2/11,5.61%,XBP1;TMEM106A
prerank,cellular response to fatty acid (GO:0071398),0.5711432318575032,1.2415651453756047,0.21927374301675978,1.0,1.0,2/12,7.65%,LPL;PID1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5367459411629089,1.2414808094574237,0.19918144611186903,1.0,1.0,6/16,15.49%,PARP1;FLCN;PID1;VCP;AK4;ATPSCKMT
prerank,negative regulation of neuron death (GO:1901215),0.4237927350933694,1.241248665241498,0.129979035639413,1.0,1.0,17/93,13.35%,FGF20;CLN3;NTF3;FZD9;CDK5;FBXO7;SNX6;SLC30A10;CD200R1;INPP5A;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,metal ion export (GO:0070839),0.48221481552058193,1.2409903323913312,0.18757612667478685,1.0,1.0,5/31,12.11%,SLC4A4;ATP1A3;KCNT2;ATP1A2;KCND3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5327118104652978,1.2407800654111043,0.20765027322404372,1.0,1.0,4/17,10.30%,BMP6;PRKCA;CARD16;LY96
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4261914174845265,1.2406819127027267,0.1392136025504782,0.9997666614207528,1.0,10/85,9.17%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4209172363279923,1.240538970404986,0.15577342047930284,0.9986418407275371,1.0,17/80,14.58%,CARMIL2;CCP110;CDC42EP5;CDC42EP4;RAC1;ACTR2;NRP1;PIK3R1;RIPOR2;CYFIP1;ENTR1;ARAP1;HTT;FAM98A;AUTS2;PLPPR5;CEP120
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4420408721367661,1.2403447080815437,0.18698224852071005,0.9978492958054058,1.0,6/45,10.71%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5240569597292337,1.2400485079963135,0.20844327176781002,0.997542927469327,1.0,8/20,16.69%,ABCA2;ERLIN2;SIK1;WNT4;BMP5;SLC27A1;ACADL;ACADVL
prerank,glycerol metabolic process (GO:0006071),-0.5027956780963445,-1.2400205440997105,0.1952662721893491,0.8865881002911152,1.0,8/10,39.26%,GK5;COQ2;COQ3;GOT1;PGP;GK;ANGPTL3;TKFC
prerank,positive regulation of organelle assembly (GO:1902117),0.44885268569100145,1.2396250147785897,0.18830409356725147,0.9978129802388129,1.0,14/44,18.17%,CCP110;LCP1;PIP4K2B;ENTR1;SDCBP;GPSM2;PIP4K2A;HTT;PIP4K2C;CEP120;CNOT6;NUMA1;IL5;CCDC88A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5977746998347065,1.2396240863284398,0.22255639097744362,0.9960008204590362,1.0,3/10,12.01%,SELENOS;PID1;ENPP1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5387912995778081,1.2390160510208152,0.21671388101983002,0.9972713638374567,1.0,1/16,0.85%,FCGR2B
prerank,positive regulation of innate immune response (GO:0045089),0.48712195245612633,1.2386395125711698,0.20368098159509201,0.9973201001123488,1.0,5/30,8.18%,PLA2G5;WNT5A;POLR3D;IFI35;TRIM62
prerank,glycogen catabolic process (GO:0005980),-0.4397945003859641,-1.2369442535473325,0.2116788321167883,0.8927089658075711,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,negative regulation of kinase activity (GO:0033673),0.4313583542164716,1.2367662585176824,0.1774370208105148,1.0,1.0,24/62,21.65%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;WARS1;THY1;DVL1;YWHAG;IRS2;PARK7;MAPT;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;PPP2R5A;TAB1;TRIM27;PRKAG2;RTRAF;HNRNPU;NPRL2;PPM1F
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.573033448570699,1.2366602122011967,0.21720116618075802,1.0,1.0,1/12,1.28%,IL34
prerank,dopaminergic neuron differentiation (GO:0071542),-0.39362222810786696,-1.2365157566104144,0.1950207468879668,0.8890450268018021,1.0,4/19,23.38%,LRP6;MANF;VEGFA;NR4A2
prerank,regulation of intracellular pH (GO:0051453),0.4670347660286657,1.2363040562023633,0.20072115384615385,1.0,1.0,3/34,0.91%,SLC4A4;SLC4A5;CLN3
prerank,regulation of protein kinase B signaling (GO:0051896),0.4031411377645324,1.2360136492015696,0.07955689828801611,1.0,1.0,34/193,14.28%,FGF20;MYORG;FGF9;MST1R;TSC2;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;FLCN;TCF7L2;PIK3R1;GAB1;RCN3;DDIT3;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;MAGI2;PARK7;DAG1;RACK1;NRG2;NRG1;RNF41;TGFB1
prerank,hepaticobiliary system development (GO:0061008),0.5179944930160405,1.2359737447654764,0.21779548472775564,1.0,1.0,6/20,12.40%,GFER;XBP1;NIPBL;WNT4;CDK5RAP3;CEBPG
prerank,histone H4-K5 acetylation (GO:0043981),-0.4388799548100971,-1.2354844061312307,0.21721311475409835,0.8823495941056844,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),-0.4388799548100971,-1.2354844061312307,0.21721311475409835,0.8823495941056844,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,regulation of feeding behavior (GO:0060259),-0.48104303561658374,-1.2353941797933639,0.19601328903654486,0.8774429144735225,1.0,3/11,5.04%,EIF2AK4;STAT3;SGIP1
prerank,I-kappaB phosphorylation (GO:0007252),-0.49437058987427207,-1.2353642134215108,0.2113095238095238,0.8724673957178799,1.0,3/10,7.06%,DAB2IP;ERC1;TLR4
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4600456614373237,1.235296050522342,0.17633410672853828,1.0,1.0,10/43,9.55%,TMEM119;IGF1;FBN2;BMP6;NELL1;DDR2;FBXO5;SUCO;WNT4;SOX11
prerank,sterol metabolic process (GO:0016125),0.43886194753302976,1.2350847069948048,0.1672203765227021,1.0,1.0,12/60,13.04%,CYP27A1;CLN6;SCAP;GBA2;CYP7B1;SOAT1;INSIG1;MSMO1;SC5D;STARD3;CYP26B1;CYP51A1
prerank,regulation of mast cell degranulation (GO:0043304),0.5491646248388787,1.2345685656581997,0.22531293463143254,1.0,1.0,1/14,0.21%,UNC13D
prerank,membrane raft organization (GO:0031579),0.5472336618466137,1.23446211124572,0.22580645161290322,1.0,1.0,6/15,22.04%,CLN3;ABCA7;EMP2;ANXA2;FLOT1;NPC1
prerank,protein deneddylation (GO:0000338),0.601762554704744,1.2338058987857212,0.2183206106870229,1.0,1.0,2/10,8.17%,COPS7A;COPS7B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5274535215870486,1.233446066347495,0.20806241872561768,1.0,1.0,9/19,22.65%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5466320879212098,1.2332512171091354,0.2105978260869565,1.0,1.0,4/15,9.62%,CBARP;ATP1A2;PACSIN3;SLC30A1
prerank,regulation of heart contraction (GO:0008016),0.4183565414282667,1.2329199907898214,0.15279241306638566,1.0,1.0,13/90,11.50%,APLN;KCNG2;DMPK;CALM3;ATP1A3;ATP2A2;ITPR1;CELF2;ATP1A2;DES;ATP2B1;TPM1;CAMK2D
prerank,histone H2A monoubiquitination (GO:0035518),0.5290593626621899,1.2326742310569592,0.21954484605087016,1.0,1.0,6/17,10.68%,PCGF1;DDB1;PCGF6;RNF168;CUL4B;KDM2B
prerank,ephrin receptor signaling pathway (GO:0048013),0.4244790955810853,1.232540809410866,0.1609442060085837,1.0,1.0,17/82,10.04%,EPHA7;EPHB2;DNM1;RAC1;GRIN1;ACTR2;ARPC1A;ARHGEF7;PAK3;EFNB3;EPHA8;KALRN;SDCBP;EFNB2;EPHA10;AP2S1;VAV2
prerank,regulation of cytokinesis (GO:0032465),0.4262533425290427,1.2315762226313012,0.16967126193001061,1.0,1.0,24/78,21.79%,CCP110;FSD1;RAB11FIP4;MYO19;CALM3;FLCN;CDC14B;PLK5;CIT;ENTR1;MAP9;GIT1;SVIL;CSPP1;PRPF40A;KLHL13;PIK3C3;KIF20B;CALM1;PIK3R4;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.44090813005042,1.231326723803879,0.18993135011441648,1.0,1.0,14/49,15.32%,UBQLN1;BAX;PPIF;EIF2AK3;FIS1;PTPMT1;DDX3X;DDIT3;BCL2;RTKN2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,nuclear body organization (GO:0030575),0.5594764134978234,1.2311624663587877,0.23687943262411348,1.0,1.0,3/12,7.40%,AFF2;USPL1;WRAP53
prerank,mitochondrial transport (GO:0006839),0.4359676896634076,1.2310472371334655,0.18161925601750548,1.0,1.0,13/53,13.20%,PPIF;BCS1L;HSP90AA1;FIS1;SLC25A24;TOMM20;FBXO7;TIMM13;MFN2;AIP;BCL2;STARD3;GDAP1
prerank,cellular response to dsRNA (GO:0071359),-0.4265618661027148,-1.2310272298920502,0.20192307692307693,0.8838021803704775,1.0,11/15,35.55%,RIOK3;CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;PDE12;MUL1;CGAS
prerank,peptidyl-methionine modification (GO:0018206),0.5612032406914984,1.2308348159319278,0.22807017543859648,1.0,1.0,4/12,13.29%,METAP1;NAA30;METAP1D;METAP2
prerank,cognition (GO:0050890),0.4576018691349699,1.2307843701957635,0.19153936545240893,0.9994972463481107,1.0,11/42,15.65%,METTL23;STRA6;MGAT3;NIPBL;CYFIP1;TTC8;APP;JAKMIP1;LINS1;RP9;SOBP
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4661250684936736,1.2306454749865186,0.17253521126760563,0.9984210260847277,1.0,14/40,17.01%,VTN;NTF3;PICK1;CD63;HNRNPK;ARRB1;EGF;MAGI2;CBL;AHI1;SERPINE1;ANXA2;FMR1;RAB21
prerank,mitotic spindle assembly (GO:0090307),0.45894712835908325,1.2303781428853737,0.192090395480226,0.9980052604444695,1.0,13/42,17.49%,CCDC61;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;OFD1;CHEK2;BCCIP
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.46737882120620866,-1.2302816704932462,0.2315112540192926,0.8813673453148352,1.0,4/11,16.22%,TASOR;PPHLN1;SETDB2;DNMT1
prerank,DNA replication initiation (GO:0006270),-0.335229929608292,-1.2296399637701318,0.0979020979020979,0.8789294031048244,1.0,28/37,45.78%,ORC4;RPA1;PURA;NOC3L;ORC5;MCM6;PRIM2;CDK2;POLA2;PRIM1;LRWD1;POLE2;CDC7;MCM4;DBF4;RPA3;ORC1;CDC34;MCM8;RPA2;CDC45;POLE;MCM3;MCM2;MCM7;POLE3;MCM5;MCM10
prerank,female gamete generation (GO:0007292),0.479587444290998,1.2294919464610792,0.20245398773006135,1.0,1.0,2/29,6.03%,FSHR;SPO11
prerank,macroautophagy (GO:0016236),0.4117168985955479,1.229108751674104,0.12045690550363447,1.0,1.0,47/118,21.47%,UBQLN1;CLN3;MVB12A;PIP4K2B;CSNK2A2;VPS16;WIPI1;SNF8;SNX14;TOMM20;MTERF3;FUNDC1;LIX1L;SQSTM1;ATG14;MFN1;HGS;MFN2;VTA1;CHMP3;VCP;ATG13;TCIRG1;VPS33B;VPS4B;VTI1B;PIP4K2A;VDAC1;ATG3;MAP1LC3B;VPS39;VPS41;STX17;VAMP8;PIK3C3;STAM2;ARL8B;PRKAA1;PRKAG2;PIK3R4;YOD1;AMBRA1;DYNLL1;UVRAG;VAMP7;CHMP4A;CHMP4B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43618329479417217,1.2288848624030961,0.15869565217391304,1.0,1.0,14/60,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;DHX36;AGO3;CBFB;MED23
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.46985718523918096,1.2286177322121044,0.20606060606060606,0.9997207137803485,1.0,8/33,12.24%,APLN;TNFAIP3;MFN2;TAFA5;TPM1;IGFBP3;NDRG4;SOD2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5007688741603165,1.2282545599379868,0.20659062103929024,0.9998677046861257,1.0,3/24,9.52%,PLA2G5;CRLS1;GPAM
prerank,response to calcium ion (GO:0051592),0.41344441275644606,1.228178733621883,0.14167528438469493,0.998528677344851,1.0,32/102,21.79%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CALM3;CARF;SLC25A24;DMTN;RASGRP2;KCNMA1;ADGRV1;PEF1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;AHCYL1;PKD2;PRKAA1;CALM1;KCNH1;SMPD1;SYT4;PDCD6;SYT11;SYT12;CALM2
prerank,protein O-linked mannosylation (GO:0035269),0.5098216921701445,1.2279176136591654,0.22807017543859648,0.9981784019660705,1.0,4/18,9.40%,TMTC4;DPM2;TMTC1;POMT2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3462914290265712,-1.227797340542754,0.15151515151515152,0.8807760830915394,1.0,13/29,16.11%,RAD23B;GTF2H1;ERCC5;RBX1;CHD1L;MNAT1;CUL4A;RPA1;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,vasculature development (GO:0001944),0.5353895394577428,1.2274744758785938,0.2350597609561753,0.9986418715950627,1.0,4/16,11.29%,STRA6;ERRFI1;STK11;PDGFRA
prerank,regulation of aerobic respiration (GO:1903715),0.544016279080344,1.227432731438923,0.22899728997289973,0.99715733294466,1.0,5/15,13.28%,SLC25A33;COX7A2;VCP;AK4;UQCC2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5280827587357966,1.2273443433080726,0.22853185595567868,0.995855589335862,1.0,6/17,19.75%,ANXA1;ARRB1;SSC5D;PTPN22;ANXA4;KLF4
prerank,chondrocyte differentiation (GO:0002062),0.47537791420331516,1.2273259412595146,0.1909307875894988,0.9942503439673116,1.0,9/32,17.13%,WNT2B;GPLD1;EIF2AK3;SULF1;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.42883324564034364,-1.2266377572269325,0.21561338289962825,0.8800511655344074,1.0,5/16,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.49083465037342644,1.2265815459909544,0.21656050955414013,0.9961692757523496,1.0,6/25,16.69%,CENPJ;STMN4;TPPP3;KATNB1;MAPT;TPPP
prerank,cellular response to estrogen stimulus (GO:0071391),0.5517391518313395,1.2265709997346281,0.2231638418079096,0.9945506178570566,1.0,4/14,12.53%,WBP2;SFRP1;SRA1;NCOA4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5183044597284009,1.2261512996793837,0.2,0.9949156210634416,1.0,5/19,6.14%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,regulation of hydrolase activity (GO:0051336),-0.2897685781511096,-1.2260897411172746,0.07042253521126761,0.877290674203477,1.0,27/71,22.99%,PRKG1;DAB2IP;RDX;RAPGEF6;RALBP1;CAV1;FGD5;OCRL;ARHGAP44;PLXNA4;FGD1;SIPA1L1;TDG;ARHGEF5;PLXNB2;PLXNC1;RASIP1;TBC1D10B;ARHGAP27;CHN2;NF1;WRN;PLXNB1;NGEF;CAMK2A;RAB3GAP1;FGD3
prerank,myelination (GO:0042552),0.4471153499882996,1.2259894024995877,0.18615209988649262,0.9940359941888934,1.0,13/46,17.90%,AMIGO1;SIRT2;MYRF;ARHGEF10;MARVELD1;CXCR4;GPC1;PLLP;B4GALT5;EPB41L3;ABCD2;TPPP;BCAS1
prerank,regulation of chromosome organization (GO:0033044),-0.37491866835435855,-1.2253022666086921,0.17672413793103448,0.8752324116650243,1.0,7/22,17.46%,WAPL;RB1;HDAC8;SMG5;CENPV;UPF1;SMG6
prerank,negative regulation of defense response (GO:0031348),0.42311419578450343,1.2250779584682299,0.15334773218142547,0.9967355060267599,1.0,10/77,7.34%,SMPDL3B;PTGER4;SIRT2;SELENOS;RORA;TNFAIP3;PPM1B;DHX58;TRAFD1;SIRPA
prerank,response to alcohol (GO:0097305),0.47979010389247195,1.224229584603569,0.2,0.9991989198119473,1.0,10/27,21.76%,GRIN1;ABCA2;GRIN2A;TGFB1;GLRA1;SLIT3;TGFBR1;TGFBR3;SMAD2;SDF4
prerank,regulation of supramolecular fiber organization (GO:1902903),0.4954527474263748,1.2221966020105968,0.23107569721115537,1.0,1.0,9/22,17.19%,MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;PARK7;AKAP13;MAPT;APOE
prerank,negative regulation of immune system process (GO:0002683),0.5359177781347748,1.2220832558247436,0.22809457579972184,1.0,1.0,2/16,8.36%,FCGR2B;SOX9
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5693988535032903,1.2219914019634244,0.24480712166172106,1.0,1.0,1/10,0.80%,WNT5A
prerank,response to exogenous dsRNA (GO:0043330),-0.4031321625213199,-1.2219023393321828,0.1862348178137652,0.8827065969112321,1.0,11/18,35.55%,CAV1;SLC3A2;IFIH1;RALB;MAVS;IFIT1;TICAM1;DHX9;PQBP1;MUL1;CGAS
prerank,negative regulation of platelet activation (GO:0010544),-0.41193128849934696,-1.2213438104386602,0.20588235294117646,0.8798635367324461,1.0,5/16,6.80%,PRKG1;SERPINE2;PRKCD;THBD;NOS3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.566934038813871,1.221130019985315,0.23348694316436253,1.0,1.0,5/11,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.5332246620668737,1.2210473331000482,0.24556616643929058,1.0,1.0,3/15,9.13%,LPL;OSBPL11;PLIN3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.45362492757100875,1.2209086294255451,0.19838523644752018,1.0,1.0,15/43,19.82%,TSC2;PIP4K2B;SLC27A4;SNX5;OGT;ZBTB7B;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;NUCKS1;SORL1;PTPRE;PRKCZ
prerank,regulation of protein kinase C signaling (GO:0090036),0.5395320268103012,1.2208457336109342,0.24251069900142652,1.0,1.0,3/14,7.66%,WNT5A;GPD1L;ADGRV1
prerank,positive regulation of neurogenesis (GO:0050769),0.422900203655571,1.220433595391939,0.18015102481121897,1.0,1.0,21/68,20.85%,AMIGO1;CUL7;SMARCD3;CDKL5;PLXNA2;FZD3;OBSL1;PLXNA1;SOX11;ROBO2;ROBO1;IL1RAPL1;NPTN;DISC1;SNW1;PLXNB3;SLITRK1;CUX1;SERPINF1;MAP6;NTRK2
prerank,liver development (GO:0001889),0.4712584303432604,1.220095603856103,0.20759193357058126,1.0,1.0,7/32,12.40%,GFER;ANXA1;XBP1;ZIC3;WNT4;CDK5RAP3;CEBPG
prerank,regulation of cilium assembly (GO:1902017),0.42743562609442576,1.2199100507960472,0.17912087912087912,1.0,1.0,22/62,18.26%,CCP110;DCDC2;CDKL5;TBC1D7;SGSM3;TBC1D13;CEP97;TCHP;ENTR1;TBC1D20;USP6NL;EVI5L;IFT20;HTT;RABGAP1;TBC1D24;ATG3;CEP120;TBC1D9B;TBC1D22B;CCDC88A;CDK10
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4820306719068752,1.2195579913749204,0.24504950495049505,1.0,1.0,10/27,19.82%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ
prerank,endomembrane system organization (GO:0010256),0.402552284946006,1.2195513605560857,0.1028225806451613,1.0,1.0,50/178,16.00%,SPTBN5;REEP4;CUL7;A4GALT;ATL1;DNM1;TJAP1;UBXN2A;EIF2AK3;DMPK;BNIP1;TRAPPC8;OBSL1;TLCD1;SQSTM1;SEC16A;ARHGEF7;MIA3;SNX10;TRIP11;SEC16B;ATP8B2;LMAN2L;ARHGAP21;TOR1B;HOOK3;TBC1D20;PLEKHM2;USP6NL;ANK3;RAB30;ALS2;SNX33;VPS33B;LEMD3;TANGO2;TMED10;SERP1;COG3;HTT;CSNK1D;SMPD4;VMP1;DNM1L;DNAJC13;CSNK1A1;SPTBN1;VAPB;STX17;VPS18
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.49551372912520264,1.2195153029968264,0.2167741935483871,1.0,1.0,3/22,6.14%,FCGR2B;UBASH3A;THY1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5684056139283684,1.2193095185997025,0.23699421965317918,0.9998226542999492,1.0,6/11,16.87%,ZFP36L1;BARD1;DHX36;CDC73;ZC3H3;AHCYL1
prerank,chemical homeostasis (GO:0048878),0.4276043509933332,1.2191108627173146,0.18708971553610504,0.9991874133945048,1.0,13/61,15.48%,SLC4A4;SLC4A5;USF1;NR1D2;DDX3X;TLCD1;RBP1;IRS2;WNK2;ZBTB20;TLCD3B;AQP4;ACOX3
prerank,xenobiotic transport (GO:0042908),-0.4080688338472696,-1.2182272615240761,0.20703125,0.88637946171296,1.0,4/17,4.18%,ABCG2;GJA1;ABCC1;SLC47A1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5300214884822534,1.2175472747448424,0.23369565217391305,1.0,1.0,3/16,7.50%,FASN;MLYCD;ACAT1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4240671171781371,1.2173510652989215,0.17967914438502675,1.0,1.0,18/68,16.33%,MLYCD;THEM4;PTHLH;ENTPD7;ACOT9;ACOT11;GPAT4;MFN1;ACAT1;CROT;AK4;ENPP1;HPRT1;ABHD14B;AK3;ACSL6;GMPR2;SULT1A1
prerank,positive regulation of developmental growth (GO:0048639),0.43867640576539413,1.2171199464462288,0.2036613272311213,1.0,1.0,11/49,17.44%,RNF157;SYT3;CDKL5;UNC13A;DBN1;PPIB;DBNL;SYT1;MAPT;SMURF1;RUFY3
prerank,cellular response to misfolded protein (GO:0071218),0.5056125445974369,1.216996595819447,0.22193548387096773,1.0,1.0,6/20,10.85%,STUB1;AUP1;POMT2;KLHL15;VCP;UGGT2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.5737655049569882,1.2166850134629639,0.24610591900311526,1.0,1.0,1/10,1.59%,SIRT2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5481757550729549,1.2162562684980556,0.24619640387275243,1.0,1.0,6/13,14.40%,PRPF8;SRSF12;PRPF6;SART3;USP4;AAR2
prerank,dendritic cell differentiation (GO:0097028),-0.37175949666048147,-1.2161796802218858,0.16417910447761194,0.889250724164777,1.0,3/22,7.89%,AXL;LGALS9;TGFBR2
prerank,cGMP-mediated signaling (GO:0019934),0.551740366565077,1.2160537758402556,0.24794520547945206,1.0,1.0,4/13,18.87%,KCNC2;HTR2C;APOE;PDE9A
prerank,retinol metabolic process (GO:0042572),0.5330560171816463,1.2159267496436508,0.24289772727272727,1.0,1.0,2/14,6.30%,RDH10;RDH11
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4360031961521096,-1.215841508038156,0.21739130434782608,0.8856535122360635,1.0,6/14,19.11%,GJA1;AGO2;CALR;SYDE1;ARHGDIB;VEGFA
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5492791044571781,1.215819309223883,0.228486646884273,1.0,1.0,5/13,7.72%,SAR1A;SEC16A;BRSK2;SEC16B;INSIG1
prerank,positive regulation of immune effector process (GO:0002699),0.4754226735417779,1.2158063645450106,0.2458808618504436,0.9989374012446103,1.0,3/27,5.93%,PLA2G5;XBP1;DHX58
prerank,cell-substrate junction assembly (GO:0007044),-0.3388804809151828,-1.2157383278230818,0.16666666666666666,0.8813051220720103,1.0,15/33,15.19%,DST;SORBS1;FERMT2;PTPRK;ITGA6;TAOK2;CTTN;TESK2;ACTN1;FN1;PLEC;ACTN2;LAMA3;ITGB4;SRC
prerank,cardiac atrium morphogenesis (GO:0003209),-0.42706101267141094,-1.2156247893116363,0.21223021582733814,0.8769743843714108,1.0,14/16,55.68%,TGFB2;ENG;NOTCH2;BMP2;HEY2;ZFPM1;DLL4;BMPR2;TBX20;NOG;MYH6;PROX1;GATA4;ISL1
prerank,negative regulation of DNA binding (GO:0043392),-0.353899557346155,-1.2153783704262882,0.15422885572139303,0.873101037417265,1.0,11/28,26.63%,LEF1;SP100;NFKBIA;ILRUN;SIN3A;JUN;HABP4;MDFI;SUMO3;HMGA2;HEY2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5653982290357437,1.2153272416410328,0.24714285714285714,0.9997335650768544,1.0,5/12,17.23%,PFDN4;VBP1;PFDN1;APOE;PFDN2
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2522664991373411,-1.2149506873861784,0.0,0.8699081408093954,1.0,41/153,12.83%,RICTOR;MAPK8;HIPK2;LATS1;PRKCH;CSNK1G3;CAB39;ERN1;MORC3;CSNK2A1;IKBKB;MARK2;STK38L;NLK;PRKCE;PRKCD;RIPK1;RPS6KA5;CSNK1G1;PRKD1;MARK1;CSNK1E;MKNK1;HIPK1;PRKACA;LRRK2;CSNK1G2;TGFBR2;NEK6;IKBKE;TTBK2;MAP3K10;MAP3K13;STK32A;LMTK2;VRK3;CAMK1;ROCK1;MAP3K12;AKT3;PRKX
prerank,negative regulation of cell development (GO:0010721),0.4836841294730394,1.2147765069771859,0.22123893805309736,1.0,1.0,8/25,23.91%,IGF1;PTHLH;HOOK3;FBN1;SORL1;APPL2;B2M;FBXW7
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.47943169889807596,-1.2137147326984048,0.2476780185758514,0.8697507597147229,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,ribosomal large subunit assembly (GO:0000027),-0.3731764370272745,-1.213364735974371,0.15865384615384615,0.866426758734819,1.0,18/24,36.65%,RPL11;RPL5;RPL6;RPL24;RPL3;RPLP0;RPL10;TRAF7;MRPL20;FASTKD2;NOP53;RPF2;NOP2;BOP1;RRS1;RSL24D1;NLE1;PPAN
prerank,negative regulation of B cell proliferation (GO:0030889),0.5569413773225942,1.213269691520223,0.2562962962962963,1.0,1.0,1/11,0.85%,FCGR2B
prerank,cholesterol homeostasis (GO:0042632),0.4224207544408864,1.2130003348756673,0.20043336944745396,1.0,1.0,20/64,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,monocyte chemotaxis (GO:0002548),-0.33669370594896975,-1.2128964971529819,0.14857142857142858,0.8634890113482088,1.0,7/32,18.94%,FLT1;IL6R;CCL15;RPS19;PTPRO;TNFRSF11A;CCL13
prerank,regulation of interferon-beta production (GO:0032648),0.4423958666284113,1.2122960673406415,0.20161290322580644,1.0,1.0,16/46,20.04%,HSP90AA1;POLR3D;DDX3X;TIRAP;PPM1B;IRF1;DHX58;TRIM56;SIRPA;IRF3;YY1;TLR3;OAS2;RELB;FLOT1;PTPRS
prerank,central nervous system myelination (GO:0022010),0.5720661583167528,1.212140678007342,0.25880551301684535,1.0,1.0,4/11,15.23%,MYRF;ABCA2;B4GALT5;TENM4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.497028769477279,1.2119712096621824,0.2270967741935484,1.0,1.0,7/22,16.79%,CBARP;CACNB4;NOS1AP;CACNB1;PDE4B;AHNAK;FMR1
prerank,mesoderm development (GO:0007498),-0.3982254187878427,-1.2116080643956038,0.19047619047619047,0.8632378257273217,1.0,7/18,19.11%,TBX3;TIE1;MESD;IKZF1;TBX1;BMX;VEGFA
prerank,regulation of smooth muscle contraction (GO:0006940),-0.39277098605741356,-1.2115118111219383,0.21810699588477367,0.8591241157660898,1.0,6/20,9.94%,KCNB2;CHRM3;CAV1;PLCE1;CTTN;SETD3
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4446232683799406,1.2113821250658765,0.2243211334120425,1.0,1.0,19/39,24.56%,TVP23B;MIA3;RAB12;RCN3;RAB10;RAB3B;TANGO2;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3;STEAP3;ARFGAP3;COPG1;OLFM2;ABCA1;SEL1L
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4911435894928339,1.2107463863971146,0.2249357326478149,1.0,1.0,5/23,9.57%,COPS7A;PARP1;DDB1;COPS7B;CUL4B
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.499327916491513,1.2103779955204863,0.23901808785529716,1.0,1.0,7/22,15.78%,HEXIM1;EEF1E1;CHD5;CDK5RAP3;RPS15;ATR;DDX5
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4907089688230045,1.210078949812235,0.23175416133162613,1.0,1.0,7/23,10.18%,SH3BP5;ERRFI1;THY1;SNX6;SH3BP5L;MVP;SRCIN1
prerank,actin filament organization (GO:0007015),0.4051847571666241,1.2099977582408763,0.1202020202020202,1.0,1.0,29/151,17.61%,MYO1A;CARMIL2;SPIRE2;LCP1;MYO19;RAC1;WHAMM;NEB;MYO1B;DMTN;DBN1;RHOD;GAS2L1;PPP1R9B;BAIAP2;RHOBTB3;TPM1;MYO5A;MPRIP;ZBED3;EFS;SVIL;EMP2;FAT1;SPIRE1;VILL;TMOD2;RUFY3;ABI1
prerank,calcium ion homeostasis (GO:0055074),0.41077321658660426,1.2092739143669562,0.16806722689075632,1.0,1.0,15/95,13.21%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;GRIN1;CXCL12;ATP2A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN
prerank,positive regulation of growth (GO:0045927),0.4200245899420889,1.2090684945551766,0.19162995594713655,1.0,1.0,12/64,12.97%,SFRP2;SFRP1;CDKN2AIP;EXOSC2;TAF9B;SLC25A33;DDX3X;USP47;SDCBP;BCL2;EIF4G2;RPS6KA3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.43544165266233376,1.2089871870504025,0.2219679633867277,1.0,1.0,13/50,16.81%,CDKN2D;DDX3X;CARD16;USP47;RFFL;XIAP;CAAP1;PARK7;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,interstrand cross-link repair (GO:0036297),0.4305214165799816,1.2084672629495485,0.2017738359201774,1.0,1.0,13/53,15.12%,RNF8;USP1;FANCE;FANCG;RNF168;VCP;DCLRE1A;FANCM;POLN;FAAP100;ATR;FANCA;NUCKS1
prerank,regulation of protein kinase activity (GO:0045859),0.4025563243365405,1.2083144786142572,0.17816683831101957,1.0,1.0,31/106,20.58%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;MAPRE3;SMG8;WARS1;DDR2;THY1;DVL1;MMD;XRCC6;MRNIP;YWHAG;JTB;ALS2;IQGAP1;PARK7;PPM1E;DAXX;ITGB1BP1;GNAQ;CAMK2N1;RASSF2;TAB1;TRIM27;PRKAG2;RTRAF;UVRAG;PTK2B
prerank,regulation of T cell chemotaxis (GO:0010819),0.5524492416657489,1.208190817726609,0.26061493411420206,1.0,1.0,1/11,0.80%,WNT5A
prerank,positive regulation of bone mineralization (GO:0030501),0.466642208632442,1.2081409568391865,0.2057074910820452,1.0,1.0,9/35,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;KL
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4762683124754921,1.2078796950645367,0.24814814814814815,1.0,1.0,11/28,21.10%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ;APPL2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5087141182277367,1.2077003536259319,0.2328042328042328,1.0,1.0,2/20,3.12%,PSRC1;MAPRE3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4920337976051314,1.2071712625325217,0.24246231155778894,1.0,1.0,1/24,0.17%,RNF157
prerank,myeloid cell differentiation (GO:0030099),-0.3084254468780214,-1.207147074219344,0.13953488372093023,0.8702550439184188,1.0,18/47,29.03%,HIPK2;MFHAS1;NCOA6;KMT2E;KIT;UBA5;RPS19;PRKX;UFL1;IKZF1;KAT8;CASP3;PRDX3;RPS14;INHBA;SLC25A5;KAT6A;TAL1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5023949467181663,1.2068822867506253,0.24538258575197888,1.0,1.0,7/19,17.00%,CD63;CCBE1;DCN;PIK3CB;ROBO1;ADAMTS3;SPRY2
prerank,sterol homeostasis (GO:0055092),0.4205954353890735,1.206665778106273,0.20326086956521738,1.0,1.0,20/65,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,ceramide catabolic process (GO:0046514),-0.43581664564910877,-1.2064669577246494,0.20634920634920634,0.8682518344641776,1.0,13/14,55.84%,ASAH1;GM2A;NAGA;NEU1;NEU3;HEXA;GLA;ACER2;NEU2;ASAH2;NEU4;ACER3;ACER1
prerank,peptide biosynthetic process (GO:0043043),-0.2521335698105157,-1.2053287226858604,0.0,0.8678268057589199,1.0,55/153,18.40%,RPS24;ABCF1;AGO2;RPL11;RPS15A;RPS23;RPL5;DMD;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;SRBD1;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;GGT5;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;RPS5;MRPL42;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;MRPS21;RPS26;RPS27;RPL10A;MRPL52;DARS1;RPS10;PCSK1;MRPS18A;MRPS15;RPL7A;MRPS33;MRPS18C
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5665422273401883,1.2050135218565365,0.2543352601156069,1.0,1.0,5/11,15.95%,UBN1;RBBP4;ASF1A;ATRX;HAT1
prerank,sensory perception of sound (GO:0007605),0.4138359198273835,1.2046707990859506,0.18220793140407288,1.0,1.0,10/88,9.17%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,ERBB2 signaling pathway (GO:0038128),0.46552884472773315,1.2046141169537004,0.22115384615384615,1.0,1.0,11/31,18.11%,HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;EGF;NRG2;CUL5;NRG1;PTPN12;ERBIN
prerank,Wnt signaling pathway (GO:0016055),0.41128512605784356,1.2044035823513612,0.17450365726227796,1.0,1.0,21/92,15.56%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;DDX3X;FZD9;FZD3;TCF7L2;KLHL12;DVL1;CD24;WNT4;WLS;DIXDC1;PORCN;GPC4;PLPP3;CSNK1A1;TCF7L1;USP34
prerank,mitochondrial membrane organization (GO:0007006),0.4625654349504503,1.2040579468733896,0.23381294964028776,1.0,1.0,9/32,13.79%,APOOL;PPIF;MICOS10;MFN1;MFN2;APOO;RCC1L;BCL2;MTX3
prerank,mesenchymal cell differentiation (GO:0048762),0.43161255396727066,1.2040245849157314,0.22334455667789002,1.0,1.0,13/51,15.78%,WNT5A;CUL7;DDX17;FGFR2;FGFR1;SNAI1;RANBP3L;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,embryonic eye morphogenesis (GO:0048048),0.5710548173776642,1.203558677838188,0.24924924924924924,1.0,1.0,5/11,12.67%,FBN2;MFAP2;MFAP5;KDM2B;FBN1
prerank,regulation of gastrulation (GO:0010470),0.5301819980325239,1.2033910224918523,0.2441860465116279,1.0,1.0,7/14,24.80%,DAG1;RACK1;TENM4;PHLDB1;OSR1;CLASP2;PHLDB2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4169805009095907,-1.202872830893988,0.2222222222222222,0.8721380275484062,1.0,7/17,15.52%,AFG1L;COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1
prerank,regulation of peptide hormone secretion (GO:0090276),0.41982168390980157,1.2028350439002875,0.20412595005428882,1.0,1.0,12/67,17.24%,CACNA2D2;KCNG2;PICK1;ITPR1;PRKCA;KCNC2;SNAP25;HTR2C;UQCC2;RFX3;CLOCK;EIPR1
prerank,bile acid and bile salt transport (GO:0015721),-0.3592220663641479,-1.2021251753142417,0.18309859154929578,0.8702322131784319,1.0,3/24,4.79%,ABCC4;ATP8B1;SLCO1C1
prerank,negative regulation of protein kinase activity (GO:0006469),0.4082685278172105,1.202071947724359,0.192102454642476,1.0,1.0,26/88,19.00%,DUSP26;TARBP2;GSKIP;TSC2;PDPK1;SH3BP5;PRKRIP1;WARS1;ABL1;THY1;DVL1;SH3BP5L;CDK5RAP3;MVP;YWHAG;SRCIN1;PARK7;NPM1;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;SORL1;TAB1;TRIM27;PRKAG2
prerank,striated muscle tissue development (GO:0014706),-0.3504222056530663,-1.2016798304913756,0.1871345029239766,0.8674750526814021,1.0,9/29,16.25%,MEF2C;PGM5;MYL6;CAV1;RBP4;SGCD;BMP7;SIX1;NDUFV2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5222916384037873,1.201199240593495,0.25106990014265335,1.0,1.0,5/14,12.60%,SELENOS;SYVN1;XBP1;PARK7;CREB3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.40363292170487713,-1.2011299705087832,0.21610169491525424,0.8648970396088638,1.0,7/17,12.55%,GJA1;ATP1A1;GJC1;GJD3;CACNA1C;PRKACA;ATP1B1
prerank,vitamin transport (GO:0051180),-0.34926718864767126,-1.2009606153521297,0.18627450980392157,0.8612242885548024,1.0,9/29,23.44%,ABCG2;TCN2;SLC35F3;SLC25A32;SLC52A1;SLC5A6;CUBN;SLC19A2;SLC2A10
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5907644024252832,1.200854416952444,0.2671532846715328,1.0,1.0,1/10,0.49%,NHP2
prerank,RNA processing (GO:0006396),0.3923216506136708,1.2003198046586279,0.11995967741935484,1.0,1.0,46/176,14.92%,KHSRP;LSM6;DDX17;RBM3;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;DHX15;USB1;SRSF5;SF3B2;SF3B1;RBM39;CELF2;DHX8;ATXN1;CELF1;HNRNPK;AKAP8L;FUS;MPHOSPH10;SRSF9;SF3A1;PRPF6;SRSF1;AURKAIP1;PPP1R9B;PABPC4;KIN;HNRNPD;LIN28B;RBMS1;NUDT21;RBMS2;DHX16;HNRNPA0;HNRNPH3;SETX;HNRNPL;NOVA1;HNRNPA2B1;RP9;THOC1
prerank,protein N-linked glycosylation (GO:0006487),0.4220343538491677,1.2001283855106974,0.2089227421109902,1.0,1.0,17/66,15.21%,ALG5;TMEM258;ALG6;MGAT3;DPM2;MGAT4B;ALG1;ALG8;DPAGT1;MGAT4C;UGGT2;ALG9;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,lipoprotein transport (GO:0042953),0.5665801754676567,1.1999753260177544,0.26398852223816355,1.0,1.0,4/10,17.86%,MIA3;LRP1;VMP1;ZDHHC17
prerank,steroid hormone biosynthetic process (GO:0120178),-0.34840729855941954,-1.1997734896941175,0.1895424836601307,0.8612218619678685,1.0,14/29,42.35%,MED1;AKR1B1;STARD3NL;FDX1;TSPO;SRD5A3;FDXR;HSD17B7;HSD17B8;DHCR7;STAR;SRD5A1;HSD17B2;TSPOAP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3995789333954413,1.199749492831784,0.14445574771108852,1.0,1.0,22/152,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;VIPR2;PTHLH;OPRK1;GPR37;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1
prerank,negative regulation of viral transcription (GO:0032897),0.5553622384188901,1.1997108833446932,0.2564102564102564,1.0,1.0,3/13,8.18%,HEXIM1;TRIM11;TRIM62
prerank,positive regulation of organelle organization (GO:0010638),0.4666524912223169,1.199683426880164,0.2286401925391095,1.0,1.0,9/32,21.24%,PLA2G5;ANXA1;KATNBL1;ANXA2;PFDN2;FYCO1;RAB3GAP2;UVRAG;ATL3
prerank,macrophage differentiation (GO:0030225),0.5435343087267194,1.1996813123351644,0.24651810584958217,1.0,1.0,2/13,4.92%,PARP1;IL31RA
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.486765693052849,1.1995908695464266,0.24528301886792453,1.0,1.0,3/25,5.62%,B3GALNT1;HS2ST1;NDST2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5458492304188868,1.198675846219215,0.26695526695526695,1.0,1.0,3/12,9.95%,ELOVL1;HSD17B4;FADS1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.3761425570322768,-1.1978434031932723,0.2033195020746888,0.86367816628324,1.0,4/21,7.55%,CACNA1D;FLNA;CACNA2D1;AKAP9
prerank,calcium ion import (GO:0070509),-0.34358236719587376,-1.1978140893041396,0.24431818181818182,0.8595399807605413,1.0,16/28,31.29%,MICU1;CACNA1D;CACNA1C;CACNA1G;MCU;MCUR1;TRPC4;CACNB2;MCUB;MAIP1;SMDT1;CACNA1B;TRPV4;MICU3;SLC8A1;CACNA1H
prerank,actin filament polymerization (GO:0030041),0.4603153410210807,1.1977898600429446,0.22303921568627452,1.0,1.0,11/29,21.44%,SPIRE2;RAC1;TTC17;WASF1;SPIRE1;GAS7;ARHGAP6;PSTPIP2;PREX1;GSN;DIAPH1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4062621044795319,1.197784727265546,0.17604166666666668,1.0,1.0,26/91,17.01%,CPLANE2;TSC2;ATP9A;USP7;NRP1;ABL1;RAB12;PACSIN3;RAB5B;CPLX1;CHMP3;RAB10;AP2S1;MBTPS1;SCFD1;RAB3B;SYT1;RAB13;MAP2K2;DNAJC13;RAB8A;RAB8B;RUFY1;NSF;RIT2;RAB21
prerank,regulation of steroid metabolic process (GO:0019218),0.4823743222614058,1.1976886636394164,0.23514538558786346,1.0,1.0,9/23,21.42%,STUB1;RORA;ABCA2;EPHX2;ACADL;ACADVL;APOE;TTC39B;ABCG1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5361484439303057,1.1965520534894032,0.26207906295754024,1.0,1.0,2/13,2.68%,SELENOS;IL33
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.42119270564086153,-1.1957109976625557,0.24363636363636362,0.862688231346872,1.0,6/15,23.62%,PRKD1;TMSB4X;THBS1;MET;HSPB1;SEMA5A
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3290042500261709,-1.19570919177388,0.16535433070866143,0.858516191647496,1.0,14/40,16.76%,RAD23B;HIPK2;LATS1;CSNK2A1;GNA12;PML;RPL11;RPL5;AXIN1;TRIM39;UBQLN4;RNF139;SGTA;UFL1
prerank,negative regulation of leukocyte activation (GO:0002695),0.5211390323647445,1.195565925646725,0.2621359223300971,1.0,1.0,2/15,4.92%,FCGR2B;IL31RA
prerank,regulation of endocytosis (GO:0030100),0.42178136761444557,1.1953745249686833,0.19093851132686085,1.0,1.0,21/61,20.27%,CALY;TSC2;CD151;ABL1;PACSIN3;LRPAP1;RAB5B;ABCA7;CLIP3;AP2S1;SNX33;SCAMP5;LRP1;RUFY1;RIT2;APOE;MCTP1;ZFYVE16;FLOT1;SMPD1;DAB2
prerank,fatty acid elongation (GO:0030497),0.540229222341939,1.1953100563116659,0.27285318559556787,1.0,1.0,7/13,27.48%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,positive regulation of lyase activity (GO:0051349),-0.42580205825476947,-1.1950198321132548,0.24516129032258063,0.8568270394164476,1.0,7/14,28.05%,CACNA1D;NOS3;CACNA1C;NF1;NOS1;FXN;ISCU
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5102502584599748,1.1949262768118931,0.2393980848153215,1.0,1.0,5/17,9.82%,SELENOS;SYVN1;HM13;AUP1;VCP
prerank,external encapsulating structure organization (GO:0045229),0.3936330090321995,1.194484072393914,0.11256281407035176,1.0,1.0,46/205,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4789053417740139,1.1944497268880354,0.25793650793650796,1.0,1.0,4/23,6.64%,APLP1;SIRT2;ABL1;GNG2
prerank,peroxisomal membrane transport (GO:0015919),0.4638579539766867,1.194408720930424,0.24090338770388958,1.0,1.0,11/27,16.83%,FIS1;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,epithelial to mesenchymal transition (GO:0001837),0.4327631395603747,1.1943645702617882,0.23414071510957324,1.0,1.0,12/47,15.78%,WNT5A;CUL7;DDX17;FGFR1;SNAI1;OLFM1;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,positive regulation of cilium assembly (GO:0045724),0.5059612004331846,1.194077875580835,0.26710526315789473,1.0,1.0,6/18,18.17%,CCP110;WRAP73;ENTR1;HTT;CEP120;CCDC88A
prerank,organelle disassembly (GO:1903008),-0.33757829934630024,-1.1936760925442294,0.1656441717791411,0.8573455239519865,1.0,12/33,16.76%,GBF1;ATG2B;MCTS1;KLC1;UBA5;DDRGK1;EIF2D;MTIF2;ULK2;ZFAND1;UFC1;UFL1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.4373080599558898,-1.1931994956404708,0.23426573426573427,0.8548492878172711,1.0,3/13,21.27%,CYRIB;NECTIN2;PVR
prerank,COPII-coated vesicle budding (GO:0090114),0.41318204395635233,1.192941214561056,0.20917822838847386,1.0,1.0,28/68,20.41%,TRAPPC10;SCAP;SAR1A;KLHL12;SEC16A;MIA3;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;VAPB;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,macrophage activation involved in immune response (GO:0002281),-0.43569969690354493,-1.1927811922349203,0.24092409240924093,0.8522221561564364,1.0,5/13,13.96%,SBNO2;LBP;PLCG2;DYSF;GRN
prerank,positive regulation of macrophage activation (GO:0043032),0.5043176991396738,1.1927596707034551,0.2516914749661705,1.0,1.0,2/17,2.68%,WNT5A;IL33
prerank,potassium ion transport (GO:0006813),0.3993639790122349,1.192598825515276,0.1772020725388601,1.0,1.0,19/120,15.90%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;KCNK2;KCNMA1;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,stabilization of membrane potential (GO:0030322),0.5180680720188423,1.1924566088580129,0.2669376693766938,1.0,1.0,2/16,5.33%,CHCHD10;KCNK2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3798064440982601,-1.1922595005667476,0.19747899159663865,0.8500150290645979,1.0,8/20,19.52%,CNOT1;TNRC6A;HELZ;AGO2;LIMD1;CNOT8;CNOT7;NRDE2
prerank,glial cell differentiation (GO:0010001),0.46791906347166756,1.1918489397407868,0.25060827250608275,1.0,1.0,7/28,9.55%,MYRF;PICK1;FGF10;CDK5;GPC1;SOX9;SOX11
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5162290745158341,1.1917211938611947,0.2566489361702128,1.0,1.0,6/17,12.60%,ALG6;ALG1;ALG8;DHDDS;DPAGT1;ALG9
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3860184283969525,-1.191527892474202,0.20491803278688525,0.8445853460753774,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3860184283969525,-1.191527892474202,0.20491803278688525,0.8445853460753774,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,positive regulation of DNA repair (GO:0045739),0.43445987391608404,1.1912326033282032,0.22768878718535468,1.0,1.0,18/46,22.00%,SPIRE2;FOXM1;PARP1;RNF8;FGF10;MGMT;SLF2;WRAP53;RNF168;CEBPG;EYA2;SPIRE1;FMN2;UIMC1;RPS3;EYA1;NPAS2;HMGB1
prerank,protein localization to cell-cell junction (GO:0150105),-0.42674802454036564,-1.1906051152056727,0.2318840579710145,0.8436944864805884,1.0,5/15,9.79%,ARHGEF18;TJP1;ACTB;F11R;LSR
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.48415801460417335,1.190418399894922,0.25170998632010944,1.0,1.0,3/21,4.16%,SMARCD3;FZD9;FZD3
prerank,insulin secretion (GO:0030073),0.49767739642912545,1.1902600537666987,0.27463863337713534,1.0,1.0,5/19,12.18%,PTPRN;ANXA1;SELENOT;PARK7;CAMK2G
prerank,neuron migration (GO:0001764),0.4303653228216156,1.189975713846311,0.23642533936651583,1.0,1.0,20/48,21.28%,RAC1;DCDC2;CDKL5;FGFR1;NRP1;CDK5;TUBB2A;SPOCK1;LRP12;USP9X;DISC1;AUTS2;PEX13;SEMA3A;NDNF;TUBGCP2;PAFAH1B1;DCX;NTRK2;FGF13
prerank,autophagy of mitochondrion (GO:0000422),0.44482621864079647,1.1897965353481799,0.23508771929824562,1.0,1.0,15/38,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,extracellular structure organization (GO:0043062),0.39215505721043903,1.1897717872825113,0.12550200803212852,1.0,1.0,46/204,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,sphingolipid catabolic process (GO:0030149),0.5298303308062767,1.189679699012536,0.24693042291950887,1.0,1.0,6/15,19.67%,SMPD2;SGPL1;ENPP2;SMPD4;SMPD1;PDXDC1
prerank,cAMP metabolic process (GO:0046058),0.5353193026816243,1.1891992412949255,0.251063829787234,1.0,1.0,4/13,16.59%,ADCY7;PTHLH;ADCY1;ADCY5
prerank,regulation of insulin secretion (GO:0050796),0.40552009667416294,1.189033548632945,0.18295218295218296,1.0,1.0,21/101,17.24%,CACNA2D2;KCNG2;SFRP1;LRRC8A;PICK1;ITPR1;CAPN10;PRKCA;TCF7L2;BRSK2;KCNC2;SNAP25;IRS2;UQCC2;NLGN2;RFX3;CLOCK;TRH;ADCY5;EPHA5;EIPR1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.46871431958762044,1.1886714712699542,0.2356687898089172,1.0,1.0,12/29,20.76%,PAIP1;FUS;PABPC1;GDNF;AXIN2;FMR1;THRAP3;DHX34;TENT5A;CIRBP;HNRNPU;YBX1
prerank,cell part morphogenesis (GO:0032990),0.5294151693544674,1.1884536431983903,0.2689075630252101,1.0,1.0,5/13,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46464676968259244,-1.188375408830981,0.24376731301939059,0.8478627626886596,1.0,5/10,22.33%,CST3;TNFRSF1A;TNFRSF1B;EMILIN1;DPP4
prerank,secondary alcohol metabolic process (GO:1902652),0.4420424513479082,1.1881508332483206,0.22587968217934165,1.0,1.0,6/42,7.49%,CYP27A1;CLN6;SCAP;IDH3B;GBA2;SOAT1
prerank,dendritic spine morphogenesis (GO:0060997),0.5191878004959237,1.1881198594041744,0.25811001410437234,1.0,1.0,3/15,6.37%,EPHB2;CTNND2;PAK3
prerank,organonitrogen compound catabolic process (GO:1901565),0.4218295351573693,1.188062759292583,0.237417943107221,1.0,1.0,9/57,10.25%,PLA2G5;ADO;CLN6;SMPD2;RENBP;ANPEP;UCHL3;SGPL1;ENPP2
prerank,cellular response to interleukin-7 (GO:0098761),-0.40061694066497144,-1.1880073779101403,0.25,0.8413006809620941,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.40061694066497144,-1.1880073779101403,0.25,0.8413006809620941,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,positive regulation of calcium ion import (GO:0090280),0.5448251686592952,1.1878862751377555,0.27896995708154504,1.0,1.0,1/12,4.50%,CXCL12
prerank,positive regulation of histone deacetylation (GO:0031065),0.5473886490831565,1.1877860116677346,0.29178470254957506,1.0,1.0,6/12,18.02%,NIPBL;AKAP8L;ZBTB7B;SAP30BP;CTBP1;PRKD2
prerank,modification-dependent protein catabolic process (GO:0019941),0.39053651787687,1.187684526432805,0.12663316582914572,1.0,1.0,61/193,18.59%,UBQLN1;CDC23;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;CDC16;RNF215;FZR1;FBXL14;FBXO7;SQSTM1;ANAPC2;DDB1;FBXO45;RFFL;PSMD11;ARRB1;UBA1;UBE3B;RNF40;RNF168;KLHL15;RNF11;CHFR;UBR3;RC3H2;ZNRF3;NTAN1;RNF19A;UBE2A;ANAPC11;WDR91;ANAPC4;RNF19B;CDC26;ANKIB1;PCYOX1;RNF217;FEM1C;CBL;TRPC4AP;UBE2E1;UBE2D1;NDFIP2;ARIH2;NEDD8;UBE2L3;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;ANAPC10;RNF111;ANAPC5
prerank,myeloid dendritic cell activation (GO:0001773),-0.4585878951354399,-1.1874510066476982,0.2376237623762376,0.8393188187223903,1.0,2/12,7.89%,DOCK2;TGFBR2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5156935747707966,1.186832123270868,0.2782258064516129,1.0,1.0,4/16,10.43%,PIGG;DPM2;PIGM;PIGA
prerank,fatty acid catabolic process (GO:0009062),0.4139935243729806,1.1858980981303955,0.2164835164835165,1.0,1.0,21/67,16.83%,SLC27A4;ACAD10;LPIN1;PCCB;HADHB;ACAT1;HSD17B4;LPIN3;MCEE;CROT;CPT2;EHHADH;LPIN2;PCCA;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.36095838015434994,-1.185562174591969,0.20297029702970298,0.8418884877262566,1.0,13/26,18.81%,SLC39A14;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC39A8;SLC39A12;SLC39A7;SLC39A10
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4852426668084428,-1.1854702548712326,0.2631578947368421,0.8383766846148172,1.0,5/10,28.20%,CD34;KDR;HIF1AN;CEACAM1;RRAS
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4157585370107132,1.1854273521470373,0.2413793103448276,1.0,1.0,7/51,12.75%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP;TMED10
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3840686667201505,1.185383846246704,0.082,1.0,1.0,80/390,14.32%,FGF20;FGF9;MST1R;IGF1;EPHA7;SIRT2;GPLD1;EPHB2;FGFRL1;DNM1;TSC2;NTF3;EIF2AK3;HSP90AA1;RAC1;FGFR2;SH2D2A;COL4A6;ATP6V0A2;FGFR1;GRIN1;ACTR2;ARPC1A;DDR1;NRP1;FGF10;POLR2B;IL31RA;ANGPTL1;DDR2;SULF1;PIK3R1;GAB1;SRMS;ARHGEF7;PAK3;EFNB3;EPHA8;TIA1;ATP6V0E2;KALRN;CYFIP1;BDKRB2;FLRT2;SDCBP;FRS2;EFNB2;FLRT1;BAIAP2;EPHA10;RAPGEF1;PLAT;HNRNPM;KL;MVP;AP2S1;MUSK;VAV2;SHC4;PRLR;IRS2;GFRA2;PIK3CB;RBFOX2;ATP6V1G1;PIK3R2;TCIRG1;PDGFRA;POLR2K;TIAL1;ATP6V0A4;GIT1;SETX;ROR2;EFS;FGFBP1;BLNK;NRG1;ROCK2;ATP6V1D
prerank,synapse organization (GO:0050808),0.39568786882658413,1.1852890202560806,0.17592592592592593,1.0,1.0,27/125,14.94%,PPFIA4;LRRC4;CHCHD10;CACNB4;UNC13A;CTNND2;OBSL1;PDZRN3;CDK5;GPC6;PAK3;DVL1;DSCAM;CYFIP1;DBNL;MUSK;CACNB1;APP;ANK3;PTPRF;NLGN3;GPC4;SPOCK2;FARP1;MAPT;NLGN2;SEMA3E
prerank,positive regulation of signal transduction (GO:0009967),0.386362524427719,1.184821748458764,0.11334002006018054,1.0,1.0,59/238,18.56%,MYORG;VTN;ATP6AP2;SFRP1;IGF1;STK36;BAX;CDKN2AIP;BMP6;NTF3;FGFR2;DCDC2;GRIN1;XBP1;CD63;RWDD3;CCBE1;SNX5;AGPAT1;RAB34;TNFAIP3;NRP1;PRKCA;SULF1;PIK3R1;DMTN;ARNT;TMEM108;ZBTB7B;SMARCB1;TUBD1;WLS;LY96;RBPJ;ROBO1;ZMIZ1;NLGN3;NPTN;PRKCI;CDC73;EMP2;DISC1;HTT;ADAMTS3;NLGN2;F3;LMO3;MN1;SNW1;JAG1;ITGB1BP1;PHIP;LANCL2;ILK;SORL1;PRKD2;PKD2;GPS2;TGFBR1
prerank,central nervous system neuron development (GO:0021954),0.5209510110416722,1.1847782049788105,0.27100271002710025,1.0,1.0,8/15,23.89%,HSP90AA1;GBA2;B4GALT5;MAPT;NTRK2;ARHGAP35;MAP2;PTEN
prerank,aminoglycan biosynthetic process (GO:0006023),0.4270661024422068,1.1841499581921862,0.23310810810810811,1.0,1.0,13/49,20.33%,B3GALNT1;HS2ST1;SLC35D2;GPC6;NDST2;GPC1;HS6ST2;GPC4;HSPG2;EXT2;GPC5;HS3ST1;GCNT2
prerank,regulation of transposition (GO:0010528),0.5352996500361279,1.1838460298786941,0.2951048951048951,1.0,1.0,1/13,1.78%,SIRT7
prerank,gland development (GO:0048732),0.418267048296607,1.183581105651654,0.23051224944320714,1.0,1.0,12/59,14.05%,GFER;STRA6;FGFR2;ANXA1;XBP1;DKK3;FGF10;WNT4;SOX9;CDK5RAP3;CEBPG;NRG1
prerank,establishment of spindle localization (GO:0051293),0.5265079531571786,1.1830326000121587,0.28319783197831977,1.0,1.0,7/14,24.57%,KPNB1;ZBED3;MAP4;CFL1;CLASP2;LLGL1;DYNC1H1
prerank,negative regulation of response to wounding (GO:1903035),0.5132497615754303,1.1828440911419231,0.26322751322751325,1.0,1.0,8/19,22.67%,AJAP1;CASK;CERS2;GIT1;SERPINE1;PTPRS;FGF2;EPHA4
prerank,regulation of dendrite morphogenesis (GO:0048814),0.45607506606322307,1.1827679732473293,0.2527075812274368,1.0,1.0,10/32,18.42%,CUL7;CDKL5;OBSL1;KNDC1;RAP2A;YWHAH;IL1RAPL1;GORASP1;CUX1;ADGRB3
prerank,monocarboxylic acid transport (GO:0015718),-0.29878990600898797,-1.1822997169636706,0.15178571428571427,0.8450229462681186,1.0,9/51,6.35%,ABCG2;SLCO3A1;ABCC4;ATP8B1;SLC16A2;SLC16A6;SLCO1C1;SLCO2A1;SLC16A1
prerank,actin filament bundle organization (GO:0061572),0.44580578520792635,1.182168151641855,0.2617611580217129,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,sodium ion transmembrane transport (GO:0035725),0.40498148323376215,1.1821066010175678,0.2045929018789144,1.0,1.0,17/84,16.34%,SLC4A4;ASIC1;NALCN;ATP1A3;SLC6A11;SCN7A;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC9A7;SLC9A6;SLC6A13
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5042915320724374,1.1821001567080383,0.2816326530612245,1.0,1.0,5/17,15.23%,IL34;BIN1;CXCR4;TGFB1;TENM4
prerank,positive regulation of inflammatory response (GO:0050729),0.4015988110814759,1.1813548588208924,0.19893617021276597,1.0,1.0,17/86,17.70%,WNT5A;LPL;PTGER4;DDT;IL33;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;NUPR1;VAMP8;AGTR1;SERPINE1;TNIP1;SNX4
prerank,negative regulation of defense response to virus (GO:0050687),0.5612172840947603,1.1811375198774123,0.3007518796992481,1.0,1.0,2/10,5.04%,TARBP2;PPM1B
prerank,vesicle transport along microtubule (GO:0047496),0.48020497448538774,1.180945198188992,0.2538265306122449,1.0,1.0,13/23,26.28%,CLN3;KIF3A;BICDL1;HTT;TRAK1;KIF5B;FYCO1;KIFAP3;PAFAH1B1;KIF3B;DYNC1H1;FBXW11;KIF5A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2688120059186252,-1.1807864858040102,0.11267605633802817,0.8459276769367072,1.0,27/70,19.67%,CRADD;DAB2IP;IL6R;CASP8AP2;BAG3;APPL1;RIPK1;MCL1;DEDD;BCL2L1;TGFB2;HIPK1;DELE1;FAS;BCL2L2;TNFRSF1A;NGF;GABARAP;DDX47;TNFRSF1B;SORT1;P2RX7;MLLT11;TNFSF12;GSK3A;DIABLO;CASP3
prerank,cellular metal ion homeostasis (GO:0006875),0.40202854610149624,1.1806751112191545,0.1931106471816284,1.0,1.0,18/102,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;ATP1A3;CXCL12;ATP2A2;KCNMA1;ATP1A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN;SLC41A1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.42042390799410456,1.1805406358657362,0.23772321428571427,1.0,1.0,17/54,21.22%,CLN6;HS2ST1;SLC35D2;GLB1;GPC6;NDST2;GPC1;HS6ST2;HGSNAT;GPC4;HSPG2;EXT2;GPC5;GUSB;HS3ST1;GCNT2;CHST9
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4568119354702545,-1.1797943421199846,0.2658959537572254,0.8454503037772483,1.0,6/11,20.24%,MBTPS2;TP53;HSPA5;CEBPB;ATF4;CREB3L1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.45558357833608837,1.1797430936381563,0.2545454545454545,1.0,1.0,9/34,18.59%,IGF1;CDC23;EDN3;CDC16;EGF;ANAPC11;ANAPC4;PHIP;ANAPC5
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5038034372896262,1.1797344523859992,0.27440633245382584,1.0,1.0,9/18,19.31%,CLN3;ABCA2;CDK5;VTI1B;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14
prerank,actin cytoskeleton reorganization (GO:0031532),0.41216893345343636,1.1796661810115625,0.23387978142076501,1.0,1.0,21/63,19.18%,S1PR2;ATP2C1;WHAMM;ANXA1;MINK1;NRP1;FGF10;CAPN10;GAB1;DMTN;BRSK2;RAP2A;ANTXR1;EFS;AUTS2;FARP2;PTK7;THSD7B;PIP5K1A;CDC42BPB;NRK
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5385892185728611,1.179552253468067,0.29775280898876405,1.0,1.0,5/13,12.60%,ALG6;ALG1;ALG8;DPAGT1;ALG9
prerank,actin filament depolymerization (GO:0030042),-0.4912981878958098,-1.1793445683093102,0.2747603833865815,0.8430679948962926,1.0,6/11,23.64%,CFL2;DSTN;TWF2;TWF1;MICAL2;MICAL1
prerank,eye morphogenesis (GO:0048592),0.49332929751052795,1.1793001018775433,0.2486910994764398,1.0,1.0,9/19,19.23%,FBN2;NIPBL;TENM3;MFAP2;MFAP5;FBN1;COL5A2;NKD1;AGTPBP1
prerank,cellular response to metal ion (GO:0071248),0.39385947764669665,1.1790583018456378,0.17604912998976457,1.0,1.0,31/123,19.12%,ALOX5AP;MAPK9;SYT3;WNT5A;SYT10;GPLD1;PPIF;ADCY7;BMP6;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;ANK3;CAMK2D;IQGAP1;SYT1;CPNE8;KCNA1;SLC41A1;GLRA1;ADCY1;DAXX;DPEP1;DLG2;PKD2;PRKAA1;KCNH1;SMPD1
prerank,regulation of ossification (GO:0030278),0.448365131911383,1.1788328224943487,0.24014336917562723,1.0,1.0,10/36,14.82%,WNT5A;SFRP1;ANKH;DDR2;SOX9;SOX11;TWIST1;RBPJ;ENPP1;SMAD6
prerank,angiogenesis involved in wound healing (GO:0060055),-0.45646922418601565,-1.1786063557576356,0.2861736334405145,0.8418280419656562,1.0,7/11,25.44%,CD34;KDR;ADIPOR2;VEGFA;GATA2;MCAM;ITGB3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4745296529795549,1.1785648948407388,0.25157232704402516,1.0,1.0,6/25,7.87%,KHSRP;GEMIN2;PRPF8;SF3B1;MPHOSPH10;PRPF6
prerank,zinc ion homeostasis (GO:0055069),-0.34394264234463773,-1.178485530676141,0.21212121212121213,0.8384384838585537,1.0,11/28,12.57%,SLC39A14;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC39A8;SLC39A12
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.25628189949730856,-1.1778032126980122,0.10526315789473684,0.8370772248278917,1.0,33/128,16.00%,PARD3;HIVEP1;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;PDCD4;TWSG1;FNTA;SLC33A1;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22;ACVR2B;BMP7;ZMIZ2;BMPR1B;JUN;SRC;ITGB5;BMP4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4492601193942068,1.177608602341018,0.24347826086956523,1.0,1.0,6/32,11.97%,TFDP1;CDK5;NPAT;BRD4;FBXO5;BACH1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5329689431133655,1.177460892979327,0.2823529411764706,1.0,1.0,3/12,22.93%,IL33;NUPR1;IL18
prerank,regulation of glycogen metabolic process (GO:0070873),-0.44337247825111226,-1.1771837915049959,0.26198083067092653,0.8354287438642337,1.0,10/12,52.74%,INPP5K;PPP1R3B;AKT1;PPP1R3C;PPP1R3F;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5511720201289885,1.176917097942597,0.2894356005788712,1.0,1.0,3/12,7.42%,UBE2S;FZR1;CDC14B
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3993073687609115,-1.1768779259911557,0.2677165354330709,0.8329436417887868,1.0,10/18,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;TGFBR2;BMP4;HEYL;TBX2;BMP2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.44664730544903664,1.17670242313312,0.24617196702002356,1.0,1.0,11/35,18.68%,VTN;RAC1;SMAP1;HNRNPK;LRPAP1;PIK3CB;CBL;SNAP91;SERPINE1;RAB21;FLOT1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4754763583121466,-1.1766302736441838,0.2701863354037267,0.8301412219982968,1.0,6/10,25.53%,RARG;RARB;RARA;TBX1;PPARG;RXRB
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4062348115913752,1.1761867289948054,0.2379421221864952,1.0,1.0,24/74,22.11%,SFRP2;SFRP1;MCRIP1;GLIPR2;SNAI1;OLFM1;EZH2;TGFB1I1;SDCBP;TWIST1;BMP5;DAG1;AXIN2;TGFB1;VASN;PHLDB1;SPRY2;TGFBR1;DAB2;GCNT2;SMAD7;CLASP2;SMAD2;SMAD3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.409898417009506,-1.1760457131145887,0.25193798449612403,0.8285816714291051,1.0,11/16,31.97%,CAV1;TRIM25;EXOC7;EXOC2;TRIM5;TRIM14;NECTIN2;HS3ST5;FUCA2;TRIM21;TRIM68
prerank,kinetochore organization (GO:0051383),0.5250707845522253,1.1760212625373179,0.2737430167597765,1.0,1.0,2/13,13.49%,CENPT;CENPC
prerank,defense response to tumor cell (GO:0002357),0.5591357367096702,1.1759078277837356,0.29249617151607965,1.0,1.0,5/10,19.75%,PLK5;RBMS3;DAPK1;DLEC1;KLF4
prerank,ribosomal small subunit assembly (GO:0000028),-0.4117029619772456,-1.175401831608292,0.23846153846153847,0.8271242333823974,1.0,12/16,35.05%,RPS19;RPS28;RPS5;RPS27;RPS14;ERAL1;RRP7A;RPS27L;MRPS7;PRKDC;MRPS11;XRCC5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39429162363836695,1.175243338510916,0.21436004162330904,1.0,1.0,14/101,9.15%,PSRC1;WNT5A;MST1R;IL34;TCIM;INCENP;EDN3;CALM3;MAPRE3;FGFR1;DDX3X;EZH2;CD24;EGF
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4053653226443632,-1.1752151827082409,0.23504273504273504,0.824206297109599,1.0,2/16,10.73%,CYRIB;PTPRC
prerank,negative regulation of macrophage activation (GO:0043031),0.5097948667077337,1.1751365014399924,0.260431654676259,1.0,1.0,2/16,4.92%,FCGR2B;IL31RA
prerank,ganglioside metabolic process (GO:0001573),0.49167592468019017,1.1747199906595394,0.2724867724867725,1.0,1.0,5/20,14.35%,CLN6;ST8SIA3;ABCA2;ST3GAL5;ST6GALNAC6
prerank,regulation of epithelial cell migration (GO:0010632),-0.29270480811156624,-1.174066701138356,0.17355371900826447,0.8245567268819959,1.0,16/51,15.19%,PTPRG;DAB2IP;BMPER;DOCK1;RREB1;PRKCE;HIF1A;TGFB2;ADIPOR1;PLCG2;DUSP10;PTPN23;PLCG1;PFN1;CAPN7;SRC
prerank,negative regulation of organelle assembly (GO:1902116),0.4447538432927242,1.1740594265581157,0.25331724969843183,1.0,1.0,10/35,15.32%,CCP110;PHF23;TBC1D7;MDM1;CEP97;TCHP;SCFD1;EVI5L;FEZ2;NUPR1
prerank,regulation of water loss via skin (GO:0033561),-0.4123849546571817,-1.1740237606462116,0.23880597014925373,0.8177203503238007,1.0,6/15,34.09%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.4123849546571817,-1.1740237606462116,0.23880597014925373,0.8177203503238007,1.0,6/15,34.09%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,regulation of p38MAPK cascade (GO:1900744),-0.31936422722646157,-1.1736388845272858,0.2289156626506024,0.8154989231509802,1.0,16/35,26.31%,MFHAS1;DAB2IP;PHLPP1;EZR;LGALS9;CYLD;DUSP10;MAP3K4;EMC10;VEGFA;DUSP1;DLG1;SASH1;ZC3H12A;BMP2;GADD45B
prerank,oligodendrocyte differentiation (GO:0048709),0.5003395139199727,1.173196687569262,0.2749003984063745,1.0,1.0,6/19,17.11%,MYRF;CDK5;SOX9;SOX6;TPPP;SOX13
prerank,cellular response to interferon-gamma (GO:0071346),0.39948981404492595,1.1731306478449304,0.22046413502109705,1.0,1.0,21/88,18.03%,WNT5A;CAMK2B;GBP3;IRF1;GBP7;SIRPA;TRIM62;IFNGR2;EPRS1;IFNGR1;IRF3;CAMK2D;CAMK2G;CD47;DAPK1;GBP6;AQP4;ICAM1;OAS2;CCL25;JAK1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3462082739211366,-1.1730362380051726,0.20574162679425836,0.8141286476762607,1.0,11/26,16.11%,RAD23B;USP45;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,response to interleukin-1 (GO:0070555),0.40386356784257416,1.1728792984515735,0.21475054229934923,1.0,1.0,12/73,12.26%,SFRP1;ADAMTS7;GBP3;NFKB1;ANXA1;PRKCA;SIRPA;SOX9;USP10;HDAC4;APP;CD47
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5037421623387618,1.1722164032877775,0.2802631578947368,1.0,1.0,2/17,4.57%,LPL;PCSK5
prerank,regulation of developmental growth (GO:0048638),0.4609843067398973,1.1717797953269475,0.2846441947565543,1.0,1.0,6/29,10.71%,IGF1;NIPBL;OLFM1;ABL1;MUSK;APP
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3365911009151987,-1.171700149677045,0.22772277227722773,0.8151164102064663,1.0,7/27,17.46%,NIBAN2;DACH1;SMG5;TOM1L1;RGCC;PDGFA;SMG6
prerank,acyl-CoA metabolic process (GO:0006637),0.4449870681645003,1.171489294570314,0.2647412755716005,1.0,1.0,8/35,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;MCEE;OGDH;ACSL6
prerank,positive regulation of cellular process (GO:0048522),0.37548123688795926,1.1714615304656693,0.038,1.0,1.0,98/565,15.68%,FGF20;SFRP2;PLA2G5;FGF9;S1PR2;FASN;WNT5A;FCGR2B;EPB41L4B;SFRP1;MST1R;IGF1;DUSP26;IL34;DVL2;FOXM1;SIRT2;TUB;EAPP;MYRF;CDKN2AIP;TBRG4;BMP6;NTF3;EDN3;RAC1;EXOSC2;TSPAN31;FGFR2;TAF9B;FGFR1;GRIN1;PTHLH;XBP1;ZFP36L1;SLC25A33;MLC1;DDX3X;CXCL12;AGPAT1;CDC123;FGF10;IL31RA;CDK13;CAPN10;PRKCA;FLCN;USP47;CNBP;FBXO5;CELF1;EZH2;RHOD;SIRPA;SOX9;SDCBP;EFNB2;DHX36;EGF;HDAC4;ABCA7;SOX11;GDNF;PRLR;IRS2;COX17;TPM1;BCL2;ADGRG1;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;EIF4G2;CD47;NPM1;HDAC1;AXIN2;UBE2A;PRMT1;RPS6KA3;EMP2;LRP1;FAM98A;MAPT;NRG1;CSPP1;TGFB1;BCLAF1;KMT2D;IL15RA;TENM4;NUPR1;FAF1;CNOT6;RPS6KA1;CTSH
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3913310767036015,1.1714608421355315,0.22048066875653083,1.0,1.0,20/100,14.97%,FSHR;IGF1;TSC2;PIP4K2B;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;TWIST1;IRS2;PIK3CB;MAZ;PDGFRA;PIP4K2A;ROR2;PIP4K2C;CBL
prerank,regulation of mitochondrion organization (GO:0010821),0.4236375299873242,1.1712707136989426,0.24351747463359638,1.0,1.0,14/47,17.62%,SIRT7;CSNK2A2;MYO19;PRMT6;FIS1;FLCN;MIEF2;SQSTM1;PID1;VDAC1;MAPT;DNM1L;PARL;OMA1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.478604022344842,1.1709375302179315,0.28169014084507044,1.0,1.0,5/21,9.16%,HS2ST1;EXTL3;SULF1;GPC1;HS6ST2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5324631243435443,1.1708271988192591,0.28939828080229224,1.0,1.0,1/12,0.85%,FCGR2B
prerank,positive regulation of axon extension (GO:0045773),0.47396868597434244,1.1707655947478712,0.2763496143958869,1.0,1.0,8/22,17.44%,CDKL5;NRP1;DBN1;DSCAM;DBNL;MAPT;MEGF8;RUFY3
prerank,mitochondrial fission (GO:0000266),0.4935288142266204,1.170758282084087,0.27448275862068966,1.0,1.0,5/16,14.84%,DNM1;FIS1;MTFR1L;GDAP1;DNM1L
prerank,spermatid development (GO:0007286),0.451197977442247,1.1706784209712984,0.2639225181598063,1.0,1.0,6/32,15.73%,IQCG;SYCP3;RNF8;CDYL;ACRBP;GALNTL5
prerank,mitotic metaphase plate congression (GO:0007080),0.4234508244329404,1.1703510758126603,0.2690124858115778,1.0,1.0,7/51,13.49%,PSRC1;CDC23;KPNB1;PIBF1;CHMP3;VPS4B;CENPC
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.47498884441069306,1.169994293707188,0.2777777777777778,1.0,1.0,9/22,24.09%,DUSP18;PPM1B;PPM1E;PPP5C;PPP2CB;PPM1A;PPM1F;DUSP16;PPM1D
prerank,skeletal system development (GO:0001501),0.38595367237505,1.1698451353083348,0.18597560975609756,1.0,1.0,37/148,20.34%,WNT5A;PTGER4;IGF1;BMP6;EIF2AK3;FGFR2;FGFR1;PTHLH;ANKH;PCSK5;SULF1;HAPLN4;TRIP11;SOX9;GNAS;PPIB;CDH11;SOX11;PTH1R;BMP5;COL1A2;SOX6;FBN1;AKAP13;RPS6KA3;SUFU;TRPS1;SOX5;BMP1;TGFBR1;WWOX;SOX4;MMP14;PAPSS1;CHD7;EVC;MMP16
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5530837870999934,1.1696795516019578,0.29705882352941176,1.0,1.0,1/10,0.80%,WNT5A
prerank,histone deacetylation (GO:0016575),0.4349099087518162,1.1696664331576403,0.267349260523322,1.0,1.0,10/43,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;PER1;HDAC4;RCOR1;MTA2;HDAC1
prerank,cellular response to leucine (GO:0071233),-0.473161793936896,-1.1695626645456418,0.2852941176470588,0.815382668733216,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,response to leucine (GO:0043201),-0.473161793936896,-1.1695626645456418,0.2852941176470588,0.815382668733216,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,signal release from synapse (GO:0099643),0.43296907841894394,1.16930116115538,0.2569124423963134,1.0,1.0,9/43,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,organic hydroxy compound transport (GO:0015850),-0.3077062653346866,-1.169038948239694,0.21052631578947367,0.8137894581879733,1.0,6/36,6.35%,ABCC4;ATP8B1;RALBP1;SLCO1C1;RBP4;SLC16A1
prerank,protein O-linked glycosylation (GO:0006493),0.39274662290063506,1.1690215261059411,0.21091290661070305,1.0,1.0,24/96,19.34%,TMTC4;C1GALT1C1;GALNT16;B3GLCT;DPM2;ST3GAL2;OGT;PLOD1;GALNT4;ST3GAL3;TMTC1;POMGNT1;POMT2;B4GALT5;GALNTL6;GXYLT1;GALNT15;GALNT14;GALNT18;TRAK1;GXYLT2;DPM1;B3GALNT2;TET1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4718176988974383,1.1684972866046606,0.2655440414507772,1.0,1.0,5/23,9.82%,SELENOS;SYVN1;SEC16A;AUP1;VCP
prerank,purine-containing compound catabolic process (GO:0072523),-0.43830618946630023,-1.168459428258327,0.26688102893890675,0.8122227269611089,1.0,8/13,34.73%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,monocarboxylic acid metabolic process (GO:0032787),0.39116459907533196,1.1684283276091967,0.20020746887966806,1.0,1.0,23/117,13.46%,FASN;LPL;IGF1;SLC27A4;THEM4;GBA2;ACOT11;PCCB;ALDH1A2;ABAT;SGPL1;MSMO1;GPAM;ALDH4A1;DLAT;CROT;AMACR;SLC6A8;ACADSB;PCCA;CYP26B1;VDAC1;MECR
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4547699086523649,1.16783868498277,0.2693236714975845,1.0,1.0,3/31,1.68%,SYT3;SYT10;CBARP
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5444777899845671,1.1677123534709877,0.2913616398243045,1.0,1.0,3/11,14.28%,IL34;PRKCA;TGFB1
prerank,cellular response to purine-containing compound (GO:0071415),-0.48016603737273156,-1.1670462115101043,0.2565597667638484,0.8134509817876164,1.0,7/10,37.92%,P2RY1;RYR2;GSTM2;SLC8A1;TRPM2;P2RY6;CASQ2
prerank,regulation of cell differentiation (GO:0045595),0.3839646253791512,1.1668608742443154,0.1773049645390071,1.0,1.0,37/148,18.56%,DDX17;MCRIP1;BIN1;NTF3;EDN3;FGFR2;FGFR1;NR1D2;PTHLH;ZFP36L1;CDK9;CASZ1;CD24;SIK1;ZFHX2;YWHAH;CDK5RAP3;FADS1;YWHAG;GDNF;ST7;DAG1;SPOCK2;RPS6KA3;UQCC2;CBFB;EMP2;TGFB1;TRPS1;BCL6;RPS6KA1;DDX5;PHLDB1;TRIP4;OCIAD1;GPS2;TGFBR1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4241154337163728,-1.1668193506352007,0.2895622895622896,0.8108422520352144,1.0,9/14,36.90%,SLC25A13;LRRC8D;SLC25A14;SLC25A30;SLC25A11;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.45215681783500705,-1.1665814936285313,0.27380952380952384,0.8083647603727863,1.0,2/11,3.85%,STAT3;STAT1
prerank,response to metal ion (GO:0010038),-0.2721696115179992,-1.1663797419380624,0.14814814814814814,0.8058284292920267,1.0,17/67,13.35%,SEC31A;CAV1;GPHN;SLC25A13;ANXA11;HIF1A;TRPC3;MTF1;TRPC1;THBS1;PLSCR1;ITPR3;SLC30A4;MT1X;MT1A;NEDD4L;D2HGDH
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.52172430438511,1.1662657356086623,0.28444444444444444,1.0,1.0,7/13,23.02%,FBN2;FSTL1;LTBP1;FBN1;GREM2;NBL1;DAND5
prerank,filopodium assembly (GO:0046847),0.4955879069464611,1.166112359315461,0.3031161473087819,1.0,1.0,4/16,8.63%,S1PR2;SRGAP2;ARHGEF4;PPP1R9B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5329446743342843,1.1658952781252303,0.2774647887323944,1.0,1.0,3/13,13.39%,SYT10;SYT1;SCAMP5
prerank,cellular response to interleukin-4 (GO:0071353),0.5443886535861651,1.1658234661223064,0.27761194029850744,1.0,1.0,2/10,3.80%,STAT6;XBP1
prerank,regulation of organelle organization (GO:0033043),0.39881460951051484,1.165547433245009,0.24866023579849947,1.0,1.0,15/80,11.49%,CLN3;CPLANE2;SIRT7;ZEB2;PRMT6;FIS1;TAOK1;SAR1A;MIEF2;SQSTM1;CAMSAP2;CAPN2;PDE4DIP;USP6NL;MYO5A
prerank,regulation of glycolytic process (GO:0006110),0.40329692062233674,1.1650456838622945,0.2379421221864952,1.0,1.0,21/68,19.14%,SLC4A4;IGF1;OGT;RAE1;ARNT;PRXL2C;HDAC4;NUP188;PGAM1;ZBTB20;APP;NUP210;GIT1;NUP88;NUP214;NUPR1;NUP153;RANBP2;PRKAA1;PRKAG2;NUP35
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4278909743586718,-1.1649648850872047,0.2711864406779661,0.807080119667178,1.0,5/13,17.64%,IRAK2;IRAK1;UNC93B1;IRAK4;PIK3AP1
prerank,positive regulation of type I interferon production (GO:0032481),0.3985683655841389,1.1649046745792468,0.2413793103448276,1.0,1.0,21/73,17.30%,NFKB1;HSP90AA1;POLR3D;STAT6;NFKB2;DDX3X;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;TLR3;PTPN22;MRE11;HSPD1;OAS2;POLR3K
prerank,regulation of cellular metabolic process (GO:0031323),0.4217484811065117,1.1646633975314675,0.26879271070615035,1.0,1.0,7/45,8.80%,FASN;FOXM1;STUB1;ABCA2;AGPAT1;PID1;SSH1
prerank,nitric oxide metabolic process (GO:0046209),-0.4171259372910604,-1.1645756321274507,0.2560553633217993,0.8049910885547183,1.0,7/14,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,inositol lipid-mediated signaling (GO:0048017),0.42241436770522894,1.164241199187973,0.25863991081382387,1.0,1.0,16/50,19.08%,IGF1;PLCH1;FGFR1;OGT;PLCL2;PIK3R1;ADAP2;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;KCNH1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.40875879777086044,1.1639078325912513,0.2505399568034557,1.0,1.0,31/76,24.50%,HDAC3;UBQLN1;PHF23;GNL3;STUB1;TBC1D7;RWDD3;SAE1;MYCBP2;XIAP;CDK5RAP3;HDAC4;MALT1;PIAS3;UBE2D1;NDFIP2;DERL1;UBE2L3;TANK;TNIP1;DCUN1D5;BIRC3;PIAS1;SMAD7;COMMD1;UBA2;FKBP1A;FBXW7;UBE3A;TRAF6;CRY1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.42342983586688676,1.1632125532728679,0.2719812426729191,1.0,1.0,9/44,12.08%,CYP27A1;PSAT1;CYP7B1;INSIG1;HSD17B4;MSMO1;SC5D;AMACR;PARK7
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.38130342566836606,1.162968227269946,0.1882591093117409,1.0,1.0,49/172,19.00%,PLA2G5;CLN3;GPD1;PIP4K2B;CSNK2A2;GPD1L;SYNJ2;PCYT2;LPIN1;CEPT1;AGPAT1;AGPAT5;CRLS1;INPP5E;PIK3R1;GPAT4;PLEKHA3;CPNE7;AGPAT3;LPIN3;GPAM;PCYT1B;PITPNM3;PIK3CB;PIK3R2;STARD7;LPIN2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;PTDSS1;FAR1;FIG4;DDHD2;SACM1L;CHKB;CDS1;PIK3C2B;SLC44A2;MTMR4;RUFY1;SLC27A1;PIK3C3;PTDSS2;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4
prerank,regulation of response to external stimulus (GO:0032101),0.38740896685474074,1.1621661551602025,0.21958762886597938,1.0,1.0,27/121,16.48%,GUCA1B;WNT5A;FCGR2B;EPHB2;USP14;NR1D2;ANXA1;TIRAP;METAP1;BRD4;IRF1;DHX58;CELF1;CXCR4;NMT1;XIAP;LRP8;EFNB2;PDGFRA;PARK7;METAP2;PTPN22;PTGS2;BCL6;LACC1;ADGRA2;AGTR1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3852399404260397,1.1620627569686195,0.1871820956256358,1.0,1.0,21/142,13.68%,WNT5A;CLN3;PTGER4;CCR9;ACKR2;FIS1;FZD9;C1QTNF1;ABL1;CXCR4;HCRTR2;ATP1A2;CD24;BDKRB2;ATP2B1;SELENOT;TBXA2R;HCRTR1;PDGFRA;NPTN;LPAR1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4245675079957508,-1.1620309861034177,0.26537216828478966,0.8098522807498182,1.0,5/13,19.19%,NIBAN2;DAB2IP;EPN2;CADM4;EMILIN1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5420854474015786,1.1620227906244789,0.30559757942511345,1.0,1.0,3/11,8.36%,WNT5A;FGFR2;SOX9
prerank,lamellipodium organization (GO:0097581),0.4400025506215289,1.162018278228342,0.2816377171215881,1.0,1.0,13/29,20.98%,RAC1;WHAMM;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;WASF1;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,intestinal absorption (GO:0050892),-0.4312085000665637,-1.1619847160695926,0.28125,0.8067465551846962,1.0,5/13,33.23%,F11R;ADRA2A;KCNQ1;SLC26A6;UGCG
prerank,regulation of centrosome duplication (GO:0010824),0.44362557190812585,1.161161407086661,0.2775061124694376,1.0,1.0,11/30,21.47%,CENPJ;ALMS1;FBXW5;CHMP3;VPS4B;NPM1;SPICE1;CEP120;CEP76;TMEM67;CHMP4B
prerank,actin filament bundle assembly (GO:0051017),0.43655450711237126,1.1610371537246118,0.28263473053892213,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5142125834658491,1.160727194023722,0.29678362573099415,1.0,1.0,4/13,13.54%,EDEM1;ERLEC1;BRSK2;UBE2J1
prerank,histone acetylation (GO:0016573),-0.2713592887189219,-1.160674179331424,0.15492957746478872,0.8075021337576261,1.0,29/69,23.87%,EPC1;TRRAP;LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;NAA40;EP300;JADE1;JADE3;WDR5;MSL3;ACTL6A;TAF5L;KAT6B;DR1;ING3;BRCA2;KAT8;PHF20L1;ING5;NAA60;APBB1;RUVBL1;TRIM16;SUPT7L;TAF6L
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5139304388448886,1.159893905761705,0.2716216216216216,1.0,1.0,4/15,9.82%,PPIF;DDX3X;DHX36;VCP
prerank,positive regulation of leukocyte activation (GO:0002696),0.48860174891329955,1.1597911871071076,0.2810810810810811,1.0,1.0,2/18,2.68%,WNT5A;IL33
prerank,negative regulation of metabolic process (GO:0009892),0.41117148423093575,1.1591555510075848,0.25975473801560756,1.0,1.0,13/54,15.42%,FIS1;NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,protein targeting to mitochondrion (GO:0006626),0.41524317530544647,1.1590210244955053,0.24642464246424642,1.0,1.0,11/52,13.20%,DNLZ;HSP90AA1;FIS1;TOMM20;FBXO7;TIMM13;PMPCA;MFN2;AIP;TIMM29;GDAP1
prerank,regulation of postsynapse organization (GO:0099175),0.45166738981592364,1.1589106152521593,0.26666666666666666,1.0,1.0,7/28,11.98%,WNT5A;FCGR2B;CDKL5;TANC2;CDK5;SRCIN1;IL1RAPL1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42336384070871547,-1.1588982803507069,0.2783171521035599,0.8100276841854627,1.0,7/13,25.22%,NFIB;PPARD;REST;NFATC4;BMP4;PPARG;PPARA
prerank,spindle assembly (GO:0051225),0.4088144021462762,1.15871216566613,0.25403659849300325,1.0,1.0,21/67,17.49%,HDAC3;CCDC61;MAPRE3;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;RCC1;HAUS3;CSNK1D;STAG2;OFD1;CHEK2;NUMA1;TNKS;TUBGCP2;BCCIP
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38619241764426343,1.15827417985735,0.2193877551020408,1.0,1.0,30/138,15.88%,GUCA1B;MST1R;EPHA7;EPHB2;NTF3;FGFR2;FGFR1;DDR1;IL31RA;ANGPTL1;DDR2;SRMS;EPHA8;BDKRB2;FRS2;EPHA10;RAPGEF1;MUSK;SHC4;GFRA2;PIK3CB;PDGFRA;PTPRF;ROR2;EFS;BLNK;ACVR1B;TRIO;NPR2;AHI1
prerank,regulation of autophagosome maturation (GO:1901096),0.5311449738056144,1.1580809629265316,0.2924791086350975,1.0,1.0,2/13,1.37%,CLN3;PHF23
prerank,regulation of receptor internalization (GO:0002090),0.43302328728151773,1.1578960437712185,0.28292682926829266,1.0,1.0,11/35,18.68%,NTF3;PICK1;CD63;ARRB1;LRPAP1;SDCBP;EGF;MAGI2;AHI1;FMR1;FLOT1
prerank,protein targeting to peroxisome (GO:0006625),0.4455325225606019,1.1574067037724252,0.27552275522755226,1.0,1.0,12/29,16.83%,FIS1;ZFAND6;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.34049542125184895,-1.1573664352521917,0.20430107526881722,0.8117021536536145,1.0,6/27,4.67%,ARL6IP5;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4280295754908839,1.1569312748794038,0.25874125874125875,1.0,1.0,7/44,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;WNK2;GABBR1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.37703565590888954,-1.1568108339092649,0.26146788990825687,0.81038292349278,1.0,11/21,34.13%,LIMCH1;GPM6B;SLK;ROCK1;ACTG1;DAPK3;RHOA;PEAK1;MACF1;EPHA3;CLASP1
prerank,negative regulation of cell aging (GO:0090344),0.4982007613348012,1.156808590433897,0.3174825174825175,1.0,1.0,4/16,9.79%,FOXM1;FBXO5;SLC30A10;TWIST1
prerank,protein K63-linked ubiquitination (GO:0070534),0.431946398923928,1.1564545826014265,0.26968973747016706,1.0,1.0,14/41,22.05%,RNF8;UBE2S;STUB1;UBE2E2;TRIM56;RNF168;UBE2V2;RNF152;HECTD1;ARIH2;TRIM27;TRAF3IP2;UBE2V1;TRAF2
prerank,regulation of mitotic cell cycle (GO:0007346),0.3803117448716435,1.1564302878445631,0.171225937183384,1.0,1.0,59/171,22.11%,CUL7;CDC23;PSMD4;UBE2S;MAD2L1;HECA;CDC16;OBSL1;FZR1;CDK13;PRKCA;CDK9;SCRIB;ANAPC2;FBXO5;PSMB10;DDB1;TRIM35;PSMD11;BRINP3;SIK1;SRA1;SDCBP;RNF40;PRMT5;CDK5RAP3;USP2;PSME2;PSMC5;TMEM8B;APP;IQGAP1;PTPN3;RCC1;ANAPC11;ANAPC4;CDC26;TGFB1;PSMD1;UBE2E1;UBE2D1;PSMD6;BRINP1;MDM2;MEIS2;ANAPC10;CDK10;ANAPC5;USP22;KIF20B;PSMD5;CDK11B;HNRNPU;PSMA4;ANGEL2;PSMA1;PSMC6;CUL9;SMAD3
prerank,regulation of spindle assembly (GO:0090169),0.4592949121446109,1.1563189426288645,0.2727272727272727,1.0,1.0,10/25,21.47%,CEP97;DRG1;CHMP3;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,positive regulation of embryonic development (GO:0040019),0.48271832678592164,1.155895737371571,0.287598944591029,1.0,1.0,8/19,21.38%,WNT4;RACK1;B4GALT5;ZBED3;NR2C2;TENM4;OSR1;CFL1
prerank,exit from mitosis (GO:0010458),0.5223977814666065,1.1554579317620268,0.29112081513828236,1.0,1.0,2/12,2.85%,SIRT7;UBE2S
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.456737933284318,1.1551132863913012,0.3008631319358816,1.0,1.0,5/28,9.77%,KDM4D;SIRT7;ACTR2;WRAP53;MRNIP
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4428688271305326,1.1550862254139367,0.281437125748503,1.0,1.0,11/33,18.57%,NHP2;ZBTB48;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,nitric oxide biosynthetic process (GO:0006809),-0.42402437097765666,-1.154465811158472,0.28052805280528054,0.8151725581811164,1.0,7/13,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5550648394740827,1.1542781181560469,0.3181818181818182,1.0,1.0,4/10,13.44%,CAMK2B;APP;NPTN;NETO1
prerank,positive regulation of protein polymerization (GO:0032273),0.39896738710427143,1.1537945373034426,0.24919441460794844,1.0,1.0,9/65,9.23%,PSRC1;CDC42EP5;CDC42EP4;BIN1;HSP90AA1;RAC1;TPPP3;BAIAP2;DRG1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47203022231090647,1.1533431357619444,0.30647291941875826,1.0,1.0,10/23,22.71%,S1PR2;CALM3;EGF;APP;TGFB1;CEMIP;CALM1;PRKAG2;CALM2;WNK3
prerank,detection of mechanical stimulus (GO:0050982),0.4830666366060834,1.1531516893438698,0.29905277401894453,1.0,1.0,5/19,24.29%,PKD2L2;JUP;PKD2;CSRP3;CDH2
prerank,rRNA transcription (GO:0009303),-0.39471421957972586,-1.152761832182093,0.24583333333333332,0.8174983582458615,1.0,5/17,3.81%,SPIN1;BRF1;CAVIN1;GTF3C3;GTF3C2
prerank,regulation of metal ion transport (GO:0010959),0.49744709167744244,1.1525326295452765,0.2859135285913529,1.0,1.0,4/16,12.18%,CAMK2B;SLC30A10;BCL2;CAMK2G
prerank,regulation of immune effector process (GO:0002697),0.42519768831458593,1.152417591364735,0.27692307692307694,1.0,1.0,3/41,5.04%,VTN;FCGR2B;SERPING1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5231450958780526,1.1521338040399125,0.3045977011494253,1.0,1.0,4/12,15.47%,MLYCD;TWIST1;IRS2;ABCD2
prerank,retinal metabolic process (GO:0042574),0.5277628978369084,1.15207105843701,0.29955947136563876,1.0,1.0,2/12,6.30%,RDH10;RDH11
prerank,protein glycosylation (GO:0006486),0.3849303052375427,1.1520655959726975,0.21779141104294478,1.0,1.0,28/125,15.81%,ALG5;B3GALNT1;C1GALT1C1;ST8SIA3;TMEM258;ALG6;MGAT3;ST3GAL2;OGT;MGAT4B;ALG1;PLOD1;ST3GAL3;ALG8;ST3GAL5;POMGNT1;DPAGT1;MGAT4C;POMT2;ALG9;B4GALT5;SERP1;COG3;DAD1;RPN2;GALNTL5;GALNT18;TRAK1
prerank,protein complex oligomerization (GO:0051259),0.3892580264895304,1.1516047416722797,0.26652452025586354,1.0,1.0,26/85,22.77%,TRMT61B;GSDMD;MPP2;KCNC1;ATL1;LRRC8A;FUS;TIFA;KCNC2;CPSF7;HGSNAT;ALS2;NUDT21;NACC2;PRMT1;DNM1L;PRMT8;CPSF6;PKD2;MAT2A;OXA1L;EHD1;ATL3;EHD3;WDCP;OPA1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.44914008502405245,1.1515615227006353,0.30552147239263805,1.0,1.0,1/29,0.14%,PLA2G5
prerank,organic cation transport (GO:0015695),0.47990756954565494,1.1515377730237861,0.29396325459317585,1.0,1.0,3/20,4.21%,SLC25A19;SLC22A18;SLC22A4
prerank,calcium ion import across plasma membrane (GO:0098703),-0.42816466050127355,-1.1513989317367415,0.30434782608695654,0.818853534416659,1.0,8/14,38.47%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,triglyceride homeostasis (GO:0070328),0.4506706604245726,1.1513810832871856,0.28094059405940597,1.0,1.0,3/26,3.85%,LPL;XBP1;RORA
prerank,endocrine system development (GO:0035270),0.47520852836273453,1.1513463120615985,0.293888166449935,1.0,1.0,3/21,8.19%,STRA6;DKK3;WNT4
prerank,Golgi organization (GO:0007030),0.38809861622418357,1.1512161845138122,0.25,1.0,1.0,37/112,19.74%,SPTBN5;CUL7;TJAP1;UBXN2A;TRAPPC8;OBSL1;STX6;SEC16A;ARHGEF7;TRIP11;STX16;SEC16B;ATP8B2;PLK5;LMAN2L;PRMT5;ARHGAP21;TBC1D20;PLEKHM2;USP6NL;RAB30;TANGO2;VTI1B;TMED10;COG3;HTT;CSNK1D;VMP1;CSNK1A1;STX17;VTI1A;STK25;GORASP1;VCPIP1;STX5;FAM174B;ZW10
prerank,regulation of cation transmembrane transport (GO:1904062),0.44783458383593555,1.151184371101203,0.2623152709359606,1.0,1.0,6/29,16.89%,KCNAB2;CD63;SLMAP;FGF12;DPP10;SLC30A5
prerank,negative regulation of lipid storage (GO:0010888),-0.37589414637104185,-1.1505255137359174,0.28125,0.8186348328756894,1.0,10/19,32.34%,ABHD5;NFKBIA;PPARD;NR1H3;NR1H2;PPARG;PPARA;ITGB3;PNPLA2;PTPN2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.46717101682633755,1.1496120912454375,0.31225296442687744,1.0,1.0,2/21,1.32%,IL34;DDT
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5187246521654106,1.1493640815483344,0.31540697674418605,1.0,1.0,4/13,7.54%,EDEM1;SAR1A;SEC16A;SEC16B
prerank,axon guidance (GO:0007411),0.3767931212164184,1.1487774872281287,0.17223910840932116,1.0,1.0,50/201,17.72%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;RAC1;PLXNA2;CXCL12;NRP1;PRKCA;PIK3R1;GAB1;EFNB3;EPHA8;CXCR4;GPC1;DSCAM;RAP1GAP;PLXNA1;CYFIP1;FRS2;EFNB2;VLDLR;TMEFF1;EPHA10;SEMA3D;GDNF;IRS2;GFRA2;PIK3CB;ROBO2;ROBO1;KIF5C;DAG1;FEZ2;NPTN;ALCAM;UNC5D;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;PLXNB3;EPHA5;KIF5B;USP33;DAB1;DCC
prerank,keratinocyte differentiation (GO:0030216),0.44770162441393896,1.1483009095845973,0.28,1.0,1.0,3/29,3.76%,WNT5A;SCEL;ANXA1
prerank,cellular response to UV-A (GO:0071492),-0.43523342132873283,-1.148004249913793,0.30564784053156147,0.8236563406036447,1.0,4/11,25.35%,MME;MMP2;MMP1;CERS1
prerank,base-excision repair (GO:0006284),0.4155963025157308,1.147970744062765,0.27242152466367714,1.0,1.0,7/48,6.98%,LIG1;PARP1;NTHL1;PRMT6;MPG;USP47;LIG3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.33381888095388124,-1.14764926760285,0.2484076433121019,0.8217989608506495,1.0,10/30,15.08%,CACNA1D;GJA1;CACNA2D1;ATP1A1;GJC1;KCNJ2;CACNA1C;CACNA1G;NEDD4L;SNTA1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5007282766480055,1.1470584449440906,0.2967651195499297,1.0,1.0,9/14,26.22%,PKIB;HTT;PKIG;PRKAR1A;ATP2B4;PKIA;PRKAR1B;PRKAR2A;RAPGEF2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.47684033766078615,1.1469709854178924,0.3053735255570118,1.0,1.0,10/18,26.37%,UNC13A;GRIK5;GRIA2;NAPA;UNC13B;CDH8;GRIK2;GRIK1;GRID1;SLC17A6
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.41544296486024,-1.1467711021187124,0.2690909090909091,0.8214144908746922,1.0,5/15,11.10%,RAPGEF3;BAG3;ANP32B;TP53;CAMK1
prerank,amino acid import across plasma membrane (GO:0089718),-0.35352570508947645,-1.1467149297375148,0.27461139896373055,0.8185135420841348,1.0,6/24,4.67%,SLC6A6;SLC16A2;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.46010550899993774,1.1464507978280227,0.2898550724637681,1.0,1.0,4/23,7.60%,DNASE1L2;FBH1;DFFB;KPNB1
prerank,plasma membrane organization (GO:0007009),0.40564487774772773,1.1463915844923442,0.27510917030567683,1.0,1.0,21/61,21.80%,CLN3;A4GALT;BIN1;WHAMM;TLCD1;CXCR4;STX2;PACSIN3;ABCA7;ANK3;SNX33;SERP1;EPB41L3;SPTBN1;ABCD2;NSF;ARL8B;SMPD1;CHMP4A;SYT11;MYH9
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.426104364163727,-1.1460851673909318,0.26813880126182965,0.8172380914292392,1.0,6/12,16.92%,KAT7;TIPIN;NBN;WRNIP1;METTL4;BLM
prerank,skeletal muscle tissue development (GO:0007519),0.44187708763796674,1.1458054604471282,0.2934131736526946,1.0,1.0,2/32,4.00%,MYORG;MYH14
prerank,lipoprotein catabolic process (GO:0042159),0.5385492907451872,1.1456414009109286,0.3124108416547789,1.0,1.0,2/11,2.89%,ABHD10;LYPLAL1
prerank,protein import (GO:0017038),0.3898370950592968,1.1455543901812948,0.2624867162592986,1.0,1.0,29/84,21.10%,MMP12;TSC2;HSP90AA1;NXT2;FIS1;NXT1;KPNB1;NUP188;PXMP4;PEX5;IPO11;SNX33;E2F3;PXMP2;NUP88;GDAP1;PEX13;IPO7;NUP214;TNPO1;ABCD2;RAB8B;ALDH3A2;APOE;NUP153;PPP1R10;HEATR3;TPR;APPL2
prerank,arachidonic acid metabolic process (GO:0019369),-0.31065439334557365,-1.1454706333513713,0.23376623376623376,0.816078492458735,1.0,19/35,40.02%,PNPLA8;PTGES3;MGLL;DAGLB;CYP1B1;PTGES;GPX1;TBXAS1;HPGDS;EPHX1;CYP2U1;PLA2G4A;CYP2A6;ALOX12;PLA2G4C;FAAH;PTGES2;CYP2S1;CBR1
prerank,response to hydrogen peroxide (GO:0042542),0.41469884810492186,1.1450629858156143,0.2881745120551091,1.0,1.0,13/45,19.43%,APTX;PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;STK25;PLEKHA1;RPS3
prerank,pinocytosis (GO:0006907),0.5432609329205423,1.1443639412186357,0.32190760059612517,1.0,1.0,5/10,20.61%,SNX5;RAB34;SNX33;CARMIL1;MAPKAPK2
prerank,negative regulation of peptidase activity (GO:0010466),0.41625092448061163,1.1441962198424451,0.2852272727272727,1.0,1.0,11/47,20.46%,VTN;SERPING1;SPOCK1;PARK7;SERPINA2;SPOCK2;LRP1;SERPINE1;SERPIND1;TIMP2;SERPINF1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.40780384983840645,1.1441445598799331,0.26557377049180325,1.0,1.0,13/56,17.34%,SPIRE2;CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SPIRE1;SON
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5265007745101904,1.1440640361259615,0.3130841121495327,1.0,1.0,3/12,10.71%,CXCL12;DOCK8;APP
prerank,protein maturation (GO:0051604),0.3881879766386596,1.143638592231073,0.264859228362878,1.0,1.0,26/95,21.27%,NDUFAB1;XPNPEP3;CPXM1;CLN3;STUB1;PCSK5;OGT;SDE2;PCSK2;CIAO2A;PTCH1;AFG3L2;CPXM2;METAP2;MMS19;ADAMTS3;F3;CASP2;HSPD1;SORL1;MMP14;NFU1;PCSK6;MMP16;NAA35;ISCA1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.38591788610705835,1.1434174408422642,0.25945378151260506,1.0,1.0,22/98,17.19%,FASN;NTF3;IFNAR1;IL10RB;PICK1;CD63;AGPAT1;SCRIB;PRELID1;VAMP3;PID1;ARRB1;EGF;MAGI2;RNF41;TGFB1;AHI1;AGTR1;NSF;ANXA2;FMR1;APOE
prerank,cellular calcium ion homeostasis (GO:0006874),0.3825471657091792,1.1426743197615974,0.21252566735112938,1.0,1.0,23/133,13.21%,TNNI3;CLN3;BAX;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;FZD9;CXCL12;ATP2A2;PDZD8;HCRTR2;ATP2B1;SLC24A4;SLC30A1;AFG3L2;PTH1R;HCRTR1;BCL2;CAMK2D;HTR2C;NPTN
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4712932218877912,1.1420100197678786,0.3091849935316947,1.0,1.0,4/20,7.75%,BBS10;HSP90AA1;NDUFAF1;PSMG3
prerank,ERBB signaling pathway (GO:0038127),0.40388492448835234,1.1419242682342838,0.2671009771986971,1.0,1.0,17/64,15.82%,PDPK1;HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;SLC30A10;SOX9;EGF;MVP;IQGAP1;NRG2;CUL5;NRG1;TGFB1;CBL;PTPN12
prerank,glutamate metabolic process (GO:0006536),0.48192268728105925,1.1418689964477053,0.3324396782841823,1.0,1.0,6/19,13.26%,GLS2;FPGS;OAT;GLUL;GCLC;DGLUCY
prerank,negative regulation of secretion by cell (GO:1903531),0.42591802240457094,1.1415488280143482,0.3125,1.0,1.0,12/38,21.57%,ANXA1;ERP29;VAMP3;SLC30A1;IL1RAPL1;CYP51A1;RHBDF1;VAMP8;TRH;APOE;SYT4;SYT11
prerank,telomere maintenance via telomerase (GO:0007004),0.4491093207310104,1.141217267221862,0.30036630036630035,1.0,1.0,10/28,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,negative regulation of wound healing (GO:0061045),0.4577909887944372,1.1407141640518024,0.31645569620253167,1.0,1.0,8/28,21.40%,VTN;AJAP1;CASK;TFPI;SERPINE1;APOE;FGF2;CLASP2
prerank,regulation of myelination (GO:0031641),0.4600307960106286,1.1406782796092867,0.30193548387096775,1.0,1.0,3/25,2.65%,SIRT2;MYRF;EIF2AK3
prerank,regulation of bone mineralization (GO:0030500),0.41212964506746746,1.1406550306270211,0.27808676307007785,1.0,1.0,13/55,12.01%,TMEM119;FBN2;BMP6;FZD9;ANKH;NELL1;DDR2;ADGRV1;WNT4;ATP2B1;KL;TWIST1;ENPP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5022670625757665,1.1405282406486328,0.30559540889526543,1.0,1.0,1/14,0.80%,WNT5A
prerank,sulfur compound catabolic process (GO:0044273),0.4272606013540181,1.140510656655761,0.30760233918128654,1.0,1.0,9/38,16.81%,ADO;MLYCD;GLB1;DCN;ACAT1;OMD;ARSB;LUM;DPEP1
prerank,phasic smooth muscle contraction (GO:0014821),0.5499302805458525,1.1404997564419812,0.3092006033182504,1.0,1.0,2/10,10.19%,EDN3;GDNF
prerank,negative regulation of cellular catabolic process (GO:0031330),0.40394238378640857,1.1393719198694614,0.2807991120976693,1.0,1.0,17/63,19.25%,IL10RA;SIRT2;GPLD1;NELL1;RRAGA;WDR6;CDK5RAP3;BCL2;LEPR;EIF4G2;PTPN3;PTPN22;NUPR1;EIF4G3;SORL1;ATRAID;TIMP2
prerank,acute-phase response (GO:0006953),-0.4305188636092754,-1.1386242913746767,0.30333333333333334,0.8349491336583559,1.0,3/12,7.50%,IL6R;LBP;PLSCR1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4608847834111837,1.1383368611548677,0.31685678073510776,1.0,1.0,6/24,18.05%,FIS1;MTCL1;MIEF2;ANK3;ITGB1BP1;CEMIP
prerank,regulation of mRNA catabolic process (GO:0061013),0.38191986237566866,1.1379780844583975,0.25,1.0,1.0,31/121,17.01%,KHSRP;EXOSC1;EXOSC3;PSMD4;EXOSC7;EXOSC2;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;PSMD11;HNRNPD;DHX36;PABPC1;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;YTHDF1;CSDC2;XRN1;NUP214;PSMD1;TNPO1;ZC3HAV1;FMR1;PSMD6
prerank,regulation of protein phosphorylation (GO:0001932),0.3727207884315602,1.1378275647083655,0.18236472945891782,1.0,1.0,50/256,14.90%,FGF20;FGF9;HDAC3;TMEM119;IL34;KDM4D;DVL2;EPHA7;EPHB2;EIF2AK3;HSP90AA1;RAC1;SMG8;WARS1;ERP29;FBLN1;FGF10;FLCN;KNDC1;FBH1;BRD4;ABL1;ATG14;AKAP8L;RAP2A;SIRPA;WDFY2;PID1;ARRB1;SOX9;PPP2R5E;CDK5RAP3;CLIP3;MUSK;APP;IGFBP3;LEPR;PARK7;NPM1;AXIN2;RACK1;PLPP3;NPTN;ZBED3;CSNK1D;ROCK2;TGFB1;FKBP8;IMPACT;PPP2R5D
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4682287885912898,-1.1376479317146633,0.32362459546925565,0.8347659117819533,1.0,3/10,7.64%,PARD3;DGKH;DGKD
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4930535249106086,1.1375504875643674,0.32386363636363635,1.0,1.0,7/16,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;VAMP7;LYST
prerank,positive regulation of protein acetylation (GO:1901985),0.5256273282998959,1.1373533626787515,0.31746031746031744,1.0,1.0,3/12,4.17%,TAOK1;DDX3X;DIP2B
prerank,peptidyl-lysine dimethylation (GO:0018027),0.47936298691244383,1.13701688308,0.31684491978609625,1.0,1.0,9/18,18.37%,KMT2B;SETD7;EHMT2;SETD1A;SUV39H1;EHMT1;KMT2D;ASH1L;KMT2A
prerank,regulation of intracellular transport (GO:0032386),0.426699789244953,1.1367211925158733,0.29001203369434414,1.0,1.0,10/38,16.13%,LCP1;ATP9A;MLC1;CAPN10;NEFH;SCFD1;TTC21B;NUP214;ATPSCKMT;NUMA1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.34234168453625347,-1.1361854543790866,0.2857142857142857,0.8365716719239331,1.0,13/25,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ADPGK;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,positive regulation of protein modification process (GO:0031401),0.3735262252195488,1.136077369073537,0.21263791374122368,1.0,1.0,53/203,21.29%,FGF20;FGF9;HDAC3;TMEM119;IL34;DVL2;HSP90AA1;RAC1;CALM3;TAOK1;ERP29;DDX3X;FGF10;FLCN;KNDC1;FBH1;ABL1;ATG14;NOS1AP;RAP2A;WDFY2;ARRB1;SOX9;NNMT;CLIP3;MUSK;APP;LEPR;AXIN2;RACK1;NPTN;CSNK1D;ROCK2;TGFB1;CAMTA1;ASPSCR1;DAXX;FMR1;ILK;PPP2R5A;TERF2IP;FLOT1;CALM1;SMPD1;PELI2;DLC1;RAB3GAP2;DAB2;LYN;ACVR2A;NTRK2;PTBP1;FGF2
prerank,regulation of biomineral tissue development (GO:0070167),0.4524189330009385,1.1359436384546269,0.3166458072590738,1.0,1.0,8/26,14.28%,ANKH;DDR2;FBXO5;SOX9;TWIST1;ENPP1;ROCK2;TGFB1
prerank,activation of GTPase activity (GO:0090630),0.3869819134430881,1.135531431430734,0.26227795193312436,1.0,1.0,20/89,14.05%,MTSS2;NTF3;SLC27A4;TBC1D7;SGSM3;RUNDC1;ARHGEF10;TBC1D13;SCRIB;SYDE2;RAP1GAP;ARHGAP42;RAP1GAP2;RABGAP1L;ARHGAP24;USP6NL;EVI5L;DOCK7;RABGAP1;ARHGAP29
prerank,calcium ion import into cytosol (GO:1902656),-0.405229034562088,-1.1353012035469656,0.2737226277372263,0.8363314575120666,1.0,8/15,38.47%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.4683589451048759,-1.1348619595465634,0.3052959501557632,0.834521125078589,1.0,5/10,18.19%,FEM1B;THOC5;WDR76;CCAR2;ETAA1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5171586828567599,1.1347420179576735,0.3163841807909605,1.0,1.0,7/13,27.48%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5050450024278791,1.134594247891744,0.3209366391184573,1.0,1.0,4/14,10.40%,GPLD1;DDB1;NNMT;IRS2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4718495394093969,1.1341946084352068,0.3272490221642764,1.0,1.0,3/21,5.55%,HKDC1;G6PC3;TKT
prerank,positive regulation of lymphocyte activation (GO:0051251),0.44563620981859514,1.1340458885071896,0.2990314769975787,1.0,1.0,6/28,15.53%,FGF10;THY1;SIRPA;XRCC6;CD47;HSPD1
prerank,positive regulation of metabolic process (GO:0009893),0.3787435603234313,1.1338240224654252,0.2565720294426919,1.0,1.0,22/103,17.62%,FASN;HDAC3;STAT6;LPIN1;AGPAT1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;PIGA;CPT2;LEPR;EHMT1;ESRRG;CAMK1D;ACADL;KDM6B;OMA1
prerank,regulation of macrophage differentiation (GO:0045649),0.4976080899561862,1.1337111566894813,0.3114754098360656,1.0,1.0,2/15,5.06%,IL34;PRKCA
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4224695954321169,1.1336188884511298,0.2955607476635514,1.0,1.0,16/40,22.11%,GLIPR2;SNAI1;OLFM1;TCF7L2;EZH2;TGFB1I1;SDCBP;TWIST1;AXIN2;TGFB1;JAG1;TGFBR1;DAB2;GCNT2;SMAD2;SMAD3
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3195779924107583,-1.1334254172713498,0.22905027932960895,0.8361320121267344,1.0,8/33,10.21%,PTPRG;DAB2IP;PTPRM;SLIT2;SP100;ADIPOR1;THBS1;DUSP10
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4447614044148131,1.133014828559185,0.30966952264381886,1.0,1.0,10/29,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,protein modification by small protein conjugation (GO:0032446),0.36820477147296043,1.132834386948936,0.14214214214214213,1.0,1.0,101/361,20.24%,ARRDC4;RNF157;CUL7;CDC23;SELENOS;RNF138;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;SYVN1;USP7;SAE1;CDC16;LZTR1;TRIM11;BRAP;PDZRN3;RAE1;SDE2;FBXO7;FBH1;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;MYCBP2;NFX1;ARRB1;TRIM62;UBA1;RNF40;RNF168;RNF103-CHMP3;CDK5RAP3;UBE2V2;TRIM41;TRIM17;CUL4B;VCP;NUP188;CHFR;UBE2Z;UBR3;PEX5;ZNRF3;RNF152;NUP210;RACK1;UBE2A;ANAPC11;NUP88;USP9X;CDC73;CUL5;PCNP;RNF220;PEX13;ATG3;RNF41;CBL;PIAS3;NUP214;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;NEDD8;UBE2L3;EIPR1;SMURF1;TOPORS;MDM2;FBXO9;DCUN1D5;URM1;KLHL20;NUP153;RNF111;HLTF;RANBP2;TRIM27;NUP35;VCPIP1;RNF38;DTX2;PIAS1;SUMO2;EYA1
prerank,spliceosomal complex assembly (GO:0000245),0.41425646461039906,1.1326626714923516,0.2939841089670829,1.0,1.0,17/46,18.52%,SMN1;SRSF5;SF3B1;CELF2;CELF1;SRSF9;SF3A1;PRPF6;SRSF1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3;GCFC2;SRPK1
prerank,cholesterol efflux (GO:0033344),0.46935211714424924,1.132652035502845,0.3089005235602094,1.0,1.0,8/20,23.97%,SOAT1;ABCA7;APOE;ABCA5;NPC2;ABCG1;NPC1;ABCA1
prerank,embryonic limb morphogenesis (GO:0030326),-0.3174651042180924,-1.132405112578935,0.24561403508771928,0.8363856598006261,1.0,9/34,11.93%,LRP6;MBNL1;RARG;WDPCP;FBXW4;TGFB2;CACNA1C;TBX3;INTU
prerank,negative regulation of mRNA processing (GO:0050686),0.49425511641643216,1.1323518293477235,0.33646112600536193,1.0,1.0,4/15,7.02%,PCBP4;SRSF12;BARD1;SRSF9
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.42516208942401434,1.1323282525499405,0.29698375870069604,1.0,1.0,5/40,6.02%,IGF1;BAX;PPIF;FAM162A;PRELID1
prerank,regulation of microtubule nucleation (GO:0010968),0.5459331050270121,1.1322678853377677,0.33533834586466166,1.0,1.0,5/10,22.50%,ARHGEF7;GIT1;EML2;MECP2;PAK1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3508396586807646,-1.1318387606189644,0.27601809954751133,0.8351026548449181,1.0,9/24,19.50%,TOMM70;EIF2AK4;STAT1;TRIM44;AIM2;SIN3A;MAVS;DTX3L;PARP9
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4291263501035573,1.1317808067089627,0.31650246305418717,1.0,1.0,11/33,19.43%,PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;PLEKHA1;RPS3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3984884997449788,1.13165152420062,0.26429341963322545,1.0,1.0,18/69,19.08%,IGF1;SIRT2;PLCH1;FGFR1;ZFP36L1;OGT;PLCL2;PIK3R1;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;PLEKHA1;KCNH1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.501788021000163,1.1310045647639577,0.327445652173913,1.0,1.0,3/15,7.08%,NHP2;CCT8;CCT6A
prerank,RNA metabolic process (GO:0016070),0.3815214019209855,1.1309985749351052,0.26791277258566976,1.0,1.0,36/127,17.85%,LAGE3;DDX17;TBRG4;EXOSC7;RNASE1;RBM3;DDX3X;POLR2B;RBM39;CELF2;DHX8;ATXN1;HNRNPK;MPHOSPH10;PABPC4;HNRNPD;DHX36;HNRNPM;MTREX;RBFOX2;RBMS1;RBMS2;POLR2K;HNRNPA0;AGO3;HNRNPH3;SETX;HNRNPL;SND1;NOVA1;HNRNPA2B1;THOC1;TP53RK;FASTKD1;PCBP2;FTO
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.48475020063480734,1.1308767652487832,0.31451612903225806,1.0,1.0,6/18,25.17%,IGF1;CD24;RPS3;HMGB1;IL18;IGFBP2
prerank,regulation of actin nucleation (GO:0051125),0.5057095662455307,1.1308756259065322,0.33821376281112736,1.0,1.0,2/12,3.83%,WHAMM;PICK1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.4106974983435619,-1.1306496795201855,0.278125,0.8356110976470712,1.0,2/13,4.65%,CAV1;ADRA1B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.46712168448163205,1.1305907740764085,0.3225388601036269,1.0,1.0,6/20,12.60%,SMAD9;XBP1;CARF;CHD6;RBPJ;CREB3
prerank,endoplasmic reticulum organization (GO:0007029),0.39537837508213736,1.1303370760256484,0.2891692954784437,1.0,1.0,23/72,19.99%,REEP4;ATL1;EIF2AK3;BNIP1;SEC16A;MIA3;GET1;SEC16B;MOSPD3;LMAN2L;RAB10;TOR1B;APP;SERP1;ZBED3;SMPD4;DNM1L;SEC61G;VAPB;ALDH3A2;VCPIP1;STX5;TOR1AIP2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42843295584612406,1.1299886591910895,0.31009615384615385,1.0,1.0,11/34,21.64%,SMPDL3B;GPR108;TNFAIP3;LGR4;LY96;LRRC14;TLR3;GPS2;PTPRS;LYN;RAB7B
prerank,second-messenger-mediated signaling (GO:0019932),0.38924807335564704,1.1298786517268633,0.2745726495726496,1.0,1.0,16/82,17.84%,PDPK1;EIF2AK3;EDN3;CCR9;ACKR2;RCAN2;CXCR4;RCAN3;INPP5A;PPP1R9B;MCTP2;NDNF;AGTR1;APOE;HRH1;MCTP1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.34603198073712493,-1.129694223159873,0.2936170212765957,0.8357024540846971,1.0,13/23,38.02%,AXL;TLR4;LGALS9;RARA;VSIR;INHBA;ZC3H12A;CD274;HAVCR2;LAPTM5;NR1H4;INHA;C1QBP
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4284449712914382,1.129669063668856,0.3181818181818182,1.0,1.0,5/33,6.02%,IGF1;PPIF;FZD9;FLCN;PRELID1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.41758492375913536,1.1291501740272865,0.3246753246753247,1.0,1.0,16/39,24.94%,AJAP1;CASK;FBLN1;DMTN;SPOCK1;SEMA3E;TBCD;JAG1;ITGB1BP1;GCNT2;NF2;MAP4K4;HOXA7;AP1AR;CORO1C;CX3CL1
prerank,protein neddylation (GO:0045116),-0.4298348582702416,-1.1288999241578364,0.3081761006289308,0.8351419687561992,1.0,3/13,4.49%,DCUN1D4;UBA3;RBX1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5221091086990026,1.1288282833315504,0.3323903818953324,1.0,1.0,4/12,12.71%,EPHB2;HSP90AA1;MYCBP2;B4GALT5
prerank,transepithelial transport (GO:0070633),0.49028884420859276,1.128755838874668,0.3245125348189415,1.0,1.0,2/15,1.59%,BEST1;GPLD1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2880140928329644,-1.128731330339131,0.24347826086956523,0.8326742209250252,1.0,25/52,24.63%,ME3;ME2;MTHFR;GCLM;MTHFS;GOT2;SLC25A32;IDH1;ACLY;MTHFD1;IDH2;PHYH;D2HGDH;ACOT8;GPT2;L2HGDH;GOT1;MTHFD1L;ALDH5A1;HOGA1;MTRR;ALDH1L1;ALDH1L2;MDH1;ALDH18A1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.37573669178418767,1.1287241941060686,0.2626680455015512,1.0,1.0,23/108,17.55%,SFRP2;ATP6AP2;SFRP1;GSKIP;TSC2;FGFR2;DCDC2;CTNND2;TNFAIP3;SULF1;WLS;APP;RACK1;KREMEN1;CBFB;CDC73;DISC1;LRP1;TCF7L1;CTNNBIP1;NKD1;PTK7;GNAQ
prerank,fatty acid biosynthetic process (GO:0006633),0.39777662214335224,1.1285869585508372,0.29262926292629265,1.0,1.0,9/63,14.72%,NDUFAB1;LPL;MLYCD;ELOVL1;XBP1;ELOVL4;FADS1;PTGS2;EPHX2
prerank,extracellular matrix organization (GO:0030198),0.3684875414811132,1.128386644177747,0.20741482965931865,1.0,1.0,77/276,21.42%,ADAMTSL2;MMP12;MMP17;VTN;LCP1;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;P4HA1;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;PLOD1;DDR2;CD151;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;FLRT2;MFAP5;CAPN2;PPIB;P4HA2;APP;ST7;ADAM12;COL1A2;CRTAP;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;TGFB1;PXDN;P3H2;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1;CAPNS1;COL11A1;BMP1;TGFBR1;SCUBE1;FLOT1;COL5A3;COL8A2;CTSK;TIMP2;MMP14;QSOX1;LOXL1;MMP16;ITGAV;ITGB1;ADAMTSL5;FGF2;GFOD2;GSN
prerank,regulation of humoral immune response (GO:0002920),0.41460766464704707,1.127643776853345,0.2921083627797409,1.0,1.0,3/44,5.04%,VTN;FCGR2B;SERPING1
prerank,purine ribonucleotide transport (GO:0015868),0.4823553718010638,1.1269350393627116,0.3163841807909605,1.0,1.0,3/16,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,cellular response to oxygen levels (GO:0071453),0.5496956917064413,1.1268545643992198,0.3399390243902439,1.0,1.0,4/10,10.79%,ATP6V0A2;PICK1;NDUFS2;ATP6V1G1
prerank,positive regulation of axonogenesis (GO:0050772),0.4159246152845938,1.126211980002909,0.3017341040462428,1.0,1.0,12/43,17.96%,AMIGO1;CDKL5;PLXNA2;DBN1;PLXNA1;DBNL;ROBO2;ROBO1;MAPT;PLXNB3;RUFY3;SLITRK1
prerank,regulation of axonogenesis (GO:0050770),0.4076161223265055,1.125961250720004,0.30855855855855857,1.0,1.0,23/51,24.29%,AMIGO1;PLXNA2;THY1;PAK3;EFNB3;BRSK2;MCF2;PLXNA1;BRSK1;ROBO2;ROBO1;PLXNB3;RUFY3;SLITRK1;CHN1;MAP6;NTRK2;ARHGAP35;PAK1;EPHA4;LRP4;PTEN;CDH2
prerank,negative regulation of translation (GO:0017148),0.3849146898327394,1.1259299007541894,0.29411764705882354,1.0,1.0,31/87,22.70%,ILF3;CPEB1;PAIP2;EIF2AK3;DDX3X;CNOT10;IGF2BP2;CELF1;EPRS1;DHX36;PUS7;EIF4E2;CNOT9;MALSU1;YTHDF3;RACK1;DAPK1;YTHDF1;ROCK2;MRPL13;FMR1;FTO;SAMD4B;YTHDF2;RPS3;YBX1;TPR;IGFBP5;SAMD4A;METTL14;RPL13A
prerank,negative regulation of phosphorylation (GO:0042326),0.38916039786607537,1.1258269627403057,0.28207847295864263,1.0,1.0,27/85,20.75%,CDKN2D;EPHB2;PRKRIP1;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;HDAC4;IRS2;IGFBP3;PARK7;GIT1;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;NUPR1;DNAJC10;TERF2IP;DYNLL1;LYN;HNRNPU;NPRL2
prerank,cellular response to glucose starvation (GO:0042149),0.4185846592086072,1.1257811839182443,0.3225806451612903,1.0,1.0,15/41,19.00%,EIF2AK3;XBP1;PICK1;NUAK2;NUAK1;ATG14;BRSK2;TBL2;SIK1;BRSK1;IMPACT;PIK3C3;PRKAA1;PRKAG2;PIK3R4
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4337779549070935,-1.1257427219099287,0.3148148148148148,0.8394153606442687,1.0,5/11,13.21%,PICALM;GPM6B;GOPC;ACTN2;NEDD4L
prerank,positive regulation of chromosome organization (GO:2001252),0.49959732800787604,1.1254876384082373,0.32967032967032966,1.0,1.0,7/15,19.62%,GNL3;DHX36;ATRX;MRE11;RAD50;RAD21;PPP1R10
prerank,central nervous system development (GO:0007417),0.3689754457029884,1.125449296672756,0.20520520520520522,1.0,1.0,51/250,18.16%,AATK;AMIGO1;AFF2;ATP6AP2;SH3GL3;POU6F1;EPHA7;MYRF;SYNJ2;GBA2;NKX2-2;GLIS2;GRIN1;NIPBL;CHD8;CDK5;DHX30;ATXN1;HAPLN4;ADAM22;ZIC3;CXCR4;GRIN2A;SPOCK1;SOX9;PTCH1;ZFHX2;CDK5RAP3;SOX11;JARID2;POU6F2;COX7B;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;RPS6KA3;ZIC2;CNTNAP2;CIC;AHI1;HSPG2;ADGRA2;TPPP;ALDH3A2;TUBGCP2;MEIS2;PKD2;ATN1
prerank,nuclear export (GO:0051168),0.3861336239826603,1.12537949513138,0.2781875658587987,1.0,1.0,30/80,23.13%,U2AF1;SRSF2;RAE1;SRSF5;ATXN1;SRSF3;THOC3;SRSF9;RANBP3L;SRSF1;NUP188;MALT1;STRADB;NEMF;THOC7;TGFB1;THOC1;NUP214;XPO6;SMURF1;SRRM1;XPO7;NUP153;RANBP3;TPR;SARNP;U2AF2;NUP155;SRSF6;CSE1L
prerank,regulation of epidermal cell differentiation (GO:0045604),0.46232804434238794,1.1252748084975035,0.3083756345177665,1.0,1.0,5/21,14.18%,MAFG;ZFP36L1;ERRFI1;CBFB;ROCK2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.41973506823259427,1.125151863741641,0.3147268408551069,1.0,1.0,5/37,8.75%,SIRT2;NFKB1;ABCA2;LRPAP1;SDCBP
prerank,camera-type eye development (GO:0043010),0.4463208518318657,1.1249670355634618,0.32869785082174463,1.0,1.0,3/25,5.55%,FBN2;STRA6;TENM3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4429245188811585,1.124955930296885,0.3235668789808917,1.0,1.0,12/27,24.06%,SYT3;SYT10;SYT1;ARL8B;SYT4;VAMP7;SYT11;SYT12;SDF4;SYT7;SYT2;PPP3CB
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.43995844911846976,1.1243859559338607,0.33125,1.0,1.0,9/26,24.17%,HSP90AA1;TMEM106A;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,primary alcohol metabolic process (GO:0034308),0.4442787103601177,1.124146429491184,0.32665832290362956,1.0,1.0,4/25,7.45%,IGF1;RDH10;RDH11;GDPD3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5128925302841844,1.124071577145386,0.3333333333333333,1.0,1.0,5/11,14.64%,P4HA1;P4HA2;CRTAP;EGLN2;P3H2
prerank,glycoprotein biosynthetic process (GO:0009101),0.39123927422436156,1.123810527944394,0.2814178302900107,1.0,1.0,14/79,13.65%,ALG5;B3GALNT1;IGF1;ST8SIA3;ST3GAL2;ALG1;TMEM106A;CHST10;ST3GAL3;ST3GAL5;B4GALT5;SERP1;COG3;DAD1
prerank,regulation of neuroblast proliferation (GO:1902692),0.47943445038721866,1.1237176651660108,0.31896551724137934,1.0,1.0,3/15,13.59%,SMARCD3;FZD3;DISC1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4309040808171649,1.1232145965976637,0.33215962441314556,1.0,1.0,7/32,18.96%,PDPK1;CALM3;THY1;HTT;PKD2;CEMIP;CALM1
prerank,positive regulation of translational initiation (GO:0045948),0.4754914371890704,1.1226161528522705,0.33967391304347827,1.0,1.0,7/18,24.24%,DDX3X;CDC123;YTHDF3;YTHDF1;YTHDF2;KHDRBS1;UHMK1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.42437856642757316,1.1222485913983091,0.298932384341637,1.0,1.0,5/35,6.98%,LIG1;PARP1;NTHL1;MPG;LIG3
prerank,protein localization to synapse (GO:0035418),0.5155445540591412,1.1218018561913983,0.33185840707964603,1.0,1.0,1/12,0.27%,MPP4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.43048909310138783,1.1217266122935445,0.31143552311435524,1.0,1.0,6/33,11.02%,IGF1;SIRT2;ZFP36L1;PIK3R1;PIK3CB;PIK3R2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35961325092305646,-1.1217162197188026,0.2924901185770751,0.8496511548463915,1.0,5/20,13.21%,CAB39;PRKCE;GOPC;ACTN2;NEDD4L
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5334283206799854,1.121674826442986,0.34775888717156106,1.0,1.0,4/10,13.57%,CPEB1;DHX36;NUDT21;CDC73
prerank,extracellular matrix assembly (GO:0085029),0.4622600981740888,1.1216354366151258,0.3424657534246575,1.0,1.0,7/23,14.59%,MFAP4;TNXB;NTNG2;FBLN5;LAMB1;TGFB1;PXDN
prerank,folic acid metabolic process (GO:0046655),-0.3796152495011986,-1.1213658944697962,0.2777777777777778,0.8477573718127231,1.0,10/18,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,cellular amide metabolic process (GO:0043603),0.3832690244564577,1.1211577649784592,0.2814122533748702,1.0,1.0,19/102,14.55%,CPXM1;MLYCD;SMPD2;THEM4;ABCA2;FPGS;ACOT9;ACOT11;PCCB;THOP1;GPAT4;DNPEP;SGPL1;NNMT;CPXM2;PCCA;PLPP3;NIT1;ACSL6
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4402896702806497,1.1211146978316338,0.3427172582619339,1.0,1.0,8/31,17.92%,ARRDC4;UBE2S;FZR1;CDC14B;UBE2L3;TOPORS;GORASP1;DCUN1D5
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4379415474455342,1.1208559900629997,0.3431013431013431,1.0,1.0,2/29,1.12%,SFRP2;SFRP1
prerank,acute inflammatory response (GO:0002526),-0.33668483270529814,-1.1207925519783053,0.29310344827586204,0.8465474843521628,1.0,4/23,7.72%,IL6R;LBP;PLSCR1;ANO6
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5170780905389073,1.1207663746003236,0.3561847988077496,1.0,1.0,7/12,25.14%,ARHGEF7;CLIP3;EML2;TBCD;TUBB4A;MAP2;STMN1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3988628697599721,1.1201618413291072,0.3132803632236095,1.0,1.0,13/56,13.22%,CDC23;UBE2E2;ANXA1;TFDP1;DDX3X;CDC16;FGF10;BRD4;FBXO5;CDC25A;VPS4B;ANAPC11;ANAPC4
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5141090197286107,1.1201273384456725,0.35398230088495575,1.0,1.0,3/13,9.60%,GLS2;GLUL;ALDH4A1
prerank,axonal transport of mitochondrion (GO:0019896),0.515482434590387,1.1198430513738142,0.34841628959276016,1.0,1.0,5/11,22.77%,NEFL;MAPT;TRAK1;ACTR10;OPA1
prerank,protein deacetylation (GO:0006476),0.4183183681079459,1.1198383777933114,0.31517960602549244,1.0,1.0,9/41,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;RCOR1;MTA2;HDAC1
prerank,fatty acid oxidation (GO:0019395),0.39516697596630923,1.1196485168643802,0.3217097862767154,1.0,1.0,15/57,16.83%,ADH5;ACAD10;HADHB;ACAT1;HSD17B4;CROT;CPT2;EHHADH;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,protein import into peroxisome membrane (GO:0045046),0.45080209910173075,1.119422412243549,0.3333333333333333,1.0,1.0,9/22,16.83%,FIS1;PXMP4;PEX5;PXMP2;GDAP1;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,negative regulation of protein metabolic process (GO:0051248),0.4094846537388842,1.1192764076696544,0.3143176733780761,1.0,1.0,13/48,19.03%,PFDN4;SIRT2;AZIN2;NFKB1;MAD2L1;VBP1;PFDN1;MDM4;CYP51A1;APOE;PFDN2;BANP;FMN2
prerank,response to organic cyclic compound (GO:0014070),0.3967349744701548,1.1190793240032724,0.29955456570155903,1.0,1.0,4/52,4.31%,CDKN2D;SFRP1;ANXA1;ABCA2
prerank,neuropeptide signaling pathway (GO:0007218),0.4050106962944641,1.1190500490697668,0.3021978021978022,1.0,1.0,9/58,14.46%,LTB4R2;OPRK1;HCRTR2;GPR37;GPR149;NMU;NXPH2;HCRTR1;GLRA1
prerank,regulation of membrane depolarization (GO:0003254),0.48024430312142913,1.118885706984684,0.35153129161118507,1.0,1.0,6/18,20.96%,GPD1L;SCN2B;CAMK2D;PTPN3;SMAD7;SCN1B
prerank,mitochondrion disassembly (GO:0061726),0.4202711112014596,1.1186477791641969,0.3147268408551069,1.0,1.0,13/34,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG2A;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,tRNA modification (GO:0006400),0.3911558429528654,1.1183849455874575,0.32599118942731276,1.0,1.0,17/62,19.95%,TRMT61B;DTWD1;ANKRD16;TRDMT1;TYW1;PUS10;AARS1;WDR6;PUS7;TRMT1;METTL2B;METTL2A;TPRKB;QTRT2;URM1;ALKBH1;WDR4
prerank,negative regulation of secretion (GO:0051048),0.5416899248724089,1.118383939298352,0.3378582202111614,1.0,1.0,4/10,16.15%,VAMP3;EGF;NRG1;VAMP8
prerank,inner ear morphogenesis (GO:0042472),0.45788938059404866,1.1181161663050188,0.3275,1.0,1.0,3/22,8.36%,EPHB2;FGFR2;SOX9
prerank,neurotransmitter secretion (GO:0007269),0.41527423435738003,1.117987974178511,0.3132947976878613,1.0,1.0,9/44,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,regulation of RNA metabolic process (GO:0051252),0.3960685926639661,1.1179727921067542,0.33109619686800895,1.0,1.0,26/59,23.96%,AFF2;FAM50A;PCBP4;IGF2BP2;CELF1;FUS;RC3H2;HNRNPH3;HNRNPL;TRA2B;NOVA1;HNRNPLL;GRSF1;AHNAK;CLK4;OAS2;SON;PCBP2;BRDT;YTHDF2;MITF;PTBP1;CLK2;RRP1B;SNRNP70;CLK1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.41599609619358324,1.1179580251526002,0.336094674556213,1.0,1.0,16/39,22.71%,GPD1L;YWHAH;SCN2B;WNK2;ANK3;SLMAP;FGF12;CAMK2D;PTPN3;FGF14;NETO1;OSR1;SCN1B;HECW2;FGF13;WNK3
prerank,positive regulation of rRNA processing (GO:2000234),0.5230365839586323,1.1178664171768233,0.3472429210134128,1.0,1.0,3/10,8.48%,SIRT7;DIMT1;BUD23
prerank,superoxide anion generation (GO:0042554),-0.4142354096851939,-1.1175963924542232,0.282312925170068,0.85393086692549,1.0,11/13,56.85%,NOX1;CYBA;NCF2;ALOX12;CYBB;NOX4;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5360916882607161,1.1170566151849834,0.33587786259541985,1.0,1.0,1/10,0.85%,FCGR2B
prerank,cellular component disassembly (GO:0022411),0.4016358802921128,1.1170185089472509,0.3269876819708847,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,endothelial cell development (GO:0001885),-0.3392696402190436,-1.116920568786288,0.2830188679245283,0.8530902894378037,1.0,8/25,16.70%,RDX;RAPGEF3;PECAM1;COL18A1;EZR;MYADM;MET;MSN
prerank,regulation of store-operated calcium entry (GO:2001256),-0.44539398834876776,-1.1161383817812487,0.3083832335329341,0.8525834866527171,1.0,4/10,26.68%,SLC8B1;HOMER3;EFHB;CD84
prerank,regulation of muscle contraction (GO:0006937),0.43459772109131306,1.1159403428603243,0.3105134474327628,1.0,1.0,6/26,13.93%,TNNC1;TNNI1;ATP1A2;TPM1;CHRM2;KCNA1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.37374837234296476,1.115865162920608,0.2978505629477994,1.0,1.0,6/117,3.71%,FSHR;PTGER4;ADCY7;ADM;VIPR2;PTHLH
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.40469449384051304,1.1152334102660533,0.3367816091954023,1.0,1.0,12/46,15.42%,NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,regulation of protein catabolic process (GO:0042176),0.38032300776619826,1.1146959384958859,0.29791666666666666,1.0,1.0,29/99,19.51%,WNT5A;SIRT2;AZIN2;ASB5;MAD2L1;FZR1;SNF8;TNFAIP3;DDB1;BARD1;HGS;MDM4;VCP;CYP51A1;WDR91;EGLN2;RNF41;FAF1;CHEK2;NKD1;NSF;TIPARP;SMURF1;MDM2;SORL1;ZDHHC2;BANP;FMN2;STX5
prerank,extracellular matrix disassembly (GO:0022617),0.4012756827052143,1.1146845016402886,0.32441471571906355,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,regulation of phosphate metabolic process (GO:0019220),0.48387017061782567,1.1145088445169034,0.3620218579234973,1.0,1.0,4/16,10.29%,SIRT2;BARD1;CD24;PGAM1
prerank,kidney development (GO:0001822),0.3926902575048189,1.114495389896446,0.30151843817787416,1.0,1.0,16/65,19.15%,STRA6;GREB1L;PCSK5;NIPBL;FGF10;SULF1;WNT4;GDNF;ROBO2;PYGO2;PYGO1;CTSH;AGTR1;OSR1;TGFBR1;SOX4
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.37529478222645163,-1.1144164660089235,0.2996389891696751,0.8551421479105812,1.0,4/18,8.16%,MTUS1;IL6R;SLIT2;SLC8B1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.41688037333946726,1.1143579255697302,0.3321718931475029,1.0,1.0,8/38,9.77%,NDUFAB1;NDUFA7;NDUFAF1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,muscle cell development (GO:0055001),0.4374760947767936,1.113956609461414,0.3421686746987952,1.0,1.0,3/30,3.12%,IGF1;BIN1;NEB
prerank,glycerolipid catabolic process (GO:0046503),-0.36384470603487895,-1.1137853824050827,0.26506024096385544,0.8542342258333848,1.0,6/19,8.66%,GPCPD1;PNPLA6;MGLL;ABHD6;ABHD2;GDPD1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5277964408647484,1.113608469863844,0.3548872180451128,1.0,1.0,4/10,12.69%,FZD9;DCN;BCL2;RACK1
prerank,cardiac muscle tissue development (GO:0048738),-0.27950800540164883,-1.113228405274743,0.25,0.8530459268497183,1.0,13/50,17.80%,SMAD4;GJA1;MAML1;RBP4;SMAD1;BMPR1A;CACNA1G;SGCD;BMP7;TBX18;BMP4;NDUFV2;NOTCH2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.41508507433501646,1.1131434888387703,0.3254437869822485,1.0,1.0,8/34,15.77%,WNT5A;SIRT2;RORA;FLCN;ENPP1;RUNX1T1;TGFB1;TRIO
prerank,Golgi to endosome transport (GO:0006895),-0.38585428240815645,-1.1130601043860315,0.30916030534351147,0.8506365820012715,1.0,7/16,16.66%,GBF1;VPS13A;RAB14;VPS13C;EPS15;KIF16B;SORT1
prerank,regulation of axon extension (GO:0030516),0.413875601617526,1.1125415161870185,0.32027649769585254,1.0,1.0,10/37,17.44%,CDKL5;DIP2B;OLFM1;ABL1;DBN1;DBNL;MAPT;SEMA3A;APOE;RUFY3
prerank,ribosome assembly (GO:0042255),-0.2868673552998561,-1.1124587725402368,0.23076923076923078,0.8496038223985903,1.0,35/47,38.76%,EIF2A;RPL11;RPL5;RPL6;RPL24;RPS19;EFL1;RPL3;RPLP0;RPL10;RPS28;RPS5;TRAF7;RPS27;MRPL20;NOP53;RPF2;RPS14;ERAL1;RRP7A;RPS27L;NOP2;MRPS7;BOP1;EIF6;DHX37;MRPS11;MRPL22;RRS1;RSL24D1;NLE1;PPAN;MPV17L2;C1QBP;PWP2
prerank,phospholipid homeostasis (GO:0055091),0.5178540697099434,1.1122837649311632,0.35294117647058826,1.0,1.0,2/11,7.81%,TLCD1;RCN3
prerank,negative regulation of cell population proliferation (GO:0008285),0.3590351692681626,1.111937576994704,0.19119119119119118,1.0,1.0,96/351,22.50%,SFRP2;CDKN2D;WNT5A;SFRP1;SIRT2;GPLD1;TSC2;CHERP;CGRRF1;GNRH1;PTHLH;WARS1;TFDP1;FBLN1;TNFAIP3;NELL1;RBBP4;FLCN;CLMN;IRF1;DLG3;ALDH1A2;CELF1;EEF1E1;MAGED1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;MFN2;IFI35;SOX9;WDR6;MDM4;SOX11;WNK2;KDM2B;APP;IGFBP3;ADGRG1;IGFBP7;BMP5;NACC2;E2F3;MAGI2;SPEG;NDRG4;SOD2;NPM1;AXIN2;ROR2;TNS2;CDC73;FGFBP1;RNF41;TGFB1;SLURP1;P3H2;SMAD6;DIS3L2;MN1;NUPR1;CTNNBIP1;CTBP1;ADAMTS1;ITGB1BP1;ABI1;CAMK2N1;PKD2;ATRAID;CDK10;PDCD5;ATP8A2;SOX4;DLC1;KLF4;MTSS1;LYN;FTH1;CTCF;PTK2B;TGFBR3;S100A11;NF2;APPL2;DLG5;TES;IGFBP5;PRKRA;PEX2;B2M;ERBB4;ITGA1;PAK1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4174678380898464,1.1113213350839726,0.33016627078384797,1.0,1.0,13/35,16.93%,WBP2;DDX17;PMEPA1;CALCOCO1;RBFOX2;ZMIZ1;TADA3;NCOA4;EGLN2;DDX5;TRIP4;DAXX;UBR5
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4412450171210057,1.1111372285265941,0.33375,1.0,1.0,4/24,8.54%,EPHA7;BAX;CDK5;DDIT3
prerank,spliceosomal snRNP assembly (GO:0000387),0.4108458914611284,1.1111120178132639,0.32413793103448274,1.0,1.0,10/38,14.40%,COIL;SMN1;GEMIN2;PRPF8;SRSF12;PRPF6;PRMT5;SART3;USP4;AAR2
prerank,aorta development (GO:0035904),0.4965637680365643,1.1106907592323274,0.36265223274695535,1.0,1.0,6/14,18.02%,ROBO2;ROBO1;LRP1;HECTD1;JAG1;PKD2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5002630297205705,1.110307025251183,0.37960339943342775,1.0,1.0,5/14,15.48%,HSD17B4;CROT;AMACR;EHHADH;ACOX3
prerank,lymphocyte proliferation (GO:0046651),-0.3538141558836164,-1.1103030214652403,0.2784313725490196,0.8535211996859224,1.0,6/22,16.70%,MEF2C;ELF4;PTPRC;LMBR1L;HELLS;MSN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5053992263105195,1.110298240065922,0.3514328808446455,1.0,1.0,2/12,4.89%,LPL;TIRAP
prerank,quinone biosynthetic process (GO:1901663),0.49339151800623016,1.1096161964985036,0.3429355281207133,1.0,1.0,2/14,2.22%,COQ6;COQ8B
prerank,cellular response to nutrient levels (GO:0031669),0.39463426473947466,1.109593545987908,0.3384615384615385,1.0,1.0,11/62,9.95%,LPL;SFRP1;XBP1;WIPI1;FLCN;ATG14;RRAGA;GAS2L1;EHMT2;RIPOR1;FADS1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.31429276563706376,-1.1095226811595535,0.2696629213483146,0.8530251072418924,1.0,13/36,15.17%,CRADD;DAB2IP;RB1;CSNK2A1;TPD52L1;CYLD;TRIM39;FAS;TMBIM6;MADD;SGMS1;DAPK2;TRAF7
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4551218954991253,-1.1094524227968106,0.34402332361516036,0.8503559203708935,1.0,2/10,1.89%,PRKCH;MED1
prerank,regulation of biosynthetic process (GO:0009889),0.5093411171608547,1.1093181539857764,0.35413642960812775,1.0,1.0,1/11,4.06%,SLC25A33
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.35953866389028566,1.108924978181264,0.20520520520520522,1.0,1.0,78/348,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;IGF1;EPHB2;BMP6;NTF3;EIF2AK3;IL33;WARS1;PICK1;ERP29;CD63;DDX3X;SNF8;C1QTNF1;FGF10;FUBP1;SCRIB;OLFM1;VAMP3;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;ARRB1;SOX9;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ANK3;MAZ;ROBO1;IFNGR1;MAGI2;PARK7;TADA3;AGO3;LAMTOR5;TLR3;PTPN22;FAM98A;ROCK2;TGFB1;EPHX2;F3;MED23;CTSH;AHI1;NSF;ANXA2;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;TGFBR1;PDCD5;MPHOSPH8;PRKAA1;FOXD1;RPS3;MITF;KLF4;GABPA
prerank,AMP metabolic process (GO:0046033),0.4990411759053535,1.1087869639875971,0.3561253561253561,1.0,1.0,3/13,13.69%,ADSL;AK4;AK3
prerank,protein ADP-ribosylation (GO:0006471),0.4314486466364064,1.1087639946659749,0.3300613496932515,1.0,1.0,10/28,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4221035311347083,-1.1085585682492964,0.35,0.8503728649971648,1.0,1/12,3.43%,ZBTB1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.518285731881018,1.10851578057812,0.34332833583208394,1.0,1.0,2/10,5.61%,GALNT16;GALNT4
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.39706545062839066,1.108424969361274,0.32004429678848284,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.39706545062839066,1.108424969361274,0.32004429678848284,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,endocardial cushion development (GO:0003197),-0.3579747195657915,-1.1081884226247989,0.3142857142857143,0.8485704899116111,1.0,10/21,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;BMP4;HEYL;CRELD1;TBX2;BMP2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5156736749095915,1.1081678842892482,0.3618320610687023,1.0,1.0,2/11,4.16%,SIRT2;FZD3
prerank,regulation of acute inflammatory response (GO:0002673),-0.3594799974879106,-1.1077321741531232,0.3254901960784314,0.8471326655209235,1.0,15/18,64.08%,PTGES;OSMR;IL6ST;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,regulation of neutrophil migration (GO:1902622),0.5310255337966433,1.1073093821494453,0.3837920489296636,1.0,1.0,2/10,8.46%,RAC1;JAM3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5071778566962472,1.1068473511313506,0.3429811866859624,1.0,1.0,2/12,9.21%,GALT;EXTL2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4830531747268911,1.106541961440459,0.34444444444444444,1.0,1.0,4/15,9.82%,SELENOS;SYVN1;AUP1;VCP
prerank,regulation of transmembrane transport (GO:0034762),-0.313255517968503,-1.1063504654951,0.2774869109947644,0.8483307974344216,1.0,6/31,13.21%,CTTNBP2NL;SLC2A1;ACTB;KCNJ2;OCLN;NEDD4L
prerank,regulation of leukocyte activation (GO:0002694),-0.40979569817606254,-1.1061451270895826,0.32432432432432434,0.8461743819872646,1.0,8/14,35.72%,MFHAS1;PLSCR1;GPR137B;SHPK;GPER1;CD74;CD200;MIF
prerank,regulation of small molecule metabolic process (GO:0062012),0.43137928419109406,1.1056540064079559,0.3473423980222497,1.0,1.0,9/28,18.70%,PDK1;MLYCD;RORA;EPHX2;ACADL;ACADVL;APOE;NCOR2;TTC39B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.35474980413309676,1.1053015999863955,0.162,1.0,1.0,90/509,15.32%,FSHR;FGF20;MYORG;FGF9;HDAC3;HEXIM1;WNT5A;MST1R;IGF1;SLC35B2;TCIM;BAX;PDPK1;MAP3K14;NTF3;ATP2C1;HSP90AA1;EDAR;RAC1;FGFR2;THEM4;FIS1;FGFR1;DDX3X;EDA2R;FGF10;TIRAP;CARD16;SLC38A9;FLCN;TCF7L2;TMEM106A;DCN;BRD4;PIK3R1;DHX58;GAB1;EPHA8;NOS1AP;RRAGA;DHX33;CHD5;CC2D1A;ADGRV1;TIFA;GPR37;IFI35;TRIM62;SOX9;DDIT3;GPRC5B;FRS2;DHX36;EGF;CDK5RAP3;SOX11;WLS;KL;MALT1;IRS2;PIK3CB;APP;USP15;PIK3R2;BCL2;TFG;MAZ;RPS15;PDGFRA;NFAT5;RTKN2;IQGAP1;PARK7;PLEKHG5;RACK1;LAMTOR5;AKAP13;NRG2;ROR2;TLR3;LPAR1;NRG1;ROCK2;TGFB1;BCLAF1;DNM1L;CBL;F3;PPP5C;NUPR1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4363846459804065,1.1052203068301836,0.34577114427860695,1.0,1.0,6/26,13.22%,CDC23;LCMT1;CDC16;FBXO5;ANAPC11;ANAPC4
prerank,positive regulation of telomere maintenance (GO:0032206),0.4316459293782737,1.1049595506293581,0.3388822829964328,1.0,1.0,11/31,19.62%,GNL3;PKIB;HNRNPD;DHX36;ATRX;HNRNPA2B1;MRE11;RAD50;TNKS;NABP2;PPP1R10
prerank,mRNA stabilization (GO:0048255),0.40485632265295657,1.1049484300477765,0.33294117647058824,1.0,1.0,14/40,21.35%,PAIP1;TIRAP;FUS;PABPC1;GDNF;HNRNPA0;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;MAPKAPK2;YBX1;ANGEL2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5298887236942555,1.104667418475795,0.3721633888048411,1.0,1.0,5/11,17.83%,PCBP4;IGF2BP2;ZNF445;NOVA1;PCBP2
prerank,adenine nucleotide transport (GO:0051503),0.4684295819462305,1.1042938933134365,0.32867132867132864,1.0,1.0,3/17,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.5141473438248454,1.1042047791052076,0.3604135893648449,1.0,1.0,1/11,0.80%,WNT5A
prerank,lipid homeostasis (GO:0055088),0.39283399295727844,1.1039717453734086,0.34213421342134215,1.0,1.0,11/57,12.73%,USF1;NR1D2;XBP1;DDX3X;ABCA2;TLCD1;RCN3;RBP1;IRS2;ZBTB20;TLCD3B
prerank,Golgi localization (GO:0051645),0.5190795850444697,1.1039340552317467,0.3850746268656716,1.0,1.0,7/11,22.64%,ARHGAP21;RIPOR1;HOOK3;STK25;UVRAG;TBCCD1;COPG1
prerank,protein localization to cilium (GO:0061512),0.424659338186753,1.1032259394171569,0.3462897526501767,1.0,1.0,12/32,20.65%,TUB;TCTN1;SNX10;IFT20;CSNK1D;ATP6V1D;TULP3;TTC21B;INVS;WDR35;RABEP1;EHD1
prerank,potassium ion transmembrane transport (GO:0071805),0.3644737359521511,1.1024671361474032,0.30643513789581206,1.0,1.0,20/135,15.90%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;ATP1A3;KCNK2;KCNT2;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,DNA biosynthetic process (GO:0071897),0.47941909518454673,1.1017067477814335,0.3603851444291609,1.0,1.0,3/16,13.73%,CDKN2D;POLH;POLD3
prerank,positive regulation of response to external stimulus (GO:0032103),0.36557495414667107,1.1016848886632082,0.30635245901639346,1.0,1.0,22/128,17.26%,WNT5A;LPL;PTGER4;DDT;BMP6;IL33;USF1;POLR3D;PRKCA;DHX58;IFI35;GPRC5B;GPR4;LY96;APP;USP15;CD47;TLR3;TGFB1;AGTR1;SERPINE1;TNIP1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.36949062123850357,1.1015581084416577,0.3119918699186992,1.0,1.0,18/124,10.55%,SFRP2;WNT5A;SFRP1;DVL2;PSMD4;RAC1;FZD9;FZD3;TCF7L2;PSMB10;DVL1;GNG2;PSMD11;WNT4;AP2S1;PSME2;PSMC5;DAAM1
prerank,regulation of chromosome segregation (GO:0051983),-0.3821649741240978,-1.101550097648454,0.29259259259259257,0.8579474772086257,1.0,3/16,1.76%,SMC5;PUM1;CSNK2A1
prerank,blood vessel endothelial cell migration (GO:0043534),0.4489818182349729,1.1015238861465804,0.3595933926302414,1.0,1.0,6/22,13.58%,GPLD1;NRP1;MIA3;EFNB2;ROBO1;EMP2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4782277393065372,1.1011539138522413,0.37583892617449666,1.0,1.0,5/17,11.30%,GPLD1;NRP1;MIA3;EFNB2;ROBO1
prerank,negative regulation of inflammatory response (GO:0050728),0.3624019786299377,1.100958737143644,0.30181086519114686,1.0,1.0,14/182,7.34%,FSHR;SMPDL3B;PTGER4;IGF1;SELENOS;ADCY7;ADM;VIPR2;PTHLH;RORA;TNFAIP3;GNG2;CD200R1;SIRPA
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.48655010733123094,1.1007264420576277,0.36792452830188677,1.0,1.0,5/15,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.42314360001532686,1.1006760793209525,0.34596577017114916,1.0,1.0,6/33,16.76%,SFRP2;EPHA8;JAM3;FOXC2;SERPINE1;ITGB1BP1
prerank,negative regulation of protein catabolic process (GO:0042177),0.4107077545518993,1.100630994714673,0.36098130841121495,1.0,1.0,12/40,19.25%,SIRT2;AZIN2;MAD2L1;NELL1;MDM4;CDK5RAP3;PTPN3;CYP51A1;ATRAID;BANP;FMN2;TIMP2
prerank,extracellular transport (GO:0006858),-0.4141337063612718,-1.1005520638407968,0.3442028985507246,0.8581704371479881,1.0,11/13,52.41%,TSG101;SPEF2;ARRDC1;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,protein lipidation (GO:0006497),0.39004112750845016,1.100512582364439,0.346448087431694,1.0,1.0,11/59,11.53%,PIGG;GPLD1;PGAP4;WIPI1;DPM2;PIGM;PIGU;ZDHHC3;GLUL;PIGA;PORCN
prerank,regulation of protein targeting to membrane (GO:0090313),0.43513827084022366,1.1004831044057592,0.35447761194029853,1.0,1.0,7/28,18.05%,FIS1;MTCL1;MIEF2;DMTN;ANK3;ITGB1BP1;CEMIP
prerank,sulfur amino acid catabolic process (GO:0000098),0.5346710853665202,1.1003500260549506,0.3560830860534125,1.0,1.0,1/10,1.95%,ADO
prerank,transition metal ion transport (GO:0000041),0.41394044439967204,1.1000766922237406,0.34652278177458035,1.0,1.0,11/35,21.53%,CP;ATP2C1;SLC30A10;SLC30A9;SLC30A1;COX17;HEPH;SLC30A5;SLC11A2;FTH1;ATOX1
prerank,wound healing (GO:0042060),0.38538558051179717,1.0997953136793894,0.3442982456140351,1.0,1.0,20/62,23.69%,MMP12;WNT5A;EPB41L4B;IGF1;FGF10;MIA3;TPM1;PPL;PDGFRA;NRG1;ARL8B;TGFBR1;SMPD1;FGF2;SYT11;MYH9;SMAD3;PAK1;SYT7;PRCP
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35671248621881047,1.09954320377875,0.229,1.0,1.0,53/348,12.69%,FGF20;SFRP2;FGF9;S1PR2;HDAC3;VTN;TMEM119;IGF1;IL34;DVL2;ARAF;BMP6;NTF3;HSP90AA1;RAC1;CALM3;MAPRE3;ERP29;DDX3X;NRP1;FGF10;CDK9;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;RAP2A;WDFY2;ARRB1;LRP8;SOX9;MMD;SDCBP;XRCC6;TEC;EGF;CLIP3;MRNIP;MUSK;JTB;ENPP2;APP;LEPR;ALS2;CNOT9;BMP5;IQGAP1;PARK7;DOCK7;AXIN2;RACK1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5013539611123482,1.0995276634799116,0.38316400580551524,1.0,1.0,6/12,18.69%,PARP1;PARP2;PARP16;TNKS;TIPARP;PARP11
prerank,protein insertion into ER membrane (GO:0045048),0.41014999541709496,1.0992231343543766,0.35106382978723405,1.0,1.0,13/37,22.53%,EMC1;EMC8;MMGT1;GET1;APP;SERP1;EMC7;SEC61G;ALDH3A2;STX5;EMC4;TRAM2;EMC2
prerank,regulation of innate immune response (GO:0045088),0.3908832878448304,1.0987451288682546,0.3304157549234136,1.0,1.0,10/57,8.14%,FCGR2B;POLR3D;TNFAIP3;TIRAP;IRF1;DHX58;TRAFD1;XIAP;IFI35;LRP8
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.24209016225581237,-1.0982586691524299,0.28378378378378377,0.8626215978420072,1.0,24/75,27.40%,SLC12A7;ATP1B3;SLC9A2;SLC39A14;CACNA2D1;ATP1A1;KCNJ2;SLC24A2;ABCC9;SLC39A8;ATP1B1;SLC39A12;SLC12A4;SLC12A9;SLC39A10;SLC12A2;KCNJ3;KCNK9;HCN2;TRPV2;SLC12A8;KCNJ12;SLC12A6;TRPV4
prerank,metallo-sulfur cluster assembly (GO:0031163),0.45186701833545884,1.098121621623585,0.36175710594315247,1.0,1.0,6/22,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3972807659706924,1.0979485485236669,0.36054421768707484,1.0,1.0,14/45,18.33%,SIRT7;NFKB1;DIMT1;PIK3R1;BUD23;LIN28B;SETX;TGFB1;MAP2K2;HNRNPLL;DDX5;GRSF1;ZC3H18;RBM22
prerank,regulation of chemokine production (GO:0032642),0.40500207295257684,1.0979089799859965,0.34933973589435774,1.0,1.0,3/36,2.68%,WNT5A;LPL;IL33
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3526839213628123,1.0977593221864155,0.129,1.0,1.0,179/834,18.39%,SFRP2;APLN;METTL23;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;GNL3;SIRT7;DDX17;EAPP;CRTC1;NFKB1;SMARCD3;BMP6;PARP1;ZEB2;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MED12;MED14;GLIS2;SMAD9;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;NFKB2;DDX3X;LPIN1;CCNC;OGT;CHD8;POU2F1;RFX5;CDK13;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;AKAP8L;ARNT;SMARCB1;TEAD1;HDAC5;MOSPD1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;SLC30A9;SOX9;SMARCD1;GCN1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;PER1;ECD;DHX36;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;BRD8;APP;TAF6;JUP;RBPJ;GLIS1;RFX4;PIK3R2;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;ABHD14B;CDC73;FOXJ3;ATRX;AUTS2;TGFB1;MED21;RGMA;BCLAF1;KMT2D;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;TNIP1;GABPB1;GABPB2;MEIS2;TBL1XR1;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3458136383648031,-1.0976379846930666,0.319047619047619,0.8617736389206353,1.0,8/24,7.89%,SMAD4;PARVA;NRP2;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.441812191235109,1.0972780776035256,0.34227330779054915,1.0,1.0,1/22,0.80%,WNT5A
prerank,regulation of mRNA processing (GO:0050684),0.4218019757528467,1.0972270339462926,0.36917562724014336,1.0,1.0,14/32,19.61%,ZFP36L1;SLTM;RBM39;SRSF3;HNRNPK;TIA1;KHDRBS2;PTCD2;SAFB2;YTHDC1;AHCYL1;SON;SRPK1;CDK11B
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4368857449098362,1.0968567789011796,0.3292079207920792,1.0,1.0,6/26,12.71%,ALG6;ST3GAL2;TKT;ALG8;RRM2B;B4GALT5
prerank,acylglycerol homeostasis (GO:0055090),0.4528138149905907,1.0968360326555846,0.36578947368421055,1.0,1.0,2/20,3.85%,LPL;RORA
prerank,synapse assembly (GO:0007416),0.3804643652351184,1.0965511265255645,0.3485838779956427,1.0,1.0,12/67,14.38%,WNT5A;LRRC4;OBSL1;CDK5;DVL1;DSCAM;DBNL;GABRB3;NLGN3;SPOCK2;FARP1;NLGN2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.521009696341105,1.096524404503495,0.363901018922853,1.0,1.0,5/11,16.39%,AUP1;POMT2;VCP;UGGT2;DERL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.37461085207511585,1.096348932672958,0.352260778128286,1.0,1.0,22/84,17.95%,WNT5A;GPLD1;ASB5;HSP90AA1;NRDC;FZR1;SNF8;TNFAIP3;DDB1;BARD1;PACSIN3;VCP;SNX33;EGLN2;RNF41;FAF1;NKD1;NSF;TIPARP;APOE;SMURF1;SORL1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.406091441604165,-1.0954527097520368,0.3554817275747508,0.8657137493402989,1.0,1/12,3.02%,IL1R1
prerank,response to fatty acid (GO:0070542),0.4760866253714713,1.09528933967965,0.3687845303867403,1.0,1.0,4/17,15.21%,LPL;PID1;SOX9;PPP5C
prerank,DNA duplex unwinding (GO:0032508),-0.27612473876344046,-1.0952122331819343,0.30357142857142855,0.8635712514382847,1.0,20/50,20.55%,RAD23B;GTF2H1;ASCC3;RBX1;CHD1L;CUL4A;RPA1;NBN;PURA;UBB;GTF2H5;GTF2H2;XPC;ERCC3;BLM;SUPV3L1;RECQL;RTEL1;MCM6;WRN
prerank,regulation of osteoblast differentiation (GO:0045667),0.3765030774472825,1.0950524032845292,0.3287086446104589,1.0,1.0,15/82,9.79%,TMEM119;IGF1;FBN2;BMP6;FGFR2;NELL1;DDR2;FBXO5;SUCO;RANBP3L;WNT4;SOX9;PTCH1;SOX11;TWIST1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.38046582043905325,1.0949638123230798,0.34541577825159914,1.0,1.0,18/80,17.92%,ARRDC4;HDAC3;UBQLN1;PHF23;STUB1;TBC1D7;MYCBP2;PEF1;XIAP;CDK5RAP3;MALT1;FANCM;UBE2D1;NDFIP2;DERL1;UBE2L3;TOPORS;DCUN1D5
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5138838571192788,1.094880431831402,0.3764705882352941,1.0,1.0,3/11,11.33%,SIRT7;SMARCB1;IPPK
prerank,cation transport (GO:0006812),0.3606534797525579,1.094838921071902,0.3011077542799597,1.0,1.0,18/167,9.54%,KCNG2;SLC4A4;CLN3;KCNA4;KCNC1;ASIC1;GRIN1;SLC22A18;SLC22A4;SCN7A;TMEM63C;CATSPER3;KCNMA1;ATP1A2;SLC39A1;KCNJ10;TRPM3;KCNQ4
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3488824465235093,-1.094768510823452,0.33047210300429186,0.8620518589063515,1.0,10/20,20.48%,MICU1;LETM1;SLC8B1;MCU;MCUR1;SPG7;MCUB;MAIP1;SMDT1;STOML2
prerank,COPII vesicle coating (GO:0048208),0.3855903503082145,1.0945283000595563,0.34868421052631576,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,vesicle coating (GO:0006901),0.3855903503082145,1.0945283000595563,0.34868421052631576,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3855903503082145,1.0945283000595563,0.34868421052631576,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4695815277159412,1.0943492594898097,0.3484042553191489,1.0,1.0,3/18,7.08%,NHP2;CCT8;CCT6A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.29854255504413263,-1.0941072515479067,0.2878787878787879,0.8612878844542392,1.0,16/39,18.82%,LATS1;DAB2IP;RDX;TJP1;EZR;TIE1;PARP10;ROCK1;VPS11;HCFC1;SPTY2D1;IRGM;MSN;PINK1;ANKRA2;GFAP
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.25672122526289975,-1.093982465318004,0.22807017543859648,0.8588730330019113,1.0,19/55,18.83%,CRADD;DAB2IP;CAV1;RIPK1;PML;GSDME;BECN1;BCL2L1;TPD52L1;TP53;TNFSF10;CYLD;TRIM39;FAS;TRAF7;LTBR;SIAH1;ING5;TNFSF12
prerank,cellular response to interferon-beta (GO:0035458),-0.3968684463270743,-1.0939057807939896,0.3485915492957746,0.8563116871500649,1.0,7/14,23.52%,UBE2K;STAT1;AIM2;IRGM;NDUFA13;IFITM2;UBE2G2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.22874757396516132,-1.093715114929582,0.16666666666666666,0.8541290399589136,1.0,28/149,10.78%,SLCO3A1;PRKCH;UBE2N;MTPN;IKBKB;CAV1;AR;FER;IRAK2;STAT3;RIPK1;RPS6KA5;PRKD1;IRAK1;NOD1;TRIM25;ERC1;NFKBIA;PSMA6;TLR4;EIF2AK2;LGALS9;EP300;DDRGK1;MAP3K13;UBB;AIM2;IKBKG
prerank,mRNA 3'-end processing (GO:0031124),0.372696969763089,1.093460881545196,0.3315677966101695,1.0,1.0,25/78,19.58%,RPRD2;SLBP;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;CPSF7;PABPC1;APP;CSTF2T;NUDT21;CPSF3;THOC7;CDC73;THOC1;GRSF1;AHCYL1;SRRM1;CPSF6;FIP1L1;MTPAP;CSTF3
prerank,response to amino acid (GO:0043200),0.4255760161577,1.0934337598702806,0.37063778580024065,1.0,1.0,8/31,14.46%,CPEB1;GRIN1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3632852485172404,1.0933460288406216,0.3255578093306288,1.0,1.0,33/151,22.16%,FSHR;PLA2G5;DDT;FGFR2;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;SLC30A10;ARRB1;PRXL2C;ABCA7;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;ICAM1;SPRY2;APOE;CCL25;PRKD2;PRKCZ;GCNT2;PTK2B;NTRK2;FGF2;MTURN;HMGB1;ERBB4
prerank,regulation of cytoplasmic translation (GO:2000765),0.48868102259931645,1.0930218821277764,0.3637640449438202,1.0,1.0,3/14,9.11%,CPEB1;CNBP;DHX36
prerank,positive regulation of myoblast differentiation (GO:0045663),0.48349813545732656,1.092967996174803,0.3744619799139168,1.0,1.0,4/16,10.88%,LRRC8A;RANBP3L;RIPOR2;IGFBP3
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5228041459935686,1.0926899241196442,0.3721286370597244,1.0,1.0,4/10,14.79%,ERRFI1;MVP;ENPP1;IMPACT
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3741099659260515,1.0923969280851298,0.3347732181425486,1.0,1.0,9/68,13.29%,WNT5A;LPL;IL33;XBP1;TIRAP;TMEM106A;TWIST1;APP;TLR3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.4855739597802865,1.0923607952223657,0.35956580732700133,1.0,1.0,3/16,13.55%,FGF10;SOX11;PTPN22
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4300822104768188,1.0923602295865549,0.353904282115869,1.0,1.0,6/25,12.16%,MVB12A;VTA1;CHMP3;VCP;LEPROT;VPS4B
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4715707898959101,1.0921122144687643,0.3855109961190168,1.0,1.0,8/17,21.42%,SCAP;ABCA2;ERLIN2;KPNB1;MBTPS1;APOE;PRKAA1;ABCG1
prerank,intracellular protein transmembrane transport (GO:0065002),0.4076937353862044,1.0920545603457177,0.35182998819362454,1.0,1.0,14/42,22.01%,DNLZ;RTN2;SEC61A2;TOMM20;PEX1;PEX5;PEX7;SEC61G;HSPD1;SEC62;TIMM44;SEC63;TIMM23;PEX2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3772639830702387,1.0919664099393482,0.3312368972746331,1.0,1.0,24/78,20.88%,UBQLN1;SIRT2;STUB1;FZR1;ZYG11B;COP1;BBS7;DVL1;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7
prerank,histone monoubiquitination (GO:0010390),0.4438952930688572,1.0916842195955954,0.35257214554579674,1.0,1.0,8/24,15.71%,PCGF1;DDB1;RNF40;RNF168;CUL4B;KDM2B;CDC73;UBE2E1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.40969103140728824,-1.091664699986529,0.35172413793103446,0.8578014096969118,1.0,3/13,7.57%,STAT3;STAT1;TYK2
prerank,calcium import into the mitochondrion (GO:0036444),-0.434864124337551,-1.0914000223280564,0.34516129032258064,0.8558899783242176,1.0,6/10,20.11%,MICU1;MCU;MCUR1;MCUB;MAIP1;SMDT1
prerank,regulation of histone methylation (GO:0031060),0.49560526159164725,1.090926640549658,0.3781869688385269,1.0,1.0,5/13,19.34%,AASS;NNMT;JARID2;NSD1;TET1
prerank,negative regulation of cell communication (GO:0010648),0.4536076050393083,1.0906566473372494,0.38491547464239273,1.0,1.0,4/21,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4154004440221146,1.090450725608299,0.36662606577344703,1.0,1.0,9/30,16.71%,DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;PARK7;ICAM1;SERPINE1;FAIM2
prerank,protein localization to chromatin (GO:0071168),-0.3610652374293523,-1.0903806160326959,0.28793774319066145,0.8563824924911484,1.0,3/18,1.11%,WAPL;TASOR;PPHLN1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3551909011233128,1.0903413253663528,0.24924924924924924,1.0,1.0,92/341,18.15%,UBQLN1;MVB12A;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;UCHL1;CDC16;RNF215;FZR1;FBXL14;TNFAIP3;OTUD7A;FBXO7;COP1;SQSTM1;ANAPC2;PSMB10;DDB1;FBXO45;RFFL;TGFB1I1;FBXW5;PSMD11;RMND5A;ARRB1;UBA1;DDIT3;TRIM9;UBE3B;RNF40;RNF168;KLHL15;RNF11;VCP;CHFR;PSME2;PSMC5;UBR3;RC3H2;ZNRF3;NTAN1;VPS4B;RNF19A;KCTD2;UBE2A;ANAPC11;USP9X;WDR91;ANAPC4;RNF19B;PCNP;ZFAND2A;CDC26;ANKIB1;RNF122;RNF217;FEM1C;CBL;PSMD1;TRPC4AP;FAF1;UBE2E1;UBE2D1;ZSWIM8;NDFIP2;CLOCK;ARIH2;NEDD8;UBE2L3;PSMD6;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;PCBP2;TBL1XR1;KLHL20;ANAPC10;RNF111
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3579439274026323,1.0903392808220356,0.3197969543147208,1.0,1.0,41/148,19.00%,HEXIM1;PDPK1;PIP4K2B;CSNK2A2;TAF9B;USP7;BRPF1;TAF4;CDK5;RBBP4;TBP;NUAK1;BARD1;STK11;CHD5;RFFL;EHMT2;MDM4;PRMT5;CDK5RAP3;USP2;TAF6;RPS15;MTA2;BRIP1;HDAC1;RMI1;ATR;EHMT1;PIP4K2A;MRE11;CHEK2;RAD50;TP53RK;DAXX;MDM2;TOP3A;RBBP8;PRKAA1;BANP;PRKAG2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.516262378436224,1.0903017909675086,0.3888888888888889,1.0,1.0,5/11,20.27%,SFRP1;CSNK1D;NKD1;MLLT3;DAB2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4007126150104093,-1.0902897192079426,0.3432343234323432,0.8538944673468214,1.0,9/13,21.77%,CAV1;RNF185;USP13;HERPUD1;RNFT1;SGTA;BAG6;NFE2L2;UBQLN2
prerank,negative regulation of cell adhesion (GO:0007162),0.3763303994719585,1.0902768845716835,0.34334763948497854,1.0,1.0,18/72,16.76%,DACT2;EPHB2;PLXNA2;FBLN1;ADAM22;DMTN;MIA3;RIPOR2;DSCAM;PLXNA1;SPOCK1;JAM3;TGFB1;TBCD;JAG1;SERPINE1;PLXNB3;ITGB1BP1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4217330054606896,1.0901849095490288,0.37185929648241206,1.0,1.0,8/28,19.43%,PSRC1;RAC1;DRG1;GIT1;MAPT;NUMA1;MECP2;RPS3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41888208439169855,1.090037967907584,0.3581730769230769,1.0,1.0,11/31,19.89%,ANK1;SCRIB;MTCL1;DLG3;RAP2A;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP;MYO9A
prerank,regulation of lipid storage (GO:0010883),0.44338798135443974,1.0899602966698403,0.37532467532467534,1.0,1.0,2/22,2.19%,LPL;NFKB1
prerank,anterograde axonal transport (GO:0008089),0.40636433151421797,1.0898690504731408,0.3635294117647059,1.0,1.0,11/37,17.51%,NEFL;KIF3A;AP3B1;KIF5C;BLOC1S2;MAPK8IP3;TRAK1;DLG2;RAB21;KIF5B;AP3B2
prerank,phospholipid transport (GO:0015914),-0.2739111472216355,-1.0898492235554165,0.24752475247524752,0.852546533219946,1.0,11/52,8.39%,ATP8B1;ATP10A;OSBPL2;PITPNA;ABCC1;ABCA4;PITPNC1;TMEM30A;SCARB1;SCP2;OSBPL5
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.33650214193614525,-1.0889379637894625,0.3232758620689655,0.852713977953084,1.0,8/22,30.79%,PDE3B;ALK;BSCL2;CCDC3;ADRA2A;CEACAM1;GPER1;ASXL3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.4939838559873374,1.0883976330187133,0.3753581661891118,1.0,1.0,4/13,15.32%,FCGR2B;EIF2AK3;USP19;NUPR1
prerank,inhibitory synapse assembly (GO:1904862),0.4995632177720145,1.0881438682747704,0.3887240356083086,1.0,1.0,2/11,9.74%,WNT5A;GABRB3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3954943214717589,1.0875833997802966,0.3563218390804598,1.0,1.0,16/46,20.88%,DUSP26;EPHB2;FBLN1;FLCN;CNKSR3;SIRPA;WNK2;LMO3;ITGB1BP1;SPRY2;TNIP1;CAMK2N1;SYNJ2BP;RANBP9;LYN;PTPRR
prerank,regulation of endopeptidase activity (GO:0052548),0.3909558380611076,1.0873526521013663,0.34170305676855894,1.0,1.0,14/59,20.46%,VTN;NRDC;SERPING1;PRELID1;SPOCK1;PSME2;HDAC1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;BIRC3;TIMP2;SERPINF1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49665842386557346,1.0871393638843154,0.38171262699564584,1.0,1.0,5/12,24.11%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49665842386557346,1.0871393638843154,0.38171262699564584,1.0,1.0,5/12,24.11%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,membrane organization (GO:0061024),0.3554503449278983,1.0870170161437303,0.3049147442326981,1.0,1.0,50/227,15.44%,WNT5A;CLN3;REEP4;DVL2;A4GALT;DNM1;AZIN2;BIN1;UBXN2A;ATP2C1;DMPK;SYNJ2;ACTR2;PICK1;ARPC1A;SAR1A;GAPVD1;TLCD1;NAPG;VAMP3;PLEKHA3;HGS;MFN2;MOSPD3;ARRB1;ATP10B;FNBP1;EGF;CHMP3;TOR1B;DNAJC6;AP2S1;TMEM43;ANK3;VPS33B;LEMD3;VPS4B;VTI1B;SYT1;SERP1;IGF2R;PRKCI;CHRM2;MTCH1;USO1;DNM1L;STX11;CBL;SPTBN1;VAPB
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.43471682702078934,-1.086321308270596,0.3392330383480826,0.8527147393498345,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.43471682702078934,-1.086321308270596,0.3392330383480826,0.8527147393498345,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.43471682702078934,-1.086321308270596,0.3392330383480826,0.8527147393498345,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,proteolysis (GO:0006508),0.3556949481742571,1.0862382997572342,0.2685370741482966,1.0,1.0,45/252,17.65%,MMP12;MMP17;XPNPEP3;CPXM1;CLN3;ATG4A;CUL7;ADAMTS7;CASP7;PCSK5;OGT;SDE2;CAPN10;PCSK2;ANPEP;THOP1;UFSP2;CAPN5;HTRA3;LAP3;ADGRV1;HM13;LRP8;PTCH1;CAPN2;PLAT;MBTPS1;ADAM33;MALT1;AFG3L2;CPXM2;CNDP2;SUFU;METAP2;ADAMTS3;CTSZ;F3;CASP2;CTSH;NEDD8;PSMD6;PARL;CAPN15;MDM2;BMP1
prerank,regulation of synapse assembly (GO:0051963),0.3942578799468939,1.0855692843517415,0.36666666666666664,1.0,1.0,15/46,19.44%,EPHB2;GPC6;MUSK;CLSTN2;APP;ROBO2;IL1RAPL1;NLGN3;GPC4;NLGN2;SLIT1;IL1RAP;SLITRK1;CLSTN3;SETD5
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5070799493454449,1.0854741789727518,0.40830945558739257,1.0,1.0,8/12,24.83%,SIRT7;TGFB1;NUP214;TPR;IFI27;KHDRBS1;UHMK1;PTPN14
prerank,positive regulation of exocytosis (GO:0045921),0.4057129008184547,1.0854709700545497,0.3619854721549637,1.0,1.0,6/35,12.16%,UNC13D;SNF8;HGS;SDCBP;RAB2B;VPS4B
prerank,regulation of Golgi organization (GO:1903358),0.46038065057727673,1.0853441330946074,0.3808255659121172,1.0,1.0,8/17,23.46%,CAMSAP2;PDE4DIP;USP6NL;MYO5A;MAP2K2;STX5;EHD3;MAP2K1
prerank,positive regulation of MAPK cascade (GO:0043410),0.35491801097951264,1.0851952469577644,0.2872872872872873,1.0,1.0,38/245,14.28%,FSHR;PLA2G5;MST1R;IGF1;IL34;DDT;EDN3;FGFR2;FGFR1;TAOK1;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;TMEM106A;EPHA8;EZH2;SLC30A10;DHX33;CD24;GPR37;ARRB1;PRXL2C;EGF;ABCA7;APP;KLHDC10;PDGFRA;ROBO1;IQGAP1;NDRG4;HTR2C;ROR2;PTPN22;LPAR1;ROCK2;TGFB1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.40830630599255063,1.0847934982158636,0.3619271445358402,1.0,1.0,8/37,13.73%,DNASE1L2;EXOSC7;ENTPD7;DFFB;PABPC4;HNRNPD;MTREX;SND1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3768727500297945,-1.084686087837038,0.37722419928825623,0.854983633736055,1.0,12/16,44.81%,RPA1;PURA;BLM;RECQL;MCM6;WRN;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,negative regulation of MAPK cascade (GO:0043409),0.3674216659626652,1.0844599034795368,0.351380042462845,1.0,1.0,29/87,21.59%,DUSP26;FOXM1;EPHB2;UCHL1;FBLN1;FLCN;CNKSR3;SIRPA;CDK5RAP3;ABCA7;WNK2;PIK3CB;PIK3R2;DAG1;LMO3;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;SORL1;SYNJ2BP;SMPD1;RANBP9;PRDM15;LYN;IGBP1;PTPRR;FOXO1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.519615940592751,1.084300698759044,0.3812316715542522,1.0,1.0,3/10,7.40%,CCT8;CCT6A;WRAP53
prerank,Rap protein signal transduction (GO:0032486),0.5115238415361575,1.0837294039951242,0.40173410404624277,1.0,1.0,3/10,9.43%,SGSM3;RAP2A;RAPGEF1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3354064380723436,-1.083692573655889,0.3020408163265306,0.855361423809171,1.0,10/22,16.11%,RAD23B;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.36951564602144227,-1.083637728486499,0.3436293436293436,0.8528643555788541,1.0,4/17,10.39%,CD46;STAT3;TLR4;MSH2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4567009748036887,1.083467678737515,0.36897001303780963,1.0,1.0,8/20,18.94%,HSP90AA1;STUB1;OGT;SDCBP;NUPR1;MLKL;FLOT1;BIRC3
prerank,regulation of response to biotic stimulus (GO:0002831),0.42213617075952437,1.0832819689458493,0.36341161928306553,1.0,1.0,6/28,8.14%,FCGR2B;TIRAP;IRF1;DHX58;XIAP;LRP8
prerank,regulation of protein localization to cell surface (GO:2000008),0.41194953530391,1.083253474772981,0.37753882915173237,1.0,1.0,8/33,11.93%,KCNAB2;GPD1L;ABCA2;EGF;ABCA7;LEPROT;SNX33;RIC3
prerank,negative regulation of histone methylation (GO:0031061),0.5319466436511846,1.0832495584869946,0.394856278366112,1.0,1.0,3/10,10.02%,AASS;PHF1;JARID2
prerank,regulation of vasculature development (GO:1901342),0.42949560439687645,1.0831676044121061,0.3561643835616438,1.0,1.0,3/26,3.79%,SFRP1;WARS1;HTATIP2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4661372392282776,1.0829098837765065,0.3796940194714882,1.0,1.0,4/15,12.08%,MAD2L1;ABL1;FBXO5;PARK7
prerank,cell differentiation in hindbrain (GO:0021533),0.5092556561705985,1.0827861165706953,0.3923076923076923,1.0,1.0,3/11,19.23%,KNDC1;FAIM2;AGTPBP1
prerank,protein import into peroxisome matrix (GO:0016558),0.50505559896529,1.0827089340672578,0.3965014577259475,1.0,1.0,6/12,22.01%,PEX1;PEX5;PEX7;PEX13;PEX5L;PEX2
prerank,positive regulation of hormone secretion (GO:0046887),0.4657961093295119,1.082163068206233,0.37945205479452054,1.0,1.0,5/17,21.27%,EDN3;SOX11;VAMP8;SNX4;VAMP7
prerank,blood vessel morphogenesis (GO:0048514),0.38918598266768706,1.0818621783846567,0.3755605381165919,1.0,1.0,8/54,10.90%,TNNI3;CUL7;STRA6;ADM;CCBE1;NRP1;EFNB2;RBPJ
prerank,regulation of lymphocyte activation (GO:0051249),-0.41412411507999564,-1.0816680239214873,0.33440514469453375,0.8561436709454741,1.0,9/12,54.29%,PAG1;KAT2A;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.460526840163302,1.0816181472430657,0.3675675675675676,1.0,1.0,4/17,8.02%,CASK;FSTL1;SULF1;XIAP
prerank,cobalamin metabolic process (GO:0009235),-0.36566956817144003,-1.0815792572884877,0.32575757575757575,0.8537336553445908,1.0,3/17,5.76%,MMAA;ABCC1;TCN2
prerank,regulation of protein secretion (GO:0050708),0.3596690080969516,1.0810825724424895,0.3473360655737705,1.0,1.0,21/119,17.24%,CACNA2D2;KCNG2;IGF1;BMP6;PICK1;ERP29;ITPR1;PRKCA;KCNC2;SNAP25;MYH10;TMED10;CYP51A1;UQCC2;TGFB1;DNM1L;RHBDF1;RFX3;CLOCK;APOE;EIPR1
prerank,steroid biosynthetic process (GO:0006694),0.3798990713005735,1.0806957243501147,0.3575418994413408,1.0,1.0,10/56,13.04%,CYP27A1;CYP7B1;LSS;INSIG1;HSD17B4;MSMO1;SC5D;PRLR;AMACR;CYP51A1
prerank,central nervous system neuron differentiation (GO:0021953),0.40987503894928023,1.0806251563238218,0.3639705882352941,1.0,1.0,12/33,23.00%,GBA2;KNDC1;CHD5;SPOCK1;MAPT;FAIM2;SOX4;AGTPBP1;MDGA2;NTRK2;RYK;MAP2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.47095856762949395,1.0806198954443873,0.39173789173789175,1.0,1.0,3/15,3.87%,WHAMM;ACTR2;ARPC1A
prerank,lipid transport (GO:0006869),-0.23922454139173532,-1.080567341624069,0.25,0.8542949948340604,1.0,17/97,9.64%,SLCO3A1;ABCC4;ATP8B1;OSBPL2;PITPNA;SLC25A17;CERT1;LBP;SLCO1C1;ABCA4;PITPNC1;SLCO2A1;SCARB1;GOT2;SCP2;OSBPL5;PPARD
prerank,epithelial structure maintenance (GO:0010669),-0.4112981356962588,-1.0802289725847771,0.375,0.8528345316328836,1.0,2/11,17.38%,RBP4;STRAP
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3634692249200626,1.0799063654505938,0.3506224066390041,1.0,1.0,19/107,11.57%,UBQLN1;BAX;SELENOS;EIF2AK3;SYVN1;ERLEC1;ATP2A2;ITPR1;PIK3R1;SEC16A;BRSK2;RCN3;DDIT3;CDK5RAP3;VCP;MBTPS1;PIK3R2;BCL2;USP19
prerank,positive regulation of response to wounding (GO:1903036),0.43305561993355035,1.0798804211650743,0.3791348600508906,1.0,1.0,3/24,6.44%,VTN;ANXA1;DMTN
prerank,sodium ion transport (GO:0006814),0.3727665049982372,1.0796222186417486,0.3505263157894737,1.0,1.0,15/85,16.34%,SLC4A4;ASIC1;NALCN;SLC6A11;SCN7A;CATSPER3;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC6A13
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4124618317831222,-1.0795387036391704,0.3783783783783784,0.8522158900707524,1.0,4/12,13.24%,MTPN;CFL2;PLEK;PIK3CA
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.42145170262424336,1.0793299987781895,0.4015151515151515,1.0,1.0,6/26,16.13%,PSRC1;RAC1;DRG1;KATNB1;MAPT;NUMA1
prerank,regulation of striated muscle contraction (GO:0006942),0.4251956137477983,1.0790590575564167,0.3862238622386224,1.0,1.0,8/27,21.79%,TNNI1;CALM3;ATP1A2;GRK2;ASB3;CALM1;SMAD7;CALM2
prerank,glycerophospholipid catabolic process (GO:0046475),0.42165202947060637,1.0790308478239052,0.3930778739184178,1.0,1.0,8/27,20.14%,PLA2G5;PRDX6;GDPD3;ENPP2;SMPD4;GDE1;PLA2G7;ABHD16A
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4107889152766107,-1.079027625191634,0.36977491961414793,0.8513785289584347,1.0,6/11,41.68%,MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,N-terminal protein amino acid modification (GO:0031365),0.47376335490071475,1.0789781495653459,0.4002808988764045,1.0,1.0,4/14,13.29%,METAP1;NTMT1;METAP1D;METAP2
prerank,regulation of phagocytosis (GO:0050764),0.3901616782301167,1.0787345406121271,0.3724137931034483,1.0,1.0,9/53,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;RACK1;IL15RA;CAMK1D
prerank,regulated exocytosis (GO:0045055),0.3565363934171272,1.078047152537203,0.33768844221105526,1.0,1.0,42/173,21.80%,MAGED2;SYT3;CLEC3B;SYT10;IGF1;APOOL;CHID1;CD63;SERPING1;CDK5;SPARC;DNAJC5;CPLX1;EGF;RAB10;APLP2;SNAP25;APP;BRPF3;VTI1B;SYT1;TMED10;NHLRC2;GTPBP2;PSAP;TGFB1;RAB31;STEAP2;F8;SERPINE1;PHACTR2;CALM1;QSOX1;PROS1;SYT4;LYN;VAMP7;SYT11;SYT12;CD9;SDF4;MYH9
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.42720969980260054,1.0779560605892182,0.36803874092009686,1.0,1.0,7/27,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.43330356713061846,1.0775529887090762,0.3972939729397294,1.0,1.0,6/26,21.07%,IGF1;CHERP;STIMATE;CAMTA1;PTBP1;ATP2B4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.37039091592922596,1.077533375002074,0.3728448275862069,1.0,1.0,14/70,11.02%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.39505509767694424,1.0775081052153304,0.372502937720329,1.0,1.0,10/44,16.81%,CDKN2D;DDX3X;CARD16;USP47;XIAP;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,dopamine metabolic process (GO:0042417),-0.3610331486098152,-1.0767129581868746,0.3281853281853282,0.8557875414462298,1.0,6/18,27.02%,MAOA;TGFB2;MAOB;GCH1;PRKN;DRD2
prerank,mRNA transport (GO:0051028),0.3632273285124285,1.076689047569287,0.341995841995842,1.0,1.0,37/101,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;FMR1;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3025129359772284,-1.0764123093216174,0.34408602150537637,0.8540366585471224,1.0,16/33,24.89%,LATS1;AR;KDM4C;UBA5;CALR;RNF6;EP300;DDRGK1;AXIN1;ESR1;UFL1;KCTD6;KLK2;UFM1;NCOA2;HDAC6
prerank,actin crosslink formation (GO:0051764),0.48958820324245594,1.0764006502590673,0.38264580369843526,1.0,1.0,3/12,9.08%,LCP1;GAS2L1;BAIAP2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.43180233122347783,1.0763900137495195,0.38268506900878296,1.0,1.0,9/24,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;LYN;NBL1;CXCL17;HMGB1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3878513725388931,1.076352270993753,0.3728813559322034,1.0,1.0,15/55,19.84%,LYVE1;GLB1;GPC6;DCN;GPC1;HGSNAT;GPC4;OMD;TGFB1;ARSB;LUM;HSPG2;CEMIP;GPC5;GUSB
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.385151528347194,-1.076253566270104,0.33557046979865773,0.8519443000623224,1.0,10/15,35.26%,SAMHD1;STAT2;METTL3;CNOT7;USP18;NLRC5;ISG15;PTPN2;CACTIN;MUL1
prerank,positive regulation of immune system process (GO:0002684),0.45987904619080766,1.0759554237544708,0.37516869095816463,1.0,1.0,3/16,10.63%,ANXA1;MIA3;PIK3CB
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4089906195325847,1.0758732618556748,0.36623067776456597,1.0,1.0,7/37,16.06%,AMIGO1;TENM3;IGSF21;IL1RAPL1;ALCAM;TENM4;ICAM1
prerank,copper ion transport (GO:0006825),0.49760210665774823,1.0758700406149737,0.38088012139605465,1.0,1.0,6/11,23.36%,COX17;STEAP2;SLC11A2;ATOX1;STEAP3;SLC31A1
prerank,nervous system development (GO:0007399),0.3481657419651069,1.0758686818389578,0.244,1.0,1.0,77/429,16.97%,PCDHA2;DPYSL4;PCDHA11;SH3GL3;MST1R;APLP1;EPHB2;CHERP;NTF3;ZEB2;GBA2;GLIS2;NINJ2;FZD9;SDHA;OBSL1;RAPGEFL1;NELL1;CDK5;IGF2BP2;DHX30;ATXN1;ALDH1A2;HAPLN4;ADAM22;EFNB3;DVL1;ZIC3;CXCR4;KALRN;TEAD1;DSCAM;ADGRV1;SPOCK1;DPF2;VLDLR;HDAC4;DBNL;NDUFS2;JARID2;GDNF;POU6F2;COX7B;GFRA2;RBFOX2;ROBO2;ROBO1;FGF12;MOBP;SOX6;NLGN3;SPOCK2;RPS6KA3;FEZ2;CYP51A1;RBM45;FARP1;CHRM2;LSAMP;LPAR1;NRG1;ZIC2;TGFB1;NLGN2;PPP2R5D;NR2C2;ACVR1B;KCNQ2;TRAK1;AHI1;BTBD3;ITM2B;ADGRA2;TMOD2;JAG1;ALDH3A2;MSI1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4796853830060045,1.0758597855228145,0.3939828080229226,1.0,1.0,2/14,7.27%,IGF1;CD200R1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.450091945130456,1.0751761991969773,0.3894039735099338,1.0,1.0,8/19,21.47%,CEP97;DRG1;CHMP3;VPS4B;EML3;HNRNPU;TPR;CHMP4B
prerank,lymphocyte differentiation (GO:0030098),-0.2554738204497031,-1.0747413901587706,0.3392857142857143,0.8541395855864313,1.0,16/68,15.12%,AXL;TOX;KAT7;KIT;KLF6;DCAF1;GPR89B;GPR89A;PLCG2;MSH2;PTPRC;LMBR1L;NHEJ1;TPD52;PTPRJ;ITGA4
prerank,Golgi to plasma membrane transport (GO:0006893),-0.28153430933850465,-1.0745576959905327,0.27350427350427353,0.8521151649419874,1.0,14/47,13.27%,EXOC6B;EXOC1;PREPL;VPS35L;GOPC;KIF13A;BLZF1;OSBPL5;ARL3;VAMP2;GCC2;BBS2;GOLGA7;EXOC2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.44181820945716466,1.0745355830292467,0.3826086956521739,1.0,1.0,6/22,13.93%,NTF3;TMEM108;RAPGEF1;MAGI2;WASF1;MAPT
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5087948690792247,1.0742569929129233,0.39322533136966126,1.0,1.0,4/10,24.79%,ZBTB7B;CBFB;HMGB1;RUNX1
prerank,chloride transport (GO:0006821),-0.2440004463879832,-1.0741556681740076,0.3142857142857143,0.8508399476751721,1.0,27/74,23.88%,ANO4;GABRB1;SLC12A7;SLC4A10;SLC26A7;GABRG2;CLCN3;CLCN6;ANO6;ANO1;GABRA5;SLC12A4;CLIC5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;TTYH3;GABRA1;GLRA3;TTYH1;FXYD1;SLC12A8
prerank,lipid oxidation (GO:0034440),-0.4122292992467829,-1.0739987887997233,0.37142857142857144,0.8486880345251524,1.0,3/12,22.13%,ADIPOR1;ADIPOR2;PPARGC1A
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.49701780338707574,1.0738568353001405,0.3854014598540146,1.0,1.0,4/12,9.91%,CLCN2;ABCA2;KPNB1;MBTPS1
prerank,positive regulation of DNA binding (GO:0043388),0.4143729190490697,1.0737802186851753,0.3906633906633907,1.0,1.0,7/31,14.28%,IGF1;SIRT2;EGF;TWIST1;PARK7;CEBPG;TGFB1
prerank,ubiquinone biosynthetic process (GO:0006744),0.4711545427080166,1.0733691673673043,0.38283378746594005,1.0,1.0,2/15,2.22%,COQ6;COQ8B
prerank,vasculogenesis (GO:0001570),0.41767109306250144,1.0733104995149412,0.3946406820950061,1.0,1.0,3/32,2.42%,TNNI3;CUL7;ADM
prerank,zinc ion transport (GO:0006829),0.4411546299603691,1.0731513374673123,0.38350785340314136,1.0,1.0,7/21,16.89%,SLC30A10;SLC39A1;SLC30A9;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30907321738792537,-1.0730373030024702,0.3507853403141361,0.8490385329464355,1.0,17/30,23.49%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;STYX;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;UBXN1;NOP53;SVIP
prerank,negative regulation of gene expression (GO:0010629),0.3498472101840185,1.073034205060137,0.308,1.0,1.0,74/302,19.89%,SFRP2;APLN;ILF3;FCGR2B;LSM6;SFRP1;PTGER4;IGF1;PAIP2;ANXA7;NFKB1;AEBP2;EIF2AK3;CREBZF;ERP29;DDX3X;CNOT10;IGF2BP2;RBBP4;FLCN;OLFM1;PHF1;CELF1;EZH2;SFMBT2;WNT4;ATP2B1;EPRS1;RBMS3;DHX36;SOX11;LGR4;NUDT12;PUS7;JARID2;RBL2;APP;ROBO1;EIF4E2;CNOT9;YY1;MALSU1;PARK7;HDAC1;AGO3;RACK1;NPTN;PARP14;DAPK1;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2;MRPL13;DIS3L2;SHQ1;NDFIP2;NUDT16L1;FMR1;TIPARP;APOE;TLE5;PPP1R11;MECP2;MPHOSPH8;NCOR2;PRKAA1;TRIM27;SAMD4B;YTHDF2;RPS3;KLF4;DNMT3A
prerank,regulation of interleukin-4 production (GO:0032673),-0.33008646800175345,-1.0729236437296183,0.34977578475336324,0.8468272789451476,1.0,9/21,32.79%,LEF1;LGALS9;RARA;CEBPB;CD86;SYK;ZFPM1;HAVCR2;FCER1G
prerank,regulation of cell motility (GO:2000145),0.36211706502320073,1.072652344994916,0.36344969199178645,1.0,1.0,21/121,14.28%,FGF20;FGF9;RAC1;PLXNA2;MGAT3;FBLN1;MINK1;FGF10;ABL1;PLXNA1;EGF;TWIST1;PRAG1;SRCIN1;ENPP2;CFAP20;SPOCK2;NRG2;NRG1;ROCK2;TGFB1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.36540706452367017,-1.072496224506892,0.3236363636363636,0.8456603151940102,1.0,5/16,16.22%,SMAD4;BCOR;PAXIP1;WDR5;DNMT1
prerank,response to ATP (GO:0033198),-0.35605543921110716,-1.0723381629094046,0.373015873015873,0.8435975045705734,1.0,6/18,19.02%,HSP90B1;TRPC3;ABCC9;P2RX7;P2RY12;DGKQ
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3883685038330908,1.0721767286513681,0.3777267508610792,1.0,1.0,14/52,18.18%,CLN3;EPHB2;PDPK1;ATP2C1;PIK3R1;SQSTM1;CLIP3;RACK1;PRKCI;LRP1;DPP10;SPTBN1;KIF5B;ZDHHC2
prerank,response to UV-B (GO:0010224),0.4918044232198121,1.0721480100852934,0.4065155807365439,1.0,1.0,2/12,6.84%,MFAP4;STK11
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3608546356987824,1.0720190875262379,0.3569937369519833,1.0,1.0,18/107,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;CXCL12;ATP2A2;SLC30A10;SLC30A9;ATP2B1;SLC24A4;SLC30A1;PTH1R;SLC39A6;HTR2C;NPTN;SLC41A1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.41133267587465533,-1.0717059805797549,0.36253776435045315,0.843023578980394,1.0,7/12,30.59%,INPP5K;REST;JUN;PSMC3;HMGA2;TARDBP;TFAP4
prerank,tetrapyrrole metabolic process (GO:0033013),-0.35525155424574506,-1.0714300837368627,0.3359073359073359,0.8414565864596353,1.0,3/18,5.76%,MMAA;ABCC1;TCN2
prerank,import into nucleus (GO:0051170),0.3703380089502045,1.071280710150598,0.38338658146964855,1.0,1.0,22/73,21.10%,MMP12;TSC2;SMN1;NXT2;NXT1;GEMIN2;HTATIP2;KPNB1;NUP188;BACH2;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;PPP1R10;GEMIN5;HEATR3;TPR;APPL2
prerank,regulation of establishment of cell polarity (GO:2000114),0.4566512809782921,1.071106902333405,0.39183673469387753,1.0,1.0,11/16,26.59%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;GSN;RAP1B;SHTN1;ARFGEF1
prerank,regulation of tissue remodeling (GO:0034103),0.44955637393477893,1.0710808281316797,0.39866666666666667,1.0,1.0,7/18,24.79%,DDR2;SUCO;LEPR;TGFB1;IL18;SYT7;RUNX1
prerank,RNA splicing (GO:0008380),0.3631272703498809,1.0710145392751842,0.3747346072186836,1.0,1.0,27/95,19.19%,KHSRP;LSM6;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;DHX15;USB1;SF3B2;SF3B1;DHX8;FUS;MPHOSPH10;PRPF6;PPP1R9B;DHX16;HNRNPH3;TRA2B;NOVA1;RP9;SRRM1;LUC7L3;SRPK1;NONO;BCAS2;RSRC1
prerank,phagosome acidification (GO:0090383),0.4273746805976937,1.070839532015217,0.38316582914572866,1.0,1.0,9/26,22.02%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;RAB7A;ATP6V1C1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.477506097880426,1.070549778031496,0.3922413793103448,1.0,1.0,5/13,18.76%,NOP9;RPS15;NPM1;NUP88;ABCE1
prerank,positive regulation of synaptic transmission (GO:0050806),0.36760147968440654,1.0705161601781963,0.3927038626609442,1.0,1.0,21/72,20.58%,MPP2;EPHB2;CACNG3;SQSTM1;ZDHHC3;GRIN2A;NMU;CLSTN2;APP;NLGN3;SYT1;NPTN;NLGN2;ADCY1;CACNG4;FMR1;ZDHHC2;CLSTN3;FLOT1;PRKCZ;PTK2B
prerank,phagosome maturation (GO:0090382),0.4099674304165161,1.0703749370793265,0.3785377358490566,1.0,1.0,13/35,22.41%,ATP6V0A2;RAB34;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;RAB31;ATP6V1B2;RAB7A;ATP6V1C1;PIKFYVE;RAB43
prerank,sensory perception (GO:0007600),0.39057399322968966,1.0701723477667164,0.38552787663107946,1.0,1.0,6/45,9.25%,TMEM150C;OPRK1;PCDH15;ADGRV1;GNAS;TTC8
prerank,maturation of SSU-rRNA (GO:0030490),-0.294642956492643,-1.0700858343063495,0.33136094674556216,0.8429780934217043,1.0,17/34,24.91%,RIOK3;RIOK2;NOL11;RPS19;RPS16;RPS28;HEATR1;NAT10;NOB1;NGDN;NOP14;WDR3;RRP36;SNU13;RPS14;TSR2;UTP3
prerank,inorganic cation transmembrane transport (GO:0098662),0.3477219694133944,1.0700322683018884,0.3113113113113113,1.0,1.0,44/268,16.34%,KCNG2;SLC4A4;KCNAB2;KCNA4;KCNC1;ASIC1;NALCN;SLC24A5;ATP2C1;ATP1A3;SLC6A11;ATP2A2;KCNK2;SCN7A;SLC30A10;ATP6V0E2;ATP1A2;KCNC2;SLC39A1;KCNJ10;SLC24A4;TRPM3;SCN2B;KCNQ4;SLC30A1;SCN1A;SLC6A8;SLC39A6;KCND3;ATP6V0A4;KCNH5;SLC6A4;SLC1A3;KCNA1;SLC41A1;SLC6A15;SLC30A3;ABCB7;TRPC4AP;SLC6A12;KCNQ2;SLC9A7;SLC9A6;SLC6A13
prerank,ion homeostasis (GO:0050801),0.4148379224569573,1.0700254227257462,0.3857493857493858,1.0,1.0,2/30,0.31%,SLC4A4;SLC4A5
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3541264403202922,1.0698989887030674,0.3633603238866397,1.0,1.0,59/173,22.69%,SPTBN5;WHAMM;KDELR3;TRAPPC8;SAR1A;ANK1;TEX261;KLHL12;SEC16A;MIA3;TRIP11;SEC16B;PEF1;ERGIC2;DCTN6;LMAN2L;COPZ2;NRBP2;TBC1D20;SCFD1;CAPZA1;PGAP1;DCTN4;TFG;ANK3;DYNC1LI1;GRIA1;VTI1B;TMED10;COG3;NRBP1;TRAPPC6B;USO1;CTSZ;MCFD2;SPTBN1;VAPB;STX17;VTI1A;F8;COG8;NSF;GORASP1;SEC24D;CNIH1;STX5;PROS1;DYNLL1;ZW10;BCAP29;PDCD6;SPTBN4;ATL3;VAMP7;NAPA;ARFGAP3;ACTR10;COPG1;GOSR1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.39464153615533387,1.069465336416569,0.37902264600715135,1.0,1.0,10/37,15.32%,BAX;FIS1;FBH1;DDIT3;BCL2;NACC2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,organophosphate biosynthetic process (GO:0090407),0.40343284362210097,1.0691966098433086,0.39669421487603307,1.0,1.0,15/37,23.07%,MOCS2;PCYT2;AGPAT5;TKT;AGPAT3;GPAM;FADS1;IPPK;IPMK;IP6K1;PIP5K1A;MOCS1;FGF2;TPI1;GNPAT
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44914788031064945,1.0690874892712643,0.40131578947368424,1.0,1.0,5/20,15.44%,FASN;FAR2;HSD17B4;FAR1;SLC25A1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3854238011950958,-1.068909129876425,0.3723404255319149,0.8440429976920716,1.0,5/14,16.22%,SMAD4;KMT2E;PAXIP1;WDR5;DNMT1
prerank,protein oxidation (GO:0018158),-0.4117060313583435,-1.0688832429287973,0.371875,0.84162885335738,1.0,5/11,31.00%,SUMF1;LOX;PRDX3;CHCHD4;TMX3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.36747761465623807,1.0686986696403342,0.3883495145631068,1.0,1.0,14/71,11.02%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,aminoglycan catabolic process (GO:0006026),0.42110359397274455,1.068579378690841,0.3869346733668342,1.0,1.0,8/28,19.84%,GLB1;GPC6;GPC1;HGSNAT;GPC4;HSPG2;GPC5;GUSB
prerank,histone H3-K9 demethylation (GO:0033169),0.48892319336688406,1.0683232590291556,0.3913690476190476,1.0,1.0,2/11,2.24%,KDM4D;KDM7A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5023537511692888,1.068181827829,0.3850746268656716,1.0,1.0,5/10,19.44%,DIP2B;FLCN;PARK7;PRKAA1;SETD5
prerank,presynaptic endocytosis (GO:0140238),0.43063365586615543,1.068017956763917,0.39848675914249687,1.0,1.0,5/24,14.38%,SYNJ2;CDK5;NLGN3;SYT1;NLGN2
prerank,histone H3 acetylation (GO:0043966),-0.28626183391895493,-1.0679465985072445,0.32413793103448274,0.8420507095030191,1.0,18/40,23.87%,LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;JADE1;JADE3;WDR5;TAF5L;KAT6B;DR1;BRCA2;ING5;NAA60;TRIM16;SUPT7L;TAF6L
prerank,establishment of apical/basal cell polarity (GO:0035089),0.47842573598986604,1.0678734885992345,0.39511494252873564,1.0,1.0,3/14,8.79%,SCRIB;RAP2A;PATJ
prerank,protein ubiquitination (GO:0016567),0.3475294627567904,1.067738693367406,0.282,1.0,1.0,138/471,22.23%,ARRDC4;RNF157;CUL7;CDC23;PSMD4;SELENOS;RNF138;FBXW10;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;FBXL12;SYVN1;USP7;CDC16;LZTR1;TRIM11;BRAP;FBXL14;PDZRN3;SDE2;FBXO7;FBH1;KLHL12;THOP1;FBXO31;PSMB10;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;PSMD11;MYCBP2;RMND5A;NFX1;ARRB1;TRIM62;UBA1;UBE3B;RNF40;RNF168;RNF103-CHMP3;UBE2V2;TRIM41;TRIM17;CUL4B;RNF11;VCP;CHFR;UBE2Z;PSME2;PSMC5;UBR3;BCL2;PEX5;RC3H2;ZNRF3;RNF152;RNF19A;RACK1;UBE2A;ANAPC11;USP9X;CBFB;UBE2J1;CDC73;CUL5;RNF19B;PCNP;RNF220;PEX13;ATG3;RNF41;ANKIB1;RNF122;RNF217;CBL;PSMD1;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;TNKS;NEDD8;UBE2L3;UBR5;PSMD6;EIPR1;FBXO22;SMURF1;TOPORS;MDM2;FBXO9;KLHL20;RNF111;HLTF;USP22;TRIM27;ZNRF2;RNF167;PELI2;VCPIP1;RNF38;PSMD5;DTX2;FANCL;RAD18;KLHL9;FBXO28;PSMA4;TRIP12;HECW2;CNOT4;COMMD1;PSMA1;TRIM26;PSMC6;UBE2V1;PEX2;TRAF2;CUL9;TAF1;PJA2
prerank,receptor catabolic process (GO:0032801),0.4266005623096165,1.067633087969026,0.3694029850746269,1.0,1.0,12/24,24.73%,MVB12A;VLDLR;AP2S1;ZNRF3;TGFB1;SMURF1;GPRASP1;PIK3R4;UVRAG;SH3GLB1;MYLIP;RNF43
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.431682765070324,1.067519555049336,0.3879641485275288,1.0,1.0,4/23,13.29%,GUCA1B;METAP1;NMT1;METAP2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4905758662033989,1.0674976870659685,0.4014388489208633,1.0,1.0,4/13,11.93%,GPD1L;ABCA7;SNX33;RIC3
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.36072967045364923,-1.067312442423697,0.3391304347826087,0.8416549523393408,1.0,5/18,11.28%,OGA;SAMHD1;DERA;FUCA1;BPGM
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.42207802008334194,1.0671467721927363,0.38860103626943004,1.0,1.0,6/24,12.69%,SELENOS;SYVN1;XBP1;PARK7;CREB3;RACK1
prerank,positive regulation of cell population proliferation (GO:0008284),0.34454024542736633,1.0668371330653503,0.272,1.0,1.0,62/423,14.28%,FGF20;SFRP2;FGF9;S1PR2;WNT5A;TMEM119;SFRP1;MST1R;IGF1;IL34;FOXM1;EAPP;TBRG4;BMP6;NTF3;EDN3;TSPAN31;FGFR2;FGFR1;PTHLH;XBP1;SLC25A33;FZD9;CDC123;FGF10;IL31RA;CDK13;LAMC1;DDR2;TCF7L2;CNBP;FBXO5;EZH2;PID1;SOX9;SDCBP;EFNB2;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;COX17;RBPJ;BCL2;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;CD47;NPM1;HDAC1;UBE2A;PRMT1;LAMB1;PRKCI;EMP2;FAM98A;NRG1;TGFB1
prerank,cAMP biosynthetic process (GO:0006171),0.507177750180705,1.0665372378617224,0.4011887072808321,1.0,1.0,3/10,16.59%,ADCY7;ADCY1;ADCY5
prerank,response to hydroxyurea (GO:0072710),-0.4128826315627805,-1.0661409660534096,0.3722397476340694,0.8427772476152996,1.0,5/11,16.92%,KAT7;SPIDR;DDI2;RTF2;BLM
prerank,protein transport (GO:0015031),0.34602398205326695,1.0660553087719256,0.3003003003003003,1.0,1.0,85/332,18.52%,ARRDC4;IL10RA;ARL4C;ATP6V0A2;SGSM3;PICK1;ERP29;KIF3A;SAR1A;RUNDC1;RAB24;DNAJC27;RAB34;TBC1D13;NAPG;STX6;TVP23B;SNX6;MIA3;VPS26B;ATP6V0E2;STX16;RAB12;RCN3;STX2;LMAN2L;RAB5B;YWHAH;VLDLR;CHMP3;RAB10;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;RAB3B;ATP6V1G1;USP6NL;ANK3;TCIRG1;AP3B1;EVI5L;SNX33;VPS33B;TLK1;TANGO2;MON1A;NPM1;ATP6V0A4;TMED10;RAB13;SCAMP5;LRP1;RABGAP1;ATP6V1D;VMP1;USO1;SCAMP1;AP4M1;STX11;RAB31;SPTBN1;STX8;STX17;RAB8A;RAB8B;GGA2;TXNIP;ATP6V1B2;RUFY1;NSF;SYNRG;RAB21;APOE;MTTP;TBC1D9B;SNX4;TBC1D22B;ZDHHC17;LRP1B;NECAB3;RAB6A;SGSM2;TOM1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.32435275394433327,-1.0659505189630785,0.3094170403587444,0.838515686318392,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.32435275394433327,-1.0659505189630785,0.3094170403587444,0.838515686318392,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4750162036148224,1.065757445092823,0.4143884892086331,1.0,1.0,5/13,16.67%,PLXNA2;NRP1;PLXNA1;SEMA3A;PLXNB3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4073701151458669,1.065605432266987,0.40190249702734837,1.0,1.0,3/33,5.06%,IL34;ZFP36L1;PRKCA
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3565400990436103,1.0655879631841456,0.38095238095238093,1.0,1.0,16/121,10.25%,VTN;IGF1;IL34;BMP6;NTF3;NRP1;FGF10;IL31RA;DLG3;ABL1;LRP8;PIBF1;GPRC5B;TEC;SRCIN1;ENPP2
prerank,establishment of protein localization to membrane (GO:0090150),-0.2548245220248288,-1.065494694070563,0.3424657534246575,0.8375186260962646,1.0,15/66,15.43%,PARD3;EGFR;SYNE3;TAOK2;REEP1;ZDHHC20;NACA;RAB3IP;VPS37B;ZDHHC15;BRAF;NECTIN3;GOLGA7;VPS37C;FRMPD1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4276194744426104,1.0653959861120954,0.40074906367041196,1.0,1.0,3/25,5.76%,BAX;PPIF;FAM162A
prerank,chromatin organization (GO:0006325),0.35748301830568807,1.0647705443081172,0.3826530612244898,1.0,1.0,35/132,17.50%,HDAC3;KDM4D;MPND;SMARCD3;FAM50A;SMARCC2;GATAD1;SNAI1;RBBP4;PHF1;SETD7;EZH2;SMARCB1;HDAC5;SOX9;SMARCD1;HDAC4;JARID2;TOP1;SUV39H1;SMARCA1;MTA2;NPM1;HDAC1;EHMT1;ATRX;BAZ2B;CHD1;NUCKS1;SATB1;TCF7L1;KDM6B;DAXX;HP1BP3;PWWP3A
prerank,regulation of neuron migration (GO:2001222),0.42164207852004715,1.0647523117665219,0.3979974968710889,1.0,1.0,7/26,18.76%,CAMK2B;NIPBL;SRGAP2;NTNG2;ADGRG1;SEMA3A;KIF20B
prerank,focal adhesion assembly (GO:0048041),-0.33838980590792606,-1.0647202203097887,0.3487394957983193,0.8373835000339814,1.0,7/21,5.56%,SORBS1;FERMT2;PTPRK;TAOK2;CTTN;TESK2;ACTN1
prerank,cell-cell junction assembly (GO:0007043),0.3687409800090642,1.0645995443990182,0.3864628820960699,1.0,1.0,18/63,17.22%,GJB2;CTNND2;PRKCA;CLDN11;FLCN;JAM3;PATJ;CDH11;GJB6;CLDN12;JUP;TLN2;CDH18;EPB41L3;TBCD;CDH20;CDH19;CDH7
prerank,alcohol catabolic process (GO:0046164),0.5089495083439093,1.0645837889676513,0.40795287187039764,1.0,1.0,1/10,1.82%,CYP27A1
prerank,covalent chromatin modification (GO:0016569),0.4746233147062248,1.0645787565037417,0.39589442815249265,1.0,1.0,6/14,19.44%,SIRT7;PARP2;PARK7;HDAC1;CHD1;SETD5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.42263117946583806,1.0643615999912115,0.3793532338308458,1.0,1.0,8/27,17.10%,NHP2;TOE1;RNASE1;LACTB2;CPSF3;RPP30;XRN1;ZC3H12C
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4212412583714902,1.0640182290675129,0.4184852374839538,1.0,1.0,5/25,10.71%,RAC1;ABCA2;LRPAP1;SDCBP;APP
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3992880975905081,-1.0637048707776426,0.35555555555555557,0.8381555076536795,1.0,4/12,10.73%,ELF1;ELF2;RC3H1;PTPRC
prerank,bile acid metabolic process (GO:0008206),0.4163735239188504,1.0636683175148187,0.3923076923076923,1.0,1.0,5/27,11.00%,CYP27A1;GBA2;CYP7B1;HSD17B4;AMACR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.37283146759607844,1.0632824775406442,0.3911637931034483,1.0,1.0,20/66,22.07%,SFRP2;SFRP1;NR2F2;FGFR2;CASK;SULF1;MAGED1;SPARC;SOX9;ROBO1;CDC73;TGFB1;NUPR1;APOE;SYNJ2BP;KRIT1;MTSS1;TGFBR3;PEX2;B2M
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.44885476745590197,1.0627929078447964,0.3781624500665779,1.0,1.0,7/18,18.02%,CRTC1;LRP8;CRTC3;ADCY1;CAMK1D;EPHA5;PRKD2
prerank,regulation of coagulation (GO:0050818),0.4992078236777988,1.062277354971247,0.38108882521489973,1.0,1.0,1/11,1.72%,EPHB2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.34784391647161444,1.062220902249691,0.36244979919678716,1.0,1.0,51/214,22.16%,FSHR;PLA2G5;DUSP26;DDT;EPHA7;EPHB2;FGFR2;GLIPR2;FBLN1;NRP1;FGF10;TIRAP;PRKCA;FLCN;SLC30A10;CNKSR3;SIRPA;ARRB1;PRXL2C;ABCA7;WNK2;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;LMO3;ICAM1;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;ZDHHC17;CCL25;PRKD2;SYNJ2BP;RANBP9;PRKCZ;GCNT2;LYN;PTK2B;TGFBR3;NTRK2;PTPRR;FGF2;MTURN;HMGB1;ERBB4
prerank,cell cycle checkpoint signaling (GO:0000075),0.49820045011443026,1.0621894958738205,0.3922413793103448,1.0,1.0,5/12,19.74%,WEE1;CHFR;ZWINT;NABP2;ZW10
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.40949309029545233,1.0620988130984006,0.400990099009901,1.0,1.0,8/31,10.18%,CAMK2B;TANC2;CDK5;DBN1;LRP8;DHX36;DBNL;SRCIN1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3529215582890776,1.0619737445531425,0.3766632548618219,1.0,1.0,42/124,23.00%,IQCG;STMN4;RAC1;GPRIN1;CDK5;EPHA8;TMEM108;TTC17;CYFIP1;PPP1R9B;GDNF;APP;TPM1;LRP12;BLOC1S2;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;ARMC2;APOE;MAP4;PKD2;ATCAY;ODF2;PLEKHA1;KIFAP3;CARMIL1;ATXN10;LIMA1;LYN;ATP1B2;EHD1;RYK;HMGB1;CAMSAP1;FAM161A;MAP2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.41770732615627787,1.0616881269784633,0.41374837872892345,1.0,1.0,4/27,11.29%,WNT5A;IGF1;DDR2;PDGFRA
prerank,positive regulation of stress fiber assembly (GO:0051496),0.38852755568090247,1.061614924083572,0.39977349943374857,1.0,1.0,20/44,22.50%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.30115018193559767,-1.060999891326764,0.36423841059602646,0.8436702711567574,1.0,13/35,22.06%,MEF2C;FLT1;CAV1;PTPRM;STAT1;THBS1;AIMP1;CAV2;SCG2;RGCC;NF1;ATOH8;PPARG
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3681154431029683,1.0607247988517208,0.37697993664202745,1.0,1.0,29/76,24.35%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;CDK5RAP3;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;SMURF1;MDM2;PIAS1;SUMO2;DAB2;SMAD7;TAF1;KEAP1;PTEN;FBXW7;TRIB2
prerank,regulation of monocyte differentiation (GO:0045655),0.47249958860026636,1.0606390308981737,0.4064245810055866,1.0,1.0,2/14,4.02%,IL34;ZFP36L1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3854133714110533,1.060429436660119,0.39707536557930256,1.0,1.0,8/48,6.44%,CUL7;RAC1;CDKL5;OBSL1;NRP1;ABL1;ARHGEF7;DMTN
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4187279030581574,1.0601421680895329,0.39622641509433965,1.0,1.0,4/28,9.15%,DLK1;TCIM;ARRB1;EGF
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5094762389486105,1.0599325302787548,0.4239290989660266,1.0,1.0,3/10,10.95%,GPLD1;IRS2;PTH1R
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3642936065738086,1.0595496589267295,0.39762931034482757,1.0,1.0,14/73,11.02%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5202377208989382,1.0594781113835534,0.42572741194486985,1.0,1.0,3/10,7.29%,MIA3;CD200R1;RIPOR2
prerank,regulation of neuron differentiation (GO:0045664),0.36682583664049995,1.0594713763869175,0.4042780748663102,1.0,1.0,14/76,10.08%,BIN1;NTF3;FGFR1;TCF4;CASZ1;ZEB1;BRINP3;MMD;GPRC5B;ZFHX2;YWHAH;CDK5RAP3;SOX11;YWHAG
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4271819575704613,-1.059163699614721,0.38387096774193546,0.8466807511233959,1.0,4/10,6.32%,DROSHA;TSN;AGO2;TSNAX
prerank,protein import into nucleus (GO:0006606),0.3681327141309256,1.05887433257533,0.3846994535519126,1.0,1.0,22/66,21.25%,MMP12;TSC2;NXT2;NXT1;KPNA3;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;RANBP2;KPNA1;NUP35;PPP1R10;HEATR3;TPR;APPL2;CBLB
prerank,glial cell development (GO:0021782),0.422747162819281,1.058706499564469,0.4083438685208597,1.0,1.0,7/25,19.15%,MYRF;PICK1;SOX11;APP;TPPP;MXRA8;SOX4
prerank,negative regulation of nervous system development (GO:0051961),0.4491598039243678,1.0585930033187145,0.4197860962566845,1.0,1.0,6/17,22.07%,HOOK3;ROBO2;SLIT1;SORL1;APPL2;B2M
prerank,regulation of cilium movement (GO:0003352),-0.43981704971762353,-1.0584165530402536,0.37037037037037035,0.8466653546565915,1.0,9/10,52.12%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,positive regulation of viral life cycle (GO:1903902),-0.32744974300071156,-1.058399974942734,0.36486486486486486,0.8443348132267792,1.0,9/22,17.98%,TSG101;AXL;P4HB;KPNA6;LGALS9;VPS37B;CHMP2B;LGALS1;VPS4A
prerank,piRNA metabolic process (GO:0034587),-0.3499560356739103,-1.0583971847633213,0.36554621848739494,0.8419655547480429,1.0,19/19,65.05%,TDRKH;MYBL1;TEX15;EXD1;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,regulation of RNA splicing (GO:0043484),0.36905799738618583,1.0583424981055345,0.39499455930359084,1.0,1.0,30/69,23.96%,AFF2;FAM50A;RBM39;PIK3R1;SRSF3;CELF1;HNRNPK;FUS;TIA1;KHDRBS2;HNRNPH3;SETX;HNRNPL;TRA2B;HNRNPLL;GRSF1;AHNAK;YTHDC1;CLK4;SON;RBM22;SRPK1;BRDT;PTBP1;CLK2;U2AF2;RRP1B;KHDRBS1;SNRNP70;CLK1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3738565563710501,-1.0582674395782516,0.37722419928825623,0.8400292989873633,1.0,4/15,16.00%,PRKCH;MED1;SFRP4;BMP4
prerank,cardiac muscle cell contraction (GO:0086003),-0.34329098668854185,-1.057455458713849,0.33472803347280333,0.8400751647613304,1.0,7/19,13.24%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;CACNA1C;CACNA1G;PIK3CA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4651286186730062,1.0573975366251553,0.41506849315068495,1.0,1.0,4/15,11.29%,FGFR2;NIPBL;TWIST1;PDGFRA
prerank,androgen receptor signaling pathway (GO:0030521),0.4898448891819113,1.0573753494116511,0.41194029850746267,1.0,1.0,5/11,16.74%,DDX17;PMEPA1;ZMIZ1;DDX5;DAXX
prerank,ganglioside biosynthetic process (GO:0001574),0.46572289597426486,1.0571256542053542,0.3947001394700139,1.0,1.0,5/15,14.35%,ST8SIA3;ST3GAL2;ST3GAL5;B4GALT5;ST6GALNAC6
prerank,monocarboxylic acid catabolic process (GO:0072329),0.43294471176625265,1.0568177205871807,0.4204398447606727,1.0,1.0,5/21,14.99%,LPIN1;LPIN3;LPIN2;CYP26B1;FAH
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.398420031240423,1.0565180121344804,0.4121863799283154,1.0,1.0,7/37,12.24%,APLN;FGF9;IGF1;MFN2;TAFA5;TPM1;SOD2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.32992002182124036,-1.0563835026003991,0.3333333333333333,0.841142973563657,1.0,11/22,37.79%,SORBS1;CREBL2;PPARD;CREB1;AKT1;PPARG;PPARA;SIRT4;DISP3;MLXIPL;ANGPTL3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3885605914574248,1.0557009228646361,0.3988505747126437,1.0,1.0,11/42,12.36%,RNF8;SMARCC2;CHD8;RBBP4;ACTR6;SMARCB1;ACTR8;ARID1B;SMARCA1;MTA2;HDAC1
prerank,regulation of defense response (GO:0031347),0.363412235706136,1.0555955747394346,0.39019189765458423,1.0,1.0,18/76,17.19%,WNT5A;FCGR2B;NR1D2;ANXA1;TIRAP;BRD4;IRF1;DHX58;CELF1;XIAP;LRP8;PARK7;PTPN22;PTGS2;BCL6;LACC1;AGTR1;APOE
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4036906495285977,1.0555058555012506,0.42168674698795183,1.0,1.0,12/32,22.35%,DUSP26;CALM3;MAGI2;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2;ITGA1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3984302699990385,1.0552585083247699,0.42839805825242716,1.0,1.0,3/34,4.76%,TNNI3;CALM3;ATP2A2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35643280420026924,1.05506375402496,0.4006243496357961,1.0,1.0,28/95,20.88%,ADAMTSL2;PDPK1;ZEB2;STUB1;DKK3;PMEPA1;FLCN;SNX6;STK11;HTRA3;TGFB1I1;SDCBP;SOX11;LEMD3;PEG10;TGFB1;SMAD6;VASN;MTMR4;SNW1;SPRY2;SMURF1;RNF111;TGFBR1;PPM1A;DAB2;TGFBR3;SMAD7
prerank,cellular response to acid chemical (GO:0071229),0.41670851595283814,1.0546649494798197,0.42066420664206644,1.0,1.0,7/27,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,positive regulation of kinase activity (GO:0033674),0.35467979253298015,1.054514973987876,0.4086687306501548,1.0,1.0,24/107,17.15%,MST1R;EPHA7;EPHB2;FGFR2;MAPRE3;FGFR1;DDR1;DDR2;EPHA8;MMD;XRCC6;EPHA10;MRNIP;MUSK;JTB;PDGFRA;ALS2;IQGAP1;ROR2;MAPT;MRE11;RAD50;DAXX;EPHA5
prerank,positive regulation of DNA recombination (GO:0045911),0.4232778292582568,1.0543626683598217,0.40707964601769914,1.0,1.0,8/27,19.65%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19;HMCES;KMT5B
prerank,regulation of necroptotic process (GO:0060544),0.43498818451748567,1.0543484968413075,0.4015056461731493,1.0,1.0,5/23,8.75%,HSP90AA1;STUB1;FZD9;OGT;SDCBP
prerank,positive regulation of neuron projection development (GO:0010976),0.35933088604428065,1.054327600916857,0.39937106918238996,1.0,1.0,31/85,20.96%,WNT5A;CAMK2B;TENM3;DBN1;PLK5;LRP8;VLDLR;DHX36;RAPGEF1;DBNL;BMP5;MAGI2;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SCARB2;LYN;ATP1B2;PTK2B;NTRK2;SCN1B
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.2648518963686234,-1.0541849387149622,0.3037974683544304,0.8451211451000092,1.0,22/54,22.62%,MEF2C;ANGPT1;NUS1;SIRT1;PRKD1;HIF1A;TMSB4X;NOS3;THBS1;KDR;AKT3;PLCG1;ANGPT2;RGCC;HSPB1;VEGFA;NF1;ATP5F1B;AKT1;PPARG;GATA2;STAT5A
prerank,negative regulation of axonogenesis (GO:0050771),0.4118090681389849,1.0540189575960033,0.4245398773006135,1.0,1.0,11/27,23.89%,DIP2B;THY1;EFNB3;MCF2;RUFY3;DCC;PTPRS;FGF13;MAP2;LRP4;PTEN
prerank,ERAD pathway (GO:0036503),0.3603586416955402,1.0539285124508657,0.3993610223642173,1.0,1.0,20/83,16.39%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLEC1;ERLIN2;BRSK2;RCN3;JKAMP;AUP1;RNF103-CHMP3;POMT2;VCP;UGGT2;USP19;UBE2J1;UBXN4;RNF121;DERL1
prerank,mitotic DNA replication (GO:1902969),0.5011514177156721,1.053642564176525,0.4254062038404727,1.0,1.0,1/10,1.55%,LIG1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.38119621681536753,1.0534823982527903,0.41418764302059496,1.0,1.0,12/47,17.19%,NFKB1;RBM4B;RBM3;METAP1;CYFIP1;SSH1;PUM3;APP;WDR91;TGFB1;AGTR1;APOE
prerank,nerve growth factor signaling pathway (GO:0038180),0.5061734790472994,1.0534181903119029,0.40995607613469986,1.0,1.0,3/10,11.88%,NTF3;RAPGEF1;MAGI2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.3890810020164847,-1.0532122373844761,0.4065573770491803,0.8457329237923633,1.0,10/12,30.20%,ACO2;ACO1;IDH1;ACLY;IDH2;IDH3A;IREB2;SIRT4;GLUD1;IDH3G
prerank,negative regulation of apoptotic process (GO:0043066),0.3393332902790558,1.0530951205362764,0.3213213213213213,1.0,1.0,84/444,17.41%,FGF20;RNF157;CDKN2D;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;CSNK2A2;NTF3;BNIP1;TAF9B;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;FZD3;NUAK2;IL31RA;MGMT;PRKCA;CARD16;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;SNX6;HNRNPK;SLC30A10;ZFAND6;IFIT3;XIAP;SOX9;NRBP2;UBE2Z;MALT1;GDNF;PRLR;KDM2B;BCL2;MAZ;BNIP2;PARK7;SOD2;DNAJB6;NPM1;HDAC1;LAMTOR5;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;NDNF;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;APOE;SON;DFFA;TOPORS
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.45636723877783114,1.0526363981416509,0.44550408719346046,1.0,1.0,7/16,16.49%,DDX17;RBFOX2;TADA3;NCOA4;EGLN2;DDX5;TRIP4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.27860754678166716,-1.0525831940413446,0.2975206611570248,0.8452136418164597,1.0,11/47,7.14%,DAB2IP;EGFR;IGF1R;ARL6IP5;TAOK2;EPHB1;PHLPP1;TGFB2;NBR1;EIF2AK2;LGALS9
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.48689452707043457,1.0525477250746926,0.41379310344827586,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.48689452707043457,1.0525477250746926,0.41379310344827586,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.48689452707043457,1.0525477250746926,0.41379310344827586,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.34114204443549073,1.0524654555990518,0.36736736736736736,1.0,1.0,77/314,18.01%,UBQLN1;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;SELENOS;UBXN2A;UBE2S;SPSB1;STUB1;EDEM1;FBXL12;SYVN1;MAD2L1;UCHL1;CDC16;FZR1;FBXL14;FBXO38;COP1;ERLIN2;ANAPC2;FBXO5;FBXO31;PSMB10;DDB1;FBXO45;RFFL;FBXW5;PSMD11;RMND5A;ARRB1;DDIT3;TRIM9;JKAMP;AUP1;RNF103-CHMP3;CUL4B;KLHL15;VCP;PSME2;PSMC5;UBR3;USP19;NEMF;KCTD2;UBE2A;ANAPC11;ANAPC4;UBE2J1;CUL5;PCNP;ZFAND2A;CDC26;RNF122;FEM1C;PSMD1;FAF1;UBE2E1;UBXN4;RNF121;UBE2D1;ZSWIM8;CLOCK;DERL1;DMAC2;PSMD6;SMURF1;TOPORS;MDM2;DNAJC10;FBXO9;PCBP2;TBL1XR1;KLHL20;ANAPC10
prerank,regulation of T cell activation (GO:0050863),0.3897230250758551,1.0522924107782412,0.40185830429732866,1.0,1.0,7/42,15.53%,PRELID1;ABL1;THY1;SIRPA;CD47;PTPN22;HSPD1
prerank,protein modification by small protein removal (GO:0070646),0.34300267636865295,1.052259545377279,0.36736736736736736,1.0,1.0,82/252,22.11%,CCP110;COPS7A;OTULINL;PSMD4;IL33;TAF9B;USP14;USPL1;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;COPS7B;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;SENP5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB;SENP7;SMAD7;PSMA4;SMAD2;PSMA1;PSMC6;OTUD6B;TRAF2;SMAD3
prerank,positive regulation of cytokine production (GO:0001819),0.33956809434601126,1.052042602977943,0.37537537537537535,1.0,1.0,49/292,15.76%,WNT5A;LPL;PTGER4;NFKB1;EIF2AK3;IL33;POLR3D;STAT6;ANXA1;XBP1;RORA;NFKB2;CCBE1;AGPAT1;TIRAP;SCRIB;TMEM106A;SULF1;IRF1;DHX58;ARNT;ZBTB7B;DHX33;DDIT3;PIBF1;XRCC6;DHX36;POLR3E;TWIST1;MALT1;APP;IRF3;PARK7;POLR2K;CEBPG;TMED10;LAMTOR5;TLR3;SCAMP5;PTPN22;ROCK2;PTGS2;TGFB1;LACC1;F3;MRE11;SPTBN1;HSPD1;PDE4B
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4552282090622007,1.0520200704786429,0.41948579161028415,1.0,1.0,5/16,21.10%,ERLIN2;SOX9;ACADL;ACADVL;APPL2
prerank,platelet degranulation (GO:0002576),0.3542461289092559,1.0513935786504207,0.4034729315628192,1.0,1.0,17/118,14.28%,MAGED2;CLEC3B;IGF1;APOOL;CHID1;CD63;SERPING1;SPARC;EGF;APLP2;APP;BRPF3;VTI1B;NHLRC2;GTPBP2;PSAP;TGFB1
prerank,positive regulation of cell junction assembly (GO:1901890),0.37001806485189703,1.051232549761337,0.40979955456570155,1.0,1.0,18/56,21.65%,SFRP1;EPHB2;RAC1;NRP1;ABL1;THY1;CLSTN2;IL1RAPL1;NLGN3;NLGN2;CNTNAP2;IL1RAP;CLSTN3;NPHP1;FLOT1;DLG5;MAP4K4;PPM1F
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4988518257061956,1.051195909146191,0.43484626647144947,1.0,1.0,3/10,14.84%,SOX9;SOX6;SOX5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.4957940991839297,1.051084321568456,0.4250720461095101,1.0,1.0,11/11,50.45%,MALT1;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;NFKBID
prerank,autophagosome assembly (GO:0000045),0.3814890670127674,1.0510599199168795,0.40154015401540155,0.9993772528797166,1.0,21/52,22.68%,UBQLN1;UBXN2A;TRAPPC8;WIPI1;ATP2A2;ATG14;MFN2;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;STX17;PIK3C3;SMURF1;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3486283757525263,1.0509653695202723,0.39838220424671383,0.9988762286142377,1.0,31/151,18.27%,ASL;MOCS2;CSNK2A2;ELOVL1;GSTT1;TYW1;ST3GAL2;LPIN1;PCSK5;CEPT1;GPAT4;CERS2;SGPL1;LPIN3;ELOVL4;PCYT1B;SPTSSA;STARD7;LPIN2;B4GALT5;PLPP3;PAM;VAPB;CHKB;SLC44A2;SLC27A1;ALDH3A2;APOE;TNIP1;PRKD2;ASS1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.38506486034896675,-1.0509244220619984,0.3535714285714286,0.8476790972323412,1.0,6/13,42.44%,LAMP1;SYK;SPHK2;ITGB2;ITGAM;FGR
prerank,cellular response to BMP stimulus (GO:0071773),0.36710823572580525,1.0508898991493139,0.4189044038668099,0.9983155425036154,1.0,22/66,22.96%,SFRP1;ADAMTS7;BMP6;SMAD9;SOX9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3;ADAMTS12
prerank,response to cholesterol (GO:0070723),0.44108134217090955,1.0507763202377753,0.4128065395095368,0.9978581201190898,1.0,4/17,8.42%,GPLD1;MLC1;ABCA2;PTCH1
prerank,dendritic spine organization (GO:0097061),0.4190022138306907,1.0505772697550928,0.41304347826086957,0.9977146613086632,1.0,4/26,6.37%,EPHB2;PICK1;CTNND2;PAK3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.29327505957785927,-1.0504201746563144,0.3620689655172414,0.8468709851894883,1.0,16/34,24.25%,FLT1;DAB2IP;ERN1;NUS1;PRKD1;SEMA6A;MT1G;RAMP2;KDR;PIK3CA;VEGFC;HSPB1;VEGFA;NR4A1;VEGFB;PGF
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.49105003287040455,1.0501511760330555,0.4307004470938897,0.998302736634199,1.0,2/11,2.08%,GSKIP;PDK1
prerank,organic substance transport (GO:0071702),0.3500548789736496,1.0498529631874616,0.3952772073921971,0.9984678260398688,1.0,34/121,24.23%,ARRDC4;PICK1;KIF3A;SLC22A18;SLC22A4;ABCA2;MIA3;RCN3;LMAN2L;CHMP3;ABCA7;SLC50A1;VPS33B;ABCA6;SCAMP5;SLC6A4;SLC18A1;SCAMP1;ABCD2;TXNIP;RUFY1;SNX4;LRP1B;TOM1;ABCA5;CMTM6;ABCG1;RAB7A;MYH9;SPNS2;ABCA9;PLEKHA8;ABCA1;PEX3
prerank,nucleotide catabolic process (GO:0009166),-0.35990555490473364,-1.0497266271984411,0.3613138686131387,0.8466294763895998,1.0,9/16,30.67%,NT5C2;SAMHD1;DERA;NT5E;ITPA;GPX1;PNP;GDA;NT5C
prerank,positive regulation of GTPase activity (GO:0043547),0.3460266877616431,1.0497148090380262,0.38190954773869346,0.9981266356928675,1.0,36/188,14.05%,SFRP1;MTSS2;NTF3;CDKL5;SLC27A4;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;ARHGEF10;TBC1D13;SCRIB;FLCN;SYDE2;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;ARHGAP42;DOCK8;RAP1GAP2;RAPGEF1;RABGAP1L;ARHGAP24;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;DOCK7;RACK1;RABGAP1;ARHGAP29
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4038468984940947,-1.0496071588054645,0.3885350318471338,0.8423758132332875,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4038468984940947,-1.0496071588054645,0.3885350318471338,0.8423758132332875,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4013902104773388,-1.0495867183096623,0.4,0.8401454133535056,1.0,5/11,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,adherens junction organization (GO:0034332),-0.2655465739883325,-1.0493487989070498,0.3119266055045872,0.8384596511930488,1.0,16/48,21.27%,FERMT2;CADM2;TJP1;ACTB;CDH6;CADM1;CDH1;CSK;RAMP2;NECTIN3;NECTIN1;PIP5K1C;CADM3;NECTIN2;DCHS1;PVR
prerank,regulation of neuron projection development (GO:0010975),0.34567367837247115,1.049108557260165,0.3876518218623482,0.9994167463790399,1.0,52/163,20.96%,WNT5A;CAMK2B;CDKL5;TANC2;CDK5;FBXO7;TENM3;KNDC1;PAK3;DBN1;BRSK2;CAMSAP2;PLK5;SPOCK1;EFNB2;RAPGEF1;PRAG1;NTNG2;SRCIN1;BRSK1;DENND5A;MAGI2;IL1RAPL1;NDRG4;CAMK2G;SETX;ROR2;NPTN;PRKCI;DISC1;LPAR1;PLPPR5;ARSB;SEMA3A;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;RUFY3;DCC;CCDC88A;ITM2C;SCARB2;PTPRS;LYN;ATP1B2;PTK2B;CHN1;NTRK2;SCN1B
prerank,cytosolic calcium ion transport (GO:0060401),-0.29951998072051206,-1.0488440966807098,0.36507936507936506,0.8377248733816275,1.0,19/28,32.09%,MICU1;CACNA2D1;CACNA1C;ITPR3;SLC35G1;MCU;MCUR1;ADRA1A;MCUB;ATP2B3;MAIP1;SMDT1;ATP2A3;RYR2;MICU3;SLC8A1;JPH2;JPH4;SLC8A2
prerank,phospholipid dephosphorylation (GO:0046839),-0.27854438617298444,-1.048477251087493,0.36046511627906974,0.8366721881887367,1.0,7/37,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,methylguanosine-cap decapping (GO:0110156),-0.42716216817705077,-1.0483330997053415,0.3951367781155015,0.8347701197985867,1.0,4/10,10.39%,DCP1A;PATL1;DCPS;LSM1
prerank,tRNA methylation (GO:0030488),0.3922657940057652,1.0478995651666516,0.4155844155844156,1.0,1.0,7/34,12.90%,TRMT61B;TRDMT1;WDR6;PRORP;TRMT1;METTL2B;METTL2A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.497200174568444,1.0469603686481916,0.43143297380585516,1.0,1.0,4/10,19.20%,ERLEC1;INSIG1;UBE2J1;YOD1
prerank,regulation of nervous system process (GO:0031644),0.4457926573529523,1.0469415461426137,0.42971887550200805,1.0,1.0,6/18,16.30%,NPTXR;TMEM108;APP;HTR2C;ROCK2;DLGAP1
prerank,cellular response to unfolded protein (GO:0034620),-0.30899254925279696,-1.0469233956706685,0.36097560975609755,0.8367113297006485,1.0,10/26,19.10%,DAB2IP;ERN1;BAG3;HSF1;TM7SF3;TMBIM6;HSPA14;ABCB10;HSPA5;HSPA13
prerank,regulation of cell population proliferation (GO:0042127),0.3364030997368992,1.0468994527074305,0.314,1.0,1.0,136/691,19.15%,FGF20;SFRP2;FGF9;S1PR2;CDKN2D;SFRP1;MST1R;IGF1;IL34;FOXM1;SIRT2;GPLD1;GNL3;EAPP;TSC2;TBRG4;CHERP;BMP6;NTF3;EDN3;TSPAN31;CGRRF1;FGFR2;TNFRSF9;GNRH1;STAT6;FGFR1;PTHLH;WARS1;XBP1;ZFP36L1;SLC25A33;CDC123;FGF10;IL31RA;CDK13;RBBP4;CLMN;TCF7L2;CNBP;IRF1;DLG3;NUAK1;FBXO5;ALDH1A2;CELF1;EZH2;EEF1E1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;XIAP;IFI35;SOX9;WDR6;PPP1R9B;SDCBP;EFNB2;XRCC6;MDM4;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;WNK2;RBFOX2;COX17;APP;JUP;IGFBP3;BCL2;ADGRG1;TCIRG1;IGFBP7;MAZ;PDGFRA;RTKN2;BMP5;NACC2;MAGI2;SPEG;SOD2;CD47;NPM1;HDAC1;AGO3;AXIN2;UBE2A;PRMT1;ROR2;TNS2;CDC73;EMP2;FGFBP1;FAM98A;NRG1;RNF41;TGFB1;SLURP1;BCL6;P3H2;SMAD6;KMT2D;DIS3L2;NUPR1;CNOT6;CTSH;CTBP1;JAG1;ADAMTS1;AGTR1;ITGB1BP1;PHIP;CAPNS1;HP1BP3;MDM2;ABI1;CAMK2N1;MEIS2;PKD2;CCDC88A;CDK10;S100A13;MECP2;TGFBR1;PDCD5;ATP8A2;KIF20B;KCNH1;KSR1;SOX4
prerank,gastrulation (GO:0007369),-0.3667303578014559,-1.046624107118833,0.35793357933579334,0.8353737592206113,1.0,1/15,0.19%,TASOR
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3639524931695778,1.0465503776117284,0.3930084745762712,1.0,1.0,5/78,3.12%,PSRC1;CDKN2D;HEXIM1;NR2F2;MAPRE3
prerank,excitatory postsynaptic potential (GO:0060079),0.44276591943426724,1.0465110869700036,0.42112299465240643,1.0,1.0,3/19,8.22%,MPP2;GRIN1;GRIN2A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4150524103132972,1.0463781486144403,0.4104193138500635,1.0,1.0,5/26,4.88%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29869017617890925,-1.0460286717575582,0.3978494623655914,0.8348799613069602,1.0,16/29,30.79%,CAV1;RIPK1;PML;THBS1;TNFSF10;CYLD;PPP2R1B;LTBR;TNFSF12;BCL10;INHBA;RET;BID;PAK2;DEDD2;GPER1
prerank,alpha-amino acid catabolic process (GO:1901606),0.408389184810823,1.0458949404978357,0.4233128834355828,1.0,1.0,5/29,14.99%,HGD;ACAT1;ALDH4A1;ACADSB;FAH
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4099782600862948,1.0458482373045928,0.4185185185185185,1.0,1.0,8/28,18.18%,EPHB2;ABL1;SQSTM1;APP;YTHDF1;ADCY1;APOE;ZDHHC2
prerank,regulation of viral transcription (GO:0046782),0.39822997225995693,1.0457023169597661,0.44589774078478,1.0,1.0,6/39,8.18%,HEXIM1;TARBP2;TRIM11;POLR2B;CDK9;TRIM62
prerank,negative regulation of cell death (GO:0060548),-0.23863475375656026,-1.0454635909406758,0.35135135135135137,0.8343079565451039,1.0,26/88,18.27%,MECOM;FERMT2;CCN2;ATG5;BNIP3L;PRKD1;BECN1;NCK1;DCPS;LRRK2;ADNP2;CD34;TM7SF3;IKBKG;DUS2;BMP7;CCN3;NENF;BNIP3;TNFRSF1B;BMP4;PINK1;KANK2;CCN5;TMEM109;CCN1
prerank,positive regulation of response to stimulus (GO:0048584),0.3921185764878138,1.045351850413883,0.4076655052264808,1.0,1.0,4/40,6.71%,WNT5A;FCGR2B;CDKN2AIP;EEF1E1
prerank,hemopoiesis (GO:0030097),0.35584810609217576,1.044625509027195,0.422008547008547,1.0,1.0,8/87,5.45%,SFRP2;WNT2B;WNT5A;SFRP1;FGFR2;TIRAP;CDK13;FLCN
prerank,protein processing (GO:0016485),0.35657866812716627,1.0446235440898988,0.42247658688865763,1.0,1.0,20/102,17.62%,XPNPEP3;CPXM1;CLN3;MYRF;PCSK5;OGT;SDE2;PCSK2;HM13;PTCH1;AFG3L2;CPXM2;PRSS12;METAP2;ADAMTS3;F3;CASP2;CTSH;PARL;OMA1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3382279952546248,1.0441519876666032,0.3777555110220441,1.0,1.0,76/308,21.52%,HDAC3;WNT5A;TMEM119;PTGER4;IL33;NKX6-1;STAT6;XBP1;GLIPR2;LPIN1;AGPAT1;OGT;ALMS1;SNAI1;OLFM1;MFAP2;FBXO5;EZH2;ZBTB7B;CXCR4;TGFB1I1;MFN2;SOX9;LRPAP1;SDCBP;GNAS;EGF;PPIB;ABCA7;SOX11;TWIST1;GDNF;PRLR;TBXA2R;CPT2;LEPR;SOX6;AXIN2;B4GALT5;EHMT1;ZBED3;SCAMP5;LRP1;TGFB1;ESRRG;SOX5;RFX3;NR2C2;ACVR1B;NUMA1;VAMP8;SERPINE1;SLC27A1;ACADL;KDM6B;APOE;OMA1;BMP1;SNX4;SORL1;HMCES;S100A13;TGFBR1;FLOT1;FOXD1;ELOVL6;KMT5B;NCOA3;PLA2R1;DAB2;GCNT2;APPL2;VAMP7;FGF2;CFL1;SMAD2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3512855498644426,-1.043651971008404,0.3880597014925373,0.8375917384065835,1.0,5/17,7.09%,ARL6IP5;TAOK2;RNF13;TGFB2;EIF2AK2
prerank,negative regulation of response to stimulus (GO:0048585),0.3686127626830687,1.043571898595804,0.41740088105726875,1.0,1.0,9/60,10.88%,FCGR2B;CASK;BRAP;THY1;FBXO5;SRMS;SLC30A10;TWIST1;IGFBP3
prerank,generation of neurons (GO:0048699),0.3419327314033539,1.0433453279582685,0.3985872855701312,1.0,1.0,28/190,14.07%,WNT2B;WNT5A;RAC1;DCDC2;CDKL5;FGFR1;FZD3;NRP1;CDK5;TUBB2A;BRSK2;WNT4;CIT;SPOCK1;PRUNE1;NRBP2;SOX11;BRSK1;LRP12;SMARCA1;IL1RAPL1;DOCK7;MYEF2;USP9X;DISC1;MAPT;AUTS2;PEX13
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.47336895613126506,1.0432682934820388,0.4309623430962343,1.0,1.0,2/13,4.65%,WNT5A;AGPAT1
prerank,vascular process in circulatory system (GO:0003018),-0.38236538914248397,-1.0427539085303474,0.3854166666666667,0.8358953895949566,1.0,6/13,14.84%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,regulation of tube diameter (GO:0035296),-0.38236538914248397,-1.0427539085303474,0.3854166666666667,0.8358953895949566,1.0,6/13,14.84%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,phospholipid translocation (GO:0045332),-0.3144412158918662,-1.042542585647195,0.3769633507853403,0.8343011919099621,1.0,10/28,13.16%,ATP8B1;ATP10A;ABCC1;PLSCR2;ABCA4;TMEM30A;PLSCR1;ANO6;ATP11C;ATP11A
prerank,regulation of urine volume (GO:0035809),0.5003857141107996,1.0425406334184555,0.44171779141104295,1.0,1.0,1/10,2.42%,ADM
prerank,lymphocyte mediated immunity (GO:0002449),-0.3970401750424606,-1.0425378823083797,0.3952702702702703,0.8321199083052668,1.0,3/12,17.35%,CD46;MSH2;GNL1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.38655301851850116,1.0424077948322228,0.4144893111638955,1.0,1.0,8/38,12.69%,TSC2;THEM4;FLCN;DDIT3;PIK3CB;MAGI2;DAG1;RACK1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.34006937661758696,1.0423290422477864,0.3997995991983968,1.0,1.0,85/264,22.27%,RAVER2;LSM6;DDX17;LSM7;COIL;SMN1;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;CDK13;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PRMT5;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;SRPK1;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,regulation of T cell mediated immunity (GO:0002709),-0.4269542920608252,-1.0423125061306275,0.4281609195402299,0.8306718646249742,1.0,2/10,15.98%,ZBTB1;TNFRSF1B
prerank,positive regulation of interferon-beta production (GO:0032728),0.39805755858788666,1.0422963799037246,0.4316807738814994,1.0,1.0,8/33,13.29%,HSP90AA1;POLR3D;DDX3X;IRF1;DHX58;TRIM56;IRF3;TLR3
prerank,detection of calcium ion (GO:0005513),0.4758563323529532,1.0422051603494675,0.41422594142259417,1.0,1.0,4/13,21.79%,CALM3;SYT1;CALM1;CALM2
prerank,transcription by RNA polymerase III (GO:0006383),-0.3085398724883781,-1.0413196279242172,0.3544973544973545,0.8315271467869122,1.0,14/27,25.76%,BRF1;GTF3C3;GTF3C2;ELL;POLR3GL;ICE1;SNAPC1;CRCP;POLR3H;GTF3C1;GTF3C5;ZC3H8;GTF3C4;POLR3G
prerank,ceramide metabolic process (GO:0006672),0.38207929429086745,1.0410545924228027,0.417420814479638,1.0,1.0,10/49,14.35%,CLN6;SMPD2;ABCA2;CERS2;SGPL1;SPTSSA;TLCD3B;PLPP3;SMPD4;ST6GALNAC6
prerank,apical protein localization (GO:0045176),-0.41864935742192216,-1.0405180798628757,0.40298507462686567,0.8317984580050392,1.0,4/10,15.14%,ATP8B1;ACTB;GOPC;MAL
prerank,maintenance of protein location in nucleus (GO:0051457),-0.33626766544497977,-1.0405091819160037,0.38095238095238093,0.829663330584913,1.0,10/20,14.38%,MORC3;PML;SKP1;SP100;SUN2;ARL2BP;TAF8;RANGAP1;BBS4;TAF3
prerank,cellular macromolecule catabolic process (GO:0044265),0.37581485500111583,1.0404846398316068,0.4416575790621592,1.0,1.0,9/49,10.46%,DNASE1L2;EXOSC7;NGLY1;DFFB;RAB12;MANBA;PABPC4;HNRNPD;MTREX
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.41100462763045587,-1.0403678881981877,0.40406976744186046,0.8279554955018323,1.0,5/10,17.43%,THRA;PSMC2;TP53;ESR1;PSMC3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.39495057901015806,1.0400557018663752,0.42857142857142855,1.0,1.0,8/33,14.38%,LRRC4;NTF3;GRIK5;LRP8;NRG3;PSMC5;NLGN3;NLGN2
prerank,anion transport (GO:0006820),0.40076140181906383,1.03995457974472,0.42054958183990443,1.0,1.0,4/33,7.43%,SLC17A5;LRRC8A;VDAC2;SLC13A4
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35681520563898383,1.0397048323365274,0.4174553101997897,1.0,1.0,30/84,21.20%,DDX17;RBM3;PCBP4;SRSF12;PRDX6;RBM39;CELF2;SRSF3;CELF1;HNRNPK;TIA1;SRSF9;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;SNW1;FMR1;THRAP3;SON;SRPK1;CIRBP;HNRNPU;TRA2A;PTBP1;RBM7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.376736062171051,-1.0392109023909095,0.3931297709923664,0.8291259035200327,1.0,4/14,7.77%,PRKG1;MEF2C;SLIT2;BMPR1A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34480013097840606,1.0389664500808329,0.43119266055045874,1.0,1.0,21/140,16.59%,PTGER4;CCR9;ACKR2;FIS1;GRIN1;C1QTNF1;ABL1;CXCR4;CD24;BDKRB2;SELENOT;GPR4;TBXA2R;PDGFRA;HTR2C;NPTN;LPAR1;LPAR6;JPH1;AGTR1;ADCY5
prerank,glycerolipid metabolic process (GO:0046486),-0.39870548913692205,-1.0383633189302228,0.4273255813953488,0.8293418649331628,1.0,6/11,28.66%,DGKB;DGKZ;DGKG;DGKQ;PLA2G15;PGP
prerank,positive regulation of viral genome replication (GO:0045070),0.4112070837849784,1.0383571770598823,0.4348370927318296,1.0,1.0,5/29,9.96%,TARBP2;DDX3X;DDB1;PPIH;PABPC1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.48758444734314277,1.0381664728550113,0.45535714285714285,1.0,1.0,3/11,12.54%,UBQLN1;PARK7;LANCL1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4218170441862214,1.037915661112927,0.41743725231175693,1.0,1.0,5/21,12.27%,BRD4;FBXO5;CDC25A;VPS4B;NPM1
prerank,regulation of telomere maintenance (GO:0032204),0.414065153481603,1.0378581629345234,0.4345679012345679,1.0,1.0,10/26,21.36%,GNL3;USP7;HNRNPD;DHX36;ATRX;MRE11;RAD50;TERF2IP;PPP1R10;SMG1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.39530234704844125,1.0376639161671783,0.4372801875732708,1.0,1.0,3/32,6.14%,PDPK1;GRIN1;THY1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.37156159079869,1.0376618472993147,0.407158836689038,1.0,1.0,14/52,16.69%,CUL7;KDELR3;EDEM1;SYVN1;XBP1;WIPI1;EXTL3;EXTL2;SERP1;PARP16;CTDSP2;VAPB;FKBP14;ACADVL
prerank,epithelium development (GO:0060429),0.35262727205354977,1.0375690538677864,0.4242738589211618,1.0,1.0,22/107,18.84%,ANXA7;FGFR2;FGF10;ERRFI1;ALDH1A2;DVL1;RCN3;WNT4;SOX9;PTCH1;SOX11;DAG1;NDRG4;HNRNPH3;VDAC1;TGFB1;AHI1;ACADVL;OSR1;ANXA4;PKD2;PGK1
prerank,regulation of viral genome replication (GO:0045069),0.3713648419248747,1.0375659810682836,0.4440789473684211,1.0,1.0,12/56,18.52%,ILF3;TARBP2;DDX3X;DDB1;PPIH;PABPC1;SHFL;VAPB;ZC3HAV1;OAS2;TNIP1;SRPK1
prerank,neuron apoptotic process (GO:0051402),0.43223560863968435,1.037159528824429,0.4518229166666667,1.0,1.0,5/19,11.07%,CDK5;FAM162A;CIT;APP;BCL2
prerank,regulation of ruffle assembly (GO:1900027),0.41445041777289,1.0371150339764834,0.4345006485084306,1.0,1.0,1/23,0.06%,CARMIL2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.35662660472434354,1.0369243483638788,0.4272251308900524,1.0,1.0,22/84,18.59%,CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;FBXO31;PSMB10;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5
prerank,embryonic organ morphogenesis (GO:0048562),0.38037680220183434,1.0367716976358443,0.43137254901960786,1.0,1.0,8/42,12.67%,FBN2;FGFR2;NIPBL;MFAP2;MFAP5;SOX11;PDGFRA;FBN1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4171555291793522,-1.036469867226743,0.39943342776203966,0.8326457122633408,1.0,4/10,13.00%,LRP6;PHACTR4;LIN7C;BMP7
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3546457868037882,-1.0363773828746945,0.38271604938271603,0.8307362446412948,1.0,6/16,11.38%,GBF1;TAPT1;VAPA;LRRK2;DDRGK1;GABARAPL2
prerank,organelle fission (GO:0048285),0.4120814136183404,1.036280723912036,0.4140127388535032,1.0,1.0,6/24,14.84%,DNM1;FIS1;SEC16B;MTFR1L;GDAP1;DNM1L
prerank,membrane fusion (GO:0061025),0.3997344027777594,1.0361881612297656,0.4431279620853081,1.0,1.0,10/33,16.55%,DNM1;UBXN2A;NAPG;VAMP3;VPS33B;VTI1B;USO1;DNM1L;STX11;NSF
prerank,negative regulation of cyclase activity (GO:0031280),0.4517091243006567,1.0360403667036253,0.41825613079019075,1.0,1.0,2/14,7.66%,LTB4R2;ADGRV1
prerank,intracellular cholesterol transport (GO:0032367),-0.3540147629055092,-1.0359883060574373,0.4068441064638783,0.8296638511062713,1.0,7/15,22.90%,LRP6;OSBPL2;SERAC1;OSBP;VPS4A;LDLRAP1;STARD4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.43728313931737883,1.035907902280399,0.4263565891472868,1.0,1.0,3/18,13.73%,LIG1;LIG3;POLD3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.426055493408561,1.0358515272932027,0.42782834850455137,1.0,1.0,6/20,18.56%,UBQLN1;HSP90AA1;ZMIZ1;DAXX;DCUN1D5;TGFBR1
prerank,negative regulation of neurogenesis (GO:0050768),0.3930872256050116,1.0358474622483775,0.4311163895486936,1.0,1.0,12/34,23.89%,THY1;EFNB3;MCF2;YWHAH;HOOK3;GORASP1;RUFY3;SORL1;APPL2;B2M;LRP4;PTEN
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.35003313343072906,-1.035524169952563,0.3938223938223938,0.8289236865974312,1.0,6/17,14.29%,CACNA1D;CACNA2D1;KCNJ2;CACNA1C;CACNA1G;CACNB2
prerank,nuclear envelope organization (GO:0006998),0.4282074198135527,1.035360557682765,0.43546284224250326,1.0,1.0,5/20,11.77%,REEP4;DMPK;TOR1B;TMEM43;LEMD3
prerank,regulation of activated T cell proliferation (GO:0046006),0.40368932205967323,1.0350655281541576,0.4375,1.0,1.0,3/30,7.55%,IGF1;SCRIB;CD24
prerank,negative regulation of signaling (GO:0023057),0.4178490840228041,1.0347728488863301,0.4521072796934866,1.0,1.0,4/25,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,mRNA processing (GO:0006397),0.3376433259796807,1.0346135618987236,0.4024024024024024,1.0,1.0,95/287,22.27%,RAVER2;LSM6;LSM7;RPRD2;TBRG4;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;CELF1;HNRNPK;AKAP8L;FUS;THOC3;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;AURKAIP1;KIN;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;GTF2H3;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CCNH;CPSF3;HNRNPA0;THOC7;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;THOC1;DDX5;YTHDC1;SNW1;CDK7;SON;SRRM1;PRPF40B;CPSF6;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;SARNP;PTBP1;SART1;SRRM2;ISY1;TCERG1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3662611539098606,1.0344653397486956,0.43640350877192985,1.0,1.0,23/61,22.00%,GNL3;APLF;RNF8;USP7;FGF10;WRAP53;RNF168;DHX36;CEBPG;USP9X;ATRX;EYA2;MRE11;RAD50;PRKD2;MECP2;UIMC1;RPS3;PPP1R10;EYA1;FGF2;NPAS2;HMGB1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.42067500667262003,1.0341181780920978,0.4320203303684879,1.0,1.0,7/24,19.23%,PARP1;TTLL4;TPGS1;CFAP20;TTLL11;AGBL4;AGTPBP1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3559761208262117,1.034077977216762,0.4246861924686193,1.0,1.0,30/91,22.18%,TCIM;CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;PSMB10;DDB1;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;MN1;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5;PSMD5;PSMA4;ATP2B4;PSMA1;PSMC6;TAF1
prerank,glycolipid metabolic process (GO:0006664),0.379581675801995,1.034074012593922,0.4585698070374574,1.0,1.0,10/47,14.35%,B3GALNT1;SMPD2;GBA2;GLB1;ABCA2;ST3GAL2;PGAP1;PSAP;SMPD4;ST6GALNAC6
prerank,negative regulation of transposition (GO:0010529),0.4489570245951711,1.0340150070780803,0.45861601085481685,1.0,1.0,1/16,1.78%,SIRT7
prerank,regulation of inflammatory response (GO:0050727),0.3381610143692711,1.033873971583374,0.41389728096676737,1.0,1.0,32/190,17.26%,SMPDL3B;WNT5A;LPL;PTGER4;DDT;SELENOS;IL33;NR1D2;ANXA1;RORA;TNFAIP3;BRD4;VAMP3;CELF1;SNX6;CD200R1;SIRPA;XIAP;IFI35;GPRC5B;GPR4;APP;PARK7;CD47;TLR3;PTGS2;BCL6;LACC1;AGTR1;SERPINE1;APOE;TNIP1
prerank,programmed necrotic cell death (GO:0097300),0.4371482945425818,1.0338026211597473,0.44021739130434784,1.0,1.0,7/18,20.53%,PPIF;LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4559474867492359,1.0337398266831448,0.4303977272727273,1.0,1.0,3/13,14.28%,SOX9;SRA1;TGFB1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.2554874077279046,-1.0334566860160732,0.42342342342342343,0.8327666116444997,1.0,13/48,11.74%,HIPK2;FNIP2;MCL1;PML;USP28;SIRT1;BCL2L1;HIPK1;TP53;EP300;IKBKE;MSH2;BCL2L2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.451673568731354,1.033027147100716,0.4444444444444444,1.0,1.0,5/16,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,defense response to fungus (GO:0050832),0.44100066611985467,1.0329697413129568,0.4530612244897959,1.0,1.0,2/17,7.78%,RNASE7;FAM3A
prerank,protein localization to cell surface (GO:0034394),0.4106470813038572,1.0326574891050428,0.4382716049382716,1.0,1.0,10/26,17.33%,FGF10;PIGU;JAM3;RIC3;FBLN5;PIGK;EMP2;USP4;GGA2;SMURF1
prerank,heart development (GO:0007507),0.3438282236724968,1.0324928633706747,0.4446700507614213,1.0,1.0,32/150,20.60%,APLN;PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;NIPBL;SOX9;FLRT2;ADAP2;FGF12;BMP5;NDRG4;FBN1;AKAP13;TGFB1;FOXC2;MEGF8;KDM6B;OSR1;PKD2;TGFBR1;SCUBE1;SOX4;KDM6A;DLC1;CHD7;TGFBR3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3381977738490356,1.0323208416946745,0.4154929577464789,1.0,1.0,29/198,14.72%,PLA2G5;DUSP28;DUSP18;XYLB;HKDC1;LPL;EPHA7;G6PC3;EPHB2;PLCH1;PIP4K2B;TAOK1;AGPAT1;CDK5;PPA2;PLPPR2;INPP5A;ACYP2;TOP1;PIK3CB;NUDT3;IPPK;ENPP1;HDHD2;PLPP3;PIP4K2A;PLPPR5;TGFB1;EPHX2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4469343899562649,1.0322198950007329,0.4743243243243243,1.0,1.0,3/17,13.55%,UBASH3A;THY1;PTPN22
prerank,negative regulation of biosynthetic process (GO:0009890),0.4443647344105349,1.0320927313231019,0.4375857338820302,1.0,1.0,5/16,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.30420717608824144,-1.0320179792773447,0.38190954773869346,0.8349893700220868,1.0,10/24,30.03%,NIBAN2;DACH1;ZRANB3;MSH2;BLM;RTEL1;MSH6;H1-0;CDKN1A;ERCC1
prerank,positive regulation of defense response (GO:0031349),0.3497538303677297,1.0318809465103567,0.4227129337539432,1.0,1.0,15/89,17.26%,WNT5A;LPL;PTGER4;DDT;IL33;POLR3D;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;AGTR1;SERPINE1;TNIP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4804446069616667,1.031766950100761,0.4561664190193165,1.0,1.0,3/11,6.98%,FBH1;FBXO5;LIG3
prerank,bone development (GO:0060348),0.3802478488346838,1.0317659702958004,0.42738095238095236,1.0,1.0,8/39,12.92%,PTGER4;FGFR2;SULF1;RANBP3L;GNAS;PPIB;CYP26B1;AKAP13
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34202931178089935,-1.031525103135561,0.3875968992248062,0.8342935354083953,1.0,12/18,33.13%,SIRT1;HIF1A;TRAP1;PINK1;HSPB1;NFE2L2;AKT1;PRKN;MAPK7;BAG5;NME5;HTRA2
prerank,osteoclast differentiation (GO:0030316),-0.32367439251072944,-1.0314428665296203,0.4051724137931034,0.8324637201182232,1.0,6/22,15.91%,FOXP1;SBNO2;OSTM1;GLO1;SRC;TNFRSF11A
prerank,negative regulation of phosphatase activity (GO:0010923),-0.30558076444818094,-1.0311147371034897,0.41414141414141414,0.8312145630993559,1.0,7/25,19.70%,URI1;TGFB2;SEMA4D;PTPA;BOD1L1;SH3RF2;ZCCHC9
prerank,histone modification (GO:0016570),0.34699764881456757,1.0307930867163364,0.4444444444444444,1.0,1.0,32/109,20.24%,SIRT2;INCENP;SIRT7;PRMT6;MIER2;PARP2;EZH2;HDAC5;EHMT2;NTMT1;HDAC4;RCOR1;BRD8;TAF6;NSD3;USP3;MTA2;PARK7;HDAC1;UBE2A;PRMT1;EHMT1;EYA2;PRMT8;NSD1;TBL1XR1;SGF29;USP22;PRMT2;CARM1;MIER1;EYA1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.39348653584872456,1.030646785074399,0.43956043956043955,1.0,1.0,9/33,19.75%,CDKN2D;WEE1;PLK5;RBL2;NACC2;CDC73;PKD2;PRMT2;KLF4
prerank,phosphatidylserine metabolic process (GO:0006658),0.39588828300497125,1.0305751631741926,0.4449818621523579,1.0,1.0,1/32,0.14%,PLA2G5
prerank,epidermal cell differentiation (GO:0009913),0.3823640993913753,1.0304797739653584,0.4485645933014354,1.0,1.0,7/41,18.58%,WNT5A;SCEL;ANXA1;HDAC1;TXNIP;JAG1;PIP5K1A
prerank,microtubule bundle formation (GO:0001578),0.382924501919846,1.0299723211915703,0.44380069524913096,1.0,1.0,4/42,7.37%,PSRC1;MTCL1;TPPP3;GAS2L1
prerank,actin polymerization or depolymerization (GO:0008154),0.36970608839322683,1.029661700834577,0.44620611551528877,1.0,1.0,17/50,21.98%,SPIRE2;RAC1;TTC17;WASF1;SVIL;SPIRE1;VILL;ABI1;GAS7;ARHGAP6;PSTPIP2;EVL;PREX1;CFL1;GSN;DIAPH1;ENAH
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4044054410870682,1.029218353085275,0.43580246913580245,1.0,1.0,9/30,20.71%,IGF1;FGF10;RASGEF1A;RAPGEF1;IRS2;STK19;ERBIN;LYN;ITGAV
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32904201367861374,1.0290432128592466,0.309,1.0,1.0,339/1667,18.39%,SFRP2;METTL23;CBX8;CAMTA2;MMP12;HDAC3;HEXIM1;TEAD3;LAGE3;WNT5A;PTPRN;ZSCAN12;ZMYM5;WBP2;HSF2;POU6F1;ZNF418;IGF1;MED24;DUSP26;SP7;DVL2;ZNF23;MPND;FOXM1;BAX;SIRT2;ZBTB48;SIRT7;POU5F2;DDX17;CRTC1;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;AASS;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;BMP6;PARP1;ZEB2;CREBZF;IL33;USF1;NR2F2;FGFR2;MLXIP;TEF;NKX6-1;MED12;TAF9B;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;GRIN1;PCGF1;ZNF8;ZFP82;HTATIP2;XBP1;ACTR2;RORA;TFDP1;MIER2;NFKB2;CARF;DDX3X;MXI1;ABCA2;ZNF205;LPIN1;SNF8;NIPBL;CCNC;OGT;CHD8;VGLL3;POU2F1;RFX5;CDK13;SNAI1;SLTM;CDK9;ZNF692;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;ZNF276;BBS7;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;ATXN1;DVL1;ZNF35;ZIC3;CASZ1;HNRNPK;EZH2;AKAP8L;FUS;ARNT;ZBTB7B;RTF1;ZEB1;SMARCB1;CHD5;TEAD1;HDAC5;PCGF6;MOSPD1;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;PID1;MED4;ZKSCAN5;DBP;NFX1;PRPF6;ARRB1;TSHZ2;SLC30A9;SOX9;SRA1;SMARCD1;PTCH1;EHMT2;DDIT3;BRD3;PGBD1;CRTC3;SDCBP;DPF2;LPIN3;ZFHX2;XRCC6;PER1;ECD;ARID1B;DHX36;MDM4;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;PSIP1;PRRX1;NKRF;GTF2H3;TCEA1;HOXB8;USP2;GDNF;ATF2;POU6F2;SSBP4;RCOR1;PSMC5;ZBTB20;BRD8;ZNF445;KDM2B;APP;TAF6;JUP;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;PIK3R2;SARS1;BACH2;MAZ;NFAT5;IRF3;CAMK2D;JAZF1;BMP5;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;MTA2;E2F3;NFIX;BRIP1;BACH1;PARK7;ZNF462;PEG3;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;LPIN2;ZFP2;AGO3;CREB3;CREB3L4;ZNF383;RPS6KA3;USP9X;PROX2;SETX;SUFU;TLR3;ZBED3;CBFB;ABHD14B;CDC73;FOXJ3;ATRX;ZHX2;EBF1;AUTS2;ZIC2;TGFB1;MED21;RGMA;TRPS1;ESRRG;CAMTA1;BCL6;BAZ2B;BCLAF1;ZNF292;IMPACT;SMAD6;SOX5;KMT2D;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;SSBP2;FOXC2;CIC;HSPD1;THAP3;RPS6KA1;DDX5;TRAK1;AHI1;GTF2IRD1;MAF;SAFB2;UBE2D1;CTBP1;HOXC8;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;CBX5;KDM6B;ITGB1BP1;THRAP3;CBX7;PHIP;ZFP37;CDK7;KDM3B;MTDH;SOX13;ZBTB41;OSR1;HSBP1;APOE;ZFP90;TNIP1;TLE5;TCF7;NSD1;MDM2;GABPB1;GABPB2;ANXA4;RAD21;MEIS2;TBL1XR1;PRKD2;PKD2;RELB;ZNF177;PHF12;RBBP8;RNF111;ATN1;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GPS2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4150169291861252,1.0288220945605444,0.43638676844783714,1.0,1.0,5/23,11.07%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4150169291861252,1.0288220945605444,0.43638676844783714,1.0,1.0,5/23,11.07%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,regulation of lymphocyte migration (GO:2000401),-0.4163449636494472,-1.028604087046919,0.4350453172205438,0.8363150843851144,1.0,6/10,27.01%,JAM2;SLC8B1;STK10;MSN;AKT1;WASL
prerank,regulation of translation (GO:0006417),0.3374324918678129,1.0285765212013172,0.44343434343434346,1.0,1.0,41/173,16.79%,ILF3;MIF4GD;PAIP2;RBM4B;EIF2AK3;RBM3;PAIP1;DDX3X;CNOT10;IGF2BP2;METAP1;EIF1B;CYFIP1;EPRS1;HNRNPD;DHX36;PUM3;PUS7;APP;ZCCHC4;SHFL;EIF4E2;CNOT9;EIF4G2;NEMF;MALSU1;YTHDF3;EIF1;NPM1;RACK1;RPS6KA3;GSPT1;DAPK1;YTHDF1;PRR16;IMPACT;MRPL13;RPS6KA1;MTG2;EIF4G3;FMR1
prerank,cellular response to hypoxia (GO:0071456),0.34379773195798735,1.0285379165353394,0.42551020408163265,1.0,1.0,29/126,17.57%,CPEB1;UBQLN1;SFRP1;SIRT2;PSMD4;STUB1;RORA;ZFP36L1;CARD16;FAM162A;PSMB10;ARNT;PSMD11;TBL2;MDM4;NDRG1;TWIST1;PSME2;PSMC5;SUV39H1;AK4;BACH1;EGLN2;PTGS2;PSMD1;NDNF;PSMD6;HP1BP3;MDM2
prerank,erythrocyte differentiation (GO:0030218),-0.28431107007228806,-1.028287668532297,0.34959349593495936,0.8351223746203278,1.0,16/44,24.13%,HIPK2;MFHAS1;MED1;KMT2E;KIT;UBA5;RPS19;UFL1;ABCB10;IKZF1;SH2B3;VEGFA;CASP3;RPS14;NCKAP1L;INHBA
prerank,positive regulation of histone modification (GO:0031058),0.39784074558203386,1.0282633493786832,0.4331288343558282,1.0,1.0,10/33,19.34%,NIPBL;CDK9;AKAP8L;ZBTB7B;ARRB1;SART3;SAP30BP;CTBP1;FMR1;TET1
prerank,regulation of catabolic process (GO:0009894),0.44016781740492117,1.0280237534518113,0.4479578392621871,1.0,1.0,7/18,20.98%,SNF8;HGS;FAF1;CHEK2;MDM2;ZDHHC2;ITGB1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.28007592528116926,-1.0279244674370511,0.40540540540540543,0.8341147340073944,1.0,8/38,10.47%,CACNA1D;CTNNA3;CAV1;CACNA2D1;KCNJ2;CACNA1C;AKAP9;CACNA1G
prerank,smooth muscle tissue development (GO:0048745),0.4882307588848405,1.0278637127263257,0.43909774436090226,1.0,1.0,2/10,8.42%,STRA6;PTCH1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4042583626395642,1.0278442231577714,0.44139650872817954,1.0,1.0,6/26,13.35%,IGF1;CAPN10;PIK3R1;CLIP3;IRS2;PRKCI
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.37503085566899963,-1.0275983984535846,0.4006849315068493,0.8330173967103253,1.0,8/13,32.88%,DDO;MTHFS;GOT2;ACOT8;GOT1;GAD1;GLUD1;QPRT
prerank,cellular response to DNA damage stimulus (GO:0006974),0.33222221187248546,1.0273485143751846,0.422,1.0,1.0,91/336,20.64%,WDHD1;XRCC2;APTX;LIG1;BAX;SIRT7;CDKN2AIP;PARP1;APLF;RNF8;PAXX;UBE2E2;TAOK1;NIPBL;PARP2;MGMT;USP47;ASF1A;FBH1;SLF2;ABL1;FBXO31;DDB1;BARD1;PHF1;SETD7;TDP1;FBXO45;STK11;FANCG;ZBTB38;XIAP;PLK5;UBA1;DDIT3;USP10;RNF168;KIN;CUL4B;MRNIP;VCP;CASP9;GTF2H3;ATF2;POLH;MTREX;BRSK1;SUV39H1;ENDOV;USP3;BCL2;ALKBH3;IRF3;YY1;BACH1;PARK7;NPM1;UBE2A;ATR;SETX;MMS19;HELB;BCL6;FANCA;MRE11;CASP2;CHEK2;RAD50;CBX5;FMR1;UBR5;TANK;TOPORS;NABP2;SUSD6;PWWP3A;DCUN1D5;HMCES;RBBP8;FMN2;RECQL5;ALKBH1;RPS3;VCPIP1;KMT5B;INO80;FANCL;UVRAG;LYN;MAPKAPK2;RAD18
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.33939941339167723,-1.0270281670124497,0.40540540540540543,0.832732820804064,1.0,4/20,7.06%,PRKCE;LBP;IRAK1;TLR4
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.30703340436314985,-1.0269177362496973,0.4439461883408072,0.8309656827922178,1.0,5/24,11.10%,MEF2A;MEF2C;SPAG9;RBM4;CAMK1
prerank,regulation of type I interferon production (GO:0032479),0.34928793624846033,1.026616664828917,0.451271186440678,1.0,1.0,16/84,13.55%,NFKB1;POLR3D;STAT6;NFKB2;TNFAIP3;TIRAP;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;PTPN22
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3980698619513145,1.0265967019697748,0.4509316770186335,1.0,1.0,12/29,22.97%,TARBP2;DGCR8;PUS10;LIN28B;ZC3H7B;AGO3;HNRNPA2B1;ZC3H7A;SMAD2;PRKRA;SMAD3;AGO4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4828469477233294,1.0264495712910138,0.4546783625730994,1.0,1.0,6/12,26.38%,STX2;SNAP25;STX11;SNAP47;SNAP23;STX1A
prerank,cartilage development (GO:0051216),0.37299256761502153,1.0264105519172468,0.4265193370165746,1.0,1.0,9/49,17.13%,WNT2B;GPLD1;SULF1;TRIP11;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3775772862670785,1.026245241356941,0.4243498817966903,1.0,1.0,15/46,18.63%,RAC1;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;ATRN;ILK;MEGF9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3411364170167055,1.0258999105420634,0.444331983805668,1.0,1.0,37/159,21.72%,AMIGO1;FGFRL1;LRRC4;ATP2C1;OBSL1;CLDN11;GPC6;TENM3;IGSF21;DSCAM;CDH11;CLDN12;IGSF11;ROBO2;ROBO1;PTPRF;IL1RAPL1;GPC4;NPTN;ALCAM;UNC5D;CDH18;TENM4;ICAM1;PLXNB3;CDH20;CDH19;CDH7;CDH4;SLITRK1;CNTN2;PTPRS;NEXN;CDH9;ITGB1;PCDHB16;CDH10
prerank,sprouting angiogenesis (GO:0002040),-0.25903546067265465,-1.025541276009177,0.41284403669724773,0.8329470087898813,1.0,15/51,12.03%,BMPER;ANGPT1;PARVA;RSPO3;SLIT2;PIK3R3;TEK;EPHB4;THBS1;ENG;OTULIN;RNF213;RAMP2;KDR;JMJD6
prerank,activation of protein kinase activity (GO:0032147),0.34511116415209603,1.0254000205489333,0.4484536082474227,1.0,1.0,29/106,21.25%,WNT5A;IGF1;PDPK1;ADCY7;NTF3;TAOK1;MINK1;TIRAP;ABL1;PAK3;STK11;PIBF1;MALT1;PRLR;STRADB;PARK7;TLR3;EMP2;NRG1;ADCY1;ADCY5;ITGB1BP1;CCDC88A;PRKAR1A;NRK;PTK2B;PAK5;MAPKAP1;MAP4K4
prerank,positive regulation of exosomal secretion (GO:1903543),0.4533059971825494,1.025388136015061,0.43651925820256776,1.0,1.0,4/15,12.16%,SNF8;HGS;SDCBP;VPS4B
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.40493093412314707,-1.025290358858588,0.447098976109215,0.8316436738481178,1.0,4/11,6.81%,YBX3;RIPK1;SLC25A4;PELI1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4820145863341512,1.0251482160362868,0.47128129602356406,1.0,1.0,2/11,4.89%,TNFAIP3;TIRAP
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.49923649835053574,1.0249935869306603,0.4553846153846154,1.0,1.0,3/10,13.55%,TIRAP;IFI35;PTPN22
prerank,early endosome to Golgi transport (GO:0034498),0.4778820510849173,1.0249137328962545,0.46370370370370373,1.0,1.0,6/11,25.20%,TRAPPC10;RAB6A;STX5;EHD3;SURF4;LMAN1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.34327341711519666,1.0246964202195574,0.44969199178644764,1.0,1.0,25/113,16.69%,LCP1;BAX;PARP1;HSP90AA1;STUB1;WARS1;DDX3X;TIRAP;SLF2;DDB1;TPPP3;DHX33;CUL4B;VCP;GTF2H3;PSMC5;PARK7;RACK1;ATR;NRG1;TGFB1;FAF1;TERF1;IL5;TPPP
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.36594621395758214,1.0243782815034699,0.4370034052213394,1.0,1.0,9/55,17.07%,FOXM1;SIRT2;RAC1;SLC25A33;PID1;RNF41;SIRT5;AGTR1;PARL
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3716420830438842,1.0243303785731122,0.4612794612794613,1.0,1.0,7/46,8.27%,DNLZ;FIS1;TOMM20;FBXO7;TIMM13;MFN2;AIP
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.29329785835358435,-1.0242290204433628,0.387434554973822,0.832659175196819,1.0,7/30,7.62%,LATS1;SMAD4;BCL9;TWSG1;TRIM33;ITGA3;ENG
prerank,L-serine metabolic process (GO:0006563),0.49913907118072504,1.0236235099685136,0.448062015503876,1.0,1.0,1/10,2.30%,PSAT1
prerank,regulation of plasminogen activation (GO:0010755),0.47331575710517393,1.0235800187749629,0.4645550527903469,1.0,1.0,3/12,16.49%,CLEC3B;CTSZ;SERPINE1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.24884161919809344,-1.0230047821361403,0.3723404255319149,0.8340936810304989,1.0,17/53,17.43%,RAD23B;DAB2IP;TMF1;GNA12;HSP90AB1;UCHL5;PRKACA;PSMC2;PSMF1;DDRGK1;UBB;GABARAPL2;UBQLN4;OSBPL7;UFL1;PINK1;PSMC3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4268741672807992,1.0229630607438442,0.45478374836173,1.0,1.0,3/21,7.87%,FGF9;IGF1;MFN2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.45519974660808127,1.0227455782201789,0.4345991561181435,1.0,1.0,2/13,7.66%,LTB4R2;ADGRV1
prerank,cellular response to reactive oxygen species (GO:0034614),0.3606416259402615,1.022558482027262,0.4488888888888889,1.0,1.0,14/59,14.79%,MAPK9;PPIF;ANXA1;TNFAIP3;PRDX5;ABL1;SIRPA;TPM1;PDGFRA;OSER1;PARK7;SETX;MAPT;IMPACT
prerank,mRNA destabilization (GO:0061157),0.3758949215891946,1.0219734085098695,0.4488836662749706,1.0,1.0,10/38,15.03%,KHSRP;PLEKHN1;ZFP36L1;CELF1;DHX36;RC3H2;YTHDF3;YTHDF1;ROCK2;DIS3L2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.47109302477804116,1.0217447753392472,0.4490084985835694,1.0,1.0,6/12,21.65%,FGF9;TPM1;DOCK7;ADAMTS1;DOCK5;IGFBP5
prerank,neuron projection development (GO:0031175),0.3339111208509786,1.0216095852098825,0.46215943491422806,1.0,1.0,53/168,23.00%,STMN4;EPHB2;NTF3;GPRIN1;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;EPHA8;DBN1;TMEM108;CAMSAP2;ADGRV1;PPP1R9B;DBNL;GDNF;APP;LRP12;ALS2;BLOC1S2;MAPK8IP3;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;EPB41L3;CNTNAP2;TRIO;SLC9A6;APOE;MAP4;ATCAY;GAS7;KIF20B;SHANK1;NRK;ATXN10;LYN;NBL1;EHD1;MAP4K4;RYK;HMGB1;CAMSAP1;PAK1;EPHA4;MAP2
prerank,positive regulation of dendritic spine development (GO:0060999),0.41889569356408485,1.0215850420852102,0.46335078534031415,1.0,1.0,9/20,21.20%,CAMK2B;DBN1;LRP8;DHX36;DBNL;FMR1;APOE;SHANK1;DLG5
prerank,positive regulation of protein localization to membrane (GO:1905477),0.34582311183175063,1.0213920932977572,0.45245559038662486,1.0,1.0,23/98,18.57%,EPHB2;PDPK1;FIS1;TFDP1;SLC5A3;MTCL1;MIEF2;PIK3R1;SQSTM1;NMT1;YWHAH;CLIP3;YWHAG;BCL2;ANK3;PRKCI;LRP1;DPP10;SPTBN1;ITGB1BP1;KIF5B;CEMIP;PDCD5
prerank,polarized epithelial cell differentiation (GO:0030859),0.4592641621720478,1.0213845619260176,0.4522111269614836,1.0,1.0,3/13,9.32%,SCRIB;RAP2A;RAB10
prerank,myoblast differentiation (GO:0045445),0.4614866022494032,1.021252133328585,0.4607703281027104,1.0,1.0,6/14,16.44%,IGF1;DDX17;TCF7L2;NRG1;DDX5;JAG1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.44897260595206384,1.0211790976523174,0.45323741007194246,1.0,1.0,6/14,22.82%,HDAC5;TBXA2R;ITGB1BP1;KLF4;STARD13;MEOX2
prerank,sensory perception of light stimulus (GO:0050953),0.34794488570280757,1.0211009636076795,0.45110410094637227,1.0,1.0,10/87,14.69%,GPR179;BEST1;RDH10;PCDH15;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,nucleosome organization (GO:0034728),0.36257222482486584,1.020788035684087,0.46756152125279643,1.0,1.0,21/55,21.67%,SMARCD3;RNF8;SMARCC2;ASF1A;ACTR6;SMARCB1;SOX9;SMARCD1;SART3;NPM1;ATRX;DAXX;BRDT;INO80;CTCF;SMARCD2;NAP1L4;ZNHIT1;VPS72;H3-3A;SRCAP
prerank,regulation of protein processing (GO:0070613),0.42355759749800026,1.020698252561269,0.4691516709511568,1.0,1.0,2/21,4.19%,CLN3;CCBE1
prerank,RNA stabilization (GO:0043489),0.3916653419491657,1.0202399896239809,0.4448484848484848,1.0,1.0,12/33,20.76%,TRDMT1;PAIP1;FUS;DHX36;PABPC1;GDNF;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;YBX1
prerank,negative regulation of innate immune response (GO:0045824),0.3886750703134948,1.0199558015769121,0.44078144078144077,1.0,1.0,7/34,12.01%,TNFAIP3;SERPING1;DHX58;TRAFD1;FAM3A;USP15;YTHDF3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.47969918528594424,1.0198469289720067,0.45677233429394815,1.0,1.0,3/11,7.40%,CCT8;CCT6A;WRAP53
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3075120996660205,-1.019829710213558,0.45064377682403434,0.8414080679973223,1.0,8/25,12.55%,ATP1B3;SLC6A9;DMD;AKAP9;TCAF1;ACTN2;NDUFA4;ATP1B1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.29408776426510397,-1.0197484565630588,0.42857142857142855,0.8395527771080192,1.0,6/29,6.64%,FLT1;KIT;IRS1;PRKD1;TEK;DGKZ
prerank,protein homooligomerization (GO:0051260),0.3355140762752081,1.019741854194016,0.45940390544707094,1.0,1.0,22/114,18.02%,ALOX5AP;TRMT61B;GSDMD;MPP2;ASIC1;ATL1;ALDH1A2;FUS;TK1;TIFA;KCNC2;ALS2;NACC2;SOD2;PRMT1;HPRT1;SLC1A5;AQP4;PRMT8;MLKL;SLC1A2;PKD2
prerank,negative regulation of cell growth (GO:0030308),0.34305133853470626,1.0196300220396877,0.4607438016528926,1.0,1.0,12/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;DIP2B;FLCN;STK11;TCHP;PPP1R9B
prerank,motor neuron axon guidance (GO:0008045),0.4461864240781857,1.0192142623281653,0.4550561797752809,1.0,1.0,6/15,22.67%,RAC1;TMEFF1;SLIT1;SEMA3A;CHN1;EPHA4
prerank,histone H4 acetylation (GO:0043967),-0.25979719550189956,-1.0192064304069952,0.4166666666666667,0.8391016066926346,1.0,22/47,22.96%,EPC1;TRRAP;LEF1;KAT7;JADE2;NAA40;EP300;JADE1;KANSL3;JADE3;WDR5;MSL3;HCFC1;ACTL6A;ING3;BRCA2;KAT8;ING5;NAA60;APBB1;RUVBL1;TRIM16
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4326852811345854,1.0191591859479605,0.4511691884456671,1.0,1.0,5/16,13.96%,OGT;ARHGAP24;PIK3CB;ALS2;AUTS2
prerank,neuron projection organization (GO:0106027),0.4516602689344932,1.0190748539029595,0.4405099150141643,1.0,1.0,4/15,15.47%,PICK1;ATP1A3;APP;ABCD2
prerank,regulation of B cell proliferation (GO:0030888),0.3743316463118336,1.0189899980446795,0.4751445086705202,1.0,1.0,5/44,11.07%,FCGR2B;EPHB2;TIRAP;IRS2;BCL2
prerank,regulation of proteolysis (GO:0030162),0.37081422712617895,1.0189496755834004,0.45475113122171945,1.0,1.0,7/48,9.66%,CLN3;CLN6;STUB1;OGT;CDK5;AURKAIP1;PLAT
prerank,cell differentiation in spinal cord (GO:0021515),0.4859100658640332,1.0187560864120715,0.4725925925925926,1.0,1.0,4/10,20.80%,SOX6;SOX13;SOX4;MDGA2
prerank,positive regulation of gene expression (GO:0010628),0.32780439652293697,1.017941208181334,0.442,1.0,1.0,94/442,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;WBP2;PTGER4;IGF1;EPHB2;BMP6;EIF2AK3;IL33;RBM3;WARS1;ERP29;DDX3X;SNF8;C1QTNF1;AGPAT1;FGF10;FUBP1;SF3B1;OLFM1;TBP;PIK3R1;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;SOX9;HNRNPD;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ZCCHC4;ANK3;MAZ;ROBO1;IFNGR1;YTHDF3;PARK7;POLR2K;NPM1;TADA3;AGO3;LAMTOR5;SETX;TLR3;SCAMP5;YTHDF1;PTPN22;FAM98A;ROCK2;PRR16;TGFB1;MAP2K2;EPHX2;F3;HNRNPLL;MED23;CTSH;DDX5;POLR1A;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;S100A13;RBM22;METTL5;TGFBR1;PDCD5;FLOT1;PRKAA1;TAF1B;FOXD1;SOX4;RPS3;MITF;KLF4;CIRBP;GABPA
prerank,L-amino acid transport (GO:0015807),-0.3044030938361346,-1.0178851387090735,0.4479166666666667,0.8410345428438742,1.0,6/28,10.89%,ARL6IP5;SLC25A13;SLC3A2;SLC7A1;SLC36A4;CTNS
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3399971539976655,1.017578810328141,0.4682875264270613,1.0,1.0,12/95,10.30%,WNT5A;FCGR2B;SIRT2;SELENOS;NFKB1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96
prerank,fibrinolysis (GO:0042730),0.45417164459508147,1.017101737603893,0.4630969609261939,1.0,1.0,2/13,16.49%,PLAT;SERPINE1
prerank,epithelial tube morphogenesis (GO:0060562),-0.29101379945951383,-1.01696272371949,0.4024390243902439,0.8415777161944301,1.0,11/32,16.72%,MEF2C;SLIT2;ACVR1;COL4A1;RHOB;PRKX;RASIP1;BMP4;HES1;MET;PODXL
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4125373358392566,1.0168626613847385,0.4588688946015424,1.0,1.0,7/23,19.74%,WEE1;PLK5;CDK5RAP3;CHFR;ZWINT;NABP2;ZW10
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.2696825967193703,-1.0168228601111386,0.43820224719101125,0.839973906929395,1.0,7/34,5.16%,FLT1;DAB2IP;KIT;IRS1;PRKD1;PIK3R3;TEK
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.40380165115342037,1.0164587898634991,0.45073891625615764,1.0,1.0,7/27,11.84%,GPD1L;YWHAH;SCN2B;SLMAP;FGF12;CAMK2D;PTPN3
prerank,positive regulation of vacuole organization (GO:0044090),0.47741796560368555,1.0163843510249528,0.4616564417177914,1.0,1.0,6/10,23.41%,PIP4K2B;PIP4K2A;PIP4K2C;ANXA2;RAB3GAP2;SH3GLB1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.44293965034317206,1.015354384564005,0.46765498652291104,1.0,1.0,2/16,9.75%,CLDN11;CLDN12
prerank,oligosaccharide metabolic process (GO:0009311),0.3729337561476898,1.014924740607306,0.453318335208099,1.0,1.0,6/46,8.34%,MAN2C1;ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;MANBA
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.39711166912273627,1.0147543235442054,0.45859085290482077,1.0,1.0,6/28,9.64%,ABITRAM;GBA2;CXCL12;PAK3;DBN1;DBNL
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3878902281942654,1.0145593099263202,0.47158403869407495,1.0,1.0,7/33,13.26%,GLS2;FPGS;OAT;GLUL;ALDH4A1;GCLC;DGLUCY
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.33178216280972506,1.014289640401936,0.4684052156469408,1.0,1.0,82/241,23.06%,RAVER2;LSM6;LSM7;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN;U2AF2;ZCRB1;SRSF6;ZMAT5
prerank,melanocyte differentiation (GO:0030318),-0.3840149335430092,-1.0140895641471985,0.42033898305084744,0.84580198606764,1.0,3/11,3.29%,MEF2C;KIT;USP13
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4497430700077389,1.0138986213405836,0.47908232118758437,1.0,1.0,3/15,10.40%,GPLD1;ADM;IRS2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39868538157792854,-1.0138593504458275,0.42996742671009774,0.8443866292463074,1.0,6/10,44.32%,PODXL;DPP4;WNK1;SKAP1;FERMT3;ADA
prerank,mitotic recombination (GO:0006312),-0.35508701781456864,-1.0138554694032165,0.45454545454545453,0.842359789304209,1.0,9/15,32.36%,SMC5;TEP1;RAD52;RAD51D;DMC1;NSMCE2;RAD54B;ERCC1;SMC6
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.3756897747685068,-1.0138505200186894,0.4198717948717949,0.8403400911781178,1.0,4/13,7.30%,LATS1;FLNA;NFKBIA;GOPC
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3838518284150322,1.013705932749055,0.48413631022326675,1.0,1.0,14/37,22.71%,S1PR2;SIRT2;CALM3;DMTN;EGF;APP;TGFB1;SPRY2;CEMIP;CALM1;PRKAG2;SMAD7;CALM2;WNK3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4157834702226756,-1.0133589875029112,0.45806451612903226,0.8398307791287386,1.0,4/10,17.43%,PCGF5;PRMT7;IGF2;KDM1B
prerank,regulation of translational initiation (GO:0006446),0.35644835067056063,1.013331484893735,0.4739178690344062,1.0,1.0,15/63,16.79%,MIF4GD;PAIP2;EIF2AK3;PAIP1;DDX3X;CDC123;EIF1B;EIF4G2;YTHDF3;EIF1;NPM1;YTHDF1;IMPACT;EIF4G3;FMR1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3425940352257843,1.0132446087455367,0.4648936170212766,1.0,1.0,18/90,17.62%,HDAC3;STAT6;LPIN1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;CPT2;LEPR;EHMT1;ESRRG;ACADL;KDM6B;OMA1
prerank,RNA catabolic process (GO:0006401),0.3683536954720198,1.0131520672394863,0.4727272727272727,1.0,1.0,11/46,16.22%,LSM6;EXOSC7;CNOT10;PABPC4;HNRNPD;NUDT12;MTREX;AGO3;SND1;DIS3L2;NUDT16L1
prerank,protein autoubiquitination (GO:0051865),0.3538100214301765,1.0128171738839202,0.46354733405875953,1.0,1.0,11/61,14.63%,RNF157;RNF8;STUB1;NFX1;TRIM17;RNF11;UBE2A;RNF19B;RNF220;RNF41;RNF122
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3425846031105641,1.012802815814059,0.4735202492211838,1.0,1.0,34/96,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,negative regulation of cell motility (GO:2000146),0.34012762981562317,1.0120483905683697,0.4865702479338843,1.0,1.0,41/108,26.15%,SFRP2;SFRP1;FBLN1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;ROBO1;MAGI2;DAG1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;DPEP1;MCTP1;MITF;DLC1;NF2;SMAD7;SRGAP1;DLG5;IGFBP5;EPHA4;DPYSL3;PTEN;ADARB1;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4;GTPBP4;RECK
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4636878561953686,1.0120229552599251,0.4644412191582003,1.0,1.0,6/11,18.62%,ABCA2;SOAT1;ABCA7;ITM2B;NECAB3;ITM2C
prerank,Golgi inheritance (GO:0048313),-0.3785249776575343,-1.0117329001757958,0.42946708463949845,0.8426082194123468,1.0,2/11,1.81%,GBF1;YWHAZ
prerank,intermediate filament organization (GO:0045109),0.437626033647874,1.0115681735181064,0.45883940620782726,1.0,1.0,4/17,16.80%,NEFL;DES;DNAJB6;BFSP2
prerank,smooth muscle cell differentiation (GO:0051145),-0.3821534113007218,-1.011375129026155,0.42033898305084744,0.8416747377557243,1.0,11/12,38.04%,MEF2C;TMEM204;TBX18;BMP4;MRTFB;HEY2;GATA6;EDNRB;MYOCD;APLNR;HEY1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.34374096204441756,1.011237341036881,0.4724576271186441,1.0,1.0,15/86,10.61%,IGF1;FOXM1;EPHB2;SGSM3;LZTR1;OGT;FGF10;FLCN;SQSTM1;RASGEF1A;MFN2;RALGPS1;RAPGEF1;IRS2;DENND4C
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4095344670067645,1.0112025476609092,0.46811224489795916,1.0,1.0,5/25,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.46836036397446235,1.0105348995458963,0.47988505747126436,1.0,1.0,1/12,1.59%,GPLD1
prerank,regulation of cell migration (GO:0030334),0.3283136506987493,1.0102635057896105,0.4774774774774775,1.0,1.0,91/382,21.29%,FGF20;CARMIL2;SFRP2;FGF9;CLN3;CAMK2B;SFRP1;IGF1;EPHB2;ELP6;FAM83H;NTF3;RAC1;PLXNA2;MGAT3;ANXA1;XBP1;CXCL12;MINK1;FGF10;PRKCA;SNAI1;FLCN;SULF1;CD151;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;RHOD;RFFL;PODN;PLXNA1;SDCBP;EGF;RIPOR1;SEMA3D;NTNG2;SRCIN1;ENPP2;TPM1;MAZ;PDGFRA;ROBO1;MAGI2;YTHDF3;DAG1;SOD2;RACK1;ROR2;LAMB1;RNF41;ROCK2;TGFB1;SLURP1;ARSB;SEMA3E;F3;SEMA3A;CTSH;NKD1;JAG1;SERPINE1;PLXNB3;DPEP1;SPRY2;RUFY3;MCTP1;SORL1;CEMIP;AMOT;TGFBR1;MMP14;MITF;CARMIL1;DLC1;DAB2;NEXN;GCNT2;PTK2B;TBCCD1;NF2;SMAD7;SRGAP1;ITGB1;APPL2;SGK3;DLG5;MAP4K4;FGF2
prerank,amide biosynthetic process (GO:0043604),0.3661781108879841,1.0102519241605141,0.4604072398190045,1.0,1.0,8/47,13.94%,ASL;SMPD2;PCSK5;CERS2;SPTSSA;TLCD3B;PAM;SMPD4
prerank,regulation of macrophage cytokine production (GO:0010935),0.45768298081975767,1.010200262514176,0.4653179190751445,1.0,1.0,4/13,14.28%,WNT5A;GPRC5B;CUEDC2;TGFB1
prerank,regulation of cell communication (GO:0010646),0.3871388911815646,1.0097442755977772,0.45095693779904306,1.0,1.0,8/35,14.61%,ANXA1;NCLN;YWHAG;GRK3;IGFBP7;CAMK2D;MTCH1;GRK2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.45788180619884133,1.0094922752070516,0.4782608695652174,1.0,1.0,3/12,8.12%,SDE2;FBXO31;PLK5
prerank,regulation of mRNA metabolic process (GO:1903311),0.47892848376760244,1.009037486614865,0.47384155455904337,1.0,1.0,5/11,19.61%,SLTM;PTCD2;SAFB2;SRPK1;CDK11B
prerank,hippo signaling (GO:0035329),0.39812575684581264,1.0080465605668738,0.4612546125461255,1.0,1.0,3/26,7.26%,TEAD3;DVL2;TEAD1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.46874227235856963,1.0073501374477396,0.47050359712230216,1.0,1.0,6/12,19.58%,ABCA2;ABCA7;TMED10;ROCK2;APOE;RANBP9
prerank,cellular iron ion homeostasis (GO:0006879),-0.24270482839763788,-1.0072386929452044,0.4166666666666667,0.8513456973360769,1.0,8/55,4.52%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.33193561396346144,1.0067972568156252,0.47874493927125505,1.0,1.0,33/148,19.18%,IL34;INCENP;HSP90AA1;CALM3;MAPRE3;TAOK1;DDX3X;MINK1;DDR2;DLG3;PAK3;EZH2;STK11;LRP8;MMD;GPRC5B;XRCC6;MRNIP;SRCIN1;JTB;STRADB;ALS2;IQGAP1;EMP2;PARP16;MAP2K2;SLC27A1;DAXX;CCDC88A;RASSF2;CALM1;PRKAG2;NRK
prerank,proteasome assembly (GO:0043248),0.4605773296643069,1.0064835781210695,0.47147147147147145,1.0,1.0,5/11,21.96%,PSMD4;PSMD11;POMP;PSMD5;OTUD6B
prerank,positive regulation of positive chemotaxis (GO:0050927),0.435932042552731,1.005687375911865,0.45706371191135736,1.0,1.0,2/15,4.50%,NTF3;CXCL12
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3183895818119026,-1.0056428715120382,0.4180327868852459,0.8537571041095268,1.0,4/20,20.32%,AKR1B1;STARD3NL;FDX1;TSPO
prerank,gliogenesis (GO:0042063),-0.3499024719683527,-1.0055461348326826,0.43389830508474575,0.8520264617407057,1.0,5/15,13.01%,NFIB;RELN;TGFB2;CDK6;METTL3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3416152214923204,-1.005495067454455,0.44,0.8501401916686415,1.0,6/18,23.74%,JAM2;SLC39A8;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.26764916602037286,-1.0054802878134497,0.43537414965986393,0.8481862140668356,1.0,16/36,27.17%,EGFR;CAV1;NUS1;HIF1A;SCARB1;NOS3;NOSTRIN;NOSIP;GCH1;AKT1;DDAH2;CYGB;TERT;SPR;WASL;S100A1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4777688982844991,1.0054460687802487,0.48089171974522293,1.0,1.0,2/10,8.54%,EIF2AK3;DDIT3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.37041563551384193,1.0050753369458438,0.47410817031070196,1.0,1.0,11/42,19.07%,PARP1;ACTR2;FBH1;FUS;WRAP53;KLHL15;MRNIP;MMS19;HELB;TERF2IP;PPP4C
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4061126510258226,1.0042296656745233,0.48089591567852435,1.0,1.0,3/22,9.49%,ALDH1A2;GC;RBP1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.35225095070366175,-1.004208638786574,0.461864406779661,0.849665261929983,1.0,4/16,10.48%,PDS5B;RB1;PDS5A;MAU2
prerank,peptidyl-lysine modification (GO:0018205),0.33704266275520345,1.003750052899686,0.487551867219917,1.0,1.0,29/99,20.92%,NDUFAB1;SIRT2;SIRT7;USPL1;SAE1;RAE1;PLOD1;ETFBKMT;HDAC4;NUP188;SENP5;VPS33B;PARK7;NUP210;NUP88;PIAS3;NUP214;ATPSCKMT;SIRT5;TOPORS;NUP153;RANBP2;NUP35;PIAS1;LOXL1;SUMO2;EYA1;SENP7;TPR
prerank,heme catabolic process (GO:0042167),-0.3595563378508534,-1.00371555626972,0.45357142857142857,0.8472119727030047,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3595563378508534,-1.00371555626972,0.45357142857142857,0.8472119727030047,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,positive regulation of catalytic activity (GO:0043085),-0.2677033259462691,-1.0036496852888015,0.4235294117647059,0.8454196985786077,1.0,10/37,16.62%,XRCC4;MAPK8;CAV1;PHACTR4;NCSTN;MSH2;IGF2;NHEJ1;ABL2;APH1A
prerank,iron-sulfur cluster assembly (GO:0016226),0.40658590359478963,1.003474511555425,0.4936868686868687,1.0,1.0,6/24,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3712630668786189,1.0033784259602292,0.478110599078341,1.0,1.0,7/41,13.71%,IL34;DLG3;LRP8;GPRC5B;EGF;SRCIN1;DOCK3
prerank,regulation of ATP metabolic process (GO:1903578),0.35485064765341356,1.003371207108798,0.470917225950783,1.0,1.0,16/54,19.14%,FIS1;SLC25A33;OGT;RAE1;COX7A2;NUP188;PGAM1;AK4;NUP210;NUP88;UQCC2;NUP214;NUP153;RANBP2;PRKAG2;NUP35
prerank,myeloid cell development (GO:0061515),-0.3288406703767269,-1.0032037120930641,0.41509433962264153,0.8446629421914714,1.0,8/18,24.04%,FOXP1;MED1;KIT;SRC;ABCB10;SH2B3;NRROS;NCKAP1L
prerank,regulation of gene expression (GO:0010468),0.3217857317715949,1.002830681457425,0.491,1.0,1.0,204/903,19.85%,FGF20;SFRP2;APLN;FGF9;KHSRP;AFF2;MAPK9;WNT5A;EPB41L4B;TMEM119;SFRP1;IGF1;DVL2;EPHB2;ANXA7;NFKB1;BMP6;FAM50A;EIF2AK3;IL33;EDN3;PCBP4;NR1D2;PCGF1;PTHLH;WARS1;ERP29;RORA;NFKB2;ZFP36L1;DDX3X;PSPC1;ZNF205;TRIM11;SNF8;C1QTNF1;NELL1;FGF10;IGF2BP2;FUBP1;FLCN;OLFM1;NPAT;CNBP;ABL1;ATXN1;PHF1;ATG14;DVL1;ZNF35;CELF1;CASZ1;HNRNPK;EZH2;FUS;ZBTB7B;NOS1AP;MAGED1;ZNF711;HGS;HDAC5;SIRPA;ADNP;SEC16B;ZBTB38;ASCC1;PID1;ZKSCAN5;ACTR8;NFX1;SFMBT2;WNT4;SOX9;DDIT3;PER1;HNRNPD;RBMS3;DHX36;EGF;PRMT5;HDAC4;TRIM17;SOX11;SAP30L;TWIST1;CALCOCO1;MUSK;FADS1;ZC3H7B;RBL2;GDNF;ATF2;POU6F2;CAVIN4;PIK3CB;APP;NSD3;RBPJ;SART3;ANK3;MAZ;ROBO1;FOXN3;IFNGR1;YY1;NUDT21;BACH1;PARK7;ZNF462;PEG3;SOX6;TADA3;HDAC1;AGO3;RACK1;HNRNPH3;LAMTOR5;HNRNPL;SUFU;PARP14;TLR3;TRA2B;PTPN22;C1D;ATRX;FAM98A;MAPT;NOVA1;ROCK2;TGFB1;ESRRG;MAP2K2;TULP3;BCL6;EPHX2;KMT2D;F3;HNRNPLL;ZUP1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;CTSH;GRSF1;AHNAK;GTF2IRD1;CHEK2;HNRNPDL;YTHDC1;NDFIP2;SBNO1;CLOCK;MEGF8;TRIP4;KDM6B;DAXX;UBE2L3;UBR5;CLK4;TIPARP;ZFP37;SPRY2;ZC3H7A;SOX13;OSR1;APOE;HP1BP3;SON;TLE5;TCF7;NFXL1;NSD1;CAMK2N1;PCBP2;PHF12;ATRAID;MECP2;GCFC2;NONO;TGFBR1;TERF2IP;PDCD5;PRKAA1;TRIM27;FOXD1;NUP35;SOX4;BRDT;YAF2;YTHDF2;RPS3;KDM6A;MITF;CDK11B;KLF4;WWC1;CARM1;GABPA;NFIA
prerank,negative regulation of translational initiation (GO:0045947),-0.373632003884777,-1.0028160179814456,0.43252595155709345,0.8437636690976269,1.0,5/13,9.38%,EIF3E;EIF2AK4;AGO2;EIF2AK1;RBM4
prerank,mitochondrion organization (GO:0007005),0.33154485109731974,1.0025649755983497,0.513677811550152,1.0,1.0,44/165,20.14%,BAX;DNM1;CHCHD10;BCS1L;PARP1;MSTO1;FIS1;AIFM2;USP30;MYH14;SLC25A33;TOMM20;FBXO7;TIMM13;MIEF2;SLC25A36;MFN1;COX7A2;FANCG;PID1;MFN2;AIP;MTFR1L;AFG3L2;PTCD2;PARK7;GDAP1;WASF1;MTX3;DNM1L;HSPD1;TFB1M;TRAK1;SIRT5;MTX2;VPS13D;OMA1;GABPB1;ATCAY;AGTPBP1;OXA1L;GABPA;TIMM44;TIMM22
prerank,eye development (GO:0001654),-0.24982665079462757,-1.002371863579394,0.41818181818181815,0.8431247959052978,1.0,14/54,16.74%,HIPK2;SMOC1;COL5A1;RAB18;RBP4;TGFB2;CACNA1C;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2
prerank,positive regulation of secretion by cell (GO:1903532),0.3493414134441947,1.002291308741105,0.47943722943722944,1.0,1.0,11/70,14.84%,UNC13D;IGF1;BMP6;EDN3;SOX11;MYH10;RAB2B;TMED10;TGFB1;GRK2;DNM1L
prerank,protein localization to cell junction (GO:1902414),0.4020700332545275,1.002153287867356,0.4782608695652174,1.0,1.0,6/22,19.05%,MPP4;KIF3A;JAM3;NLGN2;JAK1;SHANK1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41837212070741403,1.0020699746128592,0.4701298701298701,1.0,1.0,6/19,14.84%,CSNK2A2;FBXO7;PARK7;VDAC1;HTT;DNM1L
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3894975177879035,1.0019460556583932,0.48825710754017304,1.0,1.0,7/29,17.92%,ARRDC4;ABL1;FBXO5;PARK7;UBE2L3;TOPORS;DCUN1D5
prerank,cellular response to UV (GO:0034644),0.34653776676995585,1.001888009389747,0.483974358974359,1.0,1.0,14/76,12.82%,MFAP4;PARP1;SDE2;CARD16;USP47;DDB1;STK11;CDC25A;DHX36;CUL4B;CASP9;YY1;NPM1;ATR
prerank,nuclear pore complex assembly (GO:0051292),-0.4075984308388977,-1.0017907416665879,0.4367816091954023,0.8428497752676124,1.0,5/10,21.50%,NUP205;NUP93;NUP107;NDC1;TMEM170A
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.43457351750031575,1.0013155068391693,0.4825268817204301,1.0,1.0,4/16,14.35%,A4GALT;ST8SIA3;ST3GAL5;ST6GALNAC6
prerank,gene silencing by miRNA (GO:0035195),-0.2788160567614189,-1.001046118837894,0.4647058823529412,0.8430561067105373,1.0,7/32,9.38%,CNOT1;TNRC6A;PUM1;XPO5;AGO2;LIMD1;RBM4
prerank,chromatin remodeling (GO:0006338),0.3396279770048176,1.0009970089820597,0.5035897435897436,1.0,1.0,25/100,16.74%,KDM4D;MPND;SMARCD3;SMARCC2;GATAD1;CHD8;RBBP4;SMARCB1;HDAC5;ACTR8;SOX9;SMARCD1;ARID1B;HDAC4;JARID2;TOP1;SMARCA1;MTA2;NPM1;HDAC1;ATRX;BAZ2B;SATB1;KDM6B;DAXX
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29474586359060584,-1.0009896175023048,0.4205607476635514,0.8412532823351866,1.0,5/25,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,regulation of cellular component size (GO:0032535),-0.27959051009789426,-1.000954314949882,0.4375,0.8394214128618441,1.0,8/30,8.61%,PICALM;RDX;MTPN;RIN3;RARG;EPS8;EZR;RAB22A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3488784206035362,1.000598034886032,0.4936440677966102,1.0,1.0,14/75,17.48%,RNF157;GUCA1B;GNG7;METAP1;NMT1;ZDHHC3;PPP1R9B;RIC8B;GIT1;METAP2;ROCK2;TULP3;MRAP2;USP33
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37750711902655926,1.0005760770070626,0.47794994040524436,1.0,1.0,7/38,10.96%,BMP6;POLR3D;PRKCA;DHX58;IFI35;LY96;USP15
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.43337969765690976,1.000183042644526,0.4738292011019284,1.0,1.0,4/16,11.29%,NRP1;ABL1;PLAT;PDGFRA
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4376204183217359,1.0001711393467554,0.4841040462427746,1.0,1.0,3/14,10.20%,STAT6;PIK3R1;PRLR
prerank,regulation of macromolecule metabolic process (GO:0060255),0.32929325924803693,1.0001212626463403,0.4954591321897074,1.0,1.0,40/170,19.43%,KHSRP;AFF2;IGF1;EDN3;PCBP4;PTHLH;ZFP36L1;TRIM11;NELL1;IGF2BP2;FUBP1;NPAT;HNRNPK;ZNF711;SIRPA;ADNP;HNRNPD;TRIM17;GDNF;CAVIN4;ZNF445;APP;SART3;ZNF462;PEG3;C1D;NOVA1;ROCK2;ZUP1;HNRNPDL;MTMR4;MEGF8;KDM6B;APOE;PCBP2;ATRAID;FLOT1;TRIM27;SCARB2;KDM6A
prerank,fatty acid beta-oxidation (GO:0006635),0.3614323428316796,0.9999691806981986,0.49136939010356734,1.0,1.0,15/51,16.69%,ACAD10;HADHB;ACAT1;HSD17B4;CROT;AMACR;CPT2;EHHADH;MECR;ECHDC1;ABCD2;ACOX3;ETFA;ACADL;ACADVL
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32419380861650315,0.9999547800789162,0.5045226130653266,1.0,1.0,55/260,16.17%,S1PR2;TMEM138;B9D2;CENPJ;AIF1L;CPLANE2;STK36;RAC1;IFT52;WHAMM;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;MINK1;CLUAP1;NRP1;TCTN1;BBS7;INPP5E;SRGAP2;ARHGEF7;ARHGEF4;DMTN;SNX10;RAP2A;RHOD;CDC14B;CCDC28B;CYFIP1;PIBF1;PPP1R9B;SDCBP;CFAP54;TTC8;CEP126;CC2D2A;IFT80;ABLIM2;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;EMP2;DISC1;ATP6V1D;TMEM216;RFX3;OFD1;RAB8A;RAB8B;AHI1;ARHGEF6
prerank,response to interleukin-6 (GO:0070741),0.48269886103971993,0.9998681995803796,0.49056603773584906,1.0,1.0,2/10,7.65%,NFKB1;PID1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.432904807896476,0.9996049951064429,0.46879150066401065,1.0,1.0,4/16,12.87%,FLCN;RRAGA;GPR137C;LAMTOR5
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4061501870251311,0.9995490551615986,0.47477360931435963,1.0,1.0,6/24,10.02%,AEBP2;CREBZF;RBBP4;PHF1;EZH2;JARID2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.40884499570277205,0.9993346393016023,0.46983311938382544,1.0,1.0,2/22,3.11%,CDKN2D;PRKRIP1
prerank,regulation of protein localization (GO:0032880),0.3576392195884593,0.9992688411771932,0.47845303867403316,1.0,1.0,11/58,12.69%,TRIM67;PARP1;HSP90AA1;STX6;DVL1;MMD;TRIM17;RABGAP1L;PLEKHM2;DNAJB6;RACK1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.39668875556809635,-0.9991429054740026,0.4798657718120805,0.8406065933490419,1.0,4/10,45.28%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.39668875556809635,-0.9991429054740026,0.4798657718120805,0.8406065933490419,1.0,4/10,45.28%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3201219168377117,0.9991392455262663,0.494,1.0,1.0,214/1082,18.39%,PSRC1;SFRP2;METTL23;ILF3;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;SFRP1;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;ZBTB48;SIRT7;DDX17;MYRF;CRTC1;NFKB1;SMARCD3;CHCHD10;BMP6;PARP1;ZEB2;EIF2AK3;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MAPRE3;MED12;SMARCC2;MED14;GLIS2;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;KMT2B;NFKB2;DDX3X;BRPF1;LPIN1;SNX5;CCNC;OGT;CHD8;POU2F1;IL31RA;RFX5;SNAI1;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;ASF1A;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;TRIM56;AKAP8L;ARNT;ANKRD49;ZNF711;SMARCB1;DHX33;TEAD1;TGFB1I1;HDAC5;MOSPD1;RAI1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;WNT4;SLC30A9;SOX9;SMARCD1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;YWHAH;PER1;HNRNPD;ECD;ARID1B;DHX36;EGF;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;PSMC5;BRD8;APP;TAF6;NSD3;JUP;RBPJ;GLIS1;RFX4;PIK3R2;MAZ;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;TADA3;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;MMS19;ABHD14B;FOXJ3;ATRX;AUTS2;ZIC2;TGFB1;MED21;RGMA;ESRRG;MAP2K2;BCLAF1;THOC1;KMT2D;RGMB;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;CHEK2;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;TRIP4;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;APOE;ZFP90;TNIP1;NSD1;GABPB1;GABPB2;MEIS2;TBL1XR1;ILK;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,regulation of DNA repair (GO:0006282),0.36671667097279625,0.9990698188122724,0.46924829157175396,1.0,1.0,19/44,21.97%,SIRT7;RNF8;USP1;FGF10;CDK9;WRAP53;RNF168;UBE2V2;POLH;CEBPG;AXIN2;EYA2;UBR5;UIMC1;RPS3;EYA1;TRIP12;NPAS2;UBE2V1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.45455330088593027,0.9990631614303891,0.4876632801161103,1.0,1.0,5/12,23.24%,UNC13A;SYT1;UNC13B;SYT7;SYT2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.21323108844852035,-0.999019893388991,0.3939393939393939,0.8371000295062094,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,cellular response to lectin (GO:1990858),-0.21323108844852035,-0.999019893388991,0.3939393939393939,0.8371000295062094,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,negative regulation of programmed cell death (GO:0043069),0.3235706167633478,0.9989165431260969,0.502,1.0,1.0,74/355,19.03%,RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;BNIP1;TAF9B;AIFM2;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;NUAK2;IL31RA;MGMT;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;HNRNPK;ZFAND6;IFIT3;XIAP;SOX9;UBE2Z;MALT1;GDNF;PRLR;PSMC5;BCL2;BNIP2;PARK7;NPM1;HDAC1;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;TOPORS;ANXA4;GPX4;KLHL20;BAG4;PRKAA1;BIRC3;FMN2
prerank,regulation of blood coagulation (GO:0030193),0.4031076015127908,0.9983725533981553,0.49506172839506174,1.0,1.0,6/27,17.19%,VTN;EPHB2;DMTN;TFPI;SERPINE1;APOE
prerank,positive regulation of glucose import (GO:0046326),0.4077042236704471,0.9983471432107048,0.4699738903394256,1.0,1.0,5/21,13.35%,IGF1;CAPN10;PIK3R1;IRS2;PRKCI
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.36154417131895866,0.9983388453946761,0.49311926605504586,1.0,1.0,10/45,11.68%,RBM4B;RBM3;METAP1;ATG14;CYFIP1;PER1;PUM3;ZC3H7B;APP;NUDT21
prerank,aerobic electron transport chain (GO:0019646),0.3492988620835236,0.9982778682989365,0.4977924944812362,1.0,1.0,11/68,10.38%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4373458123936873,0.9980840484430796,0.4849315068493151,1.0,1.0,3/16,10.90%,IGF1;FGFR2;RBPJ
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4367660614381578,0.9974935214783367,0.5,1.0,1.0,5/15,15.82%,MVB12A;EGF;RBPJ;RHBDF1;PTPN12
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.37857373811355455,0.9974537562985633,0.4710843373493976,1.0,1.0,8/32,15.16%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;BRSK1;FOXN3;MRE11
prerank,neuron maturation (GO:0042551),0.4285636241740961,0.9972345881725706,0.4816824966078697,1.0,1.0,7/18,18.42%,PICK1;EPHA8;APP;B4GALT5;MTCH1;FARP2;ADGRB3
prerank,hexose metabolic process (GO:0019318),0.3717377099761407,0.9971407523236375,0.48259860788863107,1.0,1.0,2/39,2.71%,GALT;GALK1
prerank,histone mRNA metabolic process (GO:0008334),-0.29715821725455427,-0.9971111729176203,0.4079601990049751,0.8406700070789984,1.0,15/27,26.25%,NCBP1;TENT2;CPSF2;LSM1;SNRPB;SNRPD3;ERI1;UPF1;NCBP2;TUT1;TUT4;SNRPG;SNRPE;SNRPF;SSB
prerank,detection of visible light (GO:0009584),-0.3334609055486314,-0.996979032722959,0.4637096774193548,0.8391810872268363,1.0,4/16,24.03%,ABCA4;GNA11;CEP250;RP1
prerank,Rho protein signal transduction (GO:0007266),0.35188301674546313,0.9969770617227047,0.4966960352422907,1.0,1.0,13/53,16.48%,CDC42EP5;CDC42EP4;CTNNAL1;RHOD;RIPOR1;ADGRG1;RTKN;COL1A2;PLEKHG5;ARHGAP29;ROCK2;EPS8L1;AGTR1
prerank,embryonic heart tube development (GO:0035050),-0.35715082527008546,-0.9963748026522689,0.4312267657992565,0.8389457063160894,1.0,8/14,32.34%,IFT122;ACVR1;HES1;SOX17;CITED2;TBX2;RYR2;SOX18
prerank,positive regulation of hydrolase activity (GO:0051345),0.330870609735728,0.996124947419392,0.5051020408163265,1.0,1.0,24/137,12.69%,SFRP1;CDKL5;TBC1D7;CALM3;SGSM3;RAP1GDS1;RGS10;FLCN;MTCL1;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RCN3;RAP1GAP;DOCK8;RAPGEF1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.28249831650986884,-0.9960763841302678,0.5051546391752577,0.8379219815960833,1.0,10/29,19.16%,UBE2K;SAMHD1;IFNAR2;STAT2;HSP90AB1;CDC37;METTL3;MAVS;CNOT7;USP18
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3672359903918437,0.9960727978579478,0.49884526558891457,1.0,1.0,9/38,16.71%,SFRP1;DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;ICAM1;SERPINE1;FAIM2
prerank,blood circulation (GO:0008015),0.3581353456694383,0.9960658394337059,0.4818181818181818,1.0,1.0,9/49,16.76%,TNNI3;EDN3;CXCL12;SERPING1;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,membrane assembly (GO:0071709),0.37806806328665266,0.9958320561517358,0.4853658536585366,1.0,1.0,15/34,24.28%,UBXN2A;TLCD1;STX2;ANK3;IL1RAPL1;NLGN3;EMP2;NLGN2;SPTBN1;ANXA2;FLOT1;CHMP4B;LRP4;PTEN;NRXN2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4175142418226381,0.9955032074064932,0.4857142857142857,1.0,1.0,3/18,11.07%,PPIF;THEM4;BCL2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3634546987296655,-0.9954819654019771,0.426056338028169,0.8376027115595411,1.0,3/14,5.38%,ANKRD17;PUM1;ZDHHC5
prerank,negative regulation of ossification (GO:0030279),0.40467881739737716,0.9953019135498261,0.5145385587863464,1.0,1.0,5/23,14.82%,SFRP1;SOX9;RBPJ;ENPP1;SMAD6
prerank,regulation of fatty acid oxidation (GO:0046320),0.42816146811744904,0.9952601575811346,0.47711511789181693,1.0,1.0,6/16,21.10%,MLYCD;SOX9;ACADL;ACADVL;PRKAG2;APPL2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.26308640526348265,-0.9948480416210234,0.4264705882352941,0.8375452073062892,1.0,6/42,7.91%,DROSHA;IL6R;RNASE3;LBP;TLR4;RPS19
prerank,T cell activation involved in immune response (GO:0002286),0.46056588402921383,0.9947451607915788,0.4977843426883309,1.0,1.0,1/12,0.97%,LCP1
prerank,negative regulation of viral process (GO:0048525),0.35651924971865184,0.9940317222787213,0.5005512679162073,1.0,1.0,12/57,18.85%,ILF3;HEXIM1;TRIM11;TRIM35;TRIM62;CHMP3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;TRIM27
prerank,carbohydrate catabolic process (GO:0016052),0.37811472175387134,0.9939986932693272,0.5085714285714286,1.0,1.0,6/38,11.10%,HKDC1;MAN2C1;MANBA;PGAM4;PGAM1;ENO2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.34686722206629783,0.9939686628803585,0.5027563395810364,1.0,1.0,11/69,10.38%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.24477449964674233,-0.9937908648335713,0.49504950495049505,0.8387332907629216,1.0,11/56,10.62%,IRAK2;LBP;IRAK1;NOD1;HSP90B1;UNC93B1;TLR4;CTSL;PLCG2;UBB;ALPK1
prerank,response to peptide (GO:1901652),0.3803779043496328,0.9937472532170781,0.4807692307692308,1.0,1.0,3/33,3.76%,MMP12;STAT6;ANXA1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.37366057256303065,0.9937383400809029,0.47235023041474655,1.0,1.0,8/38,15.95%,CENPT;UBN1;RBBP4;ASF1A;NPM1;CENPC;ATRX;HAT1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4165925036400328,0.9936921357157569,0.47748976807639837,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4165925036400328,0.9936921357157569,0.47748976807639837,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,positive regulation of catabolic process (GO:0009896),0.3475517480938325,0.9934851967822689,0.5081081081081081,1.0,1.0,19/65,21.64%,WNT5A;ASB5;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;EGLN2;RNF41;NKD1;NSF;TIPARP;SMURF1;SORL1;STX5;HECW2;FOXO1;RAB7A
prerank,regulation of phospholipase C activity (GO:1900274),0.4266628494516211,0.9931944459955586,0.4993197278911565,1.0,1.0,4/15,11.29%,NTF3;FGFR1;ABL1;PDGFRA
prerank,positive regulation of cell cycle process (GO:0090068),0.33747155676389956,0.9930825582543498,0.5094736842105263,1.0,1.0,20/91,20.92%,IGF1;SIRT2;EDN3;MAD2L1;CDC14B;CIT;EGF;GPSM2;USP19;DYNC1LI1;SVIL;ATRX;CSPP1;CEP120;NUMA1;PHIP;RAD21;KIF20B;INO80;TPR
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.45110979751161323,0.9928422547175291,0.4723404255319149,1.0,1.0,4/12,16.44%,CD24;IQGAP1;MAGI2;JAG1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3449171858695118,0.9924121708869007,0.512987012987013,1.0,1.0,13/72,13.73%,COPS7A;LIG1;USP7;POLR2B;DDB1;LIG3;COPS7B;CUL4B;GTF2H3;TCEA1;POLR2K;CCNH;POLD3
prerank,protein deubiquitination (GO:0016579),0.3240813496717095,0.9921373283662601,0.522567703109328,1.0,1.0,69/242,20.05%,CCP110;OTULINL;PSMD4;IL33;TAF9B;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB
prerank,mitotic spindle organization (GO:0007052),0.33041507604406983,0.9918925312663026,0.5363636363636364,1.0,1.0,35/153,19.92%,B9D2;CENPT;CCDC61;INCENP;TAOK1;MAD2L1;STAG1;ARHGEF10;NEK9;WRAP73;KPNB1;DCTN6;PIBF1;PPP1CC;ABRAXAS2;VCP;MAP9;CEP126;GPSM2;DYNC1LI1;SPICE1;RCC1;CENPC;STAG2;ZWINT;OFD1;CHEK2;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,O-glycan processing (GO:0016266),0.35186329278455697,0.9917562817014438,0.5043956043956044,1.0,1.0,10/54,17.94%,C1GALT1C1;ST3GAL2;GALNT4;ST3GAL3;POMGNT1;B4GALT5;GXYLT1;GALNT15;GALNT14;GXYLT2
prerank,regulation of presynapse assembly (GO:1905606),0.4211645801020749,0.9915229323350718,0.47275204359673023,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),0.4211645801020749,0.9915229323350718,0.47275204359673023,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.39250838913942254,0.991175369370174,0.4841168996188056,1.0,1.0,8/25,24.17%,HSP90AA1;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,amino sugar metabolic process (GO:0006040),-0.39466642253437556,-0.9910470738087426,0.4307228915662651,0.844547138098689,1.0,7/10,31.55%,CSGALNACT1;ST3GAL1;GFPT1;GFPT2;ST6GAL1;SLC35A3;FN3K
prerank,establishment of protein localization to organelle (GO:0072594),0.34388223297358084,0.9908884875894586,0.5027322404371585,1.0,1.0,13/72,15.33%,IL10RA;MMP12;TSC2;NXT2;NXT1;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.21283885447402057,-0.9908052073499707,0.4,0.8433338325899677,1.0,21/105,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,mRNA export from nucleus (GO:0006406),0.3320699685253165,0.9907102837139737,0.5175619834710744,1.0,1.0,35/102,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;DDX19A;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,positive regulation of cell death (GO:0010942),0.3540997583492609,0.9906838294086252,0.4988888888888889,1.0,1.0,11/59,16.74%,WNT5A;FCGR2B;HTATIP2;CELF1;EFNB2;AXIN2;LRP1;MAPT;FAF1;SLC6A13;DAXX
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.35544178897161305,0.9904246243599177,0.49775280898876406,1.0,1.0,15/49,23.46%,PTGER4;LCMT1;DDX3X;PMEPA1;JAM3;PEX5;PARK7;IMPACT;SMAD6;SORL1;PPM1A;PRKCZ;HMGB1;RPL13A;IAPP
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.40627111422887663,0.9903752380360846,0.48638132295719844,1.0,1.0,9/22,21.94%,EAPP;CDK13;BRD4;CDC73;THOC1;CCNT1;CCNT2;HMGN1;TCERG1
prerank,response to estrogen (GO:0043627),0.3834719940993641,0.990218195179282,0.49938650306748467,1.0,1.0,6/31,15.00%,WBP2;SFRP1;CD24;SRA1;NCOA4;KMT2D
prerank,negative regulation of reproductive process (GO:2000242),0.4316421890587688,0.9895777581740015,0.5073825503355704,1.0,1.0,2/17,5.67%,IGF1;SULF1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4106145992476802,0.9891566438306735,0.47757255936675463,1.0,1.0,2/21,3.64%,EPHA7;GRIN1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.43361814455369363,0.9886737405174657,0.5100671140939598,1.0,1.0,3/15,9.32%,REEP4;ATL1;RAB10
prerank,mesenchyme morphogenesis (GO:0072132),-0.3410961625055414,-0.988393332969376,0.4806201550387597,0.8479179315360964,1.0,5/17,7.77%,TGFB2;NOS3;ACVR1;ENG;BMPR1A
prerank,negative regulation of telomere maintenance (GO:0032205),0.4302623240729754,0.987534942751379,0.4827586206896552,1.0,1.0,7/15,23.45%,PARP1;RAD50;TERF1;TNKS;TERF2IP;PINX1;ATM
prerank,regulation of interleukin-1 production (GO:0032652),0.43691229224478156,0.9874233708495043,0.49064171122994654,1.0,1.0,3/15,12.75%,ANXA1;SIRPA;TMED10
prerank,macromolecule catabolic process (GO:0009057),0.39041310441164523,0.9873749455201363,0.48525798525798525,1.0,1.0,7/26,20.44%,MVB12A;CLN6;UCHL3;TGFB1;SMURF1;PIK3R4;UVRAG
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.33865199872057195,0.9872383347178755,0.5164021164021164,1.0,1.0,25/87,20.73%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;SLC25A33;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;SDHAF3;COX17;UQCC2;COA8;COX16;NDUFB4;NDUFA6;DMAC2;OMA1;NDUFA2;OXA1L;NDUFB3;NDUFA12
prerank,multivesicular body assembly (GO:0036258),0.3803609064212098,0.9872299248455916,0.4968394437420986,1.0,1.0,6/30,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3631717715647703,0.9869237324561184,0.49529411764705883,1.0,1.0,11/40,16.79%,SIRT7;USP1;CDK9;ABL1;FBXO5;UBE2V2;CASP9;POLH;MAPT;BCLAF1;FMR1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.27706782464877866,-0.9866344128970601,0.4887640449438202,0.8509370269292506,1.0,6/32,7.94%,MEF2C;PREPL;RIMS2;SYN1;LRRK2;DTNBP1
prerank,cellular glucose homeostasis (GO:0001678),0.36439701900572924,0.9866175863996569,0.5017142857142857,1.0,1.0,9/41,15.12%,HKDC1;LRRC8A;XBP1;PIK3R1;ZBTB20;PIK3R2;RACK1;TRA2B;NUCKS1
prerank,regulation of telomere capping (GO:1904353),0.40239803101542754,0.9865428861485928,0.4961832061068702,1.0,1.0,6/23,17.42%,PKIB;USP7;HNRNPD;RAD50;TNKS;NABP2
prerank,positive regulation of developmental process (GO:0051094),0.3257771554985335,0.9861643117057656,0.5267406659939455,1.0,1.0,42/164,19.65%,WNT5A;TMEM119;CAMK2B;DVL2;EDN3;FIS1;FGFR1;XBP1;DCN;MIEF2;ANAPC2;FBXO5;ARHGEF7;DVL1;LRP8;SOX9;VLDLR;GDNF;ENPP2;BMP5;DAG1;SOX6;B4GALT5;RPS6KA3;ZBED3;SOX5;DNM1L;NR2C2;ACVR1B;RPS6KA1;SPIRE1;NUMA1;PHLDB1;FMR1;APOE;BMP1;SORL1;HMCES;FOXD1;SHANK1;KMT5B;NCOA3
prerank,negative regulation of viral release from host cell (GO:1902187),0.447375458247956,0.9855824506088173,0.4930167597765363,1.0,1.0,6/13,22.47%,TRIM11;TRIM35;CHMP3;MID2;TRIM26;TRIM8
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.44996222888489623,0.9853414849412209,0.5059347181008902,1.0,1.0,2/11,11.23%,ANXA1;RC3H2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2733276469533521,-0.9852727725371461,0.45294117647058824,0.8529272671059418,1.0,10/33,25.98%,CHRM3;KCNJ2;AKAP9;ANO6;NEDD4L;P2RX7;KCNJ3;KCNQ1;KCNJ12;WNK1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.2852724050464721,-0.9848891216235894,0.4752475247524752,0.8520127596048467,1.0,5/27,5.16%,FLT1;KIT;IRS1;PRKD1;TEK
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.339054158818879,0.9848441480947853,0.519453207150368,1.0,1.0,24/85,21.81%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1;MAGI2;ROR2;PSMD1;PSMD6;SMURF1;PRICKLE2;PSMD5;PSMA4;FZD2;PSMA1;RYK;PSMC6
prerank,organelle organization (GO:0006996),0.31828597346583476,0.9846084622834869,0.542,1.0,1.0,109/388,21.64%,SPTBN5;IQCG;CENPT;CUL7;ATL1;TJAP1;BIN1;CHCHD10;UBXN2A;BCS1L;PARP1;EIF2AK3;MSTO1;BNIP1;TRAPPC8;KIF3A;SAR1A;SLC25A33;ANK1;OBSL1;RAB34;TNFAIP3;MAST3;MIEF2;THY1;SEC16A;SLC25A36;ARHGEF7;DMTN;MIA3;TRIP11;PDZD8;TTC17;NCKIPSD;SEC16B;FANCG;ATP8B2;PACSIN3;DES;LMAN2L;AUP1;ARHGAP21;CHMP3;TOR1B;TBC1D20;TPM1;PLEKHM2;PEX1;USP6NL;KIF5C;RAB30;PTCD2;YTHDF3;PARK7;TANGO2;VPS4B;TMED10;COG3;PRKCI;SNX11;PEX7;YTHDF1;HTT;CSNK1D;MTX3;SMPD4;PRPF40A;VMP1;DNM1L;CSNK1A1;RAB31;ARMC2;VAPB;ABCD2;STX17;TFB1M;SIRT5;VPS18;NUMA1;MTX2;PHIP;VPS13D;APOE;GORASP1;GABPB1;KLHL20;PKD2;ZFYVE16;ODF2;CDC42BPB;AGTPBP1;KIFAP3;YTHDF2;FAM174B;FGD4;RANBP9;ZW10;GABPA;TOR1AIP2;PAK5;DYNC2H1;ATL3;RHOU;CFL1;CLASP2;DIAPH1;CHMP4A;CHMP4B;RAB7A
prerank,modulation of chemical synaptic transmission (GO:0050804),0.33060699430681123,0.9845339267798275,0.5229645093945721,1.0,1.0,19/107,12.73%,CLN3;NPTXR;LRRC4;NTF3;UNC13A;CDK5;GRIK5;TMEM108;ATP1A2;LRP8;CPLX1;NMU;NRG3;CLSTN2;PSMC5;APP;MCTP2;NLGN3;SYT1
prerank,positive regulation of DNA replication (GO:0045740),-0.34412928658676667,-0.9845250293942683,0.48226950354609927,0.8511477002694908,1.0,4/16,7.16%,EGFR;KAT7;BCAR3;STN1
prerank,keratan sulfate metabolic process (GO:0042339),0.38218659183246145,0.9840207496271626,0.5055900621118012,1.0,1.0,7/31,15.67%,SLC35D2;GLB1;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3613116623946724,0.9832255521169871,0.5029585798816568,1.0,1.0,4/40,6.52%,GSDMD;RNASE7;TIRAP;GBP7
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3844035767085325,-0.983122812129902,0.46319018404907975,0.8532030223672388,1.0,4/11,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,sulfate transport (GO:0008272),-0.3597353530172745,-0.9828976417657962,0.4259927797833935,0.8519822205970167,1.0,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45838422757043373,0.9820920136285111,0.5067873303167421,1.0,1.0,2/11,2.21%,SLC25A19;DCK
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4240661134293944,0.9818715102554115,0.5171467764060357,1.0,1.0,6/16,21.69%,SNF8;VTA1;LEPROT;CHMP4A;CHMP4B;LEPROTL1
prerank,negative regulation of receptor binding (GO:1900121),0.46906135219830103,0.9815783567974249,0.5241691842900302,1.0,1.0,2/10,11.35%,ATP2A2;PTPRF
prerank,nucleic acid-templated transcription (GO:0097659),-0.2564603540340864,-0.9814736532703238,0.45806451612903226,0.8539625917210759,1.0,25/42,35.74%,EPC1;MEF2A;RRAGC;CREBL2;POLR3A;RNPS1;MED20;DTX1;PWP1;FUBP3;NR4A2;POLR2H;BCL3;TERT;POLR2G;POLR2F;POLR2C;PAX8;POLR2E;HOXD3;POLR2J;XAB2;NFKBIB;POLR2D;E2F1
prerank,positive regulation of intracellular transport (GO:0032388),0.3646313228638236,0.9813737558273029,0.4881516587677725,1.0,1.0,13/38,20.92%,MLC1;CAPN10;STK11;RIPOR1;TBC1D20;PGAP1;NUMA1;EIPR1;RUFY3;SORL1;KIF20B;EHD1;TPR
prerank,mitotic nuclear division (GO:0140014),0.34299965899976426,0.9813584888610254,0.5154419595314164,1.0,1.0,19/71,21.47%,CCDC61;UBE2S;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;ZWINT;OFD1;CHEK2;BCCIP;ZW10;INO80;CLASP2;CHMP4B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2850926166520624,-0.9811134069749401,0.4476744186046512,0.8530487169543676,1.0,16/29,30.26%,SORBS1;CREBL2;SCARB1;CREB1;NR1H3;CNEP1R1;SREBF1;ELOVL5;CTDNEP1;NR1H2;AKT1;PPARA;SLC45A3;MFSD2A;SIRT4;MID1IP1
prerank,regulation of protein ubiquitination (GO:0031396),0.33373039953506034,0.98079684031359,0.5452674897119342,1.0,1.0,27/108,19.43%,HDAC3;UBQLN1;PHF23;SIRT7;HSP90AA1;STUB1;TBC1D7;OGT;TNFAIP3;SQSTM1;MYCBP2;XIAP;ARRB1;CDK5RAP3;MALT1;PARK7;USP4;UBE2D1;NDFIP2;DERL1;DAXX;UBE2L3;SPRY2;TGFBR1;BIRC3;SOX4;RPS3
prerank,positive regulation of cellular catabolic process (GO:0031331),0.32752628146373725,0.9800156207242147,0.5556690500510725,1.0,1.0,32/132,18.85%,SLC4A4;KHSRP;IGF1;GPLD1;HSP90AA1;NRDC;FLCN;DCN;ARNT;STK11;PACSIN3;PRXL2C;LIN28B;TWIST1;IRS2;ZBTB20;PIK3CB;APP;RNF152;SNX33;DAPK1;FAF1;ABCD2;TPCN1;GRSF1;ZC3HAV1;ZSWIM8;MTDH;APOE;ZC3H18;PRKAA1;TRIM27
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.32622156837109917,0.9799785940829563,0.5400202634245187,1.0,1.0,32/161,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;KREMEN1;CSNK1A1;PSMD1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4584087177149673,0.9795941678615833,0.49709302325581395,1.0,1.0,5/11,23.39%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4584087177149673,0.9795941678615833,0.49709302325581395,1.0,1.0,5/11,23.39%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,carboxylic acid catabolic process (GO:0046395),0.4576136287487936,0.9794031522740954,0.51931330472103,1.0,1.0,2/12,4.80%,PON3;RENBP
prerank,negative regulation of hemostasis (GO:1900047),0.46511938642583406,0.9793473788986642,0.4978902953586498,1.0,1.0,4/12,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,RNA export from nucleus (GO:0006405),0.3302892142270346,0.979163404506308,0.5295950155763239,1.0,1.0,34/100,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,hemidesmosome assembly (GO:0031581),-0.3864416926412194,-0.9789990139591391,0.4890282131661442,0.8571031064722624,1.0,5/11,13.49%,DST;ITGA6;PLEC;LAMA3;ITGB4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4390991685252724,0.9788473098948617,0.5048143053645117,1.0,1.0,5/14,18.45%,AK4;AK5;ENPP1;AK3;CMPK1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.37231542176469734,0.9785882830157703,0.5090470446320868,1.0,1.0,8/32,12.75%,RBM4B;RBM3;METAP1;CYFIP1;PUM3;PGAM1;APP;TMED10
prerank,male meiosis I (GO:0007141),0.4229433230971777,0.9785085478263346,0.4945205479452055,1.0,1.0,4/16,21.15%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.38636386644379833,-0.9784603997257922,0.4880239520958084,0.8567619163123489,1.0,2/10,9.42%,LGALS9;RARA
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.443399274767981,0.9781256592242289,0.5200553250345782,1.0,1.0,3/13,12.23%,BAX;VDAC2;BLOC1S2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.22434537027774962,-0.9780978661684733,0.5918367346938775,0.855946769905565,1.0,36/88,24.63%,ANGPT1;CAV1;PTPRM;STAT1;SIRT1;PRKD1;NRAS;NRP2;TEK;HIF1A;AGGF1;THBS1;AIMP1;TIE1;ECM1;KDR;CAV2;AKT3;SCG2;BMP4;VEGFC;RGCC;TNFSF12;EMC10;VEGFA;NF1;PDCL3;AKT1;ATOH8;STAT5A;NR4A1;PIK3CD;VEGFB;SEMA5A;PGF;BMP2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.45155589034329585,0.977494770655728,0.5050798258345428,1.0,1.0,3/13,14.06%,NOP9;RCL1;BMS1
prerank,neurogenesis (GO:0022008),0.3658259093529638,0.9772411611213611,0.5231116121758738,1.0,1.0,15/43,23.94%,ANXA1;CXCR4;CIT;SPOCK1;NDUFS2;LPAR1;MAPT;TRAK1;BTBD3;BTBD1;BTBD2;RYK;METTL14;CDK5RAP2;FAT4
prerank,regulation of DNA metabolic process (GO:0051052),0.3579789416334174,0.977042950913348,0.5222857142857142,1.0,1.0,16/44,21.97%,SIRT7;WDR18;USP1;CDK9;HNRNPD;UBE2V2;POLH;HELB;THOC1;NUCKS1;TERF2IP;MPHOSPH8;KPNA1;SUB1;SMG1;UBE2V1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3460818164675886,0.9769067742381429,0.5209513023782559,1.0,1.0,17/51,21.25%,NTF3;TAOK1;MINK1;SRGAP2;DBN1;DBNL;ALS2;WASF1;EPB41L3;CNTNAP2;TRIO;SLC9A6;GAS7;KIF20B;NRK;NBL1;MAP4K4
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3014981906061467,-0.9768056154918608,0.4840182648401826,0.8576316752053924,1.0,11/21,31.33%,BACE2;ERAP1;BACE1;NCSTN;ADAM10;APH1A;PSEN2;SPPL3;ADAM19;RBMX;PSENEN
prerank,epithelial cell morphogenesis (GO:0003382),0.42174448288322003,0.9764771055511748,0.5310810810810811,1.0,1.0,2/17,6.62%,DACT2;COL22A1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.31675433201490033,0.9764175293828816,0.59,1.0,1.0,108/497,19.43%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;PAIP2;CIART;FOXM1;SIRT2;SELENOS;ZNF568;EIF2AK3;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;DDX3X;PSPC1;NIPBL;CHD8;POU2F1;CNOT10;CDK5;IGF2BP2;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;EPRS1;DPF2;XRCC6;PER1;DHX36;HDAC4;ARID4A;TWIST1;PUS7;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;EIF4E2;FOXN3;CNOT9;NACC2;MALSU1;ENPP1;HDAC1;BCL7A;RACK1;ATR;TSC22D4;EHMT1;GCLC;CIPC;DAPK1;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;MRPL13;RFX3;CIC;CTBP1;CLOCK;SNW1;TERF1;CBX5;DAXX;FMR1;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;SAMD4B;YAF2;RPS3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.406186775910489,0.9762603092662882,0.5079365079365079,1.0,1.0,4/19,10.71%,NFKB1;TMEM106A;EGF;APP
prerank,lysosome localization (GO:0032418),0.3687705873906003,0.976238409087874,0.5177304964539007,1.0,1.0,12/37,21.80%,KXD1;RAB34;FLCN;PLEKHM2;VPS33B;BLOC1S2;FAM98A;KIF5B;S100A13;ARL8B;MAP6;MYH9
prerank,double-strand break repair (GO:0006302),0.32506170519620087,0.9760788353207025,0.5412004069175992,1.0,1.0,35/158,16.27%,KDM4D;XRCC2;APTX;RNF138;PARP1;APLF;HELQ;RNF8;PAXX;PARP2;PALB2;FBH1;BARD1;TDP1;LIG3;IFFO1;ACTR8;RNF168;XRCC6;SEM1;UBE2V2;VCP;MDC1;DCLRE1A;YY1;BRIP1;POLN;RMI1;TDP2;SETX;NUCKS1;MRE11;PPP5C;CHEK2;RAD50
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.42534135608107804,0.9756854303241191,0.5162200282087447,1.0,1.0,3/15,14.38%,CLN3;ZDHHC3;NLGN2
prerank,cilium organization (GO:0044782),0.32024302251999953,0.9756286166925526,0.5707121364092277,1.0,1.0,41/210,15.88%,CCP110;TMEM138;B9D2;IQCG;CENPJ;CPLANE2;STK36;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;TCTN1;BBS7;INPP5E;SNX10;TTC17;CDC14B;CCDC28B;PIBF1;CFAP54;TTC8;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;ATP6V1D;TMEM216;RFX3;ARMC2;OFD1;RAB8A;RAB8B;AHI1
prerank,negative regulation of cell migration (GO:0030336),0.32281753026044924,0.9755568941704723,0.5485188968335035,1.0,1.0,53/137,25.61%,SFRP2;SFRP1;RAC1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;IGFBP3;ADGRG1;ROBO1;MAGI2;DAG1;NDRG4;LRP1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;ITGB1BP1;DPEP1;MCTP1;MITF;DLC1;EVL;ATP1B2;NF2;PTPRR;SMAD7;SRGAP1;DLG5;FGF2;CLASP2;IGFBP5;PFN2;HOXA7;EPHA4;DPYSL3;PTEN;ADARB1;CORO1C;PHLDB2;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3715545038796579,0.9753658201714782,0.5147579693034239,1.0,1.0,14/35,23.86%,CALM3;NUAK1;PPP1R2;PPP6R3;MAGI2;HTT;PPP1R11;TIPRL;CALM1;CALM2;ITGA1;PPP4R4;FKBP1A;TSC1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.35546090036398126,0.9750190674764712,0.5189003436426117,1.0,1.0,7/46,12.18%,IGF1;TNFAIP3;TCF7L2;MFN2;XRCC6;IGFBP3;NDRG4
prerank,cellular response to growth factor stimulus (GO:0071363),0.3265282342729292,0.9750139540850673,0.5606060606060606,1.0,1.0,40/151,21.10%,WNT5A;CLEC3B;SFRP1;SIRT2;ADAMTS7;MTSS2;PDPK1;BMP6;SMAD9;ANXA1;ZFP36L1;NRP1;PLK5;WNT4;SOX9;RAPGEF1;IQGAP1;MAGI2;SOX6;RACK1;SETX;MAPT;TGFB1;SOX5;ACVR1B;PTPN12;NDNF;ITGB1BP1;SPRY2;PRKD2;TGFBR1;PDCD5;WWOX;KLF4;MAPKAPK2;EHD1;ACVR2A;NTRK2;SMAD7;APPL2
prerank,ceramide transport (GO:0035627),0.45088081479880737,0.9750015449309297,0.5348837209302325,1.0,1.0,3/12,13.84%,ABCA2;PLEKHA3;PSAP
prerank,negative regulation of cellular component organization (GO:0051129),0.33735987203341483,0.9748060196728303,0.5365853658536586,1.0,1.0,16/74,19.82%,CARMIL2;LCMT1;BMP6;DDX3X;PACSIN3;ABCA7;PEX5;SNX33;DNAJB6;SCAMP5;IMPACT;SPRY2;MCTP1;SORL1;CARMIL1;PRKCZ
prerank,negative regulation of lyase activity (GO:0051350),0.4155619910102931,0.9747728755561464,0.5013368983957219,1.0,1.0,2/16,7.66%,LTB4R2;ADGRV1
prerank,regulation of cellular response to stress (GO:0080135),0.32428593637944764,0.9746040623488249,0.5422680412371134,1.0,1.0,36/115,21.54%,CLN3;CAMK2B;HSP90AA1;AIFM2;DNAJC7;RAE1;NUAK1;ABL1;BAG1;NUP188;CASP9;HSPH1;CAMK2D;USP19;CAMK2G;DNAJB6;NPM1;NUP210;ATR;NUP88;MAPT;ROCK2;NUP214;NUPR1;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;RSL1D1;NUP35;MAPKAPK2;TPR;SMG1;NPAS2;DNAJC2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3224135698248805,0.9744845898980995,0.5642570281124498,1.0,1.0,52/185,21.84%,CCP110;CENPJ;CDC23;SIRT2;PSMD4;HSP90AA1;UBE2S;MAD2L1;ZFP36L1;CDC16;FZR1;ALMS1;ANAPC2;FBXO5;PSMB10;DDB1;CDC14B;PSMD11;PLK5;TUBA1A;PPP1R9B;YWHAG;PSME2;PSMC5;ANAPC11;ANAPC4;KCNH5;HAUS3;CSNK1D;CDC26;TUBB;PSMD1;OFD1;UBE2E1;UBE2D1;PSMD6;CEP76;ANAPC10;TUBB4A;ANAPC5;ODF2;PSMD5;DYNLL1;ZW10;PAFAH1B1;INO80;PSMA4;HECW2;APPL2;PSMA1;PSMC6;CNTRL
prerank,inositol phosphate metabolic process (GO:0043647),-0.24239543775793718,-0.9744781109140211,0.5111111111111111,0.8622714361389641,1.0,12/46,13.81%,IP6K2;PPIP5K1;OCRL;PLCE1;PLCD3;INPP5D;PLCB3;MINPP1;PLCG2;INPPL1;PLCG1;PLCD1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.38425735274986267,-0.9744052561780717,0.49056603773584906,0.8606452583653164,1.0,5/11,11.48%,ATP6V1A;CAV1;ATG7;ATP6AP1;FAS
prerank,atrial septum morphogenesis (GO:0060413),-0.4005838428720802,-0.9743519860343524,0.4892966360856269,0.8589350884859932,1.0,5/10,31.43%,TGFB2;ACVR1;NOTCH2;HEY2;ZFPM1
prerank,cellular response to heat (GO:0034605),0.36901433107062426,0.9743368227037166,0.5041916167664671,1.0,1.0,11/35,20.92%,TCIM;HSP90AA1;STUB1;DHX36;VCP;MAPT;DAXX;HSBP1;CLPB;PDCD6;TPR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.36784394801774506,0.9743203996949629,0.5165094339622641,1.0,1.0,16/32,27.09%,TAOK1;CAMSAP2;CLIP3;KATNB1;EML2;TBCD;TUBB4A;FGF13;CLASP2;CAMSAP1;MAP2;NAV3;STMN1;ARHGEF2;HDGFL3;APC
prerank,positive regulation of cell division (GO:0051781),0.362790597022289,0.9741230000137093,0.5041816009557945,1.0,1.0,6/38,14.15%,SIRT2;FGFR2;CDC14B;CIT;SVIL;CSPP1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.32554646468617515,0.9739581639371983,0.5471502590673575,1.0,1.0,37/119,21.36%,PIGG;TMEM150A;PGAP4;PIP4K2B;SYNJ2;DPM2;PIGM;INPP5E;PIK3R1;PIGU;PLEKHA3;PITPNM3;PIGA;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;IP6K1;PITPNM2;DPM1;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A;PIGB;FGF2;SMG1
prerank,sphingolipid biosynthetic process (GO:0030148),0.3411484701686965,0.9734766079383179,0.5364025695931478,1.0,1.0,17/71,19.12%,A4GALT;ST8SIA3;ELOVL1;SMPD2;CERS2;SGPL1;ST3GAL5;ELOVL4;SPTSSA;TLCD3B;PLPP3;SMPD4;VAPB;ALDH3A2;PRKD2;ELOVL6;SMPD1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.36399145961426616,0.9734024107622755,0.5130331753554502,1.0,1.0,10/35,23.07%,ATP2C1;CDH11;CDH18;CDH20;CDH19;CDH7;CDH9;PCDHB16;CDH10;CDH8
prerank,negative regulation of phagocytosis (GO:0050765),0.41302700162302874,0.9733498976413427,0.5128900949796472,1.0,1.0,4/17,12.69%,FCGR2B;SIRPA;CD47;RACK1
prerank,regulation of potassium ion transport (GO:0043266),0.3746961494037876,0.9732190121716473,0.5168961201501877,1.0,1.0,5/31,17.25%,KCNAB2;CD63;ANK3;DPP10;KIF5B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.31159368729053016,-0.972971446629572,0.46473029045643155,0.8610018786584468,1.0,5/20,6.32%,DROSHA;PUM1;TSN;AGO2;TSNAX
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4179589533411938,0.9728975212480248,0.5160857908847185,1.0,1.0,1/17,0.24%,S1PR2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.36841924582899527,-0.9726053587225826,0.4618055555555556,0.8601532787102838,1.0,6/12,31.29%,AKR1B1;STARD3NL;FDX1;TSPO;FDXR;CACNA1H
prerank,regulation of kinase activity (GO:0043549),0.33264862738984957,0.9725752333451625,0.5454545454545454,1.0,1.0,20/89,17.15%,MST1R;EPHA7;EPHB2;FGFR2;SMG8;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;RBL2;IRS2;PDGFRA;ROR2;EMP2;MAPT;MRE11;RAD50;EPHA5
prerank,synaptic vesicle recycling (GO:0036465),0.3771646705587782,0.9723239317679685,0.5245700245700246,1.0,1.0,6/31,14.38%,SYNJ2;CDK5;NLGN3;SYT1;TBC1D24;NLGN2
prerank,epithelial cell differentiation (GO:0030855),0.3338384272875981,0.9722860395104744,0.5377358490566038,1.0,1.0,20/88,22.16%,ANXA7;FGFR2;ANXA1;FSTL1;SCRIB;RAB10;HDAC1;HNRNPH3;VDAC1;MAF;JAG1;ACADVL;KDM6B;ANXA4;SCUBE1;PGK1;DAB2;CTSB;PTER;ERBB4
prerank,regulation of cholesterol esterification (GO:0010872),0.4600187445540831,0.9721004438939489,0.5177514792899408,1.0,1.0,4/10,21.42%,ABCA2;AGTR1;APOE;ABCG1
prerank,protein localization to kinetochore (GO:0034501),0.4287983881101936,0.9715033984254795,0.5056497175141242,1.0,1.0,1/14,0.88%,CENPT
prerank,regulation of cell aging (GO:0090342),0.4477550482336313,0.9708904865175353,0.5154639175257731,1.0,1.0,2/11,5.98%,FOXM1;NUAK1
prerank,embryonic skeletal system development (GO:0048706),0.36613886929540373,0.9708694888351583,0.5348557692307693,1.0,1.0,7/35,17.13%,WNT5A;PCSK5;SULF1;SOX11;PDGFRA;MEGF8;OSR1
prerank,circulatory system development (GO:0072359),0.32926031687511964,0.9708665494870392,0.5731832139201638,1.0,1.0,24/118,19.43%,PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;STK11;SOX9;ADAP2;FGF12;FBN1;AKAP13;TGFB1;FOXC2;HSPG2;KDM6B;OSR1;PKD2;TGFBR1;SOX4;KDM6A
prerank,regulation of apoptotic process (GO:0042981),0.31143138159221256,0.9708089261937147,0.649,1.0,1.0,146/676,19.55%,SFRP2;RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;GLS2;TCIM;BAX;GPLD1;PPIF;ARAF;LCMT1;NFKB1;BIN1;NTF3;HSP90AA1;PLEKHN1;SLC27A4;BNIP1;TAF9B;AIFM2;ANP32A;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;NUAK2;IL31RA;MGMT;CDK5;SCRIB;FLCN;OLFM1;USP47;PRDX5;FAM162A;PIK3R1;PRELID1;ABL1;SQSTM1;USP42;BAG1;BARD1;ARHGEF7;ARHGEF4;HNRNPK;EEF1E1;MAGED1;ZFAND6;KCNMA1;KALRN;TRIM35;IFIT3;CALHM2;MCF2;XIAP;PLK5;LRP8;SOX9;SRA1;NDRG1;CLIP3;VCP;CASP9;VAV2;UBE2Z;MALT1;GDNF;PRLR;IGFBP3;BCL2;RTKN;BNIP2;IRF3;TMEM219;HS1BP3;PARK7;NPM1;HDAC1;TNFRSF25;PLEKHG5;LANCL1;RACK1;AKAP13;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;DAPK1;ANKRD13C;HTT;MTCH1;EGLN2;MTCH2;TXNDC5;BCL6;RNF122;BCLAF1;SMAD6;DNM1L;CBL;SHQ1;MRE11;NUPR1;PAWR;FAF1;CASP2;HSPD1;RPS6KA1;CTSH;TRIO;AHI1;ARHGEF6;FAIM2;DAXX;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;DFFA;TOPORS;OMA1;ANXA4;KLHL20;RASSF2;BAG4;PDCD5;PRKAA1;RSL1D1;BIRC3;FMN2;PRMT2;SMPD1;SOX4;DDX42;PLEKHG2;RPS3;FGD4
prerank,negative regulation of cellular process (GO:0048523),0.3117887243211274,0.9706469060681849,0.607,1.0,1.0,89/521,15.34%,PSRC1;SFRP2;CDKN2D;FCGR2B;SFRP1;DACT2;FOXM1;SIRT2;GPLD1;EPHB2;SIRT7;CDKN2AIP;TSC2;CHERP;EIF2AK3;CGRRF1;CASK;PLXNA2;GNRH1;PTHLH;WARS1;DDX3X;FBLN1;RBBP4;FLCN;CLMN;IRF1;DLG3;SRGAP2;FBXO5;ALDH1A2;ADAM22;VAMP3;CELF1;MIA3;EEF1E1;STK11;HGS;CHD5;RIPOR2;TGFB1I1;SIRPA;IFIT3;TCHP;DSCAM;PODN;IFI35;PLXNA1;LRPAP1;WDR6;PPP1R9B;ORC6;MDM4;SOX11;WNK2;APP;TAF6;IGFBP3;BCL2;ADGRG1;IGFBP7;BMP5;NACC2;MAGI2;MALSU1;ENPP1;SPEG;PARK7;VPS4B;SOD2;NPM1;AXIN2;RACK1;ROR2;TNS2;CDC73;PARP16;FGFBP1;RNF41;TGFB1;SLURP1;BCL6;P3H2;IMPACT;SMAD6;SLIT3;DIS3L2;NUPR1;ACVR1B
prerank,microtubule polymerization (GO:0046785),0.37702883002978715,0.9705125561620931,0.5194647201946472,1.0,1.0,9/29,21.40%,CENPJ;TPPP3;CSNK1D;MAPT;TPPP;TUBGCP2;RANBP9;FGF13;CLASP2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.37484529091179264,0.9704457535588001,0.5212636695018226,1.0,1.0,6/33,6.65%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;EZH2
prerank,cellular potassium ion homeostasis (GO:0030007),0.45186344874353324,0.9703155756700541,0.527007299270073,1.0,1.0,3/13,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3596061980279806,0.970141506015252,0.5326340326340326,1.0,1.0,4/41,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4567982887240224,0.9696284504693234,0.5174927113702624,1.0,1.0,4/11,14.28%,FRS2;EFNB2;SOX6;TGFB1
prerank,lipid droplet organization (GO:0034389),-0.2931667903515663,-0.9694353516052058,0.49356223175965663,0.8667526378393211,1.0,7/22,24.02%,RAB18;ZFYVE1;FAF2;BSCL2;CDS2;RAB3GAP1;SQLE
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.26666094333233265,-0.9693290652512248,0.5211267605633803,0.8651782136794466,1.0,11/39,15.19%,MAML3;MAML1;STAT3;KAT2B;TGFB2;NOS3;EP300;EPN2;CCN3;POGLUT1;SRC
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4020203382760907,0.9692079100918765,0.5121951219512195,1.0,1.0,5/20,14.28%,IGF1;TWIST1;PARK7;LAMTOR5;TGFB1
prerank,aerobic respiration (GO:0009060),0.39755310268862776,0.9689402021000818,0.5121951219512195,1.0,1.0,4/20,9.89%,UQCRC1;NDUFS7;MDH2;MTFR1L
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3406909920206932,0.9686181083643709,0.557883131201764,1.0,1.0,10/66,10.21%,CDKN2D;UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;WEE1;PLK5;RBL2;PSME2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4144143738471159,0.968485054067397,0.5169971671388102,1.0,1.0,4/17,12.24%,APLN;TAFA5;TPM1;SOD2
prerank,limb development (GO:0060173),0.3810657159370559,0.9684343359879317,0.5216316440049443,1.0,1.0,8/28,21.30%,PCSK5;FGF10;PTCH1;ZNRF3;KREMEN1;MEGF8;CHD7;GLI3
prerank,cholesterol metabolic process (GO:0008203),0.3428596975538626,0.968191659072063,0.5502183406113537,1.0,1.0,10/68,13.04%,CYP27A1;CLN6;SCAP;GBA2;LSS;SOAT1;INSIG1;MSMO1;STARD3;CYP51A1
prerank,ether lipid metabolic process (GO:0046485),0.42385781400939443,0.9680035762564984,0.5153203342618384,1.0,1.0,8/14,23.07%,PEDS1;AGMO;PEX7;FAR1;PLA2G7;PAFAH1B1;NCEH1;GNPAT
prerank,regulation of lipid metabolic process (GO:0019216),0.3313265821064938,0.9679563684436605,0.5469904963041182,1.0,1.0,28/88,24.05%,FASN;HDAC3;SMARCD3;NR1D2;RORA;CHD9;CERS2;LSS;ABCA7;GPAM;SC5D;IRS2;CYP51A1;PSAP;TBL1XR1;GPS2;NCOR2;PRKAG2;ELOVL6;CARM1;GGPS1;NPC2;ID2;NCOA1;SP1;RXRA;TGS1;NFYA
prerank,catecholamine biosynthetic process (GO:0042423),-0.37944453651800314,-0.9677416444013817,0.47720364741641336,0.8676549877310481,1.0,3/11,23.98%,TGFB2;GCH1;DDC
prerank,negative regulation of cell cycle process (GO:0010948),0.33713481748459195,0.9676413233970946,0.5225522552255225,1.0,1.0,16/61,20.54%,CCP110;TFDP1;RBBP4;FBXO5;EZH2;PCGF6;AURKAIP1;EHMT2;EHMT1;TERF1;CBX5;RBBP8;YAF2;PPP1R10;E2F6;TOM1L2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.37734805675650884,-0.9674930903353772,0.5295950155763239,0.8664976848701732,1.0,4/11,16.00%,EGFR;RIPK1;TP53;BMP4
prerank,regulation of cartilage development (GO:0061035),0.4081980008772589,0.9673780332674515,0.5402597402597402,1.0,1.0,6/18,17.65%,PTHLH;SOX9;SOX6;TRPS1;SOX5;BMP1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3826812829367656,0.9673109606370803,0.5210918114143921,1.0,1.0,2/29,2.68%,FASN;ELOVL1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.37623789348946857,0.9672735567828867,0.5214105793450882,1.0,1.0,6/26,17.19%,NOS1AP;POR;GDNF;PIK3CB;PARK7;APOE
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.36782862688263074,0.9671722905974474,0.5338983050847458,1.0,1.0,3/33,7.26%,APLN;GNL3;TEAD1
prerank,histone mRNA catabolic process (GO:0071044),-0.34223634678750436,-0.9670560575875954,0.4967105263157895,0.8659590472900557,1.0,7/15,26.25%,TENT2;LSM1;ERI1;UPF1;TUT1;TUT4;SSB
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.22068389376856754,-0.9667783932570299,0.5526315789473685,0.8648584116306445,1.0,19/91,10.91%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1;NDFIP1;ATP6AP1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC39A8
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2525495900196356,-0.9667014257348309,0.5694444444444444,0.8632313879895928,1.0,15/41,27.28%,SLC12A7;ATP1B3;ATP1A1;KCNJ2;ABCC9;ATP1B1;SLC12A4;SLC12A9;SLC12A2;KCNJ3;KCNK9;HCN2;SLC12A8;KCNJ12;SLC12A6
prerank,response to interferon-gamma (GO:0034341),0.33463577950530216,0.9666705830051171,0.553030303030303,1.0,1.0,10/67,14.55%,WNT5A;GBP3;GBP7;SIRPA;EPRS1;SHFL;CD47;DAPK1;GBP6;AQP4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4350769906370509,0.9665313040373026,0.53,1.0,1.0,5/13,18.18%,EPHB2;SQSTM1;APP;ADCY1;ZDHHC2
prerank,intracellular protein transport (GO:0006886),0.31454877640239853,0.966120672346652,0.6116116116116116,1.0,1.0,93/304,22.84%,MMP12;ARL4C;RTN2;TSC2;BCS1L;CACNG3;NXT2;NXT1;SGSM3;PICK1;ERP29;SAR1A;RUNDC1;RAB24;SNF8;DNAJC27;TBC1D13;NAPG;STX6;SEC16A;SNX6;VPS26B;RANBP3L;STX16;KPNB1;STX2;RAB5B;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;CLIP3;NUP188;KATNB1;SCFD1;USP6NL;STRADB;AP3B1;EVI5L;IPO11;VPS33B;E2F3;TLK1;NPM1;TMED10;NUP88;RABGAP1;IPO7;TGFB1;USO1;AP4M1;STX11;RAB31;NUP214;STX8;TNPO1;STX17;TRAK1;GGA2;XPO6;NSF;SYNRG;AP4E1;RAB21;SMURF1;TBC1D9B;TBC1D22B;XPO7;SORL1;NUP153;RAB6A;SGSM2;RANBP3;STX5;PPP1R10;AP4S1;OXA1L;RAB3GAP2;PDCD6;EHD1;HEATR3;TPR;APPL2;NAPA;RAB7A;ARFGAP3;GGA3;SIL1;RAB43;HERC2;SNX27;NUP155
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.28993659730282084,-0.966006386588317,0.5296803652968036,0.8632421084979908,1.0,11/24,21.52%,MBTPS2;HIF1A;TP53;HSF1;HSPA5;CEBPB;ATF4;VEGFA;NFE2L2;CREB3L1;SESN2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.43609175076032314,0.9658178902016259,0.518840579710145,1.0,1.0,3/13,9.21%,MGAT3;RENBP;EXTL2
prerank,aortic valve morphogenesis (GO:0003180),0.37941215722054333,0.9653526296950286,0.5366748166259169,1.0,1.0,10/30,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,proteasomal protein catabolic process (GO:0010498),0.3172345979703316,0.9651408519935435,0.5849246231155779,1.0,1.0,46/201,17.99%,SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;SPSB1;STUB1;SYVN1;UCHL1;ERLEC1;COP1;PSMB10;DDB1;FBXO45;BRSK2;RFFL;FBXW5;PSMD11;RCN3;RMND5A;ARRB1;DDIT3;TRIM9;CUL4B;VCP;PSME2;PSMC5;KCTD2;UBE2A;PCNP;ZFAND2A;RNF41;RNF122;FEM1C;PSMD1;FAF1;ZSWIM8;CLOCK;DERL1;PSMD6;SMURF1;TOPORS;MDM2;PCBP2;TBL1XR1;KLHL20
prerank,negative regulation of catabolic process (GO:0009895),0.3504940735788479,0.965113817586588,0.5396825396825397,1.0,1.0,11/47,19.03%,SIRT2;AZIN2;MAD2L1;MDM4;HDAC4;GIT1;CYP51A1;NUPR1;PRKAA1;BANP;FMN2
prerank,transport along microtubule (GO:0010970),-0.3683015468782242,-0.9650294435576382,0.5338078291814946,0.8640459926673051,1.0,4/13,7.51%,COPG2;SPG11;BAG3;APBA1
prerank,homologous chromosome segregation (GO:0045143),0.4002334273483705,0.9648098860873373,0.5098554533508541,1.0,1.0,3/20,19.03%,SIRT7;CENPC;FMN2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.34620765285342403,0.9647871292049558,0.5494028230184582,1.0,1.0,9/59,13.21%,AMIGO1;OBSL1;TENM3;IGSF21;DSCAM;IGSF11;ROBO2;ROBO1;NPTN
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.43070398661501386,0.964683858817292,0.5290055248618785,1.0,1.0,3/14,7.02%,PCBP4;SRSF12;SRSF9
prerank,Notch signaling involved in heart development (GO:0061314),0.4496394906492594,0.9643762256905057,0.531700288184438,1.0,1.0,3/11,16.44%,SNAI1;RBPJ;JAG1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3870208015622191,-0.9643452009512263,0.5015673981191222,0.864136840473205,1.0,5/10,29.78%,SIRT1;NOC2L;KLF15;TAF7;THAP7
prerank,iron ion homeostasis (GO:0055072),-0.23836416181111997,-0.9638128472232034,0.5529411764705883,0.863832365877453,1.0,8/58,4.52%,ABCG2;SMAD4;PICALM;ATP6V1A;CUL1;GLRX3;ACO1;SKP1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3158109399216865,-0.963473761158204,0.46296296296296297,0.8628994868444624,1.0,9/17,22.78%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;VPS9D1;ATP5F1B;DMAC2L;ATP5F1D
prerank,glycerophospholipid metabolic process (GO:0006650),0.33443530415638145,0.9633654087216822,0.5488322717622081,1.0,1.0,17/75,19.92%,PIGG;CLN3;GPLD1;DPM2;PIGM;CRLS1;PRDX6;GDPD3;CPNE7;PIGA;SMPD4;FAR1;GDE1;PIGX;PIP5K1A;PLA2G7;PAFAH1B1
prerank,mitochondrial protein processing (GO:0034982),0.44935487211021,0.9627066943166412,0.5172413793103449,1.0,1.0,4/11,19.79%,PMPCA;AFG3L2;OMA1;IMMP1L
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32903719854221264,0.962362615067143,0.5473908413205538,1.0,1.0,20/80,22.00%,CDKN2D;EPHA7;FIS1;DDX3X;CARD16;USP47;XIAP;MALT1;DNAJB6;LAMTOR5;RPS6KA3;DAPK1;RPS6KA1;DPEP1;PDCD5;KLF4;PDCD6;IGBP1;PPM1F;HMGB1
prerank,regulation of receptor binding (GO:1900120),0.45817088157741725,0.9623348602434483,0.544360902255639,1.0,1.0,4/10,22.07%,ATP2A2;PTPRF;GREM2;B2M
prerank,carnitine metabolic process (GO:0009437),0.4392052263696272,0.9623017048530327,0.5227920227920227,1.0,1.0,4/12,16.67%,CROT;CPT2;BBOX1;ACADL
prerank,apoptotic DNA fragmentation (GO:0006309),0.41463665007424855,0.9622906147607944,0.5294964028776978,1.0,1.0,5/16,22.00%,DFFB;KPNB1;DFFA;KPNA1;HMGB1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3305385789140127,0.9612808968766834,0.5702036441586281,1.0,1.0,10/76,11.26%,CDC42EP5;CDC42EP4;BIN1;NTF3;NRP1;CDK5;ABL1;BAIAP2;KATNBL1;GPSM2
prerank,iron ion transport (GO:0006826),0.35107611488445756,0.9609732117766955,0.5499438832772167,1.0,1.0,15/47,22.41%,CP;ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ABCB7;HEPH;ATP6V1B2;SLC11A2;FTH1;STEAP3;ATP6V1C1;RAB11B
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3178258714798457,0.9609248222373855,0.5997993981945837,1.0,1.0,30/182,14.47%,SFRP2;APLN;SFRP1;IGF1;ANXA7;NFKB1;ERP29;FLCN;OLFM1;CELF1;SFMBT2;WNT4;LRPAP1;SDCBP;RBMS3;SOX11;RBL2;APP;ROBO1;YY1;PARK7;HDAC1;AGO3;RACK1;PARP14;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3463103548373909,0.9608054489991111,0.5379388448471121,1.0,1.0,20/51,22.50%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3671790627801412,-0.9607690413630658,0.4845679012345679,0.868654214498808,1.0,6/12,25.44%,NFKBIA;NR1H3;NR1H2;PPARG;PPARA;ITGB3
prerank,artery development (GO:0060840),0.3877796573610587,0.9605357711488816,0.5203045685279187,1.0,1.0,8/23,20.88%,STRA6;NRP1;ROBO2;ROBO1;HECTD1;PKD2;TGFBR1;SMAD7
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3697638155491578,-0.9605092734615297,0.4672897196261682,0.8675978861311022,1.0,2/11,6.43%,RIPK1;UNC93B1
prerank,positive regulation of nervous system process (GO:0031646),0.4099180808971086,0.9603214472608096,0.5424657534246575,1.0,1.0,5/18,16.69%,MYRF;NLGN2;TENM4;ATPSCKMT;TPPP
prerank,visual perception (GO:0007601),0.33058446936683955,0.9600060891435708,0.5539112050739958,1.0,1.0,9/84,14.69%,GPR179;BEST1;RDH10;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,negative regulation of glycolytic process (GO:0045820),0.45809034149039773,0.9597798835363772,0.5208034433285509,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.45809034149039773,0.9597798835363772,0.5208034433285509,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.38051639987926555,0.9594467855471399,0.5183312262958281,1.0,1.0,3/26,5.02%,PTGER4;RAC1;ALMS1
prerank,inositol phosphate catabolic process (GO:0071545),0.44619462678892124,0.9592892557926407,0.5177514792899408,1.0,1.0,3/12,10.73%,SYNJ2;INPP5A;NUDT3
prerank,positive regulation of tissue remodeling (GO:0034105),0.4646247229179767,0.9589736560434263,0.5358208955223881,1.0,1.0,3/10,22.93%,TMBIM1;ROCK2;IL18
prerank,cellular response to retinoic acid (GO:0071300),0.35642177373563927,0.9586951439081923,0.5525114155251142,1.0,1.0,14/42,25.32%,WNT5A;ZNF35;BRINP3;SOX9;SETX;SNW1;PTK7;BRINP1;LYN;PTK2B;ATM;WNT5B;WNT6;RORB
prerank,nuclear pore organization (GO:0006999),-0.34337638169402884,-0.9585440615556438,0.47896440129449835,0.8713426246380949,1.0,6/14,21.50%,NUP205;NUP93;NUP107;NUP133;NDC1;TMEM170A
prerank,nuclear membrane organization (GO:0071763),0.3983610709248777,0.9582997050597215,0.5267275097783573,1.0,1.0,4/19,10.12%,UBXN2A;AKAP8L;TOR1B;TMEM43
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.407830025513513,0.9580918689784179,0.5203252032520326,1.0,1.0,4/17,15.88%,NKX6-1;SOX9;RFX3;AHI1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3408867567812368,0.957883245546105,0.5566778900112234,1.0,1.0,4/51,4.57%,IL34;EDN3;CXCL12;MOSPD2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4453952890551846,0.9576143732579784,0.5349500713266762,1.0,1.0,4/12,16.69%,ERLIN2;PIBF1;ACADL;ACADVL
prerank,bicellular tight junction assembly (GO:0070830),-0.24300504752890784,-0.9575310736442679,0.5470085470085471,0.8721899075548772,1.0,7/46,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.3150401787232041,-0.9574003390905778,0.4819277108433735,0.8707539924877857,1.0,10/19,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,neuronal action potential (GO:0019228),0.3935041868787724,0.9572159189865797,0.5327342747111682,1.0,1.0,5/22,13.93%,MYH14;SCN7A;SCN1A;ANK3;KCNA1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3165340453882539,0.9569837672849182,0.5752577319587628,1.0,1.0,37/118,22.67%,SFRP1;MYO19;FGFR2;WARS1;HTATIP2;TANC2;TNFAIP3;CDK5;KNDC1;PAK3;BRSK2;PDZD8;SPARC;RAP2A;PID1;SRCIN1;GDNF;BRSK1;DAG1;EMP2;MAPT;TGFB1;BCL6;ADGRA2;PHLDB1;PHIP;RUFY3;ADGRB3;CHN1;HECW2;FGF2;CFL1;CLASP2;ARHGAP35;CAMSAP1;PAK1;EPHA4
prerank,mitochondrial genome maintenance (GO:0000002),0.45167554975246127,0.956935122391823,0.543026706231454,1.0,1.0,3/11,6.34%,PARP1;SLC25A33;SLC25A36
prerank,positive regulation of mRNA processing (GO:0050685),0.4001468151921701,0.956834713474004,0.5454545454545454,1.0,1.0,9/21,20.66%,RBM3;PRDX6;DHX36;TRA2B;CDC73;SNW1;THRAP3;CIRBP;TRA2A
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.38817680740016236,0.9567726391478233,0.5383663366336634,1.0,1.0,3/23,5.69%,BAX;HSP90AA1;TIMM13
prerank,glycine metabolic process (GO:0006544),-0.36322842792882826,-0.9566790569719797,0.5182724252491694,0.8708809290530054,1.0,8/12,52.15%,RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1;GLYAT
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.359735612763331,0.9566007062451544,0.541813898704358,1.0,1.0,11/39,17.80%,TMEM150A;PIP4K2B;PIK3R1;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;PIK3C2B;PIK3C3;IP6K1
prerank,positive regulation of autophagy (GO:0010508),-0.21858926348386376,-0.9565895901077975,0.5961538461538461,0.8693219262076709,1.0,24/81,16.81%,WAC;EIF2AK4;TFEB;FOXO3;TMEM59;BNIP3L;SH3BP4;EPM2A;SIRT1;PRKD1;LRRK2;KDR;IKBKG;ROCK1;GNAI3;PAFAH1B2;PRKAA2;BNIP3;TRIM5;TRIM65;PLK2;IRGM;UFL1;PINK1
prerank,nucleosome assembly (GO:0006334),0.37050343711391215,0.9565362344910315,0.5431034482758621,1.0,1.0,9/31,16.74%,UBN1;RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;HAT1;DAXX
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.33614034175207014,-0.9564554585226756,0.5236486486486487,0.8679185979758669,1.0,2/14,6.01%,SHLD2;PAXIP1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.38096121853512105,-0.9557195534741281,0.5043478260869565,0.8681439479510918,1.0,5/10,22.78%,ATP5F1C;ATP5PO;ATP5PD;VPS9D1;ATP5F1D
prerank,muscle organ development (GO:0007517),0.3373089298354996,0.9555040250024172,0.5438401775804661,1.0,1.0,4/54,3.12%,FHL3;POU6F1;IGF1;NEB
prerank,chromosome condensation (GO:0030261),0.3664594990015452,0.955486174383323,0.5380952380952381,1.0,1.0,4/36,6.72%,INCENP;CSNK2A2;AKAP8L;DFFB
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3361483893634977,0.9553684076907585,0.5594713656387665,1.0,1.0,11/57,11.40%,TAOK1;FZR1;SDE2;FBXO31;CDC14B;CDK5RAP3;MRNIP;ATF2;MDC1;BRSK1;FOXN3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.39958024603319964,0.9551388422668444,0.520460358056266,1.0,1.0,2/20,2.96%,HEXIM1;NR2F2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3827946864943146,0.9548764780527302,0.5373134328358209,1.0,1.0,2/25,6.14%,PDPK1;THY1
prerank,regulation of histone modification (GO:0031056),0.4231907554405198,0.9548175617761847,0.5384615384615384,1.0,1.0,5/13,12.08%,CDK9;FLCN;AKAP8L;NNMT;PARK7
prerank,lipoprotein biosynthetic process (GO:0042158),0.4494550877331313,0.9546471607367384,0.5367647058823529,1.0,1.0,4/11,17.19%,WIPI1;PORCN;PIK3C3;APOE
prerank,telomere maintenance via recombination (GO:0000722),-0.3686684024414122,-0.9546324617752907,0.5059880239520959,0.8694266540141159,1.0,3/11,10.16%,SMC5;TEP1;RAD51D
prerank,positive regulation of filopodium assembly (GO:0051491),0.38137476936749737,0.9545882692986499,0.5277419354838709,1.0,1.0,6/24,16.79%,NRP1;PIK3R1;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.29720815001557155,-0.954554852386594,0.5138339920948617,0.867872307332983,1.0,10/22,19.09%,TSG101;UBAP1;VPS36;VPS37B;MVB12B;TOM1L1;PTPN23;VPS37C;VPS4A;PLAA
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.22790420620512766,-0.9544476918010629,0.6022727272727273,0.8663751248051984,1.0,18/63,18.83%,CAV1;ITGA6;AR;RIPK1;PML;FEM1B;SP100;ACVR1;THBS1;TNFSF10;CYLD;FAS;MADD;SCG2;SRC;BMP4;LTBR;TNFSF12
prerank,regulation of telomerase activity (GO:0051972),-0.24329683030200877,-0.9544171509142575,0.496,0.8647010208064735,1.0,14/45,17.46%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TP53;TCP1;PARN;NAF1;SRC;MAP3K4;PNKP;CCT2;SMG6
prerank,protein catabolic process (GO:0030163),0.34203486932539545,0.9543324984202036,0.5626373626373626,1.0,1.0,9/59,9.82%,CLN6;HSP90AA1;NGLY1;DDB1;UCHL3;RAB12;MANBA;CUL4B;VCP
prerank,regulation of cell-cell adhesion (GO:0022407),0.3551107680618236,0.9543167393426127,0.5281933256616801,1.0,1.0,10/39,20.88%,EPHA7;MINK1;TENM3;CD47;TGFB1;JAG1;ZDHHC2;NF2;PTPRR;SMAD7
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4059582031967688,0.9541942609154114,0.538562091503268,1.0,1.0,1/18,1.59%,GPLD1
prerank,positive regulation of lipid transport (GO:0032370),0.44365397178833377,0.9534829099209988,0.5387931034482759,1.0,1.0,3/12,17.19%,PRELID1;LRP1;APOE
prerank,homeostasis of number of cells (GO:0048872),0.4404163795091655,0.9534727291949496,0.533715925394548,1.0,1.0,1/12,0.50%,OCIAD2
prerank,protein autophosphorylation (GO:0046777),0.3153087150190283,0.9531253243575435,0.5921052631578947,1.0,1.0,22/157,11.50%,AATK;CAMK2B;PDPK1;EIF2AK3;FGFR2;CDKL5;FGFR1;TAOK1;HTATIP2;DDR1;MINK1;DDR2;ABL1;SRMS;EPHA8;STK11;SIK1;TEC;MUSK;WNK2;PDGFRA;CAMK2D
prerank,maturation of LSU-rRNA (GO:0000470),0.38059946549407003,0.9530475941923455,0.5466830466830467,1.0,1.0,8/26,21.09%,NHP2;DDX18;MRPL1;RPL7L1;LAS1L;NSA2;RSL1D1;RPL7
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42211393021118004,0.9529503246619071,0.5283286118980169,1.0,1.0,2/14,7.21%,CARD16;RFFL
prerank,positive regulation of RNA splicing (GO:0033120),0.3739311206754443,0.9528617378172145,0.5417690417690417,1.0,1.0,11/29,20.66%,RBM3;PRDX6;PIK3R1;SETX;TRA2B;HNRNPLL;SNW1;THRAP3;RBM22;CIRBP;TRA2A
prerank,cellular response to mechanical stimulus (GO:0071260),0.3441094882223077,0.9525227536519973,0.5549132947976878,1.0,1.0,6/46,8.36%,PTGER4;NFKB1;MAP3K14;TMEM150C;IRF1;SOX9
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3478494537999794,0.9521056261859543,0.5469988674971688,1.0,1.0,16/45,24.20%,CAMK2B;IRF1;TRIM62;IFNGR2;IFNGR1;IRF3;CAMK2D;CAMK2G;ICAM1;OAS2;JAK1;TRIM26;B2M;TRIM8;MID1;JAK2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30918701726150793,0.9520970131356611,0.6706706706706707,1.0,1.0,87/417,19.37%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;CIART;FOXM1;SIRT2;ZNF568;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;PSPC1;NIPBL;CHD8;POU2F1;CDK5;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;DPF2;XRCC6;PER1;HDAC4;ARID4A;TWIST1;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;FOXN3;NACC2;HDAC1;BCL7A;TSC22D4;EHMT1;GCLC;CIPC;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;RFX3;CIC;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;YAF2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3648387938904157,0.9516538475513109,0.5227552275522755,1.0,1.0,11/32,22.82%,ANXA1;HDAC5;TBXA2R;FGFBP1;PTGS2;FOXC2;ITGB1BP1;KLF4;STARD13;FGF2;MEOX2
prerank,negative regulation of anoikis (GO:2000811),-0.3395278556593744,-0.9516532785760842,0.4981549815498155,0.8704298651023136,1.0,4/14,15.19%,CAV1;MCL1;PIK3CA;SRC
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30714569567517896,0.9515248861443406,0.686,1.0,1.0,145/572,22.43%,CBX8;HDAC3;HEXIM1;ZMYM5;POU6F1;DUSP26;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;IL33;NR2F2;FGFR2;NKX6-1;TAF9B;GLIS2;NR1D2;PCGF1;ZNF8;MIER2;MXI1;ZNF205;NIPBL;CHD8;SNAI1;ZNF692;FLCN;TCF7L2;CNBP;ATXN1;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;MOSPD1;MXD1;ZBTB5;CC2D1A;NFX1;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;PER1;MDM4;HDAC4;SOX11;TWIST1;USP2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;USP9X;SUFU;CBFB;CDC73;ATRX;ZHX2;TRPS1;BCL6;IMPACT;NR2C2;SATB1;TCF3;FOXC2;DDX5;GTF2IRD1;UBE2D1;CTBP1;SNW1;CBX5;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;NCOR2;TRIM27;WWOX;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;ZBTB32;SMAD7;TPR;NFATC3;GLI3;ZNF431;VPS72;SMAD2;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;HOXA7;IFI27;ID2;N4BP2L2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4154852712596775,0.9515151153602697,0.5359565807327001,1.0,1.0,5/16,16.60%,PARP1;DHX36;HNRNPA2B1;TERF1;TNKS
prerank,response to molecule of bacterial origin (GO:0002237),0.3271429550702678,0.9515087224977476,0.5547045951859956,1.0,1.0,11/69,14.82%,FCGR2B;SIRT2;IFNAR1;TNFAIP3;TIRAP;CD24;LY96;HNRNPA0;RPS6KA3;PTPN22;SMAD6
prerank,cellular protein localization (GO:0034613),0.31073102763438576,0.9513235753720495,0.626,1.0,1.0,73/285,18.60%,WNT5A;ARL4C;CPLANE2;SGSM3;TRAPPC8;PICK1;ERP29;CD63;SAR1A;RUNDC1;RAB24;WIPI1;NIPBL;DNAJC27;FGF10;TBC1D13;NAPG;STX6;PIGU;SNX6;VPS26B;RRAGA;RAP2A;HGS;STX16;MFN2;STX2;RAB5B;JAM3;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;USP6NL;ATG13;AP3B1;EVI5L;VPS33B;RIC3;TLK1;NPM1;AXIN2;TMED10;FBLN5;COG3;PIGK;EMP2;RABGAP1;USP4;USO1;EPB41L3;CNTNAP2;AP4M1;STX11;RAB31;STX8;STX17;AHI1;GGA2;NSF;SYNRG;RAB21;SMURF1;TBC1D9B;TBC1D22B;ARMCX3;ATG9A;AMOT;RAB6A;SGSM2;NPHP1
prerank,serine family amino acid catabolic process (GO:0009071),-0.38265016892850867,-0.9512001445492808,0.5125,0.8699490142374261,1.0,8/10,53.11%,AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1;DAO
prerank,platelet aggregation (GO:0070527),-0.2667389316102443,-0.9507771348071538,0.5465116279069767,0.8692531349183681,1.0,13/33,20.86%,FLNA;ACTB;ACTN1;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,atrioventricular valve development (GO:0003171),-0.34404954026143314,-0.95066205294044,0.4928571428571429,0.8678054689972121,1.0,4/14,7.89%,TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.35039937999272597,0.9505064651862055,0.5676300578034682,1.0,1.0,4/43,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3038446164174286,0.9504893830566923,0.796,1.0,1.0,344/1645,19.91%,PSRC1;SFRP2;ILF3;CAMTA2;HDAC3;HEXIM1;TEAD3;WNT5A;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SFRP1;IGF1;MED24;SP7;DVL2;ZNF23;CIART;TCIM;FOXM1;SIRT2;ZBTB48;POU5F2;DDX17;MYRF;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;ZEB2;CREBZF;USF1;NR2F2;MLXIP;TEF;NKX6-1;MAPRE3;PRMT6;MED12;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;PCGF1;ZNF8;ZFP82;HTATIP2;DKK3;RORA;TFDP1;KMT2B;NFKB2;CARF;PSPC1;BRPF1;MXI1;ABCA2;ZNF205;SNF8;NIPBL;SNX5;CCNC;OGT;CHD8;VGLL3;POU2F1;IL31RA;RFX5;SNAI1;CDK5;SLTM;MTERF3;ZNF692;NPAT;TCF4;TCF7L2;USP47;SFMBT1;TFCP2;ZNF276;BBS7;CNBP;BRD4;IRF1;MED13;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;ZIC3;SNX6;CASZ1;TRIM56;HNRNPK;EZH2;FUS;ARNT;ZBTB7B;ANKRD49;MAGED1;ZNF711;ZEB1;SMARCB1;CHD5;TEAD1;TGFB1I1;HDAC5;PCGF6;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ASCC1;MED4;ZKSCAN5;ACTR8;DBP;NFX1;SFMBT2;ARRB1;TSHZ2;WNT4;SOX9;SRA1;SMARCD1;DDIT3;BRD3;PGBD1;DPF2;ZFHX2;XRCC6;YWHAH;PER1;HNRNPD;ARID1B;DHX36;MDM4;EGF;PRMT5;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;SAP30L;TWIST1;CALCOCO1;FADS1;PSIP1;PRRX1;NKRF;JARID2;HOXB8;ATF2;POU6F2;RCOR1;PSMC5;ZBTB20;ZNF445;RBFOX2;KDM2B;NSD3;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;BACH2;MAZ;NFAT5;FOXN3;IRF3;CAMK2D;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;E2F3;NFIX;BRIP1;BACH1;PEG3;POLR2K;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;BCL7A;ZFP2;CREB3;CREB3L4;ZNF383;RPS6KA3;TSC22D4;EHMT1;PROX2;GCLC;SUFU;CIPC;CBFB;MMS19;FOXJ3;ATRX;ZHX2;EBF1;RUNX1T1;NRG1;ZIC2;TGFB1;MED21;TRPS1;ESRRG;CAMTA1;MAP2K2;TULP3;BCL6;BAZ2B;BCLAF1;ZNF292;SMAD6;SOX5;THOC1;KMT2D;RGMB;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;FOXC2;CIC;HSPD1;RPS6KA1;DDX5;TRAK1;GTF2IRD1;MAF;CHEK2;SAFB2;CTBP1;SBNO1;HOXC8;CLOCK;SNW1;CCNT1;TRIP4;CBX5;DAXX;MBD1;UBE2L3;THRAP3;PHIP;ZFP37;KDM3B;MTDH;SOX13;ZBTB41;OSR1;APOE;ZFP90;HP1BP3;TLE5;TCF7;NFXL1;NSD1;MDM2;LANCL2;ANXA4;RAD21;MEIS2;TBL1XR1;ILK;RELB;ZNF177;PHF12;RBBP8;RNF111;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GCFC2;NONO;TGFBR1;TERF2IP;MPHOSPH8;USP22;NCOR2;CHD2;FOXD1;KLF13;PRMT2;NUP35;SOX4;ZIC4;BRDT;UIMC1;YAF2;SETD5;MITF;CDK11B;PPM1A;KLF4;MLLT3;WWC1;CARM1;GABPA;NFIA;PRDM15;PIAS1
prerank,RNA 3'-end processing (GO:0031123),0.33142687124612036,0.950335110917649,0.5568669527896996,1.0,1.0,14/69,12.57%,RPRD2;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;LIN28B;CPSF7;CSTF2T;NUDT21;CPSF3;THOC7
prerank,negative regulation of cytokine production (GO:0001818),0.3114564518889873,0.9502450966609026,0.5939086294416244,1.0,1.0,22/163,13.55%,FCGR2B;PTGER4;CHID1;SELENOS;ADCY7;RAC1;ANXA1;TNFAIP3;DHX58;CD200R1;SIRPA;ARRB1;DDIT3;PIBF1;ATP2B1;CUEDC2;LGR4;SSC5D;SARS1;IRF3;NPTN;PTPN22
prerank,regulation of transport (GO:0051049),0.35820898957908864,0.9499572912604693,0.5396825396825397,1.0,1.0,7/36,11.38%,NRP1;GAPVD1;CDK5;ICA1L;MBTPS1;SCFD1;LEPR
prerank,glycogen metabolic process (GO:0005977),-0.27621220301171734,-0.9494395077511599,0.5191256830601093,0.8692231497066784,1.0,7/27,20.56%,AGL;PYGB;PHKA1;GYS1;PGM2;PHKG2;GYG1
prerank,dorsal/ventral pattern formation (GO:0009953),0.392019346353046,0.9494075984736084,0.5373525557011796,1.0,1.0,2/20,8.42%,SFRP1;PTCH1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3193739154623034,-0.9493667443635642,0.516260162601626,0.8676571986845576,1.0,4/19,10.83%,ABHD5;IRS1;PRKCD;DAGLB
prerank,regulation of stem cell proliferation (GO:0072091),0.4083260949429723,0.9484196727285875,0.5563186813186813,1.0,1.0,4/17,12.58%,ZFP36L1;FBLN1;SOX11;AGO3
prerank,organophosphate ester transport (GO:0015748),-0.2948768269378139,-0.9483614820535847,0.5333333333333333,0.8685781449137223,1.0,6/24,8.39%,OSBPL2;PITPNA;PITPNC1;SCARB1;SCP2;OSBPL5
prerank,hyaluronan catabolic process (GO:0030214),0.39816583459258326,0.9482095244903955,0.5398692810457516,1.0,1.0,5/18,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,regulation of dendrite development (GO:0050773),0.35606539010398985,0.9481476350987224,0.5641330166270784,1.0,1.0,11/37,18.42%,CDKL5;KNDC1;DBN1;RAP2A;CAMSAP2;LRP8;VLDLR;BMP5;CAMK1D;DCC;ADGRB3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.37716294174341225,-0.9479735093904326,0.5100671140939598,0.8679440585648501,1.0,5/11,16.70%,RDX;EZR;VPS11;PTPN23;MSN
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4450439954217199,0.9468166195364156,0.5444947209653092,1.0,1.0,1/10,2.58%,BMP6
prerank,response to cAMP (GO:0051591),-0.2565754071146301,-0.9466829222673546,0.5102040816326531,0.8696727606081999,1.0,13/37,25.43%,RAPGEF3;NDUFS4;STAT1;INPP5K;EZR;AKAP9;AHR;SLC5A5;DGKQ;PDE2A;HCN2;KCNQ1;HCN1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3661232506189149,0.9466565003259014,0.5539739027283511,1.0,1.0,3/31,6.58%,EPHB2;XBP1;VAMP3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.22376161580595577,-0.9465882189140359,0.5538461538461539,0.868168118837507,1.0,19/70,15.68%,LNPEP;IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,heterochromatin organization (GO:0070828),-0.3440586926470397,-0.9464471148210469,0.5278810408921933,0.8668010329103907,1.0,6/14,15.01%,MECOM;SIRT1;EZH1;SETDB2;PRDM16;SMCHD1
prerank,membrane repolarization during action potential (GO:0086011),-0.34580402476693994,-0.9457205059309902,0.5544871794871795,0.866959015325243,1.0,3/13,12.55%,ATP1A1;KCNJ2;ATP1B1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.4222150334059198,0.9457060322605133,0.557774607703281,1.0,1.0,4/13,18.96%,HSP90AA1;FPGS;QDPR;CALM1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.3704214171924833,0.9455993580397218,0.5648379052369077,1.0,1.0,5/25,11.50%,CALM3;ATP2A2;NOS1AP;JUP;CAMK2D
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23280107706212905,-0.9454236631653866,0.5909090909090909,0.8660272418504508,1.0,17/51,17.46%,NEK7;CCT3;GNL3L;SMG5;STN1;FBXO4;TCP1;PARN;NAF1;CCT5;NAT10;SRC;MAP3K4;CCT7;PNKP;CCT2;SMG6
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.42032226475983214,0.9452146289718111,0.5440340909090909,1.0,1.0,7/13,23.66%,KPNA3;KPNB1;RANBP2;KPNA1;NUP35;CBLB;NUP54
prerank,myelination in peripheral nervous system (GO:0022011),0.42665265755194637,0.9450915381152881,0.5704022988505747,1.0,1.0,2/13,4.84%,SIRT2;ARHGEF10
prerank,multivesicular body organization (GO:0036257),0.36220175193163545,0.9449297538467489,0.5517676767676768,1.0,1.0,6/31,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,histone H2B ubiquitination (GO:0033523),0.4510906164560489,0.9448603186890557,0.5639097744360902,1.0,1.0,4/10,15.71%,RNF8;RNF40;CDC73;UBE2E1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3170583612868391,-0.9445296326044205,0.5238095238095238,0.8666577953539429,1.0,9/18,26.33%,KAT2B;RPS13;TMBIM6;PTBP2;ESR1;RPS26;NRDE2;ZC3H12A;TERT
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.40161741046316374,0.9444116080039419,0.5534246575342465,1.0,1.0,4/18,12.16%,BRD4;FBXO5;CDC25A;VPS4B
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.35166670953173185,0.9442716595091752,0.5573770491803278,1.0,1.0,3/39,4.88%,SFRP2;NRP1;FGF10
prerank,protein-containing complex subunit organization (GO:0043933),0.31495622889498176,0.9442313213226038,0.6043388429752066,1.0,1.0,34/109,22.05%,CHCHD10;NDUFAF1;KPNA3;NAPG;LAMC1;DMTN;VAMP3;TEAD1;SOX9;EPRS1;MDM4;PPIH;CAPZA1;AFG3L2;ADD2;WASF1;DNM1L;FANCA;IL1RAP;TUBGCP2;MDM2;TSPAN4;KMT2A;SHANK1;NUP35;KIFAP3;MITF;RANBP9;ZW10;PTK2B;GEMIN5;TPR;LLGL1;TRAF2
prerank,negative regulation of autophagy (GO:0010507),0.3380209566412351,0.9440476185458354,0.5912162162162162,1.0,1.0,11/54,16.63%,IL10RA;SIRT2;RRAGA;WDR6;NRBP2;BCL2;LEPR;EIF4G2;PTPN22;NUPR1;EIF4G3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.31793562173993645,0.9439741932994186,0.6057385759829969,1.0,1.0,14/92,10.63%,WNT5A;EPB41L4B;GPLD1;RAC1;GLIPR2;NRP1;FGF10;PRKCA;ABL1;SPARC;SOX9;EGF;ENPP2;PIK3CB
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3276224624825303,0.9439635919569472,0.579849946409432,1.0,1.0,25/78,21.07%,CLN3;EPHB2;PDPK1;CDK5;PIK3R1;SQSTM1;TMBIM1;PID1;CLIP3;VTI1B;PRKCI;LRP1;TGFB1;DPP10;SPTBN1;STX8;VAMP8;MRAP2;KIF5B;PPP2R5A;ZDHHC2;MMP14;DAB2;ITGB1;ATP2B4
prerank,electron transport chain (GO:0022900),0.41852097740170163,0.943911501063531,0.5487106017191977,1.0,1.0,3/15,6.76%,CYB561;SDHA;POR
prerank,positive regulation of phospholipid transport (GO:2001140),0.4583836346159039,0.9433896673710116,0.5315315315315315,1.0,1.0,3/10,17.19%,PRELID1;ABCA7;APOE
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30361482951780877,0.9431237036076945,0.753,1.0,1.0,198/807,22.43%,SFRP2;ILF3;CBX8;HDAC3;HEXIM1;WNT5A;ZMYM5;POU6F1;SFRP1;DUSP26;CIART;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;CREBZF;IL33;NR2F2;FGFR2;NKX6-1;PRMT6;TAF9B;SMARCC2;GLIS2;NR1D2;PCGF1;ZNF8;DKK3;MIER2;PSPC1;MXI1;ZNF205;NIPBL;CHD8;POU2F1;SNAI1;CDK5;MTERF3;ZNF692;FLCN;TCF7L2;USP47;SFMBT1;PRDX5;CNBP;IRF1;ATXN1;SNX6;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;PCGF6;MOSPD1;MXD1;ZBTB5;ZBTB38;NFX1;SFMBT2;WNT4;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;XRCC6;PER1;MDM4;HDAC4;ARID4A;SOX11;TWIST1;NKRF;JARID2;USP2;RCOR1;RBFOX2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;FOXN3;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;BCL7A;USP9X;TSC22D4;EHMT1;GCLC;SUFU;CIPC;CBFB;CDC73;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;TRPS1;BCL6;BCLAF1;IMPACT;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;DDX5;GTF2IRD1;UBE2D1;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;LANCL2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;GCFC2;NONO;MPHOSPH8;NCOR2;TRIM27;WWOX;FOXD1;PRMT2;UIMC1;YAF2;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;PHC2;ZBTB32;SMAD7;TPR;GLI3;ZNF431;VPS72;SMAD2;FOXO1;PPM1F;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;SPINDOC;HOXA7;IFI27;ID2;N4BP2L2
prerank,muscle tissue morphogenesis (GO:0060415),-0.32894349315411164,-0.9430014738288311,0.5074074074074074,0.8689762136575564,1.0,6/16,31.43%,BMP4;TBX1;EFEMP2;BMP2;HEY2;ZFPM1
prerank,regulation of programmed cell death (GO:0043067),0.3111500982946165,0.9427063020700764,0.6253776435045317,1.0,1.0,28/161,13.36%,GLS2;BAX;LCMT1;NTF3;HSP90AA1;AIFM2;ANP32A;HTATIP2;CDK5;PRELID1;ABL1;USP42;MAGED1;PLK5;LRP8;SOX9;SRA1;NDRG1;VCP;MALT1;PSMC5;IGFBP3;RTKN;IRF3;TMEM219;HS1BP3;TNFRSF25;DAPK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3093023192522485,0.9426452158816813,0.6549295774647887,1.0,1.0,32/199,15.42%,SFRP2;FCGR2B;SFRP1;PTGER4;ADM;NRDC;FLCN;PLCL2;SFMBT1;ACOT11;STK11;ADAMTS5;SOX9;PTCH1;LRPAP1;DDIT3;ATP2B1;LGR4;RBPJ;ROBO1;IFNGR1;BMP5;DOCK7;CYP51A1;NPTN;SLC6A4;NOVA1;ROCK2;TGFB1;SMAD6;VASN;FOXC2
prerank,C-terminal protein amino acid modification (GO:0018410),0.44377927004514495,0.9425369061028455,0.5425685425685426,1.0,1.0,2/11,2.01%,GPLD1;LCMT1
prerank,positive regulation of dendrite development (GO:1900006),-0.38548999535346373,-0.9425135092980507,0.5434782608695652,0.8685713011111252,1.0,6/10,16.87%,DAB2IP;COBL;ZDHHC15;BMP7;ALK;PACSIN1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.39222357822828363,0.9424455839491824,0.5617367706919946,1.0,1.0,5/19,21.92%,IL34;JAM3;CAMK1D;MPP1;CXCL17
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3111739009312475,0.9424287864585613,0.6263846928499497,1.0,1.0,36/186,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;TSC2;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;RACK1;KREMEN1;LRP1;CSNK1A1;PSMD1;CTNNBIP1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,mitotic sister chromatid segregation (GO:0000070),0.32036090773625936,0.9423016039395586,0.6018711018711018,1.0,1.0,9/98,9.28%,PSRC1;CDC23;CSNK2A2;NIPBL;AKAP8L;WRAP73;KPNB1;PIBF1;CHMP3
prerank,regulation of lipid kinase activity (GO:0043550),0.4446065820515065,0.9422128711784018,0.5614814814814815,1.0,1.0,5/11,17.99%,PIK3R1;RBL2;PIK3R2;WDR91;PPP2R5A
prerank,regulation of cell death (GO:0010941),-0.21160079920582311,-0.9421745984383099,0.7,0.8677758292947436,1.0,25/94,18.27%,FERMT2;CCN2;ATG5;RILPL1;BNIP3L;EPHB1;PRKD1;BECN1;CDKN1B;NCK1;LRRK2;ADNP2;UBB;DUS2;BMP7;PRODH;CCN3;CHRNA7;BNIP3;CRYAB;TNFRSF1B;BMP4;CCN5;TMEM109;CCN1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.37814146325096465,0.9419966012597566,0.5464684014869888,1.0,1.0,6/25,17.56%,IGF1;SOX11;TWIST1;PARK7;TGFB1;NSD1
prerank,tight junction assembly (GO:0120192),-0.23529467146509306,-0.9419611666604563,0.5648148148148148,0.8666474042454723,1.0,8/49,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;LSR;RAMP2
prerank,positive regulation of B cell proliferation (GO:0030890),0.36912195559223365,0.9416153135926297,0.5504252733900364,1.0,1.0,4/29,11.07%,EPHB2;TIRAP;IRS2;BCL2
prerank,negative regulation of growth (GO:0045926),0.3170471860855939,0.9414282775989921,0.5948453608247423,1.0,1.0,11/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;FLCN;STK11;TCHP;PPP1R9B
prerank,positive regulation of ion transport (GO:0043270),0.3465367026308691,0.9413883014174743,0.5850340136054422,1.0,1.0,14/48,22.71%,GPD1L;CNKSR3;ATP2B1;CRACR2A;GDNF;RAB3B;ANK3;VAMP8;AHCYL1;KIF5B;SNX4;SCN1B;VAMP7;WNK3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.41166458926538185,0.9411235060353773,0.5572207084468664,1.0,1.0,4/15,10.58%,SCEL;FGFR1;CELF1;UBR3
prerank,keratan sulfate catabolic process (GO:0042340),0.4417220357420974,0.9409267310437045,0.5443786982248521,1.0,1.0,3/11,15.67%,GLB1;OMD;LUM
prerank,regulation of immune response (GO:0050776),0.31558243627100185,0.9407470571967713,0.6128048780487805,1.0,1.0,10/135,8.14%,FCGR2B;GPR108;NPDC1;ADCY7;TIRAP;IRF1;DHX58;CD200R1;XIAP;LRP8
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3863896348637485,0.9406126475196315,0.5416133162612036,1.0,1.0,6/21,23.45%,MAD2L1;FBXO5;ZWINT;ZW10;TPR;ATM
prerank,autonomic nervous system development (GO:0048483),0.40370054738468,0.9406043628782873,0.5671232876712329,1.0,1.0,5/17,19.15%,NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,B cell homeostasis (GO:0001782),-0.38003387464300376,-0.9398467323510274,0.5269121813031161,0.8706183899225897,1.0,3/10,8.32%,MEF2C;PPP2R3C;CAMLG
prerank,retrograde axonal transport (GO:0008090),0.4030037474747148,0.939791303580392,0.5575342465753425,1.0,1.0,11/16,27.83%,NEFL;TMEM108;DLG2;KIF5B;PAFAH1B1;ACTR10;DYNC1H1;FBXW11;KIF5A;KIF1A;SOD1
prerank,cilium movement (GO:0003341),-0.24209533530297783,-0.9397909499835704,0.5901639344262295,0.8690417611076904,1.0,37/48,54.45%,DNAAF5;ODAD1;DNAH9;CFAP251;CCDC39;DNHD1;SPEF2;SPEF1;DNAH11;GAS8;RSPH9;CFAP61;DNAH5;ZBBX;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAAF2;ODAD4;TEKT2;CFAP100;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3266005398141786,0.939549688080807,0.5844155844155844,1.0,1.0,16/69,17.58%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLIN2;JKAMP;AUP1;RNF103-CHMP3;VCP;USP19;UBE2J1;UBXN4;RNF121;DERL1;DNAJC10
prerank,endoderm formation (GO:0001706),-0.2611948121438498,-0.9393481681827406,0.5733333333333334,0.8685095684458737,1.0,11/35,19.68%,SETD2;COL4A2;COL8A1;COL6A1;FN1;LAMA3;ITGA4;ITGB5;MMP2;DUSP1;SOX17
prerank,regulation of cell cycle (GO:0051726),0.3028064293367085,0.9391833092654942,0.6636636636636637,1.0,1.0,42/271,11.88%,CDKN2D;SFRP1;FOXM1;SIRT2;TSC2;CSNK2A2;TBRG4;BIN1;WHAMM;FGFR2;FBXL12;FZD9;CDC123;FGF10;CDK5;CDK9;RBBP4;TCF7L2;IRF1;ABL1;FBXO5;BARD1;GADD45GIP1;STK11;GAS2L1;CDC14B;CDC25A;MFN2;XIAP;SIK1;SOX9;SRA1;WDR6;PPP1R9B;SDCBP;RNF40;CDK5RAP3;TMEM8B;TAF6;IQGAP1;EIF4G2;MAGI2
prerank,regulation of protein acetylation (GO:1901983),0.4317227607997568,0.9391743578727332,0.53125,1.0,1.0,4/12,18.57%,TAOK1;DDX3X;PARK7;TERF2IP
prerank,positive regulation of transporter activity (GO:0032411),0.42222743872094554,0.9387588894775527,0.5526695526695526,1.0,1.0,5/13,23.82%,KCTD7;KMT2A;WNK3;RXRA;SGK1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.347461848198021,0.9382228416122673,0.5667447306791569,1.0,1.0,5/37,9.24%,CHID1;ADCY7;SIRPA;PER1;CUEDC2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.35129205087037363,0.93780923150743,0.580908032596042,1.0,1.0,6/36,12.36%,EPHB2;NRP1;EGF;PARK7;NLGN3;HDAC1
prerank,DNA repair (GO:0006281),0.3046438197566586,0.9377489747152451,0.683,1.0,1.0,57/284,15.30%,CDKN2D;WDHD1;XRCC2;APTX;LIG1;PARP1;APLF;RNF8;PRMT6;USP1;MPG;PARP2;MGMT;USP47;ASF1A;FBH1;MLH1;ABL1;DDB1;BARD1;TDP1;LIG3;FANCE;FANCG;ASCC1;ACTR8;SLC30A9;RNF168;UBE2V2;CUL4B;VCP;GTF2H3;MDC1;POLH;DCLRE1A;ENDOV;USP3;ALKBH3;FANCM;BRIP1;BACH1;POLN;PARK7;NPM1;FAAP100;TDP2;UBE2A;PMS2;ATR;SETX;MMS19;POLD3;FANCA;NUCKS1;MRE11;PPP5C;ASCC2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.371779323759581,0.9375829685766254,0.5796019900497512,1.0,1.0,9/25,24.79%,ANXA1;MALT1;SPTBN1;PDE4B;PRKD2;RPS3;TRAF2;TRAF6;RUNX1
prerank,regulation of autophagy (GO:0010506),0.3070126993793671,0.9373812357618155,0.6609829488465396,1.0,1.0,49/216,17.48%,IL10RA;UBQLN1;SIRT2;PIP4K2B;CSNK2A2;ATP6V0A2;UCHL1;SNX5;ITPR1;CDK5;SLC38A9;FLCN;DCN;ABL1;SNX6;VPS26B;ATP6V0E2;STK11;RRAGA;DDIT3;WDR6;USP10;PIK3CB;ATP6V1G1;PIK3R2;ATG13;BCL2;LEPR;RNF152;EIF4G2;LAMTOR5;PIP4K2A;VDAC1;DAPK1;PTPN22;PSAP;MAPT;ATP6V1D;PIP4K2C;DNM1L;NUPR1;TPCN1;RAB8A;MTMR4;ATP6V1B2;EIF4G3;MTDH;CAPNS1;USP33
prerank,cellular response to lipid (GO:0071396),0.3072294640152059,0.937179152041654,0.647887323943662,1.0,1.0,34/191,17.06%,WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ATP1A3;TNFAIP3;CARD16;ZNF35;SIRPA;ATP1A2;PID1;INSIG1;BRINP3;SOX9;TRIM41;LY96;TFPI;NCOA4;GIT1;SETX;CDC73;ROCK2;ADCY1;PDE4B;SNW1;SERPINE1;ADCY5;PTK7;UBE2L3;BRINP1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3718625312817466,0.9369335796730844,0.5533854166666666,1.0,1.0,6/25,10.95%,NRP1;DSCAM;SDCBP;EGF;APP;PTH1R
prerank,positive regulation of mitochondrial translation (GO:0070131),0.41920516201914165,0.9368760233101723,0.5438108484005564,1.0,1.0,3/14,13.28%,TRUB2;RCC1L;UQCC2
prerank,regulation of cytokine production (GO:0001817),0.31297385541132666,0.9367933595975994,0.6302083333333334,1.0,1.0,16/126,14.57%,FCGR2B;PTGER4;IL33;ANXA1;AGPAT1;IGF2BP2;TRIM56;SIRPA;ATP2B1;PER1;LGR4;IRF3;CD47;NPTN;SCAMP5;BCL6
prerank,mitotic cytokinesis (GO:0000281),0.3409906658582672,0.9365976924438904,0.5698324022346368,1.0,1.0,11/47,17.34%,CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SON
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3976954743905755,0.9363466877494813,0.5532786885245902,1.0,1.0,4/18,12.17%,SIRT7;EIF2AK3;DHX33;POLR2K
prerank,innate immune response (GO:0045087),-0.18637692462185476,-0.9363182696220598,0.6666666666666666,0.8749335347824831,1.0,59/217,24.26%,ANKRD17;SETD2;MFHAS1;CAPZA2;IKBKB;FER;RNASE3;PML;LBP;IRAK1;TNK2;TRIM25;SP100;IFIH1;RNF135;TLR4;OTULIN;CYLD;PLCG2;POLR3A;CXCL16;ALPK1;IKBKG;TRIM39;ADAM15;DEFA6;PYDC1;IRAK4;S100B;RPL39;MAVS;AKAP1;SRC;SERINC3;RNF187;TRIM5;IRGM;SKP2;TRIM14;IFIT1;PGLYRP1;GCH1;NRROS;TBK1;FYN;CYBA;BST2;IFITM2;NUB1;ATAD3A;STYK1;PPARG;IFITM1;BCL10;PIK3CD;NLRC5;CX3CR1;TRIM59;TRIM28
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3994171072151338,0.9360856649345317,0.5539280958721704,1.0,1.0,2/17,11.13%,NOS1AP;ANK3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.30133772578142937,-0.9359003875492832,0.51953125,0.8744066950440612,1.0,6/20,17.14%,HSP90AB1;ANO6;NT5E;ENTPD1;TXN;P2RX7
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4077988304461371,0.9354102642166869,0.5649794801641587,1.0,1.0,3/15,17.37%,SRM;SMOX;MOXD1
prerank,cellular protein-containing complex assembly (GO:0034622),0.30845037661901725,0.935160059201621,0.6359959555106168,1.0,1.0,43/160,22.48%,CALY;SRP19;CENPT;BBS10;PSMD4;BIN1;HSP90AA1;NDUFAF1;TBCA;TCF4;VAMP3;COX7A2;PSMD11;PSMG3;VBP1;CHMP3;AP2S1;PDE4DIP;PRLR;CENPC;MAPT;NRG1;TGFB1;SHQ1;HSPD1;POMP;TBCD;VAMP8;OMA1;DNAAF3;GPX4;NUP153;DNAI4;UVRAG;TPR;CHMP4A;CHMP4B;SMAD2;OTUD6B;TRAF2;SMAD3;DNAJB12;GTF2B
prerank,melanosome organization (GO:0032438),-0.28210900107170256,-0.9351450638507728,0.5365853658536586,0.874649240732157,1.0,10/26,27.88%,AP3D1;KIF13A;DTNBP1;HPS4;AP1M1;BLOC1S5;RAB29;SNAPIN;HPS1;RAB38
prerank,regulation of viral release from host cell (GO:1902186),0.38815467205084214,0.9350503045619849,0.566579634464752,1.0,1.0,5/21,9.28%,TRIM11;DDB1;TRIM35;TRIM62;CHMP3
prerank,cardiac myofibril assembly (GO:0055003),0.416528073957966,0.9346393388138466,0.5619047619047619,1.0,1.0,3/15,11.29%,NEB;OBSL1;PDGFRA
prerank,vascular transport (GO:0010232),0.32232644606149435,0.9344114047726099,0.5989304812834224,1.0,1.0,16/81,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,response to retinoic acid (GO:0032526),0.3339353015308222,0.9339188550063323,0.6047774158523345,1.0,1.0,10/59,17.06%,CDKN2D;WNT5A;ZNF35;BRINP3;SOX9;SETX;CTSH;SNW1;PTK7;BRINP1
prerank,skeletal system morphogenesis (GO:0048705),0.3410170216258423,0.9335988962027045,0.5795586527293844,1.0,1.0,9/42,18.89%,FBN2;FGFR2;FGFR1;SOX11;PDGFRA;CYP26B1;MEGF8;TGFBR1;WWOX
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.383570325252222,0.9329048962152087,0.5792759051186017,1.0,1.0,4/24,12.01%,IGF1;SELENOS;IRS2;ENPP1
prerank,cell-matrix adhesion (GO:0007160),0.31774369775017747,0.9327712554625446,0.6193952033368092,1.0,1.0,15/95,13.58%,VTN;LYVE1;THBS3;RAC1;WHAMM;CD63;DDR1;THY1;ARHGEF7;RHOD;TMEM8B;ITGBL1;ECM2;FBLN5;EMP2
prerank,positive regulation of wound healing (GO:0090303),0.3503435460750534,0.9327440586942278,0.5772946859903382,1.0,1.0,7/36,16.49%,VTN;ANXA1;XBP1;DMTN;PLPP3;FOXC2;SERPINE1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3181293041117027,0.9326714183780194,0.6202127659574468,1.0,1.0,14/83,13.58%,CDKN2D;TFDP1;CDK5;NPAT;BRD4;FBXO5;CDC25A;CUL4B;E2F3;BACH1;CCNH;RCC1;GSPT1;CUL5
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3878746408390765,0.9325091265923523,0.5665349143610013,1.0,1.0,3/19,9.42%,FIS1;DMTN;STIMATE
prerank,positive regulation of cellular protein localization (GO:1903829),0.3240420419709757,0.9323619641148531,0.5970149253731343,1.0,1.0,16/69,18.71%,GNL3;EIF2AK3;GPD1L;SLC5A3;ENTR1;CDK5RAP3;ABCA7;SNX33;RIC3;PARK7;LAMTOR5;MAPT;TGFB1;NUMA1;CCDC88A;PRKAA1
prerank,MAPK cascade (GO:0000165),0.30381365120168063,0.9321228974584477,0.707,1.0,1.0,68/295,21.29%,FGF20;FGF9;SPTBN5;CAMK2B;PTGER4;IGF1;ARAF;PSMD4;NFKB1;NEFL;FGFR2;FGFR1;GRIN1;TAOK1;ZFP36L1;MINK1;BRAP;FGF10;IL31RA;PIK3R1;DLG3;PSMB10;RASGEF1A;PSMD11;SOX9;FRS2;EGF;PPP1CC;KL;GDNF;PSME2;IRS2;GFRA2;PSMC5;PIK3CB;PIK3R2;PDGFRA;PTPN3;NRG2;SETX;PDE6D;NRG1;TGFB1;MAP2K2;PSMD1;PPP5C;SPTBN1;CTSH;IL5;RIT2;DLG2;PSMD6;RASA3;MRAS;JAK1;CALM1;KSR1;NRK;RANBP9;PSMD5;RALGDS;MAPKAPK2;ITGAV;SPTBN4;PSMA4;MAP4K4;FGF13;FGF2
prerank,regulation of TOR signaling (GO:0032006),0.3247585614295943,0.9319491423702466,0.62486602357985,1.0,1.0,8/67,7.21%,HDAC3;ARAF;TSC2;TBC1D7;SLC38A9;FLCN;RRAGA;RFFL
prerank,regulation of mitochondrial translation (GO:0070129),0.38190576257546405,0.9310890072886541,0.5628205128205128,1.0,1.0,6/21,19.29%,TRUB2;RCC1L;MALSU1;UQCC2;MTG2;ALKBH1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32287886871897065,0.9308083874322817,0.6111111111111112,1.0,1.0,8/75,9.15%,APLN;WNT5A;PDPK1;FGFR1;NRP1;PRKCA;ARNT;EGF
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3251609049309836,0.9306539578768026,0.5930359085963003,1.0,1.0,9/66,11.30%,MST1R;IL34;DVL2;EDN3;FGFR1;EZH2;CD24;EGF;ROBO1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.38585008297232165,0.9305157115891393,0.5548302872062664,1.0,1.0,8/20,18.70%,ABCA2;KPNB1;MBTPS1;EPHX2;ACADL;ACADVL;APOE;TTC39B
prerank,connective tissue development (GO:0061448),0.3520267257362455,0.9304855798468065,0.5847953216374269,1.0,1.0,6/35,14.84%,XBP1;SULF1;TRIP11;SOX9;SOX6;SOX5
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.410276646323767,0.9303210586176451,0.5761494252873564,1.0,1.0,1/14,1.28%,IL34
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.38120645282781995,-0.930014388975395,0.5625,0.8863849263225684,1.0,8/10,61.90%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B;RHO;GNAT1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.25513958508094037,-0.9297698160164997,0.5789473684210527,0.8852798513542821,1.0,14/39,20.86%,FLNA;ACTB;ACTN1;MEGF11;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,cellular response to starvation (GO:0009267),0.30693038156490304,0.9297035913073154,0.6393110435663627,1.0,1.0,37/147,19.00%,SFRP1;EIF2AK3;XBP1;PICK1;WIPI1;NUAK2;SLC38A9;FLCN;NUAK1;ATG14;ATP6V0E2;RRAGA;BRSK2;GAS2L1;TBL2;SIK1;GCN1;EHMT2;RIPOR1;FADS1;ATF2;BRSK1;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;MAP1LC3B;ATP6V1D;VPS41;IMPACT;ATP6V1B2;PIK3C3;MIOS;USP33;PRKAA1;PRKAG2;PIK3R4
prerank,type I interferon signaling pathway (GO:0060337),-0.24523764069425355,-0.9296376169009687,0.6198347107438017,0.882216746530181,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,cellular response to type I interferon (GO:0071357),-0.24523764069425355,-0.9296376169009687,0.6198347107438017,0.882216746530181,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,ventricular septum morphogenesis (GO:0060412),-0.27708456209409227,-0.9295074752351874,0.5543478260869565,0.8807846007137653,1.0,9/27,17.44%,SMAD4;SLIT2;TGFB2;ACVR1;BMPR1A;TGFBR2;BMP4;HES1;HEYL
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3822380172602245,0.9294378569050304,0.5863874345549738,1.0,1.0,4/19,9.16%,HS2ST1;EXTL3;NDST2;HS6ST2
prerank,positive regulation of telomerase activity (GO:0051973),-0.25885300079921636,-0.9293808740085762,0.5802469135802469,0.8794036705383979,1.0,11/33,17.03%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TCP1;PARN;NAF1;MAP3K4;PNKP;CCT2
prerank,cell-cell junction organization (GO:0045216),-0.21376122828915153,-0.9293575338561537,0.6129032258064516,0.8777791383119437,1.0,18/79,16.07%,CADM2;LIMS2;TJP1;PKP4;CLDN5;CDH6;GJC1;CADM1;TGFB2;ARVCF;CDH1;CSK;OCLN;MYADM;NECTIN3;NECTIN1;TLN1;CADM3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2838845540467855,-0.9293160523264307,0.5641025641025641,0.8762105018611235,1.0,8/23,28.54%,SLC12A7;CLCN3;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6;PDK2
prerank,cellular component assembly (GO:0022607),0.3021710601940795,0.9292864205677964,0.6933867735470942,1.0,1.0,60/253,20.62%,WNT5A;LCP1;AIF1L;CHCHD10;RAC1;NDUFAF1;KPNA3;NEFH;TLCD1;MYO1B;RBBP4;NAPG;LAMC1;DMTN;DVL1;VAMP3;RHOD;TEAD1;SOX9;CYFIP1;EPRS1;BAIAP2;MDM4;PPIH;CAPZA1;AFG3L2;ANK3;YTHDF3;NLGN3;ADD2;WASF1;YTHDF1;TGFB1;NLGN2;VMP1;DNM1L;FANCA;SPTBN1;PAWR;IL1RAP;STK25;TUBGCP2;MDM2;TSPAN4;RAD21;ILK;KMT2A;SHANK1;KIFAP3;YTHDF2;VCPIP1;QSOX1;MITF;RANBP9;ZW10;MYO9A;DCX;LIMA1;PTK2B;GEMIN5
prerank,response to UV (GO:0009411),0.31347305930628483,0.9291194380392469,0.6231732776617954,1.0,1.0,16/95,12.82%,CDKN2D;MFAP4;PARP1;USF1;USP1;SDE2;USP47;CDC25A;DHX36;CASP9;POLH;BRSK1;YY1;NPM1;UBE2A;ATR
prerank,regulation of stress fiber assembly (GO:0051492),0.3189102729140797,0.9287730274582205,0.6078224101479915,1.0,1.0,27/74,22.50%,SFRP1;PTGER4;RAC1;ARHGEF10;NRP1;ALMS1;PIK3R1;ABL1;TPM1;ARHGEF10L;CD47;ARAP1;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;DLC1;ARHGAP6;EVL;NF2;CLASP2;PPM1F;PFN2;PAK1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.32921273238139587,-0.9282537306428219,0.5186440677966102,0.8772595188192557,1.0,5/14,22.71%,IKBKG;NECTIN2;RAB29;CD81;BCL10
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.3270312081743566,-0.9281968747889207,0.5634328358208955,0.87573496848662,1.0,7/15,23.72%,GGACT;GOT2;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3386028147526376,0.9280838633804519,0.5781609195402299,1.0,1.0,11/43,19.27%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;CHFR;BRSK1;FOXN3;MRE11;NABP2;UIMC1
prerank,myotube differentiation (GO:0014902),0.4024056019547274,0.9279162112288953,0.5668874172185431,1.0,1.0,6/17,19.08%,IGF1;ADAMTS5;ADAM12;MYEF2;ADGRB3;KCNH1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4294735841540058,0.9273295448100873,0.5726744186046512,1.0,1.0,1/11,1.51%,UQCRC1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3008971523124267,0.9271181490339148,0.7007007007007007,1.0,1.0,50/291,17.06%,CPEB1;MAPK9;WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ZFP36L1;TNFAIP3;TIRAP;CARD16;SLC38A9;PRDX5;DMTN;ZNF35;GNG2;RRAGA;SIRPA;PID1;INSIG1;BRINP3;KCNC2;SOX9;SSH1;DHX36;CAPN2;TRIM41;RAPGEF1;VCP;LY96;TPM1;PDGFRA;GIT1;LAMTOR5;SETX;DAPK1;CDC73;MAPT;ROCK2;GLRA1;IMPACT;PDE4B;SNW1;SERPINE1;PTK7;DPEP1;BRINP1
prerank,protein tetramerization (GO:0051262),0.32080138529353763,0.9269487469564072,0.6081229418221734,1.0,1.0,16/67,22.07%,FARSB;KCNC1;GRIN1;ALDH1A2;TK1;CPSF7;NUDT21;SOD2;HPRT1;AQP4;CPSF6;PKD2;OXA1L;APPL2;ACOT13;B2M
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.35279151629240374,0.9267908101193184,0.5770171149144254,1.0,1.0,4/31,13.04%,MOCS2;LSS;PRLR;CYP51A1
prerank,cell chemotaxis (GO:0060326),0.3268770702004045,0.9267608929532739,0.596529284164859,1.0,1.0,13/60,18.58%,CCR9;ACKR2;CXCL12;NRP1;CXCR4;PDGFRA;PLEKHG5;RAB13;LPAR1;AGTR1;PLXNB3;CCL25;PIP5K1A
prerank,lysosome organization (GO:0007040),0.3480518954947217,0.9265699489065059,0.5933412604042806,1.0,1.0,7/36,16.00%,CLN3;CLN6;ATP10B;MBTPS1;HOOK3;ARSB;VPS18
prerank,pyroptosis (GO:0070269),0.40951303682053036,0.9262324326536385,0.5696551724137932,1.0,1.0,1/15,1.45%,GSDMD
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.43383823524120346,0.9259385173196053,0.5798816568047337,1.0,1.0,3/10,20.88%,MALT1;RC3H2;SMAD7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.40484979367366436,0.9258174887851914,0.5820689655172414,1.0,1.0,2/15,4.33%,CDC23;CDC16
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.32344006038081496,0.9257363061903484,0.6103896103896104,1.0,1.0,16/63,19.80%,BAX;PCBP4;TFDP1;SDE2;CNOT10;FBXO31;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,respiratory electron transport chain (GO:0022904),-0.3291386598874155,-0.9251329028988142,0.5620915032679739,0.8822107896519836,1.0,11/14,35.19%,GPD2;SLC25A13;SDHB;ETFDH;NDUFA5;PPARGC1A;ETFRF1;ETFB;SLC25A22;UQCRFS1;SLC25A18
prerank,axoneme assembly (GO:0035082),-0.2581882110484187,-0.9251218975924047,0.6030927835051546,0.8805737451168806,1.0,19/31,47.99%,TOGARAM1;SPAG1;TTC12;TTLL3;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;RSPH9;CFAP46;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,carbohydrate homeostasis (GO:0033500),-0.21046513400793357,-0.9249769560738024,0.6823529411764706,0.8792668866201183,1.0,13/67,14.55%,IGF1R;CYB5R4;STAT3;IRS1;BACE2;RBP4;INPP5K;ADIPOR1;SLC8B1;RPS6;MCU;PRKAA2;ADIPOR2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.31928698571159797,-0.9248927410512531,0.5687732342007435,0.8778585425409093,1.0,9/16,39.63%,TIPIN;RAD9B;HUS1;CLSPN;DNA2;ORC1;TIMELESS;RAD9A;CDC45
prerank,positive regulation of protein secretion (GO:0050714),0.3216485693477762,0.9248855155259524,0.6109324758842444,1.0,1.0,13/69,16.41%,IGF1;LRRC8A;BMP6;CAPN10;TCF7L2;WLS;IRS2;MYH10;TMED10;TGFB1;NLGN2;DNM1L;TRH
prerank,regulation of filopodium assembly (GO:0051489),0.3411243605264604,0.9248056563777156,0.5873959571938169,1.0,1.0,8/38,16.79%,ABITRAM;NRP1;PIK3R1;DMTN;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.40879211848746183,0.9246308101807218,0.5832187070151307,1.0,1.0,7/16,20.66%,RBM3;PRDX6;TRA2B;SNW1;THRAP3;CIRBP;TRA2A
prerank,protein localization to vacuole (GO:0072665),-0.34025214245613233,-0.9245073011864117,0.5683229813664596,0.8771909212564408,1.0,9/13,36.56%,SH3BP4;SZT2;KPTN;MFSD1;CD81;RNF128;GLMP;ATP13A2;RTN4
prerank,microtubule depolymerization (GO:0007019),0.395847055490824,0.9243948043608696,0.5943775100401606,1.0,1.0,2/17,9.89%,STMN4;KATNB1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3149824003398395,0.924392534545907,0.6248693834900731,1.0,1.0,24/95,20.07%,CCP110;B9D2;CENPJ;HSP90AA1;ALMS1;TCTN1;CEP97;TUBA1A;YWHAG;CC2D2A;HAUS3;CSNK1D;TUBB;TMEM216;OFD1;AHI1;CEP76;IQCB1;TUBB4A;NPHP1;ODF2;DYNLL1;PAFAH1B1;TMEM67
prerank,positive regulation of cell development (GO:0010720),-0.261186574292148,-0.9242464335595189,0.5672514619883041,0.8762036598653717,1.0,11/31,23.74%,NIBAN2;TGM2;NUMB;NUMBL;ATP6AP1;OPRM1;MME;BMP4;FAIM;BAD;CX3CR1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3730138115902504,-0.9241971669905793,0.5344827586206896,0.8746950487395163,1.0,2/10,3.56%,ARL6IP5;SLC25A13
prerank,negative regulation of coagulation (GO:0050819),0.41989810478205597,0.9241888342069945,0.5628415300546448,1.0,1.0,4/14,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4175459946570357,0.9240690979469622,0.5898876404494382,1.0,1.0,4/14,10.53%,SCAP;SAR1A;MIA3;TBC1D20
prerank,transport across blood-brain barrier (GO:0150104),0.3182288264020468,0.924067095882609,0.624332977588047,1.0,1.0,16/83,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,polyamine metabolic process (GO:0006595),0.4238813411968214,0.9237603275256651,0.5770348837209303,1.0,1.0,4/13,15.80%,SRM;SMS;SMOX;AMD1
prerank,negative regulation of bone mineralization (GO:0030502),-0.35136963768616,-0.9236687079479637,0.5413793103448276,0.8743641601944546,1.0,3/13,10.35%,BCOR;ECM1;SRGN
prerank,ncRNA transcription (GO:0098781),0.42161586144060326,0.9233755105645516,0.5811965811965812,1.0,1.0,2/13,3.66%,SIRT7;USPL1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.35031336571436433,0.9225245968564914,0.5822328931572629,1.0,1.0,13/33,22.82%,HDAC5;TBXA2R;JUP;TGFB1;ITGB1BP1;APOE;MECP2;KLF4;STARD13;ATP2B4;FGF2;HMGB1;MEOX2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3587453668530602,0.9223474195070882,0.6052009456264775,1.0,1.0,14/33,23.91%,TCIM;EZH2;PLK5;PSME2;CDC73;MN1;INO80;ATP2B4;APPL2;TAF1;ID2;STXBP4;PTEN;FBXW7
prerank,protein-containing complex assembly (GO:0065003),0.29859122474248506,0.9219804261235771,0.7004008016032064,1.0,1.0,73/259,20.62%,TRAPPC10;GSDMD;CHCHD10;NDUFAF1;KPNA3;CXCL12;CDC123;NAPG;LAMC1;TCF7L2;KLHL12;SEC16A;DMTN;VAMP3;TEAD1;SEC16B;PEF1;SOX9;EPRS1;MDM4;PPIH;DBNL;HGSNAT;PDE4DIP;PPP6R3;TBC1D20;SCFD1;CAPZA1;AFG3L2;TFG;GRIA1;HDAC1;ADD2;AXIN2;PYGO2;TMED10;WASF1;CDC73;CSNK1D;PYGO1;TRAPPC6B;USO1;CTSZ;DNM1L;FANCA;KMT2D;MCFD2;CSNK1A1;TCF7L1;FARP2;F8;IL1RAP;NSF;ITGB1BP1;TUBGCP2;GORASP1;TCF7;MDM2;TSPAN4;PLEKHA7;ANKRD28;KMT2A;SEC24D;SHANK1;CNIH1;KIFAP3;STX5;MITF;RANBP9;ZW10;PDCD6;PTK2B;GEMIN5
prerank,regulation of cellular response to heat (GO:1900034),0.3168625211894196,0.9218492332509656,0.6316359696641387,1.0,1.0,29/77,24.13%,CAMK2B;HSP90AA1;DNAJC7;RAE1;BAG1;NUP188;HSPH1;CAMK2D;CAMK2G;DNAJB6;NUP210;ATR;NUP88;MAPT;NUP214;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;NUP35;MAPKAPK2;TPR;DNAJC2;HSPB8;NUP155;ATM;NUP54;NUP98
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.4204823900358975,0.9216719743667117,0.5766526019690577,1.0,1.0,5/13,21.79%,CALM3;ANK3;CAMK2D;CALM1;CALM2
prerank,regulation of phosphorylation (GO:0042325),0.3058631992856534,0.9216543577614826,0.6413934426229508,1.0,1.0,29/120,19.68%,CDKN2D;KDM4D;SIRT2;PRKRIP1;OGT;RAE1;NRP1;FLCN;BARD1;ATG14;DSCAM;CD24;SDCBP;EGF;NUP188;PGAM1;APP;NUP210;NUP88;EMP2;NUP214;PHIP;ILK;NUP153;CCDC88A;RANBP2;PRKAG2;NUP35;DYNLL1
prerank,cellular defense response (GO:0006968),0.3451944482922627,0.9216275964081752,0.6007109004739336,1.0,1.0,7/40,20.98%,DCDC2;CCR9;LY96;TCIRG1;LSP1;PTK2B;ITGB1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.40809988167935757,0.9214457604169951,0.5608391608391609,1.0,1.0,5/13,21.27%,ISCA2;CIAO2A;MMS19;NFU1;ISCA1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4370610991320075,0.9214348816331961,0.5764705882352941,1.0,1.0,4/10,18.96%,CALM3;NOS1AP;PDE4B;CALM1
prerank,cAMP-mediated signaling (GO:0019933),-0.2769164007620426,-0.9212874785381356,0.5774647887323944,0.8790221582841474,1.0,5/24,6.44%,RAPGEF3;ADGRG6;PDE7A;RIMS2;CAP2
prerank,negative regulation of histone acetylation (GO:0035067),-0.362883296046856,-0.9211880614647404,0.5570469798657718,0.8776159001896772,1.0,7/11,40.65%,SIRT1;SIN3A;NOC2L;TAF7;THAP7;BRCA1;SPI1
prerank,cardiac muscle cell action potential (GO:0086001),-0.2678360749454495,-0.9211518687502357,0.6,0.8760492547693238,1.0,8/30,12.55%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;DMD;CACNA1C;CACNA1G;ATP1B1
prerank,cellular response to chemical stress (GO:0062197),0.30896776572865414,0.9209748256065435,0.6369294605809128,1.0,1.0,15/96,13.10%,SIRT2;SELENOS;PARP1;MGAT3;DDX3X;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;STX2;PARK7;SOD2;SOD3;SETX
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3180625904901679,-0.9203095990439477,0.56,0.8765308265063586,1.0,8/16,21.40%,ABHD5;SCARB1;DAGLB;NR1H3;CNEP1R1;SREBF1;CTDNEP1;NR1H2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.27216540090042757,-0.9201438832208855,0.546583850931677,0.8753765192532528,1.0,14/27,30.41%,TRRAP;KAT7;KAT2B;EP300;MSL3;KAT6B;KAT8;PHF20L1;BAG6;RUVBL1;TAF6L;KAT6A;KAT5;MRGBP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.44827993189102716,0.9197971023698933,0.5880597014925373,1.0,1.0,5/10,22.67%,NELL1;CDK5RAP3;ANXA2;ATRAID;EPHA4
prerank,histone exchange (GO:0043486),0.34826022595781414,0.9196309755411902,0.6068476977567887,1.0,1.0,6/37,13.49%,CENPT;RNF8;RBBP4;ACTR6;NPM1;CENPC
prerank,cellular response to ketone (GO:1901655),0.3469813965302657,0.9195759093485711,0.6245487364620939,1.0,1.0,7/35,16.59%,SFRP1;PTGER4;GNG2;NCOA4;ROCK2;ADCY1;ADCY5
prerank,supramolecular fiber organization (GO:0097435),0.3005089816808216,0.9195385697771886,0.7297297297297297,1.0,1.0,67/334,18.81%,MYO1A;FSD1;CENPJ;COL27A1;STMN4;P4HA1;MFAP4;NEFL;MYO19;RAC1;WHAMM;COL4A6;COL4A5;MYO1B;PLOD1;DDR2;CD151;DBN1;COL22A1;TPPP3;RHOD;CAMSAP2;TNXB;DES;PPP1R9B;PPIB;CLIP3;P4HA2;KATNB1;RHOBTB3;HOOK3;APP;TPM1;CEP126;MYO5A;COL1A2;CRTAP;VPS4B;DNAJB6;MPRIP;USP9X;FBLN5;ZBED3;EMP2;MAPT;ADAMTS3;PXDN;P3H2;COL5A2;FAT1;LUM;GGA2;HSPG2;ITM2B;TMOD2;TPPP;BFSP2;TUBGCP2;RUFY3;COL11A1;MDM2;BMP1;SORL1;CCDC88A;TGFBR1;COL5A3;COL8A2
prerank,Rac protein signal transduction (GO:0016601),0.38351682376175494,0.9191842839554378,0.5864453665283541,1.0,1.0,5/18,15.66%,RAC1;CYFIP1;DBNL;WASF1;FARP2
prerank,proteoglycan metabolic process (GO:0006029),0.36729864881344376,0.9189959747654854,0.5839598997493735,1.0,1.0,3/26,6.08%,IGF1;SULF1;CHST10
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.43392704167799356,0.9188476841800619,0.589041095890411,1.0,1.0,2/10,10.20%,STAT6;PRLR
prerank,positive regulation of cell migration (GO:0030335),0.30008950642014487,0.9187334950505698,0.6920762286860582,1.0,1.0,42/253,15.68%,CARMIL2;VTN;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;GLIPR2;CXCL12;NIPBL;NRP1;FGF10;PRKCA;SNAI1;DDR2;CD151;GAB1;FBXO5;ARHGEF7;DMTN;MIA3;RHOD;SOX9;SDCBP;EGF;RIPOR1;SEMA3D;ENPP2;MAZ;PDGFRA;SOD2;RACK1;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;ACVR1B;SEMA3A;CTSH
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3184322625671566,0.9183874344826812,0.6115261472785486,1.0,1.0,13/72,16.27%,DNASE1L2;PARP1;RNASE1;FBH1;DCP1B;SPO11;DDB1;CUL4B;GTF2H3;ENPP1;POLD3;MRE11;RAD50
prerank,retinoic acid metabolic process (GO:0042573),0.40783494602654385,0.9182283301320252,0.5688888888888889,1.0,1.0,2/14,12.85%,ALDH1A2;CYP26B1
prerank,regulation of establishment of planar polarity (GO:0090175),0.3151668032900523,0.9180242692227271,0.6338912133891214,1.0,1.0,12/88,10.55%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.31731548790811837,-0.9179835504844105,0.5852842809364549,0.8792743355157459,1.0,5/15,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,cellular response to amino acid stimulus (GO:0071230),0.35275020785797623,0.9177242546008949,0.5929526123936817,1.0,1.0,7/33,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3151858271011578,0.9173653029019138,0.6269925611052072,1.0,1.0,16/74,16.91%,IGF1;DDX3X;TNFAIP3;TCF7L2;TMBIM1;RFFL;GDNF;BCL2;BMP5;PARK7;HTT;EYA2;ICAM1;SERPINE1;FAIM2;PHIP
prerank,cellular response to fluid shear stress (GO:0071498),0.41902259394252545,0.9164869064827027,0.5872340425531914,1.0,1.0,5/12,19.97%,HDAC3;PKD2;ASS1;KLF4;MTSS1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3243392075774343,0.9164844007057784,0.6059602649006622,1.0,1.0,14/54,19.80%,BAX;PCBP4;TFDP1;CNOT10;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,positive regulation of apoptotic process (GO:0043065),0.29523434961640216,0.9163989042371976,0.7327327327327328,1.0,1.0,66/293,19.69%,SFRP2;SFRP1;EPHA7;BAX;SIRT2;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;DDX3X;FZD9;CDK5;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;SIK1;DDIT3;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;NUPR1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6;TLE5;OMA1;RASSF2;TGFBR1;PDCD5;PRMT2;SMPD1;SOX4;PLEKHG2;RPS3;FGD4;DLC1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3604116507556971,0.9162379997805227,0.571964956195244,1.0,1.0,6/25,24.48%,WNT5A;MALT1;LACC1;TRAF2;B2M;TRAF6
prerank,peptidyl-arginine modification (GO:0018195),0.4009985103144334,0.9161387394302922,0.5736111111111111,1.0,1.0,4/15,15.50%,PRMT5;PARK7;PRMT1;PRMT8
prerank,positive regulation of insulin secretion (GO:0032024),0.35063885736859396,0.9161101144077954,0.6025943396226415,1.0,1.0,7/36,16.41%,GPLD1;LRRC8A;CAPN10;TCF7L2;IRS2;NLGN2;TRH
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.41975224750920676,0.9160638108705621,0.5714285714285714,1.0,1.0,3/12,13.43%,KDELR3;INSIG1;ANKRD13C
prerank,purine nucleotide metabolic process (GO:0006163),0.36979212048763044,0.9160348266335746,0.592496765847348,1.0,1.0,3/24,6.19%,ADSL;PRPSAP2;GART
prerank,protein localization to chromosome (GO:0034502),-0.2479832721313445,-0.9156999082050132,0.5506329113924051,0.8834003169317912,1.0,8/34,14.89%,WAPL;XRCC4;RB1;RPA1;TPP1;MSH2;SLF1;ESR1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3020286231049732,0.9156059521490199,0.6686991869918699,1.0,1.0,33/144,18.76%,HDAC3;CSNK2A2;FIS1;TFDP1;SAR1A;SAE1;TCF7L2;MTCL1;MIEF2;PIK3R1;SEC16A;NMT1;SEC16B;YWHAH;RIPOR1;YWHAG;JUP;PIK3R2;ATG13;BCL2;ANK3;LEPROT;TGFB1;ARIH2;ITGB1BP1;UBE2L3;UBR5;RUFY3;SORL1;CEMIP;ZDHHC2;RBM22;KIF20B
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4032758003309352,0.9156000246490615,0.5750350631136045,1.0,1.0,3/15,9.21%,MGAT3;RENBP;EXTL2
prerank,skin development (GO:0043588),0.32037895186926807,0.9155989061238159,0.6295081967213115,1.0,1.0,11/65,18.79%,WNT5A;DACT2;SCEL;ANXA1;ERRFI1;COL1A2;COL5A2;TXNIP;JAG1;PIP5K1A;COL5A3
prerank,long-chain fatty acid import into cell (GO:0044539),0.4309774061609055,0.9154809733434446,0.5922953451043339,1.0,1.0,2/10,16.50%,SLC27A4;SLC27A1
prerank,cellular response to osmotic stress (GO:0071470),-0.28550650103020747,-0.9150977650303458,0.581081081081081,0.8833344048947496,1.0,4/21,5.58%,RCSD1;CAB39;YBX3;LRRC8D
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.40986259344497294,0.9148602333075672,0.5961538461538461,1.0,1.0,4/13,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,neural crest cell differentiation (GO:0014033),-0.3064588885615655,-0.9148144226138688,0.5537848605577689,0.8823738234879794,1.0,3/18,1.20%,LRP6;MEF2C;TAPT1
prerank,positive regulation of cellular component organization (GO:0051130),0.31211955380007683,0.9140366242281117,0.6566077003121749,1.0,1.0,25/107,19.43%,CALY;CAMK2B;BAX;WARS1;TIRAP;CD151;SLF2;ANAPC2;FRMPD4;CLIP3;VCP;PLEKHM2;PARK7;RACK1;LRP1;NRG1;TGFB1;ABCB7;FAF1;TPPP;APOE;TGFBR1;FLOT1;SMPD1;RPS3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3214945319521958,-0.9138714247167917,0.5401459854014599,0.8830916510682061,1.0,2/16,4.71%,ST3GAL4;IRAK1
prerank,inflammatory response (GO:0006954),0.2989241168643769,0.9136320407265324,0.7016129032258065,1.0,1.0,27/195,18.62%,FCGR2B;PTGER4;LTB4R2;NFKB1;ADM;RAC1;IL10RB;ANXA1;GPR68;PRDX5;CXCR4;HDAC5;IL22;NFX1;BDKRB2;HDAC4;TBXA2R;HNRNPA0;BLNK;TGFB1;ADCY1;HSPG2;AGTR1;HRH1;CCL25;RELB;SCUBE1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.32051402335878293,0.9136247458823082,0.6084598698481561,1.0,1.0,24/64,25.98%,SFRP1;AJAP1;CASK;MINK1;THY1;PIK3CB;JUP;EMP2;ROCK2;SEMA3E;JAG1;CCL25;PTK2B;NF2;MAP4K4;HOXA7;TSC1;CORO1C;CX3CL1;PTPRA;DUSP3;VCL;SLC9A1;LDB1
prerank,response to reactive oxygen species (GO:0000302),0.3253287260637879,0.9133362465169125,0.6119073869900772,1.0,1.0,13/54,19.43%,MAPK9;PTPRN;APTX;PRDX5;TPM1;PDGFRA;SOD2;MAPT;COA8;STK25;APOE;PKD2;RPS3
prerank,positive regulation of cation channel activity (GO:2001259),0.3408133606366194,0.9131954925514827,0.5976190476190476,1.0,1.0,8/40,18.96%,EPHB2;CALM3;ANK3;NLGN3;HTT;ATPSCKMT;PKD2;CALM1
prerank,linoleic acid metabolic process (GO:0043651),0.3860819037676811,0.9131235030071807,0.581081081081081,1.0,1.0,2/17,9.95%,ELOVL1;FADS1
prerank,regulation of MAP kinase activity (GO:0043405),0.3096457694622608,0.9128409214556765,0.6349206349206349,1.0,1.0,13/92,11.30%,MST1R;IL34;EDN3;FGFR1;UCHL1;SNF8;EZH2;HGS;CD24;EGF;CDK5RAP3;PIK3CB;ROBO1
prerank,response to peptide hormone (GO:0043434),0.33617598863099885,0.9128223422772254,0.6036655211912944,1.0,1.0,6/43,6.72%,STAT6;ANXA1;XBP1;ZFP36L1;OGT;ZBTB7B
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.37594368092404307,-0.9124811195365619,0.592814371257485,0.8849870452090091,1.0,5/11,9.20%,CD46;THBS1;LGALS9;BMPR1A;CD34
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45016460893368654,0.9120468783180472,0.5985294117647059,1.0,1.0,4/10,20.66%,COMT;SMOX;ALDH7A1;SLC44A1
prerank,bile acid biosynthetic process (GO:0006699),0.3635111511187854,0.9119042701658828,0.5916230366492147,1.0,1.0,4/24,11.00%,CYP27A1;CYP7B1;HSD17B4;AMACR
prerank,phosphate ion transport (GO:0006817),-0.31910067146120397,-0.9118392966145176,0.5342960288808665,0.885033926963765,1.0,6/16,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,potassium ion export across plasma membrane (GO:0097623),0.4141813830283241,0.911671507819232,0.5962910128388017,1.0,1.0,2/13,12.11%,KCNT2;KCND3
prerank,neuron fate commitment (GO:0048663),0.40830037044013306,0.9116023104593715,0.5959885386819485,1.0,1.0,14/14,59.21%,TGFBR1;ID2;MYT1L;FOXN4;ISL2;EPOP;ISL1;ASCL1;PAX6;POU4F1;SHH;DLL1;DLL4;POU3F2
prerank,regulation of cell growth (GO:0001558),0.29946314945746244,0.9115554763369668,0.700502512562814,1.0,1.0,32/204,15.62%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;EXOSC2;CGRRF1;TAF9B;SLC25A33;DDX3X;FLCN;NUBP1;USP47;RASGRP2;STK11;TCHP;SPOCK1;PPP1R9B;SDCBP;NRG3;BCL2;CAMK2D;EIF4G2;ENPP1;RACK1;RPS6KA3;EGLN2;TGFB1;BCL6;SLIT3;ACVR1B;RPS6KA1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3139540736384386,0.9103839801573983,0.6376963350785341,1.0,1.0,31/85,24.35%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;VCP;PSMC5;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;NUPR1;HECTD1;ARIH2;FMR1;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7;PSMC6;TAF1;TMEM259;KEAP1;FBXW7;TRIB2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.32891572104466665,0.9102312359577264,0.6137142857142858,1.0,1.0,9/46,15.43%,CLN3;CACNG3;UNC13A;CDK5;ATP1A2;NLGN3;SYT1;NLGN2;CACNG4
prerank,action potential (GO:0001508),0.33335787792147475,0.9096196748068752,0.6082004555808656,1.0,1.0,7/44,13.93%,CLN3;MYH14;SCN7A;YWHAH;SCN1A;ANK3;KCNA1
prerank,regulation of defense response to virus (GO:0050688),0.40653583160059664,0.9093456896455206,0.5854341736694678,1.0,1.0,2/14,5.04%,TNFAIP3;PPM1B
prerank,polyol biosynthetic process (GO:0046173),0.3966543740896833,0.9092557187602027,0.5969101123595506,1.0,1.0,6/16,21.29%,CYP27A1;IPPK;ISYNA1;IPMK;IP6K1;FGF2
prerank,RNA destabilization (GO:0050779),0.37886295500565653,0.9090997420536036,0.5683646112600537,1.0,1.0,9/18,22.24%,CELF1;LIN28B;YTHDF3;YTHDF1;ROCK2;ZC3H18;FTO;YTHDF2;METTL14
prerank,cellular response to oxidative stress (GO:0034599),0.3024003234917669,0.9090927390260358,0.6711340206185566,1.0,1.0,20/118,13.93%,MAPK9;SIRT2;SELENOS;PARP1;MGAT3;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;ARNT;STX2;TPM1;PDGFRA;PARK7;SOD2;SOD3;SETX;DAPK1;MAPT
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4191166604517407,0.9087538878184149,0.5784172661870504,1.0,1.0,4/11,20.46%,PRKCA;ANK3;JAK1;LYN
prerank,receptor signaling pathway via STAT (GO:0097696),0.3585948748472132,0.9085259468030948,0.6057213930348259,1.0,1.0,3/25,4.92%,IFNAR1;STAT6;IL31RA
prerank,protein polyubiquitination (GO:0000209),0.29710966908898256,0.9082039190371024,0.7565130260521042,1.0,1.0,71/297,19.60%,CDC23;PSMD4;FBXW10;RNF8;UBE2S;SPSB1;STUB1;UBE2E2;UBE2QL1;FBXL12;SYVN1;CDC16;FZR1;FBXL14;TNFAIP3;FBXO38;FBXO7;THOP1;ANAPC2;FBXO31;PSMB10;BARD1;TRIM56;RFFL;FBXW5;PSMD11;RMND5A;TRIM62;UBE3B;RNF168;UBE2V2;CHFR;PSME2;PSMC5;BCL2;RC3H2;RNF152;RNF19A;UBE2A;ANAPC11;ANAPC4;CBFB;UBE2J1;RNF19B;CDC26;RNF41;ANKIB1;RNF217;PSMD1;UBE2E1;UBE2D1;HECTD1;ARIH2;TNKS;UBE2L3;UBR5;PSMD6;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;KLHL20;ANAPC10;ANAPC5;TRIM27;ZNRF2;RNF167;PELI2;PSMD5
prerank,amyloid-beta metabolic process (GO:0050435),-0.31211298957419187,-0.9081056045435457,0.564748201438849,0.8929172099725192,1.0,9/16,23.66%,BACE2;BACE1;NCSTN;MME;ACE;APH1A;APH1B;PSEN2;IDE
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.315811620669358,0.9079166304797713,0.631578947368421,1.0,1.0,19/70,19.40%,DACT2;RAC1;ARL13B;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;TBCD;ATRN;ILK;MEGF9;YTHDF2
prerank,negative regulation of protein depolymerization (GO:1901880),0.36466007967032416,0.9075363962981003,0.5847880299251871,1.0,1.0,12/24,27.09%,TAOK1;CAMSAP2;PLEKHH2;KATNB1;LIMA1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,mRNA modification (GO:0016556),0.36983649038611155,0.9074506409781836,0.6017699115044248,1.0,1.0,3/22,9.92%,TRMT61B;TRUB2;PUS7
prerank,positive regulation of myelination (GO:0031643),0.4297488105967736,0.9071756998695472,0.5797546012269938,1.0,1.0,3/11,16.69%,MYRF;TENM4;TPPP
prerank,cellular response to cytokine stimulus (GO:0071345),0.2928282325037099,0.9071415581582388,0.799,1.0,1.0,71/416,18.11%,IL10RA;KHSRP;WNT5A;SFRP1;IL34;ADAMTS7;GBP3;NFKB1;HSP90AA1;IFNAR1;IL10RB;STAT6;ANXA1;XBP1;RORA;ZFP36L1;CXCL12;POU2F1;IL31RA;CDK9;IRF1;PIK3R1;GBP7;ZFAND6;ZEB1;CXCR4;RIPOR2;SIRPA;PID1;IL22;LRP8;TXLNA;SOX9;DOCK8;USP10;IFNGR2;EPRS1;TEC;RAPGEF1;TWIST1;PRLR;PIK3CB;PTPN5;BCL2;NFAT5;LEPR;IFNGR1;COL1A2;IL1RAPL1;CD47;DAPK1;SMPD4;GBP6;PTGS2;TGFB1;AQP4;BCL6;CBL;F3;NPR2;PTPN12;ICAM1;IL1RAP;IL5;OXSR1;TANK;TCF7;CCL25;GREM2;JAK1;ERBIN
prerank,positive regulation of protein maturation (GO:1903319),0.42215906135111664,0.9070871262531227,0.6086309523809523,1.0,1.0,1/11,4.19%,CCBE1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.22321376210536645,-0.906898840943596,0.6530612244897959,0.8944319284844309,1.0,13/54,14.52%,UBE2K;IKBKB;RIPK1;HIPK1;OTULIN;CYLD;CASP4;TAX1BP1;IKBKG;MADD;TNFRSF1A;PYDC1;RNF31
prerank,cellular amino acid catabolic process (GO:0009063),0.3105495191780537,0.9067444270719973,0.6449579831932774,1.0,1.0,14/87,15.38%,HGD;GLS2;HMGCLL1;AASS;ACAT1;BCAT2;ABAT;GLUL;ALDH4A1;ACADSB;CARNMT1;OGDH;FAH;QDPR
prerank,rRNA methylation (GO:0031167),0.36920464229022765,0.9066826539003667,0.6038961038961039,1.0,1.0,7/22,19.52%,FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,regulation of macroautophagy (GO:0016241),0.30709416390319294,0.9065134475057058,0.6786079836233367,1.0,1.0,17/105,11.03%,UBQLN1;CLN3;TSC2;ATP6V0A2;UCHL1;SNX5;CDK5;SLC38A9;DCN;SNX6;VPS26B;ATP6V0E2;RRAGA;NRBP2;GPSM1;ATP6V1G1;ATG13
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3626408454174599,0.9064481215866322,0.5808917197452229,1.0,1.0,5/22,10.85%,EDEM1;SYVN1;MAN1A2;EDEM3;UGGT2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.30841401810825786,0.90625552134083,0.6375,1.0,1.0,20/95,18.10%,KDM4D;XRCC2;RNF138;PARP1;HELQ;NIPBL;PALB2;FBH1;LIG3;SEM1;FANCM;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RAD21;RBBP8
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.37516598170804966,0.9053056247456635,0.595460614152203,1.0,1.0,9/18,23.15%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;LLGL1;RAP1B
prerank,neuron cell-cell adhesion (GO:0007158),0.4031753238032504,0.9051659302718744,0.5805991440798859,1.0,1.0,6/14,24.90%,NINJ2;NLGN3;NLGN2;NRXN3;NRXN2;ASTN2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3181924517306721,-0.9051357156223633,0.5465116279069767,0.8972905229550172,1.0,7/16,11.55%,WBP4;SFSWAP;DCPS;SNRNP200;DDX23;WBP11;CWC15
prerank,nitrogen compound transport (GO:0071705),0.2996358070031224,0.9049600640537927,0.7017189079878665,1.0,1.0,28/141,19.36%,ARRDC4;SLC7A11;PICK1;KIF3A;SLC22A4;SLC7A2;MIA3;RCN3;LMAN2L;CHMP3;SLC6A8;VPS33B;SCAMP5;SLC6A4;SLC18A1;SLC6A15;SLC1A5;SCAMP1;SLC6A12;SLC44A2;TXNIP;SLC6A13;RUFY1;SNX4;LRP1B;TOM1;SCARB2;SLC25A47
prerank,lymphocyte migration (GO:0072676),-0.25230589247706436,-0.9048911695791537,0.6417112299465241,0.8962694379518598,1.0,6/32,25.67%,CCL15;S1PR1;MSN;CCL13;CKLF;RET
prerank,negative regulation of signaling receptor activity (GO:2000272),0.3600872503587474,0.904540534102863,0.6098484848484849,1.0,1.0,3/25,6.61%,EPHB2;ERRFI1;SNX6
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.34189354522987,0.9044679085960702,0.6174734356552538,1.0,1.0,11/37,21.40%,STMN4;MAPRE3;TAOK1;GAS2L1;MAPT;PHLDB1;TPPP;PRKAA1;MAP6D1;MAP6;CLASP2
prerank,intracellular lipid transport (GO:0032365),-0.29054276178121285,-0.9044639078843001,0.6051502145922747,0.8957520693377832,1.0,7/21,19.31%,ACACA;CERT1;PRKAB2;ACACB;PRKAA2;ARV1;ABCD3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2926741257646558,0.90355259389506,0.7227227227227228,1.0,1.0,45/208,19.94%,WNT5A;SLC35B2;PDPK1;MAP3K14;ATP2C1;EDAR;RORA;EDA2R;TNFAIP3;TIRAP;OTUD7A;PPM1B;CARD16;TMEM106A;BRD4;SQSTM1;ZFAND6;CC2D1A;TIFA;TRIM62;GPRC5B;USP10;PER1;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;TANK;TNIP1;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1
prerank,regulation of organelle assembly (GO:1902115),0.31489178496169773,0.9035283666558291,0.6613247863247863,1.0,1.0,18/73,17.79%,CENPJ;DCDC2;CDKL5;SGSM3;ALMS1;TBC1D13;TBC1D20;USP6NL;ATXN2L;NPM1;SPICE1;IFT20;RABGAP1;TBC1D24;ATG3;CEP76;TBC1D9B;TBC1D22B
prerank,regulation of Rho protein signal transduction (GO:0035023),0.31017878673146104,0.9032584051540569,0.6290672451193059,1.0,1.0,16/72,17.19%,RAC1;NRP1;FLCN;ABL1;RIPOR2;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6;EPS8L1;RIT2;APOE
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.40185998218532226,0.9030710909620135,0.6072931276297335,1.0,1.0,1/13,0.96%,LPL
prerank,positive regulation of mitochondrial fission (GO:0090141),0.37950127527414573,0.9028560444098441,0.6,1.0,1.0,5/18,15.72%,FIS1;DCN;MIEF2;DNM1L;SPIRE1
prerank,tryptophan catabolic process (GO:0006569),-0.35059635907093534,-0.9025880129421164,0.5308641975308642,0.898692916043247,1.0,11/11,64.97%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of fibroblast proliferation (GO:0048145),0.3265197237570476,0.9025763360223856,0.631336405529954,1.0,1.0,4/45,5.54%,WNT5A;SFRP1;IGF1;DDR2
prerank,monosaccharide transmembrane transport (GO:0015749),0.39333711376307967,0.9020393272020777,0.6044260027662517,1.0,1.0,2/16,11.44%,SLC5A3;SLC50A1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.355388885014633,0.9014201945714366,0.6221374045801527,1.0,1.0,5/27,16.48%,GPR4;HTR2C;LPAR1;LPAR6;AGTR1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33304883138290614,0.9012978887381657,0.6079346557759626,1.0,1.0,6/38,8.95%,RORA;TNFAIP3;OTUD7A;PPM1B;USP10;PER1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4152154289546086,0.9010755362863412,0.625,1.0,1.0,6/12,21.47%,SEC61A2;SEC61G;SEC62;SEC63;CHMP4A;CHMP4B
prerank,protein import into mitochondrial matrix (GO:0030150),0.38358560705122247,0.9009649943243424,0.6163849154746424,1.0,1.0,2/18,5.24%,DNLZ;TOMM20
prerank,secondary palate development (GO:0062009),-0.3291703549340732,-0.900883361425188,0.5403508771929825,0.9012955562407199,1.0,4/14,7.89%,SMAD4;LEF1;TGFB2;TGFBR2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.40106069002038314,0.9002938370889364,0.6022889842632332,1.0,1.0,4/13,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3658149636292123,0.9001659530925503,0.6141025641025641,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3658149636292123,0.9001659530925503,0.6141025641025641,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,energy reserve metabolic process (GO:0006112),0.37529181212967094,0.8999507996274936,0.6129032258064516,1.0,1.0,5/19,19.00%,PID1;LEPR;GBE1;MRAP2;PRKAG2
prerank,protein localization to plasma membrane (GO:0072659),0.29950155318505783,0.8997997184467675,0.6860346585117227,1.0,1.0,35/129,18.86%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;GORASP1;CCDC88A;ZDHHC2;PIP5K1A;FLOT1;ASB3
prerank,response to histamine (GO:0034776),-0.35241750205814937,-0.8997921121930798,0.595679012345679,0.9023518807887577,1.0,2/10,5.29%,GABRB1;GABRG2
prerank,regulation of protein dephosphorylation (GO:0035304),0.3370584456989789,0.8995408093247005,0.6296728971962616,1.0,1.0,15/37,21.79%,CALM3;PPP1R2;PPP6R3;HTT;PPP1R16A;TGFB1;CAMTA1;PPP2R5A;TIPRL;CALM1;ARPP19;SMPD1;DLC1;PTBP1;CALM2
prerank,defense response to bacterium (GO:0042742),-0.19468495502028477,-0.8994649100461116,0.7142857142857143,0.9014794024345056,1.0,19/105,20.09%,ANKRD17;DROSHA;IL6R;ANXA3;PRKCD;RNASE3;LBP;NOD1;TLR4;RPS19;RAB1A;DEFA6;RPL39;MAVS;IRGM;CEBPB;PLA2G6;GBP2;PGLYRP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.35057733300627264,0.8984311456366906,0.6144578313253012,1.0,1.0,5/28,11.07%,BAX;ITPR1;BRSK2;DDIT3;BCL2
prerank,recombinational repair (GO:0000725),0.3104090125711363,0.898346321044724,0.6411075612353567,1.0,1.0,19/77,19.92%,KDM4D;XRCC2;RNF138;PARP1;HELQ;PALB2;FBH1;LIG3;SEM1;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RBBP8;RECQL5;INO80
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.39006384107080705,0.8982153711061706,0.6082758620689656,1.0,1.0,2/16,7.40%,KDM4D;WRAP53
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3366824915788476,0.8978307117751048,0.6220095693779905,1.0,1.0,4/36,8.95%,HDAC3;FOXM1;SIRPA;PER1
prerank,mitochondrial translation (GO:0032543),0.3010562727983553,0.8975382400274698,0.6834016393442623,1.0,1.0,25/104,20.21%,MRPL36;MTRF1L;MRPL17;NDUFA7;MRPL19;GATB;GADD45GIP1;EARS2;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;HARS1;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;IARS2;MRPS6;OXA1L;MRPS24
prerank,regulation of protein metabolic process (GO:0051246),0.3282463979608131,0.8975319371918239,0.6428571428571429,1.0,1.0,14/44,19.75%,SNF8;HGS;SSH1;ABCA7;APP;ROCK2;FAF1;CHEK2;NEDD8;PARL;APOE;MDM2;ZDHHC2;KLF4
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3890067102606687,0.8974462096880789,0.6145404663923183,1.0,1.0,5/15,22.25%,ENTPD7;AK4;AK5;CMPK1;ENTPD5
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.37092948861030045,0.8968872631098743,0.62002567394095,1.0,1.0,2/22,2.96%,HEXIM1;NR2F2
prerank,icosanoid metabolic process (GO:0006690),0.329237945270902,0.8968229892512556,0.6316989737742303,1.0,1.0,9/40,20.61%,ALOX5AP;PON2;PON3;FADS1;PTGS2;DPEP1;GPX4;PTGS1;MAPKAPK2
prerank,cardiocyte differentiation (GO:0035051),0.4266013196659417,0.8961917162235737,0.6310395314787701,1.0,1.0,4/10,16.74%,SIK1;AKAP13;NRG1;KDM6B
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.359766240796383,-0.8958236116563443,0.5649546827794562,0.9087662908158571,1.0,3/10,11.48%,RNF13;NBR1;FAS
prerank,positive regulation of telomere capping (GO:1904355),0.3842126496700762,0.895566704172865,0.6210106382978723,1.0,1.0,4/17,17.42%,PKIB;HNRNPD;TNKS;NABP2
prerank,tRNA metabolic process (GO:0006399),0.3805496279165383,0.8951504237427946,0.6083445491251682,1.0,1.0,6/17,20.86%,YARS2;AARS1;SARS1;RPP30;FARS2;DTD1
prerank,regulation of autophagosome assembly (GO:2000785),0.34218421777497604,0.894885854793542,0.6247002398081535,1.0,1.0,17/33,26.00%,PHF23;PIP4K2B;SCFD1;IFT20;FEZ2;PIP4K2A;PIP4K2C;NUPR1;RAB3GAP2;NPRL2;CHMP4A;CHMP4B;PIKFYVE;SH3GLB1;MTM1;NPRL3;TBC1D14
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.4248539028215933,0.8945245032227552,0.6157337367624811,1.0,1.0,4/10,21.08%,ATP1A2;CAMK2D;OSR1;HECW2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3034728602860964,0.8941689229362438,0.6765641569459173,1.0,1.0,9/86,10.71%,PSRC1;CDC42EP5;CDC42EP4;BIN1;RAC1;BAIAP2;DRG1;KATNB1;APP
prerank,regulation of isotype switching (GO:0045191),-0.32103300781235466,-0.8941352189761297,0.6137184115523465,0.9112444620660384,1.0,3/14,17.03%,SHLD2;PAXIP1;SLC15A4
prerank,regulation of actin filament polymerization (GO:0030833),0.3121709754717145,0.8936335759695723,0.6736035049288062,1.0,1.0,10/69,9.64%,CDC42EP5;CDC42EP4;ABITRAM;BIN1;GBA2;PAK3;DBN1;SSH1;BAIAP2;DBNL
prerank,negative chemotaxis (GO:0050919),0.3382182485305852,0.8933965528070228,0.6213942307692307,1.0,1.0,8/33,15.56%,EPHA7;SEMA3D;ROBO1;UNC5C;SLIT1;SLIT3;SEMA3E;SEMA3A
prerank,neuron remodeling (GO:0016322),0.42490007885533415,0.893234379702985,0.6006051437216339,1.0,1.0,4/10,18.42%,EPHA8;APP;FARP2;ADGRB3
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.16958423258712138,-0.8931151421641412,1.0,0.9121917567499848,1.0,124/306,30.16%,EPC1;MEF2A;KAT7;PTMS;RPS24;ORC4;ST3GAL4;ABCF1;AGO2;RPL11;RRAGC;CREBL2;TIPIN;RPS15A;RPS23;RPL5;EEF2;RPL37A;RPL6;RPL18A;RPA1;RPL24;NBN;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;NT5M;SRBD1;POLR3A;RPS16;REV1;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;MRPL42;RPL15;RPS2;RNPS1;RPL39;RPL12;RPL27;RPS17;MRPS21;MED20;RPS26;RPS27;RPL10A;GTPBP1;MRPL52;DARS1;BLM;RPS10;MRPS18A;MRPS15;EEF1D;DTX1;RPL7A;MRPS33;ATRIP;MRPS18C;ING5;PWP1;ORC5;TBRG1;MCM6;RAD9B;MRPL27;RPL31;WRN;RFC2;RPL36A;RPL29;HUS1;FUBP3;NR4A2;RPS14;DHPS;INHBA;MRPL9;POLR2H;FAM111A;BCL3;CDK2;RPS6KB2;TSFM;RPL41;POLA2;RPL35;TERT;MRPL51;POLR2G;POLR2F;RHNO1;MRPL32;POLR2C;MRPS14;DUT;POLE2;CLSPN;PAX8;CDC7;MRPS7;KAT5;MCM4;MRPL18;IGHMBP2;MRPL43;IGF2BP3;RAD1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2639199855025886,-0.8930817351466789,0.6084905660377359,0.910632675989825,1.0,8/25,18.27%,SMAD4;UBE2O;ENG;BMPR1A;ACVR2B;BMPR1B;BMP4;CCN1
prerank,RNA biosynthetic process (GO:0032774),0.3484703481030436,0.8929156562102523,0.6325301204819277,1.0,1.0,7/31,14.54%,SMN1;TAF4;TBP;PRMT5;TAF6;SETX;HELB
prerank,cellular response to organonitrogen compound (GO:0071417),0.3008714968537814,0.8928913298808538,0.6726128016789087,1.0,1.0,16/99,14.79%,CPEB1;SFRP1;XBP1;ZFP36L1;SLC38A9;DMTN;RRAGA;SOX9;SSH1;CAPN2;RAPGEF1;GABRB3;JUP;LAMTOR5;GLRA1;IMPACT
prerank,cellular response to hormone stimulus (GO:0032870),0.3145955580107572,0.8924645766643267,0.6777301927194861,1.0,1.0,15/69,16.82%,WBP2;SFRP1;XBP1;ATP1A3;ZFP36L1;GAS2L1;ATP1A2;SRA1;BRD8;ROBO2;TFPI;NCOA4;SLIT3;CTSH;UBE2L3
prerank,negative regulation of cellular component movement (GO:0051271),-0.31175081723731357,-0.8922485758544522,0.6327272727272727,0.9109869446398494,1.0,3/15,5.70%,FRMD5;ACTN1;SP100
prerank,heterocycle biosynthetic process (GO:0018130),0.40469916117318794,0.8920949455443522,0.6017830609212481,1.0,1.0,1/14,1.75%,MOCS2
prerank,in utero embryonic development (GO:0001701),0.35387247404231253,0.8920832067376014,0.6094750320102432,1.0,1.0,3/25,5.45%,ZNF568;FGFR2;FLCN
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3537257147412088,0.8920686438280332,0.6259445843828715,1.0,1.0,6/26,15.67%,SLC35D2;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,establishment of mitotic spindle localization (GO:0040001),0.34889440608674727,0.8917742376359782,0.6204744069912609,1.0,1.0,10/28,23.05%,MAD2L1;KPNB1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CLASP2;CDK5RAP2
prerank,pre-miRNA processing (GO:0031054),0.39670308824887857,0.8913694107501393,0.6208869814020028,1.0,1.0,3/14,12.58%,TARBP2;LIN28B;AGO3
prerank,protein alkylation (GO:0008213),0.37099157835342955,0.8913515047078178,0.617300131061599,1.0,1.0,8/22,19.08%,LCMT1;ETFBKMT;PRMT1;GSPT1;FAM98A;PRMT8;PCMT1;PRMT2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31956532087593575,0.8907327614683536,0.6427783902976847,1.0,1.0,14/52,16.84%,DDX17;SRSF12;CELF2;CELF1;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;FMR1;THRAP3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.38668711442558834,0.8907107987025336,0.6137931034482759,1.0,1.0,5/15,20.16%,EDEM1;RAB10;ZFAND2A;SEC61G;RAB3GAP2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2886223921885925,-0.8902847341344112,0.588,0.9142554625324204,1.0,5/20,8.34%,PICALM;TMEM59;BCL2L1;NUMB;CSK
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3614283713889009,0.8902600658851483,0.6338383838383839,1.0,1.0,7/26,24.77%,GPLD1;BRSK2;ADCY5;EPHA5;STXBP4;PPP3CB;NR1D1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3375142380030104,0.8901838490131682,0.6167452830188679,1.0,1.0,4/36,6.64%,WNT5A;FZD3;TCF7L2;GNG2
prerank,UV-damage excision repair (GO:0070914),0.41377933262951694,0.8900533454415351,0.6278026905829597,1.0,1.0,6/12,25.49%,DDB1;CUL4B;POLD3;INO80;POLA1;XPA
prerank,cellular response to glucose stimulus (GO:0071333),0.34779732608195635,0.8899461201435053,0.6496894409937888,1.0,1.0,10/30,22.61%,PTPRN;XBP1;SELENOT;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4;RAB11B;UNC13B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.33842586709972594,-0.889666000569826,0.6073619631901841,0.9140635631281498,1.0,8/11,53.92%,PLCG2;P2RX4;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,positive regulation of synapse assembly (GO:0051965),0.3473036583502772,0.8893388297708741,0.6328320802005013,1.0,1.0,9/27,22.99%,EPHB2;CLSTN2;IL1RAPL1;NLGN3;NLGN2;IL1RAP;CLSTN3;DLG5;AGRN
prerank,mononuclear cell differentiation (GO:1903131),-0.267292460749371,-0.8892015780080526,0.6135265700483091,0.9135313588405287,1.0,8/24,22.06%,AXL;PIR;MT1G;THOC5;BMP4;IKZF1;VEGFA;PPARG
prerank,regulation of synapse maturation (GO:0090128),0.4262642605489977,0.8891041613608507,0.6260869565217392,1.0,1.0,2/10,6.19%,CAMK2B;ANAPC2
prerank,stem cell development (GO:0048864),0.3907448274231286,0.889048181669674,0.6169014084507042,1.0,1.0,4/16,14.05%,KLHL12;PEF1;SOX11;NRG1
prerank,mesenchymal cell development (GO:0014031),0.3739072336100247,0.8889110290489769,0.6149732620320856,1.0,1.0,4/18,14.05%,KLHL12;PEF1;SOX11;NRG1
prerank,antibacterial humoral response (GO:0019731),-0.3038842611205212,-0.8888807262670481,0.5925925925925926,0.9127087395901236,1.0,4/16,18.33%,RNASE3;DEFA6;RPL39;PLA2G6
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3001538140794285,0.8886723242996071,0.697286012526096,1.0,1.0,22/110,17.95%,BBS10;BAX;LCMT1;HSP90AA1;WARS1;SAR1A;DDX3X;TIRAP;NCLN;SLF2;VCP;PEX5;PARK7;RACK1;NRG1;TGFB1;IMPACT;FAF1;FARP2;TPPP;APOE;SORL1
prerank,organelle assembly (GO:0070925),0.2873483257259125,0.8886429568263965,0.794,1.0,1.0,77/385,17.36%,TMEM138;HDAC3;B9D2;UBQLN1;CENPT;CCDC61;CENPJ;CPLANE2;MVB12A;STK36;UBXN2A;IFT52;DCDC2;MAPRE3;ACTR2;KIF3A;ARL13B;WIPI1;ATAT1;DDX3X;SNF8;CLUAP1;ATP2A2;TCTN1;BBS7;INPP5E;ATG14;SNX10;HGS;CDC14B;CCDC28B;PIBF1;ATG2A;CFAP54;AUP1;VTA1;TTC8;CHMP3;DBNL;CEP126;CC2D2A;ATG13;IFT80;ATXN2L;YTHDF3;CYS1;VPS4B;NPM1;CFAP20;RCC1;CPLANE1;IFT20;YTHDF1;CENPC;PDE6D;DISC1;HAUS3;CSNK1D;MAPT;ATG3;MAP1LC3B;ATP6V1D;VMP1;TMEM216;RFX3;OFD1;RAB8A;RAB8B;FARP2;AHI1;CDS1;TMOD2;TNKS;PIK3C3;TUBGCP2;STAM2;DHX29
prerank,postsynaptic membrane organization (GO:0001941),0.38313815492964265,0.8883495041264525,0.6182065217391305,1.0,1.0,5/17,17.19%,LRRC4;MUSK;NLGN3;NLGN2;APOE
prerank,apoptotic nuclear changes (GO:0030262),0.35562734302389815,0.8881167627317181,0.6209573091849935,1.0,1.0,7/24,22.00%,DFFB;KPNB1;CDK5RAP3;DFFA;KPNA1;ACIN1;HMGB1
prerank,regulation of stem cell differentiation (GO:2000736),0.30442803154302833,0.8879275425670293,0.6936842105263158,1.0,1.0,25/89,21.81%,SP7;PSMD4;ABL1;PSMB10;PSMD11;PUS7;GDNF;PSME2;PSMC5;SETD1A;PDGFRA;NUDT21;CBFB;PSMD1;TCF3;JAG1;PSMD6;OCIAD1;KMT2A;YTHDF2;PSMD5;HNRNPU;PSMA4;PSMA1;PSMC6
prerank,positive regulation of protein transport (GO:0051222),0.3067832888142566,0.8878570945990609,0.6663066954643628,1.0,1.0,10/67,14.84%,CLN3;IGF1;BMP6;ATP2C1;RIPOR1;MYH10;RACK1;TMED10;TGFB1;DNM1L
prerank,receptor-mediated endocytosis (GO:0006898),0.2963341322102507,0.887727750230106,0.7015384615384616,1.0,1.0,27/132,17.97%,FCGR2B;CLN3;PDLIM7;DNM1;ADM;HSP90AA1;TMEM108;SPARC;VLDLR;DNAJC6;AP2S1;GRK3;HSPH1;NLGN3;IGF2R;PI4KB;WASF1;LRP1;GRK2;DNAJC13;RAB31;HSPG2;SNAP91;AP4E1;APOE;SORL1;LRP1B
prerank,tryptophan metabolic process (GO:0006568),-0.34623555762705965,-0.8876163108031373,0.5802469135802469,0.9141734247801955,1.0,10/11,64.97%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of cellular senescence (GO:2000772),0.34640098569474964,0.887606506086137,0.6080097087378641,1.0,1.0,5/28,9.79%,NUAK1;FBXO5;SLC30A10;EEF1E1;TWIST1
prerank,lysine catabolic process (GO:0006554),0.40674756056836475,0.8875440574237218,0.6103351955307262,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,lysine metabolic process (GO:0006553),0.40674756056836475,0.8875440574237218,0.6103351955307262,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,endocytic recycling (GO:0032456),0.3240758005961748,0.8874461444024965,0.6403118040089086,1.0,1.0,17/50,22.68%,ARL4C;RAB11FIP4;SNF8;STX6;ENTR1;RAB13;VPS39;CCDC93;EIPR1;SNX4;EHD1;CMTM6;RAB11FIP3;RAB7A;EHD3;RAB11B;SNX27
prerank,positive regulation of TOR signaling (GO:0032008),0.3328642289308778,0.8871915898980134,0.6608996539792388,1.0,1.0,5/40,7.73%,HDAC3;SLC38A9;FLCN;RRAGA;GPR137C
prerank,regulation of cellular component organization (GO:0051128),0.29829875639999864,0.8870323748519701,0.7147239263803681,1.0,1.0,33/135,21.11%,WNT5A;BBS10;TSC2;HSP90AA1;NCLN;NUBP1;ABL1;RASGRP2;STK11;CAMSAP2;PACSIN3;SPOCK1;RAB5B;NRG3;RAPGEF1;AP2S1;SETD1A;CAMK2D;PARK7;EGLN2;ROCK2;RUFY1;AGTR1;RIT2;APOE;DCUN1D5;ZFYVE16;SETD5;CDK11B;MLLT3;HNRNPU;PAK5;SGK3
prerank,positive regulation of JNK cascade (GO:0046330),0.3075236426435222,0.88657707689506,0.6572361262241567,1.0,1.0,9/70,10.71%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP
prerank,regulation of intracellular signal transduction (GO:1902531),0.2838107677955054,0.8865184040127603,0.839,1.0,1.0,113/420,22.25%,FSHR;WNT5A;ATP6AP2;ARAF;PDPK1;PIP4K2B;CSNK2A2;RAC1;TAF9B;USP7;TAOK1;PTPMT1;BRPF1;TAF4;MINK1;CDK5;RBBP4;FLCN;SYDE2;ARHGAP20;TBP;NUAK1;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;BARD1;ARHGEF7;PAK3;ARHGEF4;ZFAND6;STK11;RHOD;KALRN;RFFL;CD24;MCF2;RCN3;XIAP;EHMT2;MDM4;PRMT5;ARHGAP21;VAV2;USP2;ARHGAP24;TAF6;PIK3R2;MTA2;BRIP1;ARAP1;HDAC1;RMI1;PLEKHG5;FAM13A;ATR;AKAP13;EHMT1;PIP4K2A;PTPN22;MAPT;ARHGAP29;RNF41;AKAP12;PIP4K2C;MRE11;TRIO;CHEK2;ARHGEF6;RAD50;TP53RK;RIT2;DAXX;MDM2;FBXO9;TOP3A;PRKD2;RBBP8;RASSF2;PRKAR1A;PIP5K1A;PRKAA1;BANP;BIRC3;PRKAG2;NRK;PLEKHG2;FGD4;DLC1;WWC1;MYO9A;STARD13;ARHGAP6;LYN;CHN1;PEX5L;ITGAV;PAK5;NTRK2;NF2;PREX1;SRGAP1;TAF2;MAPKAP1;MAP4K4;RHOU;ARHGAP26;ARHGAP35;TELO2;TRAF2;TAF1;PJA2;ENTPD5
prerank,response to chemokine (GO:1990868),0.3919589333474436,0.8863726344521233,0.6110283159463488,1.0,1.0,3/13,8.61%,CXCL12;RIPOR2;DOCK8
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3512843624724926,0.8862939121675417,0.6362515413070283,1.0,1.0,9/26,19.65%,OGT;ETFBKMT;SETD1A;SUV39H1;KMT2D;ATPSCKMT;KMT2A;SETD5;KMT5B
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.28672358014814553,-0.886232722822785,0.640495867768595,0.9159989300673002,1.0,5/19,7.89%,SMAD4;TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.231447522263163,-0.8861210226993737,0.7152317880794702,0.9146349691105469,1.0,14/39,23.62%,ANGPT1;PDCD4;TEK;THBS1;ANO6;RAMP2;KDR;PLCG1;SCG2;ITGA4;RGCC;NFE2L2;GATA2;SEMA5A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3037020055958966,0.8859161835391707,0.6663113006396588,1.0,1.0,13/77,13.66%,IGF1;PPIF;CSNK2A2;DDX3X;FZD9;TCF7L2;PRELID1;CAAP1;BCL2;MAZ;RTKN2;PARK7;HTT
prerank,cristae formation (GO:0042407),0.3507032474562974,0.8858571144668508,0.6239103362391034,1.0,1.0,5/27,10.62%,APOOL;ATP5PF;APOO;ATP5MC3;AFG3L2
prerank,response to muramyl dipeptide (GO:0032495),-0.3439223764765723,-0.8856736730491936,0.5718954248366013,0.9140739887739456,1.0,3/12,9.34%,VIM;NOD1;CHMP5
prerank,alpha-amino acid metabolic process (GO:1901605),-0.22993176120545555,-0.8855478526662312,0.6928571428571428,0.9127601544378967,1.0,17/45,24.63%,SLC25A13;MTHFR;GOT2;FOLH1;THAP4;MTHFD1;GLS;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;MTRR;DDAH2;ALDH18A1
prerank,nucleotide-excision repair (GO:0006289),0.2998106766127005,0.8853983417584519,0.6954261954261954,1.0,1.0,17/101,13.73%,COPS7A;LIG1;PARP1;USP7;POLR2B;DDB1;LIG3;COPS7B;SLC30A9;CUL4B;GTF2H3;TCEA1;BRIP1;POLR2K;CCNH;MMS19;POLD3
prerank,negative regulation of JNK cascade (GO:0046329),0.34053724938181007,0.8853223012131125,0.6458072590738423,1.0,1.0,5/31,13.55%,HDAC3;MAPK8IP1;SIRPA;PER1;PTPN22
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.42123435882570304,0.8852764972879686,0.6203288490284006,1.0,1.0,2/10,19.73%,ETFBKMT;OXA1L
prerank,negative regulation of transport (GO:0051051),0.31825189100106227,0.8850310297914515,0.6418400876232202,1.0,1.0,16/51,22.31%,FCGR2B;SIRPA;PACSIN3;EGF;ABCA7;SNX33;RACK1;SCAMP5;NRG1;NDFIP2;MCTP1;ITGAV;SYT11;RAB7A;PPM1F;PXK
prerank,synaptic vesicle endocytosis (GO:0048488),0.33659819515027606,0.8848964874431213,0.6293622141997594,1.0,1.0,8/33,16.22%,DNM1;SYNJ2;CDK5;DNAJC6;NLGN3;SYT1;NLGN2;SNAP91
prerank,negative regulation of cell projection organization (GO:0031345),0.32592615279505094,0.8848090591052428,0.6547486033519553,1.0,1.0,17/48,23.90%,SPOCK1;EFNB2;YWHAH;PRAG1;DENND5A;LPAR1;SEMA3A;SPRY2;APOE;GORASP1;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;PTEN;MYLIP
prerank,selective autophagy (GO:0061912),0.31323776724434355,0.8841540309375743,0.6588888888888889,1.0,1.0,11/56,12.08%,UBQLN1;USP30;ARL13B;SQSTM1;ATG14;ATG2A;AUP1;ATG13;PEX5;DYNC1LI1;PARK7
prerank,DNA geometric change (GO:0032392),0.35529955183146855,0.8840960862296217,0.6280254777070063,1.0,1.0,7/24,19.20%,HMGB3;ANXA1;DHX36;HNRNPA2B1;MRE11;RAD50;RECQL5
prerank,amide transport (GO:0042886),-0.2660065447907104,-0.8840806146179944,0.6556603773584906,0.9147313387620071,1.0,9/26,22.30%,ABCG2;CERT1;SLC25A32;TAP2;SLC5A6;GLTP;ABCB9;AQP11;SLC38A5
prerank,regulation of JNK cascade (GO:0046328),0.2966328911440051,0.8839893331503257,0.6928645294725957,1.0,1.0,12/101,8.95%,HDAC3;FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;RAP2A;SIRPA;SDCBP;PER1
prerank,membrane repolarization (GO:0086009),-0.30844217039506644,-0.883309219473521,0.6219081272084805,0.9149253226424542,1.0,4/15,12.55%,ATP1B3;ATP1A1;KCNJ2;ATP1B1
prerank,regulation of viral entry into host cell (GO:0046596),-0.24963266999975203,-0.8828673758984186,0.7058823529411765,0.9144398161691983,1.0,11/30,22.45%,P4HB;TRIM25;LY6E;LGALS9;LGALS1;TRIM5;TRIM14;NECTIN2;HS3ST5;IFITM2;IFITM1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.24713568629575466,-0.8827085514299633,0.6263157894736842,0.9132102421250288,1.0,8/33,11.54%,BMPER;TJP1;CEMIP2;SEMA6A;SMAD1;THBS1;EPN2;PKM
prerank,regulation of dendritic spine development (GO:0060998),0.3653909176312118,0.882546285995616,0.6198125836680054,1.0,1.0,7/19,21.20%,CAMK2B;TANC2;FMR1;APOE;SHANK1;PTPRS;DLG5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.342618554700964,0.8825394527757526,0.6425061425061425,1.0,1.0,7/31,19.75%,CDKN2D;WEE1;RBL2;CDC73;PKD2;PRMT2;KLF4
prerank,peptidyl-threonine modification (GO:0018210),0.30570476920868667,0.8824175175399865,0.6648168701442841,1.0,1.0,18/66,18.78%,PDPK1;CSNK2A2;GALNT16;PRKCA;CDK5;GALNT4;SBK1;CIT;CAMK2D;GALNTL6;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,cellular response to drug (GO:0035690),0.3536592847110164,0.8821546609152771,0.629156010230179,1.0,1.0,6/25,18.33%,GPLD1;RAP2A;PPM1E;PDE4B;DPEP1;RBM22
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3366111841774596,-0.8821331192456165,0.5950155763239875,0.9129316000967205,1.0,3/12,17.38%,RBP4;TLR4;STRAP
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3311261430128457,0.8817554168640519,0.6382730455075846,1.0,1.0,6/35,10.52%,EPHB2;LZTR1;FLCN;RIPOR2;MFN2;ARHGAP24
prerank,anterograde trans-synaptic signaling (GO:0098916),0.28872480108742116,0.8816767804746688,0.7803410230692076,1.0,1.0,41/224,18.29%,SYT10;CACNB4;GRIN1;PDE7B;OPRK1;MINK1;CDK5;HCRTR2;GRIN2A;SDCBP;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;HCRTR1;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.27780918479932726,-0.8816325560576189,0.6534653465346535,0.9124992597429665,1.0,5/21,17.61%,MFHAS1;ENSA;PPP1R8;PTPA;BOD1L1
prerank,tRNA export from nucleus (GO:0006409),-0.2501293103809215,-0.8815326768169588,0.6772486772486772,0.9095601781116859,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2501293103809215,-0.8815326768169588,0.6772486772486772,0.9095601781116859,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.30625962482858904,0.8815063887057465,0.6771397616468039,1.0,1.0,15/72,15.93%,FOXM1;BAX;PCBP4;TFDP1;CNOT10;USP10;MDM4;NDRG1;RBL2;CNOT9;PRMT1;ATRX;CNOT6;CASP2;CHEK2
prerank,regulation of DNA recombination (GO:0000018),-0.24478177765954218,-0.8814012673628211,0.6972972972972973,0.9083403338528763,1.0,11/32,26.22%,SETD2;SHLD2;SPIDR;ZRANB3;MSH2;BLM;SMARCAD1;RTEL1;PPP4R2;MSH6;H1-0
prerank,protein targeting to lysosome (GO:0006622),0.36515977883874884,0.8813731250213747,0.6302952503209243,1.0,1.0,8/20,22.09%,HGS;NCOA4;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3
prerank,positive regulation of transferase activity (GO:0051347),0.2931831429060634,0.8813630531540338,0.7293997965412004,1.0,1.0,27/142,17.95%,ARRDC4;MST1R;EPHA7;PKIB;EPHB2;HSP90AA1;FGFR2;FGFR1;DDR1;DDR2;EPHA8;WRAP53;HNRNPD;EPHA10;MUSK;PDGFRA;ROR2;HNRNPA2B1;TGFB1;MRE11;RAD50;TNKS;UBE2L3;EPHA5;TOPORS;DCUN1D5;SORL1
prerank,regulation of protein transport (GO:0051223),0.34716371497379034,0.8809075826824012,0.6500622665006227,1.0,1.0,5/27,16.04%,LCP1;GAPVD1;SCFD1;RHBDF1;NDFIP2
prerank,synaptic vesicle transport (GO:0048489),0.4128423745120149,0.880779310307931,0.6157205240174672,1.0,1.0,4/11,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.41882396379048004,0.8806776039255103,0.6390168970814132,1.0,1.0,2/10,8.36%,FGFR2;SOX9
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.31897258474810164,0.8800932782793017,0.6548974943052391,1.0,1.0,6/47,6.44%,RAC1;FBLN1;NRP1;ABL1;ARHGEF7;DMTN
prerank,regulation of vasoconstriction (GO:0019229),0.3478764043238055,0.879917311645447,0.6398467432950191,1.0,1.0,4/27,10.66%,ADM;BDKRB2;ATP2B1;TBXA2R
prerank,positive regulation of programmed cell death (GO:0043068),0.2847125487103145,0.879784775933079,0.7877877877877878,1.0,1.0,49/272,16.17%,SFRP2;SFRP1;BAX;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;HTATIP2;DDX3X;FZD9;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6
prerank,apical junction assembly (GO:0043297),-0.21813567797016337,-0.8797766864994895,0.780952380952381,0.910614400965298,1.0,16/53,29.36%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2;CLDN14;RHOC;DLG1;ARL2;RHOA;STRN;CLDN1;PAK2;PKN2
prerank,regulation of signal transduction (GO:0009966),0.2911635603386382,0.8797611517685112,0.7818181818181819,1.0,1.0,41/190,18.59%,GSKIP;CDKN2AIP;TSC2;FGFR2;DCDC2;GNG7;CD63;RORA;BRAP;OGT;NCLN;SULF1;SRMS;TMEM108;CD24;ZDHHC3;PTCH1;PRAG1;YWHAG;GDNF;APP;GRK3;RIC8B;IGFBP3;IGFBP7;GIT1;CBFB;MTCH1;TGFB1;TULP3;GRK2;NUCKS1;TCF7L1;FRRS1L;SNW1;ITGB1BP1;USP33;ZDHHC17;ILK;SYNJ2BP;CDC42SE2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.32809060194812933,0.8791733016000458,0.641755634638197,1.0,1.0,13/37,20.74%,IFT52;KIF3A;CLUAP1;KIF3C;TRIP11;IFT80;IFT20;TTC21B;TNPO1;WDR35;KIFAP3;DYNLL1;DYNC2H1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29405767728329163,0.8791057582664085,0.7206185567010309,1.0,1.0,28/109,20.35%,PLA2G5;PIP4K2B;SYNJ2;INPP5E;PIK3R1;PLEKHA3;PITPNM3;PIK3CB;PGAP1;PIK3R2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A
prerank,indolalkylamine catabolic process (GO:0046218),-0.35057435189253655,-0.8789615918313777,0.5297619047619048,0.9109545939980495,1.0,10/10,64.97%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of acute inflammatory response (GO:0002675),0.38849177114452826,0.8789108016152586,0.6363636363636364,1.0,1.0,2/14,14.21%,PARK7;PTGS2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3605787857259653,0.8784848336697157,0.6327608982826949,1.0,1.0,3/21,8.83%,CHPF;DCN;CHSY3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.40743618102059587,0.8783662740184652,0.6195054945054945,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),0.40743618102059587,0.8783662740184652,0.6195054945054945,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,response to iron ion (GO:0010039),0.39711232587677425,0.8783388743678051,0.6142649199417758,1.0,1.0,4/12,22.07%,BMP6;BCL2;SLC11A2;B2M
prerank,regulation of JUN kinase activity (GO:0043506),-0.2488837443318317,-0.8781733686071971,0.6627218934911243,0.9111200111038966,1.0,14/33,25.25%,DAB2IP;PDCD4;DVL3;MAP3K10;DUSP10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;DNAJA1;MAP3K5;PPEF2;SASH1;HIPK3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3569532728205069,0.8778286781290803,0.6562091503267974,1.0,1.0,6/22,21.79%,CALM3;HTT;VMP1;PKD2;CALM1;CALM2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.34192213087428236,-0.877655894762476,0.6193353474320241,0.9107668101298757,1.0,2/11,1.67%,IP6K2;PPIP5K1
prerank,regulation of monooxygenase activity (GO:0032768),0.35271310272520595,0.877553480415832,0.6306306306306306,1.0,1.0,4/23,10.19%,HSP90AA1;NOS1AP;POR;GDNF
prerank,metal ion transport (GO:0030001),-0.1927921328613512,-0.8775116484330491,0.8,0.9095739752070237,1.0,25/86,21.81%,CACNA1D;NIPA2;CAV1;MRS2;SLC3A2;CACNA2D1;TRPC3;TRPC1;CACNA1C;NDFIP1;SELENOK;RAMP2;NIPA1;SLC39A8;TRPC4;CHRNA7;TRPM7;TRPC5;MAGT1;FYN;PANX1;TPT1;CALCRL;CACNG8;CAMK2A
prerank,mRNA catabolic process (GO:0006402),0.31776919761259653,0.8768188727863278,0.6485549132947976,1.0,1.0,11/44,19.40%,LSM6;CNOT10;NUDT12;AGO3;XRN1;DIS3L2;DDX5;NUDT16L1;THRAP3;DHX34;YTHDF2
prerank,positive regulation of protein metabolic process (GO:0051247),0.29256263866967497,0.8767880091667349,0.7119509703779366,1.0,1.0,29/110,21.64%,WNT5A;ASB5;ABCA2;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;APP;PRMT1;EGLN2;RNF41;ROCK2;TGFB1;NKD1;AGTR1;NSF;TIPARP;APOE;SMURF1;SORL1;SLC25A37;STX5;RANBP9;KLF4;HECW2;FOXO1;RAB7A
prerank,RNA methylation (GO:0001510),0.3062743017106238,0.8767199588980821,0.6619718309859155,1.0,1.0,9/60,12.90%,TRMT61B;TRDMT1;FBL;DIMT1;BUD23;WDR6;ZCCHC4;METTL2B;METTL2A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3154248761340783,0.8766712415520508,0.6722222222222223,1.0,1.0,18/53,21.45%,RNF8;FGF10;FBH1;EEF1E1;WRAP53;RNF168;NACC2;CEBPG;ATR;EYA2;BCLAF1;DDX5;FMR1;UIMC1;RPS3;EYA1;PLA2R1;NPAS2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3188738390203876,0.8764574949724159,0.662020905923345,1.0,1.0,5/42,6.14%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.35181644638783177,0.8758911268374517,0.649167733674776,1.0,1.0,3/24,7.11%,VTN;ARNT;HGS
prerank,Ras protein signal transduction (GO:0007265),0.2873062743321246,0.8758510966837149,0.7453798767967146,1.0,1.0,32/137,19.10%,CDC42EP5;IGF1;CDC42EP4;CTNNAL1;RAC1;SGSM3;BRAP;RASGRP2;RAP2A;RHOD;KPNB1;CYFIP1;RAPGEF1;RIPOR1;DBNL;ADGRG1;RTKN;GPSM2;COL1A2;PARK7;PLEKHG5;WASF1;ARHGAP29;ROCK2;FARP2;EPS8L1;AGTR1;RIT2;MRAS;RRAS2;USP50;KSR1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3066594568787704,0.8757683562269036,0.6761177753544165,1.0,1.0,16/67,17.79%,ABITRAM;RAC1;DCDC2;CDKL5;SGSM3;TBC1D13;DMTN;TBC1D20;USP6NL;IFT20;RABGAP1;TBC1D24;ATG3;FMR1;TBC1D9B;TBC1D22B
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.38940187772330076,0.8756674838149584,0.6351531291611185,1.0,1.0,2/15,4.02%,ANXA1;ZFP36L1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.29537269068067534,0.8754838429581948,0.7147270854788877,1.0,1.0,35/109,24.48%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22365885721064266,-0.8753782778464588,0.7054263565891473,0.9128905366568292,1.0,8/49,9.96%,STAT3;RIPK1;LBP;NOD1;AFAP1L2;TLR4;LGALS9;RAB1A
prerank,negative regulation of protein modification process (GO:0031400),0.3045325879008861,0.8752876355370888,0.6889596602972399,1.0,1.0,22/79,19.02%,EPHB2;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;IGFBP3;CDYL;PARK7;CRTAP;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;TPPP;DNAJC10;TERF2IP;PRKAA1;ARPP19
prerank,smooth muscle contraction (GO:0006939),-0.316333719428558,-0.8752665017126402,0.6517241379310345,0.9115572529788526,1.0,8/14,30.00%,EDNRA;SMTN;TPCN2;ROCK1;ADRA1A;MYH11;ACTA2;SLC8A1
prerank,hexose biosynthetic process (GO:0019319),-0.22663897660834825,-0.8751953395311708,0.6589147286821705,0.9101767067426743,1.0,16/42,24.87%,AKR1B1;SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.29635320284029554,0.8751948341426387,0.7063740856844305,1.0,1.0,22/95,20.33%,CHPF;HS2ST1;SLC35D2;ST3GAL2;GPC6;NDST2;DCN;ST3GAL3;GPC1;CHSY3;HS6ST2;B4GALT5;GPC4;OMD;LUM;HSPG2;EXT2;CEMIP;DSE;GPC5;HS3ST1;GCNT2
prerank,cellular protein modification process (GO:0006464),0.2813711382821701,0.875189857446796,0.948,1.0,1.0,196/983,19.00%,AATK;ILF3;COPS7A;ALG5;MAPK9;B3GALNT1;CAMK2B;DUSP26;CUL7;STK36;SIRT2;SPSB3;ARAF;SIRT7;PSMD4;LCMT1;PDPK1;PDK1;COQ8B;FBXW10;CP;ASB5;ST8SIA3;PARP1;EIF2AK3;DMPK;UBE2S;SPSB1;KCTD7;CDKL5;UBE2E2;FBXL12;HUNK;FGFR1;ANXA1;TAOK1;PICK1;FSTL1;WIPI1;OBSL1;NUAK2;ST3GAL2;MINK1;FBXL14;MAP4K5;PARP2;WSB2;CDK13;PPM1B;PRKCA;CDK5;FBXO7;COP1;CDK9;LAMC1;ALG1;UBXN7;METAP1;NGLY1;PIGU;NUAK1;ABL1;FBXO31;ST3GAL3;PSMB10;DDB1;PAK3;MIA3;UCHL3;STK11;BRSK2;CKAP4;FBXW5;CDC14B;PSMD11;LTBP1;SIK1;COPS7B;MANBA;ST3GAL5;SSH1;PPP2R5E;TEC;FAM20C;PPP1CC;ABCA7;NRBP2;APLP2;CUL4B;PLAT;MBTPS1;PRAG1;PSME2;METAP1D;PPM1H;WNK2;PSMC5;BRSK1;PGAP1;APP;PTPN5;GRK3;MAPK6;IGFBP3;STRADB;IGFBP7;PTPRF;CAMK2D;PORCN;PTPN3;TLK1;PARK7;DCAF5;FBN1;B4GALT5;SERP1;RAB13;COG3;PARP14;LAMB1;METAP2;NEURL2;PRKCI;DAPK1;PIGK;PTPN22;CUL5;PARP16;DAD1;CSNK1D;STK19;ATG3;NEK3;NRBP1;ROCK2;TGFB1;KLHL5;GRK2;PPM1E;FEM1C;PPP2R5D;CSNK1A1;CTDSP2;PSMD1;RPN2;PPP5C;PPM1M;KLHL13;ACVR1B;RAB8A;UBE2E1;GALNTL5;PTPN12;SIRT5;CHEK2;ZC3HAV1;CTBP1;MTMR4;MAP3K1;CCNT1;SERPIND1;TP53RK;TNKS;PIK3C3;NEDD8;UBE2L3;STK25;TIPARP;PSMD6;PPP2CB;CDK7;MXRA8;OXSR1;APOE;FBXO22;FBXO9;ILK;KLHL20;PPP2R5A;PRKD2;JAK1;NEK1;CDK10;BTBD1;PTPRE;PTAR1;TAB1;SRPK1;B3GALNT2;TGFBR1;PHKA2;PRKAA1;CDC42BPB;ASB3;PRKAG2;PIK3R4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3340861012282315,0.8751873871512409,0.6604215456674473,1.0,1.0,7/35,16.60%,CCT8;PKIB;CCT6A;DHX36;ATR;HNRNPA2B1;TNKS
prerank,regulation of mitochondrial fission (GO:0090140),0.35141649425491944,0.8751261237969608,0.650523560209424,1.0,1.0,7/24,15.72%,MYO19;FIS1;DCN;MIEF2;MAPT;DNM1L;SPIRE1
prerank,non-motile cilium assembly (GO:1905515),0.3386978573625383,0.8748670544019718,0.6399026763990268,1.0,1.0,7/30,14.82%,BBS10;ARL13B;PIBF1;TTC8;DISC1;CSNK1D;TMEM216
prerank,regulation of response to stress (GO:0080134),0.4248825131191233,0.8748153672605311,0.6503937007874016,1.0,1.0,1/10,4.10%,MLC1
prerank,protein K48-linked ubiquitination (GO:0070936),0.31296135083109083,0.8747604120698402,0.6871444823663254,1.0,1.0,14/54,17.56%,RNF8;UBE2E2;SYVN1;TNFAIP3;FBXO38;RFFL;RNF152;UBE2A;UBE2E1;UBE2D1;ARIH2;UBR5;TOPORS;TTC3
prerank,snRNA transcription (GO:0009301),0.30184444539217364,0.8747586352066123,0.6703056768558951,1.0,1.0,26/70,24.79%,RPRD2;USPL1;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,autophagosome organization (GO:1905037),0.31817596380100166,0.8743648642265048,0.6729074889867841,1.0,1.0,17/50,22.68%,UBQLN1;UBXN2A;WIPI1;ATP2A2;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;PIK3C3;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.33624662674688355,-0.8740105828470015,0.6006389776357828,0.9113948806863296,1.0,6/12,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.39273333144284106,0.8739051522995632,0.6207386363636364,1.0,1.0,4/14,22.93%,ANXA1;MALT1;PRKCZ;IL18
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3226802255856068,0.8738229653603999,0.6750285062713797,1.0,1.0,9/45,14.97%,PDPK1;PIK3R1;GAB1;SLC30A10;SOX9;EGF;IQGAP1;TGFB1;CBL
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4044241729913008,0.8736669932575277,0.6285714285714286,1.0,1.0,4/12,16.41%,SRM;SMS;AMD1;TRH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36654399870773025,0.8736421597829749,0.6486842105263158,1.0,1.0,4/20,14.28%,NFKB1;HM13;MBTPS1;TGFB1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.30526559768657074,-0.873530219862835,0.6549295774647887,0.9093444391233413,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.30526559768657074,-0.873530219862835,0.6549295774647887,0.9093444391233413,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3043498352852574,-0.8731933240824759,0.6294964028776978,0.9085928135683604,1.0,6/15,25.09%,CSGALNACT1;CSPG4;DSEL;BGN;CSPG5;CHST12
prerank,mitochondrial translational termination (GO:0070126),0.29551760816028,0.8729346848101401,0.7088477366255144,1.0,1.0,24/88,22.85%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.2334093213973984,-0.8728730710269397,0.7142857142857143,0.9077629933293173,1.0,13/44,22.64%,MEF2C;ACVR1;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;HES1;CCDC39;SOX17;MICAL2;TBX2
prerank,vasoconstriction (GO:0042310),0.4086390674322912,0.8728612843415059,0.6333333333333333,1.0,1.0,1/11,2.70%,EDN3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3680107452211486,0.8728570279071454,0.6397849462365591,1.0,1.0,2/18,7.14%,IL34;CXCR4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3326633463653136,-0.8728262590911603,0.6211180124223602,0.9063149490976387,1.0,3/11,7.14%,MEF2C;SIRT1;LGALS9
prerank,prostanoid metabolic process (GO:0006692),-0.32426301884965614,-0.872248553623806,0.6145833333333334,0.9061117631914919,1.0,5/13,25.95%,PTGES;PLAA;GSTM1;HPGDS;HPGD
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.29206461767813047,-0.8720916387352595,0.6408163265306123,0.904954382373809,1.0,8/19,22.61%,CAT;MAOB;NOX1;PRDX2;CYBA;GPX1;PRDX3;PRDX4
prerank,histone deubiquitination (GO:0016578),-0.29958011865283035,-0.8720507053588431,0.5870445344129555,0.9035110889938976,1.0,4/18,5.34%,TRRAP;BRCC3;ATXN7;USP36
prerank,cell projection assembly (GO:0030031),0.35622344434172165,0.8716707917812718,0.649867374005305,1.0,1.0,3/22,8.37%,RAC1;NEFH;CYFIP1
prerank,negative regulation of cellular senescence (GO:2000773),0.3932124013019739,0.8715347605079588,0.6418338108882522,1.0,1.0,3/13,9.79%,FBXO5;SLC30A10;TWIST1
prerank,mitochondrion distribution (GO:0048311),0.4067125718844854,0.8713538531562484,0.636094674556213,1.0,1.0,5/12,18.34%,MSTO1;MAPT;DNM1L;TRAK1;ATCAY
prerank,DNA double-strand break processing (GO:0000729),0.3716957710038039,0.8713428810427123,0.6323529411764706,1.0,1.0,7/18,21.07%,RNF138;BARD1;UBE2V2;MRE11;RAD50;RBBP8;EXD2
prerank,sphingolipid metabolic process (GO:0006665),0.2964350645948476,0.8713293791898319,0.7312049433573635,1.0,1.0,23/108,19.67%,B3GALNT1;ELOVL1;SMPD2;GBA2;GLB1;ABCA2;CERS2;SGPL1;ELOVL4;ENPP2;SPTSSA;TEX2;PLPP3;PSAP;SMPD4;ST6GALNAC6;VAPB;ALDH3A2;GALC;PRKD2;ELOVL6;SMPD1;PDXDC1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.29161506582805197,-0.8712436886052441,0.6459854014598541,0.9038886454342546,1.0,8/16,22.78%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;ATP5F1B;DMAC2L;ATP5F1D
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.28797274376821763,0.8707822170188887,0.7368421052631579,1.0,1.0,26/138,15.24%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4146298913158661,0.8706456232169358,0.6179104477611941,1.0,1.0,1/10,1.15%,NPTXR
prerank,regulation of cellular catabolic process (GO:0031329),0.3068182252283137,0.8705724872986719,0.6905286343612335,1.0,1.0,17/62,17.48%,PIP4K2B;ITPR1;ABL1;RRAGA;DDIT3;USP10;PIK3R2;WDR91;PIP4K2A;DAPK1;PSAP;MAPT;PIP4K2C;NUPR1;RAB8A;MTMR4;USP33
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.34110957973862094,0.870481137600844,0.6581196581196581,1.0,1.0,8/30,16.55%,RAB34;SEC16A;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF
prerank,positive regulation of peptidase activity (GO:0010952),0.3628431164432162,0.8704270305293661,0.6335483870967742,1.0,1.0,6/20,17.20%,PRELID1;RCN3;VCP;PSME2;CTSH;TANK
prerank,regulation of DNA replication (GO:0006275),-0.22109659582555866,-0.8702934308519631,0.7121212121212122,0.9045973698895806,1.0,7/49,7.16%,WAPL;ANKRD17;EGFR;KAT7;RBBP6;BCAR3;STN1
prerank,negative regulation of macroautophagy (GO:0016242),0.34806211488151617,0.8702885291066789,0.6625615763546798,1.0,1.0,13/26,25.36%,PHF23;TSC2;NRBP2;SCFD1;FEZ2;NUPR1;QSOX1;SMG1;CHMP4A;CHMP4B;TSC1;MTM1;CLEC16A
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3258269460356876,-0.8701320280681362,0.6293929712460063,0.9034629751816945,1.0,4/12,10.85%,RDX;MED1;CTSL;LMO2
prerank,protein autoprocessing (GO:0016540),0.37043414777906425,0.8699587608388679,0.625503355704698,1.0,1.0,3/17,17.62%,MYRF;AFG3L2;OMA1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3580167295393355,0.869700723112402,0.6584734799482536,1.0,1.0,5/22,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,fatty acid transmembrane transport (GO:1902001),-0.27533703111173874,-0.8696773659091396,0.6816479400749064,0.9029932102473792,1.0,5/19,14.03%,SLC2A1;ACACA;PRKAB2;ACACB;PRKAA2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4069824015129226,0.8695649867948283,0.6480117820324006,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4069824015129226,0.8695649867948283,0.6480117820324006,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,positive regulation of histone acetylation (GO:0035066),0.34757469210256053,0.8695339523458703,0.6544980443285529,1.0,1.0,3/23,8.07%,WBP2;SMARCB1;ARRB1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.299807037409388,0.8695263931352499,0.6944444444444444,1.0,1.0,28/80,25.12%,KDELR3;BNIP1;ATP9A;PICK1;KIF3A;KIF3C;ERGIC2;COPZ2;ATP9B;SCFD1;TMED10;PLPP3;COG3;HTT;NSF;RAB6A;KIFAP3;ZW10;UVRAG;NAPA;ARFGAP3;COPG1;KIF3B;COPA;TMED7;GOLPH3L;ERGIC1;SURF4
prerank,negative regulation of nuclear division (GO:0051784),0.4100622033853748,0.8695046403735762,0.6374622356495468,1.0,1.0,2/11,8.26%,FBXO5;AURKAIP1
prerank,defense response to protozoan (GO:0042832),0.39157537720060526,0.8693972000534663,0.6439942112879884,1.0,1.0,4/12,23.73%,GBP7;GBP6;GBP4;LYST
prerank,response to X-ray (GO:0010165),0.3833171790472248,0.8691567179965618,0.6248236953455572,1.0,1.0,4/14,15.12%,ANXA1;NIPBL;XRCC6;NUCKS1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3634663710543696,0.8688849821085354,0.6397350993377483,1.0,1.0,4/20,9.58%,PPIF;NKTR;PPIB;PPIH
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3236274621724624,-0.8686291910505792,0.6346153846153846,0.9037812169413573,1.0,4/13,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,ceramide biosynthetic process (GO:0046513),0.3248613276985659,0.8686140784084878,0.6605080831408776,1.0,1.0,8/40,14.35%,ST8SIA3;SMPD2;CERS2;ST3GAL5;SPTSSA;TLCD3B;SMPD4;ST6GALNAC6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2895848281319399,-0.8684125496954235,0.6144578313253012,0.9027765586967746,1.0,5/18,16.00%,EGFR;RIPK1;TP53;ESR1;BMP4
prerank,ncRNA export from nucleus (GO:0097064),-0.23731201628158782,-0.8677473081643177,0.7090909090909091,0.9027120089672784,1.0,13/36,17.56%,NUP160;XPOT;NUP205;PHAX;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,positive regulation of calcium ion transport (GO:0051928),0.33065505875565393,0.8677043560040026,0.66507747318236,1.0,1.0,4/36,8.98%,GRIN1;CXCL12;ATP2B1;CRACR2A
prerank,V(D)J recombination (GO:0033151),0.41054860957562445,0.8671458474641998,0.6340361445783133,1.0,1.0,3/11,15.29%,LIG1;LIG3;TCF3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3379343089905058,0.8670335431617311,0.6691542288557214,1.0,1.0,9/28,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;TPR;SMAD3
prerank,response to organonitrogen compound (GO:0010243),0.32292785594627565,0.8666952213268622,0.6705336426914154,1.0,1.0,7/38,16.39%,SYVN1;ERLEC1;BRSK2;RCN3;VCP;GLRA1;DERL1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2838075842268265,0.8665626348090297,0.7809045226130653,1.0,1.0,28/190,12.69%,RNF157;PPIF;TSC2;GPD1L;THEM4;TBC1D7;RORA;DDX3X;TNFAIP3;OTUD7A;ITPR1;PPM1B;FLCN;RFFL;IFI35;CIT;DDIT3;USP10;PER1;ABCA7;TWIST1;PIK3CB;PIK3R2;BCL2;RTKN2;MAGI2;DAG1;RACK1
prerank,positive regulation of viral process (GO:0048524),0.3054613737789366,0.8664663976419144,0.6937901498929336,1.0,1.0,13/60,18.54%,TARBP2;DDX3X;POLR2B;CDK9;DDB1;PPIH;PABPC1;TBC1D20;POLR2K;VAPB;CCNT1;SRPK1;NELFA
prerank,determination of left/right symmetry (GO:0007368),0.3282160308888336,0.8660939819480707,0.669392523364486,1.0,1.0,8/37,23.23%,BBS7;ZIC3;RFX3;OFD1;MEGF8;PKD2;DAND5;KIF3B
prerank,T-helper cell differentiation (GO:0042093),0.38464765650840244,0.8658256782166666,0.6425648021828103,1.0,1.0,1/14,1.14%,PTGER4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.36758703387686503,0.8656503157446716,0.6479250334672021,1.0,1.0,2/17,4.62%,NTHL1;MPG
prerank,dephosphorylation (GO:0016311),0.28666097197395346,0.8656274813526819,0.7550813008130082,1.0,1.0,32/147,18.51%,DUSP28;DUSP18;DUSP26;PPM1B;STK11;CDC14B;PLPPR2;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;HDHD2;PLPP3;PTPN22;PLPPR5;EPHX2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PLPP4;PTPN12;PLPP5;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1
prerank,regulation of endothelial cell migration (GO:0010594),0.2955753984063478,0.8653894128387631,0.720855614973262,1.0,1.0,23/85,21.29%,WNT5A;GPLD1;RAC1;NR2F2;NRP1;PRKCA;DCN;ABL1;SPARC;GLUL;EGF;PIK3CB;EMP2;ROCK2;FOXC2;ITGB1BP1;APOE;PRKD2;SYNJ2BP;KRIT1;PDCD6;PTK2B;FGF2
prerank,positive regulation of protein import (GO:1904591),0.33402302304486553,0.8653087612576568,0.6654228855721394,1.0,1.0,10/30,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;PDCD5;TPR;SMAD3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.37550908235683206,0.8650590015694783,0.6596583442838371,1.0,1.0,3/17,6.44%,SIRT2;CALM3;DMTN
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.21262259764738584,-0.8650442264856765,0.7096774193548387,0.9075629171005626,1.0,18/67,15.68%,IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,regulation of macrophage migration (GO:1905521),-0.34932481294057327,-0.8647386699475934,0.6484848484848484,0.9067185803698072,1.0,5/10,23.74%,MTUS1;P2RY12;EMILIN1;CD81;CX3CR1
prerank,response to thyroid hormone (GO:0097066),-0.3187762840343088,-0.8637924537040643,0.6404109589041096,0.9072931333233731,1.0,4/13,10.85%,RDX;MED1;CTSL;LMO2
prerank,protein localization to membrane (GO:0072657),0.2832244637147434,0.8636089471172121,0.7913306451612904,1.0,1.0,60/187,23.66%,TMEM150A;LRRC4;PRAM1;PICK1;ANK1;RAB34;SCRIB;DLG3;THY1;SEC16A;DVL1;RAP2A;HGS;RAB12;ZDHHC3;PTCH1;RAB10;ARL5B;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;MAGI2;RAB13;EMP2;ROCK2;NLGN2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;DLG2;PACS1;SMURF1;ZDHHC2;SYNJ2BP;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2;NPC1;EHD3;RAB11B;WNK3;NUP155;AGRN;RAB40B;SH3PXD2B;SH3GLB1;NUP54
prerank,regulation of rRNA processing (GO:2000232),0.36982017399352507,0.8635811774503047,0.6634214186369958,1.0,1.0,3/16,8.48%,SIRT7;DIMT1;BUD23
prerank,cilium assembly (GO:0060271),0.2808306630127592,0.863274538000309,0.8268268268268268,1.0,1.0,70/297,20.74%,CCP110;TMEM138;B9D2;CENPJ;CPLANE2;STK36;BBS10;HSP90AA1;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;ALMS1;TCTN1;BBOF1;BBS7;INPP5E;CEP97;SNX10;KIF3C;TRIP11;CDC14B;CCDC28B;TUBA1A;PIBF1;CFAP54;TTC8;YWHAG;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;HAUS3;CSNK1D;ATP6V1D;TUBB;TMEM216;TTC21B;RFX3;TNPO1;OFD1;RAB8A;RAB8B;AHI1;CEP76;DNAAF3;NEK1;IQCB1;TUBB4A;NPHP1;ODF2;WDR35;KIFAP3;DYNLL1;PAFAH1B1;TMEM67;DCX;LZTFL1;TMEM80;EXOC5;EHD1;DYNC2H1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2934817469369315,0.8631656915722977,0.7257731958762886,1.0,1.0,23/100,17.57%,SIRT2;ARAF;STUB1;USP7;ZYG11B;OGT;COP1;BBS7;DVL1;SDCBP;VCP;PARK7;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.34874946017032155,0.863046818068184,0.6575,1.0,1.0,11/24,25.46%,ZFP36L1;ERRFI1;CBFB;ROCK2;NUMA1;CTSK;NCOA3;HOXA7;SRSF6;RUNX1;SGPP1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.352894086518139,-0.862924201407213,0.6440677966101694,0.9077780984377001,1.0,6/10,37.39%,NR1H3;ELOVL5;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,plasma membrane tubulation (GO:0097320),0.3916143128927677,0.8629107166718433,0.6421636615811374,1.0,1.0,3/13,11.60%,WHAMM;PACSIN3;SNX33
prerank,aortic valve development (GO:0003176),0.33375869189363083,0.8628423133848392,0.6626650660264105,1.0,1.0,10/34,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,transferrin transport (GO:0033572),0.3315438151966177,0.8626148653703561,0.6787878787878788,1.0,1.0,10/33,22.41%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;STEAP3;ATP6V1C1;RAB11B
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3790274236075762,0.8623536515086033,0.6568627450980392,1.0,1.0,2/14,9.38%,CLN3;ABCA7
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3992002895784532,0.8623225883375106,0.6364922206506365,1.0,1.0,4/12,20.27%,SFRP1;HDAC1;NCOR2;DAB2
prerank,epithelial cell development (GO:0002064),0.3508761815635245,0.862306373218435,0.669260700389105,1.0,1.0,1/20,1.42%,DACT2
prerank,regulation of T cell proliferation (GO:0042129),-0.21531273753922547,-0.8622894658758851,0.7647058823529411,0.907754066345804,1.0,13/61,30.13%,CD46;SLC7A1;NCK1;SDC4;PTPRC;TNFRSF1B;CEBPB;NCKAP1L;PNP;CD80;CD274;NCK2;CD86
prerank,translational termination (GO:0006415),0.2902319582843386,0.861771353065995,0.7317574511819116,1.0,1.0,26/95,22.85%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;GSPT1;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;ABCE1;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28
prerank,inner dynein arm assembly (GO:0036159),-0.34390198765898294,-0.8616713520707616,0.6233766233766234,0.9076748198338158,1.0,2/11,18.78%,DNAAF5;CCDC39
prerank,activation of phospholipase C activity (GO:0007202),-0.2436846460067297,-0.8616196312104396,0.6902173913043478,0.9062905582056915,1.0,15/29,42.22%,EGFR;EDNRA;PLCG1;ADRA1A;P2RY12;HTR2A;BDNF;CD86;PHB2;P2RY6;LPAR2;HTR2B;ANG;TXK;RASGRP4
prerank,neurotrophin signaling pathway (GO:0038179),0.3596138128810397,0.8616081629286196,0.6406649616368286,1.0,1.0,4/21,11.88%,NTF3;FRS2;RAPGEF1;MAGI2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.27175335347776,-0.8615559495900198,0.7032520325203252,0.9049677324147772,1.0,3/21,1.12%,FOXP1;PRKCH;ELF1
prerank,leukocyte tethering or rolling (GO:0050901),-0.2952943731589954,-0.8613802613275389,0.6632302405498282,0.9038782048901355,1.0,5/17,23.74%,JAM2;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.27823115077504806,0.8612027675335479,0.8888888888888888,1.0,1.0,61/476,12.36%,PSRC1;ILF3;WNT5A;WBP2;SFRP1;IGF1;MED24;FOXM1;ZBTB48;MYRF;NFKB1;SMARCD3;NR2F2;MAPRE3;MED12;SMARCC2;MED14;GLIS2;NR1D2;RORA;KMT2B;BRPF1;SNX5;CHD8;IL31RA;SNAI1;NPAT;TCF4;CNBP;BRD4;IRF1;MED13;ZIC3;CASZ1;TRIM56;ANKRD49;ZNF711;TEAD1;TGFB1I1;RAI1;MED4;WNT4;SOX9;DDIT3;XRCC6;YWHAH;HNRNPD;ARID1B;EGF;ATMIN;HDAC4;SOX11;CALCOCO1;PSMC5;NSD3;MAZ;SMARCA1;ZMIZ1;NPM1;TADA3;HDAC1
prerank,purine-containing compound salvage (GO:0043101),0.4030688677529874,0.8611387570782137,0.6396526772793053,1.0,1.0,4/12,21.40%,DCK;HPRT1;GMPR2;ADK
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3515715200345953,0.8610129992681441,0.6443298969072165,1.0,1.0,4/21,16.59%,ADCY7;ADCY1;NPR2;ADCY5
prerank,regulation of astrocyte differentiation (GO:0048710),0.3965552282401711,0.860608367509997,0.6661828737300436,1.0,1.0,1/12,2.40%,BIN1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.29352893945939645,0.8603982964387077,0.7225130890052356,1.0,1.0,24/93,22.50%,SFRP2;ARAF;NTF3;HSP90AA1;GPD1L;DMTN;CNKSR3;APP;CNOT9;PARK7;DOCK7;RACK1;TGFB1;SPRY2;NSD1;PRKD2;RASSF2;TERF2IP;SMAD7;SPTBN4;ATP2B4;PPM1F;PFN2;PAK1
prerank,pyruvate metabolic process (GO:0006090),-0.21795452153377584,-0.8600514851332933,0.7525773195876289,0.9053226420367919,1.0,16/52,19.17%,ME3;ME2;HK1;BSG;GPI;PDHX;SLC16A1;PDHA1;PKM;GLO1;ALDOA;PDHB;PCK2;PFKFB2;ENO1;HK2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33298489605471504,0.8600444927024454,0.681437125748503,1.0,1.0,9/31,22.01%,DNLZ;TOMM20;PEX1;PEX5;PEX7;HSPD1;TIMM44;TIMM23;PEX2
prerank,DNA metabolic process (GO:0006259),0.27928977604339,0.8597780393114165,0.8268268268268268,1.0,1.0,62/270,21.07%,WDHD1;XRCC2;LIG1;SIRT7;DNASE1L2;HMGB3;PARP1;NTHL1;USP7;MPG;PARP2;MGMT;TCF7L2;ASF1A;CNBP;DDB1;BARD1;TDP1;DFFB;SMARCB1;LIG3;FANCG;ORC6;XRCC6;UBE2V2;VCP;GTF2H3;POLH;TOP1;ZNF445;ENDOV;USP3;ALKBH3;BACH1;PARK7;NPM1;AXIN2;UBE2A;ATR;MMS19;POLD3;HELB;FANCA;MRE11;RAD50;TERF1;TOP3B;NABP2;PWWP3A;TOP3A;RAD21;RBBP8;TERF2IP;RECQL5;ALKBH1;KMT5B;INO80;FANCL;UVRAG;RAD18;TOP2B;EXD2
prerank,GTP metabolic process (GO:0046039),0.37524602076741975,0.8596671766984992,0.6573033707865169,1.0,1.0,4/15,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.34691025014403176,-0.858949696947338,0.65814696485623,0.9063218548433251,1.0,5/10,32.06%,MTMR3;MTMR9;MFSD2A;MTMR2;PHB2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4026365348399248,0.8587826291641022,0.658753709198813,1.0,1.0,11/11,59.76%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2857752158186306,0.858148191811088,0.7584789311408017,1.0,1.0,29/129,20.43%,CCP110;CENPJ;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;BACH1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3442905628165308,-0.8581469692476094,0.6607142857142857,0.9051559193595957,1.0,4/10,32.26%,MYADM;WNK1;MAPK7;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3442905628165308,-0.8581469692476094,0.6607142857142857,0.9051559193595957,1.0,4/10,32.26%,MYADM;WNK1;MAPK7;MBP
prerank,cell cycle G2/M phase transition (GO:0044839),0.2860117530521344,0.8580960019235928,0.7587268993839835,1.0,1.0,29/130,20.43%,CCP110;CENPJ;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;AKAP8L;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3797232241060132,0.8580887396402405,0.6750348675034867,1.0,1.0,3/15,9.96%,ZFP36L1;DHX36;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3797232241060132,0.8580887396402405,0.6750348675034867,1.0,1.0,3/15,9.96%,ZFP36L1;DHX36;PABPC1
prerank,glycolytic process (GO:0006096),0.3446423227815477,0.8579745236180493,0.6597307221542228,1.0,1.0,4/28,11.10%,HKDC1;PGAM4;PGAM1;ENO2
prerank,aminoglycan metabolic process (GO:0006022),0.4035420879059763,0.8578868581741572,0.6676737160120846,1.0,1.0,1/10,2.20%,CLN6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2881145817108693,0.8578708729495717,0.7430051813471502,1.0,1.0,26/104,22.11%,ADAMTSL2;PDPK1;STUB1;SMAD9;PMEPA1;SNX6;HTRA3;TGFB1I1;LEMD3;MAGI2;PEG10;TGFB1;SMAD6;VASN;UBE2D1;MTMR4;SPRY2;SMURF1;SORL1;TGFBR1;PPM1A;NBL1;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,endochondral bone morphogenesis (GO:0060350),0.4121631527765169,0.857821421087341,0.67,1.0,1.0,1/11,1.00%,TMEM119
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3303947449194794,-0.8575779853871324,0.6116838487972509,0.904928768090037,1.0,4/11,31.79%,PTPRC;AHR;CEACAM1;HFE
prerank,protein hydroxylation (GO:0018126),-0.2974423782268104,-0.8572708971080475,0.6621160409556314,0.9041346480432311,1.0,9/15,25.44%,OGFOD1;VIPAS39;P3H3;ASPH;EGLN3;PLOD2;P3H1;PLOD3;HIF1AN
prerank,negative regulation of developmental growth (GO:0048640),0.3333116526628376,0.8571415965605562,0.6724782067247821,1.0,1.0,10/30,23.89%,DIP2B;PTCH1;SLC6A4;NKD1;DCC;WWC1;PTPRS;FGF13;MAP2;PTEN
prerank,zinc ion transmembrane transport (GO:0071577),0.348062165428243,0.8570920049437964,0.6792207792207792,1.0,1.0,6/22,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,lytic vacuole organization (GO:0080171),0.328033000539955,0.8568104323286325,0.6751515151515152,1.0,1.0,6/32,16.00%,CLN3;CLN6;MBTPS1;HOOK3;ARSB;VPS18
prerank,carnitine shuttle (GO:0006853),-0.33903766200492913,-0.8566376765475993,0.6818181818181818,0.9040818543871572,1.0,4/11,14.03%,ACACA;PRKAB2;ACACB;PRKAA2
prerank,regulation of platelet activation (GO:0010543),0.3522032508448632,0.8565492324875115,0.6584415584415585,1.0,1.0,4/21,11.29%,C1QTNF1;PRKCA;TEC;PDGFRA
prerank,pharyngeal system development (GO:0060037),-0.31075373546630247,-0.8565180631663705,0.6642335766423357,0.9028677109146397,1.0,6/15,17.99%,TGFB2;BMPR1A;BMP7;BMP4;HES1;TBX1
prerank,cellular response to nitrogen compound (GO:1901699),-0.28088054457146694,-0.8564650966260716,0.6805555555555556,0.9015315561470237,1.0,6/20,16.92%,RIOK3;SPIDR;DDI2;HSF1;RTF2;BLM
prerank,protein monoubiquitination (GO:0006513),-0.22833211648486967,-0.8562059834503469,0.7305389221556886,0.9006502479781563,1.0,11/36,19.24%,WAC;RBX1;TRIM25;UBE2O;PAF1;UBE3D;UBE2D3;DTX3L;HUWE1;UBE2R2;LEO1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3640036487484363,0.8561546280356845,0.6452476572958501,1.0,1.0,5/18,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,phospholipid catabolic process (GO:0009395),0.34035140522405627,0.8559999067353832,0.6717948717948717,1.0,1.0,6/24,19.12%,PRDX6;GDPD3;ENPP2;SMPD4;GDE1;SMPD1
prerank,monocyte differentiation (GO:0030224),-0.3460349882035909,-0.8559600861050343,0.653250773993808,0.8996863489550301,1.0,6/10,22.06%,PIR;MT1G;THOC5;BMP4;VEGFA;PPARG
prerank,regulation of multicellular organismal development (GO:2000026),0.34615048731679277,0.8558906789814504,0.6721311475409836,1.0,1.0,8/25,24.54%,NIPBL;CD24;DHX36;EHMT1;OAS2;TRIP12;INSR;MYSM1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3034429237556684,-0.8557600312758977,0.676056338028169,0.8986594045780304,1.0,7/14,38.99%,RARA;DENND1B;CD81;CD86;CD74;RSAD2;NOD2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.246556069417277,-0.8553607070205765,0.7098765432098766,0.8980441531844401,1.0,5/33,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,neutrophil migration (GO:1990266),-0.21143525915377825,-0.8547632608519343,0.78,0.8979965069597379,1.0,5/58,6.44%,GBF1;PECAM1;BSG;CCL15;TGFB2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3059913884129536,-0.854739133626265,0.6438356164383562,0.895175935314346,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,stress fiber assembly (GO:0043149),-0.3059913884129536,-0.854739133626265,0.6438356164383562,0.895175935314346,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,transcription preinitiation complex assembly (GO:0070897),0.3925241780893818,0.8545869048866712,0.654178674351585,1.0,1.0,5/12,22.48%,TBP;GTF2A2;TAF1B;TAF1;GTF2B
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.30171707696049127,-0.8545577890247896,0.65,0.8941781880839601,1.0,3/15,10.40%,ERN1;TSEN2;CSTF2
prerank,postreplication repair (GO:0006301),-0.22867078422762882,-0.8545368776567623,0.7482014388489209,0.8927819217825562,1.0,9/45,10.39%,WDR33;UBE2N;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;MSH2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3389121761477899,-0.8545169678368574,0.625,0.8914124717452698,1.0,4/11,15.68%,KIT;KIFC3;CCN3;ITGB5
prerank,Fc receptor signaling pathway (GO:0038093),0.2887213797275566,0.8544664080689464,0.7505154639175258,1.0,1.0,35/110,24.48%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,neuron development (GO:0048666),0.2837913550424835,0.8542183378752364,0.7767584097859327,1.0,1.0,38/141,22.15%,STMN4;GBA2;GPRIN1;XBP1;CDK5;TENM3;EPHA8;TMEM108;PPP1R9B;GDNF;APP;LRP12;BLOC1S2;BICDL1;DOCK7;TDP2;B4GALT5;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;TENM4;TBCD;EPHA5;APOE;MAP4;ATCAY;ATP8A2;ATXN10;DCX;LYN;EHD1;NTRK2;RYK;HMGB1;CAMSAP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.21719851736705953,-0.8541096820759676,0.7931034482758621,0.890872271587581,1.0,26/53,30.52%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3;PSMC3;PSMD3;PSMD8;BCKDK;ODC1;PSME3;PSMB4;PSMC4;PSMB6;PSME1;PSMB5;PSME4
prerank,acylglycerol catabolic process (GO:0046464),0.3306760664741083,0.8538887359111087,0.6950182260024301,1.0,1.0,1/30,0.96%,LPL
prerank,peroxisome organization (GO:0007031),0.33931406209681364,0.8532031433216389,0.6633416458852868,1.0,1.0,6/25,15.47%,FIS1;SEC16B;PEX1;PEX7;DNM1L;ABCD2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2149413849570198,-0.853174025182807,0.7424242424242424,0.8915279965649471,1.0,16/61,14.52%,PSMB7;AZIN1;CAV1;SIRT1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,cell junction maintenance (GO:0034331),0.3818932464984244,0.8530013333721074,0.6633663366336634,1.0,1.0,2/14,14.38%,CHCHD10;NLGN2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32506440824135796,0.8528665748072789,0.6976190476190476,1.0,1.0,8/39,19.15%,LRRC8A;CAPN10;TCF7L2;SELENOT;IRS2;NLGN2;TRH;SOX4
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.23372251090203217,-0.8528508817443995,0.75625,0.8907649059259308,1.0,19/36,35.74%,CEP63;USP28;TIPIN;DOT1L;NBN;HINFP;ATRIP;ERCC6;RAD9B;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON;SETMAR;DNA2;TIMELESS;E2F1
prerank,response to steroid hormone (GO:0048545),0.328640984360504,0.8524940253223673,0.6841477949940405,1.0,1.0,8/31,16.82%,WBP2;ATP1A3;ABCA2;CATSPER3;ATP1A2;TFPI;TGFB1;UBE2L3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.218800544292062,-0.8523602241485555,0.7835051546391752,0.8903599899183666,1.0,14/50,14.52%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.30205723633829157,0.851644759991234,0.7075892857142857,1.0,1.0,10/57,16.59%,ADCY7;OPRK1;GPR37;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1;ADCY5
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.24045016852242007,-0.8513711772999063,0.7614213197969543,0.8910219586321095,1.0,6/29,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.21486331270394474,-0.8513574891361566,0.8292682926829268,0.8896358245937148,1.0,23/59,27.54%,DAB2IP;IKBKB;IRAK2;RIPK1;ERC1;NFKBIA;TLR4;UBB;IKBKG;ROCK1;TNFRSF1A;RNF31;IRAK1BP1;FAIM;TBK1;AKT1;NFKBIL1;PRDX4;BCL10;BCL3;BIRC2;SHARPIN;TLR7
prerank,glucose import (GO:0046323),0.3867635592741139,0.8512908948294458,0.6608187134502924,1.0,1.0,3/13,16.50%,SLC27A4;SLC2A3;SLC27A1
prerank,prostanoid biosynthetic process (GO:0046457),0.37586564743397166,0.8512678177264151,0.6718092566619915,1.0,1.0,1/15,0.44%,PRXL2B
prerank,protein prenylation (GO:0018342),-0.3388806076509342,-0.8502471711636619,0.6737804878048781,0.8905249630258024,1.0,4/10,27.26%,FNTA;RABGGTB;CHM;CHML
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.35831983896559094,0.8502419565279173,0.6774628879892037,1.0,1.0,4/18,15.43%,CACNG3;NLGN3;NLGN2;CACNG4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.34834242969027424,0.8500993030022266,0.6777188328912467,1.0,1.0,3/23,8.05%,DDX3X;PPM1B;IFI35
prerank,apoptotic process (GO:0006915),0.2779191054558875,0.8497460411044054,0.817907444668008,1.0,1.0,39/203,18.34%,BAX;YARS1;TSC2;PARP1;DMPK;BNIP1;AIFM2;CASP7;OGT;CDK5;FAM162A;IRF1;STK11;CXCR4;TCHP;CIT;DPF2;CASP9;APP;BCL2;BNIP2;IRF3;RNF152;TNFRSF25;KREMEN1;VDAC1;DAPK1;BCLAF1;THOC1;MAGI3;PAWR;CASP2;HSPD1;ARHGEF6;AHCYL1;MDM2;DCC;ATN1;ATCAY
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3478566632066189,0.849164517404336,0.6569987389659521,1.0,1.0,6/20,20.58%,ZFP36L1;HOXB8;PRMT1;CDC73;MEIS2;PTK2B
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4091546932447798,0.8488016161941826,0.6686303387334315,1.0,1.0,1/10,2.64%,ZEB2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3254738236870406,0.8486840654874711,0.6810344827586207,1.0,1.0,7/31,18.56%,FGFR2;SOX11;TWIST1;PDGFRA;MEGF8;OSR1;TGFBR1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.28886098884999134,0.8486710499538745,0.7586568730325288,1.0,1.0,21/104,19.10%,CDKN2D;INCENP;CALM3;DDX3X;SNF8;ABL1;THY1;EZH2;HGS;CDC25A;CDK5RAP3;CCNH;PARP16;HTT;MAP2K2;CCNT1;SLC27A1;CDK7;BCCIP;CALM1;KSR1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.29433603683511456,0.8486589842880569,0.7392241379310345,1.0,1.0,11/73,10.02%,WBP2;AEBP2;CREBZF;RBBP4;SF3B1;TBP;PHF1;EZH2;HDAC5;HDAC4;JARID2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.29151567247153226,-0.8481840216714979,0.6879432624113475,0.8935035932169095,1.0,3/15,11.10%,RAPGEF3;EHD2;CAMK1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28815388832715766,0.8477696803865529,0.7353255069370331,1.0,1.0,15/84,15.42%,WNT5A;GPLD1;PDPK1;RAC1;FGFR1;NRP1;PRKCA;ABL1;SPARC;EGF;PIK3CB;PLPP3;ROCK2;TGFB1;FOXC2
prerank,fat cell differentiation (GO:0045444),-0.203486128789724,-0.8477309664848334,0.8275862068965517,0.8930432539979692,1.0,25/57,30.53%,MED1;BBS9;SIRT1;ERAP1;SENP2;EP300;BBS2;BBS4;TMEM120B;PRDM16;ATF5;BSCL2;CTBP2;TMEM120A;C1QTNF3;PPARG;PPARGC1A;NR4A1;NR4A2;METRNL;HMGA2;CBY1;MAFB;TRIM32;MKKS
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2890689348142566,-0.8477023091383478,0.7093425605536332,0.8916863544239562,1.0,4/17,8.99%,WASF2;GMFB;BRK1;ABI2
prerank,glucose homeostasis (GO:0042593),0.29101181679335364,0.8474228775231047,0.7357894736842105,1.0,1.0,11/83,12.44%,HKDC1;LRRC8A;USF1;TCF7L2;PIK3R1;STK11;SELENOT;PIK3R2;LEPR;PARK7;HECTD4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.330055089312202,0.8473009352467533,0.6707168894289186,1.0,1.0,7/29,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,mismatch repair (GO:0006298),0.3363702822601138,0.8469941294177162,0.6748768472906403,1.0,1.0,5/27,13.73%,LIG1;MLH1;ABL1;PMS2;POLD3
prerank,neuron differentiation (GO:0030182),0.2808599482666588,0.8469745054211584,0.7971745711402624,1.0,1.0,16/165,12.79%,WNT2B;WNT5A;XBP1;FZD3;CDK5;TENM3;BRSK2;WNT4;SPOCK1;NRBP2;SOX11;BRSK1;SMARCA1;IL1RAPL1;TDP2;MYEF2
prerank,regulation of cellular component movement (GO:0051270),0.3060978746953562,0.846916028606798,0.7005714285714286,1.0,1.0,19/49,22.50%,ZSWIM6;ABL1;MYCBP2;EGF;PRAG1;ARAP1;NRG2;YTHDF1;NRG1;ROCK2;ZSWIM8;TGFBR1;LYN;TGFBR3;IGBP1;DIAPH1;CD9;ERBB4;PKN1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3486159048905774,0.8468427770363681,0.6749672346002621,1.0,1.0,7/22,18.96%,CALM3;DDX3X;RAP2A;MRE11;RAD50;RASSF2;CALM1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33922992580052935,-0.8467650545686848,0.6417445482866043,0.8922300845995383,1.0,4/11,25.97%,TWSG1;LGALS9;VSIR;CD274
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4000615291660167,0.8467494517035348,0.6763848396501457,1.0,1.0,1/11,6.74%,NOS1AP
prerank,protein stabilization (GO:0050821),0.28010675723478173,0.8467404507029803,0.8131979695431472,1.0,1.0,37/168,19.15%,DNLZ;IGF1;CCT8;HSP90AA1;TAF9B;SYVN1;USP7;NCLN;NAPG;PIK3R1;BAG1;SEC16A;DVL1;CCT6A;GET1;MDM4;PPIB;USP2;USP19;PARK7;CRTAP;CCNH;PLPP3;USP9X;COG3;ZBED3;COA8;HSPD1;CHEK2;RAB21;CDK7;USP33;GNAQ;RASSF2;BAG4;FLOT1;SOX4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3206305333014402,0.8466139727203887,0.7023809523809523,1.0,1.0,5/34,6.44%,RAC1;NRP1;ABL1;ARHGEF7;DMTN
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.23803580116884215,-0.8464653297737912,0.7473684210526316,0.891469856659455,1.0,6/30,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3165652828335627,-0.846418399311573,0.6483870967741936,0.8901706548181364,1.0,5/13,14.40%,RHOT1;HIF1A;LRPPRC;UBB;MAP1S
prerank,negative regulation of intracellular protein transport (GO:0090317),0.34263774159048804,0.8463301490006292,0.6666666666666666,1.0,1.0,8/22,20.31%,BARD1;DMTN;INSIG1;PARK7;SUFU;ITGB1BP1;BAG4;CABP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.2487533779897544,-0.8463021298039659,0.7428571428571429,0.8890539770090862,1.0,5/27,9.60%,CTNNA3;CAV1;CACNA1C;AKAP9;SRI
prerank,negative regulation of neuron projection development (GO:0010977),0.30406349313231973,0.8459829559880768,0.7192982456140351,1.0,1.0,19/56,23.90%,THY1;EFNB3;MCF2;SPOCK1;EFNB2;PRAG1;DENND5A;LPAR1;SEMA3A;APOE;RUFY3;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;LRP4;PTEN;MYLIP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.388913646546774,0.8458265383139831,0.6710914454277286,1.0,1.0,1/13,0.91%,CLN3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3461635760213377,0.8455694452869094,0.6747448979591837,1.0,1.0,5/23,19.11%,ELOVL1;FAR2;ACSL6;FAR1;ELOVL6
prerank,"phototransduction, visible light (GO:0007603)",-0.29784283520710314,-0.8453555807343104,0.6702898550724637,0.8896202729521212,1.0,6/14,39.16%,ABCA4;GNA11;RP1;GNB1;SAG;PDE6A
prerank,phosphorylation (GO:0016310),0.27383198423409627,0.8447861253357212,0.893,1.0,1.0,89/385,20.76%,AATK;ILF3;XYLB;MAPK9;CAMK2B;STK36;EPHA7;EPHB2;PDPK1;PDK1;COQ8B;EIF2AK3;DMPK;CDKL5;HUNK;FGFR1;TAOK1;PICK1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;NUAK1;ABL1;PAK3;STK11;BRSK2;SIK1;GNPTG;TEC;FAM20C;NRBP2;PRAG1;WNK2;TOP1;BRSK1;PIK3CB;APP;GRK3;MAPK6;IGFBP3;STRADB;CAMK2D;TLK1;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;CHEK2;CTBP1;MAP3K1;CCNT1;TP53RK;STK25;CDK7;OXSR1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PGK1;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;DGKI;PRKCZ;CDK14;LYN;PTK2B;MAPKAPK2;PAK5;ACVR2A
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.30439441656113103,0.8447744771588085,0.7243303571428571,1.0,1.0,9/52,11.37%,CSNK2A2;TFDP1;SAE1;NMT1;YWHAH;YWHAG;ATG13;BCL2;LEPROT
prerank,inositol phosphate-mediated signaling (GO:0048016),0.35541776198459724,0.8446875111937733,0.6558704453441295,1.0,1.0,5/19,21.03%,EDN3;INPP5A;NFAT5;HRH1;NFATC3
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.25809905514240644,-0.8444361206945928,0.7254901960784313,0.8902250988708422,1.0,11/25,30.31%,CNNM2;CAV1;TMTC2;FAM20A;TRPM7;SELENON;CNNM4;PRKN;WFS1;SLC8A1;JPH2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3032607318417499,0.8441853826696877,0.7399553571428571,1.0,1.0,6/63,11.07%,EPHB2;ANXA1;FGF10;TIRAP;IRS2;BCL2
prerank,early endosome to late endosome transport (GO:0045022),0.35531457218173895,0.8441726229808838,0.6900826446280992,1.0,1.0,6/20,16.64%,SNF8;HOOK3;WDR91;EMP2;STX8;PIK3C3
prerank,positive regulation of blood coagulation (GO:0030194),0.3665474325341095,0.8440757215648074,0.6824512534818942,1.0,1.0,4/17,16.49%,USF1;DMTN;F3;SERPINE1
prerank,iron ion transmembrane transport (GO:0034755),-0.3297392280983036,-0.8435174623068787,0.6268221574344023,0.8908029125322648,1.0,5/10,21.79%,SLC39A14;SLC39A8;SLC40A1;SLC25A28;SCARA5
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.29030370811769857,0.8428979256784566,0.7617021276595745,1.0,1.0,22/88,22.11%,BAX;WARS1;SNF8;TIRAP;PRKCA;SLF2;HGS;SDCBP;VCP;PARK7;VPS4B;RACK1;NRG1;TGFB1;FAF1;TPPP;FLOT1;RPS3;TPR;RAB7A;PFN2;SMAD3
prerank,regulation of axon regeneration (GO:0048679),-0.3161511931810496,-0.8428714010417362,0.6666666666666666,0.8907631319189149,1.0,4/12,16.44%,INPP5F;GRN;SCARF1;RTN4RL1
prerank,regulation of defense response to virus by host (GO:0050691),0.3319627243008938,0.8423556374945086,0.6904176904176904,1.0,1.0,3/30,4.85%,TARBP2;HSP90AA1;TNFAIP3
prerank,regulation of fibrinolysis (GO:0051917),0.38522959513934857,0.8421082765454206,0.672992700729927,1.0,1.0,1/13,2.95%,USF1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.30409113720931696,-0.8420484188404803,0.7046263345195729,0.8910994061773014,1.0,2/14,2.31%,SPRED1;CAV1
prerank,protein phosphorylation (GO:0006468),0.27081757746976165,0.8404544927706227,0.911,1.0,1.0,110/479,20.88%,AATK;ILF3;MAPK9;CAMK2B;CAMK1G;STK36;INCENP;EPHB2;PDPK1;PDK1;COQ8B;CSNK2A2;EIF2AK3;DMPK;FGFR2;CDKL5;HUNK;FGFR1;TAOK1;HTATIP2;PICK1;DDR1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;DDR2;NUAK1;ABL1;SRMS;PAK3;EPHA8;STK11;BRSK2;SBK1;SIK1;CIT;TEC;FAM20C;NRBP2;PRAG1;MUSK;GTF2H3;WNK2;TOP1;BRSK1;APP;GRK3;MAPK6;IGFBP3;USP15;STRADB;PDGFRA;CAMK2D;TLK1;CCNH;ATR;RPS6KA3;TLR3;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;RPS6KA1;CHEK2;CTBP1;MAP3K1;CCNT1;CAMK1D;TP53RK;TNKS;STK25;CDK7;OXSR1;ABI1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;LYN;PTK2B;TGFBR3;MAPKAPK2;PAK5;ACVR2A;NTRK2;SMAD7
prerank,regulation of protein modification process (GO:0031399),0.3027950854656863,0.8398771685326,0.6994413407821229,1.0,1.0,8/50,9.42%,KDM4D;WARS1;ABCA2;CDK9;FLCN;ATG14;PPIB;PUM3
prerank,peptidyl-lysine methylation (GO:0018022),0.33372641459181046,0.8397908117734827,0.7001254705144291,1.0,1.0,6/26,15.49%,ETFBKMT;SETD7;EHMT2;SUV39H1;EHMT1;ATPSCKMT
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.26877772068532135,-0.8397773601469414,0.7107843137254902,0.8943774104471638,1.0,9/23,23.37%,DAB2IP;DVL3;MAP3K10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;MAP3K5;SASH1
prerank,receptor metabolic process (GO:0043112),0.3033365923508855,0.8395224339384638,0.7281879194630873,1.0,1.0,16/53,23.41%,MVB12A;DNM1;ADM;GRK3;LRP1;TGFB1;GRK2;RAB31;SMURF1;PIK3R4;UVRAG;ITGB1;CD9;EHD3;RAB11B;SH3GLB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3004279008003305,-0.8393121397555988,0.6702127659574468,0.8939292224692581,1.0,2/15,7.95%,LRP6;ANKRD11
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.33208478600664554,0.8391983838325215,0.6943765281173594,1.0,1.0,1/29,1.78%,SIRT7
prerank,transcription by RNA polymerase II (GO:0006366),0.27101768052058056,0.8391727138061448,0.8748748748748749,1.0,1.0,85/305,22.77%,HDAC3;TEAD3;RPRD2;NFKB1;SLBP;PARP1;TAF9B;NR1D2;XBP1;RORA;TFDP1;TAF4;POU2F1;POLR2B;CDK13;CDK9;TFCP2;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;TEAD1;SNAPC4;HDAC5;MED4;NFX1;NRBF2;CPSF7;PRRX1;GTF2H3;TCEA1;TAF6;RBPJ;CSTF2T;MAZ;NUDT21;E2F3;NFIX;POLR2K;CCNH;CPSF3;HDAC1;TSC22D1;SETX;CBFB;CDC73;NRBP1;ESRRG;GTF2E1;SOX5;NR2C2;MED23;DDX5;MAF;SNW1;CCNT1;MBD1;CDK7;NABP2;TBL1XR1;NELFA;NCOR2;INTS6;KLF13;FIP1L1;CSTF3;MLLT3;INTS2;PKNOX1;ELP2;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;INTS7;SNAPC3;GTF2F2;TAF1;GTF2B;MED17;BTF3;RPAP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.29731510167756164,0.8391337665558825,0.7178051511758119,1.0,1.0,8/56,11.29%,EPHB2;FGFR2;FGFR1;DDR2;ABL1;SRMS;TEC;PDGFRA
prerank,establishment of spindle orientation (GO:0051294),0.325716554350194,0.8390312935799955,0.6947890818858561,1.0,1.0,10/28,23.05%,MAD2L1;GPSM2;HTT;NUMA1;MAP4;ZW10;PAFAH1B1;ITGB1;LLGL1;CDK5RAP2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.324551342230055,0.8388542346835298,0.7107540173053152,1.0,1.0,3/29,4.92%,IFNAR1;STAT6;IL31RA
prerank,regulation of dephosphorylation (GO:0035303),-0.30247057588827714,-0.838848422090312,0.6906474820143885,0.8935306415947091,1.0,6/15,17.46%,MTMR3;SMG5;INPP5K;MTMR9;SRC;SMG6
prerank,histone H3-K4 trimethylation (GO:0080182),0.3918101292395584,0.8385437619197268,0.6870451237263464,1.0,1.0,4/11,18.37%,OGT;SETD1A;KMT2D;KMT2A
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.370115828204427,0.8383826863173381,0.656121045392022,1.0,1.0,6/14,23.12%,ATR;ATRX;TNKS;NABP2;TERF2IP;PINX1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3857762113320272,0.8379624822408733,0.6850746268656717,1.0,1.0,2/12,10.19%,SOX9;GDNF
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37475893629045587,0.8372155254533528,0.6774193548387096,1.0,1.0,6/13,21.47%,PHF23;SCFD1;FEZ2;NUPR1;CHMP4A;CHMP4B
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3764372157322005,0.837083650417856,0.6926345609065155,1.0,1.0,5/14,21.34%,AK4;AK5;AK3;CMPK1;ME1
prerank,regulation of cardiac conduction (GO:1903779),0.30026341617664276,0.8370712589111148,0.7315436241610739,1.0,1.0,6/54,8.60%,DMPK;ATP1A3;ATP2A2;ITPR1;ATP1A2;ATP2B1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.30304454267577385,0.8365311119378687,0.7155655095184771,1.0,1.0,10/48,21.79%,PDPK1;CALM3;THY1;CAMK2D;JPH1;CEMIP;CALM1;PTK2B;DIAPH1;CALM2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2919038695163722,0.8364502235112539,0.7348484848484849,1.0,1.0,11/66,14.28%,HDAC3;CCT8;EIF2AK3;PIK3R1;CCT6A;CDK5RAP3;JUP;PIK3R2;PARK7;LAMTOR5;TGFB1
prerank,peptidyl-proline modification (GO:0018208),0.3323065820527723,0.8363536606337086,0.6850899742930592,1.0,1.0,5/25,9.58%,PPIF;NKTR;NTMT1;PPIB;PPIH
prerank,regulation of neurotransmitter transport (GO:0051588),0.36565201725045754,0.8361631616084392,0.6917989417989417,1.0,1.0,5/16,18.68%,CPLX1;MCTP2;FMR1;MCTP1;FLOT1
prerank,ventricular septum development (GO:0003281),0.3152908574750631,0.8361081483249609,0.7012835472578763,1.0,1.0,13/37,23.02%,STRA6;MDM4;SOX11;ROBO2;ROBO1;SLIT3;HECTD1;TGFBR1;SOX4;TGFBR3;SMAD7;MATR3;DAND5
prerank,inner mitochondrial membrane organization (GO:0007007),0.30519009055876384,0.8360695378232483,0.7183257918552036,1.0,1.0,9/47,13.79%,APOOL;MICOS10;ATP5PF;TIMM13;APOO;ATP5MC3;AFG3L2;TIMM29;MTX3
prerank,regulation of neuron death (GO:1901214),0.2847091489174086,0.836052080186991,0.7449947312961012,1.0,1.0,16/82,18.00%,WNT5A;FCGR2B;CDK5;CD200R1;INPP5A;EFNB2;PARK7;LANCL1;EGLN2;MAPT;CTSZ;FAIM2;DAXX;DCC;SORL1;RRAS2
prerank,carboxylic acid transport (GO:0046942),0.2964978229193648,0.8358420790827114,0.7268722466960352,1.0,1.0,9/55,16.34%,SLC17A5;CLN3;SLC6A11;SLC16A12;PSAP;SLC6A15;SLC1A5;SLC6A12;SLC6A13
prerank,nuclear membrane reassembly (GO:0031468),0.2946735252215198,0.8357813854171899,0.7369589345172031,1.0,1.0,7/54,9.86%,REEP4;SIRT2;UBXN2A;CC2D1B;KPNB1;CHMP3;NUP188
prerank,chemical synaptic transmission (GO:0007268),0.27243133021943156,0.8353950366350356,0.879,1.0,1.0,49/284,18.29%,SYT10;CACNB4;UNC13A;GRIN1;PDE7B;OPRK1;MINK1;CDK5;GRIK5;DVL1;HCRTR2;GRIN2A;SDCBP;DNAJC5;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;BRSK1;HCRTR1;RIC3;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;TBC1D24;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;APOE;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,transcription by RNA polymerase I (GO:0006360),-0.227735411741801,-0.8353024062800941,0.7615894039735099,0.8994351045164681,1.0,10/34,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,mitochondrion localization (GO:0051646),0.3499710658498939,0.8351546069412331,0.6778523489932886,1.0,1.0,6/19,18.34%,MSTO1;MFN1;MFN2;ZBED3;TRAK1;ATCAY
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.31453246180512145,-0.8349571269286241,0.703125,0.8987474500238892,1.0,4/12,11.56%,SORBS1;IRS1;SIRT1;IGF2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.34287647004499133,0.8342260462997818,0.6848792884371029,1.0,1.0,10/21,27.09%,TAOK1;CAMSAP2;KATNB1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.32883609065921304,-0.8341962246457345,0.7026143790849673,0.8987969319131933,1.0,3/11,16.00%,TGFB2;BMPR1A;BMP4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3106427034287673,0.8339651507959065,0.70260663507109,1.0,1.0,6/35,11.29%,NTF3;NRP1;CDK5;ABL1;BAIAP2;PDGFRA
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.35855756100900393,0.8336847595163304,0.6734972677595629,1.0,1.0,3/16,16.46%,PRKCA;PRMT5;MRAP2
prerank,vesicle organization (GO:0016050),0.30149176331538424,0.8333043246543914,0.7220299884659747,1.0,1.0,13/46,19.06%,DNM1;SAR1A;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;SNX11;DNAJC13;VPS18;ZFYVE16;USP50
prerank,long-term synaptic potentiation (GO:0060291),0.3440790872021095,0.8332659761326638,0.7049399198931909,1.0,1.0,5/21,20.58%,MPP2;GRIN2A;NPTN;PRKCZ;PTK2B
prerank,glutamate receptor signaling pathway (GO:0007215),0.314034256781441,0.8331345191568472,0.7173144876325088,1.0,1.0,12/37,24.55%,CLN3;GRIN1;GRIN2A;APP;GRIA2;FMR1;GNAQ;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,oxoacid metabolic process (GO:0043436),-0.2433571023434259,-0.8330683359327591,0.746268656716418,0.8997289397860878,1.0,7/27,18.32%,DDO;BPNT2;MINPP1;THAP4;TPST2;PPA1;BPNT1
prerank,SNARE complex assembly (GO:0035493),0.40056245984499905,0.8328865518091272,0.6592920353982301,1.0,1.0,3/10,20.44%,VAMP3;VAMP8;UVRAG
prerank,lipid translocation (GO:0034204),0.34770409508340705,0.8328158050651862,0.6993377483443709,1.0,1.0,5/21,10.47%,ATP9A;ATP8B2;ATP10B;ABCA7;ATP9B
prerank,primary miRNA processing (GO:0031053),0.3980111038418115,0.832778314391387,0.6854961832061068,1.0,1.0,5/10,22.11%,DGCR8;PUS10;HNRNPA2B1;SMAD2;SMAD3
prerank,regulation of cholesterol transport (GO:0032374),0.3468326057443527,0.8325203308868381,0.6997389033942559,1.0,1.0,5/20,20.04%,NFKB1;ABCA2;LRP1;TTC39B;ABCA5
prerank,post-translational protein modification (GO:0043687),0.2712170211517628,0.8324511661294091,0.9029029029029029,1.0,1.0,54/332,17.27%,COPS7A;CUL7;SPSB3;PSMD4;FBXW10;CP;ASB5;SPSB1;KCTD7;FBXL12;FSTL1;OBSL1;FBXL14;WSB2;FBXO7;COP1;LAMC1;UBXN7;FBXO31;PSMB10;DDB1;MIA3;UCHL3;CKAP4;FBXW5;PSMD11;LTBP1;COPS7B;FAM20C;APLP2;CUL4B;MBTPS1;PSME2;PSMC5;APP;IGFBP3;IGFBP7;DCAF5;FBN1;RAB13;LAMB1;NEURL2;CUL5;KLHL5;FEM1C;PSMD1;KLHL13;RAB8A;SERPIND1;NEDD8;PSMD6;MXRA8;APOE;FBXO22
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3532086152576115,0.8321121145269899,0.7088274044795784,1.0,1.0,4/19,15.76%,DCK;HPRT1;POLD3;GMPR2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.32950219577924794,0.8319188686252821,0.6914357682619647,1.0,1.0,3/25,6.29%,DNAJC7;DNAJB5;BAG1
prerank,vasodilation (GO:0042311),0.3773624091560166,0.8318910405928098,0.6957787481804949,1.0,1.0,2/13,12.24%,KCNMA1;SOD2
prerank,regulation of primary metabolic process (GO:0080090),0.28089945856205767,0.8315854554880187,0.7816326530612245,1.0,1.0,39/126,24.05%,FASN;HDAC3;PSMD4;SMARCD3;NR1D2;CHD9;PSMB10;CERS2;LSS;PSMD11;ABCA7;GPAM;SC5D;PSME2;IRS2;PSMC5;CYP51A1;PSAP;ROCK2;PSMD1;PSMD6;APOE;TBL1XR1;GPS2;NCOR2;ELOVL6;PSMD5;CARM1;GGPS1;PSMA4;PSMA1;PSMC6;ID2;NCOA1;SP1;PSMA5;RXRA;TGS1;NFYA
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.32938335295301335,0.8315177479255296,0.6983930778739185,1.0,1.0,8/26,22.23%,DDX3X;TIRAP;IFI35;TLR3;PTPN22;FLOT1;HMGB1;PJA2
prerank,stress-activated MAPK cascade (GO:0051403),0.29608658426798534,0.83150697565453,0.7357456140350878,1.0,1.0,5/61,4.55%,MAPK9;PTGER4;NFKB1;ZFP36L1;MINK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2727569701073738,0.8314767787468658,0.8266129032258065,1.0,1.0,36/166,19.78%,IGF1;GPLD1;ZEB2;HSP90AA1;RBM3;DDX3X;ZNF205;DDB1;ARNT;NOS1AP;HNRNPD;NNMT;EGF;IRS2;PTH1R;ZCCHC4;BRPF3;YTHDF3;PARK7;NPM1;PRMT1;YTHDF1;PTGS2;PRR16;FAF1;SLC27A1;FMR1;SLC25A37;PRKD2;PKD2;ASS1;METTL5;ARPP19;SOX4;KLF4;CIRBP
prerank,microtubule nucleation (GO:0007020),0.34024893166447895,0.8313604307412576,0.6749688667496887,1.0,1.0,6/20,21.40%,CENPJ;CSNK1D;TPPP;TUBGCP2;RANBP9;CLASP2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35646529156463214,0.8312459275391738,0.6845549738219895,1.0,1.0,2/18,4.02%,ANXA1;ZFP36L1
prerank,snRNA metabolic process (GO:0016073),0.35672445083712595,0.8312056738245582,0.7091412742382271,1.0,1.0,8/17,24.58%,ZCCHC8;MTREX;INTS6;INTS2;RBM7;INTS7;INTS10;INTS9
prerank,histone ubiquitination (GO:0016574),0.34049715338745423,0.8303929103833909,0.6687898089171974,1.0,1.0,6/21,18.64%,RNF8;RNF40;UBE2A;CDC73;UBE2E1;USP22
prerank,membrane depolarization (GO:0051899),0.31796220693755367,0.8302772235359227,0.7180094786729858,1.0,1.0,5/32,10.99%,CACNB4;SCN7A;ABL1;YWHAH;SCN1A
prerank,positive regulation of macrophage migration (GO:1905523),0.3469193812287494,0.8302088662697561,0.692200557103064,1.0,1.0,1/19,1.28%,IL34
prerank,regulation of AMPA receptor activity (GO:2000311),0.32561132946866456,0.8302063941855229,0.6965865992414665,1.0,1.0,7/25,19.05%,CACNG3;MINK1;NLGN3;NLGN2;CACNG4;SHISA9;SHANK1
prerank,axonal transport (GO:0098930),0.31027727293919566,0.8299348220615654,0.7197062423500612,1.0,1.0,9/36,19.92%,NEFL;KIF3A;TMEM108;AP3B1;BLOC1S2;MAPT;RAB21;AP3B2;PAFAH1B1
prerank,mRNA methylation (GO:0080009),0.3611076077861153,0.8295355447603674,0.6808803301237965,1.0,1.0,1/15,0.77%,TRMT61B
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.31209910933772267,-0.829480113879837,0.686084142394822,0.9054179566016444,1.0,2/11,1.97%,TOMM70;AGK
prerank,regulation of vasculogenesis (GO:2001212),-0.2992730798485138,-0.8293818419449995,0.6877076411960132,0.9042392455800942,1.0,6/14,28.20%,CD34;KDR;HIF1AN;CEACAM1;HEY2;RRAS
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.28266264074767566,-0.8290173653070939,0.6828358208955224,0.9035363519628921,1.0,12/17,50.29%,RB1;BUB3;MTBP;MIS12;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA;IK;CDK1
prerank,regulation of complement activation (GO:0030449),0.30657100395265635,0.8289895655982689,0.7232037691401649,1.0,1.0,2/40,5.04%,VTN;SERPING1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.27165637441491347,-0.8289658581699652,0.6748971193415638,0.9022835703644824,1.0,2/18,1.25%,ANKRD17;PUM1
prerank,regulation of focal adhesion assembly (GO:0051893),0.29146884110396537,0.8288093392640443,0.724972497249725,1.0,1.0,6/54,6.44%,SFRP1;RAC1;NRP1;ABL1;THY1;DMTN
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3053549135868807,0.8286346524241784,0.7148014440433214,1.0,1.0,10/36,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3853930346532891,0.8286042739024237,0.6965620328849028,1.0,1.0,4/11,18.54%,FBXO7;PARK7;RACK1;NONO
prerank,oligosaccharide biosynthetic process (GO:0009312),0.34280008726531375,0.8285626959453609,0.6965699208443272,1.0,1.0,3/20,14.35%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,determination of bilateral symmetry (GO:0009855),0.33493211632405956,0.8282630584357481,0.70625,1.0,1.0,2/25,6.59%,BBS7;ZIC3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3329205331950412,0.828234312006222,0.6946564885496184,1.0,1.0,6/24,18.95%,PDPK1;TNFAIP3;ICAM1;NDNF;SERPINE1;KRIT1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.32759020503802766,0.8280268486100285,0.7043478260869566,1.0,1.0,5/27,15.53%,THY1;SIRPA;NFAT5;CD47;HSPD1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2964275207826687,0.8276532011890878,0.7522222222222222,1.0,1.0,16/50,23.12%,SIRT7;OGT;TNFAIP3;ABL1;SQSTM1;FBXO5;ARRB1;PARK7;USP4;SPRY2;SOX4;RPS3;SMAD7;TAF1;U2AF2;PINX1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.38365545490809383,0.8271362000236677,0.6991404011461319,1.0,1.0,2/12,7.68%,EPHB2;MYCBP2
prerank,engulfment of apoptotic cell (GO:0043652),0.3575897068913698,0.8269462564181222,0.7148997134670487,1.0,1.0,2/15,10.18%,RAC1;XKR6
prerank,regulation of angiogenesis (GO:0045765),0.2721906309866725,0.8267556618008437,0.8311557788944723,1.0,1.0,45/192,21.29%,SFRP2;WNT5A;SFRP1;PDPK1;THBS2;WARS1;HTATIP2;XBP1;TNFAIP3;PRKCA;SULF1;DCN;GAB1;SPARC;HGS;GLUL;TWIST1;ATF2;JUP;SARS1;ADAM12;EMP2;ROCK2;SEMA3E;F3;CTSH;HSPG2;ADGRA2;ADAMTS1;SERPINE1;SPRY2;MTDH;PRKD2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;PDCD6;SERPINF1;ITGB1;ATP2B4;FOXJ2;FGF2
prerank,response to estradiol (GO:0032355),0.31769249209589856,0.8265830726871529,0.7109283196239718,1.0,1.0,2/31,3.76%,SFRP1;ANXA1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.18530985713918643,-0.8263719663125725,0.8421052631578947,0.9058771372300712,1.0,28/86,21.52%,PSMB7;BAG3;RBX1;HIF1A;PSMB2;PSMD7;ELOC;PSMA6;PSMC2;PSMD13;TP53;PSMF1;PSMC1;EP300;LIMD1;UBB;PSMD9;EGLN3;PSMD2;PSMB3;PSMC3;ATF4;VEGFA;ELOB;NFE2L2;PSMD3;HIGD1A;PSMD8
prerank,collagen fibril organization (GO:0030199),0.2813487535590577,0.8263173850812418,0.774364406779661,1.0,1.0,22/88,18.81%,COL27A1;P4HA1;COL4A6;COL4A5;PLOD1;DDR2;CD151;COL22A1;PPIB;P4HA2;COL1A2;CRTAP;ADAMTS3;PXDN;P3H2;COL5A2;LUM;COL11A1;BMP1;TGFBR1;COL5A3;COL8A2
prerank,regulation of integrin activation (GO:0033623),0.3590950212610573,0.826309968935155,0.6739427012278308,1.0,1.0,3/15,15.66%,PTGER4;JAM3;FARP2
prerank,anion transmembrane transport (GO:0098656),0.28996844999945315,0.826184943650122,0.7386117136659436,1.0,1.0,13/67,17.80%,SLC35B1;SLC25A19;LRRC8A;SLC16A12;SLC7A2;SLC13A4;SLC25A38;SLC6A8;SLC1A3;SLC25A1;SLC6A13;SLC27A1;SLC1A2
prerank,intracellular pH reduction (GO:0051452),0.31835020890426646,0.8260368899773459,0.7287299630086314,1.0,1.0,7/33,16.35%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,positive regulation of cell cycle (GO:0045787),0.28932500234302855,0.8257342635034416,0.7352941176470589,1.0,1.0,12/62,18.64%,PSRC1;FGFR2;MAPRE3;PRKCA;USP2;APP;USP19;NUPR1;MDM2;MEIS2;PKD2;USP22
prerank,endodermal cell differentiation (GO:0035987),-0.23037136898948896,-0.8253557649042527,0.7914110429447853,0.9064165213488228,1.0,10/31,16.79%,SETD2;COL4A2;COL8A1;COL6A1;FN1;PAF1;LAMA3;ITGA4;ITGB5;MMP2
prerank,T cell activation (GO:0042110),-0.19456136389714251,-0.8248681901942637,0.868421052631579,0.9059615426060885,1.0,24/69,32.34%,KIF13B;EIF2AK4;KIT;NCK1;CD44;GPR89B;GPR89A;PTPRC;LMBR1L;NHEJ1;MSN;RAB29;JAG2;DPP4;PIK3CD;RHOH;MDK;DDOST;LFNG;NCK2;NLRC3;CTPS1;CD74;PTPN2
prerank,regulation of extracellular matrix organization (GO:1903053),0.3612122740371021,0.8247634863065304,0.679945054945055,1.0,1.0,3/15,13.61%,DDR1;DDR2;LRP1
prerank,positive regulation of cell motility (GO:2000147),0.27074446820976644,0.8240552059254391,0.8621730382293763,1.0,1.0,31/205,15.68%,CARMIL2;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;CXCL12;PRKCA;SNAI1;CD151;RHOD;SDCBP;EGF;RIPOR1;SEMA3D;TWIST1;MAZ;PDGFRA;SOD2;CFAP20;RACK1;SPOCK2;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;SEMA3A;CTSH
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26714359223092776,0.8233139725495582,0.8684738955823293,1.0,1.0,56/234,22.18%,WNT5A;DVL2;STK36;CRTC1;NFKB1;NKX6-1;TFDP1;NFKB2;EDA2R;TIRAP;CARD16;DDR2;SMARCB1;DHX33;HDAC5;LRP8;TRIM62;DDIT3;CRTC3;HDAC4;TRIM41;MALT1;ATF2;APP;JUP;RTKN2;PARK7;NPM1;CEBPG;LAMTOR5;PLPP3;PRKCI;ZIC2;ADCY1;TCF3;CLOCK;IL1RAP;CAMK1D;MTDH;EPHA5;PRKD2;TAB1;TERF2IP;FLOT1;TRIM27;RPS3;PRKCZ;TAB3;FZD2;MID2;RAB7B;TRIM26;UBE2V1;TRAF2;SMAD3;TAF1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.24197542452582602,-0.8230902157856315,0.7445652173913043,0.9078725321968423,1.0,10/26,26.56%,ADIPOR1;ERLIN1;PRKAB2;NR1H3;PRKAA2;ADIPOR2;ELOVL5;NR1H2;CEACAM1;SLC45A3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.32374156847444857,0.8228536222927517,0.7021276595744681,1.0,1.0,7/26,19.62%,PRKCA;USP2;APP;MDM2;MEIS2;USP22;PPP1R10
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.29720022290524706,0.8226197614656795,0.7445589919816724,1.0,1.0,12/52,17.25%,EPHB2;PDPK1;PIK3R1;SQSTM1;CLIP3;GPSM2;PRKCI;LRP1;DPP10;SPTBN1;NUMA1;KIF5B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.31886451945009564,0.8224134094364174,0.7405140758873929,1.0,1.0,2/30,1.24%,SFRP1;SP7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.29502872024013194,0.8223495273677667,0.7452934662236987,1.0,1.0,10/58,10.65%,RNF8;PAXX;BARD1;LIG3;IFFO1;RNF168;XRCC6;UBE2V2;MDC1;DCLRE1A
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3002394961074057,0.8222934060163692,0.7406542056074766,1.0,1.0,4/43,8.36%,APLN;GNL3;TEAD1;SOX9
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.32193442058215155,-0.8221060171960266,0.7049689440993789,0.9084276713610815,1.0,3/11,9.31%,SEMA6A;THBS1;EPN2
prerank,metanephric mesenchyme development (GO:0072075),0.39115381938742805,0.8220131661131577,0.6930835734870316,1.0,1.0,3/10,18.02%,WNT4;OSR1;PKD2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.30604089816096974,0.8217200435673653,0.7219069239500567,1.0,1.0,11/39,19.22%,ERRFI1;ARHGEF7;HGS;EGF;MVP;PTPN3;CBL;PTPN12;SPRY2;STAM2;EPN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.35336325755979997,0.8216994646392523,0.7108108108108108,1.0,1.0,3/16,11.50%,CALM3;ATP1A2;CAMK2D
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3705778857524695,0.8215564324890082,0.7054698457223001,1.0,1.0,2/13,10.24%,NTHL1;UPP2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.30369589439110806,-0.8213355560857581,0.7096774193548387,0.9085708605201084,1.0,4/14,30.01%,IL17D;CD80;CD84;PAEP
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.31214861660001963,0.8212150226148811,0.7110582639714625,1.0,1.0,8/33,18.95%,PDPK1;TNFAIP3;TCF7L2;NUPR1;ICAM1;NDNF;SERPINE1;KRIT1
prerank,protein localization to cell periphery (GO:1990778),0.2729012827031943,0.8210342892636322,0.8114169215086646,1.0,1.0,38/133,21.40%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;ZDHHC2;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2
prerank,cellular response to interleukin-12 (GO:0071349),0.29557618638098504,0.8210124798562127,0.7350620067643743,1.0,1.0,11/48,18.03%,LCP1;SIRPA;AIP;PSME2;CAPZA1;SOD2;CD47;HNRNPA2B1;HNRNPDL;ANXA2;JAK1
prerank,T cell differentiation in thymus (GO:0033077),0.3678284206379117,0.8209196647696828,0.7025495750708215,1.0,1.0,1/14,4.02%,ZFP36L1
prerank,hyaluronan metabolic process (GO:0030212),0.3339853443784258,0.8206790362847728,0.7090216010165185,1.0,1.0,5/23,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.36132541205035734,0.820664762940743,0.7080394922425952,1.0,1.0,2/14,8.62%,WNT5A;GPRC5B
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3151535704317422,0.8202254627889536,0.7262638717632552,1.0,1.0,9/29,17.45%,TCF7L2;HDAC1;AXIN2;PYGO2;CDC73;PYGO1;KMT2D;TCF7L1;TCF7
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.29188226285598395,-0.8199645586871837,0.7224199288256228,0.9096955136648298,1.0,7/15,23.62%,PRKD1;TMSB4X;KDR;MET;HSPB1;VEGFA;SEMA5A
prerank,cellular response to estradiol stimulus (GO:0071392),0.3472595839622467,0.8191504565173391,0.7203065134099617,1.0,1.0,1/18,1.12%,SFRP1
prerank,positive regulation of cellular component movement (GO:0051272),0.32842415379025697,0.8190336751042337,0.7170795306388527,1.0,1.0,6/24,20.46%,STK11;TWIST1;CFAP20;SPOCK2;TGFBR1;LYN
prerank,modified amino acid transport (GO:0072337),0.3587085044742889,0.8189789977249324,0.6964539007092199,1.0,1.0,3/15,16.34%,SLC16A12;SLC6A8;SLC6A13
prerank,histone lysine demethylation (GO:0070076),0.3243235237661881,0.8188037844551941,0.7021546261089987,1.0,1.0,6/25,19.43%,KDM4D;KDM7A;KDM2B;KDM6B;KDM3B;KDM6A
prerank,nucleic acid metabolic process (GO:0090304),0.28253137957440627,0.8185707528564519,0.7537960954446855,1.0,1.0,20/69,22.24%,DNASE1L2;POLR2B;HNRNPK;HNRNPD;HNRNPM;RBFOX2;ENPP1;POLR2K;HNRNPA0;HNRNPL;MMS19;HNRNPA2B1;RAD50;PCBP2;RECQL5;HNRNPU;PTBP1;EXD2;GTF2F2;METTL14
prerank,prostaglandin biosynthetic process (GO:0001516),0.3476215474410948,0.8185155461313892,0.7210242587601078,1.0,1.0,1/18,0.44%,PRXL2B
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.19373109548579767,-0.8182378034818552,0.8414634146341463,0.9116543734918418,1.0,15/62,15.93%,TNRC6A;PUM1;NUP160;STAT3;NUP205;AGO2;LIMD1;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1
prerank,Golgi to lysosome transport (GO:0090160),0.38556825150049456,0.8177267331204899,0.7071742313323572,1.0,1.0,1/11,0.91%,CLN3
prerank,macrophage migration (GO:1905517),-0.30372852344633106,-0.8176984859095198,0.6943521594684385,0.9112637132613376,1.0,7/13,45.76%,P2RY12;CKLF;EDNRB;P2RX4;TAFA4;CCR2;CCL2
prerank,sulfur amino acid metabolic process (GO:0000096),0.32960041921914524,0.8176902658347358,0.7349246231155779,1.0,1.0,4/24,16.81%,ADO;SMS;GCLC;DPEP1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.19203096272744988,-0.816896889289204,0.94,0.9114131355929201,1.0,13/84,10.78%,IKBKB;IRAK2;RIPK1;LBP;IRAK1;HSP90B1;UNC93B1;TLR4;LGALS9;CTSL;PLCG2;UBB;IKBKG
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.332530600469392,0.8167131620216874,0.7325581395348837,1.0,1.0,9/23,20.70%,TUBA1A;HOOK3;KIF5C;TUBA1B;TUBB;KIF5B;CCDC88A;MAP6D1;MAP6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.30137105384157825,0.8160242324807598,0.7375,1.0,1.0,5/41,12.62%,CHERP;GRIN1;ITPR1;GRIN2A;HTR2C
prerank,ion transport (GO:0006811),0.2737221424890574,0.8159342395609425,0.7987486965589156,1.0,1.0,15/111,15.90%,SLC17A5;SLC24A5;LRRC8A;GRIN1;SLC20A2;TMEM63C;VDAC2;SLC39A1;SLC24A4;TRPM3;VDAC1;SLC1A3;GLRA1;SLC9A7;SLC9A6
prerank,cell junction organization (GO:0034330),0.2846820474374756,0.8157873579497841,0.7758433079434167,1.0,1.0,17/71,19.89%,PPFIA4;CTNND2;PAK3;DVL1;CAPZA1;APP;NLGN3;PRKCI;MAPT;TGFB1;NLGN2;VMP1;SEMA3E;RAB8B;ILK;PPFIBP1;MYO9A
prerank,cardiac ventricle development (GO:0003231),0.3328410693049641,0.8156125024231516,0.7179144385026738,1.0,1.0,5/20,23.02%,STRA6;MDM4;HECTD1;MATR3;DAND5
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3296794327387371,0.8153400142914453,0.700507614213198,1.0,1.0,4/22,11.33%,EIF2AK3;SMARCB1;DHX33;IPPK
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3537556434019688,0.8150543999897556,0.7062068965517241,1.0,1.0,4/15,15.93%,ATF2;MDC1;MRE11;CHEK2
prerank,steroid catabolic process (GO:0006706),0.3887644933986314,0.8150040284824219,0.696165191740413,1.0,1.0,1/10,8.88%,YWHAH
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2713991790815432,0.814554480702881,0.7913593256059009,1.0,1.0,16/101,17.09%,WNT5A;SELENOS;NFKB1;XBP1;TNFAIP3;CARD16;SIRPA;TRIM41;LY96;GIT1;PTPN22;CDC73;TGFB1;PDE4B;SERPINE1;MTDH
prerank,regulation of intracellular protein transport (GO:0033157),0.31078265193275595,0.8142026197257821,0.7448856799037304,1.0,1.0,11/32,25.34%,LCP1;SIRT7;RIPOR1;TGFB1;RUFY3;KIF20B;TPR;IFI27;UHMK1;PTPN14;PRR5L
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3066926817419389,-0.8140887340194829,0.7151898734177216,0.9152868694995879,1.0,3/12,8.36%,CNOT1;CALR;ASXL1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3830962436762182,0.8140783527839782,0.702954898911353,1.0,1.0,1/10,2.68%,IL33
prerank,cellular response to hydroxyurea (GO:0072711),-0.3257939936070745,-0.8138695599341611,0.7088235294117647,0.9143342579629467,1.0,4/10,16.92%,SPIDR;DDI2;RTF2;BLM
prerank,aggrephagy (GO:0035973),0.31088493419219754,0.8135815298567673,0.7013801756587202,1.0,1.0,5/27,12.08%,UBQLN1;ARL13B;SQSTM1;DYNC1LI1;PARK7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.36514298722320215,0.8134061000009716,0.7074626865671642,1.0,1.0,2/12,11.07%,TAF9B;BCL2
prerank,regulation of TORC1 signaling (GO:1903432),0.3104554371869588,0.8132957616389727,0.7314148681055156,1.0,1.0,6/33,12.87%,FLCN;STK11;RRAGA;GPR137C;RNF152;LAMTOR5
prerank,insulin receptor signaling pathway (GO:0008286),0.2866551443972202,0.8132630560289378,0.7685683530678149,1.0,1.0,15/69,16.91%,GPLD1;ATP6V0A2;PIK3R1;GAB1;ATP6V0E2;BAIAP2;IRS2;ATP6V1G1;PIK3R2;TCIRG1;ATP6V0A4;ATP6V1D;FOXC2;ATP6V1B2;PHIP
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.33915290089006517,0.8131920967031543,0.7061923583662714,1.0,1.0,5/19,19.39%,SLC35B2;ENPP1;ABHD14B;SULT1A1;PAPSS1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.36908599698708594,0.813129782200724,0.6974063400576369,1.0,1.0,4/12,20.48%,LRIF1;CDYL;YTHDC1;HNRNPU
prerank,clathrin coat assembly (GO:0048268),0.3611186063238795,0.8123509268495308,0.7178770949720671,1.0,1.0,2/15,9.83%,CALY;AP2S1
prerank,negative regulation of cell cycle (GO:0045786),0.28521665362413456,0.8123268794345537,0.7551462621885157,1.0,1.0,14/73,17.73%,HEXIM1;NR2F2;MAD2L1;HECA;SCRIB;TRIM35;BRINP3;TAF6;PTPN3;IPO7;TGFB1;NUPR1;BRINP1;CAMK2N1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.36379177268852103,0.8122376151998436,0.7250712250712251,1.0,1.0,7/14,24.31%,PPP2R2C;PPP5C;PPP2CB;PPP2R2B;PPM1F;PPP2R2A;PPP2R2D
prerank,heart looping (GO:0001947),-0.21974637026694344,-0.8121385940234247,0.8243243243243243,0.9161878608948084,1.0,11/40,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,organelle transport along microtubule (GO:0072384),0.3100639513991097,0.8120711456493582,0.7306763285024155,1.0,1.0,9/31,19.92%,CLN3;ARHGAP21;BICDL1;HTT;MAPT;TRAK1;KIF5B;RAB6A;PAFAH1B1
prerank,transition metal ion homeostasis (GO:0055076),0.3119414222381501,0.8116674829080313,0.7440699126092385,1.0,1.0,9/28,23.52%,CP;XIAP;ABCB7;HEPH;NEO1;COMMD1;HMOX2;B2M;FBXL5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2784953657876005,0.8114874180785782,0.790356394129979,1.0,1.0,11/87,10.46%,CDKN2D;PSMD4;ZFP36L1;USP47;FBXO5;PSMB10;WEE1;PSMD11;RBL2;PSME2;PSMC5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.37268639441874907,0.8111173103143943,0.7173252279635258,1.0,1.0,2/11,11.07%,TAF9B;BCL2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21683241130337874,-0.81091309103421,0.7888198757763976,0.9171189715113667,1.0,10/36,25.40%,LEF1;CD46;ZBTB1;DUSP10;NKAP;VSIR;NCKAP1L;RHOH;MDK;PNP
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3690619926001843,0.8106263269565971,0.6980854197349042,1.0,1.0,1/12,2.30%,PSAT1
prerank,endosome organization (GO:0007032),0.29565014760790764,0.8102700995095393,0.7467911318553092,1.0,1.0,9/41,16.00%,DNM1;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;DNAJC13;VPS18
prerank,purine ribonucleotide catabolic process (GO:0009154),0.33253250521379296,0.8101353587008244,0.7137203166226913,1.0,1.0,4/21,13.10%,MLYCD;ACAT1;NUDT3;HPRT1
prerank,muscle cell differentiation (GO:0042692),0.3157467668642342,0.8097054773010025,0.7355769230769231,1.0,1.0,3/32,5.48%,NEB;RORA;MRTFA
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3128690853483739,0.8096023787086428,0.7484737484737485,1.0,1.0,2/31,9.55%,FCGR2B;SOX11
prerank,protein kinase A signaling (GO:0010737),0.370803462571315,0.8094664064728884,0.698389458272328,1.0,1.0,1/12,0.97%,LCP1
prerank,limb morphogenesis (GO:0035108),0.33797976036105376,0.8093591845992323,0.7194805194805195,1.0,1.0,5/20,16.45%,PCSK5;NIPBL;PTCH1;CYP26B1;MEGF8
prerank,magnesium ion transport (GO:0015693),0.37865524535397277,0.8090963344028003,0.6945288753799392,1.0,1.0,4/12,14.06%,MMGT1;NIPAL3;NIPAL2;SLC41A1
prerank,positive regulation of phosphatase activity (GO:0010922),0.33830578635589764,0.8090962255084212,0.7219321148825065,1.0,1.0,2/21,3.09%,GPLD1;CALM3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.28128772465297575,0.8090218660078885,0.7898706896551724,1.0,1.0,4/73,2.67%,SFRP2;ARAF;NTF3;HSP90AA1
prerank,regulation of interleukin-8 production (GO:0032677),0.2786048835175477,0.8085533862147699,0.7863340563991323,1.0,1.0,13/69,18.02%,ANXA1;TIRAP;ARRB1;DDIT3;SSC5D;PARK7;LAMTOR5;TLR3;PTPN22;F3;SERPINE1;ANXA4;PRKD2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28328405569724296,0.8085446248165915,0.7827956989247312,1.0,1.0,16/65,19.22%,MVB12A;ERRFI1;ARHGEF7;HGS;EGF;MVP;CNOT9;PTPN3;ARAP1;CBL;RHBDF1;PTPN12;SPRY2;STAM2;CCDC88A;EPN1
prerank,cellular response to light stimulus (GO:0071482),0.2823201686852806,0.8081503889026651,0.7858719646799117,1.0,1.0,9/66,12.82%,PARP1;SDE2;USP47;CDC25A;DHX36;CASP9;YY1;NPM1;ATR
prerank,hexose transmembrane transport (GO:0008645),0.3354597845940433,0.8081455662900068,0.7321899736147758,1.0,1.0,3/21,11.44%,SLC5A3;SLC2A3;SLC50A1
prerank,positive regulation of histone methylation (GO:0031062),0.32044076416423956,0.8080075267531251,0.7217391304347827,1.0,1.0,7/24,19.34%,OGT;PHF1;JARID2;AUTS2;SNW1;KMT2A;TET1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.2983064223234674,-0.8079854442786778,0.7419354838709677,0.9211845338506026,1.0,3/13,4.50%,SORBS1;IRS1;SIRT1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2798146340188918,0.8077644619955724,0.7830396475770925,1.0,1.0,25/69,24.79%,RPRD2;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,regulation of platelet aggregation (GO:0090330),0.33821427638647883,0.8073801518079338,0.6968085106382979,1.0,1.0,3/17,6.44%,C1QTNF1;PRKCA;DMTN
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.2585423179304698,-0.8072361666341635,0.7420634920634921,0.921220087879203,1.0,15/20,41.95%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.33203704298616643,0.8067742912869366,0.7295850066934404,1.0,1.0,7/20,19.70%,FPGS;CNDP2;GCLC;PTDSS1;SLC27A1;PTDSS2;HAGH
prerank,positive regulation of actin nucleation (GO:0051127),0.37220926211340694,0.8065466106183948,0.6916299559471366,1.0,1.0,3/11,13.26%,WHAMM;CYFIP1;WASF1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2971369468335262,0.8058575555772509,0.7523474178403756,1.0,1.0,6/42,13.73%,CDKN2D;USP10;VCP;POLH;POLN;POLD3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2883129631463953,0.8054808782599635,0.7713310580204779,1.0,1.0,8/48,12.17%,WBP2;SF3B1;ASF1A;TBP;SMARCD1;ARID1B;ZMIZ1;POLR2K
prerank,oogenesis (GO:0048477),-0.2840296706718473,-0.805263928967942,0.753731343283582,0.9234865713400172,1.0,1/15,0.24%,MARF1
prerank,calcium ion transmembrane transport (GO:0070588),0.2776113696660674,0.8051845858369809,0.8067226890756303,1.0,1.0,11/86,10.62%,NALCN;SLC24A5;ATP2C1;GRIN1;ATP2A2;PMPCA;GRIN2A;ATP2B1;SLC24A4;TRPM3;AFG3L2
prerank,striated muscle cell differentiation (GO:0051146),0.34564278400691223,0.8051271139860259,0.7295850066934404,1.0,1.0,5/16,16.74%,SIK1;MYEF2;AKAP13;NRG1;KDM6B
prerank,meiosis I (GO:0007127),0.3269722122205591,0.8050175978548716,0.7257217847769029,1.0,1.0,4/23,21.15%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,neutrophil degranulation (GO:0043312),0.26038342591755076,0.805003443106781,0.947,1.0,1.0,65/425,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.36603437740384154,0.8049445209246009,0.7270194986072424,1.0,1.0,5/13,23.45%,EEF1E1;ATR;DDX5;PLA2R1;ATM
prerank,translation (GO:0006412),0.2638008362581258,0.8047125308400663,0.8904522613065327,1.0,1.0,41/208,17.26%,MRPL36;FARSB;YARS1;AIMP2;NDUFA7;WARS1;RPL22L1;YARS2;GATB;DRG2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;PABPC4;DRG1;MRPL47;MRPL10;RPL35A;RPS25;SARS1;RPS15;NARS1;RPL9;HARS1;GTPBP2;MRPL3;GSPT1;EEF1B2;RPL4;MRPL13;MRRF;RWDD1;MRPL24;RPL23A;RPLP2;TNIP1
prerank,smoothened signaling pathway (GO:0007224),0.31232814180866686,0.8045392706838719,0.7524390243902439,1.0,1.0,4/32,10.88%,STK36;ARL13B;PTCH1;CC2D2A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.20039522864152803,-0.8044200837994593,0.9340659340659341,0.9236865400201598,1.0,19/55,21.52%,PSMB7;CUL1;RBX1;SKP1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;PSMD2;PSMB3;ATF5;PSMC3;AVEN;PSMD3;PSMD8
prerank,intracellular sterol transport (GO:0032366),-0.2932696456200039,-0.804267891117846,0.7380952380952381,0.922629174511581,1.0,6/13,22.90%,OSBPL2;SERAC1;OSBP;ARV1;VPS4A;STARD4
prerank,regulation of MAPK cascade (GO:0043408),0.26664063301721785,0.8041265807188698,0.851063829787234,1.0,1.0,39/157,22.00%,ATP6AP2;IGF1;EPHA7;FGFR2;FGFR1;TAOK1;MINK1;FGF10;TMEM106A;PAK3;EPHA8;DHX33;CD24;GPR37;EGF;ABCA7;PIK3R2;IQGAP1;DAG1;ROR2;LPAR1;RNF41;ROCK2;MAP2K2;RIT2;ZDHHC17;KSR1;NRK;PELI2;WWC1;PRDM15;LYN;TGFBR3;PAK5;NTRK2;MAP4K4;FGF2;RYK;HMGB1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2412765942207875,-0.8041164521720372,0.734375,0.9215398438684863,1.0,13/24,30.70%,LATS1;TMF1;UCHL5;PRKACA;UBB;PINK1;CTSC;NUB1;GPX1;PSME3;PKD1;PSME1;EFNA1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3530208441563204,0.8037940144118797,0.7271468144044322,1.0,1.0,3/15,13.76%,SFRP1;ZNRF3;CSNK1D
prerank,myoblast fusion (GO:0007520),0.3686321337934067,0.8036658318265902,0.7118155619596542,1.0,1.0,5/12,21.60%,ADAMTS5;ADAM12;ADGRB3;KCNH1;CD9
prerank,macrophage activation (GO:0042116),0.3058063301224099,0.8034934099374723,0.7310087173100872,1.0,1.0,6/34,13.93%,TMEM106A;IFI35;CRTC3;APP;IFNGR1;MAPT
prerank,synaptic vesicle localization (GO:0097479),0.3626348715494127,0.8032335238021756,0.710267229254571,1.0,1.0,4/13,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,negative regulation of lipid catabolic process (GO:0050995),0.343332232970498,0.803179800041617,0.7403846153846154,1.0,1.0,1/17,1.59%,GPLD1
prerank,neutrophil activation involved in immune response (GO:0002283),0.2596557459526283,0.8031216799456857,0.949,1.0,1.0,65/428,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3484560743128946,0.8031171960182498,0.7187060478199718,1.0,1.0,2/15,7.04%,DDX3X;DHX33
prerank,regulation of G0 to G1 transition (GO:0070316),0.2933830379328048,0.803021212308202,0.7440191387559809,1.0,1.0,10/38,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.32063847471725787,0.8028580407053599,0.7487623762376238,1.0,1.0,8/26,20.27%,SFRP1;PER1;CNOT9;HDAC1;VPS18;CLOCK;NCOR2;DAB2
prerank,regulation of calcium ion transport (GO:0051924),0.2857399618636626,0.8026983036347998,0.7607497243660419,1.0,1.0,7/54,12.18%,CAMK2B;PACSIN3;ATP2B1;CRACR2A;EGF;BCL2;CAMK2G
prerank,regulation of embryonic development (GO:0045995),0.30716601923923614,0.8026509608778242,0.7440476190476191,1.0,1.0,11/34,21.40%,NIPBL;DHX36;DAG1;B4GALT5;EHMT1;ZBED3;NR2C2;PHLDB1;TRIP12;CFL1;CLASP2
prerank,establishment of vesicle localization (GO:0051650),-0.26313798732509636,-0.8023372744941039,0.7644787644787645,0.9232671044614594,1.0,5/18,11.67%,CCDC186;SPG11;RAB27A;IKBKG;LIMK2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.33079392277276404,0.8022261292673012,0.7438867438867439,1.0,1.0,7/21,21.65%,GPD1L;DMTN;CNKSR3;RACK1;RASSF2;SMAD7;PPM1F
prerank,cellular response to virus (GO:0098586),0.30898688963641163,0.8019910179219435,0.7481927710843373,1.0,1.0,3/30,4.15%,BAX;HSP90AA1;DDX3X
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.37419771016114123,0.8019387045262992,0.7279005524861878,1.0,1.0,2/12,10.40%,IGF1;IRS2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.33351821747956123,0.8015366487387025,0.7486979166666666,1.0,1.0,8/22,21.64%,TNFAIP3;TIRAP;IFI35;PTPN22;FLOT1;LYN;APPL2;RAB7B
prerank,protein localization to condensed chromosome (GO:1903083),-0.3067020484832046,-0.801385267936086,0.7252396166134185,0.9236395139558449,1.0,9/12,50.29%,BUB3;MTBP;MIS12;ZWILCH;KNL1;TTK;SPDL1;IK;CDK1
prerank,negative regulation of cell differentiation (GO:0045596),0.26103622439705626,0.8013029949119567,0.8696969696969697,1.0,1.0,44/181,22.45%,SFRP2;WNT5A;SFRP1;SIRT2;ADAMTS7;PTHLH;RORA;RANBP3L;ADGRV1;SOX9;SRA1;PTCH1;TWIST1;HOXB8;BMP5;ENPP1;SUFU;CDC73;RUNX1T1;TGFB1;SMAD6;COL5A2;VASN;TRIO;JAG1;SPRY2;OSR1;MEIS2;IQCB1;GPS2;TGFBR1;YTHDF2;ABCA5;HNRNPU;PTK2B;ITGAV;SMAD7;PTBP1;ABCG1;FOXO1;SMAD3;METTL14;ID2;TMEM64
prerank,mitochondrial RNA metabolic process (GO:0000959),0.36280080530164793,0.8013024318383573,0.7252906976744186,1.0,1.0,4/14,17.60%,SLC25A33;EARS2;TFB1M;FASTKD1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3618971538803561,0.8012242779080739,0.7173295454545454,1.0,1.0,1/14,1.58%,BAX
prerank,positive regulation of T cell activation (GO:0050870),0.2804888353910571,0.8011622440170332,0.759075907590759,1.0,1.0,7/62,12.26%,ANXA1;XBP1;THY1;SIRPA;DOCK8;ZMIZ1;CD47
prerank,basement membrane organization (GO:0071711),0.36458417232235896,0.8008231661722349,0.7372159090909091,1.0,1.0,4/14,14.59%,FLRT2;NTNG2;LAMB1;PXDN
prerank,neural tube closure (GO:0001843),0.30423110102731643,0.8006005045456752,0.751458576429405,1.0,1.0,5/34,10.68%,DVL2;TSC2;SCRIB;DVL1;KDM2B
prerank,muscle cell migration (GO:0014812),0.38652584385893074,0.8005325494558665,0.7229832572298326,1.0,1.0,3/10,16.76%,DDR1;PLAT;ITGB1BP1
prerank,cytoskeleton organization (GO:0007010),0.26457990254584496,0.80031490722941,0.8116545265348595,1.0,1.0,30/114,21.44%,BIN1;RAC1;ANK1;OBSL1;TNFAIP3;MAST3;THY1;DMTN;PDZD8;RHOD;NCKIPSD;LRCH3;PACSIN3;DES;RHOBTB3;TPM1;PRKCI;PRPF40A;EPB41L3;PHIP;APOE;KLHL20;CDC42BPB;FGD4;RANBP9;RHOBTB1;PAK5;RHOU;CFL1;DIAPH1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3751311449963373,0.800122300185563,0.7238805970149254,1.0,1.0,1/11,1.32%,DDT
prerank,mesonephros development (GO:0001823),0.3681257273967147,0.800098064745119,0.7174556213017751,1.0,1.0,2/11,17.13%,FGF10;OSR1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3756200254395551,0.7996379682766998,0.7507645259938838,1.0,1.0,3/11,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,translational elongation (GO:0006414),0.2699529050730743,0.7990373996420792,0.8211716341212744,1.0,1.0,28/101,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;NEMF;RACK1;GTPBP2;MRPL3;EEF1B2;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;EEF2K;GFM2;MRPS35;MRPS28;GFM1
prerank,positive regulation of dephosphorylation (GO:0035306),0.309119335418752,0.7989300062067434,0.7396593673965937,1.0,1.0,9/27,21.79%,CALM3;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.32787694615670065,0.7988279288508593,0.7388451443569554,1.0,1.0,9/24,20.27%,DMTN;TMBIM1;PID1;TGFB1;MRAP2;ITGB1BP1;PPP2R5A;LZTFL1;DAB2
prerank,regulation of protein export from nucleus (GO:0046825),0.32571649836674055,0.7986134721804292,0.7428940568475452,1.0,1.0,4/23,12.08%,SIRT7;TCF7L2;BARD1;PARK7
prerank,response to ionizing radiation (GO:0010212),0.27418869194688106,0.7977637507518034,0.7908992416034669,1.0,1.0,20/70,22.18%,KDM4D;RNF8;ANXA1;COP1;STK11;RNF168;MRNIP;BRSK1;AEN;CLOCK;TANK;NABP2;PRKAA1;SMPD1;UIMC1;INO80;EYA1;INTS7;CLK2;MTA1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.26490548233228867,0.7976618721764382,0.8430173292558614,1.0,1.0,31/132,18.52%,TARBP2;COIL;SMN1;HSP90AA1;GEMIN2;SRSF5;SF3B1;CELF2;CELF1;SRSF9;PRPF6;SRSF1;PRMT5;CPSF7;SART3;RPS15;NUDT21;SETX;LUC7L2;CDC73;KHDC4;SHQ1;CELF5;YTHDC1;RPL23A;DHX29;LUC7L3;CPSF6;BRIX1;GCFC2;SRPK1
prerank,cortical cytoskeleton organization (GO:0030865),0.29095107052027813,0.7976507086780372,0.754079254079254,1.0,1.0,7/41,14.73%,LCP1;RAC1;RHOD;RHOBTB3;RAB13;ROCK2;EPB41L3
prerank,translesion synthesis (GO:0019985),-0.21411444089549256,-0.7975094061591276,0.8666666666666667,0.9289051364469287,1.0,29/42,42.90%,REV3L;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;PRIMPOL;RFC2;SPRTN;PCNA;POLE2;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;RCHY1;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,sphingoid metabolic process (GO:0046519),-0.294371007995653,-0.7970047144367048,0.7120743034055728,0.9283820796973419,1.0,3/12,16.39%,KDSR;NAAA;DEGS2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.32049888149113226,0.7967205103299979,0.7321428571428571,1.0,1.0,6/24,16.45%,NRP1;DSCAM;SEMA3D;SEMA3E;SEMA3A;MEGF8
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.2992120532316629,0.796674656551275,0.7355072463768116,1.0,1.0,8/35,16.67%,RAC1;PLXNA2;NRP1;SEMA3D;SEMA3E;SEMA3A;FARP2;PLXNB3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2566061545895535,0.7964434500164045,0.9529529529529529,1.0,1.0,90/366,20.76%,DVL2;RBM4B;RBM3;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;METAP1;CNBP;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;CYFIP1;EHMT2;DDIT3;HNRNPD;PRMT5;PUM3;SOX11;SAP30L;FADS1;ATF2;POU6F2;APP;NSD3;FOXN3;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;NUCKS1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;CCDC88A;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;USP37;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;GEMIN5;YBX1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.33818982948357634,0.7963789514710823,0.7337748344370861,1.0,1.0,1/18,1.12%,SFRP1
prerank,endothelial cell differentiation (GO:0045446),0.3700356293016942,0.795990283593054,0.7115097159940209,1.0,1.0,4/12,18.62%,FSTL1;JAG1;KDM6B;SCUBE1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.29223333337831753,0.7956120342290438,0.7663107947805456,1.0,1.0,16/41,24.13%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;LACC1;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98
prerank,cation transmembrane transport (GO:0098655),0.29388624751645337,0.7955508116109233,0.7616875712656784,1.0,1.0,5/44,10.16%,SLC25A19;SLC7A2;ATP1A2;TRPM3;SLC25A38
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.276936668933973,0.7954894853420432,0.7967567567567567,1.0,1.0,17/67,21.65%,SFRP1;RAC1;NRP1;ABL1;ARHGEF7;DMTN;JUP;FBLN2;ECM2;EMP2;NDNF;CCL25;ILK;CARMIL1;PTK2B;DOCK5;PPM1F
prerank,gluconeogenesis (GO:0006094),-0.20913482239592673,-0.7953247078893473,0.7841726618705036,0.9298502224154636,1.0,16/39,26.79%,SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH;ALDOC
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2922695175682734,-0.7943864856847185,0.74822695035461,0.9300606935502566,1.0,6/13,21.79%,NCK1;DDRGK1;PPP1R15B;UFL1;HSPA5;DNAJB9
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.29249776590636145,0.7943553250567603,0.7639680729760547,1.0,1.0,14/43,22.35%,ERRFI1;ARHGEF7;SNX6;HGS;EGF;MVP;PTPN3;CBL;SPRY2;STAM2;EPN1;CBLB;RAB7A;ITGA1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2247252065957447,-0.7940009126034571,0.8524590163934426,0.9293425358450238,1.0,9/30,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,regulation of cholesterol efflux (GO:0010874),0.30741428358183037,0.7934893568813397,0.7681874229346486,1.0,1.0,9/30,20.04%,ABCA2;PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;TTC39B;ABCA5
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3756533361613584,0.792947992763659,0.7406296851574213,1.0,1.0,3/10,16.66%,CHFR;DIS3L2;NEDD8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3601999500162226,0.7922047317332265,0.7457627118644068,1.0,1.0,2/13,9.55%,DDIT3;SOX11
prerank,neutrophil mediated immunity (GO:0002446),0.2558131837517696,0.7917260508580215,0.959,1.0,1.0,65/432,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,negative regulation of T cell activation (GO:0050868),0.3019983882586522,0.7915947117944014,0.7581227436823105,1.0,1.0,3/35,13.55%,FCGR2B;RIPOR2;PTPN22
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.32011178296385556,0.7915813917804582,0.7365038560411311,1.0,1.0,7/22,25.60%,FBXO38;MALT1;HSPD1;TRAF2;B2M;TRAF6;STX7
prerank,carboxylic acid metabolic process (GO:0019752),-0.22365963889222423,-0.7914638705091775,0.8136645962732919,0.9323331264416294,1.0,3/33,2.77%,CSGALNACT1;DDO;SLC2A1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3575916515843518,0.7912756022814125,0.7576642335766424,1.0,1.0,3/13,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.24621041569330832,-0.7912053027391357,0.7522935779816514,0.9314170447965353,1.0,7/23,18.61%,ATAD1;SLC24A2;LRRK2;SHANK2;PLK2;GRIK3;PRRT1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.26486215232117083,-0.7909708393845746,0.7808764940239044,0.930491051232557,1.0,8/18,18.89%,ITGA3;RASIP1;KANK1;KCTD13;ABL2;KCTD10;MET;CCDC125
prerank,protein K48-linked deubiquitination (GO:0071108),0.31924943317376614,0.7908961228283911,0.7288359788359788,1.0,1.0,8/23,19.59%,TNFAIP3;OTUD7A;USP34;USP33;USP50;YOD1;VCPIP1;USP37
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3459940557427374,0.7908643590859901,0.7349570200573066,1.0,1.0,3/16,13.25%,CLN3;SHFL;GSPT1
prerank,pulmonary valve morphogenesis (GO:0003184),0.3426906840195081,0.7908213347744494,0.7459239130434783,1.0,1.0,5/17,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,response to light stimulus (GO:0009416),0.28116170117219286,0.7897428892144803,0.8037486218302095,1.0,1.0,3/55,4.61%,CDKN2D;USF1;USP1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2723363591903888,0.7897409968693868,0.8302900107411385,1.0,1.0,19/79,21.29%,APLN;CASK;SMAD9;SULF1;HTRA3;HGS;GPC1;LEMD3;SMAD6;UBE2D1;SPRY2;SMURF1;SORL1;PDCD6;NBL1;ACVR2A;SMAD7;ATP2B4;FGF2
prerank,negative regulation of locomotion (GO:0040013),0.36010808599242605,0.7897342037841192,0.7371349095966621,1.0,1.0,1/12,4.45%,FBLN1
prerank,microtubule anchoring (GO:0034453),-0.297409219229948,-0.7896949830395105,0.7492063492063492,0.9312262887185955,1.0,3/12,12.21%,BICD1;PCM1;GCC2
prerank,apoptotic cell clearance (GO:0043277),0.3081475044502069,0.7896308980478054,0.7748756218905473,1.0,1.0,8/30,22.00%,RAC1;ANXA1;XKR6;LRP1;TXNDC5;RHOBTB1;ITGAV;HMGB1
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.22809264504324783,-0.7895354086400551,0.8518518518518519,0.928782085773128,1.0,20/31,34.95%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine RNA capping (GO:0009452),-0.22809264504324783,-0.7895354086400551,0.8518518518518519,0.928782085773128,1.0,20/31,34.95%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.24011891052172613,-0.7894576997258074,0.7971014492753623,0.9275965210867163,1.0,12/26,32.34%,TLR4;RARA;CDK6;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;C1QC;ZFPM1;GPR137;PTPN2
prerank,regulation of mitochondrial fusion (GO:0010635),0.36871423499968564,0.7890126457861868,0.744927536231884,1.0,1.0,3/11,17.62%,PID1;VAT1;OMA1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.30542200279651094,0.788536725610588,0.7503045066991474,1.0,1.0,13/29,23.51%,TRAPPC10;NAPG;COPZ2;VTI1B;COG3;VTI1A;COG8;NSF;RAB6A;NAPA;COPG1;GOSR1;COPA
prerank,respiratory chain complex IV assembly (GO:0008535),0.32742212973534823,0.7883259539038572,0.7253613666228647,1.0,1.0,5/21,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3194231356578907,0.7882725696624386,0.7537688442211056,1.0,1.0,4/23,14.28%,IGF1;EFNB2;NRG1;TGFB1
prerank,proteoglycan biosynthetic process (GO:0030166),0.30200501989828343,0.7881847832303309,0.7629987908101572,1.0,1.0,3/31,6.08%,IGF1;EXTL3;CHST10
prerank,ncRNA processing (GO:0034470),0.2573344327836703,0.7879045118010405,0.8962739174219537,1.0,1.0,31/200,14.23%,EXOSC1;EXOSC3;TARBP2;DGCR8;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;ZCCHC8;PUS10;EXOSC8;MPHOSPH10;AARS1;LIN28B;RCL1;ESF1;RPL35A;RPS25;MTREX;SARS1;RPS15;RPL9;AGO3;RPP30;C1D;RPL4;BMS1;HNRNPA2B1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.28735569193836125,0.787847829712854,0.7704918032786885,1.0,1.0,18/41,25.80%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;SCARB2;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,oligodendrocyte development (GO:0014003),0.34446143098713505,0.7872026593131844,0.7510259917920656,1.0,1.0,3/15,16.69%,MYRF;B4GALT5;TPPP
prerank,glycine transport (GO:0015816),-0.3202448413985418,-0.7867179531273912,0.7319277108433735,0.9309681998677187,1.0,5/10,27.84%,SLC6A9;SLC38A5;SLC6A17;SLC36A1;SLC6A5
prerank,positive regulation of interleukin-17 production (GO:0032740),0.32013839481598083,0.786689827083724,0.7458279845956355,1.0,1.0,2/22,14.28%,ZBTB7B;TGFB1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2650231671786447,-0.7865620257246937,0.7276264591439688,0.9298857174652468,1.0,11/18,30.31%,DAB2IP;MORC3;TP53;PARP10;MED25;NF1;EMD;B4GALT7;CD300A;NLRC3;TRIM32
prerank,negative regulation of RNA splicing (GO:0033119),0.33310811824578734,0.7865411946917977,0.7466666666666667,1.0,1.0,3/19,7.02%,PCBP4;SRSF12;SRSF9
prerank,aromatic amino acid family metabolic process (GO:0009072),0.37126761377497314,0.7864978436988025,0.7373134328358208,1.0,1.0,2/10,15.38%,ASRGL1;QDPR
prerank,regulation of peptidase activity (GO:0052547),0.33285884822284106,0.7863996849098406,0.7375504710632571,1.0,1.0,4/19,15.68%,NRDC;RCN3;HDAC1;CTSH
prerank,positive regulation of bone resorption (GO:0045780),-0.30714646658267675,-0.7857902311688335,0.7575757575757576,0.9298236956645751,1.0,4/11,15.91%,PLEKHM1;ATP6AP1;SPP1;TNFRSF11A
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.24949271312387145,-0.7854623787403272,0.8027522935779816,0.9290442044796596,1.0,12/22,37.73%,PSMB7;PSMB2;PSMA6;PSMB3;NFE2L2;PSMB4;PSMB6;PSMB5;PSME4;PSMB8;PSMB9;PSMA8
prerank,positive regulation of interferon-alpha production (GO:0032727),0.325404927222823,0.7853269113195867,0.7374517374517374,1.0,1.0,5/19,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,negative regulation of transferase activity (GO:0051348),0.2993620349256536,0.7851156620698883,0.7478474784747847,1.0,1.0,9/28,20.88%,ABL1;FBXO5;IRS2;PARK7;MAPT;TERF1;HNRNPU;NPRL2;SMAD7
prerank,sphingosine biosynthetic process (GO:0046512),0.3672888410769317,0.7850909159828724,0.7459379615952733,1.0,1.0,1/11,4.31%,ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),0.3672888410769317,0.7850909159828724,0.7459379615952733,1.0,1.0,1/11,4.31%,ABCA2
prerank,negative regulation of catalytic activity (GO:0043086),0.31734373204218047,0.7850842906008665,0.7451984635083226,1.0,1.0,2/24,6.95%,CLN3;TMBIM1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.2713114072578428,0.7843935609640666,0.8075675675675675,1.0,1.0,11/67,11.02%,HSP90AA1;RAC1;SH2D2A;NRP1;SULF1;PIK3R1;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3235717614443703,0.784293913044266,0.7542262678803641,1.0,1.0,2/21,6.49%,DVL2;DVL1
prerank,BMP signaling pathway (GO:0030509),0.2765268918447608,0.7839591035135559,0.8026172300981461,1.0,1.0,18/62,22.11%,BMP6;SMAD9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,mitotic cell cycle phase transition (GO:0044772),0.25555617409638715,0.7838166663232065,0.91356783919598,1.0,1.0,42/204,21.47%,CCP110;CDKN2D;CENPJ;CDC23;FOXM1;LCMT1;HSP90AA1;UBE2S;FBXL12;CDC16;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;CUL4B;YWHAG;BRSK1;E2F3;CCNH;RCC1;GSPT1;CUL5;HAUS3;CSNK1D;TUBB;ACVR1B;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;USP37;DYNLL1;PAFAH1B1;CDK14;PHLDA1;TAF2;CLASP2;CHMP4B
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.35433373340158875,0.7837375271000442,0.7388167388167388,1.0,1.0,3/13,12.69%,GPR37;PARK7;RACK1
prerank,protein localization to microtubule organizing center (GO:1905508),0.346521004700601,0.7835305060116352,0.7645429362880887,1.0,1.0,4/15,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,calcium ion transport (GO:0006816),0.2644478205683531,0.7835077057164656,0.852880658436214,1.0,1.0,10/113,8.98%,NALCN;SLC24A5;ORAI2;ATP2C1;CACNG3;ATP2A2;ITPR1;SLC24A4;TRPM3;CRACR2A
prerank,brain morphogenesis (GO:0048854),-0.30042775639997793,-0.7831396809246963,0.75,0.9317569753849406,1.0,6/12,30.53%,SHANK3;BBS2;BBS4;SPEF2;VPS51;MKKS
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2573667121204408,-0.7831170629064518,0.7961538461538461,0.9304472232976622,1.0,6/18,16.70%,RDX;EZR;VPS11;PTPN23;SRC;MSN
prerank,protein sumoylation (GO:0016925),0.27951568978299574,0.7830492109912659,0.7886363636363637,1.0,1.0,19/49,24.13%,SAE1;RAE1;NUP188;NUP210;NUP88;PIAS3;NUP214;TOPORS;NUP153;RANBP2;NUP35;PIAS1;SUMO2;EYA1;TPR;NUP155;UBA2;NUP54;NUP98
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.34642294452808015,0.7830142569395685,0.7283072546230441,1.0,1.0,4/14,21.35%,TIRAP;HNRNPA0;MAPKAPK2;ANGEL2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.34781153146923505,0.7828180215834072,0.7617728531855956,1.0,1.0,4/14,16.76%,CD63;DMTN;EMP2;ITGB1BP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3163358163656687,0.7827388536007828,0.7587548638132295,1.0,1.0,8/23,23.05%,MAD2L1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CDK5RAP2
prerank,stem cell differentiation (GO:0048863),0.29561357507368813,0.7827219659381169,0.7784290738569754,1.0,1.0,5/39,10.02%,SFRP1;SP7;FGFR2;PSMD11;JARID2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.2896787314068866,-0.7825511589656909,0.7447552447552448,0.9300398414320789,1.0,7/13,26.59%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;PPARA;NOS1
prerank,protein targeting to membrane (GO:0006612),0.2666871997600728,0.7824826462877359,0.8209745762711864,1.0,1.0,25/83,22.95%,SRP19;FIS1;ZDHHC3;SDCBP;PXMP4;PEX5;PXMP2;GDAP1;PRKCI;PEX13;ATG3;ABCD2;RAB8B;ALDH3A2;SEC62;ZDHHC2;SEC63;RTP4;CHMP4A;CHMP4B;PEX2;SIL1;PIKFYVE;ZDHHC14;ZDHHC21
prerank,negative regulation of endocytosis (GO:0045806),0.31909612586571257,0.7818194774506066,0.7654639175257731,1.0,1.0,5/24,13.39%,RAC1;PACSIN3;ABCA7;SNX33;SCAMP5
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.31626221651564607,0.7816397874085236,0.77735368956743,1.0,1.0,5/26,14.97%,ERRFI1;SNX6;EGF;APP;CBL
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3344286915611851,0.7814857115007408,0.7584345479082322,1.0,1.0,1/17,2.97%,GPD1L
prerank,renal system development (GO:0072001),0.28298185237747325,0.7814539850492139,0.8046875,1.0,1.0,9/52,18.56%,STRA6;GREB1L;PCSK5;SULF1;WNT4;PYGO2;PYGO1;AGTR1;TGFBR1
prerank,response to unfolded protein (GO:0006986),0.28072040885056415,0.7813854909889708,0.7840909090909091,1.0,1.0,10/48,18.07%,BAX;HSP90AA1;DNAJB5;DDIT3;TOR1B;HSPH1;HSPD1;DERL1;DAXX;PACRG
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.26731528524513687,0.7810372119349618,0.824468085106383,1.0,1.0,20/86,21.52%,BMP6;ZEB2;FLCN;SULF1;STK11;TGFB1I1;SDCBP;SOX11;RBPJ;BMP5;TGFB1;ACVR1B;NUMA1;SNW1;RNF111;TGFBR1;FOXD1;DAB2;ACVR2A;SMAD2
prerank,"phagocytosis, engulfment (GO:0006911)",0.29063201049980314,0.781013706022488,0.7804014167650531,1.0,1.0,2/36,2.78%,FCGR2B;RAC1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.27347071297451747,0.7810041659184948,0.8117647058823529,1.0,1.0,22/75,21.15%,THBS2;SULF1;DCN;SPARC;HGS;WNT4;ATF2;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,RNA modification (GO:0009451),0.2780938060457117,0.7808656853065851,0.7838745800671892,1.0,1.0,12/54,19.95%,DTWD1;ANKRD16;TRDMT1;AARS1;PUS7;TRMT1;TFB1M;QTRT2;URM1;ALKBH1;NSUN4;WDR4
prerank,regulation of chromatin organization (GO:1902275),0.34352154661922624,0.7808466747733424,0.7309859154929578,1.0,1.0,6/14,20.48%,CDK9;SETD1A;TLK1;SETD5;MLLT3;HNRNPU
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.25628302193328806,0.7808097957276436,0.8727272727272727,1.0,1.0,42/158,23.39%,SLC35B2;MAP3K14;ATP2C1;EDAR;EDA2R;TIRAP;CARD16;TMEM106A;BRD4;CC2D1A;TIFA;TRIM62;GPRC5B;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1;TRAF3IP2;TAB3;MID2;UBE2V1;TRAF2;TRIM8;TNFRSF19;REL;FKBP1A
prerank,DNA damage checkpoint signaling (GO:0000077),-0.22974668108336782,-0.7807644350912937,0.8762376237623762,0.931721766423177,1.0,14/28,31.86%,CEP63;USP28;DOT1L;NBN;HINFP;STK33;ATRIP;ERCC6;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3401180312592834,0.7807598991346985,0.7442799461641992,1.0,1.0,1/16,2.42%,ADM
prerank,regulation of cytoskeleton organization (GO:0051493),0.2618560354964682,0.780009570652213,0.8446502057613169,1.0,1.0,29/108,21.89%,CLN3;RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;KATNBL1;CAPN2;RHOBTB3;IQGAP1;LRP1;MAPT;ROCK2;PHLDB1;TPPP;EPHA5;PFDN2;CCDC88A;CDK10;PRKAA1;MAP6D1;DLC1;RHOBTB1;NEXN;MAP6;DIAPH1;ARHGAP35
prerank,cholesterol transport (GO:0030301),0.28318657771713723,0.7798534860798082,0.7894736842105263,1.0,1.0,11/45,22.04%,STARD5;RELCH;SOAT1;ABCA7;STARD3;APOE;ABCA5;LIMA1;NPC2;ABCG1;NPC1
prerank,regulation of microtubule-based process (GO:0032886),-0.2092285735962812,-0.7796722291579,0.8657718120805369,0.9321681557714666,1.0,13/36,24.89%,MARK2;BICD1;MARK4;CYLD;TRIM36;ROCK1;PRKAA2;KLHL42;ATF5;TRAF3IP1;ERBB2;FAM107A;HDAC6
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.30201668579677377,0.7793712147772371,0.7750906892382105,1.0,1.0,3/32,7.08%,CCT8;PKIB;CCT6A
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3301492843170212,0.7792803821971767,0.7576158940397351,1.0,1.0,4/18,15.42%,ANXA1;FGFBP1;PTGS2;FOXC2
prerank,positive regulation of chromatin organization (GO:1905269),0.3528148809987799,0.7788985120812671,0.7311669128508124,1.0,1.0,6/12,21.66%,ATRX;TERF1;DAXX;TERF2IP;MIER1;H3-3A
prerank,peptide metabolic process (GO:0006518),0.27042598426755343,0.7785166083048537,0.8247096092925026,1.0,1.0,10/75,11.82%,CPXM1;MGAT3;GSTT1;PCSK5;ANPEP;THOP1;DNPEP;HM13;CPXM2;CARNMT1
prerank,regulation of T cell cytokine production (GO:0002724),0.3376059775638634,0.778404189609983,0.7486263736263736,1.0,1.0,5/15,24.48%,MALT1;SMAD7;TRAF2;B2M;TRAF6
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.35282157166743544,0.7780543143581566,0.7396449704142012,1.0,1.0,5/13,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3276665467075368,0.7772971901750373,0.7659574468085106,1.0,1.0,1/17,0.79%,UBQLN1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3058602314889619,0.7772096398591968,0.7671232876712328,1.0,1.0,8/26,20.58%,GRIN1;TMEM108;APP;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,negative regulation of DNA replication (GO:0008156),-0.28377705017781396,-0.7771126459802223,0.8125,0.9349896365696986,1.0,2/13,10.10%,WAPL;PDS5A
prerank,UV protection (GO:0009650),0.3689205479319203,0.7769839558774053,0.7349768875192604,1.0,1.0,1/10,2.32%,MFAP4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3326320102072212,0.7767905974570872,0.7463863337713534,1.0,1.0,3/20,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,mammary gland epithelium development (GO:0061180),0.3439728931770768,0.7767328233550491,0.7526881720430108,1.0,1.0,2/14,8.19%,SCRIB;WNT4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2698906172552529,0.7764218828536721,0.8139281828073993,1.0,1.0,19/68,19.58%,SMN1;SLBP;TBP;PRMT5;CPSF7;GTF2H3;CSTF2T;MAZ;NUDT21;POLR2K;CCNH;CPSF3;SETX;POLR1A;CDK7;POLR3K;TAF1B;FIP1L1;CSTF3
prerank,CENP-A containing chromatin organization (GO:0061641),0.30564929768903026,0.776406151867151,0.7870257037943696,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30564929768903026,0.776406151867151,0.7870257037943696,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3042266031416998,-0.7762296580240666,0.7298850574712644,0.9350564052302687,1.0,3/10,12.00%,IVD;ACAD11;ETFDH
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.20669318784286345,-0.776189964435938,0.9375,0.9338053344949525,1.0,6/45,7.77%,SMAD4;TWSG1;TGFB2;ACVR1;ENG;BMPR1A
prerank,eosinophil chemotaxis (GO:0048245),-0.27992952803489257,-0.775943993635544,0.8,0.9315327974050955,1.0,11/14,61.18%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil migration (GO:0072677),-0.27992952803489257,-0.775943993635544,0.8,0.9315327974050955,1.0,11/14,61.18%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.32911239007978105,0.7758822838135125,0.7743243243243243,1.0,1.0,6/18,18.25%,HSP90AA1;NELL1;CDK5RAP3;WDR91;FAF1;ATRAID
prerank,necroptotic process (GO:0070266),0.3362325920739139,0.7757409759866202,0.7611731843575419,1.0,1.0,6/16,20.53%,LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,positive regulation of reproductive process (GO:2000243),0.3035673151863825,0.7756651495242295,0.7731196054254007,1.0,1.0,4/31,15.34%,SIRT2;PGAM4;GLRA1;ACVR1B
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.2873722828411993,0.7754458877852173,0.802784222737819,1.0,1.0,2/43,1.18%,FGF9;IGF1
prerank,primary neural tube formation (GO:0014020),0.29745761449641694,0.7753112074768229,0.7711561382598331,1.0,1.0,3/30,5.37%,DVL2;TSC2;SCRIB
prerank,muscle tissue development (GO:0060537),0.3500616791951058,0.7753049078071779,0.7542134831460674,1.0,1.0,2/13,8.42%,STRA6;PTCH1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3423991483959872,0.7738724609103346,0.7715877437325905,1.0,1.0,4/15,17.45%,ADGRV1;SCN1A;KCNA1;COL11A1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2900898163424675,0.7736979302768046,0.7935174069627852,1.0,1.0,6/37,13.73%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3582853529293328,0.7735352152268793,0.7652439024390244,1.0,1.0,2/12,14.28%,SELENOS;TGFB1
prerank,response to interleukin-4 (GO:0070670),0.3639890330300358,0.7731245216694748,0.7745839636913767,1.0,1.0,1/10,3.80%,XBP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2660827625852414,-0.7731209976375288,0.7984189723320159,0.9345279310168082,1.0,7/18,22.51%,PABPN1;MCM3AP;THOC2;NUP93;NUP133;NXF1;ZC3H11A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.37143408876695994,0.7730909971749512,0.7600574712643678,1.0,1.0,3/11,14.28%,EFNB2;DHX36;TGFB1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29037802155205544,0.7730352716477464,0.7962529274004684,1.0,1.0,6/39,11.84%,PPIF;GPD1L;YWHAH;SCN2B;FGF12;PTPN3
prerank,mesonephric tubule development (GO:0072164),0.34549436044338955,0.772832746499687,0.7564979480164159,1.0,1.0,4/15,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.32595641882355403,0.7727990561250311,0.746031746031746,1.0,1.0,3/19,9.11%,CHD8;PRDX5;DHX36
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.35043839921303627,0.7726303621478318,0.7453505007153076,1.0,1.0,3/13,14.97%,ERRFI1;SNX6;CBL
prerank,calcineurin-mediated signaling (GO:0097720),-0.31910257968083083,-0.7724632918333889,0.7674418604651163,0.9329323951676084,1.0,3/10,15.48%,NFATC1;NFATC2;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.31910257968083083,-0.7724632918333889,0.7674418604651163,0.9329323951676084,1.0,3/10,15.48%,NFATC1;NFATC2;NFATC4
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2905310151182415,0.772428991602187,0.7855450236966824,1.0,1.0,6/31,14.82%,RANBP3L;SOX9;PTCH1;TWIST1;SUFU;SMAD6
prerank,microtubule anchoring at centrosome (GO:0034454),0.3715381124623091,0.7722446999124947,0.7477341389728097,1.0,1.0,3/10,17.04%,KIF3A;HOOK3;NIN
prerank,cellular response to organic substance (GO:0071310),0.25836940693051863,0.7721206723505339,0.8735868448098664,0.9997724173531928,1.0,17/116,15.82%,KHSRP;CLEC3B;SFRP1;CDK9;CXCR4;PID1;PLK5;PTPN5;ROBO2;NFAT5;IL1RAPL1;PARK7;RACK1;TGFB1;SLIT3;ACVR1B;PTPN12
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.34411291220804596,0.7719883150084654,0.7703804347826086,0.9995498823058718,1.0,2/15,8.11%,GPLD1;SIK1
prerank,tube closure (GO:0060606),0.29601354358277365,0.7716751144742299,0.7840095465393795,0.9995738865800263,1.0,3/31,5.37%,DVL2;TSC2;SCRIB
prerank,stress granule assembly (GO:0034063),0.317595600402573,0.7714391940551925,0.7765814266487214,0.9994890361100792,1.0,7/20,19.78%,DDX3X;ATXN2L;YTHDF3;YTHDF1;MAPT;YTHDF2;CIRBP
prerank,protein export from nucleus (GO:0006611),0.3076916153755301,0.7712906713094249,0.7764127764127764,0.9992639688349827,1.0,11/27,23.16%,RANBP3L;STRADB;TGFB1;NUP214;XPO6;SMURF1;XPO7;RANBP3;TPR;CSE1L;DUSP16
prerank,cellular response to superoxide (GO:0071451),0.3635826333369674,0.7711543718981361,0.7374810318664643,0.9990386747363457,1.0,2/10,12.47%,SOD2;SOD3
prerank,positive regulation of behavior (GO:0048520),0.3654019704222735,0.7710593607033274,0.7597014925373134,0.9987590168451966,1.0,2/10,12.46%,STRA6;CFAP20
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3467962168968981,0.7706303096127561,0.7615606936416185,0.9989771124046407,1.0,3/13,15.97%,KHSRP;NUDT21;ZC3HAV1
prerank,response to axon injury (GO:0048678),-0.2539591434691898,-0.7703787911734472,0.799163179916318,0.934938354333901,1.0,13/18,46.79%,RTN4RL1;P2RY12;DHFR;FLRT3;MORN4;SARM1;TYROBP;P2RX4;NREP;GAP43;APOD;TREM2;MTR
prerank,cellular response to alkaloid (GO:0071312),-0.26628859162331964,-0.7703348991590424,0.7717391304347826,0.933689104883792,1.0,11/17,39.43%,TGM2;SPIDR;BLM;CASP3;RYR2;GSTM2;SLC8A1;CASP6;HTR1B;CASQ2;RAD51
prerank,regulation of glucose transmembrane transport (GO:0010827),0.32898205463329333,0.7702998406692574,0.7457865168539326,0.9990000423674952,1.0,2/18,9.67%,RTN2;CLIP3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3034810444306096,0.7701461882755094,0.7980173482032218,0.9987991374232026,1.0,8/27,23.39%,CACNB4;CACNB1;CAMK2D;AHNAK;JPH1;CALM1;CALM2;FKBP1A
prerank,nucleus organization (GO:0006997),0.2778701881822115,0.7701386855345006,0.798175598631699,0.9983826449652661,1.0,16/47,24.13%,REEP4;BIN1;DMPK;CHMP3;LEMD3;VPS4B;NUMA1;NUP35;TPR;SUN1;CHMP4A;CHMP4B;NUP155;SYNE1;NUP54;NUP98
prerank,regulation of GTPase activity (GO:0043087),0.25326509264520286,0.7696963425093903,0.908080808080808,0.9985754021016193,1.0,27/177,13.79%,SFRP1;CDKL5;PLXNA2;TBC1D7;SGSM3;RAP1GDS1;RGS10;FLCN;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;PLXNA1;DOCK8;RAPGEF1;VAV2;GPSM1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1;ADAP1;RABGAP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2658437367722598,0.7696948739293599,0.8507936507936508,0.9981514081756803,1.0,17/83,19.92%,CCP110;CENPJ;HSP90AA1;ALMS1;TUBA1A;YWHAG;NPM1;KCNH5;HAUS3;CSNK1D;TUBB;OFD1;CEP76;TUBB4A;ODF2;DYNLL1;PAFAH1B1
prerank,negative regulation of TOR signaling (GO:0032007),0.2911929893602232,0.769529766589708,0.7952095808383234,0.9979704563331556,1.0,15/36,25.85%,TSC2;TBC1D7;FLCN;STK11;RNF152;PRKAA1;PDCD6;NPRL2;SESN1;ATM;TSC1;TMEM127;NPRL3;CASTOR2;DEPTOR
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3207266195352878,0.7687046395586457,0.7711978465679677,0.9987089385928468,1.0,2/20,8.19%,SIK1;WNT4
prerank,estrogen metabolic process (GO:0008210),0.33601589848833674,0.7683660562114304,0.7688098495212038,0.9987649409471596,1.0,2/15,16.33%,HSD17B4;SULT1A1
prerank,regulation of protein import into nucleus (GO:0042306),0.2895183735068468,0.7681509408031565,0.8062575210589651,0.9986274182022272,1.0,11/36,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;SUFU;TGFB1;UBR5;RBM22;CABP1;TPR;SMAD3
prerank,positive regulation of binding (GO:0051099),0.26549397810469016,0.7681387986870842,0.8375796178343949,0.9982222675768664,1.0,14/84,17.48%,VTN;IGF1;KDM4D;SIRT2;TCF7L2;EGF;GPSM1;APP;CEBPG;ADD2;LRP1;DERL1;APOE;USP33
prerank,protein dephosphorylation (GO:0006470),0.2555322450348591,0.7679707329122007,0.8782961460446247,0.9980274756235566,1.0,48/135,25.66%,DUSP18;DUSP26;PPP2R2C;PPM1B;STK11;CDC14B;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PTPN12;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1;PPM1A;PTPRS;EYA1;PTPRR;PPP2R2B;PPM1F;PPP2R2A;RPAP2;DUSP16;PTEN;PPP3CB;PPP2R5C;PPM1D;PPP4R1;PPP2R2D;MTM1;PTPN14;PTPRA;DUSP3;PTPN13;FBXW11
prerank,regulation of response to oxidative stress (GO:1902882),0.36279244220109863,0.7678680667293664,0.7584187408491947,0.9977372781502609,1.0,1/11,3.34%,AIFM2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.347970860837311,0.7676984516323362,0.764792899408284,0.9975470304848951,1.0,6/13,20.92%,BARD1;PARK7;SUFU;NUP153;CABP1;TPR
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2578844475522134,0.76752801955083,0.8697435897435898,0.9973736243771171,1.0,23/125,19.92%,B9D2;CENPT;INCENP;TAOK1;MAD2L1;NEK9;KPNB1;DCTN6;PPP1CC;CEP126;GPSM2;DYNC1LI1;RCC1;CENPC;ZWINT;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,tRNA processing (GO:0008033),0.2718679544618847,0.767224647433541,0.8101694915254237,0.9973583369594541,1.0,16/61,21.86%,DTWD1;ANKRD16;TRDMT1;AARS1;SARS1;TRMT1;RPP30;PTCD1;QTRT2;URM1;RTCB;WDR4;RTRAF;FARS2;ZBTB8OS;TRMT6
prerank,peptidyl-serine modification (GO:0018209),0.2520756793919489,0.767150118204131,0.8878787878787879,0.9970418370480705,1.0,30/166,16.60%,MAPK9;CAMK1G;PDPK1;CSNK2A2;GALNT16;PARP1;EIF2AK3;DMPK;PARP2;PRKCA;CDK5;MAST3;GALNT4;SBK1;NTMT1;TOP1;BRSK1;CAMK2D;TLK1;ATR;RPS6KA3;PRKCI;CSNK1D;ROCK2;GRK2;CSNK1A1;RPS6KA1;NDNF;CAMK1D;TNKS
prerank,response to progesterone (GO:0032570),0.3208263870173844,0.7668381319743588,0.7572944297082228,0.9970516910957379,1.0,2/18,6.78%,WBP2;CATSPER3
prerank,membrane protein proteolysis (GO:0033619),0.2891181108000309,0.7668236675344002,0.7841306884480747,0.9966527512707942,1.0,13/37,24.87%,NFKB1;HM13;MBTPS1;AFG3L2;DAG1;TGFB1;CTSH;PARL;NAPSA;MYH9;SPPL2A;TRAF6;CLPP
prerank,positive regulation of transmembrane transport (GO:0034764),0.34483264381852813,0.7667979404368578,0.7474892395982783,0.9962641369744443,1.0,2/13,9.67%,AZIN2;CLIP3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.21131732187351857,-0.7661443468999937,0.8571428571428571,0.9388377272614621,1.0,9/32,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3156768886909729,0.7661345109233874,0.7755905511811023,0.9967730027075176,1.0,6/21,18.39%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3179718480045838,0.7661017734572286,0.7803617571059431,0.9963963083323886,1.0,4/21,10.62%,FIS1;RAP1GDS1;PDZD8;AFG3L2
prerank,negative regulation of cell junction assembly (GO:1901889),0.3043996418040401,0.7657707309215575,0.7914032869785083,0.9964542062123558,1.0,11/25,24.80%,DMTN;ROBO2;ROCK2;SLIT1;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,negative regulation of insulin secretion (GO:0046676),0.33099268645656316,0.7656294598332929,0.7720488466757124,0.9962300014615362,1.0,1/17,1.12%,SFRP1
prerank,protein localization to nucleus (GO:0034504),0.2602536350958848,0.7653498618975826,0.8663212435233161,0.9961994790573943,1.0,30/102,23.13%,MMP12;TSC2;CHCHD10;NXT2;NXT1;DVL1;KPNB1;ABCA7;TOR1B;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;TOPORS;MDM2;NUP153;BANP;PPP1R10;TOR1AIP2;HNRNPU;HEATR3;TPR;APPL2;PIKFYVE;NUP155;PINX1;CSE1L
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3440893759772815,0.7652337632367836,0.7635327635327636,0.9959378034355986,1.0,2/13,9.15%,PIGU;EGF
prerank,regulation of chromatin binding (GO:0035561),0.36684661518427353,0.7651294530979602,0.7797619047619048,0.9956651481531973,1.0,1/10,1.29%,KDM4D
prerank,integrated stress response signaling (GO:0140467),0.3414169637457223,0.7648189454209299,0.7697841726618705,0.9956904724601258,1.0,4/14,17.62%,EIF2AK3;DDIT3;IMPACT;OMA1
prerank,carbohydrate biosynthetic process (GO:0016051),0.3139947775950318,0.7644065626403009,0.7752956636005256,0.9958662446711591,1.0,3/21,14.35%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,T cell receptor signaling pathway (GO:0050852),0.25562932247400366,0.7640358661044396,0.8940936863543788,0.995961900358909,1.0,17/138,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;RC3H2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.297441154907181,0.7639493016132363,0.7677664974619289,0.9956673312963306,1.0,7/29,16.00%,WBP2;UFSP2;GPAM;CNOT9;CBFB;KMT2D;VPS18
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3343381564416533,0.7634168753438708,0.7687943262411348,0.9959985506761815,1.0,2/15,10.19%,SOX9;GDNF
prerank,regulation of interleukin-17 production (GO:0032660),0.29515161484378116,0.7633671285647222,0.8024539877300614,0.9956541434712127,1.0,3/31,14.28%,ZBTB7B;DDIT3;TGFB1
prerank,protein targeting (GO:0006605),0.25604543427050014,0.763306544803208,0.860204081632653,0.9953005135422582,1.0,32/118,22.95%,CACNG3;EDEM1;FIS1;TOMM20;FBXO7;TIMM13;ZFAND6;ZDHHC3;MFN2;AIP;SDCBP;KATNB1;PEX1;GDAP1;PRKCI;ZFAND2A;ATG3;AP4M1;SEC61G;TRAK1;AP4E1;SORL1;ZDHHC2;AP4S1;TIMM44;TIMM22;SEC63;RTP4;TIMM23;PIKFYVE;ZDHHC14;ZDHHC21
prerank,skeletal muscle organ development (GO:0060538),0.3018589439102639,0.7632738422699411,0.7763975155279503,0.9949232012700283,1.0,2/26,4.00%,STRA6;MYH14
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3122548013651265,0.7626241164233105,0.8,0.9953802293463263,1.0,3/24,10.16%,UROD;RSAD1;SLC25A38
prerank,gene expression (GO:0010467),0.2473715752740694,0.7624592914815306,0.967,0.9951895175665008,1.0,76/348,19.45%,MRPL36;FARSB;DDX17;DDX19B;SLBP;STUB1;RBM3;NXT1;U2AF1;SRSF2;WARS1;YARS2;RAE1;POLR2B;SRSF5;RBM39;CELF2;DHX8;ATXN1;SRSF3;HNRNPK;MPHOSPH10;THOC3;SRSF9;SRSF1;PABPC4;HNRNPD;DRG1;MRPL10;NUP188;RPL35A;RPS25;SARS1;RPS15;RBMS1;RBMS2;POLR2K;CPSF3;NUP210;RPL9;THOC7;HARS1;HNRNPH3;NUP88;SETX;HNRNPL;MRPL3;GSPT1;MMS19;RPL4;NOVA1;HNRNPA2B1;MRPL13;THOC1;NUP214;PPP5C;HSPD1;MRRF;YTHDC1;MRPL24;UPF2;RPL23A;RPLP2;TNIP1;SRRM1;TOPORS;SORL1;NUP153;SMG7;RANBP2;TAF1B;FIP1L1;NUP35;MRPS6;RPS3;RPL27A
prerank,JNK cascade (GO:0007254),0.288369725879874,0.7622812146143481,0.8028004667444574,0.995026633815236,1.0,3/40,4.55%,MAPK9;PTGER4;MINK1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2369582030725813,-0.7620013177421462,0.8223140495867769,0.9437566039344728,1.0,8/21,23.84%,SMAD4;BMPR1A;NUP93;CCN3;BMP4;TGFB3;SLC2A10;SH2B1
prerank,positive regulation of nervous system development (GO:0051962),0.27888357022609933,0.76176671551031,0.8086854460093896,0.9953245371264101,1.0,11/42,21.20%,EPHB2;SOX11;CLSTN2;IL1RAPL1;NLGN3;NLGN2;SNW1;IL1RAP;CLSTN3;SERPINF1;DLG5
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.34143231026732107,0.7617439814815091,0.7872340425531915,0.9949315059565367,1.0,1/14,2.70%,EDN3
prerank,mitotic nuclear membrane organization (GO:0101024),0.2694134453956054,0.7616159444221521,0.8270089285714286,0.9942808291175835,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2694134453956054,0.7616159444221521,0.8270089285714286,0.9942808291175835,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,mitochondrial translational elongation (GO:0070125),0.2586351886389038,0.7607886101186447,0.8730650154798761,0.994987733956223,1.0,23/88,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28;GFM1
prerank,histone H4-K16 acetylation (GO:0043984),0.3161611670459598,0.7606204003486895,0.7699346405228759,0.9947952775216081,1.0,4/19,14.00%,MSL2;OGT;MSL1;KANSL2
prerank,negative regulation of angiogenesis (GO:0016525),0.26252616861168754,0.7606033163094512,0.8569926393270242,0.9943987663088144,1.0,24/84,21.15%,THBS2;SULF1;DCN;SPARC;HGS;ATF2;PIK3CB;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SERPINE1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;EPN1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2544338024168566,0.7603141425775145,0.8854489164086687,0.9943890376768048,1.0,28/112,21.52%,WNT5A;CLEC3B;SFRP1;CGN;SMAD9;ZFP36L1;WNT4;SOX9;USP15;COL1A2;ZMIZ1;SOX6;USP9X;TGFB1;SMAD6;SOX5;CBL;SMURF1;TGFBR1;PDCD5;WWOX;PRKCZ;GCNT2;TGFBR3;SMAD7;ITGB1;APPL2;SMAD2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2081056078098991,-0.7601753458739771,0.8842975206611571,0.9451744176921463,1.0,16/41,31.15%,PNPLA8;MGLL;SCP2;DAGLB;CYP1B1;ACOT8;FADS2;ELOVL5;DEGS1;GPX1;FADS3;DECR2;EPHX1;SCD;GSTM2;PLA2G4A
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3059729299698888,-0.7600782220162281,0.764525993883792,0.9440206758891774,1.0,4/10,17.54%,SETD2;SETD3;SMYD2;SETD4
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.28154490573816965,0.7600594859673201,0.8023529411764706,0.9943344766788818,1.0,6/39,13.73%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.32120674479741784,0.7600130158752586,0.7696404793608522,0.9939830690929556,1.0,6/20,20.71%,BAX;CASP9;BCL2;CASP2;DCC;ITGAV
prerank,organophosphate catabolic process (GO:0046434),0.354435421246124,0.7598519436041858,0.7945619335347432,0.9937889721985397,1.0,1/11,10.25%,ENPP2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3490601934315247,0.7590247290434373,0.7838235294117647,0.9945194804446365,1.0,3/12,20.33%,THY1;FLOT1;GCNT2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.26978996763277946,0.759021489115682,0.8195067264573991,0.9941047803782934,1.0,10/57,12.27%,MRPL36;EBNA1BP2;GLUL;CUL4B;RBIS;RPL35A;RPS25;RPS15;MALSU1;NPM1
prerank,prostaglandin metabolic process (GO:0006693),0.29809157342932774,0.7581529235067435,0.7796817625458996,0.9948858584592835,1.0,1/26,0.44%,PRXL2B
prerank,ureteric bud development (GO:0001657),0.3296725104449285,0.7581397109684173,0.776566757493188,0.9944894077023251,1.0,4/17,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,regulation of interleukin-2 production (GO:0032663),0.2784913494961807,0.7580813692670505,0.816933638443936,0.994153994978249,1.0,12/43,25.01%,ANXA1;TNFAIP3;MALT1;SPTBN1;PDE4B;PRKD2;TRIM27;RPS3;TRAF2;TRAF6;RUNX1;NAV3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.24507121507901988,0.7578266074960596,0.95995995995996,0.9940771650285208,1.0,79/327,20.76%,DVL2;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;CNBP;ABL1;ATXN1;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;DDIT3;HNRNPD;PRMT5;SOX11;SAP30L;FADS1;ATF2;POU6F2;NSD3;FOXN3;ZMIZ1;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;YBX1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.2897410010455115,0.7577285050229249,0.8009592326139089,0.9937950739022691,1.0,5/34,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.36274422892006974,0.7576948078721125,0.767616191904048,0.9930186655026503,1.0,2/10,12.69%,SMPD2;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.36274422892006974,0.7576948078721125,0.767616191904048,0.9930186655026503,1.0,2/10,12.69%,SMPD2;RACK1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2532104904478645,0.757595248303834,0.8936170212765957,0.9927357334168317,1.0,38/146,23.12%,CCP110;CENPJ;PSMD4;HSP90AA1;ALMS1;USP47;BRD4;FBXO5;PSMB10;PSMD11;CDC25A;TUBA1A;YWHAG;PSME2;PSMC5;VPS4B;KCNH5;HAUS3;CSNK1D;TUBB;PSMD1;OFD1;PSMD6;CEP76;TUBB4A;MECP2;ODF2;PSMD5;DYNLL1;PAFAH1B1;PSMA4;PSMA1;PSMC6;CNTRL;NINL;CDK5RAP2;PSMA5;PINX1
prerank,rRNA processing (GO:0006364),0.24864277042700578,0.7574436913711992,0.9106425702811245,0.992520137787303,1.0,24/172,14.06%,NHP2;LSM6;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;MRPL1;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;BMS1
prerank,negative regulation of protein binding (GO:0032091),0.2608100348579058,0.7570388871867544,0.8450704225352113,0.9926654385516054,1.0,16/71,17.95%,BAX;ATP2A2;CARD16;DVL1;LRPAP1;PTPRF;PARK7;RACK1;DISC1;CTSZ;CTNNBIP1;PSME3IP1;ITGB1BP1;TLE5;USP33;SORL1
prerank,cyclooxygenase pathway (GO:0019371),-0.3118255564477992,-0.7570062351641945,0.7832817337461301,0.9470740483445396,1.0,4/10,24.17%,PTGES3;PTGES;TBXAS1;HPGDS
prerank,peripheral nervous system development (GO:0007422),0.30719919800770673,0.7568677471094833,0.7852604828462516,0.9924774422198982,1.0,3/23,10.19%,NTF3;GPC1;GDNF
prerank,cellular sodium ion homeostasis (GO:0006883),0.34264275794884497,0.7561512827075718,0.7731673582295989,0.993051705210215,1.0,2/15,7.53%,ATP1A3;ATP1A2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2614988949365953,0.7560320772950468,0.8623949579831933,0.9927975335027751,1.0,28/80,25.20%,TRAPPC10;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;DENND5A;VPS54;VTI1B;VTI1A;RAB6A;SGSM2;TRIM27;STX5;HEATR5A;RAB7A;RAB7B;EHD3;PIKFYVE;GOSR1;DENND2A;GGA1;HEATR5B;SURF4;LMAN1
prerank,defense response to symbiont (GO:0140546),0.25750955791770297,0.7556686101596415,0.8666666666666667,0.9928800073625803,1.0,16/92,16.96%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2
prerank,negative regulation of leukocyte migration (GO:0002686),0.3619786358517111,0.755227101928202,0.7583081570996979,0.9930587294905826,1.0,2/10,11.52%,CD200R1;BMP5
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.23580147892251585,-0.754820449909411,0.8899521531100478,0.9490241678227852,1.0,9/23,23.18%,STAT1;HSP90AB1;CDC37;NR1H3;IRGM;PARP9;NR1H2;PPARG;NLRC5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.3390889907973638,0.7547865929185665,0.7795163584637269,0.9932715707301277,1.0,5/13,22.16%,FGFR2;RBPJ;TGFBR3;FGF2;ERBB4
prerank,pore complex assembly (GO:0046931),-0.2502803652566255,-0.7547511299274298,0.8151260504201681,0.9478156761393893,1.0,9/19,22.04%,NUP205;ANO6;NUP93;NUP107;ADAM10;NDC1;P2RX7;TMEM170A;BAD
prerank,dendritic cell chemotaxis (GO:0002407),0.33295661455390213,0.7547325382179796,0.7910863509749304,0.992932096457678,1.0,14/14,66.73%,CXCR4;HMGB1;TRPM4;CCR7;CXCR2;CCR6;CCR1;CCL5;PIK3CG;CCR2;CCR5;CCL19;GPR183;TRPM2
prerank,membrane depolarization during action potential (GO:0086010),0.3058603453075295,0.7544140955779293,0.798234552332913,0.9929634252969647,1.0,5/26,10.99%,SCN7A;ATP1A2;YWHAH;SCN2B;SCN1A
prerank,receptor internalization (GO:0031623),0.27914348673383754,0.7540808974121246,0.8214702450408401,0.993024064002966,1.0,7/44,15.11%,DNM1;ADM;ARRB1;GRK3;LRP1;GRK2;RAB31
prerank,embryonic organ development (GO:0048568),0.26658915370665504,0.7539902941046399,0.8554083885209713,0.9927307310278638,1.0,9/61,14.28%,TEAD3;STRA6;FGFR2;PCSK5;TEAD1;GDNF;RBPJ;NDRG4;TGFB1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3463421531657141,0.753724201499884,0.7730978260869565,0.9926941180135289,1.0,2/13,10.40%,IGF1;IRS2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3113898297388876,0.7536842907981609,0.7684346701164295,0.991929480143545,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3113898297388876,0.7536842907981609,0.7684346701164295,0.991929480143545,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,inorganic anion transport (GO:0015698),0.2712404864168845,0.7535179585030365,0.8456375838926175,0.9917314196396618,1.0,7/53,14.46%,BEST1;CLCN2;SLC13A4;CLCN4;CLIC1;ENPP1;GLRA1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.26722825685242774,0.7530931571617124,0.8566810344827587,0.9918757366429167,1.0,23/72,24.48%,PSMD4;MAP3K14;NFKB2;TIRAP;PSMB10;PSMD11;MALT1;PSME2;PSMC5;TLR3;PSMD1;PSMD6;RELB;BIRC3;PSMD5;PSMA4;PSMA1;PSMC6;TRAF2;PSMA5;REL;PSMD14;TRAF6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.32441947177834807,0.7528671018607606,0.779291553133515,0.9913615743378716,1.0,8/16,24.80%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.32441947177834807,0.7528671018607606,0.779291553133515,0.9913615743378716,1.0,8/16,24.80%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,nuclear migration (GO:0007097),0.33600404752616675,0.7521845707816189,0.7724719101123596,0.9918695724723556,1.0,5/13,19.92%,CLMN;HOOK3;DOCK7;CEP120;PAFAH1B1
prerank,anterior/posterior axis specification (GO:0009948),0.33167666315105393,0.7516583648746085,0.7828492392807745,0.9921730547423647,1.0,2/15,9.61%,DDIT3;WLS
prerank,sodium ion homeostasis (GO:0055078),0.31486043397669183,0.7516439254094187,0.7818877551020408,0.9917823261995372,1.0,2/21,7.53%,ATP1A3;ATP1A2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.29097458810449234,0.7516169019201496,0.8090024330900243,0.9914097596803781,1.0,7/30,21.22%,CHPF;DCN;CHSY3;ARSB;NDNF;DSE;CHST9
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.355072185427972,0.751424109184274,0.7638483965014577,0.9912644422835015,1.0,2/11,6.77%,RENBP;GNPNAT1
prerank,positive regulation of chemotaxis (GO:0050921),0.27570386291120075,0.7511492048706132,0.8063010501750292,0.9912383397094015,1.0,9/43,21.65%,EDN3;NRP1;DSCAM;TGFB1;F3;MEGF8;PRKD2;FGF2;PPM1F
prerank,response to interferon-alpha (GO:0035455),-0.25646022889166825,-0.7506640235106291,0.8191881918819188,0.9523292203618432,1.0,3/16,7.09%,AXL;IFNAR2;EIF2AK2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.35848652063878383,0.7505876479448991,0.7683109118086696,0.9915738487722905,1.0,1/10,1.57%,FOXM1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3043667524027853,0.7503325270334431,0.7982120051085568,0.9914929988014546,1.0,6/24,22.83%,CHERP;ITPR1;HTR2C;PKD2;FGF2;IBTK
prerank,regulation of receptor recycling (GO:0001919),0.32725936438317743,0.7501626943433386,0.7854251012145749,0.9913163298511853,1.0,4/16,16.65%,SCRIB;VAMP3;NSF;ANXA2
prerank,cellular protein catabolic process (GO:0044257),0.26716132938095855,0.7500974080410935,0.8452115812917594,0.9909885558956588,1.0,19/59,24.87%,ADAMTS7;RAB12;VLDLR;CAPN2;AP2S1;MALT1;TCIRG1;CTSZ;CTSH;CHEK2;MDM2;CTSK;CTSO;CTSB;RAB7A;ADAMTS12;MYLIP;SIAH2;CLPP
prerank,glycoprotein metabolic process (GO:0009100),0.2755458725901673,0.7499205535969822,0.8430034129692833,0.9908276025063296,1.0,11/53,17.26%,ST8SIA3;ST3GAL2;MGAT4B;NGLY1;MAN1A2;MANBA;PARK7;B4GALT5;ST6GALNAC6;MAN1C1;TNIP1
prerank,peptide cross-linking (GO:0018149),0.2980106866448019,0.749809064719232,0.7989623865110247,0.9905754597790422,1.0,3/25,16.28%,ANXA1;ABCA7;NDNF
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3366665259569158,0.7496803502768715,0.7746870653685675,0.9903368542456529,1.0,6/15,23.39%,LEMD3;MAGI2;ACVR1B;ACVR2A;SMAD7;FKBP1A
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3539777942025296,0.749662711868465,0.7737226277372263,0.9899547114843407,1.0,5/10,25.31%,MAPT;NDFIP2;TERF1;PPM1F;WWP2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.2106226044501104,-0.7492632524758186,0.8876404494382022,0.9530566161115556,1.0,18/30,36.35%,LBR;HMGCS1;ACLY;FDFT1;ACAA2;ARV1;NSDHL;ACAT2;SQLE;DHCR24;PMVK;IDI1;MVK;HSD17B7;FDPS;PLPP6;DHCR7;EBP
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2706325356665701,-0.7490247939485628,0.825925925925926,0.9520649973760932,1.0,5/14,31.27%,LGALS9;TGFBR2;CD81;CD55;SYK
prerank,cellular response to amino acid starvation (GO:0034198),0.2593783143831789,0.7486369850135597,0.8356756756756757,0.990920036509038,1.0,15/71,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,response to amino acid starvation (GO:1990928),0.2592398564592833,0.7483459920899336,0.84375,0.9909183882630564,1.0,15/72,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.1946833650728503,-0.7474806804035482,0.9243697478991597,0.9528910781714093,1.0,15/48,23.18%,SAMHD1;STAT2;SLIT2;PTPRC;METTL3;PYDC1;NR1H3;CNOT7;SH2B3;USP18;OTUD4;CCDC3;NR1H2;PPARG;NLRC5
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2577986351866639,0.7454001056047296,0.8583690987124464,0.99435685323602,1.0,22/72,23.46%,PFDN4;TAOK1;CAMSAP2;VBP1;SSH1;PFDN1;CLIP3;PLEKHH2;KATNB1;EML2;TBCD;APOE;PFDN2;TUBB4A;SHANK1;LIMA1;FGF13;CLASP2;PFN2;CAMSAP1;MAP2;IAPP
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.2704039409937976,-0.7452540662783423,0.8231292517006803,0.9545642758063583,1.0,4/14,14.13%,NUDT5;ENTPD1;ADPRM;ENTPD6
prerank,protein homotetramerization (GO:0051289),-0.18674237443965216,-0.7449695751696702,0.9401709401709402,0.9536568154707511,1.0,15/49,25.91%,SAMHD1;OSBPL2;ACACA;KCNJ2;GLS;ACACB;GBP5;ALDOA;UPB1;MCOLN1;ALDH9A1;APIP;CBR4;HCN1;KCNJ12
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.28685663586169696,-0.7444216150249154,0.7784615384615384,0.9530799412153148,1.0,3/11,10.02%,PARP8;PARP6;PARP10
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.25350380754445817,0.7443486818758849,0.8830897703549061,0.9953393278018989,1.0,22/101,19.78%,CLN6;HSP90AA1;STUB1;RBM3;DDX3X;OGT;AURKAIP1;HNRNPD;ZCCHC4;YTHDF3;NPM1;YTHDF1;PRR16;TGFB1;FAF1;ASPSCR1;AGTR1;FMR1;METTL5;SOX4;KLF4;CIRBP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.34997949615485,0.7440650584384709,0.784992784992785,0.9952979888032485,1.0,1/11,1.59%,GPLD1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.34938324550802935,0.7438814399758464,0.7756874095513748,0.9951229705690359,1.0,4/12,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,sulfur compound transport (GO:0072348),0.28774310314440804,0.742977341164439,0.8142681426814268,0.9958724317331332,1.0,3/27,7.43%,SLC35B2;SLC25A19;SLC13A4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3523044156128282,0.742710347850433,0.7729393468118196,0.9958063769939113,1.0,3/10,17.65%,ABCA7;APOE;BMP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3452722385807301,0.7423694970816034,0.7866473149492017,0.9958570302880284,1.0,1/11,1.57%,FOXM1
prerank,cellular response to glucagon stimulus (GO:0071377),0.31765404037802136,0.7422743918047592,0.8091168091168092,0.9955811455990401,1.0,4/17,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,replication fork processing (GO:0031297),0.28109333030233186,0.7422077269781351,0.817432273262662,0.9952572565273433,1.0,8/38,15.16%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1;MRE11
prerank,T cell mediated immunity (GO:0002456),-0.27982491867529624,-0.7421898118734657,0.7956204379562044,0.9548844747451611,1.0,2/13,6.14%,CD46;CADM1
prerank,negative regulation of T cell differentiation (GO:0045581),0.351678836588571,0.7418253772569869,0.7710280373831776,0.9953522662990022,1.0,1/10,5.88%,IRF1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.26194503514811607,0.7413498473273559,0.845464725643897,0.9955628573052923,1.0,10/50,19.43%,TCIM;DDX3X;IFI35;APP;NFAT5;RTKN2;TLR3;ILK;TERF2IP;RPS3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.32849753383684577,0.7412263868439503,0.7961165048543689,0.9953240757868772,1.0,3/16,14.28%,SUCO;WNT4;TGFB1
prerank,protein modification process (GO:0036211),0.2573732890798235,0.7411080201229702,0.8617363344051447,0.9950822798695522,1.0,13/76,17.27%,ARAF;LCMT1;PARP1;UBE2S;ABL1;MANBA;PLAT;SERP1;ATG3;RPN2;NEDD8;UBE2L3;FBXO22
prerank,endodermal cell fate commitment (GO:0001711),0.35893492369445434,0.741028553930241,0.8,0.9947704894248147,1.0,2/10,13.57%,RTF1;CDC73
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.251562168533148,0.7409476009756356,0.8799582463465553,0.99445855340016,1.0,18/94,17.58%,BAX;GSKIP;PDK1;DDX3X;ITPR1;ABL1;STK11;BRSK2;CD24;DDIT3;CASP9;BCL2;CUL5;CASP2;DDX5;CHEK2;TOPORS;DNAJC10
prerank,positive regulation of B cell activation (GO:0050871),0.26758848623189935,0.7409439694834076,0.8366890380313199,0.9940550958602598,1.0,5/50,11.07%,EPHB2;XBP1;TIRAP;IRS2;BCL2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2698921837026224,0.7408975270748658,0.8162100456621004,0.9937000414957837,1.0,11/44,19.40%,KHSRP;ZFP36L1;CELF1;DHX36;PABPC1;YTHDF3;YTHDF1;ROCK2;ZC3HAV1;FTO;YTHDF2
prerank,positive regulation of isotype switching (GO:0045830),-0.2594664037474126,-0.7406244739326099,0.7908745247148289,0.9556772137380759,1.0,2/15,6.01%,SHLD2;PAXIP1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.35417726214950696,0.7405667424835001,0.7891472868217054,0.9937537310563817,1.0,1/10,2.67%,HSP90AA1
prerank,integrin-mediated signaling pathway (GO:0007229),0.2540838772787091,0.7404665699135552,0.8491978609625669,0.9934855508847565,1.0,19/73,22.29%,PRAM1;FBLN1;NRP1;ABL1;THY1;TEC;ITGBL1;CD47;PLPP3;ADAMTS1;ITGB1BP1;ILK;ERBIN;DAB2;PTK2B;ITGAV;ITGB1;MYH9;ITGA5
prerank,substrate-dependent cell migration (GO:0006929),0.33678747542045956,0.7402776488953638,0.7936288088642659,0.9933416262688959,1.0,3/14,8.75%,NRP1;EPHA8;SDCBP
prerank,sister chromatid segregation (GO:0000819),-0.20613117445550536,-0.7400243609890863,0.88,0.9551816259955097,1.0,23/31,46.53%,LATS1;RB1;NCAPG2;SMC1A;SMC4;MIS12;KIF18A;RAN;TUBG1;CENPK;KLHL22;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,membrane lipid metabolic process (GO:0006643),0.30162575922675405,0.7392797244573489,0.7909090909090909,0.9942332997797766,1.0,3/22,11.89%,SMPDL3B;AGMO;TEX2
prerank,histone H3-K4 methylation (GO:0051568),0.28885250423434616,0.7392724162268108,0.8262548262548263,0.9938353203764131,1.0,7/26,19.43%,KMT2B;OGT;SETD1A;DPY30;KMT2D;KMT2A;KDM6A
prerank,amino sugar biosynthetic process (GO:0046349),0.34642041520204253,0.7392236597621645,0.7740524781341108,0.9934860207655026,1.0,2/12,6.77%,RENBP;GNPNAT1
prerank,positive regulation by host of viral transcription (GO:0043923),0.32260587135489277,0.7386447556709552,0.7956403269754768,0.9938392644545047,1.0,7/15,23.03%,SMARCB1;CHD1;NUCKS1;SNW1;CCNT1;RRP1B;SP1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.26426030994437755,-0.7381645368396944,0.8153310104529616,0.9563603659338396,1.0,11/14,60.44%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;IL12B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.31202448180380415,0.7379920023632247,0.8128491620111732,0.9943048230129656,1.0,3/17,9.79%,SNAI1;RFFL;TWIST1
prerank,protein destabilization (GO:0031648),-0.2065047738643599,-0.7377747339078028,0.8771929824561403,0.9555423196667955,1.0,13/32,28.81%,SIRT1;SENP2;SERF2;EP300;RNF139;IRGM;SOX17;KDM8;PRKN;RAD23A;CCDC88C;BTRC;TRIM21
prerank,positive regulation of T cell proliferation (GO:0042102),0.2644961215143825,0.7375636941586028,0.838074398249453,0.9944351246820409,1.0,3/55,7.55%,IGF1;ANXA1;CD24
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.29391242636511683,0.7373917204065612,0.8329177057356608,0.9942293823832982,1.0,5/26,15.82%,PDPK1;ZFP36L1;SOX9;IQGAP1;PTPN12
prerank,striated muscle cell development (GO:0055002),-0.2693790080946793,-0.7372764553168408,0.8287671232876712,0.9549039977488661,1.0,4/14,31.69%,PGM5;TMOD1;LMOD1;SDC1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.30624972383484783,0.7368285086079855,0.8028169014084507,0.9937713603976509,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.30624972383484783,0.7368285086079855,0.8028169014084507,0.9937713603976509,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.30624972383484783,0.7368285086079855,0.8028169014084507,0.9937713603976509,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,regulation of microglial cell activation (GO:1903978),-0.2550914211190052,-0.736810227996926,0.8172043010752689,0.9541817480644665,1.0,4/15,28.50%,PTPRC;GRN;TTBK1;SPHK1
prerank,neutrophil chemotaxis (GO:0030593),-0.18174646123136273,-0.7357631106152857,0.9444444444444444,0.9542904427210792,1.0,4/53,6.44%,GBF1;BSG;CCL15;TGFB2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2836536176350647,-0.7354979138643907,0.8130563798219584,0.9533588753457612,1.0,6/11,26.82%,ASAH1;SIRT1;DGKQ;EGR1;BMP2;FGFR4
prerank,response to acidic pH (GO:0010447),0.3319864245141553,0.7352974634803872,0.7945007235890015,0.9952714595888444,1.0,4/13,25.79%,GPR4;IMPACT;RAB11B;SLC9A1
prerank,T cell differentiation (GO:0030217),0.2723715030893332,0.735123935355716,0.8503480278422274,0.9950801294536983,1.0,9/40,21.30%,ANXA1;ZFP36L1;LEPR;PTPN22;SOX13;TCF7;SOX4;CHD7;GLI3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3407189643945346,0.7349092597860629,0.8086330935251799,0.9949621873986101,1.0,5/12,22.96%,DCN;PIK3CB;SPRY2;ATP2B4;ADAMTS12
prerank,endoderm development (GO:0007492),0.3342343791804899,0.7345165726021708,0.7907949790794979,0.9950659387077498,1.0,1/13,5.43%,LAMC1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2933562625221787,0.7342262205326134,0.8176020408163265,0.9950236573406437,1.0,3/24,13.73%,LIG1;LIG3;POLD3
prerank,signal peptide processing (GO:0006465),0.3459468156864089,0.7339878106267529,0.7779411764705882,0.9949253602565616,1.0,3/11,17.07%,PCSK5;HM13;PARL
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.33067171159998365,0.7337529003858451,0.8091168091168092,0.9948219773212439,1.0,2/14,5.95%,NRP1;GAB1
prerank,negative regulation of chemotaxis (GO:0050922),-0.2019095203222239,-0.7335739102018599,0.9069767441860465,0.9546363973352197,1.0,15/31,33.03%,SLIT2;SEMA6A;THBS1;SEMA7A;SEMA4D;ANGPT2;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;PTPN2;SEMA3G;SEMA6B;SEMA4C
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.3465152525372709,0.733482196782193,0.8052708638360175,0.9947576034311556,1.0,5/11,20.88%,USP15;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.2591657333570945,-0.733416688690255,0.8293515358361775,0.9535115058779362,1.0,4/15,11.54%,BMPER;TJP1;SMAD1;PKM
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.26397416575094934,0.7332584269984234,0.8552188552188552,0.9946142718871337,1.0,15/49,22.97%,PRMT6;KMT2B;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;KMT2D;KMT2A;CNOT4;RAB7B;H3-3A;MTURN;AGO4
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.29353626989833703,0.733085897381703,0.8282442748091603,0.9944353379227007,1.0,5/23,19.11%,FADS1;PTGS2;EPHX2;GPX4;ELOVL6
prerank,artery morphogenesis (GO:0048844),0.2845962271588488,0.7329033920796731,0.8317422434367542,0.9942565489614805,1.0,7/30,20.88%,STRA6;NRP1;LRP1;JAG1;PKD2;TGFBR1;SMAD7
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25854908836992835,0.7328590916093441,0.8698924731182796,0.9939157150329231,1.0,23/70,24.79%,PSMD4;ABL1;PSMB10;PSMD11;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;N4BP2L2;PSMA5;YAP1;PSMD14;RUNX1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2579666709505657,0.7328434641342142,0.8610206297502715,0.9935335359739639,1.0,17/62,21.66%,PRMT6;KMT2B;HOXB8;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;CDC73;KMT2D;MEIS2;KMT2A;LYN;PTK2B;CNOT4;H3-3A
prerank,response to muscle stretch (GO:0035994),-0.2477743858020836,-0.7324658337576521,0.8703071672354948,0.9533813901040078,1.0,4/15,30.00%,DMD;PIK3CA;RYR2;SLC8A1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.28184980717358254,0.7320835765439111,0.8436363636363636,0.9941097530453527,1.0,10/30,22.50%,SFRP1;PARK7;HDAC1;DDX5;SAFB2;NCOR2;PRMT2;DAB2;H3-3A;PKN1
prerank,regulation of mast cell activation (GO:0033003),-0.2874011646588242,-0.7314202312665645,0.8065476190476191,0.9534684563686044,1.0,8/10,53.75%,PLSCR1;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;CD226
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3324481384046711,0.731339856566772,0.8141843971631205,0.9946296579372153,1.0,3/14,13.29%,TIRAP;MALT1;TLR3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.34470781843318904,0.7313006323191618,0.7957639939485628,0.9942765552829118,1.0,1/10,1.59%,SIRT2
prerank,bone morphogenesis (GO:0060349),0.32009250823921764,0.7312730894831307,0.7903682719546742,0.9939142400644116,1.0,2/14,12.85%,FGFR2;CYP26B1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3120501972994309,0.7305999912782677,0.810738255033557,0.9943631786144219,1.0,6/16,20.48%,FLCN;ZBTB7B;PTGS2;SOX13;FTO;HNRNPU
prerank,regulation of cell size (GO:0008361),0.292824398367041,0.7304102482516238,0.8046571798188874,0.9941952776718703,1.0,5/23,14.28%,RAC1;RAP1GAP2;VAV2;LAMTOR5;PRR16
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3104669414079995,0.7300527364150333,0.7984189723320159,0.9942429351639466,1.0,6/18,26.13%,ELOVL1;ACSL6;ELOVL6;HACD2;HACD1;ACSL3
prerank,negative regulation of protein transport (GO:0051224),0.2953842563273953,0.7299802878708908,0.8284993694829761,0.9939491775939936,1.0,5/25,17.19%,ERP29;CYP51A1;RHBDF1;NDFIP2;APOE
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25688995142186666,0.7299704534459309,0.8826695371367062,0.993558103773334,1.0,24/73,24.79%,PSMD4;ABL1;PSMB10;PSMD11;DHX36;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;METTL14;PSMA5;YAP1;PSMD14;RUNX1
prerank,response to nitric oxide (GO:0071731),0.3268845603700238,0.7294711445166543,0.8048090523338048,0.9937587454947101,1.0,3/13,21.59%,KCNC2;DPEP1;FOXO1
prerank,protein localization to Golgi apparatus (GO:0034067),0.2868187818830754,0.7293985463876619,0.8191747572815534,0.9934529100033025,1.0,9/27,18.30%,OBSL1;ARL5B;RIPOR1;TMED10;IFT20;CSNK1D;VPS13D;SORL1;RAB6A
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.28198137385545197,0.7293439099067488,0.8188585607940446,0.9931256248275236,1.0,3/27,8.83%,CHPF;DCN;CHSY3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3332376032745199,0.7291220094742121,0.7934936350777935,0.9929910295628817,1.0,2/13,6.77%,RENBP;GNPNAT1
prerank,microglial cell activation (GO:0001774),0.30237837465070183,0.7290041436269339,0.8337874659400545,0.99274736106091,1.0,3/21,13.93%,APP;IFNGR1;MAPT
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2946155189602804,0.72887268430145,0.8226857887874837,0.9925015246775384,1.0,4/22,14.99%,IRF1;CBFB;BCL6;FANCA
prerank,regulation of pH (GO:0006885),0.3431809441851724,0.7285057289634659,0.8035450516986706,0.992560718482119,1.0,3/11,15.89%,ATP6V0A4;LACC1;SLC9A7
prerank,regulation of actin filament-based process (GO:0032970),0.254266495822574,0.7284028977822606,0.869098712446352,0.9922931086531125,1.0,16/70,19.85%,RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;IQGAP1;LRP1;ROCK2;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1
prerank,response to lipopolysaccharide (GO:0032496),0.23798804227127582,0.7282481281461042,0.9108606557377049,0.9920776590772732,1.0,19/138,16.49%,WNT5A;SELENOS;NFKB1;IFNAR1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96;HNRNPA0;GIT1;RPS6KA3;PTPN22;CDC73;SMAD6;PDE4B;SERPINE1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.31190617964964085,0.7279530126102409,0.8262032085561497,0.9920614256304021,1.0,4/17,16.44%,SNAI1;RBPJ;TGFB1;JAG1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.24375660064413351,0.7277208993659815,0.9059304703476483,0.9919516218018745,1.0,26/122,19.78%,IGF1;NFKB1;IL33;RBM3;XBP1;DDX3X;TMEM106A;HNRNPD;EGF;IRS2;ZCCHC4;HSPH1;BRPF3;YTHDF3;NPM1;PRMT1;YTHDF1;PRR16;FAF1;FMR1;SLC25A37;PRKD2;METTL5;SOX4;KLF4;CIRBP
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2742240122400106,0.7275198046944706,0.816374269005848,0.991806531651956,1.0,3/36,7.14%,WNT5A;AGPAT1;CXCR4
prerank,cytoplasmic microtubule organization (GO:0031122),0.2606034190411398,0.7270369079847314,0.8789237668161435,0.9919959091013197,1.0,12/54,18.17%,FSD1;CAMSAP2;KPNB1;CLIP3;HOOK3;CEP126;VPS4B;MAPT;NUMA1;TPPP;TUBGCP2;CCDC88A
prerank,response to ketone (GO:1901654),0.290742945165992,0.7262179730221783,0.8227848101265823,0.9926026113706617,1.0,4/24,14.88%,WBP2;CATSPER3;TGFB1;SLIT3
prerank,protein K63-linked deubiquitination (GO:0070536),0.2796823006201081,0.7259038211062777,0.8349633251833741,0.9926097546029281,1.0,8/31,19.27%,USP7;TNFAIP3;OTUD7A;ABRAXAS2;USP33;USP50;YOD1;UIMC1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2509505115766722,0.7250155939212665,0.8880434782608696,0.9933228550742049,1.0,14/75,19.12%,HEXIM1;PKIB;NR2F2;UCHL1;ABL1;CDK5RAP3;PIK3CB;IPO7;PKIG;SPRY2;APOE;SORL1;PRKAR1A;SMPD1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.26589516285095816,0.7240909356206244,0.8443935926773455,0.9940695109830451,1.0,9/41,20.88%,THY1;ANK3;CD47;PLPP3;DENND6A;JAK1;FLOT1;GCNT2;SMAD7
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.2847334193087847,-0.7236870595092522,0.7987804878048781,0.9616900513782066,1.0,5/10,29.52%,LGALS9;TGFBR2;CD81;NCKAP1L;CD55
prerank,neural crest cell development (GO:0014032),0.2661315941985448,0.7236837727427363,0.8361774744027304,0.9941470292358249,1.0,9/44,15.56%,KLHL12;PEF1;SOX11;SEMA3D;GDNF;RADIL;NRG1;SEMA3E;SEMA3A
prerank,regulation of protein binding (GO:0043393),0.2426596396978865,0.7236718578524671,0.9029927760577915,0.9937647299774781,1.0,25/114,18.68%,VTN;BAX;CARD16;TCF7L2;DVL1;HDAC5;LRPAP1;HDAC4;APP;PARK7;ADD2;RACK1;DISC1;LRP1;CTSZ;CTNNBIP1;PRMT8;PSME3IP1;DERL1;ITGB1BP1;TLE5;USP33;SORL1;BTBD1;FLOT1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3032536833501691,0.7236226526891352,0.8010610079575596,0.9934250501667532,1.0,1/18,0.91%,CLN3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.30959321860233663,0.7232211175173335,0.8226666666666667,0.993492942311485,1.0,4/18,17.55%,RGS10;CHRM2;GRK2;GNAQ
prerank,negative regulation of heart contraction (GO:0045822),0.33645985946392665,0.7228546447503754,0.8239644970414202,0.9935055817341314,1.0,3/11,20.90%,ATP1A2;GRK2;SPTBN4
prerank,N-glycan processing (GO:0006491),0.30994747759289376,0.7227655437531466,0.7989556135770235,0.9932114147923496,1.0,3/18,7.62%,ST8SIA3;MGAT4B;MAN1A2
prerank,autophagy of nucleus (GO:0044804),0.3153536310667167,0.7226311527429047,0.8049113233287858,0.9929695079029661,1.0,5/16,18.15%,WIPI1;ATG2A;ATG13;ATG3;ATG9A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.250821006828738,0.722427346309296,0.8786565547128927,0.9928185083653055,1.0,9/68,12.48%,SLC25A19;FPGS;PCCB;MMAB;FLAD1;NNMT;SLC2A3;ENPP1;PCCA
prerank,cell junction assembly (GO:0034329),0.2441439718557216,0.7222431935344514,0.9047120418848168,0.9926289349280075,1.0,31/100,24.53%,CTNND2;OBSL1;CDK5;FLCN;DSCAM;CDH11;DBNL;CAPZA1;NLGN3;SPOCK2;FARP1;TLN2;CDH18;NLGN2;VMP1;CDH20;CDH19;CDH7;ILK;SLITRK1;MYO9A;CDH9;PCDHB16;CDH10;RYK;SDK1;CDH8;PTEN;NRXN2;CDH2;FLNC
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24447009355733412,0.722220764270664,0.8891235480464625,0.9922605734936177,1.0,11/93,12.93%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP;KLHDC10;PRMT1
prerank,ATP transport (GO:0015867),0.339419218894709,0.7218016926353348,0.8032786885245902,0.9923580311589697,1.0,3/10,18.61%,SLC25A24;CD47;ABCC6
prerank,positive regulation of macroautophagy (GO:0016239),0.26513615543707175,0.721758415062655,0.865909090909091,0.9920068580697409,1.0,16/48,23.41%,TSC2;PIP4K2B;DCN;GPSM1;PIP4K2A;VDAC1;HTT;PIP4K2C;VPS13D;FYCO1;SCOC;RAB3GAP2;UVRAG;SESN1;HSPB8;SH3GLB1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.23374922351122018,-0.7217485787032222,0.8832116788321168,0.9627124708326734,1.0,5/19,19.65%,GNL3L;STN1;NAT10;SRC;CTC1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2477069205509621,0.7216367367255322,0.9065420560747663,0.9917535224089546,1.0,16/88,17.64%,PSMD4;FBXL12;FBXL14;FBXO38;FBXO31;PSMB10;FBXW5;PSMD11;CUL4B;PSME2;PSMC5;CUL5;PSMD1;DMAC2;PSMD6;FBXO9
prerank,long-term memory (GO:0007616),-0.23380949332752407,-0.7215405848752767,0.8214285714285714,0.9616645281990722,1.0,3/19,15.48%,EIF2AK4;CPEB3;NFATC4
prerank,potassium ion homeostasis (GO:0055075),0.2967635160805266,0.7214187513034351,0.8167741935483871,0.991603758357257,1.0,3/23,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.3414795709940102,0.7213719025203599,0.8078668683812406,0.991260323762221,1.0,4/10,21.46%,CAMK2D;OSR1;HECW2;COMMD1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.33086328577630664,0.7210255685872878,0.8044444444444444,0.9912921155240854,1.0,3/11,18.96%,HSP90AA1;QDPR;CALM1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.349052407665614,0.7208693390665014,0.8129713423831071,0.9910850517573316,1.0,3/10,17.00%,DCN;PIK3CB;SPRY2
prerank,tRNA transport (GO:0051031),0.2707053150160962,0.7208041553870437,0.8535108958837773,0.990769884541266,1.0,16/35,25.80%,RAE1;TOMM20;NUP188;NUP210;NUP88;NUP214;NUP153;RANBP2;NUP35;YBX1;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,ribosome biogenesis (GO:0042254),0.23532014834866746,0.7203528505179538,0.9488977955911824,0.99091550870142,1.0,27/187,14.06%,MRPL36;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;GLUL;CUL4B;RBIS;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;MALSU1;NPM1;RPL9;C1D;RPL4;BMS1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2816969740053979,0.720175093930739,0.8266178266178266,0.990733357606404,1.0,5/28,12.23%,BAX;DDX3X;ZDHHC3;BCL2;BLOC1S2
prerank,ether lipid biosynthetic process (GO:0008611),0.3402045662752336,0.7200792670064609,0.8051750380517504,0.9904474910011002,1.0,5/10,23.39%,PEDS1;PEX7;FAR1;GNPAT;CHPT1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.29784712761154375,0.7199429499128084,0.8154450261780105,0.9902170660534227,1.0,3/21,11.50%,CALM3;ATP1A2;CAMK2D
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.21490611209560487,-0.7197584324428169,0.8867924528301887,0.9625137398561333,1.0,9/26,28.50%,ASAH1;NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR;SPHK1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.29865749507950634,0.7196796034797499,0.8339670468948035,0.9901380209037727,1.0,3/21,7.87%,EPHB2;LZTR1;MFN2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2836199244942135,0.7194725831101902,0.847394540942928,0.9899894922258933,1.0,7/27,20.26%,SNAI1;EEF1E1;TWIST1;ATR;DDX5;MDM2;PLA2R1
prerank,telomere capping (GO:0016233),0.3109542358125033,0.7189584880845447,0.8095909732016925,0.9902069282666798,1.0,5/16,18.57%,DCLRE1A;MRE11;RAD50;TERF1;TERF2IP
prerank,morphogenesis of an epithelium (GO:0002009),0.2859922750645828,0.7185939843263379,0.8366336633663366,0.990259975452185,1.0,5/25,15.88%,FGFR2;SOX9;KDM2B;DAG1;AHI1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3110731451375732,0.7180266625671861,0.8227334235453315,0.9905248638716833,1.0,2/15,7.50%,MLYCD;ACAT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3080269040386284,0.7178522331003242,0.8256880733944955,0.9903283163657131,1.0,5/17,22.35%,CALM3;MAGI2;CALM1;CALM2;ITGA1
prerank,RNA interference (GO:0016246),0.3137427037791998,0.7174558348138306,0.8324324324324325,0.9904018035844232,1.0,3/17,12.58%,TARBP2;CELF1;AGO3
prerank,regulation of muscle cell differentiation (GO:0051147),0.2742246000765258,0.7173522284528704,0.8454987834549879,0.9901267768562563,1.0,5/31,15.29%,FGFR2;CDK9;ABL1;BNIP2;TCF3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.23621980265301315,0.717284111172606,0.9455645161290323,0.9898147725645482,1.0,29/166,16.30%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23;TFB1M;POLR1A;SNW1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.251859300641348,0.7171134973345403,0.8678611422172452,0.9896273374780273,1.0,15/59,18.78%,PDPK1;CSNK2A2;PRKCA;CDK5;SBK1;CIT;CAMK2D;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,regulation of myoblast fusion (GO:1901739),0.33077539669088285,0.7169813199546107,0.7997054491899853,0.9893661061258563,1.0,3/11,20.65%,RIPOR2;FLOT1;EHD1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.294505299670636,0.7166864486285158,0.8521400778210116,0.9893067035540256,1.0,8/22,23.03%,ABCA2;IFNGR1;ROCK2;RANBP9;LYN;ABCG1;EPHA4;SP1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.19092234198677352,-0.7165219207563052,0.9428571428571428,0.9648813746327745,1.0,11/43,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2731901827641193,0.7163589311161177,0.8452380952380952,0.9892972500277202,1.0,5/34,15.82%,DUSP18;PTPRF;TNS2;PTPN22;PTPN12
prerank,vitamin D metabolic process (GO:0042359),0.326878396783219,0.7163551087487928,0.8218978102189781,0.9889088524259252,1.0,1/13,7.83%,GC
prerank,renal water homeostasis (GO:0003091),0.28595585579461263,0.7160972260810217,0.8365758754863813,0.988827281836993,1.0,5/23,18.28%,ADCY7;AQP4;ADCY1;ADCY5;PRKAR1A
prerank,zymogen activation (GO:0031638),0.2723865465676622,0.7160003136282341,0.8480278422273781,0.9885498809435149,1.0,7/39,19.31%,GRIN2A;PLAT;PRSS12;CTSH;OMA1;PGK1;MMP14
prerank,"transcription, DNA-templated (GO:0006351)",0.2351535347297925,0.7159741232765634,0.9557344064386318,0.9881935222421963,1.0,54/207,22.18%,NFKB1;SMN1;PARP1;TAF9B;XBP1;TFDP1;SLC25A33;TAF4;POLR2B;CDK9;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;MED4;NFX1;PRMT5;DRG1;GTF2H3;TCEA1;TAF6;NFIX;POLR2K;CCNH;TSC22D1;SETX;CBFB;MMS19;CDC73;GTF2E1;SOX5;PPP5C;DDX5;MAF;CCNT1;MBD1;CDK7;POLR3K;TOPORS;NELFA;TAF1B;KLF13;MLLT3;PKNOX1;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;SNAPC3;GTF2F2;TAF1
prerank,cell proliferation in forebrain (GO:0021846),0.34981976722153196,0.7158776025192756,0.8141732283464567,0.987909640668329,1.0,3/10,14.58%,HOOK3;DOCK7;CEP120
prerank,secretory granule organization (GO:0033363),0.3423217617983119,0.715773029390561,0.8252279635258358,0.9876553130474494,1.0,4/10,23.97%,VPS33B;BLOC1S2;LYST;ABCA1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3014423658587359,0.7155523157098069,0.8058902275769746,0.9875257899070532,1.0,7/20,20.27%,TMBIM1;PID1;TGFB1;MRAP2;PPP2R5A;LZTFL1;DAB2
prerank,endothelial cell migration (GO:0043542),0.26793672049366635,0.7155343844929468,0.8569725864123957,0.9871661541550545,1.0,7/37,16.26%,FSTL1;NRP1;ABL1;PLEKHG5;RAB13;EMP2;ADGRA2
prerank,response to glucocorticoid (GO:0051384),0.28491939050884,0.7150575828013471,0.832089552238806,0.9873395174466165,1.0,2/26,4.02%,ANXA1;ZFP36L1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.25459674109804104,0.7149691226046176,0.8818380743982495,0.9870561452492222,1.0,5/60,7.40%,CCT8;PKIB;HSP90AA1;CCT6A;WRAP53
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2224936890804019,-0.7148010015729999,0.8978723404255319,0.9656600448341921,1.0,9/22,28.50%,MFHAS1;MAP3K4;EMC10;VEGFA;SASH1;ZC3H12A;BMP2;GADD45B;SPHK1
prerank,cGMP biosynthetic process (GO:0006182),-0.2917329696256367,-0.7146845845470001,0.8485804416403786,0.9644947618167714,1.0,2/10,13.98%,GUCY1A1;NPR1
prerank,negative regulation of type I interferon production (GO:0032480),0.26554132257216234,0.7146478417024547,0.8347205707491082,0.9870603283946907,1.0,6/40,11.61%,TNFAIP3;PPM1B;DHX58;SIRPA;IRF3;YY1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3171827081526102,0.7146170844928927,0.8029294274300932,0.9867037514420641,1.0,4/15,20.27%,SMAP1;PIK3CB;SNAP91;DAB2
prerank,regulation of microtubule-based movement (GO:0060632),0.33180338339448867,0.714526711653421,0.8243243243243243,0.9864124963702829,1.0,4/11,23.00%,NEFH;TTC21B;IGBP1;MAP2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.23900815091541364,0.7144739246337245,0.9173553719008265,0.9860756896881029,1.0,25/108,22.11%,BAX;EIF2AK3;FIS1;DDX3X;FAM162A;VCP;CASP9;MALT1;ROBO1;RACK1;DAPK1;MTCH1;MAPT;F3;CASP2;HSPD1;PDCD5;RPS3;DLC1;PDCD6;GSN;PPM1F;HMGB1;TRAF2;SMAD3
prerank,epithelial cell migration (GO:0010631),0.26627137071177276,0.7144407110526779,0.8628841607565012,0.9857291490507534,1.0,4/37,6.07%,ZEB2;FSTL1;NRP1;ABL1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2289778640569668,-0.7143780275606806,0.8773234200743495,0.9635529039648897,1.0,2/19,6.30%,PARD3;EZR
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3142877055811842,0.7143637932274509,0.8193103448275862,0.9854416949463783,1.0,3/16,14.54%,FBH1;KLHL15;HELB
prerank,negative regulation of proteolysis (GO:0045861),0.2737271545577003,0.7140919793156848,0.8417945690672963,0.9853677291541577,1.0,4/34,11.84%,CLN3;CDK5;PLAT;PTPN3
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.28824584715574053,-0.7138993560984298,0.8288288288288288,0.9628191007976002,1.0,7/10,29.78%,NAGK;ST3GAL1;GNPDA2;GNPDA1;AMDHD2;ST6GAL1;NPL
prerank,positive regulation of vasculature development (GO:1904018),0.24218050604006086,0.713842903574789,0.9,0.9852611723586328,1.0,6/94,5.95%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1
prerank,blood vessel diameter maintenance (GO:0097746),0.2726800547620563,0.713742671983282,0.8475609756097561,0.9849773116014665,1.0,6/34,16.76%,EDN3;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.23618153205822484,0.7130634063878274,0.9366197183098591,0.9853826037142029,1.0,13/175,7.67%,SFRP1;ADAMTS7;GBP3;PSMD4;MAP3K14;EDAR;TNFRSF9;ZFP36L1;EDA2R;PSMB10;ZFAND6;PID1;PSMD11
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.2839724177141232,-0.712674684676196,0.8145896656534954,0.962953115490123,1.0,1/10,2.31%,CAV1
prerank,chromatin assembly or disassembly (GO:0006333),0.32865991699543223,0.7121725401695105,0.8295964125560538,0.9860028085421497,1.0,2/11,11.79%,RBBP4;MTA2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.33542945219285303,0.7110505173638749,0.8253477588871716,0.986874489978131,1.0,3/10,15.57%,UPP2;DPYD;NT5C3A
prerank,chromatin remodeling at centromere (GO:0031055),0.2744411317788581,0.7098112061851002,0.84688995215311,0.9879114812530069,1.0,4/31,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,negative regulation of complement activation (GO:0045916),0.3395330234457644,0.7097998597772945,0.8083209509658247,0.9875340200427831,1.0,1/10,5.04%,SERPING1
prerank,response to lipid (GO:0033993),0.23666621318477601,0.7093278603717408,0.9042663891779397,0.9876808726052122,1.0,14/105,15.68%,CDKN2D;IFNAR1;ANXA1;ABCA2;TIRAP;SOX9;LY96;VPS4B;HNRNPA0;RPS6KA3;PTPN22;TGFB1;SMAD6;CTSH
prerank,microvillus organization (GO:0032528),0.31887685955598194,0.7091699995944645,0.8176795580110497,0.9874776355054566,1.0,2/13,7.01%,MINK1;RAP2A
prerank,modulation by symbiont of host process (GO:0044003),0.33466185079093697,0.7090851975640342,0.7972350230414746,0.9871941787787666,1.0,4/10,25.10%,HGS;PGK1;B2M;RPS27A
prerank,regulation of cholesterol storage (GO:0010885),0.31198618669313777,0.7087339744260577,0.842032967032967,0.9872327146742311,1.0,1/15,0.96%,LPL
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2589506336706157,0.7084688620202932,0.8726851851851852,0.9871553363325578,1.0,9/46,18.33%,HDAC3;TCF7L2;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;CPSF6;RBM22
prerank,negative regulation of developmental process (GO:0051093),0.24379240874328437,0.7083919514647488,0.8861439312567132,0.9868505460282285,1.0,11/69,17.72%,SFRP1;FOXM1;SFMBT1;THY1;SOX9;VAT1;MAPT;ROCK2;TGFB1;OMA1;DCC
prerank,copper ion homeostasis (GO:0055070),0.3009601882614605,0.7082011473346959,0.8390177353342428,0.9866858632336027,1.0,5/17,23.36%,XIAP;APP;COMMD1;ATOX1;SLC31A1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2421291781146513,0.7073952575411837,0.90041928721174,0.9872001375393857,1.0,27/88,21.74%,MYO1B;HGS;ARRB1;RAB10;DNAJC6;CLINT1;SCFD1;APP;MYO5A;TXNDC5;SCAMP1;AP4M1;AP1B1;STEAP2;VAMP8;CCDC93;AP4E1;SORL1;KLHL20;AP4S1;RABEP1;EXOC5;FTH1;VAMP7;COMMD1;NAPA;LLGL1
prerank,proton transmembrane transport (GO:1902600),0.2689087374482088,0.7072359667247687,0.8607142857142858,0.9869850414389315,1.0,4/36,12.68%,ATP1A3;ATP6V0E2;ATP1A2;ATP6V0A4
prerank,manganese ion transport (GO:0006828),0.3124808326562351,0.7069804372446082,0.8286516853932584,0.9868682126146234,1.0,2/14,6.66%,ATP2C1;SLC30A10
prerank,negative regulation of centrosome duplication (GO:0010826),0.33329162376190585,0.7068172891661217,0.8263386396526773,0.9866576106975847,1.0,4/11,23.05%,MDM1;NPM1;TMEM67;CDK5RAP2
prerank,pulmonary valve development (GO:0003177),0.3032371009924249,0.7066968614518079,0.8401585204755614,0.9863998776586097,1.0,5/18,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,positive regulation of translation (GO:0045727),0.23954464421375146,0.7064327142572696,0.9100418410041841,0.9862940885880294,1.0,19/94,19.78%,RBM3;TRUB2;DDX3X;CDC123;CNBP;RCC1L;HNRNPD;DHX36;ZCCHC4;YTHDF3;NPM1;UQCC2;YTHDF1;PRR16;FMR1;METTL5;SOX4;YTHDF2;CIRBP
prerank,relaxation of muscle (GO:0090075),-0.2612482170215987,-0.7062079696268069,0.890728476821192,0.9688480975311634,1.0,4/13,13.24%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,superoxide metabolic process (GO:0006801),-0.20671030000707968,-0.706118790015123,0.9362745098039216,0.9676301030221438,1.0,6/29,20.59%,CYB5R4;NOS3;NOX1;PRDX2;NRROS;CYBA
prerank,actomyosin structure organization (GO:0031032),0.24545340147038355,0.7060295010229501,0.8950749464668094,0.986359502967159,1.0,17/75,21.82%,EPB41L4B;MYH14;ARRB1;CIT;MYH10;TPM1;FRMD6;ROCK2;EPB41L3;EPB41L1;TMOD2;CSRP2;CDC42BPB;ITGB1;PDLIM1;MYH9;CSRP3
prerank,microvillus assembly (GO:0030033),0.3107069289771719,0.7059567092769743,0.8267394270122783,0.9860682806517841,1.0,2/14,7.01%,MINK1;RAP2A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.310883513184756,0.7058618577275193,0.8130968622100955,0.985792898481708,1.0,3/15,13.57%,EZH2;NPM1;CDC73
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.28376500560475443,-0.7058452804567023,0.8190184049079755,0.966654344688115,1.0,8/10,43.76%,NAF1;NUFIP1;RUVBL1;PIH1D1;RUVBL2;ZNHIT3;TAF9;PIH1D2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2458720212201667,0.7056814071119998,0.8898488120950324,0.9856193697353975,1.0,12/73,15.53%,BAX;EIF2AK3;FAM162A;VCP;CASP9;ROBO1;RACK1;MTCH1;MAPT;F3;CASP2;HSPD1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.30583392009555027,0.7054883213750552,0.8482269503546099,0.985438365402826,1.0,1/15,2.47%,MLYCD
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2764327702640735,0.7049598043933624,0.848851269649335,0.9856325521491743,1.0,5/27,13.69%,TXNRD1;RRM2B;AK4;AK5;AK6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2758738828098591,0.7038394782849419,0.8605230386052304,0.9865011125064447,1.0,7/28,19.57%,RAC1;NOS1AP;SIRPA;CD47;SIRT5;PRKAG2;MITF
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2745165659536039,0.7035131346512435,0.8648648648648649,0.9864860718034634,1.0,7/27,20.93%,TIRAP;LY96;HSPD1;MAP3K1;TNIP1;TAB1;TAB3
prerank,defense response to virus (GO:0051607),0.23760867557132542,0.703389221120233,0.9113660062565172,0.9862366241828738,1.0,18/100,18.76%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2;CLPB;ABCE1
prerank,cellular respiration (GO:0045333),0.25941353186131644,0.7031458707454101,0.868144690781797,0.9861229535099446,1.0,9/41,19.73%,UQCRC1;SDHA;NDUFS7;MDH2;MTFR1L;ETFA;COQ10A;UQCRC2;OXA1L
prerank,protein localization to centrosome (GO:0071539),0.3058473897024539,0.7027512376415701,0.8508891928864569,0.9862003290278082,1.0,4/17,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,protein localization to organelle (GO:0033365),0.2352493016156322,0.7023794549507532,0.9488229273285568,0.9862601879738875,1.0,30/133,19.51%,TUB;FAM83H;DDX3X;OBSL1;DVL1;TIA1;SNX10;GET1;AUP1;ABCA7;RIPOR1;TOR1B;APP;SERP1;IFT20;COG3;CSNK1D;MTCH2;ATP6V1D;TULP3;SEC61G;TTC21B;ALDH3A2;TOPORS;MDM2;SORL1;RAB6A;WDR35;BANP;STX5
prerank,regulation of BMP signaling pathway (GO:0030510),0.24206353914788387,0.7021583337755573,0.9067524115755627,0.9861162927695584,1.0,19/73,21.52%,SMAD9;FSTL1;SULF1;HTRA3;XIAP;SOX11;RBPJ;LEMD3;SMAD6;UBE2D1;NUMA1;SMURF1;SORL1;FOXD1;PCSK6;NBL1;ACVR2A;SMAD7;SMAD2
prerank,cellular response to organic cyclic compound (GO:0071407),0.2317368947208435,0.7018576449885456,0.9533468559837728,0.9860551740046887,1.0,24/141,18.02%,SFRP1;RORA;ATP1A3;ZFP36L1;CASP7;DMTN;GNG2;ATP1A2;INSIG1;SSH1;RAPGEF1;GABRB3;JUP;TFPI;NCOA4;ROCK2;TGFB1;ADCY1;IMPACT;ADCY5;UBE2L3;TIPARP;HRH1;PKD2
prerank,intestinal lipid absorption (GO:0098856),0.332391713747646,0.7018469735627085,0.8311499272197962,0.985684418429916,1.0,11/11,66.78%,LIMA1;LDLR;CEL;FABP2;ABCG8;NPC1L1;ABCG5;AKR1C1;CD36;SOAT2;UGCG
prerank,B cell receptor signaling pathway (GO:0050853),0.274265425538476,0.7014084889468624,0.8524788391777509,0.9857807591218692,1.0,4/32,14.04%,BAX;TEC;BCL2;BLNK
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.23050991039111207,0.7009148802731076,0.9458631256384066,0.9859255061815785,1.0,38/140,21.89%,FOXM1;RAC1;FLCN;SYDE2;ARHGAP20;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;ARHGEF7;ARHGEF4;RHOD;KALRN;MCF2;ARHGAP21;VAV2;ARHGAP24;PIK3R2;ARAP1;PLEKHG5;FAM13A;AKAP13;ARHGAP29;TRIO;ARHGEF6;PLEKHG2;FGD4;DLC1;MYO9A;STARD13;ARHGAP6;CHN1;ITGAV;PREX1;SRGAP1;RHOU;ARHGAP26;ARHGAP35
prerank,positive regulation of cell aging (GO:0090343),-0.28030165706801724,-0.7007569486595343,0.8217522658610272,0.9708286019698956,1.0,2/11,4.50%,LMNA;SIRT1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.20481957589755775,-0.6995562355916444,0.9364161849710982,0.9707744870086673,1.0,10/28,26.41%,DAB2IP;PSMC2;DDRGK1;AXIN1;RNF139;OSBPL7;PSMC3;CTSC;ECSCR;PRKN
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.31575734755713636,0.6994140286442917,0.8291970802919708,0.9871692479062965,1.0,2/13,8.41%,SAE1;UBA1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.24997376793091775,0.6993873633629532,0.8727477477477478,0.9868152873753859,1.0,7/47,16.48%,GRIN1;SLC5A3;PID1;MAPT;RNF41;TGFB1;AGTR1
prerank,odontogenesis (GO:0042476),0.26618231637048806,0.6993722491552009,0.8819362455726092,0.9864528990697373,1.0,6/35,17.13%,FGFR2;COL1A2;HDAC1;AXIN2;LAMB1;OSR1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2601700476651894,0.698802485491715,0.8731082654249127,0.9866652338236518,1.0,7/40,15.12%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1
prerank,histone H3-K36 demethylation (GO:0070544),0.33337701344018833,0.6986257731705563,0.8484848484848485,0.9864691366546269,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,positive regulation of immune response (GO:0050778),0.24709217489232763,0.6980891598406298,0.8896247240618101,0.9866786560799335,1.0,4/64,8.05%,FCGR2B;POLR3D;XBP1;IFI35
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3087535554009388,0.6974058539161708,0.8328690807799443,0.9870451512663351,1.0,4/16,13.24%,HGS;PIBF1;LEPROT;PARP14
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2673779890638781,0.6969871933439921,0.8678090575275398,0.9871157119566782,1.0,3/30,6.29%,DNAJC7;DNAJB5;BAG1
prerank,melanosome localization (GO:0032400),0.2869094906421251,0.6965521439519824,0.8613989637305699,0.9871945219892173,1.0,3/21,11.66%,BBS7;MYO5A;VPS33B
prerank,negative regulation of DNA recombination (GO:0045910),0.2555729778254918,0.6964512037030803,0.8754325259515571,0.9869155932391941,1.0,9/43,18.57%,POLR2B;FBH1;KLHL15;POLR2K;ATRX;HELB;TERF1;DAXX;TERF2IP
prerank,relaxation of cardiac muscle (GO:0055119),-0.2528756205251219,-0.6962544395371673,0.8848684210526315,0.9730235500828207,1.0,4/13,13.24%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.22033867410346186,-0.6956749540121252,0.919831223628692,0.9723222198973756,1.0,4/22,12.41%,TOX;SLC16A2;LRRK2;PTPRZ1
prerank,monoacylglycerol metabolic process (GO:0046462),0.31061070604536256,0.6953307728808465,0.8301610541727672,0.9877381637322887,1.0,1/13,3.44%,MOGAT3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2524153568654725,0.6950772724866999,0.8804100227790432,0.9876236154860423,1.0,8/48,15.42%,PDPK1;FGFR1;ANXA1;PRKCA;FGFBP1;PTGS2;TGFB1;FOXC2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.25517987343803944,-0.6949301576693087,0.8788927335640139,0.97178149820805,1.0,5/13,27.28%,TBC1D10A;ASPH;BAD;PERP;CYFIP2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.2779876163629205,-0.6948993120323841,0.83125,0.9705323164713356,1.0,1/10,1.33%,TGFA
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.24057547122517126,-0.6948558329999346,0.8776978417266187,0.9693035439264196,1.0,8/16,29.29%,NUS1;HIF1A;SCARB1;GCH1;AKT1;TERT;S100A1;DHFR
prerank,regulation of nervous system development (GO:0051960),0.2583412754712206,0.694519911846306,0.8790419161676647,0.9878573757571341,1.0,4/37,15.23%,SIRT2;PRUNE1;DOCK7;TENM4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.27493744105310053,0.6944432114349418,0.8478543563068921,0.9875665663128914,1.0,13/24,28.26%,PARP1;XRN1;TERF1;TNKS;HNRNPU;PINX1;HNRNPC;TERF2;TENT4B;ERCC4;TNKS2;HNRNPA1;EXOSC10
prerank,regulation of histone acetylation (GO:0035065),0.26477268030932033,0.6939231060211062,0.8828606658446363,0.9877312560451392,1.0,7/33,19.44%,FLCN;HDAC5;ARRB1;PARK7;CTBP1;KMT2A;SETD5
prerank,regulation of interferon-alpha production (GO:0032647),0.2819017437614844,0.6937601741336314,0.8544303797468354,0.9875303083678397,1.0,5/23,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,negative regulation of double-strand break repair (GO:2000780),0.27149786140613275,0.693544047840653,0.8613496932515338,0.9873810658484233,1.0,6/30,16.93%,FBH1;KLHL15;TWIST1;HELB;NUDT16L1;UBR5
prerank,replicative senescence (GO:0090399),0.3206759405380458,0.693120633558102,0.8404726735598228,0.9874579968981066,1.0,5/12,23.45%,ATR;CHEK2;SERPINE1;PLA2R1;ATM
prerank,sphingosine metabolic process (GO:0006670),0.29788896098070217,0.6928277305511396,0.8503401360544217,0.9873957512697799,1.0,2/17,12.87%,ABCA2;PLPP3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3035742071791214,0.6920393344428464,0.844474761255116,0.9878518494146795,1.0,3/17,14.28%,SUCO;WNT4;TGFB1
prerank,signal transduction by p53 class mediator (GO:0072331),0.2661452257117079,0.6911180707028437,0.8784266984505363,0.988445856936807,1.0,6/30,15.78%,STK11;USP10;MDM4;NDRG1;ATRX;DDX5
prerank,regulation of centrosome cycle (GO:0046605),0.284260149440439,0.690603221672999,0.8513157894736842,0.9886060115753758,1.0,4/21,12.27%,FBXW5;CHMP3;VPS4B;NPM1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2414382485488612,0.6905580805043985,0.9148471615720524,0.9882719948706522,1.0,11/64,19.11%,ELOVL1;SLC27A4;HSD17B4;FADS1;CPT2;PTGS2;ACSL6;EPHX2;ACADL;GPX4;ELOVL6
prerank,B cell proliferation (GO:0042100),-0.24168742068565668,-0.6903143586022351,0.8784313725490196,0.9726295533334036,1.0,2/17,10.73%,MEF2C;PTPRC
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2379192487873026,0.6898806053878583,0.9207188160676533,0.9886313632979589,1.0,22/80,23.03%,SMPD2;RBM3;DDX3X;ABCA2;HNRNPD;ZCCHC4;IFNGR1;YTHDF3;NPM1;RACK1;YTHDF1;ROCK2;PRR16;FMR1;METTL5;SOX4;CIRBP;ABCG1;SAMD4A;METTL14;EPHA4;SP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.22701322205289087,0.6896335486916458,0.9512690355329949,0.9885065397606455,1.0,28/136,22.40%,COMMD6;GLIS2;USP7;RWDD3;TNFAIP3;TCF7L2;ARRB1;SIK1;PTCH1;DDIT3;CDK5RAP3;HDAC4;CEBPG;LRRC14;SUFU;NUPR1;CTNNBIP1;ANXA4;PKD2;ERBIN;PRMT2;KLF4;SMAD7;ZNF431;COMMD1;MTURN;TAF1;ID2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.271001029347302,-0.6893181832738563,0.8820058997050148,0.9723317084130289,1.0,5/11,31.76%,CFL2;PLEK;SEMA5A;TRPV4;STMN2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.26336173110077743,0.6887589921996291,0.8751515151515151,0.9890417862539842,1.0,7/33,13.10%,SLBP;CPSF7;CSTF2T;MAZ;NUDT21;CPSF3;SETX
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.27703969220869273,0.6883912493634867,0.8447837150127226,0.9890518442484806,1.0,7/24,23.39%,CALM3;CAMK2D;JPH1;PKD2;CALM1;CALM2;FKBP1A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2290390406955283,0.6876961748920164,0.9696969696969697,0.9894178580710631,1.0,18/163,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;BCL2;RC3H2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.23525342466747173,0.687306043695876,0.916754478398314,0.9894401248202458,1.0,20/87,20.58%,RAC1;NEB;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;PDGFRA;IQGAP1;LRP1;ROCK2;SEMA3E;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1;PTK2B
prerank,neuromuscular synaptic transmission (GO:0007274),-0.21846508034144757,-0.6871288776080202,0.9194915254237288,0.9732238930906743,1.0,10/18,43.44%,ERC1;FCHSD2;SLC5A7;CHRNB1;ERC2;STAC3;KIF1B;FCHSD1;TSPOAP1;CHAT
prerank,spinal cord development (GO:0021510),-0.26408033730720853,-0.6869946687372895,0.8786885245901639,0.972073240844701,1.0,2/12,4.40%,RELN;VIT
prerank,response to glucagon (GO:0033762),0.28442787759620664,0.6864223984571524,0.8672086720867209,0.9899693282150581,1.0,8/19,26.13%,ADCY7;ADCY1;ADCY5;PRKAR1A;CRY1;PRKAR1B;ADCY2;PRKAR2A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2444791778931382,0.6863212725631399,0.8996579247434435,0.9896960690912162,1.0,18/48,25.80%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98;PNPT1;POM121;SEH1L
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3077142632002028,0.6858638286667431,0.848314606741573,0.9897821795063492,1.0,3/13,16.33%,ENPP1;ABHD14B;SULT1A1
prerank,cellular response to hexose stimulus (GO:0071331),0.27714997423376414,0.6856978446920082,0.8666666666666667,0.9895604362696021,1.0,6/23,19.15%,XBP1;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4
prerank,cochlea morphogenesis (GO:0090103),0.32976851108280114,0.6851658984866446,0.8261494252873564,0.9897235437613677,1.0,1/10,8.36%,SOX9
prerank,regulation of inclusion body assembly (GO:0090083),-0.26628050371010803,-0.6848511714546078,0.865814696485623,0.9728840692008864,1.0,8/11,45.88%,SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.24744619987878705,0.6835207776309428,0.9007891770011274,0.9910487254903875,1.0,11/46,21.38%,LCP1;AIP;PSME2;CAPZA1;SOD2;HNRNPA2B1;HNRNPDL;ANXA2;JAK1;TALDO1;CFL1
prerank,DNA recombination (GO:0006310),0.2545609617069551,0.6834845007146583,0.8643274853801169,0.9907090830792333,1.0,3/37,5.73%,XRCC2;HMGB3;FBH1
prerank,signal transduction in response to DNA damage (GO:0042770),0.2489866052193259,0.6834625099109427,0.8994285714285715,0.9903573771334743,1.0,11/49,18.46%,ABL1;USP10;MDM4;NDRG1;CASP9;BRIP1;ATR;ATRX;CHEK2;CLOCK;TIPRL
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27364868412970234,0.6832501300548552,0.8753213367609255,0.9901955604869285,1.0,4/25,16.64%,ITPR1;HTT;MAPT;RIT2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.1868171521443918,-0.6830520305282445,0.9515151515151515,0.9733290523884759,1.0,4/33,7.64%,TGFA;AFAP1L2;BCAR3;DGKD
prerank,rRNA metabolic process (GO:0016072),0.2250643959475707,0.6823652901010787,0.9577039274924471,0.9907271384161714,1.0,23/160,14.80%,EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;MAPT;BMS1;XRN1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2788855883545883,0.6820789670823869,0.8857868020304569,0.9906507178861226,1.0,4/23,15.32%,SIK1;HDAC4;GIT1;NUPR1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.313483792243857,0.6820123938882252,0.8473609129814551,0.9903323801235793,1.0,2/12,10.86%,BIN1;JUP
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28249877033465454,0.6814977160552058,0.8701799485861182,0.9904935789495932,1.0,4/20,17.55%,RGS10;CHRM2;GRK2;GNAQ
prerank,cellular response to radiation (GO:0071478),-0.18460338142087002,-0.6812893077115862,0.9411764705882353,0.9736965487283717,1.0,6/40,9.55%,SIRT1;NET1;SPIDR;SWI5;TP53;RHOB
prerank,positive regulation of locomotion (GO:0040017),0.2647970192082944,0.6811312895766589,0.8739393939393939,0.9904680026583067,1.0,4/27,14.28%,TWIST1;CFAP20;SPOCK2;TGFB1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2677117075581343,-0.6804985531741867,0.8878504672897196,0.9731526155416685,1.0,6/11,25.31%,CAV1;ADIPOR1;PTPRT;SH2B3;VHL;BCL3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.22220966178610152,-0.6801177116973285,0.9049773755656109,0.9709525188041223,1.0,4/21,10.43%,MCL1;BCL2L1;EYA3;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.22220966178610152,-0.6801177116973285,0.9049773755656109,0.9709525188041223,1.0,4/21,10.43%,MCL1;BCL2L1;EYA3;EYA4
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.245147499389509,-0.6787646615431244,0.8529411764705882,0.9710020114865062,1.0,6/15,27.32%,ZFYVE27;NGF;SORT1;CASP3;DDIT4;BDNF
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.2850108611411176,0.6781417995503648,0.856953642384106,0.9930866139620139,1.0,3/19,11.79%,XBP1;XRCC6;ZMIZ1
prerank,heart morphogenesis (GO:0003007),0.24426292781453918,0.6781152941870655,0.9179775280898876,0.9927294896934322,1.0,10/50,20.60%,NIPBL;OLFM1;SOX9;FLRT2;MDM4;MEGF8;TGFBR1;DLC1;CHD7;TGFBR3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.2842908558302474,0.6778048599976472,0.8629032258064516,0.9926547151892997,1.0,2/18,4.31%,HSP90AA1;ABCA2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2508228186619053,-0.6776424301835337,0.889261744966443,0.9707831621318364,1.0,5/13,17.80%,RREB1;NAPEPLD;BMP7;SIX1;TFE3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.28585830908937676,0.6776122671754418,0.8687415426251691,0.9924598435851609,1.0,5/19,19.75%,WNT5A;CD24;CBFB;TLE5;KLF4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.2809828397076075,0.6769369337070096,0.8731642189586115,0.9927462968508287,1.0,6/19,22.16%,FGFR2;RBPJ;TGFBR1;TGFBR3;FGF2;ERBB4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3119110630546066,0.6768037738339236,0.8434650455927052,0.9925028442893521,1.0,2/11,12.08%,CAAP1;PARK7
prerank,protein acylation (GO:0043543),0.25573905501376826,0.676515310922038,0.8923076923076924,0.9924100623765331,1.0,11/38,22.95%,NAT9;ZDHHC3;GLUL;PORCN;CLOCK;ZDHHC17;ZDHHC2;FOXO1;GTF2B;ZDHHC14;ZDHHC21
prerank,lipid modification (GO:0030258),0.24944365194751383,0.6757717923793393,0.8842482100238663,0.9927834943514149,1.0,10/37,21.55%,PLPPR2;PORCN;PLPP3;PLPPR5;EPHX2;PLPP4;PLPP5;DGKI;PLA2G7;MBOAT2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.2518902884932595,-0.6757418723229273,0.890728476821192,0.9712338440848166,1.0,6/12,26.59%,ATP1B3;DMD;ATP1B1;FXYD1;WNK1;NOS1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3196432875074279,0.6756541767208583,0.8454106280193237,0.9925273095614717,1.0,2/10,13.55%,MAPK8IP1;PTPN22
prerank,negative regulation of viral entry into host cell (GO:0046597),0.31241558628982297,0.6756343333568676,0.8656294200848657,0.9921703668840227,1.0,5/12,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2308242307460414,0.6754114460717481,0.9124324324324324,0.9920203455292751,1.0,15/76,21.84%,COMMD6;USP7;RWDD3;TNFAIP3;ARRB1;DDIT3;CDK5RAP3;LRRC14;FAF1;ANXA4;ERBIN;PRMT2;KLF4;COMMD1;MTURN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24396469317156552,0.6751514130837597,0.8943820224719101,0.9919179087142028,1.0,8/50,17.73%,CDKN2D;CDC25A;CDK5RAP3;CCNH;CCNT1;CDK7;BCCIP;CAMK2N1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3034859271287043,0.6747589633156766,0.8702928870292888,0.9919438206276191,1.0,2/13,12.01%,ENTPD7;ENPP1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.2616535422253817,0.6744880407610868,0.9093078758949881,0.9918537196456609,1.0,8/35,19.10%,PDE7B;SOX9;HTR2C;ADCY1;EPHA5;APOE;PDE9A;KSR1
prerank,cytosolic transport (GO:0016482),0.22936895995582524,0.6738892072475694,0.9573361082206036,0.9920530046590776,1.0,36/108,25.13%,CLN3;SNF8;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;HOOK3;DENND5A;VPS54;VTI1B;WDR91;EMP2;AP4M1;STX8;VTI1A;PIK3C3;KLHL20;RAB6A;TRIM27;STX5;HEATR5A;RAB7A;EHD3;PIKFYVE;GOSR1;CCDC91;DENND2A;EEA1;DOP1B;GGA1;HEATR5B;SNX16
prerank,hydrogen peroxide catabolic process (GO:0042744),0.31443051529821076,0.6734404645138814,0.8601503759398497,0.9921162369053517,1.0,2/11,14.59%,PRDX5;PXDN
prerank,cell projection organization (GO:0030030),0.25939957162098193,0.6729793039334033,0.8906832298136645,0.9921809019999039,1.0,8/30,21.42%,RAC1;NEFH;CYFIP1;NPHP1;ATP1B2;ITGB1;RHOU;GSN
prerank,amino acid transport (GO:0006865),0.24490435104468491,0.6729142208586497,0.923950056753689,0.9918736427510852,1.0,7/49,15.33%,SLC7A11;SLC38A9;SLC7A2;SLC38A10;SLC6A15;SLC1A5;SLC6A12
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.31670419110131753,0.6723087963640987,0.8401826484018264,0.9920814963425042,1.0,2/10,18.28%,SCRIB;PRKAR1A
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2871316548047981,0.6717587760718958,0.866225165562914,0.9922555460712071,1.0,3/19,14.28%,SUCO;WNT4;TGFB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.2976484630741412,0.6712033361510177,0.8655221745350501,0.9924035919521349,1.0,2/14,11.13%,WNK2;ANK3
prerank,dendrite self-avoidance (GO:0070593),0.2943370795180692,0.6711937552658629,0.8636363636363636,0.9920387061677097,1.0,4/16,20.32%,DSCAM;NPTN;CNTN2;NEXN
prerank,regulation of microtubule depolymerization (GO:0031114),0.26595338845781136,0.6709437516141787,0.8767123287671232,0.9919078799353046,1.0,3/25,9.89%,TAOK1;CAMSAP2;KATNB1
prerank,positive regulation of cholesterol transport (GO:0032376),0.2647705625250677,0.6705589579220137,0.8886075949367088,0.9918971385229537,1.0,7/27,20.04%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;ABCA5
prerank,glucose transmembrane transport (GO:1904659),0.2809185593877438,0.6705134274776188,0.8623376623376623,0.991562749218589,1.0,2/18,11.24%,SLC5A3;SLC2A3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2372522021845776,0.670394326985812,0.918232044198895,0.9912913265972015,1.0,13/54,21.09%,NHP2;EBNA1BP2;MRPL1;RPL35A;MALSU1;NPM1;LAS1L;RPL23A;NSA2;BRIX1;RSL1D1;HEATR3;RPL7
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.2836500638970829,0.6701484140468481,0.8841544607190412,0.9911628228204408,1.0,6/18,20.58%,GRIN1;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,negative regulation of receptor internalization (GO:0002091),0.3066363722358427,0.6691686899231241,0.8621700879765396,0.9917326051411299,1.0,2/12,8.75%,LRPAP1;SDCBP
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2525420131749081,0.667464975620871,0.8941605839416058,0.9929751960694495,1.0,5/33,19.43%,UBASH3A;THY1;PTPN22;PRKD2;RPS3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.31502380111318784,0.6673970058737044,0.8764880952380952,0.9926649732613372,1.0,4/10,26.70%,DCLRE1A;TERF2IP;RIF1;TERF2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2952641917049095,0.6673643779664449,0.8657142857142858,0.9923203714623207,1.0,3/15,20.88%,CUEDC2;TGFB1;SMAD7
prerank,cytokine-mediated signaling pathway (GO:0019221),0.21564715009090735,0.667082124695786,1.0,0.9922266897695812,1.0,68/532,17.01%,IL10RA;LCP1;CAMK2B;IL34;PSMD4;NFKB1;MAP3K14;HSP90AA1;IL33;EDAR;IFNAR1;TNFRSF9;IL10RB;STAT6;ANXA1;RORA;CXCL12;EDA2R;POU2F1;IL31RA;IRF1;PIK3R1;SQSTM1;PSMB10;ZEB1;IFIT3;PSMD11;IL22;IFI35;LRP8;TRIM62;TXLNA;AIP;IFNGR2;TEC;RAPGEF1;TWIST1;PRLR;PSME2;IRS2;PSMC5;CAPZA1;PIK3CB;BCL2;LEPR;IFNGR1;IRF3;CAMK2D;COL1A2;CAMK2G;SOD2;TNFRSF25;PTGS2;HNRNPA2B1;TGFB1;BCL6;CBL;F3;IL15RA;PSMD1;HNRNPDL;ICAM1;IL1RAP;IL5;SLC27A1;ANXA2;OAS2;PSMD6
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.27991632096459385,0.6664767291612447,0.8751608751608752,0.9924094010628559,1.0,3/19,15.41%,AQP4;RFX3;OFD1
prerank,NAD biosynthetic process (GO:0009435),0.2780860506102758,0.666207810733803,0.8878248974008208,0.9923010442581327,1.0,4/20,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,histone lysine methylation (GO:0034968),0.2503379929955729,0.6654572859546506,0.9096385542168675,0.9926369059538034,1.0,8/33,19.43%,KMT2B;EZH2;EHMT2;DPY30;SUV39H1;KMT2D;KMT2A;KDM6A
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2713438189266501,0.6654475533906025,0.8612565445026178,0.9922709099556406,1.0,3/20,14.18%,LCP1;RAB13;ROCK2
prerank,anterior/posterior pattern specification (GO:0009952),0.24116108629746302,0.6651945182592361,0.9220489977728286,0.992121947109375,1.0,4/53,9.61%,ATP6AP2;PCSK5;DDIT3;WLS
prerank,mRNA polyadenylation (GO:0006378),0.260737436021997,0.6651753344151854,0.8846153846153846,0.9913977726835507,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,RNA polyadenylation (GO:0043631),0.260737436021997,0.6651753344151854,0.8846153846153846,0.9913977726835507,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,nitric oxide mediated signal transduction (GO:0007263),0.2873754496046021,0.6645182030957815,0.8819345661450925,0.9916247191607596,1.0,3/16,17.19%,KCNC2;NDNF;APOE
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.320623893618645,0.6641860749691841,0.8687782805429864,0.9915726997148597,1.0,1/10,4.50%,CXCL12
prerank,negative regulation of viral genome replication (GO:0045071),0.2480430293479643,0.6637275969735773,0.8962703962703963,0.9916450302868892,1.0,7/40,18.61%,ILF3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;MPHOSPH8
prerank,cholesterol biosynthetic process (GO:0006695),0.256398644027542,0.6637204726496428,0.8886198547215496,0.9912785320095869,1.0,5/31,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.28568415305981004,0.6632571757936354,0.861878453038674,0.9913358951181539,1.0,3/16,20.99%,FANCM;RMI1;TOP2B
prerank,membrane lipid biosynthetic process (GO:0046467),0.23876774534622366,0.6631142119923138,0.9317673378076062,0.9910968885494484,1.0,11/58,19.11%,ELOVL1;ST3GAL2;CERS2;SGPL1;ELOVL4;SPTSSA;PLPP3;VAPB;ALDH3A2;PRKD2;ELOVL6
prerank,activation of protein kinase A activity (GO:0034199),0.2837091707496232,0.6630544625766399,0.8675034867503487,0.9907826336940667,1.0,4/16,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,polyol metabolic process (GO:0019751),0.2434987841881884,0.6628677088743764,0.9190751445086706,0.9905813460612003,1.0,12/46,20.53%,PLCH1;SLC5A3;INPP5A;NUDT3;IPPK;ISYNA1;IPMK;IP6K1;CALM1;IMPA1;INPP4A;ITPK1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.31212199682203734,0.6615285113701813,0.8825301204819277,0.991437227731188,1.0,1/10,6.68%,MIA3
prerank,protein localization to lysosome (GO:0061462),0.2609867538650818,0.6613102550232204,0.9151061173533084,0.9912757116595343,1.0,10/28,23.25%,HGS;NCOA4;LAMTOR5;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3;LMBRD1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.25256274918537314,0.6613000205197824,0.8915956151035322,0.9909117716924476,1.0,2/31,2.90%,BAX;STUB1
prerank,muscle contraction (GO:0006936),0.22102182060119907,0.661087465862908,0.9603658536585366,0.9907553234146702,1.0,9/126,11.40%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;BDKRB2;TPM1;SLC6A8
prerank,positive regulation of biosynthetic process (GO:0009891),0.24631613223004797,0.660807639811419,0.929384965831435,0.9906384476360145,1.0,7/40,17.19%,GRIN1;SLC5A3;SUCO;WNT4;ZBTB20;TGFB1;APOE
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2674076973209488,0.6602433507282777,0.8858625162127107,0.9907659743139385,1.0,3/23,10.19%,SOX9;EGF;GDNF
prerank,modulation by host of viral genome replication (GO:0044827),0.29978810171012077,0.6598236941591451,0.8767908309455588,0.9907765871557556,1.0,6/13,22.29%,PPIB;TBC1D20;NUCKS1;FMR1;YTHDC2;IFI27
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.21909248496993175,-0.6597390110491456,0.9214876033057852,0.9837497588434376,1.0,4/18,14.70%,EZR;CD34;PTPRC;HOMER3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.26402756219648704,0.6594264066714776,0.8942065491183879,0.9907886517763668,1.0,2/26,4.91%,CHERP;ITPR1
prerank,protein-DNA complex assembly (GO:0065004),0.2217951959068708,0.6583270128346009,0.9427402862985685,0.9914230332275186,1.0,21/116,17.03%,PSMD4;PARP1;TCF4;ASF1A;PSMB10;DDB1;PSMD11;SOX9;ORC6;CUL4B;GTF2H3;PSME2;PSMC5;SART3;CCNH;NPM1;ATRX;PSMD1;DAXX;PSMD6;CDK7
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.24893779131976476,-0.6581510845949101,0.878125,0.9837307056156155,1.0,3/12,30.01%,IL17D;CD80;PAEP
prerank,ncRNA 3'-end processing (GO:0043628),0.29756770967774765,0.6581439713334549,0.8643578643578643,0.991215328396477,1.0,5/14,21.77%,TOE1;PTCD1;INTS6;INTS2;INTS7
prerank,regulation of adenylate cyclase activity (GO:0045761),0.26781684206739986,0.6572625405152202,0.9,0.9916485954338363,1.0,2/22,7.66%,LTB4R2;ADGRV1
prerank,regulation of endocytic recycling (GO:2001135),0.3074404736720812,0.656583501549034,0.8579626972740315,0.991902265388477,1.0,5/11,22.41%,ATP9A;EIPR1;SORL1;EHD1;RAB11B
prerank,negative regulation of cell activation (GO:0050866),0.29428358705705615,0.6564989945331251,0.8677685950413223,0.9916082883298167,1.0,3/14,17.19%,C1QTNF1;PDGFRA;APOE
prerank,response to laminar fluid shear stress (GO:0034616),0.3108222143918174,0.6551208593786434,0.8620689655172413,0.9925015227727468,1.0,5/10,23.97%,SMAD6;ASS1;KLF4;SMAD7;ABCA1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.2911666425465847,0.6548338867982312,0.8874269005847953,0.9923920757622763,1.0,3/13,17.57%,SNAI1;TWIST1;MDM2
prerank,camera-type eye morphogenesis (GO:0048593),0.3169830353308649,0.6534256275016697,0.8738872403560831,0.9932825358865317,1.0,2/10,10.68%,TENM3;KDM2B
prerank,adipose tissue development (GO:0060612),0.3063939448376981,0.6533629414055967,0.8541666666666666,0.9929710251946895,1.0,1/11,3.80%,XBP1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.31214695393038744,0.6532969048927798,0.8586626139817629,0.9922959998920432,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.31214695393038744,0.6532969048927798,0.8586626139817629,0.9922959998920432,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2354871013075781,0.653236999640093,0.9122807017543859,0.9919753929915914,1.0,10/44,20.46%,UCHL1;MAPK8IP1;CDK5RAP3;PIK3CB;PTPN22;SPRY2;APOE;SORL1;SMPD1;LYN
prerank,positive regulation of cartilage development (GO:0061036),0.28068716931021054,0.6527689635745472,0.9010554089709762,0.9920367080868145,1.0,4/17,17.65%,SOX9;SOX6;SOX5;BMP1
prerank,erythrocyte development (GO:0048821),-0.27139017665319076,-0.6525833350725084,0.8710691823899371,0.9866677792911132,1.0,4/10,24.04%,MED1;ABCB10;SH2B3;NCKAP1L
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.24796123471930684,0.6525303538895745,0.9009433962264151,0.9918797977665693,1.0,14/36,25.49%,RAB34;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF;GORASP1;RAB7A;GGA3;GOLGA4;GOLPH3L;GGA1;AFDN
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.23591787881607268,-0.6508892092361591,0.8606811145510835,0.9866729190716816,1.0,3/12,16.45%,NELFB;REST;HES1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.24565066266927205,-0.650641790245836,0.890282131661442,0.9855674928723199,1.0,5/12,26.33%,ESR1;PPARG;ELAVL1;ZC3H12A;TERT
prerank,regulation of RNA export from nucleus (GO:0046831),0.3071278854647787,0.6505827145840754,0.904833836858006,0.9931832877792783,1.0,5/11,23.44%,AKAP8L;CPSF6;NUP153;TPR;KHDRBS1
prerank,glutathione metabolic process (GO:0006749),0.2429496485358692,0.6497273020865942,0.8990384615384616,0.9935538835333306,1.0,8/38,20.02%,GSTT1;CNDP2;PARK7;GCLC;ETHE1;DPEP1;HAGH;GSTT2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.29577023549972536,0.6496695872252916,0.8646723646723646,0.9932305034678729,1.0,2/12,18.27%,MIA3;ASS1
prerank,centromere complex assembly (GO:0034508),0.24667244321736143,0.6487916882738399,0.9153936545240893,0.9936105945729344,1.0,4/36,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,DNA methylation (GO:0006306),0.2635864845190293,0.6483774422881807,0.9055900621118013,0.9936034076807533,1.0,4/23,13.81%,PICK1;EHMT2;EHMT1;ATRX
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2692600850451947,0.6482333290591351,0.9090909090909091,0.9933520882336386,1.0,3/20,10.90%,SNAI1;OLFM1;RBPJ
prerank,regulation of interferon-gamma production (GO:0032649),0.22756357969631616,0.6466905385960328,0.9354485776805251,0.9942936738797772,1.0,9/71,15.76%,SCRIB;SIRPA;DDIT3;CD47;CEBPG;TLR3;PTPN22;HSPD1;PDE4B
prerank,regulation of protein localization to nucleus (GO:1900180),0.23797623641374815,0.6459475179176419,0.9329479768786128,0.9945396106158266,1.0,7/43,14.28%,EIF2AK3;FLCN;GLUL;CDK5RAP3;PARK7;LAMTOR5;TGFB1
prerank,response to growth factor (GO:0070848),0.23855230511109743,0.6456176544595739,0.9137931034482759,0.9944398267297452,1.0,8/41,20.76%,SFRP1;TBC1D7;PLK5;RACK1;ACVR1B;TGFBR1;KLF4;ACVR2A
prerank,B cell activation (GO:0042113),0.22676159906437746,0.6450444009601525,0.9368983957219251,0.9945513418474683,1.0,9/68,15.53%,EPHB2;HDAC5;HDAC4;MALT1;BCL2;CEBPG;BLNK;TCF3;HSPD1
prerank,response to tumor necrosis factor (GO:0034612),0.21939073271822307,0.6449861679462959,0.9454926624737946,0.9942404800444794,1.0,6/91,7.65%,SFRP1;ADAMTS7;GBP3;ZFP36L1;ZFAND6;PID1
prerank,actin filament capping (GO:0051693),-0.21633986754244153,-0.644832436403019,0.9299610894941635,0.987203889433109,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,barbed-end actin filament capping (GO:0051016),-0.21633986754244153,-0.644832436403019,0.9299610894941635,0.987203889433109,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.24673462618959802,0.6443450182577715,0.9276236429433052,0.994392826890802,1.0,2/32,7.78%,RNASE7;FAM3A
prerank,negative regulation of endothelial cell migration (GO:0010596),0.24700274093134697,0.6442747376882457,0.9259708737864077,0.994085504579321,1.0,11/36,22.00%,NR2F2;DCN;JUP;TGFB1;APOE;SYNJ2BP;MECP2;KRIT1;ATP2B4;FGF2;HMGB1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.23375112307120952,0.6437218741378901,0.928817451205511,0.9942049312340108,1.0,4/49,13.24%,IGF1;IL31RA;PIBF1;PARP14
prerank,reverse cholesterol transport (GO:0043691),0.2864657663831468,0.6433813358746987,0.914651493598862,0.9941033253938054,1.0,4/13,23.97%,APOE;ABCA5;ABCG1;ABCA1
prerank,nucleotide metabolic process (GO:0009117),0.2591267809883929,0.6431931533942067,0.9323116219667944,0.9939050766796774,1.0,4/23,12.08%,DCK;AK4;AK5;PARK7
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.24952860473639207,0.6427953262386839,0.892059553349876,0.9938519972692992,1.0,4/26,13.92%,FGFR1;GDNF;BCL2;EYA2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3055852775259973,0.6417532554502281,0.8795180722891566,0.9943499864286605,1.0,1/10,8.54%,DDIT3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.28973777593381994,0.6417253981579403,0.8809869375907112,0.9940047865252382,1.0,4/13,24.79%,ZBTB7B;CBFB;GLI3;RUNX1
prerank,sulfur compound biosynthetic process (GO:0044272),0.21443421184302014,0.6416870785108101,0.9656964656964657,0.9936666874881032,1.0,12/104,13.12%,SLC35B2;CHPF;SLC35D2;GSTT1;ST3GAL2;DCN;ST3GAL3;CHSY3;CNDP2;B4GALT5;OMD;GCLC
prerank,cellular response to interleukin-1 (GO:0071347),0.2128417996002367,0.6412856978479738,0.9766260162601627,0.9936451133315635,1.0,13/143,10.46%,SFRP1;ADAMTS7;GBP3;PSMD4;NFKB1;SQSTM1;PSMB10;SIRPA;PSMD11;SOX9;USP10;PSME2;PSMC5
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2301686900224124,0.6409165611905401,0.9443207126948775,0.9935918670485678,1.0,11/54,19.43%,SIRT7;OGT;TNFAIP3;SQSTM1;ARRB1;PARK7;USP4;PIAS3;SPRY2;SOX4;RPS3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.25000637997679226,0.6407503505849914,0.9153374233128835,0.9933680396009484,1.0,10/30,23.91%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PDCD5;RHOU;SH3GLB1;FBXW7
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3075261260541471,0.6403511106893274,0.9009009009009009,0.9933476784659075,1.0,2/10,13.81%,JARID2;ATRX
prerank,cell cycle G1/S phase transition (GO:0044843),0.2258609303561065,0.6395413041322527,0.9506037321624589,0.9936532150483446,1.0,10/61,17.03%,CDKN2D;CDC25A;CUL4B;E2F3;CCNH;RCC1;GSPT1;CUL5;ACVR1B;CDK7
prerank,cellular protein metabolic process (GO:0044267),0.20825496508695385,0.639528172862911,0.999,0.9932983715750693,1.0,63/396,17.62%,IGF1;MRPL36;FARSB;ARAF;LCMT1;CP;UBE2S;WARS1;FSTL1;YARS2;PCSK5;LAMC1;ABL1;MIA3;CKAP4;RAB12;LTBP1;HM13;MANBA;PABPC4;FAM20C;APLP2;MRPL10;PLAT;MBTPS1;RPL35A;RPS25;AFG3L2;APP;IGFBP3;SARS1;IGFBP7;RPS15;PAPPA;RPL9;FBN1;SERP1;HARS1;MRPL3;GSPT1;LAMB1;RPL4;SFTPA1;SFTPA2;ATG3;MRPL13;RPN2;CTSH;MRRF;CHEK2;SERPIND1;MRPL24;NEDD8;UBE2L3;RPL23A;PARL;MXRA8;APOE;RPLP2;TNIP1;FBXO22;PCMT1;OMA1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.23210838139427437,0.638812647110845,0.9253393665158371,0.9935106095850091,1.0,7/48,18.85%,SCRIB;CEBPG;TLR3;PTPN22;HSPD1;PDE4B;TRIM27
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2230570967823534,0.6387072902768103,0.9498364231188658,0.9932433882933351,1.0,17/62,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.30698116243340984,0.6383767556971209,0.8990825688073395,0.99316456614153,1.0,2/10,7.32%,SMARCB1;HDAC5
prerank,regulation of anoikis (GO:2000209),0.2650418984533319,0.6382342156914653,0.8934210526315789,0.9929077206926673,1.0,6/19,22.29%,SIK1;BCL2;ANKRD13C;TLE5;ITGB1;ITGA5
prerank,regulation of sensory perception of pain (GO:0051930),0.29942895081842014,0.638209641045227,0.888235294117647,0.992564926856556,1.0,2/11,15.49%,ZFHX2;ATPSCKMT
prerank,telomere maintenance (GO:0000723),0.23134700247849263,0.637556523311089,0.9397727272727273,0.9927490606030266,1.0,10/50,18.57%,ZBTB48;PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TPRKB;TERF2IP
prerank,T cell proliferation (GO:0042098),-0.23253994913898535,-0.6363344542031356,0.9101123595505618,0.9918041721141992,1.0,3/13,16.70%,CADM1;LMBR1L;MSN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2239857764359497,0.6363035658257772,0.9471947194719472,0.9933670137852263,1.0,11/57,22.00%,FIS1;GRIN1;DDX3X;GRIN2A;MALT1;DAPK1;PDCD5;USP50;PDCD6;PPM1F;HMGB1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3003810570319325,0.6356987463427011,0.892128279883382,0.9935062639182708,1.0,2/11,10.25%,ARHGEF7;ENPP2
prerank,mitotic chromosome condensation (GO:0007076),0.2518777281595183,0.6349698621892251,0.9181141439205955,0.9937063362686458,1.0,2/26,6.66%,CSNK2A2;AKAP8L
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.28393460354084177,0.6343364369725886,0.8877400295420975,0.9938310304907374,1.0,5/14,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,cellular response to leucine starvation (GO:1990253),-0.26057164047116305,-0.6331758366304114,0.91875,0.9926150621910697,1.0,3/10,13.48%,EIF2AK4;RRAGB;LARS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.24871008475484274,0.6321166090453241,0.9129353233830846,0.9951982933540554,1.0,4/26,12.24%,FBXO7;GPR37;PARK7;SOD2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.29058943371324586,0.6318383552333955,0.9085631349782293,0.9950531466968142,1.0,3/12,17.04%,KIF3A;HOOK3;NIN
prerank,regulation of hippo signaling (GO:0035330),0.27250079660148413,0.6315511130073161,0.9027777777777778,0.994917768184159,1.0,6/17,23.31%,CIT;SOX11;WWC1;NF2;DLG5;MAP2K3
prerank,activin receptor signaling pathway (GO:0032924),0.2807377691722075,0.6314866365058999,0.8949579831932774,0.994602911797687,1.0,5/15,22.11%,ACVR1B;TGFBR1;ACVR2A;SMAD2;SMAD3
prerank,positive regulation of angiogenesis (GO:0045766),0.21153034298917905,0.6313213008885136,0.9636174636174636,0.9943751802706842,1.0,16/108,18.03%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1;TWIST1;JUP;ADAM12;F3;FOXC2;CTSH;SERPINE1;MTDH;PRKD2;JAK1
prerank,cellular response to cAMP (GO:0071320),0.24095785863477814,0.6312976650810366,0.9339045287637698,0.9940289378139279,1.0,3/30,9.43%,ZFP36L1;DMTN;RAPGEF1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.22734205124721546,0.6312443276535914,0.9415073115860517,0.9937054599443553,1.0,13/51,20.88%,SMAD9;FSTL1;HTRA3;LEMD3;FBN1;SMAD6;UBE2D1;SMURF1;GREM2;SORL1;NBL1;ACVR2A;SMAD7
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2917192924846864,0.6311087215826344,0.9113018597997139,0.9934432994191091,1.0,2/12,17.51%,SOAT1;MTTP
prerank,regulation of mononuclear cell migration (GO:0071675),0.2552222897488063,0.6304497961559337,0.9313984168865436,0.9935891045134395,1.0,1/23,1.28%,IL34
prerank,cellular response to ionizing radiation (GO:0071479),0.22816329017687975,0.6299044364059531,0.9329479768786128,0.9936577042077079,1.0,8/47,17.57%,KDM4D;NIPBL;XRCC6;ATR;NUCKS1;CLOCK;TANK;MDM2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.2745494218351817,0.6293463252082072,0.9233926128590971,0.9937255402819024,1.0,4/16,21.29%,GDNF;PKD2;FOXD1;FGF2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.28524667845706825,0.6284104924909633,0.8877697841726618,0.9940761743000784,1.0,3/12,15.88%,SCRIB;RAB10;AHI1
prerank,regulation of cell morphogenesis (GO:0022604),0.2458904438815664,0.6269050945049598,0.9193548387096774,0.9948362292028582,1.0,11/30,25.96%,PDZD8;SPARC;NTNG2;PHIP;MYO9A;CFL1;CAMSAP1;STRIP1;SH3D19;ZMYM6;BCL9L
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2786775628648777,0.6264994943713673,0.9108367626886146,0.9947727558560421,1.0,1/14,2.36%,DDX18
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.26393858630749756,0.626211561390127,0.9036939313984169,0.9946323698980587,1.0,6/18,23.03%,ABCA2;IFNGR1;ROCK2;ABCG1;EPHA4;SP1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2182889793606325,0.6254191750314623,0.962800875273523,0.994885644165248,1.0,17/64,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.23927047963151551,-0.6237703518981987,0.9316546762589928,0.9958719394995891,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.23927047963151551,-0.6237703518981987,0.9316546762589928,0.9958719394995891,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,regulation of transferase activity (GO:0051338),-0.212535441729192,-0.6226179118674192,0.9454545454545454,0.9953115158452874,1.0,9/17,37.64%,FEM1B;SMG6;FEM1A;NLRC5;PPP1R3F;SPTSSB;BAG5;JMJD8;HMBOX1
prerank,sterol biosynthetic process (GO:0016126),0.2383975521189917,0.6219145260297075,0.925748502994012,0.9970769705546438,1.0,5/33,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.24522545478930152,-0.6214107648228816,0.9290123456790124,0.9947111435471055,1.0,7/10,39.59%,HSP90AB1;FN1;LAPTM4B;GATA6;TSKU;TYROBP;CDH3
prerank,amyloid fibril formation (GO:1990000),0.22431792228298533,0.6212324548644994,0.951165371809101,0.9972021149690459,1.0,19/51,25.85%,APP;USP9X;MAPT;GGA2;HSPG2;ITM2B;MDM2;SORL1;GSN;H3-3A;B2M;GGA3;FKBP1A;IAPP;SIAH2;GGA1;RPS27A;TSPAN14;FURIN
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.26426547769682707,0.6209117685015358,0.9048257372654156,0.9970724350322205,1.0,3/18,18.27%,MIA3;PTPN22;ASS1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.22990493381426133,0.620778554348594,0.9410377358490566,0.9967963241097267,1.0,8/39,21.65%,BMP6;MIA3;TGFB1;JAG1;ASS1;KLF4;NF2;PPM1F
prerank,chondroitin sulfate catabolic process (GO:0030207),0.283469698862461,0.6205202153779802,0.911849710982659,0.9966064482225457,1.0,2/13,14.45%,DCN;ARSB
prerank,androgen metabolic process (GO:0008209),-0.20639091435056145,-0.6200035640262023,0.9308943089430894,0.9942789717069891,1.0,3/18,22.19%,MED1;SPP1;SRD5A3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2648975782680617,0.6191800669602939,0.8980169971671388,0.9972316091233336,1.0,3/15,17.57%,TAF9B;BCL2;MDM2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.21568598663045002,0.6187531570745833,0.9677072120559742,0.9971870130144687,1.0,11/74,15.20%,SIRT2;PSMD4;PSMB10;ARNT;PSMD11;PSME2;PSMC5;RBPJ;BACH1;EGLN2;PSMD1
prerank,toxin transport (GO:1901998),0.29575515389973817,0.6177155819081884,0.8947368421052632,0.9975323794627208,1.0,3/10,23.17%,ANTXR1;ANTXR2;RAB40B
prerank,regulation of acrosome reaction (GO:0060046),0.29350495828352785,0.6170615049220534,0.8943452380952381,0.9976357411930629,1.0,1/10,14.46%,GLRA1
prerank,cellular component maintenance (GO:0043954),0.2845296795580003,0.616479549256421,0.9094890510948905,0.9976985727868215,1.0,1/12,3.83%,PICK1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.25710490975337064,0.6164440564431235,0.9320905459387483,0.9973597912644411,1.0,4/20,19.15%,DIP2B;ARRB1;PRKAA1;SOX4
prerank,heterochromatin assembly (GO:0031507),0.25382614144808285,0.6144308925211681,0.9352331606217616,0.998392899007313,1.0,3/20,12.36%,SIRT2;SUV39H1;HDAC1
prerank,regulation of DNA binding (GO:0051101),0.2251497520248531,0.614312802985286,0.9516310461192351,0.9981179186816408,1.0,5/44,14.28%,IGF1;SIRT2;EGF;CEBPG;TGFB1
prerank,protein depolymerization (GO:0051261),0.24461150606706705,0.613993635616631,0.94125,0.9979735405977337,1.0,3/27,12.16%,STMN4;KATNB1;VPS4B
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.21771200777104477,0.6138349980964996,0.962486602357985,0.9977290203726649,1.0,8/65,10.46%,PSMD4;USP47;PSMB10;PSMD11;CDK5RAP3;CHFR;PSME2;PSMC5
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2100980798146627,0.6133440283847471,0.9707158351409978,0.9977180290461537,1.0,14/76,19.74%,TCIM;DDX3X;PPM1B;IFI35;APP;NFAT5;RTKN2;TLR3;PTPN22;ILK;RASSF2;TERF2IP;RPS3;PPM1A
prerank,mesoderm formation (GO:0001707),0.2614224296232656,0.6132398590985434,0.9202127659574468,0.9974359029779749,1.0,4/17,21.52%,SNAI1;KDM6B;ITGB1;SMAD2
prerank,modulation by host of symbiont process (GO:0051851),0.23660683374788552,0.6131893759102848,0.927360774818402,0.9971069195461778,1.0,7/31,16.32%,SMARCB1;HDAC1;CHD1;NUCKS1;SAP30BP;SNW1;CCNT1
prerank,regulation of phosphatase activity (GO:0010921),0.25033431353618674,0.6116203746516797,0.9341772151898734,0.9978265892843845,1.0,5/24,18.46%,PPP1R2;CDK5RAP3;PPP6R3;HTT;TIPRL
prerank,nucleoside catabolic process (GO:0009164),0.27789723948797274,0.6107507841061703,0.914074074074074,0.998071930390364,1.0,3/11,15.57%,UPP2;DPYD;NT5C3A
prerank,negative regulation of biomineral tissue development (GO:0070168),0.25253530900011656,0.610091474609325,0.928843710292249,0.9981343550033542,1.0,4/21,14.28%,SOX9;ENPP1;ROCK2;TGFB1
prerank,response to nutrient levels (GO:0031667),-0.21423984179599442,-0.6100759198236272,0.947136563876652,0.9985638348771576,1.0,3/17,23.29%,PRKAA2;ATF4;FAM107A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.25271777469992873,0.6096337323300121,0.921957671957672,0.9980836678500835,1.0,6/21,21.87%,CNOT10;CNOT9;CNOT6;SAMD4B;CNOT4;SAMD4A
prerank,positive regulation of protein binding (GO:0032092),0.21843877349705734,0.6082352306415657,0.9505061867266592,0.9986369995369668,1.0,11/56,18.68%,VTN;TCF7L2;ABL1;APP;ADD2;LRP1;DERL1;PPP2CB;APOE;USP33;FLOT1
prerank,positive regulation of vascular permeability (GO:0043117),0.2806454697315773,0.606594886978966,0.9246676514032496,0.999376710735051,1.0,1/12,2.58%,BMP6
prerank,synaptic vesicle membrane organization (GO:0048499),0.2668976267386837,0.6051122958867553,0.9272976680384087,1.0,1.0,3/17,14.94%,STX2;SNAP25;STX11
prerank,homocysteine metabolic process (GO:0050667),-0.24102521637814028,-0.6046781818224961,0.9318885448916409,1.0,1.0,7/11,48.66%,MTHFR;MTRR;CBS;CTH;NOX4;MPST;BLMH
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.25363440943165616,0.6044916974103465,0.9442231075697212,1.0,1.0,4/19,21.65%,BMP6;DENND6A;FLOT1;PPM1F
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.28704814675746537,0.6034495253829866,0.9097421203438395,1.0,1.0,1/10,5.93%,DHX58
prerank,negative regulation of protein secretion (GO:0050709),0.2274594604738306,0.6032554157096928,0.9458823529411765,1.0,1.0,2/38,3.84%,SFRP1;ERP29
prerank,endothelial tube morphogenesis (GO:0061154),0.2913410882271944,0.6022139887051993,0.8900602409638554,1.0,1.0,3/10,19.93%,RBPJ;PRKD2;STARD13
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.1783351661480645,-0.6020273686503598,0.9855769230769231,1.0,1.0,4/22,17.61%,IKBKB;ROCK1;PTPA;BOD1L1
prerank,ESCRT complex disassembly (GO:1904896),0.28701342745931696,0.6013649755590246,0.9224924012158054,1.0,1.0,2/10,12.16%,VTA1;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.28701342745931696,0.6013649755590246,0.9224924012158054,1.0,1.0,2/10,12.16%,VTA1;VPS4B
prerank,positive regulation of superoxide anion generation (GO:0032930),0.27180631409587097,0.6002255318487517,0.9198250728862973,1.0,1.0,2/13,14.28%,MAPT;TGFB1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.2269895274347941,-0.6002213898320871,0.962457337883959,0.9999289614432431,1.0,3/12,16.50%,IGF1R;BNIP3;IRGM
prerank,regulation of gene silencing by RNA (GO:0060966),0.2130004736031427,0.599714459635432,0.9628796400449944,1.0,1.0,20/50,26.21%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2130004736031427,0.599714459635432,0.9628796400449944,1.0,1.0,20/50,26.21%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,positive regulation of hemostasis (GO:1900048),0.28850673253786274,0.5996645013727937,0.9249617151607963,0.99952412695921,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,positive regulation of coagulation (GO:0050820),0.28850673253786274,0.5996645013727937,0.9249617151607963,0.99952412695921,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,regulation of superoxide anion generation (GO:0032928),0.26581987871170515,0.5989672414628452,0.9203413940256046,0.9995955118905573,1.0,2/14,14.28%,MAPT;TGFB1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.26344985420449263,0.598471327961934,0.9156293222683264,0.9995389705732431,1.0,2/15,12.69%,SMPD2;RACK1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.19850662450032636,-0.5980241036255112,0.9624060150375939,0.9997612007139155,1.0,10/17,44.74%,CACNA2D1;AKAP9;SNTA1;KCNQ1;SCN4B;KCNE4;ANK2;KCNH2;SCN5A;GJA5
prerank,regulation of Notch signaling pathway (GO:0008593),0.20918648610566212,0.5979207703215728,0.9707475622968581,0.9995351466661531,1.0,14/76,19.40%,DLK1;TCIM;ARRB1;EGF;PRAG1;RBPJ;ZMIZ1;PRKCI;SNW1;JAG1;ITGB1BP1;SYNJ2BP;MMP14;YTHDF2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2651535649116824,0.5976068353498063,0.9301675977653632,0.999371947401736,1.0,3/14,15.47%,TWIST1;IRS2;ABCD2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.26722086299178577,0.5972756323967519,0.9229671897289586,0.9992057067807255,1.0,1/14,8.56%,PIBF1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.27576645495204305,0.5970686076467252,0.9361393323657474,0.9989750378059241,1.0,2/12,11.52%,MIA3;BMP5
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.2397957587275982,0.596497744573317,0.9405815423514539,0.9989556409444196,1.0,5/24,16.69%,PID1;LEPR;MRAP2;COQ10A;ACADVL
prerank,negative regulation of viral life cycle (GO:1903901),0.26402392626524374,0.5945425786345752,0.9342465753424658,0.9997614534286644,1.0,5/15,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,carbohydrate transport (GO:0008643),0.2773275733101566,0.5944992493271788,0.9129172714078374,0.9994309621388462,1.0,1/11,11.44%,SLC50A1
prerank,regulation of interleukin-10 production (GO:0032653),0.2170270466901169,0.5929791075146388,0.9501160092807425,0.999999575802705,1.0,4/44,15.53%,FCGR2B;PIBF1;CD47;HSPD1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.2698398033564389,0.5918438366872878,0.9306518723994452,1.0,1.0,4/13,20.27%,BMP6;TGFB1;TGFBR1;DAB2
prerank,axonemal dynein complex assembly (GO:0070286),-0.17652234022497332,-0.5918195808693161,0.96875,1.0,1.0,28/28,82.39%,SPAG1;TTC12;DNAAF5;ODAD1;CCDC39;DNAH8;DNAH5;ODAD2;DRC1;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH1;DNAAF1;DNAI3;ZMYND10;CCDC103;CFAP73;DNAL1;DNAI4;LRRC49;DNAAF3
prerank,positive regulation of endopeptidase activity (GO:0010950),0.23521816125446315,0.5916694615922259,0.9453416149068323,1.0,1.0,7/26,22.67%,GRIN1;PRELID1;PSME2;ROCK2;USP50;LYN;EPHA4
prerank,regulation of response to interferon-gamma (GO:0060330),0.26383008152445225,0.5908696723539121,0.9412568306010929,1.0,1.0,4/14,19.91%,IFNGR2;IFNGR1;JAK1;PIAS1
prerank,regulation of vacuole organization (GO:0044088),0.247683256124299,0.5908446932560999,0.9239842726081258,0.9998612524374734,1.0,9/20,26.00%,ENO2;IFT20;ANXA2;SCARB2;NPRL2;PIKFYVE;MTM1;NPRL3;TBC1D14
prerank,glutathione biosynthetic process (GO:0006750),0.2728698560682876,0.5891101068341,0.9300595238095238,1.0,1.0,3/11,19.70%,CNDP2;GCLC;HAGH
prerank,negative regulation of cell division (GO:0051782),0.2835603027612226,0.5886892273237696,0.9203125,1.0,1.0,2/11,16.12%,ORC6;TXNIP
prerank,negative regulation of hippo signaling (GO:0035331),0.27245827957879165,0.5886330152151866,0.9241071428571429,1.0,1.0,4/12,23.31%,CIT;WWC1;DLG5;MAP2K3
prerank,positive regulation of viral transcription (GO:0050434),0.2353548892342347,0.5883283744092906,0.9457755359394704,0.9998916863122134,1.0,5/25,18.54%,POLR2B;CDK9;POLR2K;CCNT1;NELFA
prerank,cellular response to inorganic substance (GO:0071241),0.2421945748549587,0.5871224900397317,0.948051948051948,1.0,1.0,4/21,16.81%,KCNC2;ATRX;FMR1;DPEP1
prerank,cellular response to chemokine (GO:1990869),0.21455249457694642,0.5869916461092521,0.9641618497109826,0.9999285118397074,1.0,3/46,8.61%,CXCL12;RIPOR2;DOCK8
prerank,negative regulation of chemokine production (GO:0032682),0.2560410111919572,0.5865386584615829,0.9188811188811189,0.9998247807314701,1.0,1/14,7.34%,SIRPA
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.19805102129447083,0.5855910449968601,0.9897225077081192,1.0,1.0,21/114,22.05%,PSMD4;MAP3K14;EDAR;TNFRSF9;EDA2R;PSMB10;PSMD11;PSME2;PSMC5;TNFRSF25;PSMD1;PSMD6;ILK;BAG4;BIRC3;PSMD5;PTK2B;PSMA4;PSMA1;PSMC6;TRAF2
prerank,TOR signaling (GO:0031929),-0.17428881629503734,-0.5846271840704471,0.9951690821256038,1.0,1.0,1/26,0.08%,RICTOR
prerank,carboxylic acid transmembrane transport (GO:1905039),0.21616635452604183,0.584022770828667,0.9495305164319249,1.0,1.0,3/40,10.32%,SLC7A11;SLC38A9;SLC38A10
prerank,glucose metabolic process (GO:0006006),0.2080280710367379,0.5826237310485266,0.9787472035794184,1.0,1.0,9/58,18.84%,G6PC3;MDH2;PGAM1;IRS2;ENO2;HECTD4;SLC25A1;OMA1;PGK1
prerank,response to cytokine (GO:0034097),0.19207619472896667,0.5824108149659909,0.9918946301925026,1.0,1.0,15/141,11.98%,KHSRP;ANXA1;PRKCA;CDK9;ALDH1A2;TRIM56;CXCR4;PID1;HDAC4;APP;PTPN5;BCL2;SHFL;NFAT5;IL1RAPL1
prerank,ameboidal-type cell migration (GO:0001667),0.21130324726278152,0.5814001321347019,0.9779005524861878,1.0,1.0,13/51,22.50%,SRGAP2;SGPL1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A;MEGF8;AMOT;PDXDC1;PDLIM1;ERBB4;PKN1
prerank,cranial nerve development (GO:0021545),0.27131198995605776,0.5813690853982649,0.930576070901034,1.0,1.0,11/11,72.89%,CHD7;SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;ERBB3;TMEM126A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.265924225824983,0.580983945237506,0.9396551724137931,1.0,1.0,3/12,18.66%,LIN28B;TGFB1;NCOR2
prerank,regulation of interleukin-12 production (GO:0032655),0.2094172401252602,0.5795002342828998,0.9735023041474654,1.0,1.0,5/47,15.53%,TIRAP;PIBF1;CD47;TLR3;HSPD1
prerank,diol biosynthetic process (GO:0034312),0.25175985591741845,0.5792747368163519,0.9467787114845938,1.0,1.0,2/15,15.38%,ABCA2;QDPR
prerank,protein acetylation (GO:0006473),0.22431772315636897,0.5792614960887608,0.9656862745098039,1.0,1.0,7/30,22.48%,NAT9;MAPT;HAT1;CLOCK;NAA35;FOXO1;GTF2B
prerank,protein palmitoylation (GO:0018345),0.22566984376667024,0.5788585035769107,0.966952264381885,1.0,1.0,6/30,18.18%,ZDHHC3;GLUL;CLIP3;PORCN;ZDHHC17;ZDHHC2
prerank,cardiac muscle cell differentiation (GO:0055007),0.2398777282985956,0.5783259039662096,0.9566326530612245,1.0,1.0,4/21,16.74%,SIK1;AKAP13;NRG1;KDM6B
prerank,tRNA 5'-leader removal (GO:0001682),0.25940985472826944,0.5775304098415263,0.9504373177842566,1.0,1.0,2/13,13.56%,PRORP;RPP30
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.27533414884440643,0.5763635713387207,0.9348148148148148,1.0,1.0,2/10,12.08%,GPR37;PARK7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.2501567859612376,0.5755682543081936,0.9325997248968363,1.0,1.0,3/15,17.10%,LACTB2;RPP30;ZC3H12C
prerank,lipid droplet formation (GO:0140042),0.2706247185861317,0.5755036622949956,0.935064935064935,1.0,1.0,2/10,15.93%,AUP1;CDS1
prerank,positive regulation of ATPase activity (GO:0032781),0.21055736505164308,0.5752682400446516,0.9670975323149236,0.9998570106150011,1.0,11/41,21.93%,FGF10;TPM1;DNAJC24;VMP1;DNAJC10;DYNLL1;TOR1AIP2;HNRNPU;ATP1B2;MSH3;PFN2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.21119314560112318,0.5751321953488951,0.9708963911525029,0.9995674402113722,1.0,8/40,21.29%,NTF3;FGFR1;PDGFRA;LPAR1;GNAQ;ARHGAP6;NTRK2;FGF2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.21835717487054854,0.5750251265245564,0.9632701421800948,0.9992711432236245,1.0,5/35,15.34%,ZFP36L1;BRD1;ARNT;PRMT1;ACVR1B
prerank,regulation of cell projection organization (GO:0031344),0.2652463157788806,0.573001257648242,0.9421720733427362,0.9999565681744857,1.0,3/13,19.89%,NTNG2;SPRY2;MYO9A
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.2742643219546069,0.5716849162981759,0.9180834621329211,1.0,1.0,1/10,7.66%,ADGRV1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.26607765770423114,0.5711470987935794,0.9467455621301775,1.0,1.0,3/11,24.50%,SIK1;CLK2;CRY1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.24381247650631188,0.5710432902580376,0.9501965923984272,0.9998475687358325,1.0,2/19,6.77%,RENBP;GNPNAT1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.22924014043217794,0.5707926958941294,0.9651741293532339,0.999612932441992,1.0,3/25,10.86%,CD200R1;JAM3;JUP
prerank,chromatin assembly (GO:0031497),0.213952636623656,0.5706518478506938,0.9655581947743468,0.9993279685479063,1.0,10/38,21.66%,RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;DAXX;CTCF;NAP1L4;H3-3A
prerank,water transport (GO:0006833),0.25992498646465767,0.5704006290615281,0.9502840909090909,0.9991061274540914,1.0,1/12,14.55%,AQP4
prerank,myofibril assembly (GO:0030239),0.21248109487439626,0.5698420412892031,0.9668949771689498,0.9990275217007996,1.0,5/42,18.74%,OBSL1;TPM1;PDGFRA;TMOD2;CSRP2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.1933918619161467,-0.5697983309670827,0.9844357976653697,1.0,1.0,4/17,27.02%,ADRA1B;ADRA1A;ADRA2A;DRD2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2391355705335983,0.5695324329702713,0.9537869062901155,0.9988201078116308,1.0,1/19,2.38%,AASS
prerank,negative regulation of TORC1 signaling (GO:1904262),0.26018913867493454,0.5694704612647612,0.9618768328445748,0.9985037074395285,1.0,2/13,11.57%,STK11;RNF152
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2275588411048502,0.5694348628037594,0.9588528678304239,0.998170268438508,1.0,5/25,18.17%,RBPJ;CNOT9;ARAP1;CBL;CCDC88A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.20344613328114222,-0.5685849889543082,0.9663299663299664,1.0,1.0,8/14,41.52%,TSEN2;CSTF2;TSEN15;CPSF4;CPSF1;CLP1;TRPT1;TSEN54
prerank,entry into host (GO:0044409),0.254003588473817,0.5671013252464837,0.9401709401709402,0.9989283134420847,1.0,3/13,20.71%,CXCR4;CBL;ITGAV
prerank,regulation of oxidoreductase activity (GO:0051341),0.25772919109096765,0.5657385529582176,0.9507246376811594,0.9992200851533289,1.0,1/13,6.07%,ABL1
prerank,glutathione derivative metabolic process (GO:1901685),0.2352395024146725,0.5655720667133379,0.948069241011984,0.9985905300634795,1.0,1/20,4.08%,GSTT1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2352395024146725,0.5655720667133379,0.948069241011984,0.9985905300634795,1.0,1/20,4.08%,GSTT1
prerank,neural crest cell migration (GO:0001755),0.2162551616919803,0.5652915057444957,0.9763593380614657,0.9983686174269638,1.0,6/36,15.56%,NRP1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A
prerank,regulation of B cell apoptotic process (GO:0002902),0.2600772915095816,0.5650430046038737,0.9387464387464387,0.9981317026775696,1.0,3/12,20.46%,IRS2;BCL6;LYN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.20227504923831588,0.5643433791370651,0.9810901001112347,0.9980864327497392,1.0,10/56,20.88%,BMP6;PMEPA1;SDCBP;BMP5;TGFB1;SMAD6;TGFBR1;DAB2;ACVR2A;SMAD7
prerank,calcium ion transport into cytosol (GO:0060402),0.2324468166584842,0.5634949411637289,0.9560723514211886,0.9981227852445623,1.0,2/21,8.22%,GRIN1;GRIN2A
prerank,DNA packaging (GO:0006323),0.24223818042864603,0.5603822537806552,0.9609483960948396,0.9991815612585586,1.0,2/16,15.95%,RBBP4;HAT1
prerank,B cell differentiation (GO:0030183),0.20728940434147874,0.560242810583788,0.9761092150170648,0.9988872421445455,1.0,6/46,15.29%,SYVN1;HDAC5;HDAC4;CEBPG;BLNK;TCF3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.2115834114382803,0.5598605221865618,0.9643705463182898,0.9987114318406632,1.0,8/38,18.55%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PARL;BAG4
prerank,mitochondrial transcription (GO:0006390),0.26775915146635165,0.5596296635394545,0.9453717754172989,0.9984659575445194,1.0,2/10,15.73%,SLC25A33;TFB1M
prerank,glucan biosynthetic process (GO:0009250),-0.20679522706480014,-0.5580707663069672,0.9543859649122807,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.20679522706480014,-0.5580707663069672,0.9543859649122807,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,motile cilium assembly (GO:0044458),0.26019652265790455,0.557407111121443,0.9518950437317785,0.9990780870150283,1.0,2/12,17.63%,BBOF1;DNAAF3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.22454746566126188,0.5572732345169238,0.9560723514211886,0.9987869656017438,1.0,4/22,20.33%,THY1;FLOT1;KLF4;GCNT2
prerank,heme biosynthetic process (GO:0006783),0.231938550474066,0.5568656205632254,0.9662775616083009,0.9986121239726609,1.0,2/22,10.16%,UROD;SLC25A38
prerank,eye photoreceptor cell differentiation (GO:0001754),0.25701331992032594,0.5567094310348876,0.9575671852899575,0.9983302958514852,1.0,3/12,19.23%,DSCAM;NKD1;AGTPBP1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.21249826544727093,0.5562665236064108,0.9768856447688564,0.9981732389375834,1.0,3/31,15.53%,TIRAP;TLR3;HSPD1
prerank,phosphate ion homeostasis (GO:0055062),0.2681148142093623,0.5555978988360949,0.9508196721311475,0.9981072024095676,1.0,1/10,12.01%,ENPP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.20591374223115075,-0.5531500579275456,0.9601328903654485,1.0,1.0,12/12,79.43%,ANXA6;RYR2;MTLN;CASQ2;ANK2;CASQ1;TRDN;FKBP1B;UBASH3B;LIME1;DIAPH1;PTK2B
prerank,tRNA wobble base modification (GO:0002097),-0.19892639811006205,-0.5530737508773413,0.9896907216494846,1.0,1.0,11/14,49.84%,ELP3;TRMT9B;DPH3;ELP4;GTPBP3;MOCS3;KTI12;ALKBH8;ADAT2;CTU2;CTU1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.2572689914778208,0.5527454210848431,0.9443609022556391,0.998952397530341,1.0,2/10,16.49%,JAM3;SERPINE1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.19168638557575993,0.5515257907799818,0.9892703862660944,0.9987339006217199,1.0,8/78,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.19168638557575993,0.5515257907799818,0.9892703862660944,0.9987339006217199,1.0,8/78,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,dendritic cell migration (GO:0036336),0.23502118787877738,0.5515013781430526,0.9610738255033557,0.9983919853013612,1.0,1/16,7.14%,CXCR4
prerank,mitochondrial gene expression (GO:0140053),0.2032409264400935,0.5514814903972147,0.9742990654205608,0.9980506516241254,1.0,5/42,12.81%,NDUFA7;SLC25A33;GATB;MRPL47;HARS1
prerank,lymphocyte chemotaxis (GO:0048247),-0.15681520008846062,-0.5512719908141913,0.9939759036144579,1.0,1.0,6/34,22.73%,CCL15;CXCL16;CCL13;SLC12A2;CKLF;PIK3CD
prerank,protein insertion into membrane (GO:0051205),0.2132253798284678,0.5511031317864631,0.9806996381182147,0.9978505999506567,1.0,9/32,22.11%,GET1;APP;SERP1;SEC61G;ALDH3A2;STX5;OXA1L;RTP4;TRAM2
prerank,thymus development (GO:0048538),0.2478938997497391,0.5507048200144966,0.9534206695778749,0.9976547947462242,1.0,1/13,4.88%,FGF10
prerank,embryonic digit morphogenesis (GO:0042733),0.23391329920890153,0.5494284076052539,0.9568151147098516,0.9978227775017893,1.0,4/18,21.30%,TWIST1;HDAC1;OSR1;GLI3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.22939470437795628,0.5493174542646486,0.9670619235836627,0.9975190533053775,1.0,6/20,24.48%,MALT1;PRKCZ;TRAF2;B2M;IL18;TRAF6
prerank,macrophage chemotaxis (GO:0048246),-0.21925805034210027,-0.5483441480818436,0.9686609686609686,1.0,1.0,10/10,78.09%,CKLF;EDNRB;TAFA4;CCL2;CCL5;CCL3;LGALS3;EDN2;SAA1;CXCL17
prerank,granulocyte chemotaxis (GO:0071621),0.19795925416514698,0.5480756643994624,0.9866071428571429,0.9976517545700468,1.0,3/55,9.33%,EDN3;ANXA1;PPIB
prerank,outer dynein arm assembly (GO:0036158),-0.19019213864121565,-0.5474039484885466,0.981549815498155,1.0,1.0,15/15,81.00%,DNAAF5;ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAAF1;ZMYND10;CCDC103;DNAL1;LRRC49
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.26949737243521954,0.5473156828668325,0.9473684210526315,0.9975946971213868,1.0,3/10,20.87%,PIBF1;PARP14;NF2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.24046896505309495,0.5456509601182503,0.9687943262411347,0.9978769095794615,1.0,3/15,21.42%,APOE;ABCA5;ABCG1
prerank,positive regulation of cytokinesis (GO:0032467),0.20792473839169023,0.5446779450181674,0.978021978021978,0.9979127020215264,1.0,4/32,14.15%,CDC14B;CIT;SVIL;CSPP1
prerank,diol metabolic process (GO:0034311),0.22428156138656274,0.5431066902359217,0.9558232931726908,0.9981553477291699,1.0,1/19,2.67%,HSP90AA1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.188696998666664,0.5427253290377698,0.9956989247311828,0.9979507681586113,1.0,8/79,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,cardiac muscle cell development (GO:0055013),0.23078144408069032,0.5423044662147304,0.9595300261096605,0.9977613415459674,1.0,2/20,11.29%,OBSL1;PDGFRA
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.2474788675383816,0.5408654539347604,0.9606413994169096,0.9979294426514086,1.0,1/13,7.25%,CLPTM1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.25822330054213516,0.5401019704318365,0.9561270801815431,0.997852654933015,1.0,4/10,26.00%,RAP2A;MYO9A;CDC42;OPHN1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.238223405032712,0.5395711802007372,0.9613733905579399,0.9976866339285397,1.0,3/14,15.57%,UPP2;DPYD;NT5C3A
prerank,catecholamine metabolic process (GO:0006584),0.23984428957116835,0.539332335766387,0.9722222222222222,0.9974147799283617,1.0,14/14,76.04%,COMT;DBH;DRD4;PAH;TH;ATP7A;DRD1;SNCAIP;LRTOMT;DRD3;RNF180;DRD2;PRKN;DDC
prerank,synaptonemal complex organization (GO:0070193),-0.18974413141307192,-0.5381088671324625,0.9852941176470589,1.0,1.0,9/15,52.34%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.18974413141307192,-0.5381088671324625,0.9852941176470589,1.0,1.0,9/15,52.34%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,snRNA processing (GO:0016180),0.23364544791719313,0.537908386749078,0.9631205673758865,0.9975667617524049,1.0,1/16,2.38%,TOE1
prerank,pentose-phosphate shunt (GO:0006098),0.25041871510886854,0.5369832877940802,0.9594202898550724,0.9975542084556503,1.0,3/11,20.31%,TKT;RPIA;TALDO1
prerank,eye photoreceptor cell development (GO:0042462),0.23313096857073218,0.5359019875781084,0.9694555112881806,0.997592370861578,1.0,2/15,17.41%,THY1;TOPORS
prerank,positive regulation of cellular senescence (GO:2000774),0.258095853519428,0.5309930682439389,0.9604863221884499,0.9989259770307708,1.0,1/10,6.71%,EEF1E1
prerank,cellular response to interleukin-15 (GO:0071350),-0.1958979635542269,-0.5298129590503339,0.980327868852459,1.0,1.0,1/13,2.79%,STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.1958979635542269,-0.5298129590503339,0.980327868852459,1.0,1.0,1/13,2.79%,STAT3
prerank,DNA replication (GO:0006260),0.17678442578246414,0.5290423769986314,0.9937952430196484,0.9992292380440015,1.0,15/105,18.10%,WDHD1;BARD1;MCMBP;ORC6;KIN;TOP1;RBMS1;BRIP1;RMI1;ATR;HELB;MRE11;RAD50;TOP3A;RBBP8
prerank,maturation of 5.8S rRNA (GO:0000460),0.22790630535009726,0.5285018637507187,0.9722607489597781,0.9990549835238279,1.0,4/17,17.60%,MTREX;C1D;LAS1L;NSA2
prerank,cellular response to ATP (GO:0071318),-0.19177698296454523,-0.527777083252959,0.9863481228668942,1.0,1.0,3/14,18.46%,HSP90B1;P2RX7;P2RY12
prerank,inorganic ion transmembrane transport (GO:0098660),-0.19577850983803607,-0.5270491257746421,0.9935691318327974,1.0,1.0,5/12,43.97%,ABCC9;CACNA1H;KCNJ8;PKD2L1;ABCC8
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.25148198697345503,0.5266510504218744,0.9602941176470589,0.9992747277529322,1.0,1/10,7.55%,CD24
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.24219562893266178,0.5266048010037988,0.9677891654465594,0.9989429460396503,1.0,1/12,5.78%,DCN
prerank,melanosome transport (GO:0032402),0.2211983195917,0.5234294357796722,0.9748010610079576,0.9992323402613151,1.0,2/18,11.49%,BBS7;MYO5A
prerank,pigment granule transport (GO:0051904),0.2211983195917,0.5234294357796722,0.9748010610079576,0.9992323402613151,1.0,2/18,11.49%,BBS7;MYO5A
prerank,sensory perception of pain (GO:0019233),0.2174253121342378,0.5229507289367918,0.9676985195154778,0.9990363275131762,1.0,1/21,4.13%,OPRK1
prerank,positive regulation of neuron migration (GO:2001224),0.25004694168260705,0.522620539299986,0.962178517397882,0.9987837951838264,1.0,6/11,26.22%,NIPBL;SEMA3A;KIF20B;SHTN1;ARHGEF2;RAPGEF2
prerank,tRNA 5'-end processing (GO:0099116),0.2268321771037369,0.5198863796925541,0.9783549783549783,0.9992307372416778,1.0,2/15,13.56%,PRORP;RPP30
prerank,cGMP metabolic process (GO:0046068),-0.19976609496906683,-0.5197406700753322,0.9771986970684039,1.0,1.0,3/12,23.06%,GUCY1A1;NPR1;PDE2A
prerank,negative regulation of ion transport (GO:0043271),0.20912607669441052,0.519620512147707,0.987012987012987,0.9989549201646402,1.0,6/24,22.71%,PACSIN3;WNK2;PTK2B;SYT11;PXK;WNK3
prerank,fluid transport (GO:0042044),0.23684720038968674,0.5165016898860549,0.9739130434782609,0.9994787631701034,1.0,1/12,14.55%,AQP4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.17399247388455683,-0.5158262407833132,1.0,1.0,1.0,5/17,31.08%,SLC9A2;SLC12A2;HCN2;SLC8A1;SLC9A5
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23435124891754966,0.5157034439848904,0.9657738095238095,0.9993490672437718,1.0,3/12,19.70%,CNDP2;GCLC;HAGH
prerank,establishment of melanosome localization (GO:0032401),0.2170804242499865,0.5156661034079729,0.9800531914893617,0.9990155833511578,1.0,2/19,11.49%,BBS7;MYO5A
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19055725545797478,0.5130143394262341,0.9930232558139535,0.9993739880495126,1.0,9/42,26.55%,CXCL12;OXSR1;CCL25;PTK2B;CX3CL1;ACKR3;CCL14;RBM15;FOXC1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.18203127211342135,0.5084489530074946,0.9943946188340808,1.0,1.0,3/57,8.56%,IGF1;IL31RA;PIBF1
prerank,pre-replicative complex assembly (GO:0036388),0.17997456857775115,0.5075550178891325,0.9935275080906149,1.0,1.0,6/64,10.46%,PSMD4;PSMB10;PSMD11;ORC6;PSME2;PSMC5
prerank,plasma membrane repair (GO:0001778),0.22893229708454657,0.5071519272361423,0.9632352941176471,0.999868719284102,1.0,5/13,23.19%,ARL8B;SMPD1;SYT11;MYH9;SYT7
prerank,receptor recycling (GO:0001881),-0.2056791124851111,-0.5069832050778665,0.9846625766871165,1.0,1.0,5/10,34.25%,LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,serine family amino acid metabolic process (GO:0009069),0.2172963998171223,0.5065426632268872,0.9809004092769441,0.9996776263884561,1.0,2/16,13.12%,SARS1;GCLC
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.2246051978756693,0.5059878478856896,0.9815864022662889,0.9994721328862395,1.0,5/14,24.26%,SUFU;FAF1;PKD2;KEAP1;G3BP2
prerank,telomere organization (GO:0032200),0.18562368128666695,0.5052170689497745,0.9942660550458715,0.9993225263232158,1.0,8/43,18.57%,PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TERF2IP
prerank,dermatan sulfate metabolic process (GO:0030205),0.22593661082247257,0.501944304104103,0.9726224783861671,0.9997505458601322,1.0,1/13,5.78%,DCN
prerank,regulation of hemopoiesis (GO:1903706),0.23823373933046527,0.5018032767370644,0.9674074074074074,0.9994355145202316,1.0,3/10,24.79%,CBFB;MYSM1;RUNX1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2269445665139055,0.49868282747546644,0.9704225352112676,0.9997990750546571,1.0,12/12,77.32%,CENPC;SEH1L;CDT1;CHAMP1;KIF2C;NUF2;MAD1L1;RMDN1;NDC80;CENPE;BOD1;MIS12
prerank,microtubule-based transport (GO:0099111),0.22658211953792057,0.49789257596392794,0.9728958630527818,0.999625945194178,1.0,13/13,77.36%,HTT;CCDC103;DYNC1I2;DNAAF4;CCDC40;DNAAF2;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;DYNC1I1;SPEF2
prerank,error-free translesion synthesis (GO:0070987),-0.15753255468235605,-0.49784438889446536,0.9864253393665159,1.0,1.0,13/22,42.90%,RPA1;UBB;REV1;RFC2;SPRTN;PCNA;RPA3;RCHY1;RFC3;UBA52;RPA2;RFC4;POLD1
prerank,regulation of cell development (GO:0060284),0.18576671575989143,0.4949767684993364,0.9938949938949939,0.999917688985326,1.0,9/36,24.94%,PRUNE1;DOCK7;ADGRA2;CLOCK;FBXO22;YTHDF2;FOXO1;YAP1;CX3CL1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.19622325305297458,-0.4940959117301705,0.9852507374631269,1.0,1.0,1/10,2.90%,SACS
prerank,cellular response to gamma radiation (GO:0071480),0.20973548819553348,0.4938433890253178,0.978523489932886,0.9998164507181079,1.0,6/17,25.59%,XRCC6;ATR;MDM2;ATM;YAP1;MAP3K20
prerank,gas transport (GO:0015669),0.23287929194651955,0.4932602654629273,0.9845916795069337,0.9996000161364025,1.0,10/10,76.73%,CA2;AQP5;AQP6;RHAG;NGB;MB;AQP1;MYC;CYGB;IPCEF1
prerank,regulation of neurogenesis (GO:0050767),0.17324882524170107,0.49284181624282325,0.996629213483146,0.9993345403159779,1.0,13/55,24.98%,PRUNE1;SOX11;HOOK3;DOCK7;SNW1;SORL1;YTHDF2;SERPINF1;APPL2;B2M;YAP1;CX3CL1;NAP1L1
prerank,photoreceptor cell development (GO:0042461),-0.17452308095207536,-0.4913876402623598,0.9857651245551602,1.0,1.0,5/14,28.07%,ARL3;VEGFA;RP1;CEP290;MFSD2A
prerank,DNA-dependent DNA replication (GO:0006261),0.16350144051152038,0.4868438684929578,0.9989775051124744,1.0,1.0,9/128,10.46%,WDHD1;SIRT7;PSMD4;PSMB10;MCMBP;PSMD11;ORC6;PSME2;PSMC5
prerank,midbody abscission (GO:0061952),0.20460469304105985,0.4839747955974241,0.9823609226594301,1.0,1.0,6/17,26.29%,CHMP3;VPS4B;CHMP4A;CHMP4B;PDCD6IP;MITD1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.19570690408453198,0.48374202319649656,0.9873096446700508,0.9997074278418929,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.19570690408453198,0.48374202319649656,0.9873096446700508,0.9997074278418929,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,cellular response to interleukin-2 (GO:0071352),0.226239799121155,0.4824437330514881,0.9819004524886877,0.9992457500873768,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.226239799121155,0.4824437330514881,0.9819004524886877,0.9992457500873768,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,response to gamma radiation (GO:0010332),0.1896251832463296,0.4777624223257661,0.991128010139417,0.9997332469440136,1.0,8/24,25.94%,XRCC6;ATR;MDM2;PRKAA1;ATM;YAP1;MAP3K20;DCUN1D3
prerank,DNA alkylation (GO:0006305),0.20114169120729303,0.47313197398914897,0.9895287958115183,0.9997939824540968,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,DNA methylation or demethylation (GO:0044728),0.20114169120729303,0.47313197398914897,0.9895287958115183,0.9997939824540968,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.16272958997477466,0.472971066919537,0.998914223669924,0.9994746210380628,1.0,9/76,17.53%,OPRK1;GPR4;PTH1R;HTR2C;CHRM2;LPAR1;LPAR6;AGTR1;HRH1
prerank,cilium-dependent cell motility (GO:0060285),-0.14567135998610142,-0.4724082433723698,0.9961089494163424,1.0,1.0,8/22,34.46%,CFAP44;CCDC39;EFHC2;EFHC1;DNAH2;DNAH8;GAS8;RSPH9
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.19933733187923175,0.46605830075043714,0.9863574351978172,1.0,1.0,4/18,23.91%,FBN1;TLR3;TCTA;FBXW7
prerank,regulation of actin filament-based movement (GO:1903115),-0.19230906059840133,-0.4642627412982329,0.9970845481049563,1.0,1.0,6/10,45.39%,SRI;PDE4D;PLN;ANK2;SCN5A;STC1
prerank,negative regulation of axon extension (GO:0030517),0.18117654859601254,0.46239513283035927,0.9938271604938271,1.0,1.0,4/30,15.56%,DIP2B;SEMA3D;SEMA3E;SEMA3A
prerank,aorta morphogenesis (GO:0035909),0.19903114133616834,0.46100796104946495,0.9933774834437086,1.0,1.0,3/17,16.44%,RBPJ;LRP1;JAG1
prerank,sulfation (GO:0051923),0.21330822347771508,0.4605877564316505,0.9912280701754386,0.9998819171653122,1.0,11/11,78.68%,SULT1A1;UST;SULT2A1;CHST4;SULT1C4;SULT1C2;SULT6B1;SULT2B1;CHST5;SULT4A1;HS3ST5
prerank,thyroid hormone generation (GO:0006590),-0.19044629966731527,-0.46025491706181737,0.9914285714285714,1.0,1.0,10/10,80.97%,SLC5A5;FOXE1;DIO2;TG;TPO;DUOX1;IYD;CPQ;DUOX2;CTSK
prerank,ureteric bud morphogenesis (GO:0060675),0.1966858146891257,0.45629538690862875,0.9905277401894452,1.0,1.0,3/16,21.29%,GDNF;PKD2;FGF2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.12691727432738245,-0.4540316787425102,1.0,1.0,1.0,33/33,87.34%,TLR4;CEBPB;PRXL2A;GPR137B;TMEM178A;MAFB;GPR137;FSTL3;LILRB3;CARTPT;MTOR;LRRC17;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;CCL3;IL12B;GPR55;UBASH3B;POU4F2;IFNG;CAMK4;TRAF6;TCTA;TLR3;FBN1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.17419794611343734,0.453810523879238,0.9915458937198067,1.0,1.0,1/29,1.88%,NOP9
prerank,neurotransmitter biosynthetic process (GO:0042136),0.19980631804211474,0.4516350251486984,0.9890260631001372,0.9999409648154046,1.0,2/14,17.37%,SLC6A4;MOXD1
prerank,cellular glucan metabolic process (GO:0006073),0.2053987574123634,0.4387590494159395,0.9914651493598862,1.0,1.0,2/11,19.00%,GBE1;PRKAG2
prerank,DNA strand elongation (GO:0022616),0.1857152843069626,0.4377776647107989,0.9973684210526316,1.0,1.0,3/18,16.27%,POLD3;MRE11;RAD50
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.17387483522691605,-0.4237343240561799,0.9940476190476191,1.0,1.0,10/10,82.63%,PTPRC;SH2B3;MAPK7;SIGIRR;MAP2K5;PALM3;APOA1;IRAK3;KLF4;TLE5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.18143875629975156,0.4233772643676029,0.9945429740791268,1.0,1.0,3/16,21.29%,FGFBP1;AGTR1;FGF2
prerank,neuron projection regeneration (GO:0031102),0.20134742679880277,0.4185562804295207,0.9970544918998527,1.0,1.0,1/10,12.38%,MAPK8IP3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.1888025492037974,0.4162005026507889,0.9942196531791907,1.0,1.0,6/13,28.71%,NFAT5;ZDHHC21;TRAF6;FUT9;RELA;ETS1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.16488622566359262,-0.4157712866416089,1.0,1.0,1.0,3/10,28.83%,ANO6;NCKAP1L;CD300A
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.12990220208208003,-0.4124365909239719,1.0,1.0,1.0,6/20,34.38%,ADRA1B;ADRA1A;ADRA2A;DRD2;PDE4D;ADRB2
prerank,cardiac cell development (GO:0055006),0.1910860012554928,0.4055304354424609,0.9928057553956835,1.0,1.0,11/11,80.90%,JAG1;CXADR;NOTCH1;ALPK2;MYH6;TCAP;ALPK3;TTN;SLC8A1;MYH11;VEGFA
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.17051123501328488,0.40155766097766404,0.9986702127659575,1.0,1.0,2/19,17.19%,RIC3;APOE
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.1911932659664304,0.40113403698187744,0.9970149253731343,1.0,1.0,3/10,24.20%,ATRX;INO80;SSBP1
prerank,tRNA wobble uridine modification (GO:0002098),-0.14360040659669818,-0.3969549189073442,1.0,0.9997075961771493,1.0,1/14,3.41%,ELP3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.1786050599535438,0.39668648427674524,0.998587570621469,1.0,1.0,12/12,82.15%,CHEK2;RAD17;NAE1;TOPBP1;TICRR;CDC6;HUS1B;ORC1;SETMAR;CLSPN;HUS1;STK33
prerank,negative regulation of T cell proliferation (GO:0042130),0.15440935829667127,0.39291935822068114,0.9962406015037594,1.0,1.0,1/28,5.37%,SCRIB
prerank,atrial septum development (GO:0003283),0.17732130185696993,0.3909052287809711,0.9971264367816092,1.0,1.0,1/13,9.14%,MDM4
prerank,cellular copper ion homeostasis (GO:0006878),0.16908645425930813,0.3775781007469378,1.0,1.0,1.0,3/14,23.36%,APP;ATOX1;SLC31A1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.1357585484762602,0.3723291316108839,1.0,1.0,1.0,4/53,17.53%,ANXA1;HTR2C;CHRM2;HRH1
prerank,mitotic cytokinetic process (GO:1902410),0.1493106990887605,0.3615035683832789,1.0,1.0,1.0,4/20,21.47%,CHMP3;VPS4B;CHMP4A;CHMP4B
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.156275581787032,0.3558040952701621,1.0,0.999988789368711,1.0,2/15,21.30%,HSPH1;GLI3
prerank,sarcomere organization (GO:0045214),0.12470047658468579,0.31355996745879444,1.0,0.9999656869799746,1.0,25/27,64.16%,TPM1;CSRP2;CSRP3;WDR1;CSRP1;ANKRD1;MYOZ1;MYH3;TNNT1;LMOD2;TNNT2;MYOZ2;SYNPO2L;MYH6;OBSCN;TCAP;MYLK3;MYPN;CAPN3;CASQ1;TTN;KRT19;MYOM2;SIX4;TNNT3
